United States cancer statistics: 2002 incidence and mortality by U.S. Cancer Statistics Working Group
United
States
Cancer
Statistics
2002 INCIDENCE AND MORTALITY
PUBLICATION YEAR 2005
U . S .  D E P A R T M E N T  O F  H E A L T H  A N D  H U M A N  S E R V I C E S
National Program of Cancer Registries (NPCR)
National Center for Chronic Disease 
Prevention and Health Promotion
Centers for Disease Control and Prevention
4770 Buford Highway, MS K-53
Atlanta, GA 30341-3717
Phone: (770) 488-4783
Fax: (770) 488-4759
http://www.cdc.gov/cancer/npcr
National Center for Health Statistics
Centers for Disease Control and Prevention
3311 Toledo Road
Hyattsville, MD 20782-2064
Phone: (301) 458-4000
E-mail: nchsquery@cdc.gov
http://www.cdc.gov/nchs
Surveillance, Epidemiology, and End  
Results (SEER) Program
Surveillance Research Program
Division of Cancer Control and Population 
Sciences
National Cancer Institute
Suite 504, MSC 8316
6116 Executive Boulevard
Bethesda, MD 20892-8316
Phone: (301) 496-8510
Fax: (301) 496-9949
http://seer.cancer.gov
For more information, contact
Suggested citation: U.S. Cancer Statistics Working Group. United States Cancer Statistics:
2002 Incidence and Mortality. Atlanta: U.S. Department of Health and Human Services,
Centers for Disease Control and Prevention and National Cancer Institute; 2005.
All material in this report is in the public domain and may be reproduced or copied 
without permission. However, citation as to source is requested.
United States Cancer Statistics will be published annually. All sections of this report are available
on the Web sites listed below:
•  http://www.cdc.gov/cancer/npcr/uscs
•  http://seer.cancer.gov/statistics
A CD-ROM of this report may be ordered at http://www.cdc.gov/cancer/npcr/uscs.
Web-site addresses of nonfederal organizations are provided solely as a service to our
readers. Their provision does not constitute an endorsement of these organizations
by CDC or the federal government, and none should be inferred. CDC is not
responsible for the content of other organizations’ Web pages. The Web-site
addresses listed in this report were accurate as of November 2005.
United
States
Cancer
Statistics
2002 Incidence and Mortality
U.S. Cancer Statistics Working Group
ii
U.S. Cancer Statistics Working Group 
Editors
Centers for Disease North American Association 
Control and Prevention National Cancer Institute of Central Cancer Registries
National Center for Chronic Brenda K. Edwards, PhD Holly L. Howe, PhD
Disease Prevention and Marsha E. Reichman, PhD Betsy A. Kohler, MPH, CTR
Health Promotion
Lyn Almon, MSPH
Cheryll Cardinez, MSPH
Temeika Fairley, PhD
Robert R. German, DrPH
Donald Haverkamp, MPH
Patricia M. Jamison, MPH
Jessica B. King, MPH
Joseph D. Rogers, BS
Sherri L. Stewart, PhD
Trevor D. Thompson, BS
Hannah K. Weir, PhD
Phyllis A. Wingo, PhD, MS
National Center for Health Statistics
Robert N. Anderson, PhD
United States Cancer Statistics: 2002 Incidence and Mortality
iii
The Centers for Disease Control and Prevention and the National Cancer
Institute thank the staff in state and metropolitan area cancer registries for their
commitment to cancer surveillance and control programs. The consistent efforts
of registry staff to collect complete, timely, and high-quality cancer incidence
data are essential for monitoring progress toward reducing the burden of cancer
in the United States. Appendix A provides a list of state and metropolitan area
cancer registries in the National Program of Cancer Registries (NPCR) and the
Surveillance, Epidemiology, and End Results (SEER) program.
We thank the NPCR’s Scientific Working Group members (Appendix B) for
their assistance in designing and reviewing this report. 
We also wish to thank vital registration and statistics staff in the 50 states, New
York City, and the District of Columbia for their efforts to provide high-quality,
timely, and comparable mortality data.
National partner organizations are crucial to the success of cancer registration
and cancer surveillance in the United States. This report, and many advances in
cancer surveillance in the United States, would not have been possible without
the tireless efforts and many achievements of these organizations. The Centers
for Disease Control and Prevention and the National Cancer Institute gratefully
acknowledge and thank the American Cancer Society, the American College of
Surgeons Commission on Cancer, the American Joint Committee on Cancer,
the National Cancer Registrars Association, and our collaborating partner, the
North American Association of Central Cancer Registries, for their support for
cancer registration and cancer surveillance provided over many years. Appendix
C has contact information for these national partner organizations. 
We wish to thank several people from the Centers for Disease Control and
Prevention: Kimbelian Barnes, Ryan Intlekofer, Karen Ledford, Mary Lewis,
Fran Michaud, Phyllis (Janie) Nichols, and Reda Wilson for verifying the data
and assisting with the appendices; Gayle Clutter and Dr. Roger E. McLendon
for their assistance in preparing and reviewing the data on brain cancer by
histologic group; and Dr. Harland Austin for his expert contributions to the
Technical Notes and Appendix L. 
Additionally, we would like to acknowledge several people who were involved in
the production and distribution of this year’s report: Kathleen Carey, Mary
Kaeser, Diana Toomer, and the Division of Cancer Prevention and Control Web
Development Team: Phuong Huynh, Aimee Murphy, Shannon Orr, Marcy
Pendley, Blakeslee Potter, Wies Rafi, Corey Schuman, and Ramesh Thalluru.
Publication support was provided by Palladian Partners, Inc., under Contract
No. 200-980-0415 for the National Center for Chronic Disease Prevention 
and Health Promotion, Centers for Disease Control and Prevention, U.S.
Department of Health and Human Services.
Acknowledgments

vPreface
United States Cancer Statistics: 2002 Incidence and Mortality is a joint
publication of the Centers for Disease Control and Prevention (CDC)
in Atlanta, Georgia; the National Cancer Institute (NCI) in Bethesda,
Maryland; and the North American Association of Central Cancer
Registries (NAACCR) in Springfield, Illinois. This is the fourth annual
joint report produced, in collaboration with NAACCR, by the two
federal programs that support population-based cancer registries in the
United States: CDC’s National Program of Cancer Registries (NPCR)
and NCI’s Surveillance, Epidemiology, and End Results (SEER)
Program. This report contains official federal government cancer
statistics for more than 1 million invasive cancer cases diagnosed during
2002 among residents of 44 states, 6 metropolitan areas, and the
District of Columbia, and these geographic areas are inhabited by about
93% of the U.S. population. Data from population-based central cancer
registries in these states and metropolitan areas meet the selected
criteria for inclusion in this report (see “Registry Eligibility Criteria” in
the Technical Notes).  
In addition to cancer incidence data, we present cancer mortality data
collected and processed by CDC’s National Center for Health Statistics
(NCHS). Mortality statistics, based on records of deaths that occurred
during 2002, are available for all 50 states and the District of Columbia.
The age-adjusted incidence and death rates are adjusted to the 2000
U.S. standard population, consistent with rates published in previous
United States Cancer Statistics reports. Readers should not compare these
data with published cancer rates that were not adjusted to the 2000 U.S.
standard.
The race and ethnicity categories have been expanded this year to
include national cancer incidence and mortality data for American
Indians/Alaska Natives. In addition, malignant brain and central
nervous system cancer incidence data are provided for the United
States, categorized by histologic subtype, age, and sex. In future 
reports, more comprehensive cancer statistics will be provided while
maintaining high-quality data standards. 
A Web-based version of the report with current (2002) and updated
(1999–2001) cancer incidence and mortality statistics is available at
http://www.cdc.gov/cancer/npcr/uscs. Data at this Web site are
provided in an HTML format that can be viewed in a variety of ways. 
A downloadable ASCII-formatted version of the data that can be
manipulated to meet the needs of the user is also available. 

vii
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
Preface  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
List of Tables, Figures, and Appendices  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Executive Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
Format for Numbering the Tables and Figures  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xxi
Technical Notes
Background  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Federal Programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Collaborating Partner  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Data Sources  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Registry Eligibility Criteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Populations Covered by This Report  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Statistical Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Interpreting the Data  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
HTML Edition of United States Cancer Statistics  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
References  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Cancer Incidence and Mortality for Adults and Children: All Areas Combined  . . . . . . . . . . . . . . . . 25
Cancer Incidence and Mortality by U.S. Census Region and Division, State,
and Metropolitan Area  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
State and Metropolitan Area Incidence Rates and State Death Rates for the 
Most Common Cancers  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 236
Appendices 
List of Abbreviations  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Inside back cover
Table of Contents

ix
List of Tables, Figures, and Appendices
Cancer Incidence and Mortality for Adults and Children: All Areas Combined
Figure 1  Geographic Areas Contributing Data to United States Cancer 
Statistics: 2002 Incidence and Mortality  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Tables 1.1.1.1M– Age-adjusted invasive cancer incidence and death rates and   
1.1.1.2F   95% confidence intervals by primary site, race and ethnicity, 
and sex, United States, 2002  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Tables 1.1.2.1M– All cancer sites combined. Invasive cancer incidence and death 
1.1.2.2F rates and 95% confidence intervals by age, race and ethnicity, 
and sex, United States, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Tables 1.2.1.1M– Age-adjusted invasive cancer incidence rates and 95% confidence 
1.2.1.1F intervals for ages 0–19 by International Classification of Childhood 
Cancer (ICCC) group and subgroup, race and ethnicity, and sex, 
United States, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Table 1.2.2.1  Age-Adjusted Invasive Cancer Incidence Rates and 95% Confidence 
Intervals by International Classification of Childhood Cancer 
(ICCC) Group and Subgroup and Age, United States. All Races, 
Males and Females, 2002  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Table 1.2.3.1  Invasive Cancer Incidence Rates and 95% Confidence Intervals by 
International Classification of Childhood Cancer (ICCC) Group and 
Subgroup and Age, United States. All Races, Males and Females, 2002  . . . . . . 44
Tables 1.2.4.1M– Childhood age-adjusted invasive cancer incidence and death rates 
1.2.4.2F and 95% confidence intervals for ages 0–19 by primary site, race 
and ethnicity, and sex, United States, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
Tables 1.2.5.1–  Childhood age-adjusted invasive cancer incidence and death rates 
1.2.5.2 and 95% confidence intervals by primary site and age, United States. 
All races, males and females, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Tables 1.2.6.1–  Childhood invasive cancer incidence and death rates and 95% 
1.2.6.2 confidence intervals by primary site and age, United States. 
All races, males and females, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
Table 1.3.1.1  Age-Adjusted Invasive Cancer of the Brain and Other Nervous System 
Incidence Rates and 95% Confidence Intervals by Standard Histology 
Group and Subgroup, Age, and Sex, United States. All Races, 2002  . . . . . . . . . 50
Cancer Incidence and Mortality by U.S. Census Region and Division, State, and 
Metropolitan Area
Figure 2  Geographic Areas Contributing Data to United States Cancer Statistics: 
2002 Incidence and Mortality, by U.S. Census Region and Division  . . . . . . . . . . . 51
United States Cancer Statistics: 2002 Incidence and Mortality
x
Tables 2.1.1.1M– Age-adjusted cancer incidence and death rates and 95% confidence 
2.27.1.2F intervals by U.S. Census region and division, state, metropolitan area, 
and race and ethnicity, by primary site and sex, United States, 2002
All Cancer Sites Combined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
Brain and Other Nervous System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Breast  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Breast, in situ  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
Cervix Uteri  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
Colon and Rectum  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Corpus and Uterus, NOS  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
Esophagus  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
Hodgkin Lymphoma  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
Kaposi Sarcoma  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Kidney and Renal Pelvis  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Larynx  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Leukemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .126
Liver and Intrahepatic Bile Duct  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
Lung and Bronchus  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Melanomas of the Skin  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
Mesothelioma  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
Multiple Myeloma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
Non-Hodgkin Lymphoma  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
Oral Cavity and Pharynx  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
Ovary  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
Pancreas  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Prostate  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
Stomach  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
Testis  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
Thyroid  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
Urinary Bladder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226
xi
State and Metropolitan Area Incidence Rates and State Death Rates for the
Most Common Cancers
Figures 3.1.M1– Age-adjusted cancer incidence and death rates for the 10 primary 
3.58.F2 sites with the highest rates within race- and ethnic-specific categories, 
by geographic area and sex, 2002
United States  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 236
Alabama  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240
Alaska . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244
Arizona  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
Arkansas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
California . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 256
Los Angeles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 260
San Francisco-Oakland  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 264
San Jose-Monterey  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 268
Colorado  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 272
Connecticut  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 276
Delaware  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 280
District of Columbia  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 284
Florida  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288
Georgia  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 292
Atlanta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
Hawaii  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300
Idaho  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 304
Illinois  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308
Indiana  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 312
Iowa  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 316
Kansas  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320
Kentucky  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324
Louisiana  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 328
Maine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 332
Maryland  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 336
Massachusetts  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 340
List of Tables, Figures, and Appendices
United States Cancer Statistics: 2002 Incidence and Mortality
xii
Michigan  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 344
Detroit  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 348
Minnesota  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 352
Mississippi  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 356
Missouri  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 360
Montana . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 364
Nebraska  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 368
Nevada  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 372
New Hampshire  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 376
New Jersey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 380
New Mexico . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 384
New York  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 388
North Carolina  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 392
North Dakota  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 396
Ohio  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 400
Oklahoma  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 404
Oregon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 408
Pennsylvania  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412
Rhode Island  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 416
South Carolina . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 420
South Dakota . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 424
Tennessee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 428
Texas  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432
Utah  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 436
Vermont  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440
Virginia  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 444
Washington  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 448
Seattle-Puget Sound  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 452
West Virginia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 456
Wisconsin  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 460
Wyoming  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 464
xiii
Appendices
Appendix A State and Metropolitan Area Cancer Registries
Appendix B National Program of Cancer Registries: Scientific Working Group Members
Appendix C National Partner Organizations
Appendix D Invasive cancer incidence counts and cancer death counts by primary 
site, sex, race and ethnicity, and age (all ages, <1, 1–4, 5–9, 10–14, 15–19, 
and 0–19), United States, 2002 
Appendix E Invasive cancer incidence counts and cancer death counts by U.S. Census
region and division, state, metropolitan area, sex, and race and ethnicity, 
United States, 2002
Appendix F Age-adjusted invasive cancer incidence and death rates and 
95% confidence intervals for Asians/Pacific Islanders and American 
Indians/Alaska Natives by state, metropolitan area, primary site, and sex, 
United States, 2002
Appendix G State and Metropolitan Area Cancer Registries by Affiliation in 
Federal Cancer Surveillance Program, 2005
Appendix H State, Metropolitan Area, and Territory Cancer Registries by Federal 
Funding Source and First Diagnosis Year for Which Cancer Cases Were 
Reportable to CDC’s NPCR or NCI’s SEER Program
Appendix I Data quality criteria for cancer incidence and mortality data
Appendix J Primary cancer site, histology, and cause-of-death codes based on International
Classification of Diseases: ICD–O–3 (incidence) and ICD–10 (mortality)
Appendix K Population counts by U.S. Census region and division, state, metropolitan 
area, sex, age (all ages, ages 0–19), and race and ethnicity, 2002
Appendix L Criteria for Reporting Age-Adjusted Cancer Incidence Rates for U.S. 
Census Regions and Divisions
List of Tables, Figures, and Appendices

xv
Executive Summary
The Centers for Disease Control and Prevention (CDC) and the
National Cancer Institute (NCI), in collaboration with the North
American Association of Central Cancer Registries (NAACCR), are
pleased to release the fourth annual United States Cancer Statistics report.
This report provides official federal government cancer statistics for cases
diagnosed in 2002 and for cancer deaths that occurred in 2002. Cancer
incidence statistics included in this report come from CDC’s National
Program of Cancer Registries (NPCR) and NCI’s Surveillance,
Epidemiology, and End Results (SEER) Program. Cancer mortality
statistics are from CDC’s National Vital Statistics System (NVSS).
Incidence data from 44 states, 6 metropolitan areas, and the District of
Columbia are included in the report. The data obtained from NPCR and
SEER registries in these areas cover 93% of the U.S. population.
Mortality data from NVSS are presented for all 50 states and the District
of Columbia and therefore cover 100% of the U.S. population. 
Cancer incidence and mortality statistics are reported for 68 selected
primary cancer sites and subsites for men of all ages and 72 selected
primary cancer sites and subsites for women of all ages. These data are
presented in tables and graphs in the following categories: (1) by
geography: all areas combined, U.S. Census regions and divisions, states,
and selected metropolitan areas and (2) by race and ethnicity: all races
combined, whites, blacks, Asians/Pacific Islanders, American
Indians/Alaska Natives, and Hispanics/Latinos. Age-specific analyses are
also presented.
The childhood cancer section includes incidence data for more than
12,000 cancer cases and 2,000 cancer deaths among children and
adolescents aged 19 years or younger. These data are presented by race
and ethnicity, sex, age, and primary site, as well as by specific cancer 
types classified according to the International Classification of Childhood
Cancer (ICCC).
The inclusion of cancer incidence and mortality data for American
Indians/Alaska Natives is a new feature of this year’s report. American
Indian/Alaska Native incidence data are classified according to race
information obtained from medical records and recorded in the registry.
Additionally, NPCR registries linked their registry records with those of
the Indian Health Service (IHS), which provides medical services to
approximately 55% of the American Indian/Alaska Native population.
This IHS linkage helps address racial misclassification in the registries.
For mortality data, American Indian/Alaska Native race is reported as
recorded on the death certificate.  
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Also new to this year’s report is the inclusion of detailed malignant brain
and central nervous system cancer incidence data. These data are grouped
by age and sex, as well as by specific cancer type and subtype as defined by
the Consensus Conference on Cancer Registration of Brain and Central
Nervous System Tumors. In future publications, we plan to expand this
list to include incidence data on benign brain and central nervous system
tumors.
Age-adjusted cancer incidence and death rates, with 95% confidence
intervals, are provided in each section. All rates in this report are age-
adjusted to the 2000 U.S. standard population. Age-adjustment allows
researchers to compare data across populations by controlling for the
effect of age on populations with different age distributions. In this
report, population estimates for 2002 were obtained from the 2000 U.S.
Census and slightly modified by SEER for the Native Hawaiian
population. These modified population estimates improve the accuracy of
the rates for some racial and geographic populations. Readers should be
cautious when interpreting comparisons between age-adjusted incidence
rates and death rates because of differences in population coverage (93%
for incidence and 100% for mortality). In addition, readers should not
compare the rates published in this report with cancer rates that were
calculated using different methods or standardized to different
populations.
Major Findings
Rates are shown in parentheses where appropriate and are per 100,000
persons.
Cancer Among Men*
Three most common cancers among men of all racial and
Hispanic origin populations:
• Prostate cancer (161.2)
• Lung cancer (86.4)
• Colorectal cancer (61.3)
Three leading causes of cancer death among men:
• Lung cancer (73.5)
➤ First among men of all racial and Hispanic origin populations.
• Prostate cancer
➤ Second among white (25.8), black (63.0), and Hispanic (22.0)
men.
➤ Third among American Indian/Alaska Native men (15.7).
* All races combined rate is presented when ranking of cancer sites did not differ across
race and ethnicity; race- or ethnic-specific rates are presented when ranking differed
depending on race and ethnicity.
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• Colorectal cancer 
➤ Second among American Indian/Alaska Native men (16.1).
➤ Third among white (23.2), black (33.4), Asian/Pacific Islander
(15.9),† and Hispanic (17.1) men.
• Liver cancer 
➤ Second among Asian/Pacific Islander men (15.9).†
Cancer Among Women*
Three most common cancers among women:
• Breast cancer (124.9)
➤ First among women of all racial and Hispanic origin
populations.
• Lung cancer
➤ Second among white (54.9) and American Indian/Alaska Native
(32.9) women.
➤ Third among black (50.3), Asian/Pacific Islander (26.7), and
Hispanic (25.2) women.
• Colorectal cancer
➤ Second among black (51.8), Asian/Pacific Islander (34.3), and
Hispanic (34.9) women.
➤ Third among white (43.9) and American Indian/Alaska Native
women (26.8).
Three leading causes of cancer death among women:
• Lung cancer
➤ First among white (42.6), black (40.2), Asian/Pacific Islander
(17.6), and American Indian/Alaska Native (27.5) women.
➤ Second among Hispanic women (14.8).
• Breast cancer
➤ First among Hispanic women (15.7).
➤ Second among white (24.9), black (34.1), Asian/Pacific Islander
(12.9), and American Indian/Alaska Native (13.9) women.
• Colorectal cancer
➤ Third among women of all racial and Hispanic origin
populations (16.5).
* All races combined rate is presented when ranking of cancer sites did not differ across
race and ethnicity; race- or ethnic-specific rates are presented when ranking differed
depending on race and ethnicity.
† Colorectal cancer death rate for Asian/Pacific Islander men is 15.85; liver cancer death
rate for Asian/Pacific Islander men is 15.86.
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Cancer Among Children‡
The most common cancers in children aged 0–19 years:
• Leukemia (4.1)
➤ Highest incidence rate found among children aged 1–4 years.
• Brain and central nervous system cancer (2.9)
➤ Highest incidence rate of brain cancer found among children
aged 1–4 years.
Leading causes of cancer death in children:
• Leukemia (0.8)
➤ First among children aged less than 1 and aged 10–19 years.
• Brain and central nervous system cancer (0.7)
➤ First among children aged 5–9 years.
Racial or Ethnic Variations
All cancers combined, men:
• Incidence rates are highest among blacks (615.1), followed by 
whites (536.8), Hispanics (422.8), Asians/Pacific Islanders (324.3), 
and American Indians/Alaska Natives (267.2).
• Death rates are highest among blacks (322.9), followed by whites
(236.0), Hispanics (163.9), American Indians/Alaska Natives
(145.3), and Asians/Pacific Islanders (138.8).
All cancers combined, women:
• Incidence rates are highest among whites (408.9), followed by 
blacks (377.5), Hispanics (310.4), Asians/Pacific Islanders (264.5),
and American Indians/Alaska Natives (215.4).
• Death rates are highest among blacks (190.9), followed by whites
(161.9), American Indians/Alaska Natives (114.5), Hispanics
(107.4), and Asians/Pacific Islanders (96.6).
Among the five races and ethnicities presented:
• American Indian/Alaska Native men have the lowest cancer
incidence rates; however, Asian/Pacific Islander men have the
lowest cancer death rates.
• White women have the highest cancer incidence rates; however,
black women have the highest cancer death rates.
• American Indian/Alaska Native women have the lowest cancer
incidence rates and the third highest cancer death rates.
‡ Rates presented are for males and females combined, all races combined, and children
aged 0–19 years. 
§ Race- or ethnic-specific rates are presented for all cancer sites combined.
§
xix
Executive Summary
Geographic Variations¶
Breast cancer:
• The incidence rate for the United States is 124.9; state incidence
rates range from 109.0 to 147.8; approximately 53% of states have
incidence rates at or above the national rate.
• The death rate for the United States is 25.5; state death rates range
from 16.2 to 34.3; approximately 47% of states have death rates at
or above the national rate.
Prostate cancer:
• The incidence rate for the United States is 161.2; state incidence
rates range from 106.1 to 217.1; approximately 58% of states have
incidence rates at or above the national rate.
• The death rate for the United States is 28.1; state death rates range
from 17.6 to 51.8; approximately 59% of states have death rates at
or above the national rate.
Lung cancer:
• Men
➤ The incidence rate for the United States is 86.4; state incidence
rates range from 38.1 to 133.8; approximately 47% of states
have incidence rates at or above the national rate.
➤ The death rate for the United States is 73.5; state death rates
range from 32.2 to 112.6; approximately 47% of states have
death rates at or above the national rate.
• Women
➤ The incidence rate for the United States is 53.7; state incidence
rates range from 20.9 to 73.0; approximately 49% of states have
incidence rates at or above the national rate.
➤ The death rate for the United States is 41.5; state death rates
range from 18.7 to 57.5; approximately 47% of states have death
rates at or above the national rate.
Colorectal cancer: 
• Men
➤ The incidence rate for the United States is 61.3; state incidence
rates range from 43.7 to 75.1; approximately 56% of states have
incidence rates at or above the national rate.
➤ The death rate for the United States is 23.8; state death rates
range from 16.6 to 30.5; approximately 53% of states have death
rates at or above the national rate.
• Women
➤ The incidence rate for the United States is 44.9; state incidence
rates range from 32.2 to 55.0; approximately 47% of states have
incidence rates at or above the national rate.
¶Geographic variations are presented for the four most common cancers.
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➤ The death rate for the United States is 16.5; state death rates
range from 12.9 to 21.5; approximately 53% of states have death
rates at or above the national rate.
Two points should be kept in mind when interpreting the data in this
report. First, differences in cancer incidence and death rates among
racial and ethnic populations should be interpreted with caution. Recent
studies involving cancer mortality data show that death rates for whites
and blacks are generally reliable, whereas death rates for Asians/Pacific
Islanders, American Indians/Alaska Natives, and Hispanics are
underestimated. Studies involving cancer incidence data suggest similar
results. Therefore, incidence and mortality data published in this report
may be underestimated for some populations. Also, specific
subpopulations, which are not presented in this report because of small
numbers and possible misclassification, may have higher cancer
incidence or death rates than the U.S. population. For example, overall
cancer mortality among American Indians/Alaska Natives residing in
the Alaska and the Northern Plains regions is higher compared with the
U.S. population; the American Indian/Alaska Native population as a
whole has lower cancer mortality than the U.S. general population.
Indian Health Service coverage of American Indian/Alaska Native
populations varies by region and under-represents American
Indian/Alaska Natives who live in certain urban areas or who are
members of non-federally recognized tribes.
Second, geographic variations in cancer incidence and death rates may
be influenced by a number of factors: (1) areas in which a high
percentage of the population is screened for cancer will have more
cancer cases diagnosed than areas in which a low percentage of the
population is screened; (2) rates for certain cancers differ among
different racial and ethnic populations (e.g., black men have higher
prostate cancer rates than other racial or ethnic groups), and thus when
comparing cancer rates across geographic areas, the racial and ethnic
makeup of that area should be considered; and (3) the population burden
of cancer in a geographic area is determined by the number of cases
diagnosed and the number of cancer deaths, not by the age-adjusted
rate; therefore, a relatively high or low cancer age-adjusted rate may not
be a reflection of the true cancer burden within that geographic area.
United States Cancer Statistics: 2002 Incidence and Mortality provides a
basis for states and researchers to describe the variability in cancer
incidence and death rates across different populations and to identify
certain populations for evidence-based cancer control measures. We will
continue to ensure data from all NPCR and SEER registries are of the
highest quality. Since the publication of our first report covering
diagnosis year 1999, additional registries have contributed data each
year, resulting in increased coverage of the U.S. population with every
new report. We expect that future reports will include high-quality data
from the few remaining state registries, thus allowing a more
comprehensive description of the cancer burden across racial, ethnic,
and geographic populations in the United States.
match section
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Table 1.1.1.1M
Format for Numbering the Tables and Figures
Format for Numbering the Tables and Figures
The tables and figures in United States Cancer Statistics: 2002 Incidence and Mortality have 
a unique numbering system, and the diagrams below illustrate what each number or letter 
represents. There are four main sections of this report. The diagram specific to each 
section is repeated on the dividers.
Figure 3.1.M1
Consecutive numbering of states 
in alphabetical order beginning 
with the United States
M = males
F = females
1 = incidence rate
2 = death rate
3 = figures that display data for states
Figures 1 and 2 are maps of the 
United States.
Consecutive numbering based on table series
In the Table 1 series (U.S. rates), for example, a
second digit of “1” indicates all cancer sites for all
ages, a second digit of “2” indicates childhood
cancers, and a second digit of “3” indicates brain
by histology.  
In the Table 2 series (e.g., regional, state, metropol-
itan area), the second digit indicates consecutive
numbering of cancer sites in alphabetical order
beginning with all cancer sites.
Specific types or categorization of rates
M = males
F = females
If no M or F, then table presents both sexes or cancer
that occurs only or primarily in either males or
females (e.g., prostate for males, ovary for females).
1 = incidence rate
2 = death rate
Rate can be age-adjusted or age-specific.
1 = U.S. rates
2 = geographic area rates
Organized by cancer site
Tables
Figures
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Table D.1.1M
Consecutive numbering of tables 
within the appendix
M = males
F = females
If no M or F, then table presents both sexes or cancer
that occurs only or primarily in either males or
females (e.g., prostate for males, ovary for females).
1 = incidence rate
2 = death rate
If no second number, then incidence and death rates 
are presented together.
Identifies specific appendix (some
appendices do not include tables)
Appendices
Technical Notes

Background 
Cancer is the second leading cause of death among
Americans. One of every four deaths in the United
States is due to cancer.1,2 The American Cancer
Society estimates that in 2005, about 1,372,910
Americans will receive a new diagnosis of invasive
cancer, and 570,280 Americans will die of this
disease. These estimates do not include in situ
cancers or the more than 1 million cases of basal
and squamous cell skin cancers expected to be
diagnosed this year. The National Cancer Institute
(NCI) recently estimated that on January 1, 2002,
10.1 million Americans were alive with a history of
invasive cancer.3
According to the 2005 Annual Report to the
Nation on the Status of Cancer, age-adjusted
incidence rates for all cancers combined were stable
from 1995 through 2002 in men, but rates in
women have increased 0.3% annually since 1987.
U.S. death rates for all cancer sites combined
decreased beginning in 1993.4 However, the
number of Americans diagnosed with cancer each
year is expected to double in the next 50 years,
from 1.3 million to 2.6 million. The anticipated
growth and aging of the U.S. population are factors
that will increase the number of people who are
diagnosed with and treated for cancer.5
The National Institutes of Health estimated that
in 2005, the overall annual cost of cancer would be
about $209.9 billion,6 broken down as follows: 
• Direct medical costs, including health
expenditures: $74.0 billion.
• Indirect costs associated with lost
productivity due to illness: $17.5 billion.
• Indirect costs associated with lost
productivity due to premature death:
$118.4 billion.
These costs are likely to increase because of the
anticipated growth and aging of the U.S.
population.
There are effective primary and secondary
prevention measures that could substantially reduce
the number of new cancer cases and prevent many
cancer-related deaths. To reduce the nation’s 
cancer burden, we must reduce behavioral and
environmental factors that increase cancer risk, 
and we must ensure that high-quality screening
services and evidence-based treatments are
available and accessible, particularly to medically
underserved populations.7,8
Cancer registries collect data about the occurrence
of cancer (incidence), the types of cancer
(morphology), the site in the body where the
cancer first occurred (primary site), the extent 
of disease at the time of diagnosis (stage), the
planned first course of treatment, and the outcome
of treatment and clinical management (survival 
and vital status).9,10 Cancer data are reported 
to metropolitan area, regional, and statewide
cancer registries from a variety of medical facilities,
including hospitals, physicians’ offices, radiation
facilities, freestanding surgical centers, and
pathology laboratories. Cancer death data are
recorded on death certificates that are sent to state
vital statistics offices. Death certificates contain
information regarding primary cancer site and
morphology.
Information derived from population-based central
cancer registries and from death certificates is
critical for directing effective geographic area- 
or population-specific cancer prevention and
control programs that focus on preventing
behaviors that put people at increased risk for
cancer (e.g., smoking) and on reducing
environmental risk factors (e.g., occupational
exposure to known carcinogens). This information
is also essential for deciding which geographic
areas should have cancer-screening programs and
for making long-term plans for adequate diagnostic
and treatment services. Pooled data at the national,
regional, and state levels will help federal and state
public health officials establish, prioritize, and
monitor national public health surveillance
initiatives and track progress toward the national
goals and objectives set forth in Healthy People
2010,11 which contains a set of health objectives for
the nation for the first decade of the 21st century.
For more information on Healthy People 2010, visit
http://www.healthypeople.gov/document.
Technical Notes
1
Federal Programs
Surveillance, Epidemiology, and End
Results (SEER) Program
In 1971, Congress passed the National Cancer 
Act that mandated the collection, analysis, and
dissemination of data useful for the prevention,
diagnosis, and treatment of cancer.12 This mandate
led to the establishment of the Surveillance,
Epidemiology, and End Results (SEER) Program.13
For more than 30 years, the NCI’s SEER Program
has provided statistics regarding cancer incidence,
survival, and mortality in the United States;
monitored cancer incidence trends in geographic
and demographic population groups; provided
information on trends in extent of disease at
diagnosis, therapy, and patient survival; promoted
studies measuring progress in cancer control 
and etiology; provided specialty training in
epidemiology, biostatistics, surveillance research,
and tumor registry methodology, operations, 
and management; and developed new statistical
methods, models, and software for the analysis 
and presentation of national and small-area
statistics.
The SEER Program currently collects and
publishes cancer incidence and survival data from
14 population-based cancer registries and 3
supplemental registries covering approximately
26% of the U.S. population (Appendix G).
Information on more than 3 million in situ and
invasive cancer cases is included in the SEER
database, and approximately 170,000 new cases are
added each year within SEER coverage areas. (See
Appendix H for the first diagnosis year for which
data were reported to NCI for each SEER area.)
The mortality data reported by SEER are provided
by the National Center for Health Statistics
(NCHS). A public use data set is issued each year
by the SEER Program for additional analyses. 
For more information on the SEER Program, visit
http://seer.cancer.gov.
National Program of Cancer 
Registries (NPCR) 
Recognizing the need for more complete local,
state, regional, and national cancer incidence data,
Congress established the National Program of
Cancer Registries (NPCR) in 1992 by enacting the
Cancer Registries Amendment Act, Public Law
102-515; the program was reauthorized in 1998.14
Congress mandated the Centers for Disease
Control and Prevention (CDC) to provide funds 
to state and territorial health departments (or 
their authorized agencies) at a ratio of $3:$1 to
match state support for the central cancer registry.
As of 2005, CDC funds a total of 49 statewide and
territorial cancer registries at two levels: capacity
building for new registries or basic implementation
for existing registries (Appendix G). 
NPCR registries cover 96% of the U.S.
population. NPCR has the state and national
capacity to monitor the cancer burden; identify
cancer incidence variation for racial and ethnic
populations and for regions within a state, among
states, and among regions; provide data for
research; provide guidance for health resource
allocation; respond to public concerns and inquiries
about cancer; improve planning for future health
care needs; and evaluate cancer prevention and
control activities.15 
In January 2001, NPCR registries began annually
reporting their incidence data to CDC from the
first diagnosis year for which a state or territorial
cancer registry collected data with the assistance of
NPCR funds (Appendix H). Data from the SEER
metropolitan areas and SEER special population
cancer registries operating in Alaska, Arizona,
California, Georgia, Michigan, and Washington
are reported to their respective NPCR state cancer
registry for inclusion in the state’s incidence data
and are transmitted to CDC as part of the state’s
annual data submission. In January 2005, CDC
received information on more than 9 million
invasive cancer cases diagnosed during 1995–2002
and more than 1 million new invasive cancer cases
are added each year. Two new data sets will be 
issued by NPCR for additional analyses in late
2005: (1) a public use data set of precalculated 
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cancer incidence rates will be available on 
CDC WONDER (http://wonder.cdc.gov), and 
(2) a restricted access file of individual record 
level data will be made available to selected state
and national partners. 
For more information on NPCR, visit http://www.
cdc.gov/cancer/npcr.
National Vital Statistics System (NVSS)
The nation’s vital statistics are available from the
National Vital Statistics System (NVSS), which is
maintained by NCHS. These vital statistics are
provided through state-operated registration
systems and are based on vital records filed in state
vital statistics offices. The recording of vital events
is the responsibility of the individual states and
independent registration areas (e.g., District of
Columbia, New York City, territories) in which 
the event occurs. Legal responsibility for the
registration of vital events rests with the individual
states. Through its Vital Statistics Cooperative
Program, NCHS cooperates with state vital
statistics offices to develop and recommend
standard forms for data collection and model
procedures to ensure uniform registration of the
events monitored by the NVSS. Detailed annual
data on births, deaths (including infant deaths), 
and fetal deaths are available for the United States
and for states, counties, and other local areas. 
Data variables include cause of death, age, race,
Hispanic origin, sex, marital status, place of birth,
residence of decedent, education level, and place 
of death. Monthly provisional data on vital
statistics are available for the United States and
each state. A public use data set is issued each year
by NCHS for additional analyses. 
For more information on NCHS and its NVSS,
visit http://www.cdc.gov/nchs.
Collaborating Partner 
North American Association of Central
Cancer Registries (NAACCR)
Both federally funded registry programs (i.e., 
the SEER Program and NPCR) work closely 
with the North American Association of Central
Cancer Registries (NAACCR) to promote cancer
incidence surveillance in the United States and
Canada. Established in 1987, NAACCR is an
organization of population-based cancer registries,
governmental agencies, professional associations,
and private groups in North America dedicated 
to its mission to develop and promote cancer
registration standards; provide education and
training; certify population-based cancer registries;
evaluate and publish data; and promote the use of
cancer surveillance data and systems for cancer
control, epidemiologic research, public health
programs, and patient care to reduce the burden of
cancer in North America. All state and metropolitan
area registries participating in NPCR and SEER, 
as well as all provincial and territorial registries 
in Canada, are members of NAACCR. A public
online query system, CINA Plus Online, is updated
annually with the most recent 5 years of incidence
data (see http://www.naaccr.org/cinap). An
incidence data file from 1995 forward is also
updated annually for qualified researchers. For
more information about this file, contact the
NAACCR office (Appendix C).
In 1992, NAACCR began annual reviews of
member registries’ data for completeness, accuracy,
and timeliness. In 1997, this process was formalized
into a certification program, whereby registries
report their data in December and NAACCR
evaluates the data using standard, objective
measures. Registries that meet the highest
standards for data quality are recognized through
certification.16-18
In 1997, when NAACCR evaluated 1995 incidence
data, 9 NPCR registries and all 10 SEER registries
were certified. Eight years later, when NAACCR
evaluated the 2002 incidence in 2005, 34 NPCR
registries, 4 NPCR/SEER registries, and 9 SEER
registries were certified. (Data from San Francisco-
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Oakland and San Jose-Monterey are combined and
evaluated as the Greater Bay Area.)
For more information on NAACCR, visit
http://www.naaccr.org.
Data Sources 
Incidence Data 
Data from the registries participating in NPCR
were reported to CDC as of January 31, 2005. 
Data from registries in the SEER Program were
reported to NCI as of November 1, 2004, and
made available through the SEER Program 
public use data file released in April 2005
(http://www.seer.cancer.gov/publicdata). For this
report, data from California, Kentucky, Louisiana,
and New Jersey (states that are supported by both
NPCR and SEER) are presented as reported to
CDC as of January 31, 2005.
The primary source of cancer incidence data is
medical records. Staff at health care facilities
abstract cancer incidence data from patients’
medical records, enter the data into the facility’s
own cancer registry if it has one, and then send the
data to the regional or state registry. Both NPCR
and SEER registries collect data using uniform
data items and codes as documented by NAACCR.
This uniformity ensures that data items collected
by the two federal programs are comparable.10,19
Information on primary site and histology was
coded according to the International Classification 
of Diseases for Oncology, Third Edition (ICD–O–3)20
and categorized according to the revised SEER
recodes dated January 27, 2003, which define
standard groupings of primary cancer sites
(Appendix J, Table J.1).3 NPCR and SEER cancer
registries consider as reportable all incident cases
with a behavior code of 2 (in situ, noninvasive) or 
3 (invasive, primary site only) in the ICD–O–3 
with the exception of in situ cancer of the cervix.
Basal and squamous cell carcinomas of the skin are
also excluded, with the exception of those on the
skin of the genital organs.20 To ensure as much
comparability as possible between ICD–O–2 and
ICD–O–3, the following exclusions were made:
borderline tumors of the ovary, refractory anemias
(shortage of blood cells that are unresponsive to
treatment), and other myelodysplastic syndromes
(conditions caused by abnormalities of the blood-
forming cells in the bone marrow); pilocytic
astrocytomas (slow-growing, cystic brain cancer)
were included.4 The January 2003 SEER recodes
were used to ensure (1) consistent site-type
definitions over time and (2) consistency with other
published 2002 cancer incidence data.3,21
This report also contains data for two rare cancers,
Kaposi sarcoma (KS) and mesothelioma. KS is 
a cancer of connective tissue such as cartilage,
bone, fat, muscle, and blood vessels. Since the vast
majority of KS cases have developed in association
with human immunodeficiency virus (HIV) infection
and acquired immunodeficiency syndrome (AIDS),
HIV/AIDS is listed as the underlying cause of
death. Therefore, KS death rates were not included
in this report. Mesothelioma is a cancer that
generally occurs in the chest, abdominal region, 
and areas surrounding the heart. It is typically
associated with exposure to asbestos. Because KS
and mesothelioma are considered separate cancers
for this report, they were removed from counts of
other primary cancer sites. 
Childhood cancer incidence data are published 
in two formats. The first format is according 
to the SEER Modification of the International
Classification of Childhood Cancer (ICCC) (Appendix
J, Table J.2), consistent with previous United States
Cancer Statistics reports. The ICCC, which is
based on ICD–O–2, was published in 1996 by 
the International Agency for Research on Cancer
(IARC). The ICCC presents childhood cancers 
in 12 groups classified primarily by morphology.
The SEER modification, which affects the
classification of nervous system and bone tumors
(http://seer.cancer.gov/iccc), was chosen for
compatibility with other published data on
childhood cancer rates in the United States. 
The second format is according to the SEER site
recode, which is based primarily on cancer site; the
incidence data are presented in this format to make
them comparable with other published mortality
data. This format allows the incidence data for
childhood cancers to be categorized into the same
groups as adult cancers. Although these groupings
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are not as appropriate for children as they are for
adults, they are necessary to allow comparisons
between childhood incidence and childhood
mortality.
In situ bladder cancers were recoded to invasive
bladder cases because the information needed to
distinguish between in situ and invasive bladder
cases is not always available or reliable. Case counts
and rates for invasive cancers are included in this
report. This report also includes counts and rates
for in situ breast cancer cases among women; these
are reported separately and are not included in
counts or rates for the “all sites” category. Case
counts and rates for leukemias were calculated for
acute and chronic lymphocytic leukemia, acute and
chronic myeloid leukemia, and other leukemias,
which include other myeloid/monocytic leukemias.
Nonreportable cancers and cancers in patients 
of unknown sex or age were omitted from all
calculations, but cases in patients of unknown 
race were included in the “all races” category.
Counts of cases used in this report are listed in
Appendices D and E.
For the first time, this year’s report features
incidence data on primary intracranial and central
nervous system (CNS) tumors using site and
histology groupings agreed upon by a consensus
conference at the Society for Neuro-Oncology
annual meeting in 2000.22 Conference attendees
agreed with the site definition proposed by the
National Coordinating Council on Cancer
Surveillance’s (NCCCS) Brain Tumor Working
Group formed in response to a request to
investigate national, population-based incidence
data on CNS tumors. The Benign Brain Tumor
Cancer Registries Amendment Act changed
NPCR’s definition of reportable tumors to include
benign CNS tumors. Subsequently, in addition to
NPCR, both SEER and the Commission on
Cancer (CoC) agreed to require reporting of
nonmalignant brain tumors, beginning with cases
diagnosed on or after January 1, 2004. Beginning
this year, Table 1.3.1.1 will include malignant
incident cases only. In 2007, cases for
nonmalignant brain tumors will be added, and an
increase in rates will be seen in the following
histology groups and subgroups: (groups) tumors
of the cranial and spinal nerves; tumors of the sellar
region and (subgroups) unique astrocytoma
variants; neuronal/glial, neuronal; meningioma;
hemangioma.
Mortality Data 
Cancer mortality statistics in this report are based
on information from all death certificates filed 
in the 50 states and the District of Columbia 
and processed by NVSS at NCHS for deaths 
that occurred in 2002. The model for the state
registration of deaths in 2002 is the 1989 revision
of the U.S. Standard Certificate of Death.23,24 
The cancer mortality data were compiled in
accordance with World Health Organization
(WHO) regulations, which specify that member
nations classify and code causes of death in
accordance with the current revision of the
International Classification of Diseases (ICD).
Effective with deaths that occurred in 1999, 
the United States began using the Tenth Revision
of this classification (ICD–10).25
The ICD not only details disease classification 
but also provides definitions, tabulation lists, 
the format of the death certificate, and the rules 
for coding cause of death. Cause-of-death data
presented in this report were coded by procedures
outlined in annual issues of the NCHS Instruction
Manuals.26,27
Tabulations of cause-of-death statistics are based
solely on the underlying cause of death. The
underlying cause is defined by WHO as “the
disease or injury that initiated the train of events
leading directly to death, or the circumstances of
the accident or violence that produced the fatal
injury.”25 The underlying cause of death is selected
from the conditions entered by the physician in the
cause-of-death section of the death certificate.
Generally, more medical information is reported
on death certificates than is directly reflected in the
underlying cause of death. This information is
captured in NCHS multiple cause-of-death
statistics.28-30
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Since 1968, NCHS has computerized the coding 
of the underlying cause of death in accordance with
WHO rules. In this system, called “Automated
Classification of Medical Entities” (ACME),31
multiple cause-of-death codes serve as inputs to 
the computer software that selects the underlying
cause of death. In addition, NCHS has developed
two computer systems as inputs to ACME.
Beginning with 1990 data, the Mortality Medical
Indexing, Classification, and Retrieval (MICAR)
system32,33 has been applied to automate coding 
of multiple causes of death. Then, beginning with
data year 1993, SuperMICAR, an enhancement of
the MICAR system, was applied to allow for literal
entry of the multiple cause-of-death text as reported
by medical certifiers in the states. Records that
cannot be automatically processed by MICAR or
SuperMICAR are manually multiple-cause coded
and then further processed through ACME. For
the 2002 mortality statistics, approximately 77% 
of the nation’s death records were multiple-cause
coded using SuperMICAR, and 23% were
processed using MICAR only.
For consistency with the cancer incidence data,
cancer sites in mortality data were grouped
according to the revised SEER recodes dated
January 27, 2003.3 Because NCHS uses different
groupings for some sites, the death rates in this
report may differ slightly from those published by
NCHS. In addition, under the ICD, differences
occur in mortality and incidence coding. For
example, there are several codes for mesothelioma
in ICD–10 (depending on the primary site).
However, one code in ICD–O–3 captures all the
primary sites that mesothelioma affects. SEER
recodes for cancer mortality are listed in 
Appendix J. In addition, counts of cancer incidence
cases are updated continuously, but cancer
mortality data are not.
All states and the District of Columbia submitted
part or all of their 2002 mortality data in electronic
data files to NCHS. All states provided precoded
cause-of-death data to NCHS except Illinois,
Kentucky, Ohio, West Virginia, and the District 
of Columbia.34 For 2002, all states submitted
precoded demographic data (e.g., sex and race 
of the deceased) for all deaths. Mortality data 
for the entire United States refer to deaths that
occurred within the United States; data for
geographic areas are by the decedent’s place of
residence. Deaths among overseas Armed Forces
personnel are not included.
One index of the quality of reporting causes of
death is the proportion of death certificates coded
to ICD–10 codes R00–R99 (i.e., symptoms, signs,
and abnormal clinical and laboratory findings not
elsewhere classified). Although deaths occur for
which the underlying causes are impossible to
determine, the proportion classified as R00–R99
indicates the care and consideration given to the
cause-of-death statement by the medical certifier.
This proportion also may be used as a rough
measure of the specificity of the medical diagnoses
made by the certifier in various areas. In 2002, 
the percentage of all reported deaths in the United
States assigned to symptoms, signs, and abnormal
clinical and laboratory findings not elsewhere
classified, was 1.23%, which was lower than in
2000 (1.33%) and 2001 (1.34%), but higher than 
in 1999 (1.12%).34 In general, from 1990 through
1999, the percentage of deaths from this cause for
all ages combined was fairly stable (1.08%–1.18%).
In addition, causes of death are more likely to 
be misclassified for populations other than white 
as symptoms, signs, and abnormal clinical and
laboratory findings not elsewhere classified, and
this misclassification may affect comparisons of
cause-specific death data.35
Population Denominator Data 
The population estimates for the denominators 
of incidence and death rates presented in this
report are race-specific (all races, whites, 
blacks, Asians/Pacific Islanders, and American
Indians/Alaska Natives), Hispanic-specific, and 
sex-specific county population estimates aggregated
to the state or metropolitan-area level. The county
population estimates that are incorporated into
NCI’s SEER*Stat software (http://www.seer.
cancer.gov/seerstat) to calculate cancer incidence
and death rates are available at http://www.seer.
cancer.gov/popdata. The SEER*Stat population
estimates are a slight modification of the annual
time series of July 1 county population estimates
(by age, sex, race, and Hispanic origin) produced by
the Population Estimates Program of the U.S.
Bureau of the Census (Census Bureau) with
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support from NCI through an interagency
agreement. The Census Bureau’s population
estimates and documentation of the procedures
used to develop them are available at http://www.
census.gov/popest/counties. The estimates used in
this report are postcensal estimates for 2002 (based
on the 2000 census) that include bridged single-
race estimates derived from the multiple-race
categories through collaboration between the
Census Bureau and CDC’s NCHS. For more
information on the 2000 bridged population
estimates, see http://www.cdc.gov/nchs/about/
major/dvs/popbridge/popbridge.htm.
Documentation regarding modifications made by
NCI to Census Bureau estimates is available at
http://www.seer.cancer.gov/popdata. Briefly, the
modification affects only population estimates 
for Hawaii and is based on information from the
Epidemiology Program of the Hawaii Cancer
Research Center. The modified population
estimates were obtained by SEER using survey 
data collected by the Hawaii Department of Health
to address concerns that the Native Hawaiian
population had been undercounted in previous
censuses. The “Hawaii-adjustment” to Census
Bureau estimates has the net result of reducing 
the estimated white population and increasing 
the estimated Asian/Pacific Islander population 
in the state. Census Bureau estimates for the total
population, black population, and American Indian
and Alaska Native populations in Hawaii are
unaffected. 
Registry Eligibility Criteria 
Cancer incidence data included in this report are
from statewide or metropolitan area cancer
registries that have high-quality cancer incidence
data for 2002 as demonstrated by meeting the
following data quality criteria for all cancer sites
combined:
• Case ascertainment is 90% or more complete.
The registry data include at least 90% of
the expected, unduplicated cases where the
expected cases are estimated by using
methods developed by NAACCR.17,18,21,36
Because some cancer patients receive
diagnostic or treatment services at more
than one reporting facility, cancer 
registries perform a procedure known as
“unduplication” to ensure that each 
cancer case is counted only once.37
• No more than 5% of cases are ascertained 
solely on the basis of a death certificate. The
proportion of cases ascertained solely on
the basis of a death certificate, with no
other information on the case available
after the registry has completed a routine
procedure known as “death clearance and
followback,”37-39 is another measure of the
completeness of case ascertainment.
• No more than 3% of cases are missing
information on sex. 
• No more than 3% of cases are missing
information on age.
• No more than 5% of cases are missing
information on race.
• At least 97% of the registry’s records passed a
set of single-field and interfield computerized
edits. Computerized edits are computer
programs that test the validity and logic 
of data components. For example, if (a) a
patient received a diagnosis of cancer in
1999, (b) the patient’s age was reported as
80 years, and (c) the patient’s year of birth
was reported as 1942, a computerized edit
could, without human intervention, identify
these components as incompatible. The
computerized edits applied to the data in
this report were designed by the SEER
Program for use by SEER registries.
During the 1990s, these edits were
expanded and incorporated into NAACCR
standards (http://www.naaccr.org) and 
into the EDITS software designed and
maintained by CDC (http://www.cdc.gov/
cancer/edits/edits.htm).
Appendix I, Table I.1, shows state- and
metropolitan area-specific measures for the data
quality criteria used to determine which registries’
data were eligible for inclusion in this report. 
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Populations Covered 
by This Report 
Incidence data on more than 1.1 million invasive
cancer cases (including approximately 12,000 cases
among children younger than 20 years) diagnosed
during 2002 and reported by 44 state cancer
registries (35 NPCR, 4 NPCR/SEER, and 5
SEER), the District of Columbia (NPCR), and 6
SEER metropolitan areas (Atlanta, Detroit, Los
Angeles, San Francisco-Oakland, San Jose-
Monterey, and Seattle-Puget Sound) are included
in this report. In total, the NPCR and SEER
cancer registries whose data are included in this
report cover 93% of the U.S. population (Figure 1)
(93% of the white population, 89% of the black
population, 96% of the Asian/Pacific Islander
population, 95% of the American Indian/Alaska
Native population, and 98% of the Hispanic
population). Population coverage may be affected
by the suppression of state incidence data if there
are only 16 or fewer cases or if the state requests
that the data be suppressed. (For more information,
see the discussions under “Suppression of Rates
and Counts at the State, Regional, Division, and
National Levels,” “Hispanics,” and “American
Indians/Alaska Natives.”)
Mortality data on 557,271 deaths in 2002 from
malignant neoplasms (i.e., cancers) as recorded in
NVSS from the 50 states and the District of
Columbia are included in this report; therefore,
with regard to mortality data, 100% of the U.S.
population is covered.34 In 2002, malignant
neoplasms caused 23% of the total deaths and were
overall the second leading cause of death in the
United States.34 In Alaska, Maine, Minnesota, and
Oregon, 2002 age-adjusted death rates indicated
that cancer was the leading cause of death; age-
adjusted death rates in 2002 were similar for
cancers and diseases of the heart for Massachusetts,
Montana, and Washington State.34
Statistical Methods 
Crude and Age-Specific Incidence and
Death Rates
Crude rates are available at http://www.cdc.gov/
cancer/npcr/uscs. Age-specific rates are presented
in this report and on the Web.
The crude and age-specific incidence rates equal
the total number of new cancer cases diagnosed in
2002 in the population category of interest, divided
by the at-risk population for that category, and
multiplied by 100,000 (cancers by primary site) or
by 1 million (ICCC groupings of childhood cancers).
The crude and age-specific death rates equal the total
number of cancer deaths in 2002 in the population
category of interest, divided by the at-risk population
for that category, and multiplied by 100,000.
Age-Adjusted Incidence and 
Death Rates
The occurrence of many cancers increases with
age, as does cancer mortality. The age distribution
of a population (i.e., the number of people in
particular age categories) can change over time 
and can be different in different geographic areas.
Age-adjusting the rates ensures that differences 
in incidence or deaths from one year to another 
or from one geographic area to another are not 
due to differences in the age distribution of the
populations being compared.
The standard population used to age-adjust the
rates in this report is the 2000 U.S. standard
population, in accordance with a 1998 U.S.
Department of Health and Human Services
recommendation.40,41 The 2000 U.S. standard
population is based on the proportion of the 2000
population in specific age groups (younger than 
1 year, 1–4 years, 5–9 years, 10–14 years, 15–19
years, . . . 85 years or older). The proportions of
the 2000 population in these age groups serve as
weights for calculating age-adjusted incidence or
death rates. However, NCHS uses a different set 
of age groups in its age-adjustment of death rates.
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Therefore the cancer death rates in this report may
differ slightly from those published by NCHS. 
In addition, the 2000 U.S. standard population
weights are not race or sex specific, so they do 
not adjust for differences in race or sex between
geographic areas or among populations being
compared. They do, however, provide the basis 
for adjusting for differences in the age distributions
across groups defined by sex, race, geography, or
other categories.
The 2000 U.S. standard population weights used
for this report are based on single years of age from
the Census P25-1130 series estimates of the 2000
U.S. population. For the 5-year age groups, the
single years of age populations are summed to form
the 5-year age groups. For more information, visit
http://seer.cancer.gov/stdpopulations/single_age.html.
These standard weights are used to compute age-
adjusted incidence and death rates by the method
of direct standardization as implemented in NCI
SEER*Stat software (http://www.seer.cancer.gov/
seerstat) and are described as follows:42
If Nj is the number of incident cases diagnosed in
2002, or the number of cancer deaths in 2002, in
age category j, and Pj is the population size at risk
in age category j, then the incidence or death rate
Rj in age category j is defined as
Rj = Nj/Pj
If wj is the 2000 U.S. standard population weight
for age category j, then the age-adjusted (directly
standardized) incidence or death rate Radj is
computed as
Radj = Rj wj Rj x 100,000
Note from the multiplier in the above formula that
incidence or death rates are expressed as cases or
deaths per 100,000 persons. For childhood cancers
coded according to ICCC, the multiplier in the
formula is 1,000,000 because the childhood cancer
rates are expressed per million persons.
Confidence Intervals
Confidence intervals reflect the range of variation
in the estimation of the cancer rates. The width 
of a confidence interval depends on the amount 
of variability in the data. Sources of variability
include the underlying occurrence of cancer as 
well as uncertainty about when cancer is detected
and diagnosed, when a death from cancer occurs,
and when the data about the cancer are sent to the
registry or the state health department. In any
given year, when large numbers of a particular
cancer are diagnosed or when large numbers of
cancer patients die, the effects of random variability
are small compared with the large numbers, and
the confidence interval will be narrow. With rare
cancers, however, the rates are small and the chance
occurrence of more or fewer cases or deaths in 
a given year can markedly affect the rate. Under
these circumstances, the confidence interval will 
be wide to indicate uncertainty or instability in 
the cancer rate.
To estimate the extent of this uncertainty, a
statistical framework is applied.43 The standard
model used for rates for vital statistics is the
Poisson process,44 which assigns more uncertainty
to rare events relative to the size of the rate than 
it does to common events. The population risk
profile is positioned to influence the underlying
Poisson process from which rates arise, and only 
a single realization of that process is observed. 
Parameters are estimated for the underlying disease
process. For this report, we estimated a single
parameter to represent the incidence rate and its
variability. Of note, the Poisson model is capable 
of estimating separate parameters that represent
contributions to the rate from various population
risk factors, the effects of cancer control interventions,
and other attributes of the population risk profile
in any particular year.
For this report, we used confidence intervals that
are expected to include the true underlying rate
95% of the time. Confidence intervals in this
report were computed by using SEER*Stat Version
6.1.4 software (http://www.seer.cancer.gov/seerstat)
and are based on the gamma method.45 These
gamma intervals are approximations to exact
Poisson confidence intervals. The gamma method
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performs better than other methods, especially 
for small incidence rates or for populations with
age distributions that differ from the standard age
distribution. Various factors such as population
heterogeneity can sometimes lead to “extra-Poisson”
variation in which the rates are more variable 
than would be predicted by a Poisson model. No
attempt was made to correct for this. In addition, 
as discussed in “Interpreting the Data,” the
confidence intervals do not account for systematic
(i.e., nonrandom) biases in the incidence rates.
Users of this report who want to know if the
differences between the rates of various groups 
are statistically significant might check whether 
the confidence intervals overlap. However, we
discourage the use of overlapping confidence
intervals to test for statistically significant differences
between two rates because the practice more
frequently fails to detect significant differences
than does standard hypothesis testing.46
Another consideration when comparing differences
between rates is their public health importance.
For some rates in this report, numerators and
denominators are large and standard errors are
therefore small, resulting in statistically significant
differences that may be so small as to lack
importance for decisions related to population-
based public health programs.
Suppression of Rates and Counts 
at the State, Regional, Division, 
and National Levels
When the numbers of cases or deaths used to
compute rates are small, those rates tend to 
have poor reliability.44 Therefore, to discourage
misinterpretation or misuse of rates or counts 
that are unstable because case or death counts 
are small, incidence and death rates and counts 
are not shown in tables and figures if the case or
death counts are less than 16. A count of less than
about 16 results in a standard error of the rate that
is approximately 25% or more as large as the rate
itself. Similarly, a case count of less than
approximately 16 results in the width of the 95%
confidence interval around the rate being at least as
large as the rate itself. These relationships were
derived under the assumption of a Poisson process
and with the standard population age distribution
assumed to be similar to the observed population
age distribution.
Another important reason for using a cell
suppression threshold value is to protect the
confidentiality of patients whose data are included
in a report by reducing or eliminating the risk 
of identity disclosure.47,48 The cell suppression
threshold value of 16, which was selected to reduce
misuse and misinterpretation of unstable rates 
and counts in this report, is more than sufficient 
to protect patient confidentiality given the low
level of geographic and clinical detail provided 
in the report.49
Because the incidence and death rates shown in 
the state-, sex-, and race-specific bar graphs in
Figures 3.1.M1 through 3.58.F2 are presented in
rank order, we applied a data suppression criterion
in addition to the threshold value of 16 cases. In
these figures, incidence rates are not ranked or
shown for any sex-specific population groups of
less than 50,000 people.
U.S. Census Regions and Divisions
Rates for U.S. Census regions and divisions were
calculated by aggregating data reported from the
states in each region and division. Only data from
state registries that met the criteria for inclusion 
in this report (see “Registry Eligibility Criteria”)
were included in calculations of incidence rates 
for U.S. Census regions and divisions. There is a
potential for bias in the incidence rates for Census
regions and divisions where data for some states
were excluded. We estimated cancer rates for
Census regions or divisions with ineligible cancer
registries by assuming that the incidence-to-
mortality ratio in the portion of the region or
division that is covered by eligible registries is 
the same as the incidence-to-mortality ratio in 
the portion that is not covered by eligible cancer
registries. The age-adjusted incidence rates for
U.S. Census regions and divisions are reported
only if (1) at least 80% of the population for the
Census region or division is covered by cancer
registries that meet the criteria for inclusion in this
report and (2) the 95% confidence intervals around
the observed age-adjusted region or division
incidence rates based on data from eligible
United States Cancer Statistics: 2002 Incidence and Mortality
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registries for each of six major cancer sites
(prostate, female breast, male colorectal, female
colorectal, male lung and bronchus, female lung
and bronchus) included the estimate of the region
or division rate calculated using the methods
described in Appendix L.
On the basis of these analyses, we present in this
report the observed age-adjusted incidence rates
for all U.S. Census regions and divisions with the
exception of the South and its divisions (South
Atlantic, East South Central, and West South
Central). The estimate of rates based on the methods
described in Appendix L are not presented in this
report but are used for determining the exclusion
of observed age-adjusted rates for Census regions
and divisions.
Case counts for U.S. Census regions and divisions
are in Appendix E if all state cancer registries in the
region or division met the criteria for inclusion in
this report unless the count for exactly one state in
the region or division is suppressed due to a count
of less than 16.
Total United States
Cancer incidence rates for the United States are
aggregate rates based on more than 1.2 million
cancer cases reported from central cancer registries
in 44 states, 6 metropolitan areas, and the District
of Columbia. The United States rate calculated
using the methods described in Appendix L was
higher than the upper confidence limit for the
observed rate for both male prostate and male lung
and bronchus cancers. The same statistical criteria
that were applied to rates and counts for U.S.
Census regions and divisions were also applied to
the rates for the entire United States (see “U.S.
Census Regions and Divisions” and Appendix L).
Although the cancer rates for the entire United
States do not meet these criteria, we report the
observed cancer rates for the 93% of the U.S.
population covered by eligible cancer registries. 
As of 2005, these rates are the best estimates of 
the U.S. cancer burden available that are based 
on observed data.
Case counts for the U.S. incidence rates for all ages
combined are in Appendix D, Table D.1.1M and
Table D.1.1F. The U.S. case counts are provided
only to allow readers to verify the crude rates
(available at http://www.cdc.gov/cancer/
npcr/uscs) by recalculation. The U.S. counts and
U.S. cancer incidence rates in this report pertain to
the 93% of the U.S. population covered by eligible
cancer registries.
Interpreting the Data 
Age-adjusted and age-specific rates are presented 
in the print version of this report. Crude rates 
have also been calculated and can be found at
http://www.cdc.gov/cancer/npcr/uscs. Crude rates
are helpful in determining burden and specific
needs for services for a given population, compared
with another population, regardless of size. 
Crude rates are influenced by the underlying 
age distribution of the state’s population. Even 
if two states have the same age-adjusted rates, 
the state with the relatively older population (as
demonstrated by having a higher median age) will
have higher crude rates because incidence or death
rates for most cancers increase with increasing age.
Ideally, crude, age-adjusted, and age-specific rates
are all used to plan for population-based cancer
prevention and control interventions.41
Incidence Data 
Published age-adjusted cancer incidence rates 
for diagnosis years before 1999 were calculated 
by using the 1970 U.S. standard population; for
mortality data, the 1940 standard population was
used. Beginning with the publication of data for the
1999 diagnosis year, cancer incidence rates were
age-adjusted to the 2000 U.S. standard population.
This change conforms to U.S. Department of
Health and Human Services policy for reporting
death and disease rates.40,41 This policy was
motivated by a need to standardize age-adjustment
procedures across government agencies.40 The
change to the 2000 U.S. standard updated the
calculation of age-adjusted rates to more closely
reflect the current age distribution of the U.S.
population and the current burden of cancer.
Because of the aging of the U.S. population, the
2000 U.S. standard population gives more weight
to older age categories than did the 1940 and 1970
standard populations.5,41
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Because cancer incidence increases with age, 
the change to the 2000 U.S. standard population
resulted in higher incidence rates for most cancers.
The data published here should not be compared
with cancer incidence rates adjusted to different
standard populations.
Incidence rates are also influenced by the choice 
of population denominators used in calculating 
the rates. Because some state health departments
use customized state population projections when
calculating incidence rates, the rates published in
this report may differ slightly from those published
by individual states. 
The new population estimates based on the 
2000 census improve the accuracy of cancer
incidence rates (see “Population Denominator
Data”). Previously reported overall cancer rates,
when recalculated with the new denominators, do
not appear to change appreciably (Dr. Francis P.
Boscoe, New York State Cancer Registry, and Dr.
Barry Miller, NCI, personal communication, July
2003). However, rates for geographic areas with
small populations and for specific racial or ethnic
populations appear to be affected to a greater
degree and should be interpreted with caution.50
Furthermore, since corrections to the population
denominators extrapolated from the 1990 census
were larger in the late 1990s than earlier in the
decade, rates calculated for the late 1990s may be
subject to more change than rates calculated for the
early 1990s. We published United States Cancer
Statistics: 1999 Incidence using extrapolated 1999
population estimates based on the 1990 census,
with the expectation that the 1999 incidence rates
would be revised when the intercensal (i.e., based
on both the 1990 census and the 2000 census) 
race-specific population estimates for 1999 became
available.51 The incidence rates published in 
United States Cancer Statistics: 1999 Incidence have 
been revised to incorporate the modified 1999
population denominators and are available at
http://www.cdc.gov/cancer/npcr/uscs.
Statistical bias can arise if, within a region, division,
or country, the sub-area for which data are
available has rates that are substantially different
from the rates in the sub-area for which data are
not available. Because of bias, rates for a U.S. Census
region or division, or the country, may not meet
statistical criteria for inclusion in this report. It is
possible to have some statistical bias even if the
percentage of coverage is high and large numbers
of cases are recorded. Where coverage is less than
100%, merely increasing the percentage of the
population covered may not reduce statistical bias
unless the covered population is similar to the
uncovered population in terms of cancer rates or
proportions. The U.S. counts and rates in this
report pertain to the 93% of the U.S. population
covered by eligible cancer registries. The 7% of 
the population that is not covered by eligible
cancer registries may have different cancer rates
than does the 93% that is covered, so reported
observed cancer rates may not be representative of
the entire United States. Of note, however, rates
for the entire United States that were estimated
using the method described in Appendix L for the
six specific major cancer sites (prostate, female
breast, male colorectal, female colorectal, male
lung and bronchus, and female lung and bronchus)
and the rates for the same sites that are published
in this report did not differ by more than 1.8%.
This observation provides strong support that 
the reported rates are representative of those 
for the entire United States.
Data quality is routinely evaluated by NPCR and
the SEER Program.52,53 Some evaluation activities
are conducted intermittently to find missing cases
or to identify errors in the data. Although the
cancer registries whose data are included in this
report meet data quality criteria for all invasive
sites combined, the completeness and quality of
site-specific data may vary. The observed rates 
may have been influenced by differences in the
timeliness, completeness, and accuracy of the data
from one registry to another, from one reporting
period to another, and from one primary cancer
site to another.
Completeness and accuracy of the site-specific 
data may also be affected by the time interval
allowed for reporting data to the two federal
programs. For this report of 2002 data, the NPCR
and SEER time interval for reporting data differed
by 3 months. NPCR allowed an interval of 25
months after the close of the diagnosis year (data
submission by January 31, 2005), and SEER
United States Cancer Statistics: 2002 Incidence and Mortality
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allowed a shorter interval of 22 months after the
close of the diagnosis year (data submission by
November 1, 2004). 
Delays in reporting cancer cases can affect timely
and accurate calculation of cancer incidence rates.52
Cases are reported continuously to state and
metropolitan area cancer registries in accordance
with statutory and contractual reporting
requirements. After the initial submission of the
most recent year’s data to the federal funding
agency, cancer registries continue to revise and
update their data on the basis of new information
received. Therefore, some cancer cases for the
2002 diagnosis year will likely have been reported
to state and metropolitan area cancer registries
after these registries submitted their 2002 data 
to CDC or NCI. For this reason, incidence rates
and case counts reported directly by state or
metropolitan area cancer registries may differ 
from those in this publication. Reporting delays
appear to be more common for cancers that are
usually diagnosed and treated in nonhospital
settings such as physician offices (e.g., early-stage
prostate and breast cancer, melanoma of the skin).
NCI routinely models SEER reporting patterns
and estimates that the delay-adjusted 2002
incidence rate for all sites combined is about 
4% higher than the observed 2002 age-adjusted
incidence rate. Delay adjustments for 2002 SEER
age-adjusted rates vary: melanoma is 12%, prostate
cancer is 5%, and breast cancer is 2% (Dr. Brenda
K. Edwards, NCI, personal communication,
August 2005). Updates to observed data and
reported cancer rates are due to improvements in
the registry database gained through additional
knowledge that only comes with increased time 
and effort (Dr. Brenda K. Edwards, NCI, personal
communication, August 2005). Methods to adjust
incidence rates for reporting delay were not applied
to the data in this report.54
Each year, not only do state cancer registries
submit data for a new diagnosis year to CDC or
NCI, but they also submit an updated version of
previous years’ data. Federal agencies in turn
update their cancer incidence statistics with each
data submission and document the states’ data
submission date whenever the data are published.
These continual updates by state and federal
agencies illustrate the dynamic nature of cancer 
surveillance and the attention to detail that is
characteristic of cancer registries. Each year when
United States Cancer Statistics is published, we
publish updates to previous years’ data on the Web.
Users of cancer incidence data published by federal
agencies should be mindful of the data submission
date for all data used in their comparisons. See
“HTML Edition of United States Cancer Statistics”
for more information.
Geographic variation in cancer incidence rates 
may be the result of regional differences in the
exposure of the population to known or unknown
risk factors.55-57 A comparison of incidence rates
based on data from all NPCR registries combined
and from all SEER registries combined revealed
that the two federal programs had different cancer
incidence rates for some cancer sites.58 Higher
incidence rates for tobacco-related cancers and 
for colon cancer were observed in all NPCR 
areas combined when compared with SEER areas
combined. The relationship was reversed (i.e., 
rates were higher in all SEER areas combined) for
melanoma, prostate cancer, female breast cancer,
and cancers that are more common among Asians/
Pacific Islanders (e.g., stomach cancer, cancer of
the liver/intrahepatic bile duct). Rates for cancer
sites classified as ill-defined were higher in all
NPCR areas combined. These registry program
differences may arise because of differences in
sociodemographic population characteristics (e.g.,
age, race and ethnicity, geographic region, urban 
or rural residence), screening use, health-related
behaviors (e.g., behaviors related to tobacco use,
diet, physical activity), exposure to cancer-causing
agents, or registry operations factors (e.g.,
completeness, timeliness, specificity in coding
cancer sites). Cancer researchers are investigating
variability associated with known factors that affect
cancer rates and risks by using model-based
statistical techniques and other approaches for
surveillance research. Differences in registry
operations are being evaluated to ensure the
consistency and quality in reporting data.
Mortality Data 
The cancer mortality statistics in this report are
influenced by the accuracy of information on the
death certificate. Cause of death determined by
autopsy combined with clinical data is considered
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the best estimate of the true cause of death.59
Autopsy studies of mortality data coded according
to the eighth or ninth revision of ICD (ICD–8A 
or ICD–9) indicate that, when neoplasms (i.e.,
cancers) are an underlying cause of death, the
sensitivity of death certificates was 87%–93%, and
their predictive value positive was 85%–96%.59-61
However, these studies are limited by selection
bias, and currently less than 10% of deaths in the
United States are autopsied.62 The percentage of
cancers coded as the underlying cause of death on
the death certificate that agree with the cancer
diagnosis in the medical record is an indication of
the reliability with which underlying cause of death
can be determined from the death certificate.
Available studies show that 78%–85% of malignant
neoplasms coded as an underlying cause of death
on death certificates agreed with the clinical cancer
diagnosis in medical records under ICD–8A or
ICD–9,63-65 with a range of 69% for larynx cancer to
98% for prostate cancer under ICD–9 (Appendix I,
Table I.2). These results underscore the need to
further monitor the accuracy of cancer mortality
data overall and by anatomic site.
Some cancer patients may die with cancer (rather
than die of it) as an underlying cause of death.
Comparing the original cancer diagnosis in the
medical record with those cancers later coded as 
an underlying cause of death on death certificates 
is a way of measuring if a person died with cancer
rather than of it. Findings from an 11-year study
under ICD–9 showed that about 83% of malignant
neoplasms recorded on the medical record in ICD
for oncology were also coded as an underlying
cause of death from death certificates;65 this
percentage ranged from 72% for larynx cancer to
97% for multiple myeloma (Appendix I, Table I.2).
The SEER study suggests that misattribution bias
(i.e., the mistaken assignment of cancer as the
underlying cause of death because the decedent
received a diagnosis of cancer) affects how cancer 
is recorded on death certificates.66
In collaboration with the Social Security
Administration and the National Association 
for Public Health Statistics and Information
Systems, NCHS is developing a Model Vital 
Event Re-Engineered System to improve the
accuracy and timeliness of vital statistics
disseminated through the NVSS. Under the 
system, standard certificates for births and deaths
will be revised, and state data systems will be re-
engineered to better accommodate revisions,
special studies or projects, and linkage with other
health promotion programs. With regard to
mortality statistics, handbooks have been revised
for professionals who complete death certificates.
In 2003, the standard certificate of death was
revised.67 For 2005, plans are in place for up to 21
states to adopt the revised death certificate.
Race and Ethnicity in Cancer Data 
The NAACCR Race and Ethnicity Identifier
Assessment Project confirmed the importance 
of publishing cancer rates by race and ethnicity.68
In cancer incidence, race and ethnicity information
is abstracted from medical records and then
grouped into race and ethnicity categories.19
Although state registries across the country use
standardized data items and codes for both race 
and ethnicity (i.e., Hispanic origin), the initial
collection of this information by health care
facilities and practitioners and the procedures 
for assigning and verifying codes for race and
ethnicity are not well standardized.68 Thus, some
inconsistency is expected in this information. 
In cancer mortality, race and Hispanic origin are
reported separately on the death certificate by 
the funeral director as provided by an informant 
or, in the absence of an informant, on the basis 
of observation.34 Inconsistencies in the collection
and coding of data on race and Hispanic origin 
and their effect on mortality statistics have 
been described previously.69 The net effect of
misclassification is an underestimation of deaths
and death rates for races other than white or black.
In addition, under-coverage of minority populations
in the census and resultant population estimates
introduce biases into death rates by race.69-71 For 
the white population, published death rates are
overstated by an estimated 1% and for the black
population by 5%, resulting principally from
undercounts of these populations in the census.
In this United States Cancer Statistics report, cancer
incidence and mortality data are presented for 
all races combined and by race (whites, blacks,
Asians/Pacific Islanders, and American 
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Indians/Alaska Natives) and ethnicity (Hispanics).
Data for Asians/Pacific Islanders and American
Indians/Alaska Natives are presented only for the
nation and for states with at least 100,000
population because of concerns regarding possible
misclassification of race data and the relatively
small sizes of these populations in the United
States (see Figures 3.1.M1–3.58.F2). 
Asians/Pacific Islanders
For the first time, data for Asians/Pacific Islanders
were included in United States Cancer Statistics:
2000 Incidence.72 The Asian/Pacific Islander
population in the United States is approximately
12.5 million or 4.4% of the 2002 U.S. population,
substantially smaller than the white or black
populations.73 The Asian/Pacific Islander population
is concentrated in several states: California, 
New York, Hawaii, Texas, New Jersey, Illinois, 
and Washington.74,75
Grouping Asians and Pacific Islanders into 
one racial population can mask differences in
subpopulations. The U.S. Asian/Pacific Islander
population is not a homogeneous group. Rather, 
it comprises many subpopulations that differ in
language, culture, and length of residence in the
United States.73,76 The three largest Asian
subpopulations in the United States are Chinese,
Filipino, and Asian Indian.75 Although state cancer
registries have designated codes for race that allow
them to document the occurrence of cancer in 23
different Asian/Pacific Islander subpopulations,19
the subpopulations are grouped into a single
Asian/Pacific Islander race group in this report
because of small numbers and concerns regarding
the possible misclassification of race for
Asian/Pacific Islander subpopulations.
Studies show that a person self-reported as
Asian/Pacific Islander in a census or survey was
sometimes reported as white on the death
certificate.77,78 Death rates are understated for
Asians/Pacific Islanders by approximately 11%.69
Studies are under way to examine the misclassification
of race for Asian/Pacific Islander subpopulations
and the underreporting of Asian/Pacific Islander
race in cancer incidence data (Dr. Holly L. Howe,
NAACCR, personal communication, August 2005).
Hispanics
The Office of Management and Budget defines
Hispanics (or Latinos) as persons of Cuban,
Mexican, Puerto Rican, South or Central
American, or other Spanish culture or origin
regardless of race.79 For the first time, data for
Hispanics were included in United States Cancer
Statistics: 2001 Incidence and Mortality.80 Hispanics
have one of the highest growth rates among
minority groups in the United States with
approximately 37.4 million in the 2002 U.S.
population, similar in size to the U.S. black
population.81-83 The three largest Hispanic
subpopulations living in the United States are
Mexican, Puerto Rican, and Cuban. States with 
1 million or more Hispanics include California,
Texas, New York, Florida, Illinois, Arizona, and
New Jersey.81
NAACCR convened an expert panel to develop 
a best practices approach to improving Hispanic
identification and is addressing Hispanic origin
misclassification in central cancer registries. 
NPCR registries assigned Hispanic ethnicity
through the standardized use of the NAACCR
Hispanic Identification Algorithm (NHIA).84
NHIA uses a combination of NAACCR variables
to directly or indirectly classify cancer cases as
Hispanic for analytic purposes. Cases reported as
having Spanish/Hispanic origin (as indicated by
NAACCR data element 190 with values 1–619) 
are directly identified as Hispanic in the dataset.
Cases reported as non-Spanish/non-Hispanic,
Spanish surname only, or unknown whether Spanish
(NAACCR data element 190 with a value of 0, 7,
or 919) are evaluated for possible Hispanic ethnicity
through indirect identification. The ultimate goal
of the algorithm is to classify these cases as Hispanic
or non-Hispanic on the basis of an evaluation 
of the strength of the birthplace, race, and/or
surname associations with Hispanic ethnicity. 
After applying the NHIA, cases not classified as
Hispanic are classified as non-Hispanic, leaving 
no cases with unknown Hispanic status. More
detailed information on the algorithm is available
at http://www.naaccr.org.85
In this report, NHIA-classified case counts and
incidence rates for Hispanics are presented for 33
NPCR registries. The following states have opted 
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not to present state-specific, NHIA-classified
Hispanic counts and rates: Florida, Kentucky, 
New Hampshire, Pennsylvania, South Carolina,
and Wisconsin. Some registries may have a small
percentage of Hispanics in their states. Quality
reviews of NHIA and the data elements that make
up the NHIA, including but not limited to Hispanic
ethnicity, race, birthplace, surname, and maiden
name for women, have been conducted.86 National
rates include data for registries that opted not to
present state-specific, NHIA-classified Hispanic
counts and incidence rates. Preliminary data
analyses showed that exclusion of these registry
data did not appreciably change the overall
incidence rates. 
In this report, counts and incidence rates for the 
11 SEER registries are based on the NAACCR
Spanish/Hispanic Origin data element only. Data
for the Connecticut, Hawaii, Iowa, New Mexico,
and Utah SEER registries are included in the
national rate; counts and rates for Hawaii and
metropolitan Detroit are not presented because of
the small percentage of Hispanics in those areas.
Death counts and rates for Hispanics are presented
at the national and state levels for all 50 states and
for the District of Columbia. Hispanic origin is
assigned to cancer mortality data on the basis of
information collected from death certificates. 
The National Longitudinal Mortality Study
examined the reliability of Hispanic origin and
reported a 89.7% record-by-record agreement and
a net underreporting of Hispanic origin on death
certificates by 7% compared with self-reports on
the surveys.69 Death rates for the Hispanic-origin
population are also affected by under-coverage 
of this population group in the census and the
resultant population estimates; the estimated net
correction, taking into account both sources of
bias, is 1.6%.71
American Indians/Alaska Natives
Over 560 American Indian tribes are recognized 
by individual states and the federal government.8,87,88
The American Indian/Alaska Native population in
the United States is approximately 2.8 million or
1.0% of the 2002 U.S. population, substantially
smaller than the white or black populations and
smaller than the Asian/Pacific Islander population.89
The American Indian/Alaska Native population is
concentrated in several states: California has 15%
of the nation’s American Indian/Alaska Native
population; Arizona, 10%; Oklahoma, 10%; New
Mexico, 7%; Texas, 5%; Alaska, 4%; New York,
4%; North Carolina, 4%; and Washington, 4%.89
Previous studies have found racial misclassification
to contribute to lower death rates and lower cancer
incidence rates among the American Indian/Alaska
Native population. Based on a comparison of race
reported on death certificates from 1979–1989 with
nine Current Population Survey files for the years
1973–1985 from the National Longitudinal
Mortality Study conducted by the U.S. Bureau of
the Census, record-by-record agreement was only
57% for American Indians.69 When the net
agreement of counts by race was examined between
the two sources, almost 40% more persons were
reported as American Indian/Alaska Native in the
Current Population Survey files than on the death
certificates.69 The range of underestimation of
cancer incidence rates among this population are
similar. Studies that estimate misclassification
among American Indians/Alaska Natives using
cancer registry data report these rates are
underreported by 40%–57%, depending on the
region of the country.88,90,91
Studies measuring racial misclassification with
cancer registry data have linked cases with Indian
Health Service (IHS) administrative records.88,90,91
Similarly in 2004, NPCR cancer registries were
required to link cancer cases diagnosed from
1995–2002 with the IHS patient registration
database to identify American Indians/Alaska
Natives that were classified in the registry as 
non-native. IHS provides medical services to
American Indians/Alaska Natives who are members
of federally recognized tribes, estimated to be
approximately 55% of the American Indian/Alaska
Native population (Dr. David Espey, IHS, personal
communication, July 2005). IHS coverage of these
populations varies by region, does not include
American Indians/Alaska Natives who are 
members of non-federally recognized tribes, 
and underrepresents those who live in certain
urban areas. However, American Indians/Alaska
Natives who live outside of service counties may
continue to receive IHS services or may have
received services before moving. Patient identifying
information from cancer cases in state registries
were linked to a database that included all
American Indians/Alaska Natives that received
medical care during 1985–2002 through IHS.
Results of the linkage were captured in a new 
data element, IHS Link (NAACCR data element
192),19 that was sent back to state cancer registries
to include in their January 31, 2005, NPCR data
submission.
In this report, national incidence counts and rates
for American Indians/Alaska Natives for the 41
NPCR registries included in this report are based
on Race1 (NAACCR data element 160)19 and IHS
Link. Counts and incidence rates for the five state
SEER registries are based on Race1 only. California
opted not to present state-specific American
Indian/Alaska Native case counts, incidence rates,
death counts, and death rates.
National death counts and rates consist of data
obtained from all 50 states and the District of
Columbia. American Indian/Alaska Native race 
for these data is obtained from information on 
the death certificate.
HTML Edition of United
States Cancer Statistics
A printable version of United States Cancer Statistics:
2002 Incidence and Mortality is available on the 
Web at http://www.cdc.gov/cancer/npcr/uscs. The
HTML edition replicates all the text, tables, and
figures in this report and adds the following:
• Expanded Tables 1 and 2 with cancer
incidence rates for men and women
combined.
• Expanded Tables 1 and 2 to include crude
rates.
• State rankings of incidence and mortality 
of selected major invasive cancers. 
Previous versions of United States Cancer Statistics
have been updated on the Web with the additional
data mentioned previously as well as the following:
• Cancer mortality statistics for 1999 and 2000.
• 1999–2001 cancer cases as reported to
CDC as of January 31, 2005, and as
reported to NCI as of November 1, 2004,
and made available through the SEER
Program public use file (see “Interpreting
the Data: Incidence Data”). The updated
population coverage for incidence rates are
as follows:
➤1999 incidence: 93% of the U.S. population
➤2000 incidence: 94% of the U.S. population
➤2001 incidence: 91% of the U.S. population
• Cancer cases grouped according to the
January 2003 modification to the SEER 
site recodes (see “Data Sources: Incidence
Data”).
All data presented in the HTML version can be
downloaded in ASCII or Microsoft Excel format
for use in other applications. 
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Cancer Incidence and Mortality
for Adults and Children: 
All Areas Combined
Table 1.1.1.1M
Consecutive numbering based on table series
In the series, a second digit of “1” indicates all
cancer sites for all ages, a second digit of “2”
indicates childhood cancers, and a second digit
of “3” indicates brain by histology.
Specific types or categorization of rates
M = males
F = females
If no M or F, then table presents both sexes.
1 = incidence rate
2 = death rate
Rate can be age-adjusted or age-specific.
1 = U.S. rates
Organized by cancer site
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Table 1.1.1.1M: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by Primary
Site and Race and Ethnicity, United States†‡
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander§ Alaska Native§ Hispanic§‖
All Sites 545.5 (544.1-546.8) 536.8 (535.4-538.2) 615.1 (610.0-620.3) 324.3 (318.4-330.4) 267.2 (254.7-280.3) 422.8 (418.0-427.6)
Oral Cavity and Pharynx 15.5 ( 15.3- 15.7) 15.3 ( 15.0- 15.5) 17.5 ( 16.7- 18.3) 10.7 ( 9.8- 11.8) 7.7 ( 5.8- 10.1) 10.4 ( 9.6- 11.1)
Lip 1.4 ( 1.4- 1.5) 1.6 ( 1.5- 1.6) ∼ ∼ ∼ 0.6 ( 0.4- 0.8)
Tongue 4.0 ( 3.8- 4.1) 4.0 ( 3.9- 4.1) 3.8 ( 3.4- 4.2) 1.9 ( 1.5- 2.4) 2.1 ( 1.1- 3.7) 2.6 ( 2.2- 3.0)
Salivary Gland 1.5 ( 1.4- 1.6) 1.5 ( 1.5- 1.6) 0.9 ( 0.7- 1.1) 1.0 ( 0.7- 1.4) ∼ 1.0 ( 0.8- 1.3)
Floor of Mouth 1.1 ( 1.0- 1.1) 1.0 ( 1.0- 1.1) 1.5 ( 1.3- 1.8) ∼ ∼ 0.6 ( 0.4- 0.8)
Gum and Other Mouth 1.9 ( 1.8- 1.9) 1.8 ( 1.7- 1.9) 2.4 ( 2.1- 2.8) 1.2 ( 0.9- 1.6) ∼ 1.3 ( 1.1- 1.7)
Nasopharynx 0.8 ( 0.8- 0.9) 0.6 ( 0.5- 0.6) 1.2 ( 1.0- 1.4) 4.1 ( 3.5- 4.7) ∼ 0.6 ( 0.5- 0.8)
Tonsil 2.4 ( 2.4- 2.5) 2.5 ( 2.4- 2.6) 2.8 ( 2.5- 3.1) 1.0 ( 0.7- 1.4) 1.5 ( 0.9- 2.8) 1.6 ( 1.3- 1.9)
Oropharynx 0.6 ( 0.6- 0.7) 0.6 ( 0.5- 0.6) 1.4 ( 1.1- 1.6) ∼ ∼ 0.5 ( 0.4- 0.7)
Hypopharynx 1.3 ( 1.2- 1.4) 1.2 ( 1.1- 1.3) 2.4 ( 2.2- 2.8) 0.7 ( 0.5- 1.1) ∼ 1.1 ( 0.8- 1.4)
Other Oral Cavity and Pharynx 0.5 ( 0.5- 0.5) 0.5 ( 0.4- 0.5) 0.9 ( 0.8- 1.2) ∼ ∼ 0.4 ( 0.3- 0.6)
Digestive System 106.9 (106.3-107.5) 103.7 (103.1-104.4) 129.4 (127.0-131.8) 103.3 ( 99.9-106.7) 63.7 ( 57.7- 70.4) 102.2 ( 99.8-104.6)
Esophagus 8.3 ( 8.2- 8.5) 8.2 ( 8.0- 8.4) 10.9 ( 10.2- 11.6) 3.4 ( 2.9- 4.1) 5.6 ( 3.9- 8.1) 5.3 ( 4.8- 5.9)
Stomach 10.1 ( 9.9- 10.3) 9.1 ( 9.0- 9.3) 16.6 ( 15.7- 17.5) 18.1 ( 16.7- 19.6) 7.9 ( 5.9- 10.6) 14.8 ( 13.8- 15.7)
Small Intestine 2.1 ( 2.0- 2.2) 2.0 ( 1.9- 2.1) 3.3 ( 2.9- 3.7) 1.2 ( 0.9- 1.6) ∼ 1.6 ( 1.3- 1.9)
Colon and Rectum 61.3 ( 60.9- 61.8) 60.5 ( 60.0- 61.0) 67.9 ( 66.2- 69.7) 46.6 ( 44.4- 49.0) 34.1 ( 29.8- 39.2) 49.8 ( 48.2- 51.5)
Colon excluding Rectum 43.3 ( 43.0- 43.7) 42.5 ( 42.1- 42.9) 51.9 ( 50.3- 53.4) 30.6 ( 28.8- 32.6) 24.2 ( 20.4- 28.6) 33.7 ( 32.3- 35.1)
Rectum and Rectosigmoid Junction 18.0 ( 17.8- 18.2) 18.0 ( 17.7- 18.3) 16.1 ( 15.3- 16.9) 16.0 ( 14.8- 17.4) 10.0 ( 7.9- 12.7) 16.1 ( 15.2- 17.1)
Anus, Anal Canal and Anorectum 1.2 ( 1.1- 1.2) 1.2 ( 1.1- 1.2) 1.5 ( 1.3- 1.7) ∼ ∼ 0.9 ( 0.8- 1.2)
Liver and Intrahepatic Bile Duct 7.9 ( 7.8- 8.1) 7.0 ( 6.8- 7.2) 10.9 ( 10.3- 11.6) 20.3 ( 18.9- 21.8) 6.7 ( 5.0- 9.1) 14.5 ( 13.6- 15.4)
Gallbladder 0.8 ( 0.8- 0.9) 0.8 ( 0.7- 0.8) 0.8 ( 0.7- 1.1) 1.2 ( 0.9- 1.7) ∼ 1.4 ( 1.1- 1.8)
Other Biliary 2.0 ( 1.9- 2.0) 2.0 ( 1.9- 2.0) 1.5 ( 1.3- 1.8) 2.3 ( 1.8- 2.9) ∼ 2.1 ( 1.8- 2.5)
Pancreas 12.3 ( 12.1- 12.5) 12.1 ( 11.9- 12.3) 15.1 ( 14.3- 15.9) 8.9 ( 7.9- 9.9) 5.5 ( 3.7- 7.9) 10.8 ( 10.1- 11.7)
Retroperitoneum 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.2 ( 0.1- 0.3) ∼ ∼ 0.5 ( 0.3- 0.7)
Peritoneum, Omentum and Mesentery 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Other Digestive Organs 0.4 ( 0.4- 0.4) 0.4 ( 0.3- 0.4) 0.6 ( 0.4- 0.8) 0.6 ( 0.3- 0.9) ∼ 0.3 ( 0.2- 0.5)
Respiratory System 94.7 ( 94.1- 95.3) 93.6 ( 93.0- 94.2) 117.9 (115.7-120.2) 52.2 ( 49.7- 54.7) 52.3 ( 46.8- 58.4) 57.7 ( 55.9- 59.6)
Nose, Nasal Cavity and Middle Ear 0.9 ( 0.8- 0.9) 0.9 ( 0.8- 0.9) 0.9 ( 0.8- 1.1) 0.5 ( 0.3- 0.8) ∼ 0.7 ( 0.5- 0.9)
Larynx 7.2 ( 7.0- 7.3) 6.9 ( 6.7- 7.1) 11.1 ( 10.5- 11.8) 2.9 ( 2.4- 3.6) 4.0 ( 2.6- 6.1) 6.1 ( 5.6- 6.7)
Lung and Bronchus 86.4 ( 85.8- 86.9) 85.6 ( 85.0- 86.1) 105.7 (103.5-107.8) 48.7 ( 46.3- 51.1) 47.9 ( 42.6- 53.8) 50.6 ( 48.8- 52.4)
Pleura 0.1 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.2 ( 0.1- 0.3) ∼ ∼ 0.3 ( 0.2- 0.4)
Bones and Joints 1.1 ( 1.0- 1.1) 1.1 ( 1.0- 1.1) 1.0 ( 0.9- 1.2) 0.7 ( 0.5- 1.0) ∼ 1.0 ( 0.9- 1.3)
Soft Tissue including Heart 3.4 ( 3.3- 3.6) 3.5 ( 3.3- 3.6) 3.1 ( 2.8- 3.5) 2.1 ( 1.7- 2.6) ∼ 3.0 ( 2.6- 3.4)
Skin excluding Basal and Squamous 22.7 ( 22.4- 22.9) 24.6 ( 24.3- 24.9) 1.7 ( 1.5- 2.0) 2.1 ( 1.7- 2.7) 3.8 ( 2.6- 5.6) 5.4 ( 4.8- 5.9)
Melanomas of the Skin 20.9 ( 20.6- 21.1) 22.8 ( 22.5- 23.1) 0.9 ( 0.7- 1.1) 1.4 ( 1.1- 1.9) 3.5 ( 2.3- 5.3) 4.5 ( 4.1- 5.1)
Other Non-Epithelial Skin 1.8 ( 1.7- 1.9) 1.9 ( 1.8- 1.9) 0.8 ( 0.7- 1.0) 0.7 ( 0.4- 1.0) ∼ 0.8 ( 0.6- 1.1)
Breast 1.4 ( 1.3- 1.5) 1.4 ( 1.3- 1.4) 1.8 ( 1.5- 2.1) 0.6 ( 0.4- 0.9) ∼ 0.8 ( 0.6- 1.1)
Male Genital System 167.3 (166.6-168.1) 158.3 (157.5-159.1) 236.6 (233.5-239.9) 86.0 ( 83.0- 89.2) 78.2 ( 71.3- 85.6) 139.9 (137.2-142.7)
Prostate 161.2 (160.4-161.9) 151.5 (150.7-152.2) 234.1 (230.9-237.3) 84.0 ( 81.0- 87.2) 74.2 ( 67.5- 81.5) 135.1 (132.4-137.9)
Testis 5.1 ( 5.0- 5.2) 5.8 ( 5.6- 5.9) 1.4 ( 1.2- 1.6) 1.4 ( 1.1- 1.7) 3.0 ( 2.2- 4.4) 3.5 ( 3.2- 3.8)
Penis 0.8 ( 0.8- 0.9) 0.8 ( 0.8- 0.9) 1.0 ( 0.8- 1.2) ∼ ∼ 1.2 ( 1.0- 1.5)
Other Male Genital Organs 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) ∼ ∼ ∼ ∼
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Table 1.1.1.1M: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by Primary
Site and Race and Ethnicity, United States†‡ (continued)
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander§ Alaska Native§ Hispanic§‖
Urinary System 56.3 ( 55.8- 56.7) 58.4 ( 57.9- 58.9) 37.2 ( 35.9- 38.5) 23.2 ( 21.6- 24.9) 23.7 ( 20.1- 28.1) 37.5 ( 36.0- 39.0)
Urinary Bladder¶ 37.0 ( 36.7- 37.4) 39.0 ( 38.6- 39.4) 17.7 ( 16.8- 18.7) 15.4 ( 14.1- 16.9) 9.3 ( 6.9- 12.5) 19.9 ( 18.8- 21.0)
Kidney and Renal Pelvis 18.0 ( 17.8- 18.2) 18.1 ( 17.8- 18.3) 18.8 ( 18.0- 19.7) 6.9 ( 6.1- 7.8) 14.1 ( 11.4- 17.3) 16.9 ( 16.0- 17.9)
Ureter 0.9 ( 0.8- 0.9) 0.9 ( 0.9- 1.0) 0.2 ( 0.2- 0.4) 0.7 ( 0.4- 1.0) ∼ 0.4 ( 0.3- 0.6)
Other Urinary Organs 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.3 ( 0.2- 0.5) ∼ ∼ 0.3 ( 0.2- 0.5)
Eye and Orbit 0.9 ( 0.9- 1.0) 1.0 ( 0.9- 1.0) 0.3 ( 0.2- 0.4) ∼ ∼ 0.6 ( 0.5- 0.8)
Brain and Other Nervous System 7.8 ( 7.6- 7.9) 8.2 ( 8.0- 8.4) 4.4 ( 4.1- 4.9) 4.0 ( 3.4- 4.7) 3.0 ( 2.1- 4.6) 6.1 ( 5.6- 6.6)
Brain 7.4 ( 7.2- 7.5) 7.8 ( 7.7- 8.0) 4.2 ( 3.8- 4.6) 3.7 ( 3.2- 4.3) 2.8 ( 1.9- 4.4) 5.8 ( 5.3- 6.3)
Cranial Nerves and Other Nervous System 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼ 0.3 ( 0.2- 0.4)
Endocrine System 5.0 ( 4.9- 5.1) 5.1 ( 5.0- 5.3) 3.1 ( 2.7- 3.4) 4.8 ( 4.2- 5.5) 1.5 ( 0.8- 2.9) 4.2 ( 3.8- 4.7)
Thyroid 4.3 ( 4.2- 4.4) 4.5 ( 4.3- 4.6) 2.2 ( 1.9- 2.5) 4.0 ( 3.4- 4.6) 1.4 ( 0.8- 2.8) 3.6 ( 3.3- 4.0)
Other Endocrine including Thymus 0.7 ( 0.7- 0.8) 0.7 ( 0.6- 0.7) 0.9 ( 0.7- 1.1) 0.8 ( 0.6- 1.1) ∼ 0.6 ( 0.5- 0.8)
Lymphomas 25.1 ( 24.8- 25.4) 25.6 ( 25.2- 25.9) 19.1 ( 18.2- 19.9) 15.7 ( 14.5- 17.1) 10.7 ( 8.5- 13.6) 22.6 ( 21.6- 23.7)
Hodgkin Lymphoma 3.1 ( 3.0- 3.2) 3.2 ( 3.1- 3.3) 2.7 ( 2.4- 3.0) 1.3 ( 1.0- 1.7) ∼ 2.9 ( 2.5- 3.2)
Non-Hodgkin Lymphoma 22.0 ( 21.7- 22.3) 22.4 ( 22.1- 22.6) 16.4 ( 15.6- 17.2) 14.4 ( 13.1- 15.7) 9.7 ( 7.5- 12.5) 19.8 ( 18.8- 20.8)
Multiple Myeloma 6.5 ( 6.3- 6.6) 6.0 ( 5.9- 6.2) 12.0 ( 11.3- 12.7) 3.2 ( 2.6- 3.8) 3.5 ( 2.3- 5.4) 5.6 ( 5.0- 6.2)
Leukemias 14.6 ( 14.4- 14.8) 15.0 ( 14.7- 15.2) 11.0 ( 10.3- 11.7) 7.7 ( 6.9- 8.6) 6.1 ( 4.5- 8.4) 11.7 ( 10.9- 12.5)
Acute Lymphocytic 1.6 ( 1.5- 1.7) 1.7 ( 1.6- 1.8) 0.9 ( 0.8- 1.1) 1.3 ( 1.0- 1.7) 1.6 ( 0.9- 3.0) 2.2 ( 2.0- 2.4)
Chronic Lymphocytic 4.7 ( 4.6- 4.8) 4.8 ( 4.6- 4.9) 3.6 ( 3.2- 4.1) 0.9 ( 0.6- 1.3) ∼ 2.4 ( 2.1- 2.9)
Acute Myeloid 4.5 ( 4.4- 4.6) 4.6 ( 4.5- 4.7) 3.4 ( 3.0- 3.8) 3.3 ( 2.8- 4.0) 1.9 ( 1.0- 3.4) 3.8 ( 3.3- 4.3)
Chronic Myeloid 1.7 ( 1.6- 1.8) 1.7 ( 1.6- 1.8) 1.4 ( 1.2- 1.7) 1.0 ( 0.8- 1.4) ∼ 1.7 ( 1.4- 2.1)
Other Leukemias 2.1 ( 2.1- 2.2) 2.2 ( 2.1- 2.3) 1.6 ( 1.4- 1.9) 1.1 ( 0.8- 1.5) ∼ 1.6 ( 1.3- 2.0)
Mesothelioma 2.0 ( 2.0- 2.1) 2.2 ( 2.1- 2.3) 1.0 ( 0.8- 1.2) ∼ ∼ 1.5 ( 1.2- 1.8)
Kaposi Sarcoma 0.8 ( 0.8- 0.9) 0.7 ( 0.6- 0.7) 1.9 ( 1.6- 2.1) 0.4 ( 0.3- 0.7) ∼ 1.5 ( 1.3- 1.8)
Miscellaneous 13.4 ( 13.2- 13.6) 13.2 ( 13.0- 13.4) 16.2 ( 15.3- 17.0) 7.1 ( 6.2- 8.1) 8.5 ( 6.3- 11.2) 11.2 ( 10.4- 12.1)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for data
quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
¶ Includes invasive and in situ.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.1.1.1F: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by Primary
Site and Race and Ethnicity, United States†‡
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander§ Alaska Native§ Hispanic§‖
All Sites 405.0 (403.9-406.0) 408.9 (407.8-410.0) 377.5 (374.3-380.7) 264.5 (260.0-269.0) 215.4 (206.1-225.2) 310.4 (307.0-313.8)
Oral Cavity and Pharynx 6.0 ( 5.9- 6.1) 6.0 ( 5.9- 6.1) 5.5 ( 5.1- 5.9) 4.8 ( 4.3- 5.5) 3.2 ( 2.1- 4.6) 3.7 ( 3.3- 4.1)
Lip 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) ∼ ∼ ∼ 0.2 ( 0.1- 0.3)
Tongue 1.6 ( 1.5- 1.6) 1.6 ( 1.5- 1.7) 1.2 ( 1.0- 1.4) 1.3 ( 1.0- 1.7) ∼ 1.0 ( 0.8- 1.2)
Salivary Gland 0.9 ( 0.9- 1.0) 0.9 ( 0.8- 0.9) 0.8 ( 0.7- 1.0) 0.9 ( 0.7- 1.2) ∼ 0.7 ( 0.6- 0.9)
Floor of Mouth 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼ ∼
Gum and Other Mouth 1.2 ( 1.2- 1.3) 1.2 ( 1.2- 1.3) 1.1 ( 1.0- 1.3) 0.8 ( 0.5- 1.1) ∼ 0.9 ( 0.7- 1.1)
Nasopharynx 0.3 ( 0.3- 0.4) 0.3 ( 0.2- 0.3) 0.4 ( 0.3- 0.6) 1.3 ( 1.0- 1.7) ∼ 0.2 ( 0.2- 0.4)
Tonsil 0.6 ( 0.5- 0.6) 0.6 ( 0.5- 0.6) 0.6 ( 0.4- 0.7) ∼ ∼ 0.2 ( 0.1- 0.3)
Oropharynx 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.3 ( 0.2- 0.4) ∼ ∼ ∼
Hypopharynx 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.4 ( 0.3- 0.5) ∼ ∼ ∼
Other Oral Cavity and Pharynx 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Digestive System 71.4 ( 71.0- 71.8) 68.9 ( 68.5- 69.4) 88.1 ( 86.5- 89.7) 66.4 ( 64.1- 68.8) 48.0 ( 43.5- 52.9) 68.7 ( 67.1- 70.4)
Esophagus 2.0 ( 1.9- 2.1) 1.8 ( 1.8- 1.9) 3.4 ( 3.1- 3.8) 1.2 ( 0.9- 1.6) ∼ 1.2 ( 1.0- 1.5)
Stomach 4.8 ( 4.7- 4.9) 4.2 ( 4.0- 4.3) 8.6 ( 8.1- 9.1) 10.0 ( 9.1- 11.0) 4.7 ( 3.3- 6.4) 8.7 ( 8.1- 9.3)
Small Intestine 1.5 ( 1.4- 1.6) 1.4 ( 1.4- 1.5) 2.2 ( 2.0- 2.5) 0.8 ( 0.5- 1.1) ∼ 1.4 ( 1.1- 1.6)
Colon and Rectum 44.9 ( 44.6- 45.2) 43.9 ( 43.6- 44.3) 51.8 ( 50.6- 53.0) 34.3 ( 32.6- 36.1) 26.8 ( 23.4- 30.5) 34.9 ( 33.8- 36.2)
Colon excluding Rectum 34.1 ( 33.8- 34.4) 33.2 ( 32.9- 33.5) 41.2 ( 40.2- 42.3) 24.3 ( 22.9- 25.8) 19.6 ( 16.7- 22.8) 26.0 ( 25.0- 27.1)
Rectum and Rectosigmoid Junction 10.8 ( 10.7- 11.0) 10.7 ( 10.6- 10.9) 10.6 ( 10.0- 11.1) 10.0 ( 9.1- 10.9) 7.2 ( 5.6- 9.2) 9.0 ( 8.4- 9.6)
Anus, Anal Canal and Anorectum 1.5 ( 1.5- 1.6) 1.6 ( 1.5- 1.7) 1.3 ( 1.1- 1.5) 0.6 ( 0.4- 0.8) ∼ 1.6 ( 1.3- 1.9)
Liver and Intrahepatic Bile Duct 2.8 ( 2.8- 2.9) 2.6 ( 2.5- 2.6) 3.6 ( 3.3- 3.9) 7.4 ( 6.7- 8.3) 2.2 ( 1.4- 3.5) 5.8 ( 5.3- 6.3)
Gallbladder 1.3 ( 1.3- 1.4) 1.3 ( 1.2- 1.3) 1.7 ( 1.5- 1.9) 1.3 ( 1.0- 1.7) 2.4 ( 1.5- 3.8) 2.7 ( 2.4- 3.1)
Other Biliary 1.3 ( 1.3- 1.4) 1.3 ( 1.2- 1.4) 1.3 ( 1.1- 1.5) 2.2 ( 1.8- 2.7) ∼ 1.7 ( 1.4- 2.0)
Pancreas 9.5 ( 9.4- 9.7) 9.2 ( 9.0- 9.4) 12.9 ( 12.3- 13.5) 7.4 ( 6.7- 8.3) 6.7 ( 5.0- 8.7) 9.4 ( 8.7- 10.0)
Retroperitoneum 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.5 ( 0.4- 0.6) 0.3 ( 0.2- 0.5) ∼ 0.4 ( 0.3- 0.5)
Peritoneum, Omentum and Mesentery 0.9 ( 0.9- 1.0) 1.0 ( 0.9- 1.0) 0.4 ( 0.3- 0.5) 0.5 ( 0.3- 0.8) ∼ 0.6 ( 0.5- 0.8)
Other Digestive Organs 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.4 ( 0.3- 0.5) ∼ ∼ 0.4 ( 0.3- 0.5)
Respiratory System 55.8 ( 55.4- 56.2) 57.0 ( 56.6- 57.4) 53.1 ( 51.9- 54.3) 27.4 ( 25.9- 28.9) 33.8 ( 30.0- 37.9) 26.5 ( 25.5- 27.6)
Nose, Nasal Cavity and Middle Ear 0.5 ( 0.5- 0.5) 0.5 ( 0.5- 0.5) 0.4 ( 0.3- 0.5) 0.4 ( 0.2- 0.6) ∼ 0.5 ( 0.4- 0.7)
Larynx 1.5 ( 1.4- 1.6) 1.4 ( 1.4- 1.5) 2.3 ( 2.1- 2.6) ∼ ∼ 0.7 ( 0.6- 0.9)
Lung and Bronchus 53.7 ( 53.3- 54.1) 54.9 ( 54.5- 55.3) 50.3 ( 49.1- 51.5) 26.7 ( 25.2- 28.2) 32.9 ( 29.2- 37.0) 25.2 ( 24.2- 26.2)
Pleura 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Bones and Joints 0.8 ( 0.7- 0.8) 0.8 ( 0.7- 0.8) 0.7 ( 0.6- 0.8) 0.5 ( 0.4- 0.8) ∼ 0.7 ( 0.6- 0.8)
Soft Tissue including Heart 2.5 ( 2.4- 2.5) 2.4 ( 2.4- 2.5) 2.7 ( 2.5- 3.0) 1.5 ( 1.2- 1.9) 1.7 ( 1.0- 2.8) 2.2 ( 2.0- 2.5)
Skin excluding Basal and Squamous 14.7 ( 14.5- 14.9) 16.2 ( 16.0- 16.5) 1.7 ( 1.5- 1.9) 1.9 ( 1.5- 2.3) 2.8 ( 1.8- 4.1) 4.7 ( 4.3- 5.1)
Melanomas of the Skin 13.6 ( 13.4- 13.8) 15.2 ( 15.0- 15.4) 0.9 ( 0.7- 1.1) 1.2 ( 0.9- 1.6) 2.3 ( 1.4- 3.5) 3.9 ( 3.6- 4.3)
Other Non-Epithelial Skin 1.1 ( 1.0- 1.1) 1.0 ( 1.0- 1.1) 0.8 ( 0.7- 1.0) 0.6 ( 0.4- 0.9) ∼ 0.7 ( 0.6- 0.9)
Breast 124.9 (124.4-125.5) 126.8 (126.2-127.4) 110.1 (108.4-111.8) 79.8 ( 77.4- 82.2) 56.7 ( 52.1- 61.6) 88.7 ( 86.9- 90.5)
Female Genital System 48.9 ( 48.6- 49.3) 49.4 ( 49.0- 49.8) 45.3 ( 44.2- 46.4) 33.6 ( 32.0- 35.1) 25.1 ( 22.1- 28.4) 44.9 ( 43.6- 46.1)
Cervix 8.7 ( 8.5- 8.8) 8.2 ( 8.0- 8.4) 12.4 ( 11.8- 12.9) 7.7 ( 7.0- 8.5) 4.9 ( 3.7- 6.4) 13.1 ( 12.5- 13.7)
Corpus 22.8 ( 22.6- 23.0) 23.4 ( 23.1- 23.7) 18.4 ( 17.7- 19.1) 14.1 ( 13.1- 15.2) 11.5 ( 9.5- 13.9) 17.3 ( 16.5- 18.1)
Uterus, NOS 0.8 ( 0.7- 0.8) 0.7 ( 0.6- 0.7) 1.4 ( 1.2- 1.6) 0.4 ( 0.2- 0.6) ∼ 0.6 ( 0.5- 0.8)
Ovary 13.1 ( 12.9- 13.2) 13.5 ( 13.3- 13.7) 9.8 ( 9.3- 10.4) 9.5 ( 8.7- 10.4) 5.4 ( 4.0- 7.1) 11.0 ( 10.3- 11.6)
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Table 1.1.1.1F: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by Primary
Site and Race and Ethnicity, United States†‡ (continued)
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander§ Alaska Native§ Hispanic§‖
Vagina 0.7 ( 0.7- 0.8) 0.7 ( 0.6- 0.7) 1.0 ( 0.9- 1.2) 0.6 ( 0.4- 0.9) ∼ 0.8 ( 0.6- 1.0)
Vulva 2.3 ( 2.2- 2.4) 2.4 ( 2.3- 2.4) 1.7 ( 1.4- 1.9) 0.8 ( 0.6- 1.1) ∼ 1.6 ( 1.4- 1.9)
Other Female Genital Organs 0.7 ( 0.6- 0.7) 0.7 ( 0.6- 0.7) 0.6 ( 0.5- 0.7) 0.5 ( 0.3- 0.7) ∼ 0.5 ( 0.4- 0.6)
Urinary System 19.1 ( 18.9- 19.3) 19.5 ( 19.3- 19.8) 17.5 ( 16.9- 18.3) 6.9 ( 6.2- 7.7) 10.6 ( 8.5- 13.0) 14.8 ( 14.1- 15.6)
Urinary Bladder¶ 9.4 ( 9.3- 9.6) 9.8 ( 9.6- 10.0) 7.1 ( 6.7- 7.6) 2.9 ( 2.4- 3.5) 3.2 ( 2.1- 4.7) 5.6 ( 5.1- 6.1)
Kidney and Renal Pelvis 9.2 ( 9.1- 9.4) 9.2 ( 9.1- 9.4) 10.0 ( 9.5- 10.5) 3.6 ( 3.1- 4.2) 7.2 ( 5.6- 9.3) 9.0 ( 8.4- 9.6)
Ureter 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.4) 0.2 ( 0.1- 0.3) ∼ ∼ 0.2 ( 0.1- 0.3)
Other Urinary Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.2 ( 0.2- 0.3) ∼ ∼ ∼
Eye and Orbit 0.6 ( 0.6- 0.7) 0.7 ( 0.6- 0.7) 0.2 ( 0.1- 0.3) ∼ ∼ 0.6 ( 0.4- 0.7)
Brain and Other Nervous System 5.5 ( 5.4- 5.6) 5.9 ( 5.7- 6.0) 3.3 ( 3.0- 3.6) 3.0 ( 2.5- 3.5) 2.1 ( 1.3- 3.3) 4.7 ( 4.4- 5.2)
Brain 5.1 ( 5.0- 5.2) 5.4 ( 5.3- 5.6) 2.9 ( 2.6- 3.2) 2.7 ( 2.3- 3.2) 2.0 ( 1.3- 3.2) 4.3 ( 4.0- 4.7)
Cranial Nerves and Other Nervous System 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.4 ( 0.3- 0.5) 0.3 ( 0.2- 0.5) ∼ 0.4 ( 0.3- 0.6)
Endocrine System 12.6 ( 12.4- 12.8) 13.1 ( 12.9- 13.3) 8.0 ( 7.6- 8.5) 13.1 ( 12.2- 14.0) 5.6 ( 4.3- 7.2) 12.6 ( 12.0- 13.2)
Thyroid 12.1 ( 11.9- 12.3) 12.5 ( 12.3- 12.7) 7.4 ( 6.9- 7.8) 12.4 ( 11.6- 13.4) 5.5 ( 4.2- 7.1) 12.1 ( 11.5- 12.7)
Other Endocrine including Thymus 0.6 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 0.7 ( 0.5- 0.8) 0.6 ( 0.4- 0.9) ∼ 0.5 ( 0.4- 0.7)
Lymphomas 17.9 ( 17.7- 18.2) 18.6 ( 18.3- 18.8) 12.5 ( 11.9- 13.1) 10.9 ( 10.0- 11.8) 8.8 ( 7.0- 11.0) 15.5 ( 14.8- 16.3)
Hodgkin Lymphoma 2.5 ( 2.4- 2.5) 2.6 ( 2.5- 2.7) 2.0 ( 1.8- 2.3) 1.1 ( 0.8- 1.4) ∼ 1.9 ( 1.7- 2.1)
Non-Hodgkin Lymphoma 15.5 ( 15.3- 15.7) 16.0 ( 15.7- 16.2) 10.5 ( 9.9- 11.0) 9.8 ( 9.0- 10.8) 8.1 ( 6.4- 10.2) 13.7 ( 12.9- 14.4)
Multiple Myeloma 4.2 ( 4.1- 4.3) 3.7 ( 3.6- 3.8) 8.4 ( 8.0- 8.9) 2.5 ( 2.1- 3.1) 3.7 ( 2.5- 5.2) 4.3 ( 3.9- 4.7)
Leukemias 8.8 ( 8.7- 9.0) 8.9 ( 8.8- 9.1) 7.1 ( 6.7- 7.5) 5.5 ( 4.9- 6.2) 4.2 ( 3.1- 5.7) 7.7 ( 7.2- 8.2)
Acute Lymphocytic 1.2 ( 1.2- 1.3) 1.3 ( 1.2- 1.4) 0.7 ( 0.6- 0.8) 1.3 ( 1.0- 1.6) ∼ 1.8 ( 1.6- 2.0)
Chronic Lymphocytic 2.5 ( 2.4- 2.5) 2.5 ( 2.4- 2.6) 1.8 ( 1.6- 2.1) 0.7 ( 0.5- 1.0) ∼ 1.2 ( 1.0- 1.5)
Acute Myeloid 2.9 ( 2.8- 3.0) 2.9 ( 2.8- 3.0) 2.5 ( 2.2- 2.8) 2.3 ( 1.9- 2.8) 1.2 ( 0.7- 2.0) 2.7 ( 2.4- 3.1)
Chronic Myeloid 1.0 ( 1.0- 1.1) 1.0 ( 1.0- 1.1) 0.9 ( 0.7- 1.0) 0.7 ( 0.5- 0.9) ∼ 0.8 ( 0.7- 1.0)
Other Leukemias 1.2 ( 1.2- 1.3) 1.2 ( 1.2- 1.3) 1.2 ( 1.0- 1.4) 0.5 ( 0.4- 0.8) ∼ 1.1 ( 0.9- 1.4)
Mesothelioma 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.2 ( 0.1- 0.3) ∼ ∼ 0.4 ( 0.2- 0.5)
Kaposi Sarcoma 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.2 ( 0.1- 0.3) ∼ ∼ 0.2 ( 0.2- 0.4)
Miscellaneous 10.6 ( 10.5- 10.8) 10.4 ( 10.2- 10.6) 12.8 ( 12.2- 13.4) 6.4 ( 5.6- 7.1) 8.8 ( 6.9- 11.1) 9.4 ( 8.7- 10.0)
Breast, in situ ∗∗ 28.6 ( 28.4- 28.9) 29.0 ( 28.7- 29.3) 23.5 ( 22.7- 24.3) 23.0 ( 21.7- 24.3) 11.3 ( 9.3- 13.7) 18.3 ( 17.6- 19.2)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for data
quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
¶ Includes invasive and in situ.
∗∗ Rates for in situ female breast cancer are listed separately and are not included in rates for the "all sites" category.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.1.1.2M: Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by Primary Site and
Race and Ethnicity, United States†
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 239.9 (239.0-240.7) 236.0 (235.0-236.9) 322.9 (319.3-326.6) 138.8 (134.9-142.9) 145.3 (136.0-155.3) 163.9 (160.8-167.1)
Oral Cavity and Pharynx 4.1 ( 4.0- 4.2) 3.9 ( 3.7- 4.0) 6.3 ( 5.8- 6.8) 3.2 ( 2.7- 3.9) 3.2 ( 2.0- 5.0) 2.7 ( 2.3- 3.1)
Lip 0.0 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Tongue 0.9 ( 0.9- 1.0) 0.9 ( 0.9- 1.0) 1.3 ( 1.1- 1.5) 0.6 ( 0.4- 0.9) ∼ 0.7 ( 0.5- 0.9)
Salivary Gland 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.4) 0.2 ( 0.1- 0.4) ∼ ∼ ∼
Floor of Mouth 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.3) ∼ ∼ ∼
Gum and Other Mouth 0.5 ( 0.5- 0.6) 0.5 ( 0.5- 0.5) 0.8 ( 0.6- 1.0) ∼ ∼ 0.3 ( 0.2- 0.4)
Nasopharynx 0.3 ( 0.3- 0.3) 0.2 ( 0.2- 0.3) 0.4 ( 0.3- 0.5) 1.6 ( 1.2- 2.0) ∼ 0.2 ( 0.1- 0.3)
Tonsil 0.4 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.6 ( 0.5- 0.8) ∼ ∼ 0.3 ( 0.1- 0.4)
Oropharynx 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.3) 0.7 ( 0.6- 0.9) ∼ ∼ 0.3 ( 0.2- 0.4)
Hypopharynx 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.3 ( 0.2- 0.5) ∼ ∼ ∼
Other Oral Cavity and Pharynx 0.9 ( 0.9- 1.0) 0.8 ( 0.8- 0.9) 1.8 ( 1.6- 2.1) ∼ ∼ 0.6 ( 0.4- 0.9)
Digestive System 59.1 ( 58.7- 59.5) 56.9 ( 56.5- 57.4) 83.8 ( 82.0- 85.7) 54.1 ( 51.7- 56.7) 43.4 ( 38.4- 48.9) 51.8 ( 50.1- 53.6)
Esophagus 7.8 ( 7.6- 8.0) 7.8 ( 7.6- 7.9) 10.2 ( 9.6- 10.9) 2.8 ( 2.2- 3.4) 5.5 ( 3.8- 8.0) 4.2 ( 3.8- 4.8)
Stomach 5.9 ( 5.8- 6.1) 5.2 ( 5.1- 5.4) 12.0 ( 11.3- 12.8) 9.8 ( 8.8- 11.0) 6.4 ( 4.5- 8.9) 8.9 ( 8.2- 9.7)
Small Intestine 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.7 ( 0.5- 0.9) ∼ ∼ 0.3 ( 0.1- 0.4)
Colon and Rectum 23.8 ( 23.5- 24.1) 23.2 ( 22.9- 23.5) 33.4 ( 32.2- 34.6) 15.9 ( 14.5- 17.3) 16.1 ( 13.2- 19.6) 17.1 ( 16.1- 18.2)
Colon excluding Rectum 19.9 ( 19.6- 20.2) 19.3 ( 19.1- 19.6) 28.7 ( 27.6- 29.9) 12.9 ( 11.7- 14.2) 12.1 ( 9.6- 15.3) 14.6 ( 13.6- 15.6)
Rectum and Rectosigmoid Junction 3.9 ( 3.8- 4.0) 3.8 ( 3.7- 4.0) 4.6 ( 4.2- 5.1) 3.0 ( 2.4- 3.6) 3.9 ( 2.6- 5.9) 2.5 ( 2.2- 2.9)
Anus, Anal Canal and Anorectum 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Liver and Intrahepatic Bile Duct 7.2 ( 7.0- 7.3) 6.5 ( 6.4- 6.7) 10.0 ( 9.4- 10.6) 15.9 ( 14.6- 17.2) 7.2 ( 5.4- 9.8) 10.9 ( 10.1- 11.7)
Gallbladder 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.7) 0.7 ( 0.4- 1.1) ∼ 0.8 ( 0.6- 1.1)
Other Biliary 0.6 ( 0.6- 0.7) 0.6 ( 0.6- 0.7) 0.6 ( 0.4- 0.8) 0.8 ( 0.5- 1.2) ∼ 0.6 ( 0.4- 0.9)
Pancreas 12.2 ( 12.0- 12.4) 12.0 ( 11.8- 12.2) 15.4 ( 14.7- 16.3) 7.8 ( 6.9- 8.8) 6.4 ( 4.6- 8.9) 8.6 ( 7.9- 9.3)
Retroperitoneum 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Peritoneum, Omentum and Mesentery 0.1 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Other Digestive Organs 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.7 ( 0.5- 0.9) ∼ ∼ 0.3 ( 0.2- 0.5)
Respiratory System 76.2 ( 75.7- 76.7) 75.2 ( 74.7- 75.8) 100.9 ( 99.0-103.0) 37.4 ( 35.3- 39.5) 43.4 ( 38.4- 49.1) 38.7 ( 37.2- 40.2)
Nose, Nasal Cavity and Middle Ear 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.3) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Larynx 2.3 ( 2.2- 2.4) 2.1 ( 2.1- 2.2) 4.8 ( 4.4- 5.3) 0.5 ( 0.3- 0.9) ∼ 1.8 ( 1.5- 2.1)
Lung and Bronchus 73.5 ( 73.0- 74.0) 72.7 ( 72.2- 73.2) 95.7 ( 93.8- 97.7) 36.6 ( 34.6- 38.8) 42.1 ( 37.2- 47.7) 36.7 ( 35.2- 38.2)
Pleura 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.2) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Bones and Joints 0.5 ( 0.5- 0.5) 0.5 ( 0.5- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼ 0.5 ( 0.4- 0.7)
Soft Tissue including Heart 1.4 ( 1.3- 1.5) 1.4 ( 1.3- 1.5) 1.5 ( 1.3- 1.7) 0.8 ( 0.5- 1.1) ∼ 1.3 ( 1.0- 1.6)
Skin excluding Basal and Squamous 5.2 ( 5.0- 5.3) 5.7 ( 5.6- 5.8) 1.5 ( 1.3- 1.8) 0.7 ( 0.5- 1.1) ∼ 1.5 ( 1.2- 1.9)
Melanomas of the Skin 3.8 ( 3.7- 3.9) 4.2 ( 4.1- 4.4) 0.5 ( 0.4- 0.7) 0.6 ( 0.4- 0.9) ∼ 0.8 ( 0.6- 1.1)
Other Non-Epithelial Skin 1.4 ( 1.3- 1.5) 1.5 ( 1.4- 1.5) 1.0 ( 0.8- 1.2) ∼ ∼ 0.7 ( 0.5- 0.9)
Breast 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.6 ( 0.5- 0.8) ∼ ∼ ∼
Male Genital System 28.6 ( 28.3- 28.9) 26.3 ( 26.0- 26.7) 63.4 ( 61.6- 65.2) 10.5 ( 9.3- 11.8) 16.4 ( 13.0- 20.5) 22.6 ( 21.3- 24.0)
Prostate 28.1 ( 27.8- 28.4) 25.8 ( 25.5- 26.2) 63.0 ( 61.2- 64.8) 10.3 ( 9.1- 11.6) 15.7 ( 12.4- 19.8) 22.0 ( 20.7- 23.3)
Testis 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.2 ( 0.1- 0.3) ∼ ∼ 0.3 ( 0.2- 0.4)
Penis 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.3) ∼ ∼ 0.3 ( 0.2- 0.5)
Other Male Genital Organs 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
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Table 1.1.1.2M: Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by Primary Site and
Race and Ethnicity, United States† (continued)
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
Urinary System 13.9 ( 13.7- 14.2) 14.4 ( 14.2- 14.7) 11.6 ( 10.9- 12.3) 5.6 ( 4.8- 6.6) 11.2 ( 8.8- 14.4) 9.7 ( 8.9- 10.5)
Urinary Bladder 7.5 ( 7.3- 7.7) 7.8 ( 7.7- 8.0) 5.5 ( 5.0- 6.1) 3.1 ( 2.5- 3.8) 2.8 ( 1.5- 4.8) 4.2 ( 3.7- 4.8)
Kidney and Renal Pelvis 6.1 ( 6.0- 6.3) 6.3 ( 6.1- 6.4) 5.8 ( 5.4- 6.3) 2.3 ( 1.8- 2.9) 8.0 ( 6.0- 10.6) 5.3 ( 4.8- 5.9)
Ureter 0.1 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) ∼ ∼ ∼ ∼
Other Urinary Organs 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) ∼ ∼ ∼ ∼
Eye and Orbit 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Brain and Other Nervous System 5.5 ( 5.3- 5.6) 5.8 ( 5.7- 6.0) 3.2 ( 2.9- 3.6) 3.0 ( 2.5- 3.6) 2.0 ( 1.2- 3.4) 3.5 ( 3.1- 3.9)
Endocrine System 0.8 ( 0.7- 0.8) 0.8 ( 0.7- 0.8) 0.7 ( 0.6- 0.9) 0.7 ( 0.5- 1.1) ∼ 0.8 ( 0.6- 1.0)
Thyroid 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼ 0.6 ( 0.4- 0.8)
Other Endocrine including Thymus 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) 0.3 ( 0.2- 0.6) ∼ 0.2 ( 0.1- 0.3)
Lymphoma 10.2 ( 10.0- 10.4) 10.6 ( 10.4- 10.8) 7.4 ( 6.9- 8.0) 5.5 ( 4.8- 6.4) 3.0 ( 1.9- 4.7) 7.2 ( 6.6- 7.9)
Hodgkin Lymphoma 0.6 ( 0.5- 0.6) 0.6 ( 0.5- 0.6) 0.6 ( 0.4- 0.7) ∼ ∼ 0.5 ( 0.3- 0.7)
Non-Hodgkin Lymphoma 9.6 ( 9.4- 9.8) 10.0 ( 9.8- 10.2) 6.9 ( 6.4- 7.4) 5.3 ( 4.5- 6.1) 3.0 ( 1.9- 4.7) 6.7 ( 6.1- 7.4)
Multiple Myeloma 4.8 ( 4.6- 4.9) 4.5 ( 4.4- 4.7) 8.3 ( 7.7- 8.9) 1.8 ( 1.4- 2.4) 2.5 ( 1.4- 4.4) 4.3 ( 3.8- 4.8)
Leukemias 10.1 ( 9.9- 10.3) 10.4 ( 10.2- 10.6) 8.8 ( 8.2- 9.4) 5.2 ( 4.5- 6.0) 4.9 ( 3.3- 7.1) 6.1 ( 5.6- 6.8)
Acute Lymphocytic 0.6 ( 0.6- 0.6) 0.6 ( 0.6- 0.7) 0.4 ( 0.3- 0.5) 0.6 ( 0.4- 0.9) ∼ 0.8 ( 0.6- 1.0)
Chronic Lymphocytic 2.2 ( 2.2- 2.3) 2.3 ( 2.2- 2.4) 2.2 ( 1.9- 2.5) ∼ ∼ 0.7 ( 0.5- 1.0)
Acute Myeloid 3.6 ( 3.5- 3.7) 3.7 ( 3.6- 3.9) 2.6 ( 2.3- 3.0) 2.4 ( 1.9- 3.0) 2.0 ( 1.1- 3.7) 2.1 ( 1.8- 2.5)
Chronic Myeloid 0.6 ( 0.6- 0.7) 0.6 ( 0.5- 0.6) 0.9 ( 0.7- 1.1) 0.4 ( 0.2- 0.7) ∼ 0.5 ( 0.3- 0.7)
Other Leukemias 3.0 ( 2.9- 3.1) 3.1 ( 3.0- 3.2) 2.8 ( 2.4- 3.1) 1.6 ( 1.2- 2.1) ∼ 2.1 ( 1.7- 2.5)
Mesothelioma 1.7 ( 1.6- 1.8) 1.8 ( 1.7- 1.9) 0.8 ( 0.6- 1.0) ∼ ∼ 1.0 ( 0.8- 1.3)
Miscellaneous 17.6 ( 17.3- 17.8) 17.3 ( 17.0- 17.5) 23.5 ( 22.5- 24.5) 9.6 ( 8.6- 10.7) 11.1 ( 8.7- 14.2) 12.0 ( 11.2- 12.9)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.1.1.2F: Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by Primary Site and
Race and Ethnicity, United States†
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 162.7 (162.1-163.4) 161.9 (161.3-162.6) 190.9 (188.8-193.1) 96.6 ( 93.8- 99.4) 114.5 (107.6-121.8) 107.4 (105.3-109.5)
Oral Cavity and Pharynx 1.5 ( 1.5- 1.6) 1.5 ( 1.4- 1.6) 1.7 ( 1.5- 1.9) 1.6 ( 1.3- 2.1) 1.5 ( 0.9- 2.6) 0.7 ( 0.5- 0.9)
Lip 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
Tongue 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.3 ( 0.2- 0.4) 0.4 ( 0.3- 0.7) ∼ 0.2 ( 0.1- 0.4)
Salivary Gland 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) ∼ ∼ ∼
Floor of Mouth 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
Gum and Other Mouth 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼ ∼
Nasopharynx 0.2 ( 0.1- 0.2) 0.1 ( 0.1- 0.1) 0.2 ( 0.2- 0.3) 0.7 ( 0.5- 1.0) ∼ ∼
Tonsil 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) ∼ ∼ ∼
Oropharynx 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Hypopharynx 0.0 ( 0.0- 0.1) 0.0 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Other Oral Cavity and Pharynx 0.3 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) 0.4 ( 0.3- 0.5) ∼ ∼ ∼
Digestive System 35.9 ( 35.6- 36.2) 34.4 ( 34.1- 34.7) 50.6 ( 49.4- 51.7) 32.6 ( 30.9- 34.3) 31.6 ( 28.0- 35.7) 32.4 ( 31.2- 33.5)
Esophagus 1.7 ( 1.7- 1.8) 1.6 ( 1.6- 1.7) 2.9 ( 2.7- 3.2) 1.0 ( 0.7- 1.3) ∼ 0.9 ( 0.7- 1.1)
Stomach 3.0 ( 2.9- 3.1) 2.5 ( 2.5- 2.6) 6.1 ( 5.7- 6.5) 6.4 ( 5.7- 7.2) 4.9 ( 3.5- 6.6) 5.1 ( 4.6- 5.6)
Small Intestine 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.5 ( 0.4- 0.6) ∼ ∼ ∼
Colon and Rectum 16.5 ( 16.3- 16.7) 16.0 ( 15.8- 16.2) 22.8 ( 22.1- 23.6) 10.1 ( 9.2- 11.1) 12.7 ( 10.4- 15.4) 11.2 ( 10.5- 11.9)
Colon excluding Rectum 14.2 ( 14.1- 14.4) 13.8 ( 13.6- 14.0) 20.1 ( 19.4- 20.9) 8.3 ( 7.5- 9.2) 10.7 ( 8.6- 13.2) 9.7 ( 9.1- 10.4)
Rectum and Rectosigmoid Junction 2.3 ( 2.2- 2.4) 2.3 ( 2.2- 2.3) 2.7 ( 2.4- 3.0) 1.8 ( 1.4- 2.2) 2.0 ( 1.2- 3.2) 1.5 ( 1.3- 1.8)
Anus, Anal Canal and Anorectum 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.2 ( 0.1- 0.2) ∼ ∼ ∼
Liver and Intrahepatic Bile Duct 3.0 ( 2.9- 3.1) 2.8 ( 2.7- 2.9) 3.6 ( 3.3- 3.9) 6.1 ( 5.4- 6.9) 3.9 ( 2.7- 5.6) 4.9 ( 4.5- 5.4)
Gallbladder 0.8 ( 0.8- 0.9) 0.8 ( 0.7- 0.8) 1.2 ( 1.0- 1.3) 0.7 ( 0.5- 1.0) ∼ 1.4 ( 1.2- 1.7)
Other Biliary 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.3- 0.5) 0.3 ( 0.2- 0.6) ∼ 0.5 ( 0.3- 0.6)
Pancreas 9.2 ( 9.0- 9.3) 8.9 ( 8.8- 9.1) 12.3 ( 11.8- 12.9) 7.2 ( 6.4- 8.0) 6.8 ( 5.2- 8.8) 7.5 ( 6.9- 8.0)
Retroperitoneum 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Peritoneum, Omentum and Mesentery 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.2 ( 0.2- 0.3) ∼ ∼ 0.2 ( 0.1- 0.3)
Other Digestive Organs 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼ 0.3 ( 0.2- 0.4)
Respiratory System 42.2 ( 41.9- 42.5) 43.2 ( 42.9- 43.6) 41.2 ( 40.2- 42.3) 17.8 ( 16.6- 19.1) 27.9 ( 24.5- 31.7) 15.3 ( 14.5- 16.2)
Nose, Nasal Cavity and Middle Ear 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ 0.2 ( 0.1- 0.3)
Larynx 0.5 ( 0.5- 0.5) 0.5 ( 0.4- 0.5) 0.8 ( 0.7- 1.0) ∼ ∼ 0.3 ( 0.2- 0.4)
Lung and Bronchus 41.5 ( 41.2- 41.8) 42.6 ( 42.2- 42.9) 40.2 ( 39.3- 41.3) 17.6 ( 16.4- 18.9) 27.5 ( 24.1- 31.2) 14.8 ( 14.0- 15.6)
Pleura 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Bones and Joints 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼ 0.2 ( 0.2- 0.3)
Soft Tissue including Heart 1.1 ( 1.1- 1.2) 1.1 ( 1.1- 1.2) 1.3 ( 1.2- 1.5) 0.7 ( 0.5- 0.9) ∼ 0.8 ( 0.7- 1.0)
Skin excluding Basal and Squamous 2.1 ( 2.1- 2.2) 2.4 ( 2.3- 2.5) 0.6 ( 0.5- 0.7) 0.4 ( 0.3- 0.7) ∼ 0.9 ( 0.7- 1.1)
Melanomas of the Skin 1.7 ( 1.7- 1.8) 2.0 ( 1.9- 2.0) 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.6) ∼ 0.7 ( 0.5- 0.9)
Other Non-Epithelial Skin 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.3 ( 0.2- 0.4) ∼ ∼ 0.2 ( 0.1- 0.3)
Breast 25.5 ( 25.3- 25.8) 24.9 ( 24.7- 25.2) 34.1 ( 33.2- 35.0) 12.9 ( 11.9- 13.9) 13.9 ( 11.7- 16.5) 15.7 ( 14.9- 16.5)
Female Genital System 16.7 ( 16.5- 16.9) 16.5 ( 16.3- 16.7) 20.6 ( 19.9- 21.3) 10.3 ( 9.5- 11.3) 11.9 ( 9.8- 14.4) 13.3 ( 12.6- 14.0)
Cervix 2.5 ( 2.5- 2.6) 2.3 ( 2.2- 2.4) 5.0 ( 4.6- 5.3) 2.3 ( 1.9- 2.7) 3.0 ( 2.0- 4.3) 3.2 ( 2.9- 3.6)
Corpus 1.9 ( 1.9- 2.0) 1.8 ( 1.8- 1.9) 3.2 ( 3.0- 3.5) 1.3 ( 1.0- 1.7) ∼ 1.5 ( 1.3- 1.8)
Uterus, NOS 2.2 ( 2.1- 2.3) 2.0 ( 2.0- 2.1) 4.1 ( 3.8- 4.4) 1.3 ( 1.0- 1.6) 2.2 ( 1.3- 3.4) 1.8 ( 1.6- 2.1)
Ovary 9.0 ( 8.9- 9.2) 9.4 ( 9.2- 9.5) 7.4 ( 7.0- 7.9) 5.1 ( 4.5- 5.7) 4.9 ( 3.6- 6.6) 6.0 ( 5.6- 6.6)
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Table 1.1.1.2F: Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by Primary Site and
Race and Ethnicity, United States† (continued)
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
Vagina 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.3 ( 0.2- 0.4) ∼ ∼ 0.2 ( 0.1- 0.3)
Vulva 0.5 ( 0.4- 0.5) 0.5 ( 0.5- 0.5) 0.3 ( 0.2- 0.4) ∼ ∼ 0.4 ( 0.2- 0.5)
Other Female Genital Organs 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼ 0.2 ( 0.1- 0.3)
Urinary System 5.3 ( 5.2- 5.4) 5.3 ( 5.2- 5.4) 6.1 ( 5.7- 6.5) 2.2 ( 1.8- 2.7) 5.1 ( 3.8- 6.9) 3.9 ( 3.5- 4.3)
Urinary Bladder 2.4 ( 2.3- 2.4) 2.3 ( 2.3- 2.4) 3.0 ( 2.8- 3.3) 1.1 ( 0.8- 1.5) ∼ 1.5 ( 1.3- 1.8)
Kidney and Renal Pelvis 2.8 ( 2.7- 2.8) 2.8 ( 2.7- 2.9) 2.8 ( 2.6- 3.1) 1.1 ( 0.8- 1.4) 3.5 ( 2.4- 5.0) 2.3 ( 2.0- 2.6)
Ureter 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Other Urinary Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Eye and Orbit 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Brain and Other Nervous System 3.6 ( 3.5- 3.7) 3.9 ( 3.8- 4.0) 2.2 ( 2.0- 2.5) 1.4 ( 1.1- 1.7) 1.5 ( 0.8- 2.5) 2.4 ( 2.1- 2.7)
Endocrine System 0.8 ( 0.7- 0.8) 0.7 ( 0.7- 0.8) 0.8 ( 0.7- 1.0) 0.8 ( 0.6- 1.1) ∼ 0.8 ( 0.6- 1.0)
Thyroid 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) 0.6 ( 0.4- 0.9) ∼ 0.6 ( 0.5- 0.8)
Other Endocrine including Thymus 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼ 0.2 ( 0.1- 0.3)
Lymphoma 6.5 ( 6.4- 6.7) 6.8 ( 6.7- 6.9) 4.7 ( 4.3- 5.0) 4.1 ( 3.6- 4.8) 2.7 ( 1.7- 4.0) 5.6 ( 5.2- 6.2)
Hodgkin Lymphoma 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼ 0.4 ( 0.3- 0.5)
Non-Hodgkin Lymphoma 6.2 ( 6.0- 6.3) 6.4 ( 6.3- 6.5) 4.4 ( 4.1- 4.8) 3.8 ( 3.3- 4.5) 2.6 ( 1.6- 3.9) 5.3 ( 4.8- 5.8)
Multiple Myeloma 3.1 ( 3.0- 3.2) 2.9 ( 2.8- 2.9) 6.0 ( 5.6- 6.4) 1.8 ( 1.5- 2.3) 2.4 ( 1.5- 3.6) 2.7 ( 2.4- 3.1)
Leukemias 5.7 ( 5.6- 5.8) 5.8 ( 5.7- 5.9) 5.4 ( 5.0- 5.7) 3.1 ( 2.6- 3.6) 3.2 ( 2.2- 4.6) 4.1 ( 3.7- 4.5)
Acute Lymphocytic 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.5) ∼ 0.6 ( 0.5- 0.8)
Chronic Lymphocytic 1.1 ( 1.0- 1.1) 1.1 ( 1.0- 1.1) 1.1 ( 0.9- 1.3) ∼ ∼ 0.4 ( 0.2- 0.5)
Acute Myeloid 2.2 ( 2.1- 2.2) 2.2 ( 2.1- 2.3) 1.8 ( 1.6- 2.0) 1.3 ( 1.0- 1.6) ∼ 1.4 ( 1.2- 1.6)
Chronic Myeloid 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.5 ( 0.4- 0.6) 0.3 ( 0.2- 0.6) ∼ 0.3 ( 0.2- 0.4)
Other Leukemias 1.7 ( 1.6- 1.8) 1.7 ( 1.7- 1.8) 1.7 ( 1.5- 2.0) 0.9 ( 0.7- 1.2) ∼ 1.4 ( 1.2- 1.7)
Mesothelioma 0.3 ( 0.2- 0.3) 0.3 ( 0.3- 0.3) 0.1 ( 0.1- 0.2) ∼ ∼ 0.2 ( 0.1- 0.3)
Miscellaneous 11.9 ( 11.8- 12.1) 11.7 ( 11.6- 11.9) 15.1 ( 14.5- 15.8) 6.5 ( 5.8- 7.3) 9.9 ( 7.9- 12.3) 8.3 ( 7.7- 8.9)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.1.2.1M: All Cancer Sites Combined. Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals
by Age and Race and Ethnicity, United States†‡
Males, 2002
Asian/Pacific American Indian/
Age at Diagnosis(years) All Races White Black Islander§ Alaska Native§ Hispanic§‖
<1 25.0 ( 22.8- 27.3) 26.4 ( 23.8- 29.1) 14.3 ( 10.4- 19.3) 18.8 ( 11.0- 30.2) ∼ 23.2 ( 18.9- 28.2)
1-4 22.2 ( 21.1- 23.2) 23.5 ( 22.3- 24.8) 13.6 ( 11.5- 15.9) 18.2 ( 14.0- 23.3) 16.6 ( 9.5- 27.0) 23.0 ( 20.7- 25.5)
5-9 11.9 ( 11.2- 12.6) 12.4 ( 11.7- 13.3) 8.3 ( 6.9- 9.9) 9.6 ( 6.9- 13.0) ∼ 11.9 ( 10.4- 13.5)
10-14 12.5 ( 11.9- 13.2) 13.2 ( 12.4- 14.0) 8.5 ( 7.1- 10.1) 11.5 ( 8.6- 15.1) ∼ 13.4 ( 11.8- 15.2)
15-19 22.2 ( 21.2- 23.1) 23.8 ( 22.7- 24.9) 13.5 ( 11.7- 15.6) 11.3 ( 8.4- 14.9) 17.0 ( 10.9- 25.2) 23.3 ( 21.0- 25.7)
20-24 30.5 ( 29.4- 31.6) 32.9 ( 31.6- 34.2) 17.0 ( 14.8- 19.4) 16.5 ( 13.1- 20.5) 16.8 ( 10.5- 25.4) 23.5 ( 21.5- 25.8)
25-29 43.9 ( 42.5- 45.3) 46.1 ( 44.5- 47.7) 30.6 ( 27.5- 34.0) 24.1 ( 20.2- 28.6) 21.2 ( 13.6- 31.6) 31.0 ( 28.5- 33.5)
30-34 60.0 ( 58.5- 61.6) 61.9 ( 60.2- 63.7) 47.7 ( 43.8- 51.7) 33.7 ( 29.2- 38.8) 34.3 ( 24.3- 47.1) 42.9 ( 39.9- 46.0)
35-39 87.9 ( 86.1- 89.7) 88.6 ( 86.6- 90.6) 80.3 ( 75.3- 85.5) 51.4 ( 45.4- 58.0) 36.9 ( 26.5- 50.0) 60.3 ( 56.5- 64.2)
40-44 148.7 ( 146.3- 151.0) 146.7 ( 144.2- 149.2) 161.6 ( 154.6- 168.9) 81.4 ( 73.5- 90.0) 79.8 ( 64.0- 98.5) 101.3 ( 96.0- 106.9)
45-49 278.3 ( 275.0- 281.7) 268.2 ( 264.7- 271.8) 359.5 ( 348.1- 371.1) 155.4 ( 143.7- 167.8) 131.0 ( 109.0- 156.2) 187.1 ( 178.8- 195.8)
50-54 539.8 ( 534.8- 544.7) 520.6 ( 515.4- 525.9) 717.2 ( 699.4- 735.3) 269.2 ( 252.4- 286.9) 270.6 ( 235.1- 310.0) 362.3 ( 348.9- 376.1)
55-59 977.7 ( 970.3- 985.2) 945.3 ( 937.5- 953.3) 1299.7 (1271.1-1328.9) 473.6 ( 447.3- 501.1) 480.0 ( 424.2- 541.0) 681.5 ( 659.4- 704.0)
60-64 1543.5 (1532.8-1554.3) 1501.0 (1489.6-1512.5) 1995.1 (1954.2-2036.6) 780.5 ( 741.6- 821.0) 696.1 ( 616.5- 783.1) 1140.9 (1107.2-1175.3)
65-69 2258.4 (2243.9-2272.9) 2223.5 (2208.1-2239.0) 2613.4 (2560.8-2666.8) 1253.4 (1196.7-1312.1) 1052.3 ( 935.5-1179.8) 1795.1 (1746.6-1844.5)
70-74 2788.8 (2771.6-2806.1) 2758.6 (2740.5-2776.8) 3056.4 (2990.6-3123.3) 1619.2 (1544.7-1696.3) 1231.4 (1082.6-1395.0) 2218.3 (2157.2-2280.7)
75-79 3102.6 (3082.2-3123.0) 3066.1 (3044.8-3087.5) 3171.2 (3092.4-3251.5) 2163.6 (2062.6-2268.2) 1699.4 (1484.6-1936.6) 2553.4 (2474.4-2634.3)
80-84 3106.1 (3081.0-3131.4) 3062.2 (3036.0-3088.5) 3177.5 (3075.5-3282.0) 2270.0 (2136.8-2409.2) 1680.8 (1401.2-1999.8) 2523.3 (2418.3-2631.7)
85+ 2951.3 (2921.7-2981.0) 2937.6 (2906.7-2968.8) 2935.9 (2818.8-3056.6) 1947.4 (1799.3-2104.4) 1407.9 (1105.5-1767.5) 2480.4 (2354.9-2610.9)
∗ Rates are per 100,000 persons.
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for data
quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (age, race, ethnicity).
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Table 1.1.2.1F: All Cancer Sites Combined. Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals
by Age and Race and Ethnicity, United States†‡
Females, 2002
Asian/Pacific American Indian/
Age at Diagnosis(years) All Races White Black Islander§ Alaska Native§ Hispanic§‖
<1 21.4 ( 19.3- 23.6) 23.1 ( 20.7- 25.7) 12.4 ( 8.7- 17.2) ∼ ∼ 20.5 ( 16.4- 25.4)
1-4 17.6 ( 16.7- 18.6) 18.4 ( 17.3- 19.5) 12.1 ( 10.1- 14.3) 13.4 ( 9.8- 17.9) ∼ 18.6 ( 16.5- 20.9)
5-9 10.6 ( 10.0- 11.3) 10.9 ( 10.2- 11.7) 8.4 ( 7.0- 10.0) 8.7 ( 6.1- 12.0) ∼ 10.1 ( 8.7- 11.7)
10-14 11.4 ( 10.7- 12.0) 11.4 ( 10.6- 12.2) 10.4 ( 8.9- 12.1) 10.5 ( 7.7- 14.2) ∼ 10.3 ( 8.8- 11.9)
15-19 19.5 ( 18.6- 20.4) 20.5 ( 19.5- 21.6) 13.0 ( 11.2- 15.0) 14.5 ( 11.1- 18.7) ∼ 16.8 ( 14.8- 19.0)
20-24 34.4 ( 33.2- 35.6) 36.5 ( 35.1- 37.9) 23.6 ( 21.1- 26.3) 21.9 ( 18.0- 26.5) ∼ 27.5 ( 25.0- 30.2)
25-29 60.9 ( 59.3- 62.6) 63.6 ( 61.8- 65.6) 48.1 ( 44.3- 52.1) 34.4 ( 29.7- 39.5) 20.1 ( 12.4- 30.7) 45.5 ( 42.3- 48.9)
30-34 103.4 ( 101.4- 105.4) 106.1 ( 103.8- 108.5) 88.2 ( 83.2- 93.4) 65.5 ( 59.2- 72.2) 36.8 ( 26.2- 50.3) 79.8 ( 75.4- 84.3)
35-39 162.4 ( 160.0- 164.9) 164.5 ( 161.7- 167.3) 146.6 ( 140.3- 153.2) 115.1 ( 106.3- 124.4) 93.7 ( 76.5- 113.5) 131.3 ( 125.4- 137.4)
40-44 268.1 ( 265.0- 271.2) 269.3 ( 265.9- 272.8) 246.5 ( 238.3- 255.0) 206.9 ( 194.6- 219.7) 127.8 ( 107.9- 150.4) 218.6 ( 210.4- 227.0)
45-49 400.6 ( 396.7- 404.5) 401.3 ( 397.0- 405.6) 390.8 ( 379.7- 402.1) 289.2 ( 274.1- 304.9) 174.2 ( 149.3- 202.1) 317.6 ( 306.6- 328.9)
50-54 568.3 ( 563.4- 573.3) 569.6 ( 564.1- 575.0) 560.6 ( 546.2- 575.4) 404.6 ( 385.3- 424.5) 258.1 ( 224.5- 295.4) 436.7 ( 422.2- 451.6)
55-59 803.0 ( 796.5- 809.6) 810.6 ( 803.4- 817.8) 753.3 ( 733.6- 773.4) 528.9 ( 502.8- 556.1) 423.3 ( 372.8- 478.8) 605.0 ( 585.1- 625.4)
60-64 1056.1 (1047.6-1064.6) 1069.8 (1060.6-1079.1) 995.4 ( 969.9-1021.5) 616.3 ( 583.7- 650.2) 638.7 ( 565.4- 718.8) 765.8 ( 740.1- 792.1)
65-69 1350.6 (1340.2-1361.0) 1370.5 (1359.1-1381.9) 1252.6 (1221.2-1284.5) 813.5 ( 772.3- 856.3) 766.4 ( 673.6- 868.4) 973.7 ( 941.6-1006.7)
70-74 1607.4 (1595.7-1619.2) 1624.9 (1612.4-1637.6) 1495.5 (1457.8-1533.9) 1002.0 ( 951.8-1054.2) 894.4 ( 780.1-1020.7) 1184.8 (1145.7-1224.9)
75-79 1824.4 (1811.3-1837.6) 1843.4 (1829.4-1857.4) 1682.5 (1638.2-1727.7) 1079.5 (1019.0-1142.6) 1042.2 ( 898.9-1201.8) 1394.3 (1345.1-1444.9)
80-84 1898.3 (1882.9-1913.7) 1912.9 (1896.7-1929.2) 1724.5 (1670.3-1780.0) 1238.3 (1155.8-1325.2) 967.8 ( 799.0-1161.7) 1458.7 (1395.0-1524.5)
85+ 1751.6 (1736.7-1766.7) 1748.3 (1732.6-1764.1) 1695.5 (1640.6-1751.7) 1278.5 (1183.1-1379.6) 1017.5 ( 839.3-1222.3) 1512.5 (1443.2-1584.3)
∗ Rates are per 100,000 persons.
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for data
quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (age, race, ethnicity).
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Table 1.1.2.2M: All Cancer Sites Combined. Cancer Death Rates∗ and 95% Confidence Intervals by Age and
Race and Ethnicity, United States†
Males, 2002
Asian/Pacific American Indian/
Age at Diagnosis(years) All Races White Black Islander‡ Alaska Native§ Hispanic‡§
<1 2.1 ( 1.5- 2.8) 2.2 ( 1.5- 3.1) ∼ ∼ ∼ ∼
1-4 2.7 ( 2.4- 3.1) 2.7 ( 2.3- 3.1) 2.6 ( 1.8- 3.7) ∼ ∼ 2.2 ( 1.5- 3.0)
5-9 2.9 ( 2.6- 3.3) 2.9 ( 2.5- 3.3) 3.3 ( 2.5- 4.3) ∼ ∼ 2.6 ( 2.0- 3.5)
10-14 2.8 ( 2.5- 3.1) 2.7 ( 2.4- 3.1) 2.9 ( 2.1- 3.8) 3.9 ( 2.3- 6.2) ∼ 3.2 ( 2.4- 4.1)
15-19 4.1 ( 3.7- 4.5) 4.2 ( 3.7- 4.6) 4.1 ( 3.2- 5.2) ∼ ∼ 4.9 ( 3.9- 6.0)
20-24 5.7 ( 5.2- 6.2) 5.9 ( 5.4- 6.4) 4.9 ( 3.9- 6.2) 5.0 ( 3.3- 7.4) ∼ 5.4 ( 4.4- 6.5)
25-29 7.1 ( 6.5- 7.6) 6.9 ( 6.4- 7.6) 8.2 ( 6.7- 9.9) 6.6 ( 4.7- 9.1) ∼ 5.1 ( 4.2- 6.2)
30-34 11.3 ( 10.7- 12.0) 11.1 ( 10.4- 11.9) 14.1 ( 12.2- 16.3) 8.9 ( 6.7- 11.6) ∼ 8.1 ( 6.8- 9.5)
35-39 19.9 ( 19.0- 20.7) 19.2 ( 18.3- 20.2) 25.7 ( 23.1- 28.5) 17.2 ( 13.9- 21.1) ∼ 12.2 ( 10.6- 14.1)
40-44 42.9 ( 41.7- 44.1) 41.3 ( 40.0- 42.6) 60.6 ( 56.5- 64.8) 29.1 ( 24.5- 34.3) 26.2 ( 17.6- 37.3) 26.7 ( 24.0- 29.6)
45-49 89.9 ( 88.1- 91.7) 85.5 ( 83.6- 87.5) 137.3 ( 130.7- 144.2) 59.4 ( 52.4- 67.1) 44.2 ( 32.1- 59.3) 55.1 ( 50.6- 59.8)
50-54 171.8 ( 169.2- 174.5) 163.0 ( 160.2- 165.9) 271.8 ( 261.5- 282.4) 109.4 ( 98.9- 120.7) 116.2 ( 93.9- 142.2) 112.5 ( 105.1- 120.3)
55-59 308.9 ( 304.8- 312.9) 296.8 ( 292.5- 301.1) 485.4 ( 468.9- 502.4) 169.6 ( 154.2- 186.0) 208.8 ( 173.6- 249.2) 206.6 ( 194.7- 219.1)
60-64 520.2 ( 514.2- 526.2) 503.8 ( 497.5- 510.2) 779.6 ( 755.4- 804.4) 294.5 ( 271.1- 319.2) 338.3 ( 285.0- 398.8) 326.1 ( 308.3- 344.6)
65-69 796.5 ( 788.2- 804.8) 785.2 ( 776.4- 794.1) 1080.9 (1048.9-1113.6) 391.6 ( 360.7- 424.5) 478.9 ( 403.1- 564.7) 522.2 ( 496.4- 549.1)
70-74 1155.9 (1145.2-1166.6) 1143.4 (1132.1-1154.8) 1535.7 (1491.7-1580.7) 593.7 ( 549.5- 640.5) 787.2 ( 672.0- 916.5) 758.5 ( 723.1- 795.2)
75-79 1551.5 (1537.7-1565.5) 1534.4 (1519.8-1549.1) 2046.8 (1987.1-2107.8) 913.9 ( 849.4- 982.1) 928.2 ( 774.9-1102.9) 1112.0 (1060.3-1165.5)
80-84 1955.7 (1936.4-1975.1) 1938.3 (1918.1-1958.6) 2523.6 (2438.1-2611.4) 1182.6 (1087.9-1283.4) 1347.9 (1104.7-1628.9) 1338.2 (1262.5-1417.3)
85+ 2515.1 (2488.7-2541.7) 2512.4 (2484.7-2540.4) 2986.0 (2875.9-3099.2) 1547.6 (1417.1-1687.0) 1047.7 ( 795.6-1354.4) 1868.8 (1760.8-1981.7)
∗ Rates are per 100,000 persons.
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (age, race, ethnicity).
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Table 1.1.2.2F: All Cancer Sites Combined. Cancer Death Rates∗ and 95% Confidence Intervals by Age and
Race and Ethnicity, United States†
Females, 2002
Asian/Pacific American Indian/
Age at Diagnosis(years) All Races White Black Islander‡ Alaska Native§ Hispanic‡§
<1 1.6 ( 1.1- 2.3) 1.4 ( 0.9- 2.1) ∼ ∼ ∼ ∼
1-4 2.4 ( 2.1- 2.8) 2.3 ( 2.0- 2.8) 3.2 ( 2.3- 4.4) ∼ ∼ 2.4 ( 1.7- 3.3)
5-9 2.5 ( 2.2- 2.8) 2.6 ( 2.3- 3.0) 1.9 ( 1.2- 2.6) ∼ ∼ 2.8 ( 2.1- 3.7)
10-14 2.3 ( 2.0- 2.6) 2.4 ( 2.0- 2.7) 2.1 ( 1.5- 2.9) ∼ ∼ 2.9 ( 2.2- 3.8)
15-19 3.0 ( 2.7- 3.4) 3.0 ( 2.6- 3.4) 3.1 ( 2.3- 4.2) ∼ ∼ 2.6 ( 1.9- 3.6)
20-24 4.2 ( 3.8- 4.6) 4.4 ( 3.9- 4.9) 4.0 ( 3.0- 5.1) ∼ ∼ 4.5 ( 3.5- 5.6)
25-29 6.2 ( 5.7- 6.8) 6.2 ( 5.6- 6.8) 7.9 ( 6.5- 9.5) 3.7 ( 2.3- 5.6) ∼ 4.5 ( 3.5- 5.6)
30-34 13.8 ( 13.1- 14.5) 13.3 ( 12.6- 14.2) 18.4 ( 16.3- 20.7) 9.0 ( 6.8- 11.7) 14.3 ( 8.2- 23.3) 11.0 ( 9.4- 12.8)
35-39 27.4 ( 26.4- 28.4) 26.5 ( 25.4- 27.6) 37.2 ( 34.2- 40.4) 16.0 ( 12.9- 19.7) 21.4 ( 13.9- 31.6) 20.8 ( 18.5- 23.3)
40-44 52.3 ( 51.0- 53.7) 50.0 ( 48.6- 51.5) 75.5 ( 71.2- 80.0) 32.5 ( 27.8- 37.7) 25.9 ( 17.6- 36.8) 38.6 ( 35.3- 42.2)
45-49 91.6 ( 89.8- 93.4) 87.1 ( 85.1- 89.1) 133.8 ( 127.8- 140.1) 61.1 ( 54.4- 68.4) 61.8 ( 47.7- 78.8) 61.6 ( 56.9- 66.6)
50-54 152.0 ( 149.5- 154.5) 147.0 ( 144.3- 149.7) 210.4 ( 202.1- 219.0) 99.3 ( 90.0- 109.3) 104.5 ( 84.0- 128.4) 101.3 ( 94.4- 108.6)
55-59 247.2 ( 243.7- 250.7) 242.3 ( 238.5- 246.1) 330.7 ( 318.4- 343.5) 147.1 ( 133.7- 161.5) 152.5 ( 123.5- 186.2) 145.4 ( 135.8- 155.5)
60-64 381.7 ( 376.8- 386.7) 381.0 ( 375.7- 386.3) 456.6 ( 440.2- 473.4) 206.1 ( 187.8- 225.8) 273.9 ( 227.8- 326.6) 229.1 ( 215.2- 243.6)
65-69 548.7 ( 542.3- 555.1) 547.7 ( 540.8- 554.6) 650.8 ( 629.5- 672.7) 303.5 ( 278.9- 329.7) 394.5 ( 330.3- 467.6) 327.5 ( 309.1- 346.7)
70-74 753.0 ( 745.3- 760.8) 755.9 ( 747.6- 764.3) 849.7 ( 822.9- 877.1) 421.1 ( 389.2- 454.9) 577.9 ( 488.8- 678.5) 480.3 ( 455.6- 505.9)
75-79 960.1 ( 950.9- 969.3) 965.5 ( 955.7- 975.4) 1053.2 (1020.2-1087.0) 525.1 ( 483.6- 569.1) 645.8 ( 536.8- 770.6) 630.6 ( 597.8- 664.7)
80-84 1158.3 (1146.7-1170.0) 1164.1 (1151.9-1176.4) 1224.5 (1181.6-1268.5) 730.1 ( 667.7- 796.8) 808.1 ( 658.2- 982.0) 789.7 ( 743.3- 838.2)
85+ 1395.2 (1382.3-1408.2) 1399.3 (1385.7-1413.0) 1469.5 (1421.7-1518.5) 917.0 ( 837.3-1002.3) 1012.5 ( 838.8-1211.6) 1038.9 ( 982.0-1098.3)
∗ Rates are per 100,000 persons.
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (age, race, ethnicity).
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Table 1.2.1.1M: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals for Ages 0-19 by
International Classification of Childhood Cancer (ICCC†) Group and Subgroup, and Race and Ethnicity, United
States‡
Males, 2002
Asian/Pacific American Indian/
ICCC Group and Subgroup All Races White Black Islander§ Alaska Native§ Hispanic§‖
All ICCC Groups Combined 172.4 (168.3-176.6) 182.9 (178.1-187.7) 109.8 (101.6-118.6) 126.3 (110.3-144.0) 111.4 ( 84.7-144.6) 178.3 (168.7-188.3)
I Leukemia 44.6 ( 42.5- 46.8) 47.5 ( 45.1- 50.0) 24.0 ( 20.2- 28.2) 40.3 ( 31.5- 50.9) 40.0 ( 24.7- 62.1) 58.3 ( 53.0- 64.1)
I(a) Lymphoid leukemia 33.6 ( 31.8- 35.5) 36.4 ( 34.2- 38.6) 16.1 ( 13.0- 19.7) 29.5 ( 22.1- 38.7) ∼ 46.8 ( 42.0- 51.9)
Acute lymphocytic leukemia (ALL) 32.5 ( 30.7- 34.3) 35.1 ( 33.1- 37.3) 15.6 ( 12.6- 19.1) 27.8 ( 20.6- 36.8) ∼ 45.0 ( 40.4- 50.1)
Lymphoid excluding ALL 1.1 ( 0.8- 1.5) 1.2 ( 0.9- 1.7) ∼ ∼ ∼ ∼
I(b) Acute non-lymphocytic leukemia 8.2 ( 7.3- 9.1) 8.2 ( 7.3- 9.3) 5.8 ( 4.1- 8.1) ∼ ∼ 8.3 ( 6.3- 10.7)
I(c) Chronic myeloid leukemia 1.3 ( 1.0- 1.8) 1.3 ( 0.9- 1.7) ∼ ∼ ∼ ∼
I(d) Other specified leukemia ∼ ∼ ∼ ∼ ∼ ∼
I(e) Unspecified leukemia 1.3 ( 0.9- 1.7) 1.3 ( 1.0- 1.8) ∼ ∼ ∼ ∼
II Lymphoma and reticuloendothelial neoplasms 26.3 ( 24.7- 28.0) 27.8 ( 26.0- 29.7) 18.8 ( 15.5- 22.6) 17.2 ( 11.6- 24.5) ∼ 28.0 ( 24.2- 32.3)
II(a) Hodgkin lymphoma 11.8 ( 10.8- 13.0) 12.3 ( 11.1- 13.6) 8.5 ( 6.3- 11.2) ∼ ∼ 11.2 ( 8.8- 14.0)
II(b) Non-Hodgkin lymphoma 9.9 ( 9.0- 11.0) 10.5 ( 9.4- 11.8) 7.9 ( 5.8- 10.6) ∼ ∼ 11.6 ( 9.2- 14.4)
II(c) Burkitt lymphoma 4.0 ( 3.4- 4.7) 4.4 ( 3.7- 5.2) ∼ ∼ ∼ 4.4 ( 3.0- 6.3)
II(d) Miscellaneous lymphoreticular neoplasms ∼ ∼ ∼ ∼ ∼ ∼
II(e) Unspecified lymphoma ∼ ∼ ∼ ∼ ∼ ∼
III CNS and misc intracranial and intraspinal
neoplasms 30.8 ( 29.1- 32.6) 33.2 ( 31.2- 35.3) 21.2 ( 17.6- 25.2) 12.5 ( 7.8- 18.9) ∼ 26.7 ( 23.1- 30.8)
III(a) Ependymoma 3.2 ( 2.6- 3.8) 3.4 ( 2.8- 4.2) ∼ ∼ ∼ 3.4 ( 2.2- 5.0)
III(b) Astrocytoma 14.7 ( 13.5- 15.9) 16.0 ( 14.7- 17.5) 9.1 ( 6.9- 11.9) ∼ ∼ 11.8 ( 9.4- 14.6)
III(c) Primitive neuroectodermal tumors 6.8 ( 6.0- 7.7) 7.4 ( 6.4- 8.4) 4.2 ( 2.7- 6.2) ∼ ∼ 5.5 ( 4.0- 7.5)
III(d) Other gliomas 4.9 ( 4.2- 5.7) 5.3 ( 4.5- 6.1) 3.9 ( 2.5- 5.8) ∼ ∼ 4.8 ( 3.3- 6.7)
III(e) Misc intracranial and intraspinal
neoplasms ∼ ∼ ∼ ∼ ∼ ∼
III(f) Unspecified intracranial and intraspinal
neoplasm 1.0 ( 0.7- 1.3) 0.9 ( 0.6- 1.3) ∼ ∼ ∼ ∼
IV Sympathetic nervous system tumors 8.5 ( 7.6- 9.4) 8.8 ( 7.8- 9.9) 6.6 ( 4.7- 9.1) ∼ ∼ 6.0 ( 4.5- 8.0)
IV(a) Neuroblastoma and ganglioneuroblastoma 8.2 ( 7.4- 9.2) 8.6 ( 7.6- 9.7) 6.1 ( 4.3- 8.5) ∼ ∼ 5.7 ( 4.2- 7.6)
IV(b) Other sympathetic nervous system tumors ∼ ∼ ∼ ∼ ∼ ∼
V Retinoblastoma 3.0 ( 2.4- 3.5) 2.6 ( 2.1- 3.3) 3.8 ( 2.4- 5.7) ∼ ∼ 2.7 ( 1.7- 4.1)
VI Renal tumors 6.2 ( 5.4- 7.0) 6.2 ( 5.4- 7.2) 6.2 ( 4.4- 8.6) ∼ ∼ 4.8 ( 3.4- 6.6)
VI(a) Wilms tumor, rhabdoid and clear cell
sarcoma 5.6 ( 4.9- 6.4) 5.9 ( 5.1- 6.8) 4.9 ( 3.2- 7.0) ∼ ∼ 4.5 ( 3.2- 6.2)
VI(b) Renal carcinoma 0.5 ( 0.3- 0.8) ∼ ∼ ∼ ∼ ∼
VI(c) Unspecified malignant renal tumors ∼ ∼ ∼ ∼ ∼ ∼
VII Hepatic tumors 2.1 ( 1.7- 2.7) 2.0 ( 1.5- 2.5) ∼ ∼ ∼ ∼
VII(a) Hepatoblastoma 1.6 ( 1.2- 2.0) 1.5 ( 1.1- 2.0) ∼ ∼ ∼ ∼
VII(b) Hepatic carcinoma 0.5 ( 0.3- 0.8) ∼ ∼ ∼ ∼ ∼
VII(c) Unspecified malignant hepatic tumors ∼ ∼ ∼ ∼ ∼ ∼
VIII Malignant bone tumors 10.8 ( 9.8- 11.9) 11.4 ( 10.2- 12.7) 7.8 ( 5.7- 10.4) ∼ ∼ 12.3 ( 9.8- 15.2)
VIII(a) Osteosarcoma 5.9 ( 5.2- 6.8) 6.0 ( 5.2- 6.9) 5.2 ( 3.6- 7.5) ∼ ∼ 7.8 ( 5.9- 10.3)
VIII(b) Chrondosarcoma 0.6 ( 0.4- 0.9) 0.6 ( 0.4- 1.0) ∼ ∼ ∼ ∼
VIII(c) Ewing sarcoma 3.6 ( 3.1- 4.3) 4.1 ( 3.4- 4.9) ∼ ∼ ∼ 3.0 ( 1.9- 4.6)
VIII(d) Other specified malignant bone tumors 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.9) ∼ ∼ ∼ ∼
VIII(e) Unspecified malignant bone tumors ∼ ∼ ∼ ∼ ∼ ∼
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Table 1.2.1.1M: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals for Ages 0-19 by
International Classification of Childhood Cancer (ICCC†) Group and Subgroup, and Race and Ethnicity, United
States‡ (continued)
Males, 2002
Asian/Pacific American Indian/
ICCC Group and Subgroup All Races White Black Islander§ Alaska Native§ Hispanic§‖
IX Soft-tissue sarcomas 13.6 ( 12.5- 14.8) 13.9 ( 12.6- 15.2) 10.8 ( 8.3- 13.8) 11.9 ( 7.3- 18.1) ∼ 11.3 ( 9.0- 14.0)
IX(a) Rhabdomyosarcoma and embryonal sarcoma 5.9 ( 5.2- 6.7) 6.1 ( 5.3- 7.1) 4.8 ( 3.2- 7.0) ∼ ∼ 4.7 ( 3.3- 6.5)
IX(b) Fibrosarcoma, neurofibrosar and other
fibromatous neoplasms 2.1 ( 1.6- 2.6) 2.0 ( 1.6- 2.6) ∼ ∼ ∼ ∼
IX(c) Kaposi sarcoma ∼ ∼ ∼ ∼ ∼ ∼
IX(d) Other specified soft-tissue sarcomas 4.2 ( 3.6- 4.9) 4.3 ( 3.6- 5.1) 3.2 ( 1.9- 5.0) ∼ ∼ 3.9 ( 2.6- 5.7)
IX(d) excluding misclassification from III(c) 3.8 ( 3.2- 4.4) 3.8 ( 3.1- 4.5) 3.1 ( 1.8- 4.8) ∼ ∼ 3.6 ( 2.3- 5.3)
PNET - not in brain/CNS/bone 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.8) ∼ ∼ ∼ ∼
IX(e) Unspecified soft-tissue sarcomas 1.4 ( 1.1- 1.8) 1.4 ( 1.0- 1.9) ∼ ∼ ∼ ∼
X Germ-cell, trophoblastic and other gonadal
neoplasms 13.2 ( 12.1- 14.4) 15.1 ( 13.8- 16.6) 3.1 ( 1.8- 4.9) ∼ ∼ 17.6 ( 14.6- 21.1)
X(a) Intracranial and intraspinal germ-cell
tumors 2.2 ( 1.7- 2.7) 2.3 ( 1.8- 2.9) ∼ ∼ ∼ ∼
X(b) Other and unspecified non-gonadal germ-cell
tumors 1.2 ( 0.8- 1.5) 1.2 ( 0.9- 1.7) ∼ ∼ ∼ 2.1 ( 1.2- 3.5)
X(c) Gonadal germ-cell tumors 9.7 ( 8.8- 10.8) 11.5 ( 10.3- 12.7) ∼ ∼ ∼ 13.2 ( 10.6- 16.3)
X(d) Gonadal carcinomas ∼ ∼ ∼ ∼ ∼ ∼
X(e) Other and unspecified malignant gonadal
tumors ∼ ∼ ∼ ∼ ∼ ∼
XI Carcinomas and other malignant epithelial
neoplasms 11.9 ( 10.8- 13.0) 12.8 ( 11.6- 14.2) 5.1 ( 3.5- 7.3) ∼ ∼ 7.2 ( 5.3- 9.5)
XI(a) Adrenocortical carcinoma ∼ ∼ ∼ ∼ ∼ ∼
XI(b) Thyroid carcinoma 2.1 ( 1.7- 2.6) 2.3 ( 1.8- 2.9) ∼ ∼ ∼ ∼
XI(c) Nasopharyngeal carcinoma 0.8 ( 0.5- 1.1) ∼ ∼ ∼ ∼ ∼
XI(d) Malignant melanoma 5.7 ( 4.9- 6.5) 6.7 ( 5.8- 7.7) ∼ ∼ ∼ ∼
XI(e) Skin carcinoma ∼ ∼ ∼ ∼ ∼ ∼
XI(f) Other and unspecified carcinomas 3.1 ( 2.5- 3.7) 3.1 ( 2.5- 3.8) ∼ ∼ ∼ ∼
XII Other and unspecified malignant neoplasms 0.9 ( 0.6- 1.2) 0.8 ( 0.5- 1.2) ∼ ∼ ∼ ∼
XII(a) Other specified malignant tumors ∼ ∼ ∼ ∼ ∼ ∼
XII(b) Other unspecified malignant tumors 0.6 ( 0.4- 0.9) 0.6 ( 0.3- 0.9) ∼ ∼ ∼ ∼
Not classified by ICCC 0.6 ( 0.4- 0.9) 0.7 ( 0.4- 1.1) ∼ ∼ ∼ ∼
∗ Rates are per 1,000,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† SEER modification of the 1996 International Classification of Childhood Cancer based on ICD-0-2. See Technical Notes.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for data quality
criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.2.1.1F: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals for Ages 0-19 by
International Classification of Childhood Cancer (ICCC†) Group and Subgroup, and Race and Ethnicity, United
States‡
Females, 2002
Asian/Pacific American Indian/
ICCC Group and Subgroup All Races White Black Islander§ Alaska Native§ Hispanic§‖
All ICCC Groups Combined 149.0 (145.1-153.0) 154.9 (150.3-159.5) 109.6 (101.2-118.5) 117.4 (101.7-135.0) 100.9 ( 75.0-133.5) 139.6 (131.0-148.8)
I Leukemia 37.1 ( 35.2- 39.1) 38.6 ( 36.4- 40.9) 22.9 ( 19.2- 27.2) 39.8 ( 30.9- 50.5) 37.2 ( 22.4- 58.9) 48.7 ( 43.7- 54.1)
I(a) Lymphoid leukemia 26.9 ( 25.2- 28.6) 28.7 ( 26.7- 30.7) 13.0 ( 10.2- 16.3) 29.7 ( 22.1- 39.1) ∼ 37.8 ( 33.5- 42.6)
Acute lymphocytic leukemia (ALL) 26.1 ( 24.5- 27.8) 27.7 ( 25.8- 29.7) 12.8 ( 10.0- 16.1) 29.1 ( 21.6- 38.4) ∼ 35.7 ( 31.4- 40.3)
Lymphoid excluding ALL 0.8 ( 0.5- 1.1) 0.9 ( 0.6- 1.4) ∼ ∼ ∼ ∼
I(b) Acute non-lymphocytic leukemia 7.6 ( 6.8- 8.6) 7.5 ( 6.5- 8.5) 7.9 ( 5.8- 10.6) ∼ ∼ 7.7 ( 5.8- 10.1)
I(c) Chronic myeloid leukemia 1.2 ( 0.9- 1.6) 1.2 ( 0.8- 1.7) ∼ ∼ ∼ ∼
I(d) Other specified leukemia ∼ ∼ ∼ ∼ ∼ ∼
I(e) Unspecified leukemia 1.1 ( 0.8- 1.5) 1.0 ( 0.6- 1.4) ∼ ∼ ∼ ∼
II Lymphoma and reticuloendothelial neoplasms 19.7 ( 18.3- 21.2) 20.3 ( 18.7- 22.0) 16.1 ( 13.0- 19.8) 19.2 ( 13.1- 27.1) ∼ 15.5 ( 12.6- 18.9)
II(a) Hodgkin lymphoma 11.9 ( 10.8- 13.1) 12.6 ( 11.4- 14.0) 8.5 ( 6.3- 11.3) 9.6 ( 5.5- 15.7) ∼ 7.7 ( 5.7- 10.3)
II(b) Non-Hodgkin lymphoma 6.1 ( 5.3- 7.0) 5.8 ( 5.0- 6.8) 7.1 ( 5.1- 9.7) ∼ ∼ 6.2 ( 4.4- 8.4)
II(c) Burkitt lymphoma 1.2 ( 0.8- 1.6) 1.3 ( 0.9- 1.7) ∼ ∼ ∼ ∼
II(d) Miscellaneous lymphoreticular neoplasms ∼ ∼ ∼ ∼ ∼ ∼
II(e) Unspecified lymphoma ∼ ∼ ∼ ∼ ∼ ∼
III CNS and misc intracranial and intraspinal
neoplasms 24.8 ( 23.2- 26.5) 26.2 ( 24.4- 28.1) 18.1 ( 14.8- 22.0) 15.4 ( 10.1- 22.7) ∼ 20.6 ( 17.4- 24.3)
III(a) Ependymoma 2.5 ( 2.0- 3.1) 2.5 ( 1.9- 3.1) 2.8 ( 1.6- 4.5) ∼ ∼ 2.4 ( 1.5- 3.9)
III(b) Astrocytoma 11.9 ( 10.8- 13.1) 12.9 ( 11.6- 14.3) 7.6 ( 5.5- 10.2) ∼ ∼ 9.2 ( 7.0- 11.7)
III(c) Primitive neuroectodermal tumors 4.7 ( 4.0- 5.5) 4.9 ( 4.1- 5.8) 3.6 ( 2.3- 5.6) ∼ ∼ 3.9 ( 2.6- 5.7)
III(d) Other gliomas 4.7 ( 4.1- 5.5) 4.9 ( 4.1- 5.8) 3.6 ( 2.3- 5.6) ∼ ∼ 4.6 ( 3.1- 6.5)
III(e) Misc intracranial and intraspinal
neoplasms ∼ ∼ ∼ ∼ ∼ ∼
III(f) Unspecified intracranial and intraspinal
neoplasm 0.7 ( 0.5- 1.0) 0.8 ( 0.5- 1.2) ∼ ∼ ∼ ∼
IV Sympathetic nervous system tumors 7.1 ( 6.3- 8.1) 7.7 ( 6.7- 8.7) 4.7 ( 3.1- 6.8) ∼ ∼ 4.5 ( 3.2- 6.3)
IV(a) Neuroblastoma and ganglioneuroblastoma 6.9 ( 6.1- 7.8) 7.5 ( 6.5- 8.6) 4.3 ( 2.8- 6.4) ∼ ∼ 4.4 ( 3.1- 6.1)
IV(b) Other sympathetic nervous system tumors ∼ ∼ ∼ ∼ ∼ ∼
V Retinoblastoma 2.5 ( 2.0- 3.1) 2.5 ( 1.9- 3.1) ∼ ∼ ∼ 3.2 ( 2.1- 4.7)
VI Renal tumors 6.3 ( 5.5- 7.1) 5.7 ( 4.9- 6.7) 7.9 ( 5.8- 10.5) ∼ ∼ 4.4 ( 3.0- 6.2)
VI(a) Wilms tumor, rhabdoid and clear cell
sarcoma 5.9 ( 5.2- 6.8) 5.5 ( 4.6- 6.4) 7.2 ( 5.2- 9.7) ∼ ∼ 4.4 ( 3.0- 6.2)
VI(b) Renal carcinoma ∼ ∼ ∼ ∼ ∼ ∼
VI(c) Unspecified malignant renal tumors ∼ ∼ ∼ ∼ ∼ ∼
VII Hepatic tumors 1.2 ( 0.9- 1.6) 1.4 ( 1.0- 1.9) ∼ ∼ ∼ ∼
VII(a) Hepatoblastoma 0.8 ( 0.5- 1.1) 0.9 ( 0.6- 1.3) ∼ ∼ ∼ ∼
VII(b) Hepatic carcinoma 0.4 ( 0.2- 0.7) ∼ ∼ ∼ ∼ ∼
VII(c) Unspecified malignant hepatic tumors ∼ ∼ ∼ ∼ ∼ ∼
VIII Malignant bone tumors 7.5 ( 6.6- 8.4) 8.0 ( 7.0- 9.1) 5.6 ( 3.9- 7.9) ∼ ∼ 7.4 ( 5.4- 9.8)
VIII(a) Osteosarcoma 3.8 ( 3.2- 4.5) 3.6 ( 2.9- 4.3) 4.9 ( 3.3- 7.1) ∼ ∼ 3.6 ( 2.3- 5.4)
VIII(b) Chrondosarcoma ∼ ∼ ∼ ∼ ∼ ∼
VIII(c) Ewing sarcoma 2.7 ( 2.2- 3.3) 3.4 ( 2.7- 4.1) ∼ ∼ ∼ ∼
VIII(d) Other specified malignant bone tumors ∼ ∼ ∼ ∼ ∼ ∼
VIII(e) Unspecified malignant bone tumors ∼ ∼ ∼ ∼ ∼ ∼
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Table 1.2.1.1F: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals for Ages 0-19 by
International Classification of Childhood Cancer (ICCC†) Group and Subgroup, and Race and Ethnicity, United
States‡ (continued)
Females, 2002
Asian/Pacific American Indian/
ICCC Group and Subgroup All Races White Black Islander§ Alaska Native§ Hispanic§‖
IX Soft-tissue sarcomas 10.2 ( 9.2- 11.3) 9.9 ( 8.8- 11.1) 11.1 ( 8.6- 14.2) ∼ ∼ 8.6 ( 6.6- 11.1)
IX(a) Rhabdomyosarcoma and embryonal sarcoma 3.6 ( 3.0- 4.3) 3.4 ( 2.8- 4.2) 4.8 ( 3.2- 6.9) ∼ ∼ 3.1 ( 2.0- 4.8)
IX(b) Fibrosarcoma, neurofibrosar and other
fibromatous neoplasms 2.1 ( 1.7- 2.6) 2.1 ( 1.6- 2.7) ∼ ∼ ∼ ∼
IX(c) Kaposi sarcoma ∼ ∼ ∼ ∼ ∼ ∼
IX(d) Other specified soft-tissue sarcomas 3.3 ( 2.7- 4.0) 3.3 ( 2.7- 4.1) ∼ ∼ ∼ 3.1 ( 1.9- 4.7)
IX(d) excluding misclassification from III(c) 2.8 ( 2.3- 3.4) 2.9 ( 2.3- 3.6) ∼ ∼ ∼ 2.9 ( 1.8- 4.6)
PNET - not in brain/CNS/bone 0.5 ( 0.3- 0.7) ∼ ∼ ∼ ∼ ∼
IX(e) Unspecified soft-tissue sarcomas 1.2 ( 0.9- 1.6) 1.1 ( 0.7- 1.5) ∼ ∼ ∼ ∼
X Germ-cell, trophoblastic and other gonadal
neoplasms 8.3 ( 7.4- 9.3) 8.2 ( 7.2- 9.3) 7.7 ( 5.6- 10.3) ∼ ∼ 10.4 ( 8.0- 13.2)
X(a) Intracranial and intraspinal germ-cell
tumors 1.0 ( 0.7- 1.4) 1.1 ( 0.8- 1.6) ∼ ∼ ∼ ∼
X(b) Other and unspecified non-gonadal germ-cell
tumors 1.8 ( 1.4- 2.3) 1.6 ( 1.1- 2.1) ∼ ∼ ∼ ∼
X(c) Gonadal germ-cell tumors 4.4 ( 3.8- 5.2) 4.4 ( 3.7- 5.2) 4.0 ( 2.5- 6.0) ∼ ∼ 6.8 ( 5.0- 9.2)
X(d) Gonadal carcinomas 0.7 ( 0.4- 1.0) 0.7 ( 0.4- 1.1) ∼ ∼ ∼ ∼
X(e) Other and unspecified malignant gonadal
tumors 0.4 ( 0.2- 0.7) ∼ ∼ ∼ ∼ ∼
XI Carcinomas and other malignant epithelial
neoplasms 22.2 ( 20.7- 23.8) 24.4 ( 22.6- 26.2) 10.1 ( 7.6- 13.1) 13.8 ( 8.8- 20.8) ∼ 13.5 ( 10.7- 16.7)
XI(a) Adrenocortical carcinoma ∼ ∼ ∼ ∼ ∼ ∼
XI(b) Thyroid carcinoma 9.0 ( 8.1- 10.0) 10.2 ( 9.0- 11.4) ∼ ∼ ∼ 5.7 ( 4.0- 8.0)
XI(c) Nasopharyngeal carcinoma 0.5 ( 0.3- 0.8) ∼ ∼ ∼ ∼ ∼
XI(d) Malignant melanoma 6.9 ( 6.1- 7.9) 8.2 ( 7.2- 9.3) ∼ ∼ ∼ ∼
XI(e) Skin carcinoma ∼ ∼ ∼ ∼ ∼ ∼
XI(f) Other and unspecified carcinomas 5.2 ( 4.5- 6.0) 5.1 ( 4.3- 6.0) 5.9 ( 4.0- 8.2) ∼ ∼ 5.1 ( 3.5- 7.3)
XII Other and unspecified malignant neoplasms 1.4 ( 1.1- 1.9) 1.4 ( 1.0- 1.9) ∼ ∼ ∼ ∼
XII(a) Other specified malignant tumors 0.9 ( 0.6- 1.3) 0.9 ( 0.6- 1.3) ∼ ∼ ∼ ∼
XII(b) Other unspecified malignant tumors 0.5 ( 0.3- 0.8) ∼ ∼ ∼ ∼ ∼
Not classified by ICCC 0.7 ( 0.4- 1.0) 0.7 ( 0.4- 1.0) ∼ ∼ ∼ ∼
∗ Rates are per 1,000,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† SEER modification of the 1996 International Classification of Childhood Cancer based on ICD-0-2. See Technical Notes.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for data quality
criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.2.2.1 : Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by International Classification of Childhood Cancer (ICCC†) Group and Subgroup,
and Age, United States‡
All Races, Males and Females, 2002
Age (years)
ICCC Group and Subgroup 0-14 0-19
All ICCC Groups Combined 145.0 (141.9-148.2) 161.0 (158.2-163.9)
I Leukemia 45.2 ( 43.5- 47.0) 41.0 ( 39.5- 42.4)
I(a) Lymphoid leukemia 35.0 ( 33.5- 36.6) 30.3 ( 29.1- 31.6)
Acute lymphocytic leukemia (ALL) 34.0 ( 32.5- 35.5) 29.4 ( 28.1- 30.6)
Lymphoid excluding ALL 1.0 ( 0.8- 1.3) 1.0 ( 0.7- 1.2)
I(b) Acute non-lymphocytic leukemia 7.6 ( 6.9- 8.4) 7.9 ( 7.3- 8.6)
I(c) Chronic myeloid leukemia 1.1 ( 0.9- 1.5) 1.3 ( 1.0- 1.6)
I(d) Other specified leukemia ∼ 0.3 ( 0.2- 0.4)
I(e) Unspecified leukemia 1.3 ( 1.0- 1.6) 1.2 ( 0.9- 1.5)
II Lymphoma and reticuloendothelial neoplasms 14.3 ( 13.3- 15.3) 23.1 ( 22.0- 24.2)
II(a) Hodgkin lymphoma 5.2 ( 4.6- 5.8) 11.9 ( 11.1- 12.7)
II(b) Non-Hodgkin lymphoma 6.1 ( 5.5- 6.8) 8.1 ( 7.4- 8.7)
II(c) Burkitt lymphoma 2.6 ( 2.2- 3.1) 2.6 ( 2.3- 3.0)
II(d) Miscellaneous lymphoreticular neoplasms ∼ ∼
II(e) Unspecified lymphoma ∼ 0.3 ( 0.2- 0.5)
III CNS and misc intracranial and intraspinal neoplasms 30.7 ( 29.2- 32.2) 27.9 ( 26.7- 29.1)
III(a) Ependymoma 3.5 ( 3.0- 4.0) 2.8 ( 2.5- 3.3)
III(b) Astrocytoma 14.0 ( 13.0- 15.0) 13.3 ( 12.5- 14.2)
III(c) Primitive neuroectodermal tumors 6.8 ( 6.2- 7.6) 5.8 ( 5.3- 6.4)
III(d) Other gliomas 5.1 ( 4.5- 5.8) 4.8 ( 4.3- 5.4)
III(e) Misc intracranial and intraspinal neoplasms ∼ 0.3 ( 0.2- 0.4)
III(f) Unspecified intracranial and intraspinal neoplasm 1.0 ( 0.7- 1.3) 0.8 ( 0.6- 1.1)
IV Sympathetic nervous system tumors 10.2 ( 9.4- 11.1) 7.8 ( 7.2- 8.5)
IV(a) Neuroblastoma and ganglioneuroblastoma 10.1 ( 9.3- 10.9) 7.6 ( 7.0- 8.2)
IV(b) Other sympathetic nervous system tumors ∼ 0.2 ( 0.1- 0.4)
V Retinoblastoma 3.7 ( 3.2- 4.2) 2.7 ( 2.4- 3.1)
VI Renal tumors 7.9 ( 7.2- 8.7) 6.2 ( 5.7- 6.8)
VI(a) Wilms tumor, rhabdoid and clear cell sarcoma 7.7 ( 7.0- 8.4) 5.8 ( 5.2- 6.3)
VI(b) Renal carcinoma ∼ 0.4 ( 0.3- 0.6)
VI(c) Unspecified malignant renal tumors ∼ ∼
VII Hepatic tumors 1.9 ( 1.6- 2.3) 1.7 ( 1.4- 2.0)
VII(a) Hepatoblastoma 1.6 ( 1.2- 1.9) 1.2 ( 0.9- 1.4)
VII(b) Hepatic carcinoma 0.3 ( 0.2- 0.5) 0.5 ( 0.3- 0.7)
VII(c) Unspecified malignant hepatic tumors ∼ ∼
VIII Malignant bone tumors 7.0 ( 6.4- 7.7) 9.2 ( 8.5- 9.9)
VIII(a) Osteosarcoma 3.7 ( 3.2- 4.2) 4.9 ( 4.4- 5.4)
VIII(b) Chrondosarcoma ∼ 0.5 ( 0.4- 0.7)
VIII(c) Ewing sarcoma 2.7 ( 2.3- 3.2) 3.2 ( 2.8- 3.6)
VIII(d) Other specified malignant bone tumors 0.3 ( 0.2- 0.5) 0.4 ( 0.3- 0.6)
VIII(e) Unspecified malignant bone tumors ∼ ∼
IX Soft-tissue sarcomas 10.9 ( 10.1- 11.8) 12.0 ( 11.2- 12.8)
IX(a) Rhabdomyosarcoma and embryonal sarcoma 5.2 ( 4.7- 5.9) 4.8 ( 4.3- 5.3)
IX(b) Fibrosarcoma, neurofibrosar and other fibromatous neoplasms 1.8 ( 1.4- 2.2) 2.1 ( 1.8- 2.4)
IX(c) Kaposi sarcoma ∼ ∼
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Table 1.2.2.1 : Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by International Classification of Childhood Cancer (ICCC†) Group and Subgroup,
and Age, United States‡ (continued)
All Races, Males and Females, 2002
Age (years)
ICCC Group and Subgroup 0-14 0-19
IX(d) Other specified soft-tissue sarcomas 2.8 ( 2.4- 3.3) 3.8 ( 3.4- 4.2)
IX(d) excluding misclassification from III(c) 2.5 ( 2.1- 2.9) 3.3 ( 2.9- 3.8)
PNET - not in brain/CNS/bone 0.3 ( 0.2- 0.5) 0.5 ( 0.3- 0.6)
IX(e) Unspecified soft-tissue sarcomas 1.1 ( 0.9- 1.4) 1.3 ( 1.1- 1.6)
X Germ-cell, trophoblastic and other gonadal neoplasms 5.3 ( 4.7- 6.0) 10.8 ( 10.1- 11.6)
X(a) Intracranial and intraspinal germ-cell tumors 1.4 ( 1.1- 1.8) 1.6 ( 1.3- 1.9)
X(b) Other and unspecified non-gonadal germ-cell tumors 1.4 ( 1.1- 1.7) 1.5 ( 1.2- 1.8)
X(c) Gonadal germ-cell tumors 2.3 ( 1.9- 2.7) 7.2 ( 6.6- 7.8)
X(d) Gonadal carcinomas ∼ 0.3 ( 0.2- 0.5)
X(e) Other and unspecified malignant gonadal tumors ∼ 0.3 ( 0.2- 0.4)
XI Carcinomas and other malignant epithelial neoplasms 6.3 ( 5.6- 7.0) 16.9 ( 16.0- 17.8)
XI(a) Adrenocortical carcinoma ∼ 0.3 ( 0.2- 0.4)
XI(b) Thyroid carcinoma 1.8 ( 1.4- 2.1) 5.5 ( 5.0- 6.0)
XI(c) Nasopharyngeal carcinoma ∼ 0.7 ( 0.5- 0.9)
XI(d) Malignant melanoma 2.2 ( 1.9- 2.7) 6.3 ( 5.7- 6.9)
XI(e) Skin carcinoma ∼ ∼
XI(f) Other and unspecified carcinomas 1.7 ( 1.3- 2.0) 4.1 ( 3.7- 4.6)
XII Other and unspecified malignant neoplasms 0.8 ( 0.6- 1.1) 1.1 ( 0.9- 1.4)
XII(a) Other specified malignant tumors 0.4 ( 0.3- 0.6) 0.6 ( 0.4- 0.8)
XII(b) Other unspecified malignant tumors 0.4 ( 0.2- 0.6) 0.6 ( 0.4- 0.8)
Not classified by ICCC 0.8 ( 0.6- 1.1) 0.7 ( 0.5- 0.9)
∗ Rates are per 1,000,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† SEER modification of the 1996 International Classification of Childhood Cancer based on ICD-0-2. See Technical Notes.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined.
See Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, age).
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Table 1.2.3.1 : Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by International
Classification of Childhood Cancer (ICCC†) Group and Subgroup, and Age, United States‡
All Races, Males and Females, 2002
Age (years)
ICCC Group and Subgroup <1 1-4 5-9 10-14 15-19
All ICCC Groups Combined 232.1 (216.9-248.1) 199.3 (192.1-206.7) 112.7 (107.9-117.6) 119.6 (114.8-124.5) 208.6 (202.1-215.2)
I Leukemia 41.3 ( 35.1- 48.4) 81.6 ( 77.0- 86.4) 37.1 ( 34.4- 40.0) 26.5 ( 24.3- 28.9) 28.2 ( 25.9- 30.7)
I(a) Lymphoid leukemia 16.9 ( 13.0- 21.6) 68.4 ( 64.2- 72.7) 30.5 ( 28.0- 33.1) 17.6 ( 15.8- 19.6) 16.4 ( 14.6- 18.3)
Acute lymphocytic leukemia (ALL) 16.6 ( 12.8- 21.3) 67.0 ( 62.8- 71.3) 29.3 ( 26.9- 31.9) 16.9 ( 15.1- 18.8) 15.6 ( 13.9- 17.5)
Lymphoid excluding ALL ∼ 1.4 ( 0.8- 2.1) 1.2 ( 0.7- 1.8) ∼ ∼
I(b) Acute non-lymphocytic leukemia 17.2 ( 13.2- 21.9) 10.3 ( 8.7- 12.1) 4.4 ( 3.5- 5.5) 7.0 ( 5.8- 8.2) 8.8 ( 7.5- 10.3)
I(c) Chronic myeloid leukemia ∼ 1.1 ( 0.6- 1.8) ∼ 1.2 ( 0.8- 1.8) 1.7 ( 1.2- 2.4)
I(d) Other specified leukemia ∼ ∼ ∼ ∼ ∼
I(e) Unspecified leukemia ∼ 1.6 ( 1.0- 2.4) 1.2 ( 0.7- 1.8) ∼ 1.0 ( 0.6- 1.5)
II Lymphoma and reticuloendothelial neoplasms 4.6 ( 2.7- 7.3) 7.9 ( 6.5- 9.4) 12.4 ( 10.8- 14.1) 22.9 ( 20.8- 25.1) 49.3 ( 46.2- 52.5)
II(a) Hodgkin lymphoma ∼ ∼ 3.1 ( 2.4- 4.0) 11.6 ( 10.2- 13.3) 31.8 ( 29.4- 34.5)
II(b) Non-Hodgkin lymphoma ∼ 4.8 ( 3.8- 6.1) 5.7 ( 4.7- 6.9) 8.0 ( 6.8- 9.3) 14.0 ( 12.4- 15.8)
II(c) Burkitt lymphoma ∼ 2.0 ( 1.3- 2.9) 3.2 ( 2.4- 4.1) 2.9 ( 2.2- 3.8) 2.7 ( 2.0- 3.5)
II(d) Miscellaneous lymphoreticular neoplasms ∼ ∼ ∼ ∼ ∼
II(e) Unspecified lymphoma ∼ ∼ ∼ ∼ ∼
III CNS and misc intracranial and intraspinal
neoplasms 32.5 ( 26.9- 38.8) 39.1 ( 36.0- 42.5) 32.2 ( 29.7- 34.9) 22.4 ( 20.3- 24.6) 19.6 ( 17.6- 21.7)
III(a) Ependymoma 6.7 ( 4.3- 9.9) 6.1 ( 4.9- 7.5) 2.1 ( 1.5- 2.9) 2.2 ( 1.6- 2.9) 1.0 ( 0.6- 1.5)
III(b) Astrocytoma 11.5 ( 8.4- 15.5) 16.2 ( 14.2- 18.4) 15.0 ( 13.3- 16.8) 11.8 ( 10.4- 13.5) 11.4 ( 9.9- 13.0)
III(c) Primitive neuroectodermal tumors 6.7 ( 4.3- 9.9) 9.4 ( 7.9- 11.1) 7.8 ( 6.6- 9.2) 4.0 ( 3.2- 5.0) 2.6 ( 2.0- 3.5)
III(d) Other gliomas ∼ 5.5 ( 4.4- 6.9) 6.8 ( 5.6- 8.1) 3.7 ( 2.9- 4.6) 4.0 ( 3.1- 5.0)
III(e) Misc intracranial and intraspinal
neoplasms ∼ ∼ ∼ ∼ ∼
III(f) Unspecified intracranial and intraspinal
neoplasm 4.6 ( 2.7- 7.3) 1.7 ( 1.1- 2.5) ∼ ∼ ∼
IV Sympathetic nervous system tumors 58.8 ( 51.2- 67.1) 18.7 ( 16.5- 21.0) 3.5 ( 2.7- 4.5) 1.2 ( 0.7- 1.8) ∼
IV(a) Neuroblastoma and ganglioneuroblastoma 58.8 ( 51.2- 67.1) 18.4 ( 16.3- 20.7) 3.5 ( 2.7- 4.5) 1.0 ( 0.6- 1.6) ∼
IV(b) Other sympathetic nervous system tumors ∼ ∼ ∼ ∼ ∼
V Retinoblastoma 23.1 ( 18.5- 28.5) 8.2 ( 6.8- 9.8) ∼ ∼ ∼
VI Renal tumors 16.9 ( 13.0- 21.6) 19.2 ( 17.0- 21.5) 4.6 ( 3.6- 5.6) 1.1 ( 0.7- 1.6) 1.1 ( 0.7- 1.7)
VI(a) Wilms tumor, rhabdoid and clear cell
sarcoma 16.9 ( 13.0- 21.6) 19.0 ( 16.8- 21.4) 4.3 ( 3.4- 5.3) ∼ ∼
VI(b) Renal carcinoma ∼ ∼ ∼ ∼ 1.0 ( 0.6- 1.6)
VI(c) Unspecified malignant renal tumors ∼ ∼ ∼ ∼ ∼
VII Hepatic tumors 7.0 ( 4.6- 10.2) 4.3 ( 3.3- 5.5) ∼ ∼ 1.0 ( 0.6- 1.6)
VII(a) Hepatoblastoma 6.7 ( 4.3- 9.9) 4.0 ( 3.0- 5.2) ∼ ∼ ∼
VII(b) Hepatic carcinoma ∼ ∼ ∼ ∼ 1.0 ( 0.6- 1.5)
VII(c) Unspecified malignant hepatic tumors ∼ ∼ ∼ ∼ ∼
VIII Malignant bone tumors ∼ 1.6 ( 1.0- 2.4) 6.0 ( 4.9- 7.2) 13.4 ( 11.9- 15.1) 15.7 ( 14.0- 17.6)
VIII(a) Osteosarcoma ∼ ∼ 2.6 ( 1.9- 3.5) 7.9 ( 6.7- 9.2) 8.6 ( 7.3- 10.0)
VIII(b) Chrondosarcoma ∼ ∼ ∼ ∼ 1.5 ( 1.0- 2.2)
VIII(c) Ewing sarcoma ∼ ∼ 2.8 ( 2.1- 3.7) 4.4 ( 3.5- 5.4) 4.6 ( 3.7- 5.7)
VIII(d) Other specified malignant bone tumors ∼ ∼ ∼ ∼ ∼
VIII(e) Unspecified malignant bone tumors ∼ ∼ ∼ ∼ ∼
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Table 1.2.3.1 : Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by International
Classification of Childhood Cancer (ICCC†) Group and Subgroup, and Age, United States‡
(continued)
All Races, Males and Females, 2002
Age (years)
ICCC Group and Subgroup <1 1-4 5-9 10-14 15-19
IX Soft-tissue sarcomas 17.2 ( 13.2- 21.9) 11.5 ( 9.8- 13.4) 9.3 ( 8.0- 10.8) 10.9 ( 9.5- 12.5) 15.0 ( 13.3- 16.8)
IX(a) Rhabdomyosarcoma and embryonal sarcoma 7.0 ( 4.6- 10.2) 8.3 ( 6.9- 9.9) 4.9 ( 3.9- 6.0) 2.9 ( 2.2- 3.8) 3.4 ( 2.6- 4.4)
IX(b) Fibrosarcoma, neurofibrosar and other
fibromatous neoplasms 5.4 ( 3.3- 8.3) ∼ 1.3 ( 0.8- 1.9) 2.2 ( 1.6- 3.0) 3.0 ( 2.3- 3.9)
IX(c) Kaposi sarcoma ∼ ∼ ∼ ∼ ∼
IX(d) Other specified soft-tissue sarcomas ∼ 1.8 ( 1.2- 2.6) 2.2 ( 1.6- 3.0) 4.1 ( 3.2- 5.1) 6.6 ( 5.5- 7.9)
IX(d) excluding misclassification from III(c) ∼ 1.4 ( 0.8- 2.1) 2.0 ( 1.4- 2.7) 3.6 ( 2.8- 4.6) 5.8 ( 4.7- 6.9)
PNET - not in brain/CNS/bone ∼ ∼ ∼ ∼ 0.8 ( 0.5- 1.4)
IX(e) Unspecified soft-tissue sarcomas ∼ ∼ 1.0 ( 0.6- 1.5) 1.7 ( 1.2- 2.4) 2.0 ( 1.4- 2.7)
X Germ-cell, trophoblastic and other gonadal
neoplasms 22.3 ( 17.7- 27.6) 3.1 ( 2.3- 4.1) 2.6 ( 1.9- 3.5) 6.5 ( 5.4- 7.7) 27.2 ( 24.9- 29.6)
X(a) Intracranial and intraspinal germ-cell
tumors ∼ ∼ 1.1 ( 0.7- 1.7) 2.5 ( 1.9- 3.4) 2.2 ( 1.6- 2.9)
X(b) Other and unspecified non-gonadal germ-cell
tumors 14.8 ( 11.1- 19.2) 1.2 ( 0.7- 2.0) ∼ ∼ 1.6 ( 1.1- 2.3)
X(c) Gonadal germ-cell tumors 5.6 ( 3.5- 8.6) 1.5 ( 1.0- 2.3) 1.3 ( 0.8- 1.9) 3.3 ( 2.6- 4.2) 21.6 ( 19.6- 23.8)
X(d) Gonadal carcinomas ∼ ∼ ∼ ∼ 1.0 ( 0.6- 1.6)
X(e) Other and unspecified malignant gonadal
tumors ∼ ∼ ∼ ∼ ∼
XI Carcinomas and other malignant epithelial
neoplasms ∼ 2.3 ( 1.6- 3.2) 3.8 ( 2.9- 4.7) 12.5 ( 11.0- 14.2) 48.4 ( 45.3- 51.7)
XI(a) Adrenocortical carcinoma ∼ ∼ ∼ ∼ ∼
XI(b) Thyroid carcinoma ∼ ∼ 1.0 ( 0.6- 1.5) 4.1 ( 3.2- 5.1) 16.5 ( 14.7- 18.4)
XI(c) Nasopharyngeal carcinoma ∼ ∼ ∼ ∼ 1.9 ( 1.3- 2.6)
XI(d) Malignant melanoma ∼ 1.1 ( 0.6- 1.8) 1.7 ( 1.1- 2.4) 3.8 ( 3.0- 4.7) 18.4 ( 16.5- 20.4)
XI(e) Skin carcinoma ∼ ∼ ∼ ∼ ∼
XI(f) Other and unspecified carcinomas ∼ ∼ ∼ 3.7 ( 2.9- 4.7) 11.4 ( 9.9- 13.0)
XII Other and unspecified malignant neoplasms ∼ ∼ ∼ 1.2 ( 0.7- 1.8) 2.2 ( 1.6- 2.9)
XII(a) Other specified malignant tumors ∼ ∼ ∼ ∼ 1.1 ( 0.6- 1.6)
XII(b) Other unspecified malignant tumors ∼ ∼ ∼ ∼ 1.1 ( 0.7- 1.7)
Not classified by ICCC 4.3 ( 2.5- 7.0) 1.2 ( 0.7- 2.0) ∼ ∼ ∼
∗ Rates are per 1,000,000 persons.
† SEER modification of the 1996 International Classification of Childhood Cancer based on ICD-0-2. See Technical Notes.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I
for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, age).
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Table 1.2.4.1M: Childhood Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals for Ages 0-19 by Primary Site and Race and Ethnicity, United States†
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 17.2 (16.8-17.7) 18.3 (17.8-18.8) 11.0 (10.2-11.9) 12.6 (11.0-14.4) 11.1 ( 8.5-14.5) 17.8 (16.9-18.8)
Bones and Joints 1.1 ( 1.0- 1.2) 1.1 ( 1.0- 1.2) 0.8 ( 0.6- 1.1) ∼ ∼ 1.2 ( 1.0- 1.5)
Brain and Other Nervous System 3.2 ( 3.0- 3.4) 3.5 ( 3.2- 3.7) 2.2 ( 1.8- 2.6) 1.5 ( 1.0- 2.2) ∼ 2.8 ( 2.4- 3.2)
Hodgkin Lymphoma 1.2 ( 1.1- 1.3) 1.2 ( 1.1- 1.4) 0.9 ( 0.6- 1.1) ∼ ∼ 1.1 ( 0.9- 1.4)
Kidney and Renal Pelvis 0.6 ( 0.6- 0.7) 0.7 ( 0.6- 0.8) 0.7 ( 0.5- 0.9) ∼ ∼ 0.5 ( 0.4- 0.7)
Leukemia 4.5 ( 4.3- 4.7) 4.8 ( 4.5- 5.0) 2.4 ( 2.0- 2.8) 4.0 ( 3.2- 5.1) 4.0 ( 2.5- 6.2) 5.8 ( 5.3- 6.4)
Acute Lymphocytic 3.3 ( 3.1- 3.5) 3.6 ( 3.4- 3.8) 1.6 ( 1.3- 1.9) 2.9 ( 2.2- 3.8) ∼ 4.6 ( 4.1- 5.1)
Acute Myeloid 0.7 ( 0.6- 0.8) 0.7 ( 0.6- 0.8) 0.5 ( 0.4- 0.8) ∼ ∼ 0.7 ( 0.5- 0.9)
Non-Hodgkin Lymphoma 1.4 ( 1.3- 1.5) 1.5 ( 1.4- 1.7) 1.0 ( 0.8- 1.3) 1.0 ( 0.6- 1.6) ∼ 1.7 ( 1.4- 2.0)
Soft Tissue 1.0 ( 0.9- 1.1) 1.1 ( 0.9- 1.2) 0.6 ( 0.4- 0.8) 1.2 ( 0.8- 1.9) ∼ 1.0 ( 0.8- 1.2)
Other 4.2 ( 4.0- 4.4) 4.5 ( 4.3- 4.7) 2.5 ( 2.1- 2.9) 3.1 ( 2.3- 4.0) 3.2 ( 1.9- 5.2) 3.7 ( 3.3- 4.2)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Table 1.2.4.2M: Childhood Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals for
Ages 0-19 by Primary Site and Race and Ethnicity, United States†
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 3.1 ( 2.9- 3.3) 3.1 ( 2.9- 3.3) 3.2 ( 2.7- 3.6) 2.9 ( 2.2- 3.8) ∼ 3.2 ( 2.8- 3.7)
Bones and Joints 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼ ∼ 0.2 ( 0.1- 0.4)
Brain and Other Nervous System 0.8 ( 0.7- 0.9) 0.8 ( 0.7- 0.9) 0.9 ( 0.7- 1.1) ∼ ∼ 0.7 ( 0.5- 0.9)
Hodgkin Lymphoma 0.0 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Kidney and Renal Pelvis 0.1 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Leukemia 0.9 ( 0.8- 1.0) 1.0 ( 0.8- 1.1) 0.8 ( 0.6- 1.0) 0.9 ( 0.5- 1.5) ∼ 1.3 ( 1.0- 1.6)
Acute Lymphocytic 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) 0.3 ( 0.2- 0.5) ∼ ∼ 0.7 ( 0.5- 0.9)
Acute Myeloid 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼ 0.4 ( 0.2- 0.5)
Non-Hodgkin Lymphoma 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) ∼ ∼ ∼ ∼
Soft Tissue 0.2 ( 0.2- 0.2) 0.2 ( 0.1- 0.2) 0.3 ( 0.2- 0.4) ∼ ∼ ∼
Other 0.7 ( 0.6- 0.7) 0.7 ( 0.6- 0.8) 0.7 ( 0.5- 0.9) ∼ ∼ 0.6 ( 0.4- 0.8)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.2.4.1F: Childhood Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals for Ages 0-19 by Primary Site and Race and Ethnicity, United States†
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 14.9 (14.5-15.3) 15.5 (15.0-15.9) 11.0 (10.1-11.8) 11.7 (10.2-13.5) 10.1 ( 7.5-13.3) 14.0 (13.1-14.9)
Bones and Joints 0.7 ( 0.7- 0.8) 0.8 ( 0.7- 0.9) 0.6 ( 0.4- 0.8) ∼ ∼ 0.7 ( 0.5- 0.9)
Brain and Other Nervous System 2.6 ( 2.4- 2.7) 2.7 ( 2.5- 2.9) 1.8 ( 1.5- 2.2) 1.6 ( 1.1- 2.3) ∼ 2.2 ( 1.9- 2.6)
Hodgkin Lymphoma 1.2 ( 1.1- 1.3) 1.3 ( 1.1- 1.4) 0.8 ( 0.6- 1.1) 1.0 ( 0.6- 1.6) ∼ 0.8 ( 0.6- 1.0)
Kidney and Renal Pelvis 0.6 ( 0.6- 0.7) 0.6 ( 0.5- 0.7) 0.8 ( 0.6- 1.1) ∼ ∼ 0.5 ( 0.3- 0.7)
Leukemia 3.7 ( 3.5- 3.9) 3.9 ( 3.6- 4.1) 2.3 ( 1.9- 2.7) 4.0 ( 3.1- 5.1) 3.7 ( 2.2- 5.9) 4.9 ( 4.4- 5.4)
Acute Lymphocytic 2.6 ( 2.5- 2.8) 2.8 ( 2.6- 3.0) 1.3 ( 1.0- 1.6) 2.9 ( 2.2- 3.8) ∼ 3.6 ( 3.2- 4.1)
Acute Myeloid 0.7 ( 0.6- 0.7) 0.6 ( 0.6- 0.7) 0.7 ( 0.5- 0.9) ∼ ∼ 0.7 ( 0.5- 0.9)
Non-Hodgkin Lymphoma 0.8 ( 0.7- 0.9) 0.8 ( 0.7- 0.9) 0.8 ( 0.6- 1.0) ∼ ∼ 0.8 ( 0.6- 1.0)
Soft Tissue 0.9 ( 0.8- 1.0) 0.9 ( 0.8- 1.0) 0.9 ( 0.6- 1.1) ∼ ∼ 0.8 ( 0.6- 1.0)
Other 4.4 ( 4.1- 4.6) 4.6 ( 4.4- 4.9) 3.0 ( 2.5- 3.4) 2.7 ( 2.0- 3.6) ∼ 3.4 ( 3.0- 3.9)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Table 1.2.4.2F: Childhood Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals for
Ages 0-19 by Primary Site and Race and Ethnicity, United States†
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 2.5 ( 2.4- 2.7) 2.5 ( 2.4- 2.7) 2.5 ( 2.2- 3.0) 2.2 ( 1.5- 3.0) ∼ 2.7 ( 2.3- 3.1)
Bones and Joints 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼ ∼ 0.2 ( 0.1- 0.4)
Brain and Other Nervous System 0.6 ( 0.5- 0.7) 0.6 ( 0.5- 0.7) 0.7 ( 0.5- 0.9) ∼ ∼ 0.5 ( 0.4- 0.7)
Hodgkin Lymphoma ∼ ∼ ∼ ∼ ∼ ∼
Kidney and Renal Pelvis 0.1 ( 0.0- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Leukemia 0.8 ( 0.7- 0.8) 0.8 ( 0.7- 0.9) 0.6 ( 0.4- 0.8) 1.0 ( 0.6- 1.6) ∼ 1.1 ( 0.8- 1.3)
Acute Lymphocytic 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼ ∼ 0.6 ( 0.5- 0.9)
Acute Myeloid 0.3 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.5) ∼ ∼ 0.3 ( 0.2- 0.4)
Non-Hodgkin Lymphoma 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Soft Tissue 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) ∼ ∼ ∼ ∼
Other 0.5 ( 0.5- 0.6) 0.5 ( 0.4- 0.6) 0.7 ( 0.5- 1.0) ∼ ∼ 0.5 ( 0.3- 0.7)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.2.5.1: Childhood Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by Primary Site and Age, United States†
All Races, Males and Females, 2002
Age (years)
Primary Site 0-14 0-19
All Sites 14.5 (14.2-14.8) 16.1 (15.8-16.4)
Bones and Joints 0.7 ( 0.6- 0.8) 0.9 ( 0.8- 1.0)
Brain and Other Nervous System 3.2 ( 3.0- 3.3) 2.9 ( 2.8- 3.0)
Hodgkin Lymphoma 0.5 ( 0.5- 0.6) 1.2 ( 1.1- 1.3)
Kidney and Renal Pelvis 0.8 ( 0.7- 0.9) 0.6 ( 0.6- 0.7)
Leukemia 4.5 ( 4.4- 4.7) 4.1 ( 4.0- 4.2)
Acute Lymphocytic 3.4 ( 3.3- 3.6) 3.0 ( 2.9- 3.1)
Acute Myeloid 0.6 ( 0.6- 0.7) 0.7 ( 0.6- 0.8)
Non-Hodgkin Lymphoma 0.9 ( 0.8- 1.0) 1.1 ( 1.0- 1.2)
Soft Tissue 1.0 ( 0.9- 1.0) 1.0 ( 0.9- 1.1)
Other 2.9 ( 2.8- 3.1) 4.3 ( 4.1- 4.4)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites
combined. See Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the
U.S. population.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, age).
Table 1.2.5.2: Childhood Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by Primary Site and Age, United States†
All Races, Males and Females, 2002
Age (years)
Primary Site 0-14 0-19
All Sites 2.6 (2.4-2.7) 2.8 (2.7-2.9)
Bones and Joints 0.1 (0.1-0.2) 0.2 (0.2-0.3)
Brain and Other Nervous System 0.8 (0.7-0.8) 0.7 (0.7-0.8)
Hodgkin Lymphoma ∼ 0.0 (0.0-0.1)
Kidney and Renal Pelvis 0.1 (0.1-0.1) 0.1 (0.0-0.1)
Leukemia 0.7 (0.7-0.8) 0.8 (0.8-0.9)
Acute Lymphocytic 0.4 (0.3-0.4) 0.4 (0.4-0.4)
Acute Myeloid 0.2 (0.2-0.3) 0.3 (0.2-0.3)
Non-Hodgkin Lymphoma 0.1 (0.1-0.2) 0.1 (0.1-0.2)
Soft Tissue 0.2 (0.1-0.2) 0.2 (0.2-0.2)
Other 0.6 (0.5-0.6) 0.6 (0.6-0.7)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, age).
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Table 1.2.6.1: Childhood Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals
by Primary Site and Age, United States†
All Races, Males and Females, 2002
Age (years)
Primary Site <1 1-4 5-9 10-14 15-19
All Sites 23.2 (21.7-24.8) 19.9 (19.2-20.7) 11.3 (10.8-11.8) 12.0 (11.5-12.5) 20.9 (20.2-21.5)
Bones and Joints ∼ 0.2 ( 0.1- 0.2) 0.6 ( 0.5- 0.7) 1.3 ( 1.2- 1.5) 1.5 ( 1.4- 1.7)
Brain and Other Nervous System 3.7 ( 3.1- 4.4) 4.0 ( 3.6- 4.3) 3.3 ( 3.0- 3.6) 2.4 ( 2.1- 2.6) 2.0 ( 1.8- 2.2)
Hodgkin Lymphoma ∼ ∼ 0.3 ( 0.2- 0.4) 1.2 ( 1.0- 1.3) 3.2 ( 2.9- 3.4)
Kidney and Renal Pelvis 1.8 ( 1.4- 2.3) 2.0 ( 1.7- 2.2) 0.5 ( 0.4- 0.6) 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.2)
Leukemia 4.1 ( 3.5- 4.8) 8.2 ( 7.7- 8.6) 3.7 ( 3.4- 4.0) 2.7 ( 2.4- 2.9) 2.8 ( 2.6- 3.1)
Acute Lymphocytic 1.7 ( 1.3- 2.1) 6.8 ( 6.3- 7.2) 3.0 ( 2.7- 3.2) 1.7 ( 1.6- 1.9) 1.6 ( 1.4- 1.8)
Acute Myeloid 1.3 ( 0.9- 1.7) 0.8 ( 0.7- 1.0) 0.4 ( 0.3- 0.5) 0.6 ( 0.5- 0.8) 0.8 ( 0.7- 1.0)
Non-Hodgkin Lymphoma ∼ 0.7 ( 0.6- 0.9) 0.9 ( 0.8- 1.1) 1.1 ( 1.0- 1.3) 1.7 ( 1.6- 1.9)
Soft Tissue 3.0 ( 2.5- 3.6) 1.1 ( 1.0- 1.3) 0.6 ( 0.5- 0.7) 0.8 ( 0.7- 0.9) 1.1 ( 0.9- 1.2)
Other 10.0 ( 9.0-11.1) 3.8 ( 3.5- 4.1) 1.4 ( 1.2- 1.6) 2.4 ( 2.2- 2.6) 8.4 ( 8.0- 8.8)
∗ Rates are per 100,000 persons.
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined.
See Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, age).
Table 1.2.6.2: Childhood Cancer Death Rates∗ and 95% Confidence Intervals by Primary Site
and Age, United States†
All Races, Males and Females, 2002
Age (years)
Primary Site <1 1-4 5-9 10-14 15-19
All Sites 1.8 (1.5-2.3) 2.6 (2.3-2.8) 2.7 (2.5-2.9) 2.5 (2.3-2.8) 3.6 (3.3-3.8)
Bones and Joints ∼ ∼ 0.1 (0.1-0.2) 0.3 (0.2-0.4) 0.5 (0.4-0.6)
Brain and Other Nervous System ∼ 0.7 (0.6-0.9) 1.0 (0.9-1.2) 0.6 (0.5-0.8) 0.5 (0.4-0.6)
Hodgkin Lymphoma ∼ ∼ ∼ ∼ 0.1 (0.1-0.2)
Kidney and Renal Pelvis ∼ ∼ 0.1 (0.1-0.2) ∼ ∼
Leukemia 0.5 (0.3-0.8) 0.7 (0.5-0.8) 0.7 (0.6-0.9) 0.8 (0.7-0.9) 1.2 (1.0-1.3)
Acute Lymphocytic ∼ 0.2 (0.2-0.3) 0.4 (0.3-0.5) 0.4 (0.3-0.5) 0.5 (0.4-0.6)
Acute Myeloid ∼ 0.3 (0.2-0.4) 0.2 (0.1-0.2) 0.2 (0.2-0.3) 0.4 (0.3-0.5)
Non-Hodgkin Lymphoma ∼ ∼ ∼ 0.2 (0.1-0.3) 0.2 (0.2-0.3)
Soft Tissue ∼ 0.1 (0.1-0.2) 0.1 (0.1-0.2) 0.2 (0.1-0.3) 0.3 (0.2-0.4)
Other 0.8 (0.5-1.1) 0.9 (0.7-1.0) 0.5 (0.4-0.6) 0.4 (0.3-0.5) 0.7 (0.6-0.9)
∗ Rates are per 100,000 persons.
† Data are from the National Vital Statistics System (NVSS).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, age).
U
nited States C
ancer Statistics: 2002 Incidence and M
ortality
50
Table 1.3.1.1: Age-Adjusted Invasive Cancer of the Brain and Other Nervous System Incidence
Rates∗ and 95% Confidence Intervals by Standard Histology Group and Subgroup†, Age, and
Sex, United States‡
All Races, 2002
0-19 years 20+ years
Histology Group and Subgroup Male Female Male Female
Total 3.4 ( 3.2- 3.6) 2.7 ( 2.5- 2.8) 10.4 (10.1-10.6) 7.2 ( 7.1- 7.4)
Tumors of Neuroepithelial Tissue 3.1 ( 2.9- 3.2) 2.5 ( 2.3- 2.6) 8.8 ( 8.6- 9.0) 5.9 ( 5.7- 6.0)
Pilocytic astrocytoma 0.7 ( 0.6- 0.8) 0.7 ( 0.6- 0.8) 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.1)
Diffuse astrocytoma 0.1 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1)
Anaplastic astrocytoma 0.1 ( 0.1- 0.2) 0.1 ( 0.0- 0.1) 0.7 ( 0.6- 0.8) 0.5 ( 0.4- 0.5)
Unique astrocytoma variants ∼ ∼ ∼ 0.0 ( 0.0- 0.0)
Astrocytoma, NOS 0.3 ( 0.3- 0.4) 0.2 ( 0.1- 0.2) 0.6 ( 0.6- 0.7) 0.5 ( 0.4- 0.5)
Glioblastoma 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.1) 5.4 ( 5.3- 5.6) 3.3 ( 3.2- 3.4)
Oligodendroglioma 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.7 ( 0.6- 0.7) 0.5 ( 0.5- 0.6)
Ependymoma 0.3 ( 0.2- 0.4) 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2)
Mixed glioma 0.0 ( 0.0- 0.1) ∼ 0.3 ( 0.2- 0.3) 0.2 ( 0.2- 0.2)
Glioma malignant, NOS 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.4- 0.4) 0.3 ( 0.3- 0.4)
Choroid plexus ∼ ∼ ∼ ∼
Neuroepithelial ∼ ∼ ∼ 0.0 ( 0.0- 0.0)
Neuronal/glial, neuronal 0.1 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) ∼ ∼
Pineal parenchymal ∼ 0.1 ( 0.0- 0.1) ∼ ∼
Embryonal/primitive/medulloblastoma 0.7 ( 0.6- 0.8) 0.5 ( 0.4- 0.5) 0.1 ( 0.1- 0.1) 0.1 ( 0.0- 0.1)
Tumors of Cranial and Spinal Nerves ∼ ∼ 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0)
Tumors of the Meninges ∼ ∼ 0.2 ( 0.1- 0.2) 0.3 ( 0.2- 0.3)
Meningioma ∼ ∼ 0.1 ( 0.1- 0.2) 0.2 ( 0.2- 0.3)
Other mesenchymal ∼ ∼ 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0)
Lymphomas and Hematopoietic Neoplasms ∼ ∼ 0.7 ( 0.6- 0.8) 0.5 ( 0.5- 0.5)
Germ Cell Tumors 0.2 ( 0.2- 0.3) 0.1 ( 0.1- 0.1) 0.0 ( 0.0- 0.1) ∼
Tumors of Sellar Region ∼ ∼ 0.0 ( 0.0- 0.0) ∼
Local Extensions from Regional Tumors ∼ ∼ 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0)
Unclassified Tumors ∼ 0.0 ( 0.0- 0.1) 0.6 ( 0.5- 0.7) 0.5 ( 0.4- 0.5)
Hemangioma ∼ ∼ ∼ ∼
Neoplasm, unspecified ∼ 0.0 ( 0.0- 0.1) 0.6 ( 0.5- 0.6) 0.5 ( 0.4- 0.5)
All other ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† As determined by the Consensus Conference on Cancer Registration of Brain and Central Nervous System Tumors. See Technical Notes and Appendix J.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (histology, age, sex).
Cancer Incidence and Mortality 
by U.S. Census Region and Division,
State, and Metropolitan Area
Table 2.1.1.1M
Consecutive numbering based on table series
In the series, the second digit indicates consec-
utive numbering of cancer sites in alphabetical 
order beginning with all cancer sites.
Specific types or categorization of rates
M = males
F = females
If no M or F, then cancer occurs only or 
primarily in either males or females (e.g.,
prostate for males, ovary for females).1 = incidence rate
2 = death rate
Rate can be age-adjusted or age-specific.
2 = geographic area rates
Organized by cancer site
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Table 2.1.1.1M: All Cancer Sites Combined. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 545.5 (544.1- 546.8) 536.8 (535.4- 538.2) 615.1 (610.0- 620.3) 422.8 (418.0- 427.6)
Northeast 584.2 (581.2- 587.2) 578.1 (574.9- 581.3) 600.8 (589.9- 611.9) 473.0 (460.0- 486.3)
New England 588.7 (582.8- 594.7) 586.4 (580.4- 592.5) 568.1 (536.5- 601.8) 514.7 (476.9- 555.4)
Connecticut 582.3 (570.6- 594.2) 575.8 (563.6- 588.2) 628.0 (576.0- 685.3) 539.8 (477.1- 610.2)
Maine 605.4 (586.5- 624.8) 602.4 (583.5- 621.9) 744.3 (400.7-1465.6) ∼
Massachusetts 591.4 (582.6- 600.4) 591.9 (582.7- 601.2) 539.0 (495.4- 586.3) 483.5 (431.3- 541.7)
New Hampshire 573.2 (553.4- 593.6) 560.5 (540.7- 580.8) ∼ -
Rhode Island 620.6 (598.8- 643.0) 627.0 (604.5- 650.1) 449.6 (349.4- 586.3) 553.4 (432.2- 709.1)
Vermont 536.5 (510.0- 564.1) 537.4 (510.8- 565.2) ∼ ∼
Middle Atlantic 582.6 (579.1- 586.1) 574.8 (571.1- 578.6) 604.4 (592.8- 616.2) 467.3 (453.5- 481.5)
New Jersey 629.3 (621.4- 637.4) 620.1 (611.6- 628.7) 669.1 (642.1- 697.2) 534.2 (504.8- 565.2)
New York 554.0 (549.0- 559.1) 551.4 (545.8- 556.9) 538.2 (523.6- 553.3) 429.0 (413.0- 445.6)
Pennsylvania 592.8 (586.8- 599.0) 577.5 (571.3- 583.8) 708.6 (683.0- 735.2) -
Midwest 551.1 (548.4- 553.9) 533.1 (530.3- 535.9) 646.1 (634.7- 657.7) 392.5 (374.8- 411.0)
East North Central 558.1 (554.8- 561.4) 537.5 (534.1- 540.9) 650.8 (638.3- 663.4) 392.0 (372.4- 412.6)
Illinois 574.5 (568.0- 581.2) 562.9 (556.0- 570.0) 630.8 (609.8- 652.5) 385.2 (359.5- 412.8)
Indiana 534.3 (525.5- 543.3) 525.5 (516.4- 534.8) 607.0 (568.6- 647.7) 333.5 (277.8- 400.5)
Michigan 585.3 (578.1- 592.6) 554.6 (547.2- 562.1) 726.8 (701.5- 753.0) 379.9 (331.7- 435.3)
Detroit 660.4 (648.2- 672.9) 634.9 (621.3- 648.7) 759.8 (729.8- 790.9) -
Ohio 538.8 (532.4- 545.2) 507.4 (500.9- 513.9) 599.4 (576.0- 623.7) 415.1 (355.2- 484.9)
Wisconsin 541.6 (532.4- 550.8) 533.5 (524.3- 542.9) 734.4 (667.9- 808.3) -
West North Central 535.2 (530.3- 540.1) 523.7 (518.7- 528.7) 620.1 (591.5- 650.0) 391.7 (351.9- 435.7)
Iowa 541.2 (529.2- 553.4) 532.3 (520.3- 544.5) 581.0 (467.9- 719.9) 348.4 (245.4- 486.7)
Kansas 512.6 (499.9- 525.5) 495.3 (482.5- 508.4) 568.2 (499.6- 644.6) 346.0 (281.0- 425.1)
Minnesota 561.1 (551.1- 571.2) 546.2 (536.2- 556.4) 696.9 (600.1- 810.1) 376.6 (283.0- 497.2)
Missouri 523.6 (514.8- 532.5) 515.9 (506.8- 525.2) 629.5 (593.3- 667.7) 447.9 (363.8- 550.8)
Nebraska 524.5 (508.6- 540.7) 507.3 (491.5- 523.6) 580.8 (471.3- 714.3) 445.4 (335.2- 587.1)
North Dakota 535.8 (510.6- 562.0) 534.9 (509.4- 561.4) ∼ ∼
South Dakota
South
South Atlantic
Delaware 580.5 (556.1- 605.9) 563.9 (537.9- 591.0) 671.1 (596.3- 755.2) 412.5 (251.6- 671.7)
District of Columbia 606.9 (575.4- 639.8) 438.8 (393.2- 489.5) 695.0 (652.5- 739.9) 274.8 (175.2- 435.2)
Florida 531.6 (526.9- 536.3) 530.2 (525.2- 535.2) 552.1 (534.5- 570.3) -
Georgia 573.9 (565.2- 582.8) 557.4 (547.7- 567.3) 652.1 (630.7- 674.2) 339.3 (286.8- 401.1)
Atlanta 565.9 (549.5- 582.8) 545.2 (526.6- 564.5) 670.6 (632.2- 711.4) 329.6 (254.8- 426.3)
Maryland 580.8 (570.8- 591.0) 585.4 (574.0- 597.1) 612.5 (588.2- 637.7) 357.9 (299.1- 427.3)
North Carolina 499.7 (492.2- 507.3) 483.8 (475.7- 492.0) 587.0 (566.3- 608.3) 259.4 (206.1- 324.9)
South Carolina 587.8 (576.4- 599.5) 556.0 (543.3- 568.9) 680.8 (654.0- 708.5) -
Virginia
West Virginia 558.0 (542.8- 573.6) 559.4 (543.9- 575.2) 587.0 (489.5- 699.7) ∼
East South Central
Alabama 530.3 (520.1- 540.6) 518.1 (507.0- 529.5) 584.3 (559.5- 610.1) 258.1 (186.6- 355.0)
Kentucky 604.8 (593.3- 616.5) 591.7 (580.0- 603.7) 713.6 (659.3- 772.0) -
Mississippi
Tennessee
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Table 2.1.1.1M: All Cancer Sites Combined. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 608.7 (597.3- 620.4) 593.1 (580.1- 606.3) 670.9 (646.0- 696.7) 632.2 (546.5- 730.7)
Oklahoma 545.3 (533.8- 557.1) 539.5 (527.3- 551.9) 584.3 (530.1- 643.2) 453.9 (366.5- 560.2)
Texas 506.4 (501.4- 511.5) 495.8 (490.5- 501.1) 603.7 (584.7- 623.2) 394.1 (383.7- 404.8)
West 509.1 (506.3- 511.8) 511.1 (508.1- 514.1) 575.5 (560.3- 591.1) 405.2 (397.8- 412.9)
Mountain 490.2 (485.2- 495.2) 491.3 (486.2- 496.4) 460.2 (426.3- 497.1) 411.7 (397.1- 426.9)
Arizona 441.1 (432.8- 449.5) 443.4 (434.8- 452.1) 434.1 (376.6- 500.9) 369.2 (344.7- 395.4)
Colorado 508.8 (497.8- 520.0) 498.6 (487.4- 510.0) 468.6 (406.5- 541.5) 447.9 (413.8- 484.8)
Idaho 530.9 (512.1- 550.3) 533.7 (514.7- 553.4) ∼ 427.8 (318.9- 572.0)
Montana 549.5 (528.0- 571.7) 534.2 (512.6- 556.5) ∼ 577.6 (367.8- 929.0)
Nevada 560.0 (544.5- 575.9) 563.7 (547.5- 580.5) 501.5 (431.0- 585.5) 414.2 (362.1- 474.5)
New Mexico 477.1 (462.1- 492.5) 497.0 (481.1- 513.4) 449.4 (340.8- 591.4) 435.9 (410.1- 463.2)
Utah 483.6 (468.0- 499.6) 491.8 (475.8- 508.2) 467.4 (263.1- 829.7) 394.7 (321.7- 485.2)
Wyoming
Pacific 516.9 (513.6- 520.2) 520.5 (516.9- 524.1) 597.3 (580.5- 614.6) 403.1 (394.4- 412.0)
Alaska 497.3 (463.4- 534.1) 501.3 (463.0- 543.1) 415.4 (254.0- 732.0) 367.0 (135.1- 982.7)
California 510.8 (507.0- 514.7) 513.6 (509.4- 517.8) 599.6 (581.9- 617.9) 405.9 (397.0- 415.0)
San Francisco-Oakland 503.1 (492.7- 513.7) 516.5 (504.0- 529.3) 563.9 (526.5- 603.8) 428.1 (395.4- 463.3)
San Jose-Monterey 491.6 (477.1- 506.6) 507.8 (491.1- 524.9) 634.0 (519.4- 779.6) 451.4 (412.2- 494.2)
Los Angeles 498.2 (490.8- 505.8) 491.4 (482.9- 500.1) 632.2 (604.8- 660.7) 397.3 (382.9- 412.1)
Hawaii 458.2 (441.3- 475.6) 537.6 (501.8- 575.6) 474.3 (313.3- 712.5) -
Oregon 521.2 (510.2- 532.5) 513.7 (502.5- 525.2) 570.2 (457.4- 709.0) 351.2 (288.3- 427.5)
Washington 562.1 (552.9- 571.5) 558.2 (548.7- 567.9) 604.9 (539.0- 679.1) 398.8 (347.5- 457.3)
Seattle-Puget Sound 571.1 (559.8- 582.7) 583.7 (571.6- 595.9) 625.5 (554.4- 706.1) 290.1 (233.1- 362.0)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary
bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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54 Table 2.1.1.1F: All Cancer Sites Combined. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 405.0 (403.9- 406.0) 408.9 (407.8- 410.0) 377.5 (374.3- 380.7) 310.4 (307.0- 313.8)
Northeast 429.4 (427.1- 431.7) 435.4 (432.9- 437.8) 370.2 (363.5- 376.9) 308.4 (300.3- 316.7)
New England 442.6 (438.1- 447.2) 446.0 (441.3- 450.8) 365.0 (344.6- 386.4) 348.4 (323.5- 375.1)
Connecticut 435.6 (426.6- 444.8) 439.0 (429.4- 448.7) 401.8 (369.3- 436.7) 403.7 (360.6- 451.3)
Maine 442.7 (428.1- 457.6) 442.1 (427.5- 457.2) ∼ 518.2 (289.7- 892.4)
Massachusetts 449.4 (442.6- 456.2) 454.2 (447.1- 461.4) 337.7 (310.0- 367.4) 299.4 (266.3- 336.2)
New Hampshire 441.2 (425.7- 457.1) 439.3 (423.8- 455.4) ∼ -
Rhode Island 444.9 (428.6- 461.8) 452.4 (435.4- 470.0) 344.8 (270.4- 437.6) 328.5 (255.6- 419.8)
Vermont 411.3 (390.4- 433.2) 413.0 (392.0- 435.1) ∼ ∼
Middle Atlantic 424.8 (422.2- 427.5) 431.2 (428.3- 434.1) 370.7 (363.7- 377.8) 302.9 (294.3- 311.7)
New Jersey 439.9 (434.1- 445.8) 450.6 (444.1- 457.1) 403.4 (386.9- 420.5) 332.0 (313.7- 351.2)
New York 414.0 (410.2- 417.8) 425.4 (421.1- 429.8) 334.9 (326.1- 343.8) 282.5 (272.6- 292.7)
Pennsylvania 431.6 (426.9- 436.2) 427.7 (422.8- 432.6) 437.2 (421.1- 453.7) -
Midwest 411.1 (409.0- 413.2) 407.5 (405.3- 409.7) 413.9 (406.6- 421.4) 318.1 (304.6- 332.1)
East North Central 413.2 (410.7- 415.7) 409.1 (406.5- 411.8) 417.6 (409.5- 425.7) 315.6 (300.7- 331.2)
Illinois 423.0 (418.1- 427.9) 422.2 (416.9- 427.6) 431.7 (417.9- 445.9) 308.1 (289.0- 328.4)
Indiana 415.0 (408.1- 421.9) 414.0 (406.9- 421.3) 423.3 (396.9- 451.1) 332.5 (282.3- 390.8)
Michigan 420.8 (415.4- 426.2) 414.8 (409.0- 420.6) 434.3 (418.3- 450.7) 260.4 (225.6- 299.8)
Detroit 445.0 (436.3- 453.8) 452.5 (442.4- 462.9) 432.8 (414.6- 451.7) -
Ohio 397.0 (392.2- 401.8) 388.8 (383.7- 393.9) 380.8 (365.7- 396.4) 381.9 (333.7- 436.0)
Wisconsin 411.2 (404.0- 418.5) 410.6 (403.1- 418.1) 405.0 (366.1- 447.4) -
West North Central 406.2 (402.4- 410.1) 404.0 (400.1- 408.1) 393.7 (375.5- 412.7) 330.6 (299.4- 364.6)
Iowa 424.1 (414.4- 434.0) 420.8 (411.0- 430.8) 404.7 (321.2- 504.3) 247.1 (177.9- 342.7)
Kansas 393.4 (383.3- 403.7) 389.7 (379.3- 400.3) 402.9 (354.7- 456.0) 295.3 (244.9- 355.0)
Minnesota 414.2 (406.4- 422.0) 408.9 (401.0- 416.9) 401.9 (341.9- 471.7) 307.8 (236.5- 398.0)
Missouri 396.2 (389.4- 403.1) 397.9 (390.6- 405.2) 393.0 (370.6- 416.5) 357.7 (293.5- 433.4)
Nebraska 417.8 (404.9- 431.0) 414.6 (401.5- 428.2) 324.2 (258.6- 403.0) 480.8 (375.7- 611.2)
North Dakota 376.4 (356.6- 397.1) 370.7 (350.7- 391.7) ∼ ∼
South Dakota
South
South Atlantic
Delaware 417.3 (398.7- 436.5) 418.0 (397.6- 439.4) 397.2 (350.3- 449.1) 197.8 (112.5- 340.9)
District of Columbia 399.6 (377.9- 422.4) 380.0 (341.1- 423.7) 397.4 (371.0- 425.8) 327.9 (232.8- 451.9)
Florida 401.9 (398.1- 405.8) 407.4 (403.2- 411.6) 365.0 (353.4- 377.0) -
Georgia 396.2 (390.1- 402.3) 402.0 (394.9- 409.3) 379.4 (367.0- 392.2) 291.6 (250.3- 339.0)
Atlanta 397.6 (386.5- 409.0) 403.7 (390.2- 417.6) 404.2 (382.5- 427.0) 290.9 (233.9- 360.3)
Maryland 424.2 (416.8- 431.7) 449.8 (440.7- 459.0) 382.3 (367.6- 397.6) 328.5 (285.4- 377.1)
North Carolina 362.1 (356.6- 367.7) 369.1 (362.8- 375.4) 335.7 (323.4- 348.3) 280.1 (233.6- 335.1)
South Carolina 384.7 (376.7- 392.8) 392.4 (383.0- 402.0) 352.6 (337.4- 368.3) -
Virginia
West Virginia 414.7 (402.9- 426.8) 418.1 (406.1- 430.5) 362.0 (298.0- 436.6) 341.1 (197.8- 565.0)
East South Central
Alabama 376.3 (368.8- 383.9) 386.9 (378.3- 395.8) 336.2 (321.2- 351.8) 368.3 (285.1- 470.8)
Kentucky 428.0 (419.6- 436.6) 426.0 (417.3- 434.9) 435.7 (401.2- 472.5) -
Mississippi
Tennessee
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Table 2.1.1.1F: All Cancer Sites Combined. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 394.8 (386.9- 402.9) 395.8 (386.4- 405.4) 397.5 (382.1- 413.3) 483.4 (422.1- 551.4)
Oklahoma 397.0 (388.2- 405.9) 392.9 (383.5- 402.5) 398.7 (361.7- 438.6) 334.4 (274.4- 406.5)
Texas 372.4 (368.7- 376.2) 370.6 (366.6- 374.7) 374.8 (362.9- 387.1) 287.5 (280.2- 294.9)
West 393.9 (391.7- 396.0) 403.2 (400.8- 405.6) 360.9 (350.8- 371.3) 304.5 (299.1- 309.9)
Mountain 374.9 (370.9- 378.8) 379.6 (375.5- 383.8) 308.0 (283.6- 334.1) 299.2 (288.7- 310.1)
Arizona 354.9 (348.0- 361.8) 363.0 (355.8- 370.4) 250.8 (211.1- 296.4) 284.9 (267.1- 303.7)
Colorado 394.6 (386.2- 403.2) 393.4 (384.7- 402.2) 314.9 (271.6- 363.7) 337.0 (312.1- 363.6)
Idaho 395.5 (380.5- 410.9) 398.0 (382.8- 413.7) ∼ 400.1 (307.4- 518.2)
Montana 393.2 (376.3- 410.8) 385.8 (368.6- 403.6) ∼ 270.6 (150.6- 479.4)
Nevada 419.3 (406.9- 431.9) 426.0 (412.8- 439.6) 379.3 (327.8- 437.9) 312.2 (275.1- 354.2)
New Mexico 345.7 (334.1- 357.6) 361.6 (349.1- 374.4) 263.8 (188.5- 361.1) 281.3 (263.2- 300.4)
Utah 345.2 (333.2- 357.5) 350.2 (337.9- 362.8) ∼ 338.6 (282.9- 404.7)
Wyoming
Pacific 401.4 (398.8- 404.0) 414.0 (411.1- 416.9) 370.4 (359.3- 381.7) 306.3 (300.2- 312.6)
Alaska 367.8 (342.3- 394.9) 343.2 (315.4- 373.3) 388.1 (232.0- 643.2) ∼
California 392.8 (389.9- 395.8) 408.4 (405.0- 411.8) 369.9 (358.3- 381.7) 306.9 (300.6- 313.4)
San Francisco-Oakland 407.6 (399.4- 416.0) 433.2 (422.8- 443.7) 410.4 (383.5- 438.7) 360.3 (336.1- 386.1)
San Jose-Monterey 370.5 (359.4- 381.9) 400.1 (387.0- 413.6) 305.0 (233.3- 395.0) 331.2 (304.4- 360.0)
Los Angeles 380.7 (375.0- 386.4) 396.3 (389.6- 403.1) 374.1 (357.1- 391.7) 296.3 (286.6- 306.2)
Hawaii 374.7 (360.5- 389.4) 447.6 (415.8- 481.7) ∼ -
Oregon 428.2 (419.1- 437.6) 422.1 (412.7- 431.6) 375.1 (296.8- 469.4) 384.5 (326.1- 451.9)
Washington 441.2 (433.8- 448.6) 438.3 (430.6- 446.1) 394.1 (346.8- 446.7) 316.5 (276.1- 362.2)
Seattle-Puget Sound 451.5 (442.5- 460.7) 466.2 (456.4- 476.1) 404.9 (354.4- 461.2) 195.2 (151.9- 248.9)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary
bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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56 Table 2.1.1.2M: All Cancer Sites Combined. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 239.9 (239.0- 240.7) 236.0 (235.0- 236.9) 322.9 (319.3- 326.6) 163.9 (160.8- 167.1)
Northeast 237.0 (235.1- 239.0) 236.5 (234.5- 238.6) 278.8 (271.0- 286.9) 158.3 (150.3- 166.7)
New England 243.9 (240.0- 247.8) 244.7 (240.7- 248.7) 271.3 (247.5- 297.2) 151.6 (129.9- 176.5)
Connecticut 230.1 (222.6- 237.8) 229.6 (221.9- 237.5) 272.1 (235.0- 315.1) 162.3 (125.8- 207.7)
Maine 268.3 (255.4- 281.6) 267.8 (254.9- 281.2) ∼ ∼
Massachusetts 246.0 (240.1- 251.9) 247.1 (241.1- 253.2) 278.9 (245.0- 317.0) 145.4 (115.4- 182.2)
New Hampshire 250.9 (237.3- 265.1) 252.1 (238.4- 266.5) ∼ ∼
Rhode Island 245.8 (232.0- 260.2) 247.8 (233.7- 262.7) 249.8 (171.5- 368.2) 173.6 (104.2- 282.8)
Vermont 227.5 (209.8- 246.5) 228.3 (210.5- 247.3) ∼ ∼
Middle Atlantic 234.6 (232.3- 236.8) 233.4 (231.0- 235.8) 279.7 (271.4- 288.3) 159.2 (150.6- 168.2)
New Jersey 236.4 (231.4- 241.5) 234.0 (228.7- 239.4) 297.3 (278.3- 317.6) 160.1 (142.9- 179.3)
New York 223.3 (220.0- 226.6) 224.7 (221.1- 228.3) 248.7 (238.2- 259.6) 155.5 (145.2- 166.4)
Pennsylvania 248.3 (244.4- 252.4) 243.6 (239.5- 247.7) 336.9 (318.5- 356.3) 190.6 (157.9- 229.4)
Midwest 246.0 (244.2- 247.9) 241.0 (239.1- 243.0) 335.0 (326.4- 343.8) 135.2 (124.3- 147.0)
East North Central 250.4 (248.1- 252.7) 244.7 (242.4- 247.1) 333.8 (324.5- 343.3) 135.5 (123.3- 148.9)
Illinois 250.6 (246.2- 255.1) 244.0 (239.3- 248.7) 333.3 (317.4- 349.8) 126.2 (110.6- 143.9)
Indiana 259.7 (253.3- 266.1) 255.4 (248.9- 262.0) 355.9 (325.3- 389.0) 130.9 ( 95.8- 178.4)
Michigan 244.1 (239.3- 248.9) 236.7 (231.7- 241.8) 319.8 (302.5- 338.0) 152.5 (120.3- 192.9)
Ohio 259.5 (255.0- 264.1) 253.6 (248.9- 258.3) 342.7 (324.4- 361.9) 177.6 (136.4- 229.8)
Wisconsin 232.0 (225.9- 238.3) 230.1 (224.0- 236.5) 312.7 (266.1- 367.5) 123.9 ( 83.1- 182.0)
West North Central 236.4 (233.1- 239.7) 233.3 (230.0- 236.6) 341.4 (319.3- 364.8) 134.7 (111.0- 162.7)
Iowa 234.7 (226.8- 242.8) 234.3 (226.3- 242.5) 335.8 (244.4- 455.6) ∼
Kansas 232.1 (223.4- 240.9) 227.7 (219.0- 236.8) 370.2 (313.3- 435.1) 116.6 ( 77.5- 171.7)
Minnesota 228.0 (221.5- 234.6) 227.6 (221.0- 234.3) 309.0 (241.2- 395.0) 109.8 ( 62.3- 186.8)
Missouri 255.0 (248.8- 261.4) 248.8 (242.4- 255.4) 348.0 (320.2- 377.9) 174.6 (122.4- 247.1)
Nebraska 225.6 (215.1- 236.4) 224.6 (214.0- 235.7) 275.0 (198.8- 376.8) 201.6 (126.1- 312.0)
North Dakota 211.4 (195.7- 228.1) 209.4 (193.6- 226.3) ∼ ∼
South Dakota 219.7 (204.8- 235.5) 216.3 (201.2- 232.2) ∼ ∼
South 253.5 (252.0- 255.0) 243.7 (242.1- 245.3) 340.8 (335.6- 346.0) 169.3 (164.2- 174.6)
South Atlantic 244.0 (242.0- 246.0) 233.6 (231.5- 235.8) 330.4 (323.6- 337.2) 160.2 (152.9- 167.8)
Delaware 249.3 (232.8- 266.8) 241.9 (224.5- 260.5) 325.3 (269.2- 391.9) ∼
District of Columbia 301.2 (278.6- 325.4) 170.9 (141.7- 205.5) 383.9 (351.9- 418.4) ∼
Florida 223.6 (220.5- 226.6) 221.8 (218.7- 225.0) 280.6 (267.0- 294.8) 170.1 (162.0- 178.6)
Georgia 262.4 (256.1- 268.7) 244.5 (237.8- 251.4) 350.4 (333.7- 367.9) 96.4 ( 68.0- 135.3)
Maryland 247.1 (240.3- 254.1) 235.5 (228.1- 243.2) 321.4 (302.6- 341.2) 101.2 ( 69.8- 144.2)
North Carolina 259.5 (253.9- 265.3) 245.5 (239.5- 251.6) 346.6 (329.8- 364.1) 88.5 ( 56.9- 133.6)
South Carolina 273.0 (264.8- 281.3) 255.7 (246.7- 264.9) 340.5 (320.7- 361.3) 124.5 ( 68.0- 217.4)
Virginia 253.7 (247.7- 259.9) 240.5 (234.0- 247.1) 351.7 (333.3- 371.0) 163.9 (123.9- 214.5)
West Virginia 270.0 (259.3- 281.1) 269.9 (259.0- 281.2) 321.2 (249.7- 408.3) ∼
East South Central 285.2 (281.2- 289.3) 274.9 (270.6- 279.2) 359.0 (346.9- 371.4) 80.8 ( 56.6- 113.3)
Alabama 278.0 (270.4- 285.8) 262.7 (254.5- 271.2) 349.1 (329.4- 369.9) ∼
Kentucky 297.3 (289.0- 305.8) 295.2 (286.6- 303.9) 357.6 (318.0- 401.5) 171.0 (100.2- 285.4)
Mississippi 291.2 (281.2- 301.6) 265.7 (254.5- 277.3) 369.8 (347.4- 393.4) ∼
Tennessee 279.6 (272.8- 286.6) 272.0 (264.8- 279.3) 360.1 (336.3- 385.2) ∼
West South Central 253.7 (250.8- 256.6) 245.5 (242.5- 248.6) 354.1 (343.2- 365.2) 180.0 (172.8- 187.6)
Arkansas 277.0 (267.7- 286.5) 270.2 (260.5- 280.3) 351.9 (318.4- 388.2) ∼
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Table 2.1.1.2M: All Cancer Sites Combined. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 288.1 (280.0- 296.4) 265.4 (256.5- 274.6) 369.5 (350.5- 389.4) 127.7 ( 88.7- 181.4)
Oklahoma 258.5 (250.4- 266.9) 258.4 (249.9- 267.2) 377.4 (331.8- 428.0) 165.5 (113.6- 237.8)
Texas 241.0 (237.4- 244.7) 234.9 (231.2- 238.7) 342.4 (327.4- 358.0) 182.9 (175.4- 190.7)
West 212.8 (211.0- 214.6) 216.5 (214.5- 218.4) 286.4 (274.9- 298.3) 165.3 (160.2- 170.6)
Mountain 211.4 (208.1- 214.8) 213.3 (209.9- 216.8) 250.0 (222.0- 281.3) 192.4 (181.7- 203.8)
Arizona 211.9 (206.1- 217.9) 214.5 (208.5- 220.7) 273.1 (222.9- 333.6) 196.5 (177.5- 217.5)
Colorado 211.6 (204.2- 219.3) 213.0 (205.3- 220.8) 241.4 (192.2- 302.7) 197.3 (173.3- 224.4)
Idaho 206.0 (194.1- 218.6) 207.7 (195.6- 220.4) ∼ ∼
Montana 220.0 (206.2- 234.5) 216.9 (203.0- 231.5) ∼ ∼
Nevada 237.3 (226.7- 248.4) 242.3 (231.2- 254.0) 243.7 (189.2- 313.8) 119.3 ( 89.8- 158.0)
New Mexico 214.7 (204.3- 225.5) 218.2 (207.3- 229.5) 281.1 (187.6- 412.2) 210.9 (191.8- 231.5)
Utah 181.4 (171.5- 191.8) 183.5 (173.4- 194.1) ∼ 159.2 (109.6- 228.9)
Wyoming 207.7 (188.2- 228.9) 208.7 (189.0- 230.2) ∼ 194.7 (106.6- 338.9)
Pacific 213.5 (211.4- 215.7) 218.2 (215.8- 220.6) 293.5 (281.0- 306.6) 155.5 (149.8- 161.4)
Alaska 235.2 (209.0- 264.6) 226.9 (197.5- 260.3) ∼ ∼
California 210.2 (207.7- 212.8) 214.2 (211.4- 217.0) 294.5 (281.3- 308.2) 154.6 (148.7- 160.6)
Hawaii 180.7 (170.1- 191.8) 210.1 (187.1- 235.5) ∼ 466.5 (345.3- 622.7)
Oregon 231.9 (224.4- 239.5) 233.0 (225.3- 240.8) 323.6 (231.9- 444.6) 105.2 ( 69.8- 155.6)
Washington 226.8 (220.8- 232.9) 228.3 (222.0- 234.6) 285.5 (236.6- 343.6) 132.5 (100.2- 173.1)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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58 Table 2.1.1.2F: All Cancer Sites Combined. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 162.7 (162.1- 163.4) 161.9 (161.3- 162.6) 190.9 (188.8- 193.1) 107.4 (105.3- 109.5)
Northeast 165.7 (164.3- 167.1) 167.1 (165.6- 168.6) 174.4 (169.8- 179.1) 95.8 ( 91.1- 100.8)
New England 167.5 (164.8- 170.2) 168.7 (165.9- 171.5) 168.5 (154.2- 183.9) 90.6 ( 77.2- 105.8)
Connecticut 157.8 (152.6- 163.2) 157.4 (152.0- 163.1) 171.5 (149.8- 195.7) 91.1 ( 69.9- 117.3)
Maine 177.3 (168.4- 186.6) 177.6 (168.7- 187.0) ∼ ∼
Massachusetts 171.7 (167.6- 175.8) 173.9 (169.7- 178.2) 166.4 (146.3- 188.6) 104.2 ( 83.3- 129.2)
New Hampshire 166.7 (157.3- 176.6) 168.1 (158.7- 178.1) ∼ ∼
Rhode Island 167.0 (157.5- 177.1) 167.4 (157.6- 177.8) 184.0 (127.8- 260.1) ∼
Vermont 158.6 (146.0- 172.3) 158.9 (146.2- 172.7) ∼ ∼
Middle Atlantic 165.1 (163.6- 166.7) 166.5 (164.8- 168.3) 175.3 (170.4- 180.3) 96.7 ( 91.7- 102.0)
New Jersey 172.1 (168.6- 175.7) 173.1 (169.3- 177.1) 196.0 (184.3- 208.2) 87.9 ( 78.2- 98.6)
New York 158.7 (156.4- 161.0) 163.3 (160.7- 165.9) 154.0 (148.0- 160.2) 98.2 ( 92.1- 104.6)
Pennsylvania 169.7 (166.9- 172.5) 166.7 (163.8- 169.6) 212.9 (201.7- 224.6) 111.6 ( 90.5- 136.5)
Midwest 168.0 (166.7- 169.3) 165.2 (163.9- 166.6) 211.9 (206.5- 217.3) 93.4 ( 85.6- 101.8)
East North Central 171.1 (169.5- 172.7) 167.9 (166.2- 169.5) 214.0 (208.2- 220.0) 94.2 ( 85.5- 103.6)
Illinois 170.3 (167.3- 173.4) 165.2 (161.9- 168.5) 225.3 (215.2- 235.8) 90.8 ( 79.8- 103.1)
Indiana 177.2 (172.8- 181.7) 174.6 (170.1- 179.2) 231.7 (212.1- 252.8) 93.6 ( 65.1- 131.4)
Michigan 169.2 (165.8- 172.6) 165.4 (161.9- 169.1) 202.9 (191.9- 214.4) 101.8 ( 79.2- 129.5)
Ohio 174.8 (171.7- 178.0) 172.3 (169.1- 175.6) 207.8 (196.6- 219.5) 114.7 ( 87.2- 148.9)
Wisconsin 161.4 (157.0- 165.9) 160.6 (156.1- 165.2) 185.5 (158.7- 216.0) 68.8 ( 43.1- 106.5)
West North Central 160.8 (158.5- 163.1) 159.6 (157.2- 162.0) 200.5 (187.3- 214.5) 89.0 ( 72.1- 109.1)
Iowa 157.3 (151.7- 163.1) 157.3 (151.6- 163.2) 232.5 (168.4- 313.7) ∼
Kansas 159.7 (153.5- 166.1) 158.2 (151.8- 164.7) 205.6 (171.3- 245.0) 89.3 ( 60.2- 129.1)
Minnesota 155.5 (150.9- 160.2) 156.2 (151.5- 161.0) 152.8 (114.2- 202.2) 94.9 ( 55.9- 155.0)
Missouri 169.9 (165.6- 174.4) 167.3 (162.8- 172.0) 206.6 (190.2- 224.1) 93.4 ( 60.6- 138.8)
Nebraska 158.6 (151.0- 166.6) 157.9 (150.1- 166.0) 165.9 (119.0- 226.7) 108.2 ( 58.8- 186.8)
North Dakota 149.6 (137.7- 162.4) 146.1 (134.2- 159.0) ∼ ∼
South Dakota 156.6 (145.3- 168.6) 155.5 (144.0- 167.8) ∼ ∼
South 163.3 (162.2- 164.3) 159.6 (158.5- 160.8) 190.6 (187.6- 193.6) 108.7 (105.4- 112.2)
South Atlantic 160.3 (158.9- 161.7) 156.5 (155.0- 158.0) 184.6 (180.8- 188.4) 101.6 ( 96.8- 106.5)
Delaware 157.2 (146.1- 169.1) 155.7 (143.6- 168.7) 176.1 (144.6- 212.9) ∼
District of Columbia 185.8 (171.4- 201.4) 136.3 (114.2- 163.5) 206.9 (188.4- 227.4) ∼
Florida 152.6 (150.4- 154.9) 151.5 (149.1- 154.0) 171.3 (163.1- 179.8) 106.4 (101.1- 111.9)
Georgia 162.0 (158.1- 166.0) 156.2 (151.8- 160.7) 183.1 (174.3- 192.2) 64.8 ( 45.0- 91.6)
Maryland 171.2 (166.5- 175.9) 166.0 (160.7- 171.5) 198.3 (187.3- 209.7) 77.1 ( 55.2- 105.4)
North Carolina 163.3 (159.7- 167.0) 159.5 (155.5- 163.6) 183.0 (173.9- 192.4) 75.1 ( 49.5- 110.7)
South Carolina 160.5 (155.4- 165.7) 155.2 (149.4- 161.1) 177.8 (167.0- 189.2) ∼
Virginia 164.6 (160.6- 168.6) 160.5 (156.1- 165.0) 194.3 (183.7- 205.3) 98.4 ( 74.7- 128.0)
West Virginia 176.8 (169.4- 184.5) 177.0 (169.4- 184.8) 208.0 (161.7- 264.8) ∼
East South Central 171.6 (169.0- 174.2) 168.3 (165.5- 171.1) 192.1 (185.2- 199.1) 87.6 ( 65.3- 115.6)
Alabama 162.3 (157.5- 167.2) 158.5 (153.2- 164.1) 178.1 (167.2- 189.5) ∼
Kentucky 183.0 (177.6- 188.6) 181.5 (175.9- 187.2) 221.3 (196.7- 248.3) 131.4 ( 74.4- 217.8)
Mississippi 170.9 (164.5- 177.4) 161.7 (154.3- 169.3) 194.4 (181.7- 207.8) ∼
Tennessee 171.5 (167.1- 176.0) 168.1 (163.5- 172.9) 199.9 (186.3- 214.2) 94.8 ( 56.2- 152.3)
West South Central 164.0 (162.0- 166.0) 160.2 (158.1- 162.3) 205.0 (198.5- 211.6) 115.1 (110.4- 120.0)
Arkansas 169.3 (163.0- 175.7) 164.7 (158.1- 171.5) 205.5 (185.4- 227.2) ∼
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Table 2.1.1.2F: All Cancer Sites Combined. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 179.4 (174.1- 184.8) 167.7 (161.8- 173.9) 211.6 (200.3- 223.4) 91.6 ( 65.6- 124.8)
Oklahoma 169.0 (163.4- 174.8) 169.5 (163.5- 175.7) 198.2 (171.9- 227.5) 105.2 ( 70.1- 154.3)
Texas 158.7 (156.2- 161.1) 156.2 (153.6- 158.9) 201.7 (192.8- 211.0) 116.5 (111.7- 121.6)
West 152.8 (151.4- 154.1) 156.5 (155.0- 157.9) 187.0 (179.6- 194.7) 113.2 (109.8- 116.7)
Mountain 147.6 (145.1- 150.0) 148.0 (145.5- 150.5) 173.9 (155.1- 194.5) 121.6 (114.5- 129.0)
Arizona 142.9 (138.6- 147.3) 144.1 (139.6- 148.6) 167.6 (134.6- 206.7) 112.7 (101.0- 125.5)
Colorado 149.1 (143.9- 154.5) 149.4 (144.0- 154.9) 174.1 (140.7- 213.6) 131.0 (114.8- 149.0)
Idaho 146.9 (137.9- 156.4) 146.7 (137.7- 156.3) ∼ 107.8 ( 58.5- 187.0)
Montana 170.2 (159.4- 181.6) 167.3 (156.4- 178.9) ∼ ∼
Nevada 177.4 (169.3- 185.7) 178.9 (170.4- 187.8) 216.4 (176.2- 264.1) 97.0 ( 75.0- 124.5)
New Mexico 142.9 (135.6- 150.6) 145.0 (137.2- 153.1) ∼ 133.0 (120.2- 146.8)
Utah 118.1 (111.1- 125.4) 118.0 (110.9- 125.5) ∼ 94.1 ( 62.5- 138.0)
Wyoming 154.4 (139.8- 170.1) 154.8 (140.1- 170.8) ∼ ∼
Pacific 154.9 (153.3- 156.5) 160.4 (158.7- 162.2) 189.3 (181.2- 197.6) 110.4 (106.5- 114.5)
Alaska 157.7 (139.9- 177.4) 149.2 (129.5- 171.3) ∼ ∼
California 152.6 (150.8- 154.5) 157.6 (155.5- 159.6) 190.2 (181.8- 198.9) 110.5 (106.5- 114.6)
Hawaii 116.5 (108.8- 124.7) 141.9 (124.4- 161.8) ∼ 158.7 (105.7- 235.0)
Oregon 173.4 (167.6- 179.2) 174.6 (168.7- 180.6) 221.5 (159.8- 300.1) 96.2 ( 65.3- 137.7)
Washington 164.5 (160.0- 169.0) 166.9 (162.3- 171.7) 178.4 (145.7- 216.6) 101.5 ( 77.4- 131.6)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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60 Table 2.2.1.1M: Brain and Other Nervous System. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 7.8 ( 7.6- 7.9) 8.2 ( 8.0- 8.4) 4.4 ( 4.1- 4.9) 6.1 ( 5.6- 6.6)
Northeast 8.0 ( 7.6- 8.3) 8.4 ( 8.0- 8.8) 3.9 ( 3.1- 4.9) 5.9 ( 4.7- 7.5)
New England 8.3 ( 7.6- 9.0) 8.5 ( 7.8- 9.3) ∼ 9.1 ( 5.2- 16.1)
Connecticut 8.4 ( 7.0- 9.9) 8.9 ( 7.4- 10.5) ∼ ∼
Maine 10.3 ( 7.9- 13.2) 10.5 ( 8.1- 13.4) ∼ ∼
Massachusetts 8.0 ( 7.0- 9.1) 8.0 ( 7.0- 9.2) ∼ ∼
New Hampshire 7.4 ( 5.4- 10.1) 7.6 ( 5.5- 10.3) ∼ -
Rhode Island 8.2 ( 5.9- 11.2) 8.6 ( 6.2- 11.8) ∼ ∼
Vermont 8.8 ( 5.8- 13.1) 9.0 ( 5.9- 13.4) ∼ ∼
Middle Atlantic 7.8 ( 7.4- 8.3) 8.3 ( 7.9- 8.8) 3.9 ( 3.1- 4.9) 5.5 ( 4.2- 7.2)
New Jersey 7.6 ( 6.8- 8.6) 8.1 ( 7.2- 9.2) 3.3 ( 1.9- 6.1) 5.9 ( 3.5- 10.2)
New York 7.9 ( 7.3- 8.5) 8.5 ( 7.8- 9.2) 4.1 ( 3.0- 5.6) 5.1 ( 3.6- 7.3)
Pennsylvania 8.0 ( 7.3- 8.7) 8.3 ( 7.5- 9.1) 3.9 ( 2.3- 6.5) -
Midwest 7.8 ( 7.5- 8.1) 8.1 ( 7.8- 8.5) 4.7 ( 3.8- 5.8) 5.9 ( 4.3- 8.3)
East North Central 7.7 ( 7.3- 8.0) 8.0 ( 7.6- 8.4) 4.6 ( 3.7- 5.8) 5.5 ( 3.8- 8.4)
Illinois 6.4 ( 5.8- 7.1) 6.9 ( 6.2- 7.7) 3.8 ( 2.3- 6.0) 6.8 ( 4.1- 11.7)
Indiana 7.8 ( 6.8- 8.9) 7.9 ( 6.9- 9.1) ∼ ∼
Michigan 8.1 ( 7.3- 9.0) 8.6 ( 7.7- 9.5) 5.3 ( 3.4- 8.0) ∼
Detroit 8.4 ( 7.1- 9.9) 9.4 ( 7.8- 11.2) 5.5 ( 3.3- 9.0) -
Ohio 7.9 ( 7.2- 8.7) 8.1 ( 7.3- 8.9) 5.0 ( 3.3- 7.8) ∼
Wisconsin 8.8 ( 7.7- 10.1) 9.0 ( 7.9- 10.3) ∼ -
West North Central 8.2 ( 7.6- 8.8) 8.4 ( 7.8- 9.0) 5.1 ( 3.0- 8.5) 7.8 ( 4.2- 16.0)
Iowa 8.2 ( 6.8- 9.8) 8.3 ( 6.8- 9.9) ∼ ∼
Kansas 9.1 ( 7.5- 11.0) 9.6 ( 7.9- 11.6) ∼ ∼
Minnesota 8.6 ( 7.4- 9.9) 8.5 ( 7.4- 9.9) ∼ ∼
Missouri 7.4 ( 6.4- 8.6) 7.8 ( 6.8- 9.1) ∼ ∼
Nebraska 8.6 ( 6.7- 10.9) 8.8 ( 6.9- 11.2) ∼ ∼
North Dakota 6.0 ( 3.6- 9.5) 6.1 ( 3.6- 9.7) ∼ ∼
South Dakota
South
South Atlantic
Delaware 6.5 ( 4.2- 9.9) 6.3 ( 3.8- 10.0) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 7.5 ( 7.0- 8.1) 7.9 ( 7.2- 8.5) 4.8 ( 3.5- 6.9) -
Georgia 7.7 ( 6.7- 8.7) 8.3 ( 7.2- 9.5) 5.0 ( 3.6- 7.1) ∼
Atlanta 7.3 ( 5.7- 9.4) 8.2 ( 6.2- 10.8) 5.4 ( 2.8- 11.0) ∼
Maryland 7.7 ( 6.6- 8.9) 9.0 ( 7.6- 10.5) 3.6 ( 2.1- 6.2) ∼
North Carolina 7.8 ( 7.0- 8.8) 8.6 ( 7.6- 9.8) 4.6 ( 2.9- 7.1) ∼
South Carolina 7.0 ( 5.9- 8.4) 8.3 ( 6.8- 10.0) ∼ -
Virginia
West Virginia 8.5 ( 6.7- 10.7) 8.6 ( 6.8- 10.8) ∼ ∼
East South Central
Alabama 7.7 ( 6.5- 9.0) 8.5 ( 7.1- 10.1) 4.9 ( 3.1- 7.6) ∼
Kentucky 6.9 ( 5.8- 8.3) 7.1 ( 5.9- 8.5) ∼ -
Mississippi
Tennessee
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Table 2.2.1.1M: Brain and Other Nervous System. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 7.5 ( 6.3- 8.9) 8.6 ( 7.1- 10.4) 4.3 ( 2.6- 6.8) ∼
Oklahoma 7.7 ( 6.4- 9.2) 7.7 ( 6.3- 9.4) ∼ ∼
Texas 8.0 ( 7.4- 8.6) 8.2 ( 7.5- 8.9) 5.7 ( 4.1- 7.8) 6.2 ( 5.2- 7.6)
West 7.7 ( 7.4- 8.0) 8.4 ( 8.0- 8.7) 3.5 ( 2.6- 4.8) 6.0 ( 5.2- 6.8)
Mountain 8.0 ( 7.4- 8.6) 8.3 ( 7.7- 9.0) ∼ 6.4 ( 4.9- 8.4)
Arizona 7.4 ( 6.4- 8.5) 7.6 ( 6.5- 8.8) ∼ 5.6 ( 3.0- 10.3)
Colorado 7.8 ( 6.5- 9.2) 8.1 ( 6.8- 9.6) ∼ 8.4 ( 4.8- 15.2)
Idaho 10.1 ( 7.8- 13.0) 10.3 ( 7.9- 13.2) ∼ ∼
Montana 11.1 ( 8.2- 14.8) 11.4 ( 8.4- 15.2) ∼ ∼
Nevada 7.6 ( 6.0- 9.7) 8.1 ( 6.3- 10.4) ∼ ∼
New Mexico 7.0 ( 5.3- 9.1) 7.5 ( 5.7- 9.8) ∼ 6.0 ( 3.6- 9.9)
Utah 8.8 ( 7.0- 11.1) 9.1 ( 7.2- 11.5) ∼ ∼
Wyoming
Pacific 7.6 ( 7.2- 8.0) 8.4 ( 8.0- 8.8) 3.5 ( 2.5- 5.0) 5.8 ( 5.0- 6.9)
Alaska 6.8 ( 4.1- 13.0) 7.3 ( 4.3- 14.9) ∼ ∼
California 7.4 ( 6.9- 7.8) 8.2 ( 7.7- 8.7) 3.9 ( 2.8- 5.5) 5.8 ( 4.9- 6.9)
San Francisco-Oakland 6.3 ( 5.2- 7.5) 7.6 ( 6.2- 9.3) ∼ ∼
San Jose-Monterey 6.9 ( 5.4- 8.8) 8.1 ( 6.2- 10.5) ∼ ∼
Los Angeles 6.7 ( 5.9- 7.5) 7.9 ( 6.9- 9.0) 3.9 ( 2.2- 7.0) 5.4 ( 4.0- 7.3)
Hawaii 4.4 ( 2.9- 6.4) ∼ ∼ -
Oregon 8.6 ( 7.2- 10.1) 8.8 ( 7.4- 10.4) ∼ ∼
Washington 8.9 ( 7.8- 10.1) 9.3 ( 8.1- 10.6) ∼ ∼
Seattle-Puget Sound 8.7 ( 7.4- 10.2) 9.4 ( 7.9- 11.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
U
nited States C
ancer Statistics: 2002 Incidence and M
ortality
62 Table 2.2.1.1F: Brain and Other Nervous System. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 5.5 ( 5.4- 5.6) 5.9 ( 5.7- 6.0) 3.3 ( 3.0- 3.6) 4.7 ( 4.4- 5.2)
Northeast 5.5 ( 5.3- 5.8) 5.9 ( 5.6- 6.2) 3.3 ( 2.7- 3.9) 4.4 ( 3.5- 5.4)
New England 5.5 ( 5.0- 6.1) 5.8 ( 5.2- 6.4) ∼ 5.6 ( 3.3- 9.8)
Connecticut 4.8 ( 3.8- 5.9) 5.1 ( 4.0- 6.3) ∼ ∼
Maine 5.8 ( 4.2- 8.0) 5.8 ( 4.2- 8.0) ∼ ∼
Massachusetts 5.9 ( 5.1- 6.8) 6.3 ( 5.4- 7.2) ∼ ∼
New Hampshire 5.6 ( 3.9- 7.7) 5.5 ( 3.8- 7.7) ∼ -
Rhode Island 5.7 ( 3.9- 8.0) 6.1 ( 4.2- 8.7) ∼ ∼
Vermont 4.9 ( 2.9- 8.2) 5.0 ( 2.9- 8.4) ∼ ∼
Middle Atlantic 5.5 ( 5.2- 5.9) 5.9 ( 5.6- 6.3) 3.4 ( 2.8- 4.1) 4.1 ( 3.3- 5.3)
New Jersey 5.1 ( 4.5- 5.8) 5.3 ( 4.5- 6.0) 4.2 ( 2.7- 6.3) 3.8 ( 2.2- 6.3)
New York 5.4 ( 4.9- 5.8) 5.8 ( 5.3- 6.4) 3.2 ( 2.4- 4.2) 4.3 ( 3.2- 5.8)
Pennsylvania 6.1 ( 5.5- 6.7) 6.5 ( 5.8- 7.1) 3.1 ( 1.9- 4.8) -
Midwest 5.6 ( 5.4- 5.9) 5.9 ( 5.6- 6.2) 3.2 ( 2.6- 3.9) 4.7 ( 3.2- 6.6)
East North Central 5.6 ( 5.3- 5.9) 5.9 ( 5.6- 6.3) 2.9 ( 2.2- 3.6) 5.4 ( 3.7- 7.8)
Illinois 5.4 ( 4.9- 6.0) 5.8 ( 5.2- 6.5) 3.0 ( 2.0- 4.3) 6.1 ( 3.8- 9.7)
Indiana 5.7 ( 4.9- 6.5) 5.8 ( 5.0- 6.8) ∼ ∼
Michigan 5.9 ( 5.3- 6.6) 6.4 ( 5.7- 7.2) 3.2 ( 2.0- 4.8) ∼
Detroit 6.0 ( 5.0- 7.2) 7.2 ( 5.9- 8.6) ∼ -
Ohio 5.3 ( 4.8- 5.9) 5.7 ( 5.1- 6.4) ∼ ∼
Wisconsin 5.5 ( 4.7- 6.5) 5.7 ( 4.8- 6.7) ∼ -
West North Central 5.7 ( 5.2- 6.2) 5.8 ( 5.3- 6.3) 4.9 ( 3.0- 7.4) ∼
Iowa 6.2 ( 5.1- 7.6) 6.3 ( 5.1- 7.7) ∼ ∼
Kansas 4.5 ( 3.5- 5.8) 4.7 ( 3.6- 6.0) ∼ ∼
Minnesota 6.2 ( 5.3- 7.2) 6.1 ( 5.1- 7.2) ∼ ∼
Missouri 5.9 ( 5.1- 6.8) 6.1 ( 5.2- 7.1) ∼ ∼
Nebraska 4.5 ( 3.3- 6.2) 4.7 ( 3.4- 6.4) ∼ ∼
North Dakota 5.2 ( 3.1- 8.5) 5.5 ( 3.2- 9.0) ∼ ∼
South Dakota
South
South Atlantic
Delaware 5.4 ( 3.4- 8.2) 6.1 ( 3.7- 9.6) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 5.7 ( 5.2- 6.2) 6.2 ( 5.6- 6.7) 3.4 ( 2.4- 4.8) -
Georgia 5.1 ( 4.5- 5.9) 5.8 ( 4.9- 6.7) 3.5 ( 2.5- 5.0) ∼
Atlanta 4.6 ( 3.5- 6.0) 5.7 ( 4.2- 7.6) 3.0 ( 1.6- 5.6) ∼
Maryland 5.0 ( 4.2- 5.9) 6.2 ( 5.1- 7.4) 2.2 ( 1.3- 3.8) ∼
North Carolina 5.3 ( 4.7- 6.1) 5.7 ( 4.9- 6.5) 4.2 ( 2.9- 5.8) ∼
South Carolina 5.5 ( 4.6- 6.6) 6.5 ( 5.3- 7.9) 3.0 ( 1.8- 4.8) -
Virginia
West Virginia 5.0 ( 3.7- 6.7) 5.2 ( 3.9- 7.0) ∼ ∼
East South Central
Alabama 5.4 ( 4.5- 6.4) 6.2 ( 5.1- 7.5) ∼ ∼
Kentucky 6.1 ( 5.1- 7.2) 6.2 ( 5.2- 7.5) ∼ -
Mississippi
Tennessee
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Table 2.2.1.1F: Brain and Other Nervous System. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 3.9 ( 3.2- 4.9) 4.5 ( 3.5- 5.7) 2.9 ( 1.8- 4.5) ∼
Oklahoma 6.4 ( 5.3- 7.7) 7.1 ( 5.8- 8.5) ∼ ∼
Texas 5.6 ( 5.1- 6.0) 5.7 ( 5.2- 6.2) 4.8 ( 3.6- 6.3) 3.9 ( 3.1- 4.8)
West 5.4 ( 5.2- 5.7) 5.8 ( 5.5- 6.1) 3.2 ( 2.3- 4.2) 5.1 ( 4.5- 5.8)
Mountain 5.4 ( 4.9- 5.9) 5.5 ( 5.0- 6.1) ∼ 5.2 ( 4.0- 6.8)
Arizona 4.8 ( 4.0- 5.7) 5.1 ( 4.3- 6.1) ∼ 6.1 ( 3.8- 9.6)
Colorado 5.5 ( 4.5- 6.6) 5.6 ( 4.6- 6.7) ∼ ∼
Idaho 6.4 ( 4.6- 8.6) 6.6 ( 4.7- 8.9) ∼ ∼
Montana 6.9 ( 4.8- 9.7) 6.3 ( 4.3- 9.2) ∼ ∼
Nevada 5.8 ( 4.4- 7.5) 5.7 ( 4.3- 7.5) ∼ ∼
New Mexico 4.5 ( 3.3- 6.1) 4.8 ( 3.4- 6.5) ∼ 5.3 ( 3.2- 8.4)
Utah 5.8 ( 4.4- 7.5) 6.0 ( 4.5- 7.8) ∼ ∼
Wyoming
Pacific 5.4 ( 5.1- 5.7) 6.0 ( 5.6- 6.3) 2.9 ( 2.1- 4.1) 5.1 ( 4.4- 5.9)
Alaska ∼ ∼ ∼ ∼
California 5.2 ( 4.9- 5.6) 5.8 ( 5.4- 6.2) 2.9 ( 2.0- 4.1) 5.3 ( 4.5- 6.1)
San Francisco-Oakland 5.2 ( 4.3- 6.3) 5.6 ( 4.4- 6.9) ∼ ∼
San Jose-Monterey 5.4 ( 4.1- 6.9) 5.9 ( 4.4- 7.8) ∼ 7.4 ( 4.1- 12.8)
Los Angeles 5.0 ( 4.4- 5.7) 5.9 ( 5.1- 6.8) ∼ 5.1 ( 4.0- 6.5)
Hawaii 4.0 ( 2.7- 5.9) ∼ ∼ -
Oregon 5.5 ( 4.5- 6.7) 5.6 ( 4.6- 6.9) ∼ ∼
Washington 6.7 ( 5.8- 7.7) 7.1 ( 6.1- 8.2) ∼ ∼
Seattle-Puget Sound 6.3 ( 5.3- 7.5) 6.9 ( 5.7- 8.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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64 Table 2.2.1.2M: Brain and Other Nervous System. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 5.5 ( 5.3- 5.6) 5.8 ( 5.7- 6.0) 3.2 ( 2.9- 3.6) 3.5 ( 3.1- 3.9)
Northeast 5.0 ( 4.7- 5.3) 5.4 ( 5.1- 5.7) 2.1 ( 1.6- 2.8) 2.7 ( 1.9- 3.9)
New England 5.8 ( 5.2- 6.4) 6.0 ( 5.4- 6.7) ∼ ∼
Connecticut 5.3 ( 4.2- 6.5) 5.6 ( 4.5- 7.0) ∼ ∼
Maine 6.9 ( 5.0- 9.3) 7.0 ( 5.1- 9.5) ∼ ∼
Massachusetts 5.5 ( 4.7- 6.4) 5.7 ( 4.8- 6.6) ∼ ∼
New Hampshire 7.2 ( 5.2- 9.8) 7.3 ( 5.3- 10.0) ∼ ∼
Rhode Island 6.3 ( 4.3- 8.9) 6.7 ( 4.6- 9.5) ∼ ∼
Vermont 5.7 ( 3.4- 9.4) 5.8 ( 3.4- 9.5) ∼ ∼
Middle Atlantic 4.7 ( 4.4- 5.1) 5.1 ( 4.8- 5.5) 2.1 ( 1.6- 2.9) 2.6 ( 1.8- 4.0)
New Jersey 4.5 ( 3.8- 5.2) 4.8 ( 4.0- 5.6) ∼ ∼
New York 4.8 ( 4.3- 5.3) 5.4 ( 4.9- 6.0) 1.9 ( 1.2- 3.0) 2.1 ( 1.3- 3.7)
Pennsylvania 4.8 ( 4.3- 5.4) 5.0 ( 4.5- 5.7) ∼ ∼
Midwest 5.6 ( 5.4- 5.9) 5.9 ( 5.6- 6.2) 3.5 ( 2.8- 4.5) 3.4 ( 2.0- 5.9)
East North Central 5.5 ( 5.2- 5.9) 5.8 ( 5.4- 6.1) 3.7 ( 2.9- 4.8) 3.0 ( 1.6- 5.8)
Illinois 4.7 ( 4.2- 5.4) 5.1 ( 4.4- 5.8) 3.2 ( 1.9- 5.3) ∼
Indiana 5.7 ( 4.9- 6.7) 6.0 ( 5.1- 7.1) ∼ ∼
Michigan 5.9 ( 5.2- 6.7) 6.2 ( 5.4- 7.0) 4.2 ( 2.6- 6.8) ∼
Ohio 5.7 ( 5.1- 6.4) 5.9 ( 5.2- 6.6) 4.9 ( 3.1- 7.7) ∼
Wisconsin 5.9 ( 5.0- 7.0) 6.1 ( 5.1- 7.2) ∼ ∼
West North Central 5.8 ( 5.3- 6.3) 6.0 ( 5.5- 6.6) ∼ ∼
Iowa 5.8 ( 4.6- 7.1) 5.6 ( 4.4- 7.0) ∼ ∼
Kansas 7.0 ( 5.6- 8.7) 7.3 ( 5.9- 9.1) ∼ ∼
Minnesota 5.5 ( 4.5- 6.5) 5.7 ( 4.7- 6.8) ∼ ∼
Missouri 5.3 ( 4.4- 6.2) 5.7 ( 4.8- 6.7) ∼ ∼
Nebraska 6.0 ( 4.4- 8.0) 6.2 ( 4.6- 8.3) ∼ ∼
North Dakota 5.3 ( 3.1- 8.7) 5.6 ( 3.2- 9.1) ∼ ∼
South Dakota 7.9 ( 5.3- 11.4) 7.4 ( 4.8- 11.0) ∼ ∼
South 5.6 ( 5.3- 5.8) 6.0 ( 5.7- 6.2) 3.6 ( 3.1- 4.1) 4.0 ( 3.3- 4.8)
South Atlantic 5.2 ( 5.0- 5.5) 5.6 ( 5.3- 6.0) 3.6 ( 3.0- 4.4) 4.2 ( 3.1- 5.5)
Delaware 5.7 ( 3.5- 9.0) 5.4 ( 3.1- 9.0) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 5.3 ( 4.8- 5.8) 5.6 ( 5.1- 6.1) 3.3 ( 2.1- 5.3) 4.0 ( 2.9- 5.4)
Georgia 5.5 ( 4.7- 6.5) 6.0 ( 5.0- 7.1) 3.8 ( 2.4- 6.0) ∼
Maryland 4.7 ( 3.9- 5.7) 5.2 ( 4.2- 6.4) 3.4 ( 2.0- 6.1) ∼
North Carolina 5.8 ( 5.1- 6.7) 6.4 ( 5.5- 7.4) 3.6 ( 2.1- 6.0) ∼
South Carolina 5.8 ( 4.7- 7.1) 6.7 ( 5.3- 8.3) ∼ ∼
Virginia 4.5 ( 3.8- 5.4) 4.6 ( 3.8- 5.5) 4.7 ( 3.0- 7.5) ∼
West Virginia 6.1 ( 4.7- 8.0) 6.3 ( 4.7- 8.2) ∼ ∼
East South Central 6.1 ( 5.5- 6.7) 6.5 ( 5.9- 7.2) 4.0 ( 2.9- 5.4) ∼
Alabama 5.7 ( 4.7- 6.9) 6.5 ( 5.3- 7.9) ∼ ∼
Kentucky 5.9 ( 4.8- 7.1) 6.2 ( 5.0- 7.5) ∼ ∼
Mississippi 5.5 ( 4.2- 7.0) 5.6 ( 4.1- 7.5) 5.0 ( 2.9- 8.4) ∼
Tennessee 6.8 ( 5.8- 7.9) 7.0 ( 6.0- 8.3) 4.9 ( 2.8- 8.5) ∼
West South Central 5.8 ( 5.4- 6.3) 6.3 ( 5.9- 6.8) 3.2 ( 2.3- 4.4) 3.9 ( 3.0- 5.1)
Arkansas 6.0 ( 4.7- 7.6) 6.6 ( 5.2- 8.3) ∼ ∼
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Table 2.2.1.2M: Brain and Other Nervous System. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 5.2 ( 4.2- 6.4) 5.7 ( 4.5- 7.2) 4.0 ( 2.3- 6.6) ∼
Oklahoma 6.2 ( 5.1- 7.6) 6.9 ( 5.6- 8.4) ∼ ∼
Texas 5.9 ( 5.4- 6.4) 6.3 ( 5.7- 6.9) 2.9 ( 1.8- 4.8) 3.7 ( 2.9- 4.9)
West 5.5 ( 5.2- 5.8) 5.9 ( 5.6- 6.2) 3.0 ( 1.9- 4.4) 3.2 ( 2.6- 3.9)
Mountain 5.0 ( 4.5- 5.5) 5.2 ( 4.7- 5.7) ∼ 3.3 ( 2.2- 5.0)
Arizona 5.3 ( 4.4- 6.3) 5.5 ( 4.6- 6.6) ∼ ∼
Colorado 4.5 ( 3.6- 5.6) 4.7 ( 3.7- 5.9) ∼ ∼
Idaho 5.7 ( 3.9- 8.0) 5.8 ( 4.0- 8.2) ∼ ∼
Montana 4.5 ( 2.8- 7.0) 4.7 ( 2.9- 7.3) ∼ ∼
Nevada 4.3 ( 3.1- 6.0) 4.7 ( 3.4- 6.6) ∼ ∼
New Mexico 4.6 ( 3.3- 6.4) 5.0 ( 3.5- 6.9) ∼ ∼
Utah 6.2 ( 4.6- 8.3) 6.2 ( 4.5- 8.3) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 5.7 ( 5.4- 6.1) 6.3 ( 5.9- 6.7) 3.0 ( 1.9- 4.7) 3.2 ( 2.5- 4.1)
Alaska ∼ ∼ ∼ ∼
California 5.5 ( 5.1- 5.9) 6.1 ( 5.7- 6.6) 3.4 ( 2.1- 5.2) 3.1 ( 2.4- 4.0)
Hawaii 4.2 ( 2.7- 6.2) ∼ ∼ ∼
Oregon 7.0 ( 5.8- 8.4) 7.1 ( 5.8- 8.5) ∼ ∼
Washington 6.6 ( 5.6- 7.6) 6.8 ( 5.8- 7.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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66 Table 2.2.1.2F: Brain and Other Nervous System. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 3.6 ( 3.5- 3.7) 3.9 ( 3.8- 4.0) 2.2 ( 2.0- 2.5) 2.4 ( 2.1- 2.7)
Northeast 3.2 ( 3.0- 3.4) 3.5 ( 3.2- 3.7) 1.9 ( 1.4- 2.4) 1.6 ( 1.1- 2.4)
New England 3.4 ( 3.0- 3.9) 3.5 ( 3.1- 4.0) ∼ ∼
Connecticut 3.0 ( 2.3- 3.9) 3.0 ( 2.3- 4.0) ∼ ∼
Maine 4.2 ( 2.8- 6.0) 4.2 ( 2.9- 6.1) ∼ ∼
Massachusetts 3.3 ( 2.7- 3.9) 3.3 ( 2.8- 4.0) ∼ ∼
New Hampshire 4.0 ( 2.6- 5.9) 4.1 ( 2.7- 6.0) ∼ ∼
Rhode Island 4.1 ( 2.6- 6.1) 4.2 ( 2.7- 6.4) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.2 ( 2.9- 3.4) 3.4 ( 3.2- 3.7) 1.7 ( 1.3- 2.3) 1.7 ( 1.1- 2.5)
New Jersey 2.9 ( 2.4- 3.4) 3.2 ( 2.7- 3.9) ∼ ∼
New York 3.1 ( 2.8- 3.5) 3.4 ( 3.0- 3.8) 2.1 ( 1.4- 2.9) 2.0 ( 1.2- 3.0)
Pennsylvania 3.4 ( 3.0- 3.8) 3.6 ( 3.2- 4.1) ∼ ∼
Midwest 3.8 ( 3.6- 4.0) 4.0 ( 3.8- 4.2) 1.9 ( 1.5- 2.5) ∼
East North Central 3.6 ( 3.4- 3.8) 3.8 ( 3.6- 4.1) 1.9 ( 1.4- 2.5) ∼
Illinois 3.0 ( 2.6- 3.4) 3.2 ( 2.8- 3.7) 2.1 ( 1.3- 3.3) ∼
Indiana 4.2 ( 3.5- 5.0) 4.4 ( 3.7- 5.2) ∼ ∼
Michigan 3.9 ( 3.4- 4.4) 4.2 ( 3.7- 4.9) ∼ ∼
Ohio 3.6 ( 3.2- 4.1) 3.9 ( 3.4- 4.4) ∼ ∼
Wisconsin 3.7 ( 3.0- 4.4) 3.8 ( 3.1- 4.6) ∼ ∼
West North Central 4.1 ( 3.8- 4.5) 4.3 ( 3.9- 4.7) ∼ ∼
Iowa 4.6 ( 3.6- 5.8) 4.7 ( 3.7- 6.0) ∼ ∼
Kansas 4.5 ( 3.5- 5.7) 4.7 ( 3.6- 6.1) ∼ ∼
Minnesota 4.1 ( 3.3- 4.9) 4.2 ( 3.5- 5.1) ∼ ∼
Missouri 3.7 ( 3.1- 4.4) 3.8 ( 3.2- 4.6) ∼ ∼
Nebraska 4.1 ( 2.9- 5.7) 4.2 ( 3.0- 5.8) ∼ ∼
North Dakota 5.3 ( 3.2- 8.3) 4.8 ( 2.8- 7.9) ∼ ∼
South Dakota 4.0 ( 2.3- 6.6) 3.9 ( 2.2- 6.6) ∼ ∼
South 3.7 ( 3.6- 3.9) 4.0 ( 3.8- 4.2) 2.5 ( 2.1- 2.8) 2.7 ( 2.2- 3.3)
South Atlantic 3.5 ( 3.3- 3.7) 3.8 ( 3.5- 4.0) 2.3 ( 1.9- 2.8) 2.5 ( 1.9- 3.4)
Delaware 4.3 ( 2.6- 6.8) 4.9 ( 2.8- 8.1) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 3.5 ( 3.1- 3.9) 3.7 ( 3.3- 4.2) 2.0 ( 1.2- 3.1) 2.6 ( 1.8- 3.6)
Georgia 3.4 ( 2.9- 4.0) 3.9 ( 3.2- 4.7) 2.0 ( 1.2- 3.2) ∼
Maryland 3.2 ( 2.6- 3.9) 3.7 ( 3.0- 4.7) ∼ ∼
North Carolina 3.8 ( 3.3- 4.4) 3.9 ( 3.3- 4.7) 3.5 ( 2.4- 5.0) ∼
South Carolina 4.0 ( 3.2- 4.9) 4.5 ( 3.6- 5.7) ∼ ∼
Virginia 3.1 ( 2.5- 3.7) 3.2 ( 2.6- 3.9) 2.7 ( 1.7- 4.3) ∼
West Virginia 3.7 ( 2.6- 5.0) 3.8 ( 2.7- 5.2) ∼ ∼
East South Central 4.3 ( 3.9- 4.8) 4.6 ( 4.2- 5.1) 2.7 ( 1.9- 3.6) ∼
Alabama 3.8 ( 3.1- 4.6) 4.2 ( 3.3- 5.2) ∼ ∼
Kentucky 3.7 ( 2.9- 4.6) 3.8 ( 3.0- 4.7) ∼ ∼
Mississippi 5.0 ( 4.0- 6.3) 6.2 ( 4.9- 7.9) ∼ ∼
Tennessee 4.9 ( 4.1- 5.7) 4.9 ( 4.1- 5.8) 3.7 ( 2.1- 6.1) ∼
West South Central 3.9 ( 3.6- 4.2) 4.2 ( 3.8- 4.5) 2.6 ( 1.9- 3.4) 2.9 ( 2.2- 3.8)
Arkansas 4.8 ( 3.8- 6.0) 5.1 ( 4.0- 6.5) ∼ ∼
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Table 2.2.1.2F: Brain and Other Nervous System. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 3.4 ( 2.7- 4.2) 3.7 ( 2.8- 4.8) 2.6 ( 1.5- 4.3) ∼
Oklahoma 4.2 ( 3.4- 5.3) 4.8 ( 3.8- 6.0) ∼ ∼
Texas 3.8 ( 3.4- 4.2) 4.0 ( 3.6- 4.4) 2.7 ( 1.8- 3.9) 3.0 ( 2.3- 3.9)
West 3.6 ( 3.4- 3.8) 4.0 ( 3.8- 4.2) 2.1 ( 1.4- 3.0) 2.6 ( 2.2- 3.2)
Mountain 3.3 ( 3.0- 3.7) 3.5 ( 3.1- 3.9) ∼ 1.7 ( 1.0- 2.8)
Arizona 2.9 ( 2.3- 3.6) 3.1 ( 2.4- 3.8) ∼ ∼
Colorado 4.2 ( 3.3- 5.1) 4.2 ( 3.4- 5.2) ∼ ∼
Idaho 3.8 ( 2.4- 5.6) 3.9 ( 2.5- 5.8) ∼ ∼
Montana 4.7 ( 3.0- 7.2) 3.8 ( 2.3- 6.2) ∼ ∼
Nevada 3.5 ( 2.4- 4.9) 3.7 ( 2.6- 5.2) ∼ ∼
New Mexico 2.3 ( 1.4- 3.5) 2.4 ( 1.5- 3.8) ∼ ∼
Utah 3.5 ( 2.4- 5.0) 3.6 ( 2.5- 5.2) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 3.7 ( 3.5- 4.0) 4.2 ( 4.0- 4.6) 2.1 ( 1.4- 3.2) 2.9 ( 2.4- 3.6)
Alaska ∼ ∼ ∼ ∼
California 3.5 ( 3.2- 3.8) 4.0 ( 3.7- 4.3) 2.0 ( 1.2- 3.1) 3.0 ( 2.4- 3.7)
Hawaii ∼ ∼ ∼ ∼
Oregon 5.2 ( 4.2- 6.4) 5.3 ( 4.3- 6.5) ∼ ∼
Washington 4.6 ( 3.9- 5.4) 4.8 ( 4.0- 5.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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68 Table 2.3.1.1: Breast. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 124.9 (124.4- 125.5) 126.8 (126.2- 127.4) 110.1 (108.4- 111.8) 88.7 ( 86.9- 90.5)
Northeast 127.1 (125.8- 128.3) 129.4 (128.0- 130.8) 104.2 (100.7- 107.8) 84.5 ( 80.4- 88.8)
New England 133.1 (130.6- 135.7) 134.3 (131.7- 136.9) 110.3 ( 99.6- 122.1) 95.3 ( 82.8- 109.4)
Connecticut 133.9 (128.8- 139.0) 135.0 (129.7- 140.5) 121.7 (104.4- 141.3) 107.2 ( 86.6- 132.3)
Maine 127.0 (119.2- 135.2) 127.5 (119.7- 135.8) ∼ ∼
Massachusetts 134.1 (130.4- 137.9) 135.6 (131.7- 139.6) 105.9 ( 91.1- 122.6) 76.7 ( 60.9- 96.2)
New Hampshire 136.0 (127.5- 145.0) 135.7 (127.1- 144.7) ∼ -
Rhode Island 129.9 (121.1- 139.3) 132.1 (122.9- 142.0) 71.3 ( 40.8- 121.6) 123.0 ( 79.7- 186.0)
Vermont 132.4 (120.7- 145.2) 132.8 (121.0- 145.6) ∼ ∼
Middle Atlantic 125.0 (123.5- 126.4) 127.5 (125.9- 129.1) 103.3 ( 99.7- 107.1) 83.0 ( 78.7- 87.6)
New Jersey 128.9 (125.8- 132.2) 132.7 (129.2- 136.4) 112.5 (104.0- 121.5) 89.6 ( 80.5- 99.6)
New York 122.9 (120.8- 125.0) 127.5 (125.1- 129.9) 92.0 ( 87.5- 96.7) 78.7 ( 73.7- 84.1)
Pennsylvania 125.1 (122.6- 127.7) 124.2 (121.6- 126.9) 124.9 (116.4- 133.9) -
Midwest 126.5 (125.3- 127.7) 126.2 (125.0- 127.5) 118.5 (114.6- 122.5) 91.0 ( 84.1- 98.3)
East North Central 125.4 (124.0- 126.8) 124.8 (123.3- 126.3) 120.1 (115.9- 124.5) 89.0 ( 81.6- 97.1)
Illinois 127.9 (125.2- 130.6) 128.3 (125.3- 131.3) 124.5 (117.3- 132.1) 86.0 ( 76.7- 96.5)
Indiana 124.1 (120.3- 127.9) 123.9 (120.0- 127.9) 126.2 (112.1- 141.6) 91.7 ( 68.0- 123.4)
Michigan 126.9 (124.0- 130.0) 126.7 (123.5- 130.0) 119.4 (111.2- 128.1) 86.0 ( 66.8- 109.9)
Detroit 129.3 (124.6- 134.1) 133.2 (127.8- 138.9) 119.8 (110.4- 129.9) -
Ohio 120.8 (118.2- 123.5) 118.6 (115.8- 121.4) 112.5 (104.4- 121.0) 91.7 ( 69.4- 120.0)
Wisconsin 128.3 (124.3- 132.5) 128.4 (124.3- 132.7) 120.1 ( 99.7- 144.0) -
West North Central 129.2 (127.0- 131.4) 129.5 (127.3- 131.8) 109.8 (100.4- 119.9) 99.0 ( 82.7- 118.2)
Iowa 129.5 (124.1- 135.1) 128.8 (123.3- 134.5) 125.8 ( 82.4- 185.5) ∼
Kansas 130.2 (124.4- 136.2) 129.9 (123.9- 136.2) 110.9 ( 86.5- 140.5) 74.9 ( 51.7- 107.6)
Minnesota 134.7 (130.3- 139.3) 134.0 (129.5- 138.6) 104.3 ( 76.8- 141.5) 101.6 ( 66.0- 156.2)
Missouri 123.1 (119.2- 127.0) 125.0 (120.9- 129.2) 111.0 ( 99.4- 123.7) 109.0 ( 75.3- 154.4)
Nebraska 135.8 (128.4- 143.5) 138.0 (130.4- 145.9) 78.7 ( 48.9- 122.3) 159.3 (100.1- 246.0)
North Dakota 121.6 (110.4- 133.9) 116.8 (105.6- 129.0) ∼ ∼
South Dakota
South
South Atlantic
Delaware 123.2 (113.1- 133.9) 125.5 (114.3- 137.6) 103.2 ( 80.9- 130.6) ∼
District of Columbia 126.7 (114.6- 140.1) 146.9 (123.2- 175.6) 113.8 ( 99.8- 129.7) ∼
Florida 122.0 (119.9- 124.2) 123.7 (121.4- 126.1) 105.0 ( 99.0- 111.4) -
Georgia 125.1 (121.7- 128.5) 128.2 (124.2- 132.3) 114.6 (107.9- 121.5) 77.2 ( 57.4- 103.3)
Atlanta 128.2 (122.1- 134.6) 133.2 (125.6- 141.2) 120.1 (109.0- 132.3) 85.9 ( 56.7- 128.3)
Maryland 119.5 (115.6- 123.5) 125.1 (120.4- 130.0) 108.5 (100.9- 116.5) 70.0 ( 52.0- 93.6)
North Carolina 116.3 (113.1- 119.5) 118.7 (115.1- 122.3) 106.5 ( 99.7- 113.7) 68.8 ( 48.2- 98.2)
South Carolina 118.9 (114.4- 123.4) 124.5 (119.2- 130.1) 100.0 ( 92.1- 108.5) -
Virginia
West Virginia 109.0 (103.0- 115.4) 109.6 (103.4- 116.1) 99.4 ( 67.0- 143.1) ∼
East South Central
Alabama 116.4 (112.3- 120.7) 120.1 (115.3- 125.2) 102.3 ( 94.1- 111.0) 80.9 ( 44.7- 137.8)
Kentucky 121.5 (117.0- 126.1) 120.5 (115.9- 125.3) 128.9 (110.6- 149.6) -
Mississippi
Tennessee
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Table 2.3.1.1: Breast. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 118.9 (114.6- 123.4) 117.8 (112.6- 123.1) 122.5 (114.2- 131.4) 163.2 (128.7- 204.7)
Oklahoma 125.6 (120.6- 130.7) 124.8 (119.5- 130.3) 127.5 (107.3- 150.6) 89.3 ( 62.1- 128.9)
Texas 117.3 (115.2- 119.4) 118.1 (115.8- 120.3) 106.7 (100.5- 113.2) 81.5 ( 77.8- 85.5)
West 128.8 (127.6- 130.1) 132.7 (131.3- 134.1) 111.2 (105.7- 116.9) 88.1 ( 85.3- 90.9)
Mountain 119.4 (117.2- 121.7) 121.7 (119.3- 124.0) 90.4 ( 77.9- 104.6) 88.0 ( 82.4- 93.8)
Arizona 112.7 (108.9- 116.7) 116.4 (112.3- 120.7) 68.9 ( 49.8- 93.9) 81.4 ( 72.2- 91.6)
Colorado 129.2 (124.4- 134.1) 128.9 (124.0- 134.0) 98.0 ( 75.6- 125.8) 94.4 ( 81.8- 108.7)
Idaho 131.5 (122.9- 140.5) 132.7 (124.0- 141.9) ∼ 148.6 ( 93.2- 231.6)
Montana 114.1 (105.2- 123.7) 112.9 (103.8- 122.7) ∼ ∼
Nevada 124.3 (117.7- 131.2) 126.3 (119.2- 133.8) 101.8 ( 77.2- 133.6) 93.1 ( 74.5- 116.4)
New Mexico 110.0 (103.5- 116.8) 117.0 (109.9- 124.4) ∼ 84.1 ( 74.4- 94.7)
Utah 114.4 (107.5- 121.6) 116.2 (109.1- 123.6) ∼ 119.2 ( 89.2- 159.5)
Wyoming
Pacific 132.6 (131.1- 134.1) 137.8 (136.1- 139.5) 114.8 (108.8- 121.1) 88.1 ( 84.9- 91.4)
Alaska 117.1 (103.5- 132.4) 119.4 (103.7- 137.3) ∼ ∼
California 129.4 (127.7- 131.1) 136.1 (134.2- 138.1) 115.3 (108.9- 121.9) 88.4 ( 85.1- 91.8)
San Francisco-Oakland 141.7 (136.8- 146.7) 158.6 (152.3- 165.0) 123.6 (109.1- 139.6) 121.5 (107.9- 136.5)
San Jose-Monterey 122.5 (116.2- 129.0) 133.5 (126.0- 141.4) 105.8 ( 67.6- 162.4) 89.2 ( 76.0- 104.5)
Los Angeles 122.7 (119.5- 126.0) 128.7 (124.8- 132.6) 119.1 (109.7- 129.1) 82.6 ( 77.6- 87.8)
Hawaii 128.2 (119.9- 137.0) 157.4 (138.8- 178.4) ∼ -
Oregon 139.9 (134.6- 145.3) 136.7 (131.4- 142.2) 143.9 ( 98.3- 205.5) 102.0 ( 73.5- 139.9)
Washington 147.8 (143.5- 152.1) 146.3 (141.9- 150.9) 108.4 ( 85.1- 136.7) 94.7 ( 74.7- 119.9)
Seattle-Puget Sound 151.7 (146.6- 157.1) 158.8 (153.1- 164.6) 109.1 ( 84.8- 139.2) 65.3 ( 43.0- 97.8)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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70 Table 2.3.1.2: Breast. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 25.5 ( 25.3- 25.8) 24.9 ( 24.7- 25.2) 34.1 ( 33.2- 35.0) 15.7 ( 14.9- 16.5)
Northeast 26.5 ( 25.9- 27.1) 26.4 ( 25.8- 27.0) 31.6 ( 29.6- 33.6) 14.6 ( 12.8- 16.5)
New England 25.1 ( 24.0- 26.2) 25.2 ( 24.1- 26.3) 26.1 ( 20.9- 32.3) 15.0 ( 10.1- 21.8)
Connecticut 25.1 ( 23.0- 27.3) 25.1 ( 22.9- 27.5) 27.7 ( 19.5- 38.4) ∼
Maine 23.9 ( 20.6- 27.6) 24.0 ( 20.7- 27.7) ∼ ∼
Massachusetts 26.3 ( 24.7- 27.9) 26.5 ( 24.9- 28.3) 24.4 ( 17.6- 33.3) 16.4 ( 9.3- 27.8)
New Hampshire 24.1 ( 20.6- 28.0) 24.3 ( 20.8- 28.3) ∼ ∼
Rhode Island 23.4 ( 19.9- 27.5) 23.3 ( 19.6- 27.5) ∼ ∼
Vermont 21.3 ( 16.9- 26.8) 21.2 ( 16.7- 26.7) ∼ ∼
Middle Atlantic 27.0 ( 26.3- 27.6) 26.8 ( 26.1- 27.5) 32.2 ( 30.1- 34.3) 14.6 ( 12.7- 16.7)
New Jersey 28.4 ( 26.9- 29.9) 28.1 ( 26.5- 29.7) 36.0 ( 31.2- 41.4) 13.2 ( 9.8- 17.5)
New York 25.9 ( 24.9- 26.8) 26.2 ( 25.2- 27.3) 27.8 ( 25.4- 30.5) 14.4 ( 12.2- 17.0)
Pennsylvania 27.7 ( 26.6- 28.9) 26.8 ( 25.6- 28.0) 40.6 ( 35.8- 45.8) 20.6 ( 12.4- 33.0)
Midwest 26.1 ( 25.6- 26.6) 25.3 ( 24.7- 25.8) 37.0 ( 34.9- 39.3) 14.1 ( 11.4- 17.5)
East North Central 26.6 ( 26.0- 27.3) 25.7 ( 25.0- 26.4) 36.9 ( 34.5- 39.4) 14.7 ( 11.6- 18.6)
Illinois 26.9 ( 25.7- 28.2) 25.5 ( 24.3- 26.9) 39.3 ( 35.2- 43.8) 16.6 ( 12.2- 22.3)
Indiana 25.6 ( 23.9- 27.3) 24.9 ( 23.2- 26.7) 35.0 ( 27.7- 43.6) ∼
Michigan 26.8 ( 25.4- 28.2) 25.5 ( 24.1- 27.0) 36.8 ( 32.3- 41.8) ∼
Ohio 27.8 ( 26.5- 29.1) 27.0 ( 25.7- 28.4) 35.8 ( 31.3- 40.8) ∼
Wisconsin 24.4 ( 22.7- 26.2) 24.4 ( 22.6- 26.2) 28.3 ( 18.5- 42.2) ∼
West North Central 24.8 ( 23.9- 25.8) 24.3 ( 23.4- 25.3) 38.2 ( 32.6- 44.4) 11.3 ( 6.1- 19.8)
Iowa 24.8 ( 22.6- 27.3) 24.9 ( 22.6- 27.3) ∼ ∼
Kansas 26.5 ( 23.9- 29.2) 25.6 ( 23.0- 28.4) 47.0 ( 31.6- 67.6) ∼
Minnesota 22.5 ( 20.8- 24.4) 22.8 ( 21.0- 24.7) ∼ ∼
Missouri 26.0 ( 24.3- 27.8) 24.9 ( 23.1- 26.7) 38.2 ( 31.4- 46.1) ∼
Nebraska 24.2 ( 21.2- 27.5) 23.6 ( 20.7- 27.0) ∼ ∼
North Dakota 25.9 ( 21.0- 31.8) 25.5 ( 20.5- 31.4) ∼ ∼
South Dakota 23.8 ( 19.4- 28.9) 23.6 ( 19.1- 28.9) ∼ ∼
South 25.7 ( 25.3- 26.1) 24.2 ( 23.8- 24.6) 34.3 ( 33.1- 35.6) 16.8 ( 15.5- 18.1)
South Atlantic 25.5 ( 25.0- 26.1) 23.8 ( 23.2- 24.4) 33.5 ( 31.9- 35.1) 15.7 ( 13.9- 17.7)
Delaware 23.6 ( 19.4- 28.6) 21.9 ( 17.5- 27.3) 35.4 ( 22.5- 53.7) ∼
District of Columbia 34.3 ( 28.1- 41.7) 26.5 ( 16.9- 41.7) 38.8 ( 30.8- 48.8) ∼
Florida 23.7 ( 22.8- 24.7) 22.7 ( 21.7- 23.7) 31.6 ( 28.3- 35.3) 16.7 ( 14.6- 19.0)
Georgia 25.3 ( 23.7- 26.8) 23.6 ( 21.9- 25.4) 30.3 ( 27.0- 34.1) ∼
Maryland 29.2 ( 27.3- 31.2) 27.3 ( 25.1- 29.6) 36.2 ( 31.8- 41.1) ∼
North Carolina 26.4 ( 24.9- 27.9) 24.5 ( 22.9- 26.2) 34.2 ( 30.4- 38.3) ∼
South Carolina 26.9 ( 24.8- 29.1) 24.9 ( 22.6- 27.5) 32.6 ( 28.1- 37.7) ∼
Virginia 26.8 ( 25.2- 28.5) 24.8 ( 23.1- 26.7) 36.3 ( 31.9- 41.2) ∼
West Virginia 22.7 ( 20.1- 25.7) 22.7 ( 20.0- 25.8) ∼ ∼
East South Central 26.3 ( 25.3- 27.3) 24.9 ( 23.8- 26.0) 33.2 ( 30.5- 36.2) ∼
Alabama 25.5 ( 23.6- 27.5) 24.5 ( 22.4- 26.8) 28.9 ( 24.7- 33.7) ∼
Kentucky 27.6 ( 25.5- 29.9) 27.0 ( 24.8- 29.3) 36.9 ( 27.5- 48.8) ∼
Mississippi 26.6 ( 24.1- 29.3) 22.1 ( 19.4- 25.1) 37.4 ( 32.0- 43.5) ∼
Tennessee 25.8 ( 24.1- 27.6) 24.6 ( 22.8- 26.5) 33.4 ( 28.1- 39.6) ∼
West South Central 25.7 ( 24.9- 26.5) 24.4 ( 23.6- 25.3) 37.4 ( 34.7- 40.2) 17.8 ( 16.0- 19.7)
Arkansas 25.4 ( 23.0- 28.0) 23.4 ( 20.9- 26.1) 39.2 ( 30.8- 49.3) ∼
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Table 2.3.1.2: Breast. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 29.6 ( 27.5- 31.9) 25.5 ( 23.2- 28.0) 40.2 ( 35.4- 45.4) ∼
Oklahoma 27.0 ( 24.8- 29.4) 26.7 ( 24.3- 29.3) 42.6 ( 31.0- 57.4) ∼
Texas 24.6 ( 23.7- 25.6) 23.9 ( 22.9- 25.0) 34.7 ( 31.2- 38.6) 17.9 ( 16.1- 19.9)
West 23.5 ( 23.0- 24.1) 24.2 ( 23.6- 24.8) 32.1 ( 29.1- 35.3) 15.3 ( 14.1- 16.6)
Mountain 23.5 ( 22.5- 24.5) 23.7 ( 22.7- 24.7) 32.9 ( 25.2- 42.5) 17.6 ( 15.1- 20.4)
Arizona 22.7 ( 21.0- 24.5) 22.7 ( 20.9- 24.6) 39.0 ( 24.6- 59.7) 17.6 ( 13.4- 22.9)
Colorado 23.0 ( 21.0- 25.1) 23.4 ( 21.3- 25.6) ∼ 13.0 ( 8.6- 19.2)
Idaho 25.0 ( 21.4- 29.0) 25.0 ( 21.4- 29.1) ∼ ∼
Montana 27.3 ( 23.1- 32.2) 27.1 ( 22.8- 32.1) ∼ ∼
Nevada 26.0 ( 22.9- 29.3) 26.1 ( 22.9- 29.7) 33.5 ( 19.4- 55.7) ∼
New Mexico 21.9 ( 19.1- 25.1) 22.7 ( 19.7- 26.1) ∼ 20.7 ( 16.0- 26.5)
Utah 24.2 ( 21.1- 27.7) 24.3 ( 21.1- 27.8) ∼ ∼
Wyoming 19.6 ( 14.6- 25.8) 19.3 ( 14.3- 25.6) ∼ ∼
Pacific 23.6 ( 23.0- 24.2) 24.5 ( 23.8- 25.2) 32.0 ( 28.8- 35.5) 14.6 ( 13.2- 16.0)
Alaska 21.0 ( 15.0- 28.9) 21.1 ( 14.3- 30.4) ∼ ∼
California 23.8 ( 23.1- 24.5) 24.6 ( 23.8- 25.4) 32.5 ( 29.1- 36.2) 14.5 ( 13.2- 16.0)
Hawaii 16.2 ( 13.4- 19.5) 20.1 ( 13.8- 29.0) ∼ ∼
Oregon 24.7 ( 22.6- 27.0) 24.9 ( 22.7- 27.3) ∼ ∼
Washington 23.6 ( 22.0- 25.4) 24.2 ( 22.5- 26.1) 28.0 ( 16.7- 45.0) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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72 Table 2.4.1.1: Breast, In Situ . Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 28.6 ( 28.4- 28.9) 29.0 ( 28.7- 29.3) 23.5 ( 22.7- 24.3) 18.3 ( 17.6- 19.2)
Northeast 34.4 ( 33.7- 35.0) 35.6 ( 34.8- 36.3) 22.8 ( 21.2- 24.5) 22.6 ( 20.6- 24.8)
New England 42.3 ( 40.9- 43.7) 43.1 ( 41.6- 44.6) 21.5 ( 16.9- 27.0) 34.3 ( 27.5- 42.8)
Connecticut 41.4 ( 38.7- 44.4) 43.0 ( 40.0- 46.2) 22.9 ( 15.9- 32.4) 44.9 ( 32.4- 61.8)
Maine 36.3 ( 32.2- 40.9) 36.2 ( 32.1- 40.8) ∼ ∼
Massachusetts 47.5 ( 45.2- 49.8) 48.5 ( 46.1- 50.9) 22.4 ( 15.9- 31.0) 27.5 ( 19.2- 39.5)
New Hampshire 39.5 ( 34.9- 44.5) 39.9 ( 35.3- 45.0) ∼ -
Rhode Island 30.1 ( 25.9- 35.0) 30.9 ( 26.4- 35.9) ∼ ∼
Vermont 34.6 ( 28.8- 41.6) 35.1 ( 29.1- 42.1) ∼ ∼
Middle Atlantic 31.6 ( 30.9- 32.3) 32.6 ( 31.8- 33.4) 23.0 ( 21.3- 24.8) 20.9 ( 18.8- 23.2)
New Jersey 35.1 ( 33.4- 36.8) 37.7 ( 35.8- 39.7) 22.9 ( 19.2- 27.1) 24.5 ( 20.1- 29.9)
New York 30.4 ( 29.4- 31.5) 31.6 ( 30.4- 32.8) 20.2 ( 18.1- 22.4) 18.9 ( 16.5- 21.6)
Pennsylvania 30.9 ( 29.6- 32.2) 30.6 ( 29.3- 32.0) 30.8 ( 26.7- 35.5) -
Midwest 28.6 ( 28.0- 29.1) 28.3 ( 27.8- 28.9) 27.8 ( 26.0- 29.8) 19.3 ( 16.3- 22.8)
East North Central 29.8 ( 29.1- 30.5) 29.7 ( 28.9- 30.4) 28.6 ( 26.6- 30.8) 20.2 ( 16.8- 24.2)
Illinois 28.8 ( 27.5- 30.1) 29.7 ( 28.2- 31.2) 23.3 ( 20.2- 26.7) 17.5 ( 13.8- 22.4)
Indiana 27.7 ( 25.9- 29.5) 27.7 ( 25.9- 29.7) 27.3 ( 21.0- 35.0) ∼
Michigan 35.5 ( 33.9- 37.1) 34.8 ( 33.1- 36.6) 35.7 ( 31.3- 40.6) 19.9 ( 11.3- 33.7)
Detroit 41.8 ( 39.2- 44.6) 43.4 ( 40.3- 46.8) 37.3 ( 32.2- 43.1) -
Ohio 29.3 ( 28.0- 30.6) 29.0 ( 27.6- 30.4) 27.5 ( 23.6- 31.9) 34.5 ( 21.0- 54.5)
Wisconsin 25.2 ( 23.4- 27.1) 24.3 ( 22.5- 26.3) 36.1 ( 25.9- 49.9) -
West North Central 25.5 ( 24.5- 26.5) 25.4 ( 24.4- 26.4) 23.4 ( 19.2- 28.4) 15.4 ( 9.7- 24.3)
Iowa 25.3 ( 22.9- 27.9) 25.0 ( 22.6- 27.6) ∼ ∼
Kansas 24.0 ( 21.5- 26.7) 23.6 ( 21.1- 26.4) ∼ ∼
Minnesota 26.8 ( 24.8- 28.8) 26.4 ( 24.4- 28.5) ∼ ∼
Missouri 25.1 ( 23.4- 26.9) 25.4 ( 23.5- 27.3) 24.3 ( 19.0- 30.7) ∼
Nebraska 28.8 ( 25.5- 32.6) 28.6 ( 25.2- 32.4) ∼ ∼
North Dakota 16.4 ( 12.4- 21.4) 17.0 ( 12.8- 22.2) ∼ ∼
South Dakota
South
South Atlantic
Delaware 36.0 ( 30.6- 42.0) 37.7 ( 31.6- 44.7) 27.9 ( 17.5- 43.5) ∼
District of Columbia 30.0 ( 24.2- 37.0) 41.8 ( 29.5- 59.6) 23.4 ( 17.3- 31.7) ∼
Florida 27.7 ( 26.7- 28.8) 28.2 ( 27.1- 29.4) 24.5 ( 21.6- 27.8) -
Georgia 27.4 ( 25.8- 29.0) 28.8 ( 26.9- 30.7) 23.8 ( 20.8- 27.1) ∼
Atlanta 32.0 ( 29.0- 35.3) 36.5 ( 32.6- 40.8) 24.6 ( 19.8- 30.4) ∼
Maryland 26.1 ( 24.3- 28.0) 27.2 ( 25.1- 29.6) 22.5 ( 19.2- 26.3) 21.3 ( 12.0- 36.6)
North Carolina 23.0 ( 21.6- 24.5) 23.7 ( 22.1- 25.4) 21.5 ( 18.5- 24.9) ∼
South Carolina 27.3 ( 25.2- 29.5) 28.8 ( 26.3- 31.5) 22.7 ( 19.0- 26.9) -
Virginia
West Virginia 25.7 ( 22.9- 29.0) 26.3 ( 23.3- 29.6) ∼ ∼
East South Central
Alabama 27.4 ( 25.4- 29.5) 29.2 ( 26.9- 31.8) 21.3 ( 17.6- 25.5) ∼
Kentucky 23.5 ( 21.5- 25.6) 23.3 ( 21.2- 25.4) 25.4 ( 17.5- 35.6) -
Mississippi
Tennessee
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Table 2.4.1.1: Breast, In Situ . Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 21.5 ( 19.6- 23.4) 22.5 ( 20.3- 24.9) 18.5 ( 15.4- 22.2) 33.2 ( 19.0- 54.8)
Oklahoma 22.7 ( 20.6- 25.0) 22.3 ( 20.1- 24.7) 26.1 ( 17.5- 37.6) ∼
Texas 23.4 ( 22.5- 24.4) 23.1 ( 22.1- 24.1) 23.0 ( 20.2- 26.2) 13.7 ( 12.2- 15.3)
West 27.9 ( 27.3- 28.5) 27.8 ( 27.2- 28.4) 20.4 ( 18.1- 23.0) 17.0 ( 15.8- 18.3)
Mountain 25.7 ( 24.7- 26.7) 26.0 ( 24.9- 27.1) 17.6 ( 12.3- 24.6) 15.8 ( 13.5- 18.5)
Arizona 22.7 ( 21.0- 24.6) 23.3 ( 21.5- 25.3) ∼ 14.7 ( 11.1- 19.5)
Colorado 31.7 ( 29.4- 34.2) 30.9 ( 28.5- 33.5) 22.5 ( 12.6- 38.3) 22.4 ( 16.5- 30.1)
Idaho 23.8 ( 20.3- 27.9) 24.1 ( 20.5- 28.3) ∼ ∼
Montana 29.1 ( 24.6- 34.3) 29.0 ( 24.4- 34.4) ∼ ∼
Nevada 26.6 ( 23.6- 29.9) 26.9 ( 23.6- 30.4) ∼ 13.9 ( 7.4- 25.9)
New Mexico 22.1 ( 19.3- 25.3) 23.8 ( 20.7- 27.3) ∼ 12.1 ( 8.6- 16.7)
Utah 22.5 ( 19.5- 25.9) 22.9 ( 19.8- 26.3) ∼ ∼
Wyoming
Pacific 28.8 ( 28.1- 29.5) 28.6 ( 27.9- 29.4) 21.0 ( 18.5- 23.8) 17.4 ( 16.0- 18.9)
Alaska 36.9 ( 29.6- 46.0) 33.1 ( 25.1- 43.4) ∼ ∼
California 27.3 ( 26.5- 28.1) 27.8 ( 26.9- 28.7) 21.4 ( 18.7- 24.3) 17.3 ( 15.9- 18.8)
San Francisco-Oakland 31.5 ( 29.2- 33.9) 31.6 ( 28.8- 34.6) 22.4 ( 16.4- 29.9) 19.3 ( 14.1- 25.9)
San Jose-Monterey 26.9 ( 24.0- 30.1) 26.7 ( 23.3- 30.3) ∼ 18.1 ( 12.4- 26.0)
Los Angeles 25.1 ( 23.7- 26.6) 26.1 ( 24.4- 27.9) 19.5 ( 15.8- 23.8) 15.8 ( 13.8- 18.2)
Hawaii 40.5 ( 35.9- 45.6) 30.0 ( 22.4- 40.0) ∼ -
Oregon 29.2 ( 26.8- 31.7) 28.3 ( 25.9- 30.9) ∼ ∼
Washington 33.7 ( 31.7- 35.8) 32.7 ( 30.6- 34.9) ∼ 28.5 ( 17.7- 45.0)
Seattle-Puget Sound 35.4 ( 33.0- 38.1) 36.2 ( 33.5- 39.1) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ In situ cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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74 Table 2.5.1.1: Cervix Uteri. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 8.7 ( 8.5- 8.8) 8.2 ( 8.0- 8.4) 12.4 ( 11.8- 12.9) 13.1 ( 12.5- 13.7)
Northeast 8.0 ( 7.7- 8.4) 7.3 ( 6.9- 7.6) 12.8 ( 11.6- 14.0) 12.0 ( 10.6- 13.6)
New England 6.6 ( 6.0- 7.2) 6.4 ( 5.8- 7.0) 9.5 ( 6.7- 13.3) 11.1 ( 7.3- 16.7)
Connecticut 5.9 ( 4.8- 7.1) 5.5 ( 4.4- 6.8) 9.8 ( 5.5- 16.5) ∼
Maine 7.2 ( 5.3- 9.6) 7.0 ( 5.2- 9.4) ∼ ∼
Massachusetts 6.6 ( 5.8- 7.6) 6.3 ( 5.4- 7.2) 9.9 ( 6.0- 15.9) 15.6 ( 9.0- 26.2)
New Hampshire 7.4 ( 5.5- 9.8) 7.6 ( 5.6- 10.0) ∼ -
Rhode Island 6.3 ( 4.4- 8.8) 6.3 ( 4.3- 9.0) ∼ ∼
Vermont 8.3 ( 5.5- 12.4) 8.5 ( 5.6- 12.6) ∼ ∼
Middle Atlantic 8.5 ( 8.2- 8.9) 7.6 ( 7.2- 8.1) 13.1 ( 11.9- 14.5) 12.3 ( 10.8- 14.1)
New Jersey 9.2 ( 8.3- 10.1) 8.5 ( 7.6- 9.5) 13.7 ( 10.8- 17.0) 14.7 ( 11.5- 18.8)
New York 8.6 ( 8.0- 9.2) 7.3 ( 6.7- 8.0) 13.1 ( 11.4- 14.9) 10.9 ( 9.2- 13.0)
Pennsylvania 8.1 ( 7.4- 8.8) 7.5 ( 6.8- 8.3) 13.0 ( 10.4- 16.1) -
Midwest 7.9 ( 7.6- 8.2) 7.5 ( 7.1- 7.8) 11.5 ( 10.3- 12.8) 12.0 ( 9.9- 14.7)
East North Central 8.1 ( 7.7- 8.5) 7.6 ( 7.3- 8.0) 11.5 ( 10.2- 12.9) 12.8 ( 10.3- 16.0)
Illinois 9.3 ( 8.5- 10.0) 8.6 ( 7.8- 9.4) 13.9 ( 11.6- 16.6) 15.3 ( 11.6- 20.1)
Indiana 8.6 ( 7.6- 9.7) 8.5 ( 7.5- 9.7) 10.7 ( 7.0- 15.9) ∼
Michigan 7.4 ( 6.7- 8.2) 6.7 ( 5.9- 7.5) 11.0 ( 8.7- 13.8) ∼
Detroit 8.3 ( 7.2- 9.6) 7.5 ( 6.2- 9.0) 11.1 ( 8.4- 14.5) -
Ohio 7.7 ( 7.0- 8.4) 7.3 ( 6.6- 8.1) 9.0 ( 6.9- 11.7) ∼
Wisconsin 7.2 ( 6.2- 8.3) 7.0 ( 6.0- 8.1) ∼ -
West North Central 7.4 ( 6.9- 8.0) 7.0 ( 6.5- 7.6) 11.5 ( 8.7- 15.1) 8.5 ( 5.1- 14.9)
Iowa 7.6 ( 6.3- 9.1) 7.6 ( 6.2- 9.1) ∼ ∼
Kansas 6.6 ( 5.3- 8.1) 5.9 ( 4.6- 7.4) ∼ ∼
Minnesota 6.8 ( 5.8- 7.9) 6.1 ( 5.2- 7.2) ∼ ∼
Missouri 7.9 ( 7.0- 9.0) 7.5 ( 6.4- 8.6) 12.1 ( 8.5- 16.7) ∼
Nebraska 8.7 ( 6.8- 11.0) 8.7 ( 6.8- 11.1) ∼ ∼
North Dakota 7.4 ( 4.6- 11.3) 7.3 ( 4.4- 11.4) ∼ ∼
South Dakota
South
South Atlantic
Delaware 7.5 ( 5.1- 10.7) 6.8 ( 4.2- 10.4) ∼ ∼
District of Columbia 10.4 ( 7.1- 14.9) ∼ 12.2 ( 7.8- 18.9) ∼
Florida 10.0 ( 9.4- 10.7) 9.6 ( 8.9- 10.4) 14.5 ( 12.3- 17.0) -
Georgia 9.6 ( 8.7- 10.6) 8.6 ( 7.6- 9.7) 13.1 ( 11.0- 15.6) ∼
Atlanta 8.3 ( 6.8- 10.0) 5.9 ( 4.4- 7.8) 13.3 ( 9.8- 18.1) ∼
Maryland 18.4 ( 16.9- 20.1) 19.6 ( 17.6- 21.8) 19.0 ( 16.0- 22.4) 24.6 ( 15.5- 39.1)
North Carolina 7.4 ( 6.6- 8.3) 6.9 ( 6.1- 7.9) 9.2 ( 7.3- 11.5) ∼
South Carolina 10.1 ( 8.8- 11.6) 9.3 ( 7.8- 11.0) 13.0 ( 10.3- 16.3) -
Virginia
West Virginia 9.5 ( 7.6- 11.7) 9.5 ( 7.7- 11.8) ∼ ∼
East South Central
Alabama 10.6 ( 9.3- 12.0) 8.8 ( 7.4- 10.3) 15.9 ( 12.8- 19.5) ∼
Kentucky 10.3 ( 9.0- 11.8) 10.1 ( 8.7- 11.6) 12.7 ( 7.5- 20.4) -
Mississippi
Tennessee
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Table 2.5.1.1: Cervix Uteri. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 10.1 ( 8.8- 11.5) 7.9 ( 6.6- 9.5) 15.0 ( 12.3- 18.3) ∼
Oklahoma 8.8 ( 7.5- 10.4) 8.1 ( 6.7- 9.7) 13.8 ( 8.0- 22.7) ∼
Texas 9.5 ( 8.9- 10.1) 9.2 ( 8.6- 9.8) 12.1 ( 10.1- 14.4) 14.3 ( 12.8- 15.9)
West 8.1 ( 7.8- 8.5) 8.2 ( 7.8- 8.5) 7.6 ( 6.3- 9.2) 13.4 ( 12.4- 14.4)
Mountain 7.5 ( 7.0- 8.1) 7.4 ( 6.8- 8.0) 7.7 ( 4.4- 12.8) 9.6 ( 8.0- 11.5)
Arizona 7.2 ( 6.2- 8.3) 7.0 ( 6.0- 8.2) ∼ 9.0 ( 6.4- 12.6)
Colorado 7.2 ( 6.1- 8.4) 6.9 ( 5.8- 8.1) ∼ 11.2 ( 7.6- 16.4)
Idaho 8.1 ( 6.0- 10.7) 7.9 ( 5.8- 10.6) ∼ ∼
Montana 7.6 ( 5.3- 10.7) 7.9 ( 5.5- 11.2) ∼ ∼
Nevada 8.9 ( 7.2- 10.9) 8.8 ( 6.9- 11.0) ∼ ∼
New Mexico 8.0 ( 6.3- 10.1) 8.3 ( 6.4- 10.6) ∼ 8.2 ( 5.5- 12.0)
Utah 7.1 ( 5.5- 9.0) 6.8 ( 5.2- 8.8) ∼ ∼
Wyoming
Pacific 8.4 ( 8.0- 8.8) 8.6 ( 8.1- 9.0) 7.6 ( 6.2- 9.4) 14.6 ( 13.4- 15.9)
Alaska 7.2 ( 4.3- 12.0) 8.1 ( 4.6- 14.1) ∼ ∼
California 8.9 ( 8.5- 9.4) 9.3 ( 8.8- 9.8) 7.5 ( 6.0- 9.3) 14.8 ( 13.6- 16.2)
San Francisco-Oakland 6.5 ( 5.5- 7.6) 6.2 ( 5.0- 7.7) 7.1 ( 4.1- 11.8) 9.6 ( 6.2- 14.5)
San Jose-Monterey 7.4 ( 6.0- 9.2) 8.6 ( 6.8- 10.9) ∼ 16.0 ( 11.2- 22.8)
Los Angeles 11.2 ( 10.3- 12.2) 12.2 ( 11.0- 13.4) 7.3 ( 5.1- 10.1) 17.5 ( 15.4- 19.8)
Hawaii 7.0 ( 5.2- 9.4) ∼ ∼ -
Oregon 7.0 ( 5.9- 8.4) 6.8 ( 5.6- 8.2) ∼ ∼
Washington 6.7 ( 5.8- 7.7) 6.3 ( 5.4- 7.3) ∼ ∼
Seattle-Puget Sound 7.1 ( 6.1- 8.4) 6.9 ( 5.8- 8.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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76 Table 2.5.1.2: Cervix Uteri. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 2.5 ( 2.5- 2.6) 2.3 ( 2.2- 2.4) 5.0 ( 4.6- 5.3) 3.2 ( 2.9- 3.6)
Northeast 2.4 ( 2.2- 2.6) 2.1 ( 2.0- 2.3) 4.5 ( 3.8- 5.3) 2.9 ( 2.1- 3.8)
New England 1.8 ( 1.5- 2.2) 1.8 ( 1.5- 2.1) ∼ ∼
Connecticut 1.7 ( 1.2- 2.4) 1.5 ( 1.0- 2.2) ∼ ∼
Maine 2.1 ( 1.2- 3.6) 2.2 ( 1.2- 3.6) ∼ ∼
Massachusetts 1.5 ( 1.2- 2.0) 1.4 ( 1.0- 1.9) ∼ ∼
New Hampshire 2.3 ( 1.3- 3.8) 2.3 ( 1.3- 3.9) ∼ ∼
Rhode Island 2.9 ( 1.7- 4.7) 3.1 ( 1.8- 5.0) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.6 ( 2.4- 2.8) 2.3 ( 2.1- 2.5) 4.7 ( 4.0- 5.6) 3.1 ( 2.3- 4.1)
New Jersey 2.4 ( 1.9- 2.8) 2.0 ( 1.6- 2.5) 5.1 ( 3.5- 7.5) ∼
New York 2.7 ( 2.4- 3.0) 2.5 ( 2.1- 2.8) 4.4 ( 3.4- 5.5) 2.7 ( 1.8- 3.9)
Pennsylvania 2.5 ( 2.2- 3.0) 2.3 ( 1.9- 2.7) 5.5 ( 3.8- 7.6) ∼
Midwest 2.4 ( 2.3- 2.6) 2.1 ( 2.0- 2.3) 5.3 ( 4.5- 6.2) 2.3 ( 1.4- 3.8)
East North Central 2.5 ( 2.4- 2.8) 2.2 ( 2.0- 2.4) 5.2 ( 4.4- 6.2) 2.4 ( 1.4- 4.3)
Illinois 3.1 ( 2.7- 3.5) 2.6 ( 2.2- 3.0) 6.4 ( 4.9- 8.3) ∼
Indiana 2.4 ( 1.9- 2.9) 2.2 ( 1.7- 2.8) ∼ ∼
Michigan 2.1 ( 1.7- 2.5) 1.8 ( 1.4- 2.2) 4.3 ( 2.9- 6.2) ∼
Ohio 2.9 ( 2.5- 3.3) 2.6 ( 2.2- 3.1) 4.6 ( 3.1- 6.6) ∼
Wisconsin 1.7 ( 1.2- 2.2) 1.5 ( 1.1- 2.0) ∼ ∼
West North Central 2.1 ( 1.9- 2.4) 2.0 ( 1.7- 2.3) 5.7 ( 3.7- 8.4) ∼
Iowa 2.2 ( 1.6- 3.1) 2.2 ( 1.6- 3.1) ∼ ∼
Kansas 2.4 ( 1.7- 3.4) 2.2 ( 1.5- 3.2) ∼ ∼
Minnesota 1.3 ( 0.9- 1.8) 1.2 ( 0.8- 1.7) ∼ ∼
Missouri 2.6 ( 2.1- 3.3) 2.3 ( 1.8- 3.0) 6.2 ( 3.7- 9.8) ∼
Nebraska 2.7 ( 1.8- 4.1) 2.6 ( 1.7- 4.0) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.9 ( 2.8- 3.1) 2.5 ( 2.4- 2.7) 5.3 ( 4.8- 5.8) 3.3 ( 2.8- 4.0)
South Atlantic 2.7 ( 2.5- 2.9) 2.4 ( 2.2- 2.6) 4.6 ( 4.0- 5.2) 2.1 ( 1.5- 2.9)
Delaware 3.6 ( 2.0- 5.9) ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.9 ( 2.5- 3.3) 2.6 ( 2.2- 3.0) 5.8 ( 4.4- 7.5) 2.3 ( 1.6- 3.2)
Georgia 3.1 ( 2.6- 3.7) 2.5 ( 2.0- 3.2) 4.8 ( 3.5- 6.4) ∼
Maryland 2.5 ( 1.9- 3.1) 1.7 ( 1.2- 2.4) 4.8 ( 3.3- 6.8) ∼
North Carolina 2.5 ( 2.0- 3.0) 2.1 ( 1.7- 2.7) 3.9 ( 2.7- 5.5) ∼
South Carolina 2.9 ( 2.2- 3.7) 2.3 ( 1.7- 3.2) 4.5 ( 2.9- 6.6) ∼
Virginia 2.3 ( 1.8- 2.8) 2.1 ( 1.6- 2.7) 3.4 ( 2.1- 5.1) ∼
West Virginia 3.1 ( 2.1- 4.4) 3.1 ( 2.1- 4.4) ∼ ∼
East South Central 3.1 ( 2.7- 3.4) 2.5 ( 2.2- 2.9) 6.2 ( 5.0- 7.6) ∼
Alabama 3.0 ( 2.4- 3.8) 2.2 ( 1.6- 3.1) 5.9 ( 4.1- 8.3) ∼
Kentucky 2.4 ( 1.8- 3.1) 2.4 ( 1.8- 3.2) ∼ ∼
Mississippi 4.1 ( 3.1- 5.2) 2.8 ( 1.8- 4.1) 7.4 ( 5.1- 10.4) ∼
Tennessee 3.1 ( 2.5- 3.8) 2.7 ( 2.1- 3.4) 6.4 ( 4.2- 9.5) ∼
West South Central 3.2 ( 2.9- 3.5) 2.9 ( 2.6- 3.2) 6.2 ( 5.1- 7.4) 4.3 ( 3.5- 5.3)
Arkansas 4.1 ( 3.1- 5.3) 3.4 ( 2.4- 4.6) 10.2 ( 6.1- 16.1) ∼
continued
C
ancer Incidence and M
ortality by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
77
Table 2.5.1.2: Cervix Uteri. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 3.0 ( 2.3- 3.8) 2.0 ( 1.4- 2.9) 5.6 ( 3.9- 7.8) ∼
Oklahoma 3.0 ( 2.2- 3.9) 2.9 ( 2.1- 4.0) ∼ ∼
Texas 3.2 ( 2.9- 3.6) 3.0 ( 2.6- 3.4) 6.1 ( 4.7- 7.9) 4.4 ( 3.5- 5.4)
West 2.2 ( 2.1- 2.4) 2.1 ( 2.0- 2.3) 3.5 ( 2.6- 4.7) 3.3 ( 2.8- 3.9)
Mountain 2.1 ( 1.8- 2.4) 1.9 ( 1.6- 2.2) ∼ 2.5 ( 1.7- 3.7)
Arizona 2.3 ( 1.8- 2.9) 2.3 ( 1.7- 3.0) ∼ 3.9 ( 2.2- 6.7)
Colorado 1.8 ( 1.3- 2.4) 1.7 ( 1.2- 2.4) ∼ ∼
Idaho 2.7 ( 1.6- 4.3) 2.8 ( 1.7- 4.5) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.7 ( 1.8- 3.9) 2.2 ( 1.3- 3.4) ∼ ∼
New Mexico 2.0 ( 1.2- 3.2) ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 2.3 ( 2.1- 2.5) 2.2 ( 2.0- 2.5) 3.5 ( 2.6- 4.8) 3.5 ( 2.9- 4.3)
Alaska ∼ ∼ ∼ ∼
California 2.4 ( 2.2- 2.6) 2.4 ( 2.1- 2.7) 3.4 ( 2.4- 4.8) 3.6 ( 3.0- 4.3)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.4 ( 1.8- 3.2) 2.4 ( 1.7- 3.3) ∼ ∼
Washington 1.4 ( 1.1- 1.9) 1.4 ( 1.0- 1.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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78 Table 2.6.1.1M: Colon and Rectum. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 61.3 ( 60.9- 61.8) 60.5 ( 60.0- 61.0) 67.9 ( 66.2- 69.7) 49.8 ( 48.2- 51.5)
Northeast 67.9 ( 66.9- 69.0) 67.9 ( 66.8- 69.0) 63.0 ( 59.4- 66.8) 57.6 ( 53.1- 62.5)
New England 68.4 ( 66.4- 70.5) 68.5 ( 66.4- 70.6) 51.2 ( 42.2- 62.4) 45.7 ( 35.1- 59.4)
Connecticut 68.2 ( 64.2- 72.4) 67.6 ( 63.4- 71.9) 63.8 ( 47.9- 85.7) 56.7 ( 37.9- 84.1)
Maine 75.1 ( 68.5- 82.3) 75.3 ( 68.6- 82.5) ∼ ∼
Massachusetts 68.4 ( 65.4- 71.6) 68.9 ( 65.8- 72.1) 44.6 ( 33.2- 60.2) 43.8 ( 29.5- 64.7)
New Hampshire 59.3 ( 52.9- 66.3) 58.9 ( 52.5- 65.9) ∼ -
Rhode Island 73.6 ( 66.1- 81.6) 74.6 ( 66.9- 82.9) ∼ ∼
Vermont 62.2 ( 53.3- 72.4) 62.4 ( 53.5- 72.6) ∼ ∼
Middle Atlantic 67.7 ( 66.5- 68.9) 67.7 ( 66.4- 69.0) 64.3 ( 60.4- 68.4) 59.2 ( 54.3- 64.6)
New Jersey 70.8 ( 68.1- 73.6) 69.8 ( 67.0- 72.8) 77.9 ( 68.5- 88.6) 62.0 ( 52.0- 73.8)
New York 65.0 ( 63.2- 66.7) 65.8 ( 63.9- 67.8) 54.4 ( 49.7- 59.5) 55.4 ( 49.7- 61.7)
Pennsylvania 69.5 ( 67.4- 71.7) 68.7 ( 66.6- 70.9) 76.1 ( 67.6- 85.6) -
Midwest 64.0 ( 63.1- 65.0) 62.6 ( 61.7- 63.6) 74.9 ( 70.9- 79.0) 50.8 ( 44.5- 58.0)
East North Central 64.5 ( 63.4- 65.7) 62.9 ( 61.7- 64.1) 75.3 ( 71.0- 79.8) 50.2 ( 43.4- 58.2)
Illinois 70.0 ( 67.7- 72.4) 68.9 ( 66.5- 71.4) 79.5 ( 71.9- 87.8) 52.8 ( 43.5- 64.2)
Indiana 66.3 ( 63.2- 69.6) 65.4 ( 62.2- 68.8) 77.9 ( 64.1- 94.3) 31.2 ( 17.1- 58.3)
Michigan 60.5 ( 58.1- 62.9) 58.0 ( 55.6- 60.5) 77.6 ( 69.4- 86.7) 50.9 ( 34.8- 75.1)
Detroit 66.1 ( 62.3- 70.2) 62.8 ( 58.6- 67.3) 80.7 ( 70.9- 91.6) -
Ohio 62.8 ( 60.6- 65.1) 61.2 ( 59.0- 63.6) 63.4 ( 55.8- 71.9) 41.3 ( 23.2- 71.4)
Wisconsin 61.5 ( 58.4- 64.7) 60.0 ( 56.9- 63.3) 93.4 ( 69.6- 125.6) -
West North Central 62.9 ( 61.2- 64.7) 62.1 ( 60.4- 63.8) 72.9 ( 63.1- 84.1) 51.6 ( 37.1- 70.7)
Iowa 67.8 ( 63.6- 72.2) 67.4 ( 63.2- 71.8) ∼ ∼
Kansas 57.8 ( 53.5- 62.3) 56.5 ( 52.2- 61.1) 65.4 ( 43.5- 95.6) ∼
Minnesota 59.2 ( 56.0- 62.6) 57.8 ( 54.6- 61.2) 67.4 ( 40.3- 113.7) ∼
Missouri 64.7 ( 61.6- 67.9) 64.3 ( 61.0- 67.6) 72.7 ( 60.6- 87.1) 74.1 ( 40.1- 130.8)
Nebraska 65.9 ( 60.3- 71.8) 64.8 ( 59.2- 70.8) 93.5 ( 52.0- 162.4) ∼
North Dakota 65.0 ( 56.4- 74.5) 64.3 ( 55.7- 73.9) ∼ ∼
South Dakota
South
South Atlantic
Delaware 59.1 ( 51.3- 67.9) 55.5 ( 47.4- 64.8) 82.7 ( 55.8- 120.6) ∼
District of Columbia 61.6 ( 51.7- 73.0) 29.2 ( 18.4- 45.7) 78.7 ( 64.6- 95.2) ∼
Florida 58.7 ( 57.1- 60.3) 58.4 ( 56.8- 60.1) 59.3 ( 53.4- 65.8) -
Georgia 62.6 ( 59.7- 65.7) 61.3 ( 58.0- 64.7) 68.7 ( 61.7- 76.4) 40.6 ( 22.3- 70.3)
Atlanta 55.6 ( 50.4- 61.3) 50.4 ( 44.7- 56.8) 73.6 ( 60.5- 89.3) ∼
Maryland 55.6 ( 52.5- 58.8) 54.6 ( 51.1- 58.3) 60.8 ( 53.2- 69.6) 52.3 ( 30.0- 87.1)
North Carolina 55.1 ( 52.6- 57.7) 52.8 ( 50.1- 55.6) 68.8 ( 61.7- 76.6) 37.6 ( 18.1- 71.5)
South Carolina 64.1 ( 60.3- 68.1) 61.3 ( 57.2- 65.8) 73.3 ( 64.6- 83.0) -
Virginia
West Virginia 68.7 ( 63.4- 74.4) 69.3 ( 63.9- 75.2) ∼ ∼
East South Central
Alabama 60.2 ( 56.7- 63.8) 59.3 ( 55.5- 63.3) 64.8 ( 56.7- 73.9) ∼
Kentucky 68.3 ( 64.4- 72.4) 67.7 ( 63.7- 71.9) 79.5 ( 61.7- 101.8) -
Mississippi
Tennessee
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Table 2.6.1.1M: Colon and Rectum. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 71.0 ( 67.1- 75.1) 70.6 ( 66.1- 75.3) 73.0 ( 64.9- 81.9) 67.6 ( 42.4- 107.2)
Oklahoma 63.4 ( 59.4- 67.6) 63.4 ( 59.2- 67.8) 59.0 ( 42.8- 80.1) ∼
Texas 57.9 ( 56.2- 59.7) 56.3 ( 54.5- 58.1) 77.3 ( 70.4- 84.8) 46.4 ( 42.9- 50.1)
West 53.5 ( 52.6- 54.4) 52.8 ( 51.8- 53.8) 60.8 ( 55.7- 66.4) 44.2 ( 41.7- 46.8)
Mountain 51.2 ( 49.5- 52.8) 51.1 ( 49.4- 52.8) 55.5 ( 43.4- 71.0) 47.3 ( 42.4- 52.7)
Arizona 48.5 ( 45.8- 51.4) 49.3 ( 46.5- 52.3) 46.0 ( 28.0- 75.1) 39.7 ( 31.6- 49.7)
Colorado 49.8 ( 46.3- 53.5) 49.2 ( 45.7- 53.0) 55.6 ( 33.8- 90.6) 53.1 ( 42.2- 66.8)
Idaho 54.1 ( 48.2- 60.6) 54.5 ( 48.5- 61.0) ∼ ∼
Montana 56.4 ( 49.6- 64.0) 53.1 ( 46.4- 60.6) ∼ ∼
Nevada 63.7 ( 58.5- 69.4) 62.6 ( 57.2- 68.5) 66.6 ( 42.6- 106.7) 45.6 ( 30.7- 69.6)
New Mexico 51.1 ( 46.2- 56.3) 52.4 ( 47.3- 57.9) ∼ 54.1 ( 45.3- 64.5)
Utah 43.7 ( 39.1- 48.8) 43.7 ( 39.0- 49.0) ∼ ∼
Wyoming
Pacific 54.5 ( 53.4- 55.6) 53.6 ( 52.4- 54.8) 61.8 ( 56.2- 67.9) 43.1 ( 40.3- 46.1)
Alaska 52.0 ( 41.4- 65.8) 51.4 ( 39.5- 67.2) ∼ ∼
California 54.5 ( 53.2- 55.8) 54.3 ( 52.9- 55.7) 61.9 ( 56.0- 68.3) 43.9 ( 41.0- 47.1)
San Francisco-Oakland 56.5 ( 53.0- 60.2) 55.4 ( 51.3- 59.7) 62.9 ( 50.5- 77.8) 50.7 ( 39.4- 64.7)
San Jose-Monterey 52.2 ( 47.5- 57.3) 51.6 ( 46.4- 57.4) ∼ 45.3 ( 32.9- 61.9)
Los Angeles 55.5 ( 53.0- 58.1) 54.7 ( 51.9- 57.7) 64.9 ( 55.8- 75.3) 39.9 ( 35.5- 44.8)
Hawaii 67.0 ( 60.7- 73.9) 54.6 ( 43.6- 68.0) ∼ -
Oregon 51.8 ( 48.3- 55.4) 50.3 ( 46.8- 54.0) ∼ ∼
Washington 53.6 ( 50.8- 56.6) 52.5 ( 49.6- 55.6) 59.0 ( 40.0- 87.3) 26.3 ( 14.4- 46.6)
Seattle-Puget Sound 53.3 ( 49.8- 56.9) 53.7 ( 50.0- 57.5) 56.4 ( 37.1- 86.4) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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80 Table 2.6.1.1F: Colon and Rectum. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 44.9 ( 44.6- 45.2) 43.9 ( 43.6- 44.3) 51.8 ( 50.6- 53.0) 34.9 ( 33.8- 36.2)
Northeast 49.5 ( 48.8- 50.3) 49.2 ( 48.4- 50.0) 49.1 ( 46.6- 51.6) 39.0 ( 36.0- 42.3)
New England 49.4 ( 48.0- 50.9) 49.3 ( 47.8- 50.8) 46.2 ( 39.0- 54.5) 41.7 ( 32.8- 52.6)
Connecticut 49.8 ( 46.9- 53.0) 49.3 ( 46.3- 52.6) 48.5 ( 37.5- 61.9) 51.5 ( 35.8- 72.3)
Maine 52.2 ( 47.4- 57.4) 51.8 ( 47.0- 57.1) ∼ ∼
Massachusetts 49.3 ( 47.1- 51.5) 49.2 ( 47.0- 51.5) 46.4 ( 36.1- 58.8) 29.4 ( 19.1- 44.0)
New Hampshire 49.4 ( 44.4- 55.0) 49.3 ( 44.2- 54.8) ∼ -
Rhode Island 48.8 ( 43.7- 54.4) 49.7 ( 44.4- 55.6) ∼ ∼
Vermont 42.4 ( 36.0- 49.9) 42.4 ( 36.0- 49.9) ∼ ∼
Middle Atlantic 49.5 ( 48.7- 50.4) 49.1 ( 48.2- 50.1) 49.4 ( 46.8- 52.1) 38.7 ( 35.5- 42.1)
New Jersey 52.0 ( 50.1- 54.0) 51.2 ( 49.1- 53.3) 58.1 ( 51.8- 65.0) 43.1 ( 36.1- 51.0)
New York 48.5 ( 47.3- 49.8) 48.5 ( 47.1- 49.9) 44.6 ( 41.4- 48.0) 35.6 ( 32.0- 39.5)
Pennsylvania 49.3 ( 47.8- 50.8) 48.7 ( 47.1- 50.3) 54.5 ( 48.9- 60.6) -
Midwest 46.6 ( 46.0- 47.3) 45.2 ( 44.5- 45.9) 57.2 ( 54.5- 60.1) 32.2 ( 27.7- 37.3)
East North Central 46.9 ( 46.1- 47.8) 45.2 ( 44.4- 46.1) 57.4 ( 54.4- 60.6) 33.2 ( 28.1- 39.0)
Illinois 49.6 ( 47.9- 51.3) 47.7 ( 46.0- 49.5) 61.4 ( 56.2- 67.0) 30.3 ( 24.1- 37.9)
Indiana 49.1 ( 46.8- 51.5) 48.8 ( 46.4- 51.3) 53.5 ( 44.3- 64.1) ∼
Michigan 45.9 ( 44.2- 47.7) 43.4 ( 41.6- 45.2) 60.5 ( 54.5- 66.9) 23.4 ( 13.4- 38.9)
Detroit 50.9 ( 48.1- 54.0) 47.6 ( 44.5- 51.0) 63.1 ( 56.1- 70.6) -
Ohio 45.5 ( 43.9- 47.1) 43.3 ( 41.7- 45.0) 51.9 ( 46.4- 57.9) 54.0 ( 35.8- 79.1)
Wisconsin 43.6 ( 41.4- 46.0) 43.5 ( 41.2- 45.9) 47.8 ( 34.4- 65.1) -
West North Central 46.0 ( 44.7- 47.3) 45.2 ( 43.9- 46.5) 55.6 ( 48.8- 63.1) 28.7 ( 19.8- 40.7)
Iowa 52.1 ( 48.9- 55.5) 51.4 ( 48.2- 54.8) ∼ ∼
Kansas 43.6 ( 40.4- 47.0) 42.3 ( 39.0- 45.8) 58.0 ( 40.7- 80.5) ∼
Minnesota 45.3 ( 42.8- 47.9) 44.4 ( 41.9- 47.1) 47.5 ( 27.6- 78.8) ∼
Missouri 44.1 ( 41.9- 46.4) 43.1 ( 40.8- 45.5) 56.6 ( 48.3- 66.1) ∼
Nebraska 47.4 ( 43.2- 51.9) 46.9 ( 42.7- 51.5) ∼ ∼
North Dakota 42.5 ( 36.3- 49.6) 42.1 ( 35.9- 49.3) ∼ ∼
South Dakota
South
South Atlantic
Delaware 45.0 ( 39.1- 51.6) 41.0 ( 35.0- 48.0) 62.7 ( 44.3- 86.7) ∼
District of Columbia 44.1 ( 37.3- 52.2) 30.4 ( 20.5- 45.8) 49.0 ( 40.2- 59.7) ∼
Florida 44.0 ( 42.8- 45.2) 43.4 ( 42.1- 44.7) 48.8 ( 44.5- 53.5) -
Georgia 45.3 ( 43.3- 47.5) 42.5 ( 40.2- 44.8) 55.7 ( 50.9- 60.9) 37.8 ( 23.8- 58.6)
Atlanta 46.9 ( 43.0- 51.0) 43.8 ( 39.4- 48.6) 56.2 ( 47.9- 65.7) ∼
Maryland 43.3 ( 40.9- 45.7) 41.7 ( 39.0- 44.5) 49.8 ( 44.4- 55.7) 29.2 ( 16.7- 48.2)
North Carolina 40.2 ( 38.4- 42.1) 38.5 ( 36.6- 40.6) 46.9 ( 42.3- 51.8) ∼
South Carolina 44.0 ( 41.3- 46.7) 40.3 ( 37.3- 43.4) 54.7 ( 48.8- 61.1) -
Virginia
West Virginia 55.0 ( 50.9- 59.5) 54.4 ( 50.2- 58.8) 81.6 ( 53.6- 120.5) ∼
East South Central
Alabama 41.9 ( 39.5- 44.4) 40.8 ( 38.1- 43.7) 47.2 ( 41.7- 53.3) ∼
Kentucky 52.0 ( 49.1- 55.0) 50.7 ( 47.8- 53.8) 70.2 ( 56.7- 86.1) -
Mississippi
Tennessee
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Table 2.6.1.1F: Colon and Rectum. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 49.8 ( 47.0- 52.6) 46.6 ( 43.5- 49.9) 58.4 ( 52.5- 64.8) 40.1 ( 23.7- 64.0)
Oklahoma 43.4 ( 40.6- 46.4) 42.2 ( 39.3- 45.4) 47.0 ( 34.8- 62.3) ∼
Texas 39.7 ( 38.5- 40.9) 37.8 ( 36.5- 39.1) 53.8 ( 49.3- 58.7) 30.1 ( 27.7- 32.7)
West 39.9 ( 39.2- 40.6) 39.5 ( 38.8- 40.3) 45.1 ( 41.5- 49.0) 30.6 ( 28.8- 32.4)
Mountain 38.4 ( 37.1- 39.7) 38.5 ( 37.2- 39.8) 34.0 ( 26.1- 43.8) 31.7 ( 28.2- 35.6)
Arizona 37.2 ( 35.0- 39.4) 37.9 ( 35.6- 40.3) 28.9 ( 16.3- 48.2) 31.3 ( 25.3- 38.4)
Colorado 40.8 ( 38.1- 43.7) 40.9 ( 38.1- 43.8) ∼ 37.9 ( 29.5- 48.3)
Idaho 33.7 ( 29.5- 38.4) 33.5 ( 29.2- 38.2) ∼ ∼
Montana 42.0 ( 36.7- 48.0) 40.6 ( 35.3- 46.7) ∼ ∼
Nevada 43.2 ( 39.3- 47.5) 42.7 ( 38.5- 47.1) 53.5 ( 34.7- 80.3) 24.8 ( 14.4- 40.9)
New Mexico 32.2 ( 28.7- 36.0) 32.4 ( 28.7- 36.4) ∼ 28.8 ( 23.1- 35.6)
Utah 40.2 ( 36.2- 44.6) 40.7 ( 36.6- 45.2) ∼ 49.0 ( 29.4- 80.2)
Wyoming
Pacific 40.4 ( 39.6- 41.2) 39.9 ( 39.0- 40.8) 46.9 ( 42.9- 51.1) 30.2 ( 28.2- 32.4)
Alaska 48.5 ( 38.8- 60.1) 37.5 ( 27.9- 49.6) ∼ ∼
California 39.8 ( 38.8- 40.7) 39.6 ( 38.5- 40.6) 47.3 ( 43.1- 51.8) 30.3 ( 28.2- 32.4)
San Francisco-Oakland 40.4 ( 37.9- 43.1) 40.2 ( 37.1- 43.4) 38.6 ( 30.7- 48.1) 35.7 ( 28.0- 44.9)
San Jose-Monterey 36.9 ( 33.5- 40.7) 37.5 ( 33.6- 41.8) ∼ 29.7 ( 21.7- 40.1)
Los Angeles 41.4 ( 39.6- 43.3) 39.2 ( 37.2- 41.4) 55.5 ( 49.0- 62.6) 28.7 ( 25.6- 32.1)
Hawaii 43.2 ( 38.5- 48.3) 42.2 ( 32.9- 54.1) ∼ -
Oregon 42.6 ( 39.8- 45.6) 41.6 ( 38.8- 44.6) ∼ 43.3 ( 24.2- 73.1)
Washington 41.7 ( 39.5- 44.0) 40.5 ( 38.3- 42.9) 51.0 ( 34.3- 73.5) 28.9 ( 17.4- 46.5)
Seattle-Puget Sound 43.0 ( 40.2- 45.8) 42.9 ( 40.1- 46.0) 52.4 ( 34.6- 76.7) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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82 Table 2.6.1.2M: Colon and Rectum. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 23.8 ( 23.5- 24.1) 23.2 ( 22.9- 23.5) 33.4 ( 32.2- 34.6) 17.1 ( 16.1- 18.2)
Northeast 25.5 ( 24.9- 26.2) 25.5 ( 24.8- 26.2) 28.9 ( 26.4- 31.7) 17.7 ( 15.1- 20.7)
New England 24.8 ( 23.6- 26.1) 24.9 ( 23.6- 26.2) 25.8 ( 19.0- 35.1) 11.7 ( 6.1- 20.9)
Connecticut 23.3 ( 21.0- 25.8) 23.4 ( 21.0- 26.1) 25.0 ( 14.9- 41.8) ∼
Maine 27.6 ( 23.6- 32.2) 27.5 ( 23.5- 32.1) ∼ ∼
Massachusetts 25.2 ( 23.3- 27.1) 25.2 ( 23.3- 27.2) 28.4 ( 18.4- 42.9) ∼
New Hampshire 22.2 ( 18.3- 26.8) 22.2 ( 18.2- 26.8) ∼ ∼
Rhode Island 25.8 ( 21.5- 30.8) 26.2 ( 21.8- 31.4) ∼ ∼
Vermont 26.3 ( 20.5- 33.4) 26.3 ( 20.4- 33.4) ∼ ∼
Middle Atlantic 25.8 ( 25.0- 26.5) 25.8 ( 25.0- 26.6) 29.3 ( 26.6- 32.2) 18.5 ( 15.7- 21.7)
New Jersey 26.4 ( 24.8- 28.2) 26.4 ( 24.6- 28.2) 28.5 ( 23.1- 35.3) 16.9 ( 11.8- 23.9)
New York 24.9 ( 23.8- 26.1) 25.2 ( 24.0- 26.5) 27.1 ( 23.6- 31.0) 19.3 ( 15.8- 23.4)
Pennsylvania 26.4 ( 25.1- 27.7) 26.0 ( 24.7- 27.4) 34.6 ( 28.9- 41.4) ∼
Midwest 24.7 ( 24.1- 25.3) 24.1 ( 23.5- 24.7) 34.9 ( 32.1- 37.8) 14.5 ( 11.1- 18.9)
East North Central 25.2 ( 24.5- 25.9) 24.4 ( 23.7- 25.2) 34.9 ( 31.9- 38.1) 14.8 ( 11.0- 19.9)
Illinois 26.7 ( 25.2- 28.2) 25.9 ( 24.4- 27.5) 35.0 ( 30.0- 40.8) 13.7 ( 8.9- 20.8)
Indiana 26.0 ( 24.0- 28.1) 25.5 ( 23.5- 27.7) 36.5 ( 27.2- 48.5) ∼
Michigan 23.7 ( 22.2- 25.2) 22.5 ( 21.0- 24.1) 35.8 ( 30.1- 42.4) ∼
Ohio 25.9 ( 24.5- 27.4) 25.1 ( 23.6- 26.6) 34.5 ( 28.9- 41.0) ∼
Wisconsin 22.4 ( 20.5- 24.4) 22.2 ( 20.3- 24.3) 25.1 ( 12.8- 47.2) ∼
West North Central 23.8 ( 22.7- 24.8) 23.4 ( 22.3- 24.5) 34.9 ( 28.1- 43.2) ∼
Iowa 23.6 ( 21.1- 26.2) 23.6 ( 21.1- 26.3) ∼ ∼
Kansas 23.4 ( 20.7- 26.4) 22.8 ( 20.0- 25.8) 39.0 ( 22.2- 64.6) ∼
Minnesota 21.4 ( 19.5- 23.5) 21.3 ( 19.3- 23.5) ∼ ∼
Missouri 26.2 ( 24.2- 28.4) 25.6 ( 23.5- 27.8) 35.1 ( 26.6- 45.9) ∼
Nebraska 25.1 ( 21.7- 28.9) 24.6 ( 21.2- 28.5) ∼ ∼
North Dakota 20.9 ( 16.1- 26.7) 20.6 ( 15.9- 26.5) ∼ ∼
South Dakota 21.7 ( 17.1- 27.0) 21.5 ( 17.0- 27.1) ∼ ∼
South 24.2 ( 23.7- 24.7) 22.9 ( 22.4- 23.4) 35.1 ( 33.5- 36.8) 17.8 ( 16.2- 19.6)
South Atlantic 23.4 ( 22.7- 24.0) 22.2 ( 21.6- 22.9) 32.6 ( 30.5- 34.8) 18.5 ( 16.1- 21.3)
Delaware 27.1 ( 21.7- 33.5) 25.8 ( 20.2- 32.6) 45.1 ( 25.0- 77.1) ∼
District of Columbia 29.5 ( 22.6- 38.0) ∼ 35.0 ( 25.8- 46.8) ∼
Florida 21.5 ( 20.6- 22.5) 21.2 ( 20.2- 22.2) 28.2 ( 23.9- 33.1) 20.6 ( 17.9- 23.8)
Georgia 24.4 ( 22.5- 26.5) 23.0 ( 21.0- 25.3) 30.8 ( 25.9- 36.4) ∼
Maryland 24.9 ( 22.8- 27.2) 23.5 ( 21.2- 26.0) 34.6 ( 28.5- 42.0) ∼
North Carolina 23.6 ( 21.9- 25.4) 21.7 ( 20.0- 23.6) 34.9 ( 29.6- 40.9) ∼
South Carolina 25.4 ( 23.0- 28.0) 22.7 ( 20.1- 25.6) 36.2 ( 30.1- 43.4) ∼
Virginia 23.8 ( 22.0- 25.7) 22.4 ( 20.5- 24.5) 33.5 ( 28.0- 40.0) ∼
West Virginia 28.1 ( 24.7- 31.9) 28.2 ( 24.7- 32.1) ∼ ∼
East South Central 26.4 ( 25.2- 27.7) 25.1 ( 23.8- 26.4) 35.7 ( 31.9- 39.8) ∼
Alabama 24.0 ( 21.8- 26.5) 22.0 ( 19.6- 24.6) 33.9 ( 28.0- 40.8) ∼
Kentucky 30.0 ( 27.4- 32.9) 29.5 ( 26.8- 32.5) 37.4 ( 25.0- 54.7) ∼
Mississippi 27.4 ( 24.3- 30.7) 25.4 ( 22.0- 29.2) 34.0 ( 27.4- 41.8) ∼
Tennessee 25.3 ( 23.2- 27.5) 23.8 ( 21.7- 26.1) 40.0 ( 32.3- 49.2) ∼
West South Central 24.5 ( 23.6- 25.5) 22.9 ( 21.9- 23.8) 41.5 ( 37.8- 45.4) 17.5 ( 15.4- 20.0)
Arkansas 25.6 ( 22.8- 28.7) 24.0 ( 21.1- 27.2) 41.3 ( 30.5- 55.1) ∼
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Table 2.6.1.2M: Colon and Rectum. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 30.5 ( 27.9- 33.3) 26.7 ( 23.9- 29.8) 43.6 ( 37.3- 50.9) ∼
Oklahoma 25.1 ( 22.6- 27.8) 24.6 ( 22.0- 27.5) 41.0 ( 26.8- 60.7) ∼
Texas 22.8 ( 21.7- 23.9) 21.6 ( 20.4- 22.7) 40.1 ( 35.0- 45.7) 17.8 ( 15.6- 20.4)
West 20.4 ( 19.9- 21.0) 20.4 ( 19.8- 21.0) 28.9 ( 25.3- 33.0) 16.6 ( 15.0- 18.3)
Mountain 21.3 ( 20.2- 22.4) 21.4 ( 20.3- 22.5) 25.0 ( 16.4- 37.5) 23.9 ( 20.2- 28.2)
Arizona 20.6 ( 18.8- 22.5) 20.8 ( 19.0- 22.8) ∼ 22.2 ( 15.9- 30.7)
Colorado 22.1 ( 19.7- 24.6) 22.1 ( 19.7- 24.8) ∼ 30.5 ( 21.8- 42.4)
Idaho 18.2 ( 14.8- 22.3) 18.4 ( 14.9- 22.5) ∼ ∼
Montana 22.9 ( 18.6- 28.0) 21.9 ( 17.6- 27.0) ∼ ∼
Nevada 26.2 ( 22.7- 30.2) 26.9 ( 23.2- 31.2) ∼ ∼
New Mexico 22.7 ( 19.4- 26.4) 22.8 ( 19.4- 26.7) ∼ 25.1 ( 18.8- 33.1)
Utah 18.2 ( 15.1- 21.7) 18.4 ( 15.3- 22.1) ∼ ∼
Wyoming 16.6 ( 11.5- 23.5) 16.9 ( 11.7- 24.0) ∼ ∼
Pacific 20.1 ( 19.5- 20.8) 20.0 ( 19.3- 20.7) 29.8 ( 25.8- 34.2) 13.9 ( 12.3- 15.8)
Alaska 19.0 ( 12.5- 28.9) 13.0 ( 7.2- 23.3) ∼ ∼
California 19.9 ( 19.1- 20.7) 19.8 ( 18.9- 20.6) 29.9 ( 25.8- 34.6) 14.3 ( 12.6- 16.2)
Hawaii 22.1 ( 18.5- 26.3) 26.2 ( 18.5- 36.5) ∼ ∼
Oregon 22.4 ( 20.1- 24.9) 22.3 ( 20.0- 24.8) ∼ ∼
Washington 19.3 ( 17.6- 21.2) 19.4 ( 17.6- 21.3) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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84 Table 2.6.1.2F: Colon and Rectum. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 16.5 ( 16.3- 16.7) 16.0 ( 15.8- 16.2) 22.8 ( 22.1- 23.6) 11.2 ( 10.5- 11.9)
Northeast 17.6 ( 17.1- 18.0) 17.5 ( 17.1- 18.0) 20.0 ( 18.5- 21.7) 11.0 ( 9.4- 12.8)
New England 17.6 ( 16.8- 18.5) 17.7 ( 16.8- 18.6) 20.2 ( 15.3- 26.1) 12.6 ( 7.8- 19.4)
Connecticut 16.4 ( 14.8- 18.2) 16.5 ( 14.8- 18.4) 15.5 ( 9.5- 24.2) ∼
Maine 17.0 ( 14.4- 20.0) 17.1 ( 14.5- 20.1) ∼ ∼
Massachusetts 18.6 ( 17.4- 20.0) 18.8 ( 17.5- 20.2) 23.8 ( 16.4- 33.4) ∼
New Hampshire 14.9 ( 12.2- 18.1) 15.1 ( 12.3- 18.3) ∼ ∼
Rhode Island 18.5 ( 15.5- 22.0) 18.2 ( 15.1- 21.8) ∼ ∼
Vermont 18.7 ( 14.6- 23.8) 18.8 ( 14.7- 24.0) ∼ ∼
Middle Atlantic 17.5 ( 17.0- 18.1) 17.5 ( 16.9- 18.0) 20.1 ( 18.4- 21.8) 10.8 ( 9.1- 12.7)
New Jersey 17.9 ( 16.8- 19.1) 17.8 ( 16.6- 19.1) 22.9 ( 19.0- 27.5) 10.2 ( 7.0- 14.6)
New York 17.2 ( 16.5- 18.0) 17.4 ( 16.6- 18.2) 18.6 ( 16.5- 20.8) 11.3 ( 9.3- 13.7)
Pennsylvania 17.7 ( 16.9- 18.7) 17.4 ( 16.5- 18.4) 21.9 ( 18.4- 25.9) ∼
Midwest 17.2 ( 16.8- 17.6) 16.7 ( 16.3- 17.2) 24.0 ( 22.2- 25.9) 9.7 ( 7.2- 12.9)
East North Central 17.2 ( 16.7- 17.7) 16.6 ( 16.1- 17.1) 24.5 ( 22.5- 26.6) 9.7 ( 6.9- 13.3)
Illinois 18.5 ( 17.5- 19.5) 17.5 ( 16.5- 18.5) 27.4 ( 23.9- 31.3) 8.7 ( 5.4- 13.5)
Indiana 17.9 ( 16.5- 19.3) 17.5 ( 16.1- 19.0) 24.9 ( 18.7- 32.5) ∼
Michigan 15.9 ( 14.9- 16.9) 15.1 ( 14.0- 16.2) 22.4 ( 18.9- 26.5) ∼
Ohio 17.5 ( 16.5- 18.5) 17.0 ( 16.1- 18.1) 23.6 ( 19.9- 27.8) ∼
Wisconsin 15.5 ( 14.2- 17.0) 15.5 ( 14.2- 16.9) ∼ ∼
West North Central 17.3 ( 16.5- 18.0) 17.0 ( 16.3- 17.8) 20.9 ( 16.8- 25.8) ∼
Iowa 17.1 ( 15.4- 19.1) 17.0 ( 15.3- 19.0) ∼ ∼
Kansas 17.5 ( 15.5- 19.6) 17.0 ( 15.0- 19.1) 28.5 ( 16.8- 45.5) ∼
Minnesota 16.0 ( 14.6- 17.5) 15.8 ( 14.3- 17.3) ∼ ∼
Missouri 17.4 ( 16.0- 18.8) 17.3 ( 15.9- 18.8) 18.6 ( 13.9- 24.4) ∼
Nebraska 19.7 ( 17.1- 22.6) 19.5 ( 16.9- 22.4) ∼ ∼
North Dakota 19.7 ( 15.6- 24.8) 19.1 ( 15.0- 24.2) ∼ ∼
South Dakota 16.5 ( 13.1- 20.6) 16.5 ( 13.0- 20.7) ∼ ∼
South 16.4 ( 16.1- 16.7) 15.3 ( 15.0- 15.7) 23.6 ( 22.6- 24.7) 12.2 ( 11.1- 13.5)
South Atlantic 16.2 ( 15.8- 16.7) 15.2 ( 14.7- 15.7) 22.5 ( 21.1- 23.8) 14.3 ( 12.5- 16.2)
Delaware 16.3 ( 12.8- 20.5) 15.0 ( 11.5- 19.5) ∼ ∼
District of Columbia 21.5 ( 16.9- 27.4) ∼ 26.1 ( 19.9- 34.4) ∼
Florida 15.1 ( 14.4- 15.8) 14.5 ( 13.8- 15.3) 22.3 ( 19.4- 25.6) 15.1 ( 13.1- 17.3)
Georgia 16.1 ( 14.9- 17.4) 13.9 ( 12.6- 15.2) 23.8 ( 20.6- 27.3) ∼
Maryland 17.4 ( 16.0- 19.0) 16.6 ( 15.0- 18.4) 22.0 ( 18.4- 26.1) ∼
North Carolina 16.7 ( 15.5- 17.9) 15.9 ( 14.6- 17.2) 21.3 ( 18.2- 24.7) ∼
South Carolina 16.0 ( 14.4- 17.7) 14.9 ( 13.1- 16.8) 20.0 ( 16.5- 24.1) ∼
Virginia 17.1 ( 15.8- 18.4) 15.9 ( 14.5- 17.4) 23.9 ( 20.3- 28.0) ∼
West Virginia 18.8 ( 16.4- 21.4) 18.6 ( 16.3- 21.3) ∼ ∼
East South Central 17.1 ( 16.3- 17.9) 15.9 ( 15.1- 16.8) 24.0 ( 21.6- 26.6) ∼
Alabama 14.9 ( 13.5- 16.4) 13.2 ( 11.7- 14.9) 21.7 ( 18.0- 25.9) ∼
Kentucky 20.4 ( 18.7- 22.4) 19.7 ( 17.9- 21.6) 35.4 ( 26.0- 47.2) ∼
Mississippi 18.6 ( 16.5- 20.8) 15.8 ( 13.6- 18.3) 25.6 ( 21.1- 30.8) ∼
Tennessee 15.9 ( 14.6- 17.3) 15.1 ( 13.7- 16.5) 21.8 ( 17.5- 26.9) ∼
West South Central 16.4 ( 15.7- 17.0) 15.2 ( 14.5- 15.8) 26.4 ( 24.1- 28.8) 10.6 ( 9.1- 12.2)
Arkansas 17.3 ( 15.4- 19.5) 16.3 ( 14.3- 18.6) 24.3 ( 17.8- 32.4) ∼
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Table 2.6.1.2F: Colon and Rectum. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 18.1 ( 16.5- 19.9) 15.9 ( 14.1- 17.8) 25.5 ( 21.6- 29.8) ∼
Oklahoma 16.2 ( 14.6- 18.1) 15.2 ( 13.5- 17.1) 28.3 ( 19.0- 40.7) ∼
Texas 15.8 ( 15.1- 16.6) 14.8 ( 14.1- 15.7) 27.2 ( 24.0- 30.8) 10.8 ( 9.3- 12.5)
West 14.6 ( 14.2- 15.1) 14.6 ( 14.2- 15.1) 21.7 ( 19.2- 24.5) 10.5 ( 9.5- 11.7)
Mountain 14.5 ( 13.8- 15.3) 14.5 ( 13.7- 15.3) 23.3 ( 16.8- 31.7) 13.3 ( 11.1- 16.0)
Arizona 13.5 ( 12.2- 14.9) 13.6 ( 12.3- 15.1) ∼ 10.8 ( 7.5- 15.3)
Colorado 15.3 ( 13.6- 17.0) 15.0 ( 13.3- 16.8) ∼ 14.8 ( 9.7- 21.9)
Idaho 12.9 ( 10.4- 15.9) 12.8 ( 10.3- 15.9) ∼ ∼
Montana 14.3 ( 11.3- 17.9) 14.2 ( 11.2- 17.9) ∼ ∼
Nevada 17.4 ( 14.9- 20.2) 17.2 ( 14.6- 20.2) ∼ ∼
New Mexico 14.1 ( 11.8- 16.6) 14.2 ( 11.9- 17.0) ∼ 17.7 ( 13.2- 23.3)
Utah 13.7 ( 11.4- 16.3) 13.4 ( 11.1- 16.1) ∼ ∼
Wyoming 20.9 ( 15.8- 27.3) 21.3 ( 16.1- 27.8) ∼ ∼
Pacific 14.7 ( 14.2- 15.2) 14.7 ( 14.2- 15.2) 21.4 ( 18.7- 24.4) 9.6 ( 8.4- 10.8)
Alaska 16.2 ( 10.7- 23.7) 12.3 ( 6.9- 20.4) ∼ ∼
California 14.7 ( 14.2- 15.3) 14.7 ( 14.1- 15.4) 21.7 ( 18.9- 24.9) 9.6 ( 8.4- 10.9)
Hawaii 13.4 ( 10.9- 16.4) 15.6 ( 10.3- 23.5) ∼ ∼
Oregon 14.4 ( 12.8- 16.1) 14.4 ( 12.8- 16.2) ∼ ∼
Washington 14.8 ( 13.5- 16.2) 14.8 ( 13.5- 16.3) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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86 Table 2.7.1.1: Corpus and Uterus, NOS. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 23.6 ( 23.3- 23.8) 24.1 ( 23.8- 24.3) 19.8 ( 19.1- 20.6) 17.9 ( 17.1- 18.7)
Northeast 28.4 ( 27.8- 29.0) 29.5 ( 28.8- 30.1) 20.3 ( 18.8- 22.0) 19.4 ( 17.4- 21.6)
New England 29.4 ( 28.2- 30.6) 29.8 ( 28.6- 31.1) 19.2 ( 14.7- 24.6) 25.8 ( 19.8- 33.6)
Connecticut 28.8 ( 26.5- 31.3) 29.1 ( 26.7- 31.7) 22.3 ( 15.3- 31.9) 31.1 ( 21.0- 45.8)
Maine 30.5 ( 26.8- 34.8) 30.5 ( 26.7- 34.7) ∼ ∼
Massachusetts 30.3 ( 28.6- 32.2) 31.2 ( 29.4- 33.2) 16.1 ( 10.4- 23.9) 22.4 ( 14.6- 34.0)
New Hampshire 27.2 ( 23.4- 31.4) 27.2 ( 23.4- 31.5) ∼ -
Rhode Island 26.9 ( 23.0- 31.4) 27.0 ( 23.0- 31.7) ∼ ∼
Vermont 29.2 ( 23.9- 35.7) 29.0 ( 23.7- 35.5) ∼ ∼
Middle Atlantic 28.0 ( 27.4- 28.7) 29.3 ( 28.6- 30.1) 20.5 ( 18.9- 22.2) 18.4 ( 16.3- 20.7)
New Jersey 27.9 ( 26.5- 29.4) 29.4 ( 27.8- 31.1) 22.6 ( 18.8- 27.0) 19.2 ( 15.0- 24.4)
New York 27.2 ( 26.2- 28.2) 28.5 ( 27.4- 29.6) 20.5 ( 18.4- 22.8) 18.0 ( 15.6- 20.7)
Pennsylvania 29.5 ( 28.3- 30.8) 30.5 ( 29.2- 31.8) 18.6 ( 15.4- 22.3) -
Midwest 26.2 ( 25.6- 26.7) 26.5 ( 25.9- 27.0) 20.8 ( 19.2- 22.6) 19.9 ( 16.8- 23.6)
East North Central 26.4 ( 25.7- 27.0) 26.7 ( 26.1- 27.4) 21.1 ( 19.3- 23.0) 20.2 ( 16.7- 24.4)
Illinois 25.6 ( 24.4- 26.9) 26.5 ( 25.2- 27.9) 20.6 ( 17.7- 23.9) 20.8 ( 16.2- 26.7)
Indiana 27.1 ( 25.4- 28.9) 27.7 ( 25.8- 29.6) 20.8 ( 15.3- 27.7) ∼
Michigan 27.7 ( 26.3- 29.1) 27.2 ( 25.8- 28.8) 26.7 ( 22.9- 31.1) ∼
Detroit 27.3 ( 25.2- 29.6) 27.8 ( 25.4- 30.5) 25.9 ( 21.6- 30.9) -
Ohio 25.2 ( 24.0- 26.5) 25.4 ( 24.1- 26.8) 17.6 ( 14.5- 21.2) 23.4 ( 13.4- 39.7)
Wisconsin 27.4 ( 25.5- 29.3) 28.1 ( 26.2- 30.2) ∼ -
West North Central 25.7 ( 24.7- 26.7) 25.8 ( 24.8- 26.8) 19.5 ( 15.6- 24.1) 18.7 ( 12.2- 28.2)
Iowa 26.5 ( 24.1- 29.1) 26.6 ( 24.1- 29.2) ∼ ∼
Kansas 23.9 ( 21.4- 26.6) 23.9 ( 21.3- 26.7) ∼ ∼
Minnesota 28.5 ( 26.5- 30.6) 28.4 ( 26.3- 30.5) ∼ ∼
Missouri 23.7 ( 22.0- 25.4) 24.0 ( 22.3- 25.9) 20.6 ( 15.7- 26.6) ∼
Nebraska 26.4 ( 23.2- 30.0) 26.2 ( 23.0- 29.9) ∼ ∼
North Dakota 24.9 ( 19.9- 30.9) 25.1 ( 20.0- 31.2) ∼ ∼
South Dakota
South
South Atlantic
Delaware 30.6 ( 25.8- 36.2) 31.4 ( 26.0- 37.8) 28.2 ( 16.6- 45.4) ∼
District of Columbia 26.0 ( 20.7- 32.5) 19.8 ( 11.8- 33.6) 26.6 ( 20.1- 35.1) ∼
Florida 21.2 ( 20.4- 22.2) 21.4 ( 20.5- 22.4) 22.5 ( 19.6- 25.7) -
Georgia 19.2 ( 17.9- 20.6) 19.5 ( 18.0- 21.1) 18.5 ( 15.8- 21.6) 18.4 ( 9.6- 34.2)
Atlanta 19.2 ( 16.8- 21.8) 19.6 ( 16.8- 22.9) 18.5 ( 14.1- 24.0) ∼
Maryland 21.6 ( 19.9- 23.3) 22.0 ( 20.1- 24.1) 20.3 ( 17.0- 24.1) 40.4 ( 25.8- 61.2)
North Carolina 20.8 ( 19.5- 22.2) 21.1 ( 19.7- 22.7) 19.6 ( 16.7- 22.9) ∼
South Carolina 18.8 ( 17.1- 20.7) 17.7 ( 15.8- 19.9) 21.4 ( 17.7- 25.6) -
Virginia
West Virginia 27.3 ( 24.4- 30.6) 28.1 ( 25.0- 31.5) ∼ ∼
East South Central
Alabama 14.6 ( 13.2- 16.2) 14.4 ( 12.8- 16.2) 15.5 ( 12.4- 19.2) ∼
Kentucky 22.1 ( 20.2- 24.1) 22.0 ( 20.1- 24.1) 19.5 ( 12.8- 28.6) -
Mississippi
Tennessee
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Table 2.7.1.1: Corpus and Uterus, NOS. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 17.6 ( 16.0- 19.4) 18.8 ( 16.8- 21.0) 15.7 ( 12.7- 19.1) 32.6 ( 18.6- 53.8)
Oklahoma 17.5 ( 15.7- 19.5) 17.7 ( 15.8- 19.9) ∼ ∼
Texas 18.1 ( 17.3- 18.9) 18.4 ( 17.5- 19.3) 17.2 ( 14.6- 20.0) 15.6 ( 14.0- 17.4)
West 21.3 ( 20.8- 21.8) 21.5 ( 21.0- 22.1) 19.6 ( 17.3- 22.2) 16.0 ( 14.8- 17.3)
Mountain 19.9 ( 19.0- 20.9) 20.0 ( 19.1- 21.0) 16.4 ( 11.0- 23.7) 13.6 ( 11.5- 16.0)
Arizona 19.3 ( 17.7- 21.0) 19.3 ( 17.7- 21.1) ∼ 11.8 ( 8.7- 16.1)
Colorado 19.5 ( 17.7- 21.5) 19.5 ( 17.6- 21.6) ∼ 12.8 ( 8.4- 19.1)
Idaho 21.7 ( 18.3- 25.6) 22.1 ( 18.6- 26.1) ∼ ∼
Montana 22.4 ( 18.6- 27.0) 21.5 ( 17.6- 26.1) ∼ ∼
Nevada 19.8 ( 17.3- 22.7) 20.7 ( 17.9- 23.9) ∼ ∼
New Mexico 19.5 ( 16.8- 22.5) 19.3 ( 16.5- 22.5) ∼ 13.7 ( 10.0- 18.5)
Utah 21.4 ( 18.5- 24.7) 21.6 ( 18.6- 24.9) ∼ ∼
Wyoming
Pacific 21.8 ( 21.2- 22.4) 22.2 ( 21.5- 22.9) 20.3 ( 17.7- 23.1) 16.8 ( 15.4- 18.3)
Alaska 17.2 ( 12.1- 24.2) 16.6 ( 10.9- 24.8) ∼ ∼
California 21.4 ( 20.7- 22.1) 22.2 ( 21.4- 23.0) 19.7 ( 17.1- 22.6) 16.9 ( 15.5- 18.4)
San Francisco-Oakland 23.8 ( 21.8- 25.9) 24.1 ( 21.7- 26.7) 26.0 ( 19.6- 34.0) 16.8 ( 11.9- 23.2)
San Jose-Monterey 20.4 ( 17.8- 23.2) 22.8 ( 19.8- 26.2) ∼ 16.3 ( 11.0- 23.8)
Los Angeles 21.8 ( 20.5- 23.2) 23.1 ( 21.5- 24.8) 19.9 ( 16.1- 24.3) 16.7 ( 14.5- 19.2)
Hawaii 25.9 ( 22.2- 30.1) 27.8 ( 20.3- 37.8) ∼ -
Oregon 23.0 ( 20.9- 25.3) 22.5 ( 20.4- 24.8) ∼ ∼
Washington 22.9 ( 21.2- 24.6) 22.0 ( 20.4- 23.9) 26.0 ( 14.9- 42.7) 18.6 ( 9.8- 33.6)
Seattle-Puget Sound 23.4 ( 21.4- 25.5) 23.8 ( 21.6- 26.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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88 Table 2.7.1.2: Corpus and Uterus, NOS. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 4.2 ( 4.1- 4.3) 3.9 ( 3.8- 4.0) 7.3 ( 6.9- 7.8) 3.4 ( 3.0- 3.8)
Northeast 4.8 ( 4.5- 5.0) 4.5 ( 4.3- 4.8) 7.4 ( 6.5- 8.5) 3.2 ( 2.3- 4.2)
New England 4.3 ( 3.9- 4.8) 4.2 ( 3.8- 4.7) 6.6 ( 4.0- 10.4) ∼
Connecticut 3.8 ( 3.0- 4.7) 3.5 ( 2.8- 4.5) ∼ ∼
Maine 4.3 ( 3.0- 6.1) 4.4 ( 3.0- 6.2) ∼ ∼
Massachusetts 4.6 ( 3.9- 5.3) 4.5 ( 3.8- 5.2) ∼ ∼
New Hampshire 4.1 ( 2.7- 6.0) 4.2 ( 2.8- 6.1) ∼ ∼
Rhode Island 3.0 ( 1.8- 4.7) 3.1 ( 1.9- 4.9) ∼ ∼
Vermont 7.4 ( 4.9- 11.1) 7.4 ( 4.9- 11.2) ∼ ∼
Middle Atlantic 4.9 ( 4.6- 5.2) 4.7 ( 4.4- 5.0) 7.5 ( 6.5- 8.6) 3.5 ( 2.6- 4.7)
New Jersey 5.3 ( 4.7- 5.9) 5.0 ( 4.3- 5.7) 9.1 ( 6.6- 12.1) ∼
New York 4.8 ( 4.4- 5.2) 4.5 ( 4.1- 5.0) 7.1 ( 5.9- 8.6) 3.6 ( 2.5- 5.0)
Pennsylvania 4.8 ( 4.3- 5.3) 4.6 ( 4.2- 5.2) 7.1 ( 5.2- 9.5) ∼
Midwest 4.5 ( 4.3- 4.7) 4.2 ( 4.0- 4.5) 7.6 ( 6.6- 8.7) 2.8 ( 1.7- 4.6)
East North Central 4.7 ( 4.4- 4.9) 4.4 ( 4.1- 4.7) 7.3 ( 6.3- 8.5) 3.2 ( 1.8- 5.4)
Illinois 4.6 ( 4.1- 5.1) 4.2 ( 3.7- 4.7) 7.2 ( 5.5- 9.3) ∼
Indiana 5.1 ( 4.4- 5.9) 4.8 ( 4.1- 5.7) 10.0 ( 6.2- 15.1) ∼
Michigan 4.8 ( 4.2- 5.4) 4.5 ( 3.9- 5.1) 7.0 ( 5.1- 9.4) ∼
Ohio 4.4 ( 3.9- 4.9) 4.2 ( 3.7- 4.7) 7.1 ( 5.2- 9.6) ∼
Wisconsin 4.7 ( 4.0- 5.5) 4.7 ( 4.0- 5.6) ∼ ∼
West North Central 4.1 ( 3.7- 4.5) 3.9 ( 3.6- 4.3) 9.3 ( 6.6- 12.9) ∼
Iowa 4.4 ( 3.5- 5.5) 4.3 ( 3.4- 5.4) ∼ ∼
Kansas 3.6 ( 2.7- 4.7) 3.3 ( 2.5- 4.4) ∼ ∼
Minnesota 3.9 ( 3.2- 4.7) 3.8 ( 3.1- 4.7) ∼ ∼
Missouri 4.2 ( 3.5- 4.9) 3.8 ( 3.1- 4.5) 9.1 ( 5.9- 13.4) ∼
Nebraska 4.2 ( 3.0- 5.8) 4.3 ( 3.1- 6.0) ∼ ∼
North Dakota 5.8 ( 3.6- 9.0) 5.6 ( 3.5- 8.9) ∼ ∼
South Dakota 3.6 ( 2.1- 5.9) 3.4 ( 1.9- 5.7) ∼ ∼
South 3.8 ( 3.6- 3.9) 3.2 ( 3.1- 3.4) 7.2 ( 6.7- 7.8) 3.8 ( 3.2- 4.4)
South Atlantic 3.8 ( 3.6- 4.0) 3.3 ( 3.1- 3.5) 7.0 ( 6.2- 7.8) 4.0 ( 3.1- 5.1)
Delaware 3.6 ( 2.1- 5.9) ∼ ∼ ∼
District of Columbia 9.4 ( 6.4- 13.6) ∼ 10.9 ( 7.1- 16.8) ∼
Florida 3.7 ( 3.4- 4.1) 3.3 ( 3.0- 3.7) 8.6 ( 6.8- 10.7) 4.1 ( 3.1- 5.3)
Georgia 3.5 ( 2.9- 4.1) 2.5 ( 2.0- 3.2) 7.1 ( 5.3- 9.1) ∼
Maryland 4.5 ( 3.8- 5.3) 4.2 ( 3.4- 5.1) 6.3 ( 4.5- 8.6) ∼
North Carolina 3.8 ( 3.3- 4.4) 3.2 ( 2.6- 3.8) 6.9 ( 5.2- 9.0) ∼
South Carolina 3.7 ( 3.0- 4.6) 2.8 ( 2.1- 3.7) 6.7 ( 4.7- 9.3) ∼
Virginia 3.6 ( 3.0- 4.2) 3.4 ( 2.8- 4.1) 4.5 ( 3.0- 6.6) ∼
West Virginia 3.8 ( 2.8- 5.2) 3.9 ( 2.9- 5.3) ∼ ∼
East South Central 3.6 ( 3.2- 4.0) 2.9 ( 2.5- 3.3) 7.5 ( 6.2- 9.0) ∼
Alabama 3.7 ( 3.0- 4.5) 2.5 ( 1.9- 3.3) 8.2 ( 6.0- 11.0) ∼
Kentucky 3.1 ( 2.5- 4.0) 3.1 ( 2.4- 3.9) ∼ ∼
Mississippi 3.8 ( 2.9- 4.9) 2.2 ( 1.4- 3.3) 8.1 ( 5.7- 11.3) ∼
Tennessee 3.7 ( 3.1- 4.4) 3.3 ( 2.7- 4.1) 6.9 ( 4.6- 10.1) ∼
West South Central 3.8 ( 3.5- 4.1) 3.3 ( 3.0- 3.6) 7.7 ( 6.5- 9.1) 3.6 ( 2.8- 4.5)
Arkansas 3.6 ( 2.8- 4.7) 3.0 ( 2.2- 4.0) 9.7 ( 5.6- 15.6) ∼
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Table 2.7.1.2: Corpus and Uterus, NOS. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 3.2 ( 2.5- 4.0) 1.7 ( 1.2- 2.5) 7.5 ( 5.5- 10.0) ∼
Oklahoma 4.2 ( 3.4- 5.2) 3.8 ( 3.0- 4.9) ∼ ∼
Texas 3.9 ( 3.5- 4.3) 3.6 ( 3.2- 4.0) 7.7 ( 6.0- 9.8) 3.6 ( 2.8- 4.6)
West 3.8 ( 3.6- 4.0) 3.8 ( 3.6- 4.0) 6.7 ( 5.3- 8.3) 3.1 ( 2.6- 3.8)
Mountain 3.5 ( 3.1- 3.9) 3.4 ( 3.1- 3.9) ∼ 3.8 ( 2.6- 5.3)
Arizona 2.6 ( 2.0- 3.2) 2.5 ( 2.0- 3.2) ∼ ∼
Colorado 3.9 ( 3.1- 4.9) 4.0 ( 3.1- 4.9) ∼ ∼
Idaho 3.0 ( 1.9- 4.7) 3.1 ( 1.9- 4.8) ∼ ∼
Montana 5.2 ( 3.5- 7.6) 5.2 ( 3.4- 7.7) ∼ ∼
Nevada 3.8 ( 2.7- 5.2) 3.5 ( 2.4- 5.0) ∼ ∼
New Mexico 4.2 ( 3.1- 5.8) 4.1 ( 2.9- 5.7) ∼ ∼
Utah 3.7 ( 2.5- 5.2) 3.7 ( 2.5- 5.2) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 4.0 ( 3.7- 4.2) 3.9 ( 3.7- 4.2) 7.1 ( 5.6- 8.9) 2.9 ( 2.3- 3.6)
Alaska ∼ ∼ ∼ ∼
California 4.0 ( 3.7- 4.3) 4.0 ( 3.7- 4.4) 7.2 ( 5.6- 9.1) 3.0 ( 2.3- 3.7)
Hawaii 3.6 ( 2.4- 5.4) ∼ ∼ ∼
Oregon 3.9 ( 3.1- 4.9) 3.8 ( 3.0- 4.9) ∼ ∼
Washington 3.8 ( 3.2- 4.6) 3.7 ( 3.1- 4.5) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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90 Table 2.8.1.1M: Esophagus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 8.3 ( 8.2- 8.5) 8.2 ( 8.0- 8.4) 10.9 ( 10.2- 11.6) 5.3 ( 4.8- 5.9)
Northeast 9.2 ( 8.9- 9.6) 9.2 ( 8.9- 9.7) 9.7 ( 8.3- 11.2) 8.2 ( 6.6- 10.2)
New England 10.9 ( 10.1- 11.7) 11.0 ( 10.2- 11.8) 11.1 ( 7.1- 17.5) 11.9 ( 6.6- 20.7)
Connecticut 9.5 ( 8.1- 11.2) 9.3 ( 7.8- 11.0) ∼ ∼
Maine 10.4 ( 8.0- 13.2) 10.3 ( 8.0- 13.2) ∼ ∼
Massachusetts 11.7 ( 10.5- 13.0) 11.9 ( 10.6- 13.2) ∼ ∼
New Hampshire 13.6 ( 10.7- 17.1) 13.6 ( 10.7- 17.2) ∼ -
Rhode Island 9.7 ( 7.2- 12.9) 10.0 ( 7.4- 13.3) ∼ ∼
Vermont 9.3 ( 6.2- 13.8) 9.4 ( 6.2- 13.9) ∼ ∼
Middle Atlantic 8.6 ( 8.2- 9.1) 8.6 ( 8.1- 9.1) 9.5 ( 8.1- 11.2) 7.7 ( 6.0- 9.8)
New Jersey 8.1 ( 7.2- 9.0) 8.0 ( 7.1- 9.0) 9.7 ( 6.8- 13.9) 6.3 ( 3.9- 10.7)
New York 8.4 ( 7.8- 9.1) 8.4 ( 7.7- 9.1) 8.9 ( 7.1- 11.2) 7.2 ( 5.2- 9.9)
Pennsylvania 9.3 ( 8.6- 10.1) 9.1 ( 8.4- 10.0) 10.7 ( 7.7- 14.7) -
Midwest 9.0 ( 8.7- 9.4) 8.8 ( 8.4- 9.2) 11.2 ( 9.8- 12.9) 4.9 ( 3.1- 7.7)
East North Central 9.1 ( 8.7- 9.5) 8.9 ( 8.5- 9.4) 10.5 ( 9.0- 12.2) 5.9 ( 3.6- 9.4)
Illinois 9.1 ( 8.3- 10.0) 9.0 ( 8.2- 10.0) 11.0 ( 8.5- 14.3) ∼
Indiana 8.2 ( 7.2- 9.4) 8.3 ( 7.2- 9.5) ∼ ∼
Michigan 9.1 ( 8.3- 10.1) 9.0 ( 8.1- 10.0) 10.5 ( 7.7- 14.1) ∼
Detroit 9.4 ( 8.0- 11.1) 9.3 ( 7.7- 11.1) 10.8 ( 7.5- 15.2) -
Ohio 8.9 ( 8.1- 9.8) 8.5 ( 7.7- 9.4) 9.9 ( 7.1- 13.8) ∼
Wisconsin 10.2 ( 8.9- 11.5) 10.0 ( 8.7- 11.3) ∼ -
West North Central 8.8 ( 8.2- 9.4) 8.5 ( 7.9- 9.2) 15.6 ( 11.2- 21.5) ∼
Iowa 8.8 ( 7.3- 10.5) 8.8 ( 7.3- 10.5) ∼ ∼
Kansas 5.8 ( 4.6- 7.4) 5.4 ( 4.2- 7.0) ∼ ∼
Minnesota 9.3 ( 8.1- 10.7) 9.3 ( 8.0- 10.7) ∼ ∼
Missouri 9.6 ( 8.5- 10.9) 9.1 ( 7.9- 10.4) 17.3 ( 11.7- 25.3) ∼
Nebraska 8.4 ( 6.5- 10.7) 8.2 ( 6.3- 10.5) ∼ ∼
North Dakota 11.3 ( 7.9- 15.8) 10.6 ( 7.3- 15.1) ∼ ∼
South Dakota
South
South Atlantic
Delaware 11.2 ( 8.0- 15.5) 11.7 ( 8.2- 16.5) ∼ ∼
District of Columbia 13.6 ( 9.3- 19.6) ∼ 15.6 ( 9.8- 23.9) ∼
Florida 7.6 ( 7.1- 8.2) 7.4 ( 6.8- 8.0) 10.5 ( 8.2- 13.5) -
Georgia 7.9 ( 6.9- 9.0) 6.9 ( 5.9- 8.1) 12.3 ( 9.7- 15.6) ∼
Atlanta 6.9 ( 5.3- 9.0) 5.8 ( 4.0- 8.2) 10.8 ( 6.8- 17.6) ∼
Maryland 8.7 ( 7.5- 10.0) 8.9 ( 7.6- 10.5) 8.9 ( 6.2- 12.7) ∼
North Carolina 8.3 ( 7.3- 9.3) 7.2 ( 6.3- 8.3) 14.4 ( 11.3- 18.2) ∼
South Carolina 10.1 ( 8.7- 11.8) 7.7 ( 6.3- 9.4) 18.3 ( 14.4- 23.3) -
Virginia
West Virginia 9.1 ( 7.2- 11.4) 9.0 ( 7.1- 11.2) ∼ ∼
East South Central
Alabama 7.9 ( 6.7- 9.3) 6.9 ( 5.7- 8.4) 12.5 ( 9.2- 16.7) ∼
Kentucky 8.1 ( 6.8- 9.5) 7.7 ( 6.4- 9.2) ∼ -
Mississippi
Tennessee
continued
C
ancer Incidence and M
ortality by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
91
Table 2.8.1.1M: Esophagus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 8.8 ( 7.5- 10.3) 8.4 ( 6.9- 10.1) 11.1 ( 8.1- 14.9) ∼
Oklahoma 8.9 ( 7.5- 10.5) 8.8 ( 7.4- 10.6) ∼ ∼
Texas 7.4 ( 6.8- 8.0) 7.2 ( 6.6- 7.9) 10.1 ( 7.7- 13.1) 5.2 ( 4.1- 6.6)
West 7.2 ( 6.8- 7.5) 7.5 ( 7.1- 7.8) 7.5 ( 5.9- 9.6) 4.4 ( 3.6- 5.3)
Mountain 7.0 ( 6.5- 7.7) 7.2 ( 6.6- 7.9) ∼ 3.9 ( 2.6- 5.8)
Arizona 6.8 ( 5.8- 8.0) 7.0 ( 5.9- 8.1) ∼ ∼
Colorado 7.6 ( 6.3- 9.1) 7.7 ( 6.4- 9.3) ∼ ∼
Idaho 6.9 ( 4.9- 9.4) 6.9 ( 4.9- 9.5) ∼ ∼
Montana 6.3 ( 4.2- 9.2) 6.3 ( 4.2- 9.2) ∼ ∼
Nevada 8.7 ( 7.0- 11.0) 9.1 ( 7.2- 11.5) ∼ ∼
New Mexico 5.9 ( 4.3- 7.9) 6.1 ( 4.4- 8.3) ∼ ∼
Utah 5.9 ( 4.3- 7.9) 6.1 ( 4.4- 8.2) ∼ ∼
Wyoming
Pacific 7.2 ( 6.8- 7.6) 7.6 ( 7.2- 8.0) 8.0 ( 6.1- 10.4) 4.5 ( 3.6- 5.7)
Alaska 12.4 ( 7.2- 21.5) ∼ ∼ ∼
California 6.8 ( 6.4- 7.3) 7.3 ( 6.8- 7.8) 8.0 ( 6.0- 10.5) 4.7 ( 3.7- 5.8)
San Francisco-Oakland 6.9 ( 5.7- 8.3) 8.2 ( 6.7- 10.0) ∼ ∼
San Jose-Monterey 6.5 ( 4.9- 8.6) 7.3 ( 5.4- 9.7) ∼ ∼
Los Angeles 5.7 ( 4.9- 6.5) 5.6 ( 4.7- 6.6) 8.5 ( 5.6- 12.9) 5.2 ( 3.6- 7.5)
Hawaii 5.9 ( 4.1- 8.2) ∼ ∼ -
Oregon 9.2 ( 7.8- 10.8) 9.2 ( 7.8- 10.9) ∼ ∼
Washington 8.2 ( 7.1- 9.4) 8.2 ( 7.0- 9.4) ∼ ∼
Seattle-Puget Sound 7.2 ( 5.9- 8.6) 7.3 ( 6.0- 8.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
U
nited States C
ancer Statistics: 2002 Incidence and M
ortality
92 Table 2.8.1.1F: Esophagus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 2.0 ( 1.9- 2.1) 1.8 ( 1.8- 1.9) 3.4 ( 3.1- 3.8) 1.2 ( 1.0- 1.5)
Northeast 2.3 ( 2.1- 2.4) 2.1 ( 1.9- 2.3) 3.6 ( 3.0- 4.3) 2.0 ( 1.4- 2.9)
New England 2.5 ( 2.2- 2.9) 2.5 ( 2.2- 2.9) ∼ ∼
Connecticut 2.7 ( 2.0- 3.5) 2.6 ( 1.9- 3.5) ∼ ∼
Maine 2.3 ( 1.4- 3.7) 2.3 ( 1.4- 3.7) ∼ ∼
Massachusetts 2.7 ( 2.2- 3.2) 2.6 ( 2.1- 3.2) ∼ ∼
New Hampshire 2.6 ( 1.5- 4.1) 2.6 ( 1.6- 4.2) ∼ -
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.1 ( 2.0- 2.3) 1.9 ( 1.8- 2.1) 3.6 ( 2.9- 4.3) 2.0 ( 1.3- 2.9)
New Jersey 2.4 ( 2.0- 2.9) 2.3 ( 1.9- 2.8) 3.2 ( 1.9- 5.1) ∼
New York 2.3 ( 2.0- 2.6) 2.0 ( 1.8- 2.3) 3.5 ( 2.6- 4.6) ∼
Pennsylvania 1.9 ( 1.6- 2.2) 1.6 ( 1.4- 2.0) 4.0 ( 2.6- 5.9) -
Midwest 2.1 ( 1.9- 2.2) 1.9 ( 1.8- 2.1) 3.7 ( 3.1- 4.5) ∼
East North Central 2.2 ( 2.0- 2.4) 2.0 ( 1.8- 2.2) 3.8 ( 3.0- 4.6) ∼
Illinois 2.3 ( 1.9- 2.7) 2.0 ( 1.7- 2.4) 3.9 ( 2.7- 5.5) ∼
Indiana 2.2 ( 1.8- 2.8) 2.0 ( 1.5- 2.5) ∼ ∼
Michigan 2.3 ( 1.9- 2.7) 2.1 ( 1.7- 2.5) 3.6 ( 2.3- 5.4) ∼
Detroit 2.5 ( 1.9- 3.2) 2.0 ( 1.4- 2.8) 4.1 ( 2.5- 6.4) -
Ohio 2.0 ( 1.6- 2.3) 1.8 ( 1.4- 2.1) 3.4 ( 2.1- 5.2) ∼
Wisconsin 2.6 ( 2.1- 3.3) 2.6 ( 2.0- 3.3) ∼ -
West North Central 1.8 ( 1.5- 2.1) 1.7 ( 1.5- 2.0) ∼ ∼
Iowa 1.9 ( 1.3- 2.7) 1.9 ( 1.3- 2.7) ∼ ∼
Kansas 1.6 ( 1.0- 2.4) 1.6 ( 1.0- 2.4) ∼ ∼
Minnesota 1.7 ( 1.2- 2.3) 1.6 ( 1.2- 2.2) ∼ ∼
Missouri 1.9 ( 1.4- 2.4) 1.7 ( 1.3- 2.2) ∼ ∼
Nebraska 2.0 ( 1.2- 3.1) 1.9 ( 1.2- 3.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.0 ( 1.7- 2.3) 1.8 ( 1.5- 2.1) 4.0 ( 2.8- 5.5) -
Georgia 2.1 ( 1.7- 2.6) 1.4 ( 1.0- 1.9) 4.2 ( 3.0- 5.8) ∼
Atlanta 1.9 ( 1.2- 3.0) ∼ ∼ ∼
Maryland 2.0 ( 1.5- 2.6) 1.7 ( 1.2- 2.4) 2.9 ( 1.7- 4.7) ∼
North Carolina 1.6 ( 1.3- 2.1) 1.4 ( 1.0- 1.8) 2.4 ( 1.5- 3.7) ∼
South Carolina 2.7 ( 2.1- 3.5) 2.2 ( 1.5- 3.0) 4.5 ( 2.9- 6.7) -
Virginia
West Virginia 1.7 ( 1.1- 2.7) 1.8 ( 1.1- 2.8) ∼ ∼
East South Central
Alabama 1.9 ( 1.4- 2.5) 1.3 ( 0.9- 2.0) 4.0 ( 2.5- 6.1) ∼
Kentucky 1.4 ( 1.0- 2.0) 1.4 ( 1.0- 2.1) ∼ -
Mississippi
Tennessee
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Table 2.8.1.1F: Esophagus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 1.8 ( 1.3- 2.4) 1.8 ( 1.2- 2.6) ∼ ∼
Oklahoma 1.2 ( 0.8- 1.8) 1.0 ( 0.6- 1.7) ∼ ∼
Texas 1.8 ( 1.6- 2.1) 1.7 ( 1.4- 2.0) 3.1 ( 2.1- 4.5) 1.3 ( 0.8- 2.0)
West 1.8 ( 1.7- 2.0) 1.8 ( 1.7- 2.0) 2.9 ( 2.0- 4.0) 1.0 ( 0.7- 1.4)
Mountain 1.6 ( 1.4- 1.9) 1.6 ( 1.3- 1.9) ∼ ∼
Arizona 1.5 ( 1.1- 2.0) 1.5 ( 1.0- 2.0) ∼ ∼
Colorado 2.0 ( 1.4- 2.7) 1.9 ( 1.3- 2.6) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.1 ( 1.3- 3.2) 2.1 ( 1.3- 3.3) ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 1.9 ( 1.7- 2.1) 1.9 ( 1.7- 2.1) 2.4 ( 1.6- 3.6) 1.0 ( 0.6- 1.4)
Alaska ∼ ∼ ∼ ∼
California 1.9 ( 1.7- 2.1) 2.0 ( 1.7- 2.2) 2.4 ( 1.5- 3.5) 1.0 ( 0.6- 1.5)
San Francisco-Oakland 2.0 ( 1.5- 2.7) 1.9 ( 1.3- 2.8) ∼ ∼
San Jose-Monterey 1.6 ( 1.0- 2.6) ∼ ∼ ∼
Los Angeles 1.9 ( 1.5- 2.3) 2.0 ( 1.5- 2.5) ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon 1.7 ( 1.2- 2.4) 1.8 ( 1.2- 2.5) ∼ ∼
Washington 2.0 ( 1.6- 2.6) 2.0 ( 1.5- 2.6) ∼ ∼
Seattle-Puget Sound 1.7 ( 1.2- 2.3) 1.6 ( 1.1- 2.3) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
U
nited States C
ancer Statistics: 2002 Incidence and M
ortality
94 Table 2.8.1.2M: Esophagus. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 7.8 ( 7.6- 8.0) 7.8 ( 7.6- 7.9) 10.2 ( 9.6- 10.9) 4.2 ( 3.8- 4.8)
Northeast 8.3 ( 8.0- 8.7) 8.4 ( 8.0- 8.8) 9.3 ( 8.0- 10.8) 4.8 ( 3.6- 6.5)
New England 9.3 ( 8.6- 10.1) 9.4 ( 8.7- 10.2) 9.9 ( 6.2- 16.0) ∼
Connecticut 7.6 ( 6.3- 9.1) 7.5 ( 6.2- 9.1) ∼ ∼
Maine 11.0 ( 8.6- 13.9) 11.1 ( 8.7- 14.0) ∼ ∼
Massachusetts 9.9 ( 8.8- 11.1) 10.0 ( 8.9- 11.3) ∼ ∼
New Hampshire 10.8 ( 8.3- 14.1) 11.0 ( 8.4- 14.3) ∼ ∼
Rhode Island 7.7 ( 5.4- 10.7) 7.9 ( 5.5- 10.9) ∼ ∼
Vermont 9.7 ( 6.4- 14.3) 9.8 ( 6.4- 14.4) ∼ ∼
Middle Atlantic 8.0 ( 7.6- 8.4) 8.0 ( 7.6- 8.5) 9.2 ( 7.8- 10.8) 4.8 ( 3.5- 6.6)
New Jersey 7.4 ( 6.6- 8.4) 7.5 ( 6.6- 8.6) 8.7 ( 5.9- 12.8) ∼
New York 7.2 ( 6.6- 7.8) 7.3 ( 6.6- 7.9) 8.4 ( 6.6- 10.6) 4.9 ( 3.3- 7.4)
Pennsylvania 9.4 ( 8.6- 10.2) 9.3 ( 8.5- 10.1) 11.5 ( 8.5- 15.5) ∼
Midwest 8.5 ( 8.1- 8.8) 8.4 ( 8.1- 8.8) 10.2 ( 8.8- 11.8) 4.2 ( 2.4- 7.0)
East North Central 8.6 ( 8.2- 9.1) 8.6 ( 8.2- 9.1) 10.1 ( 8.6- 11.8) 4.2 ( 2.3- 7.6)
Illinois 8.0 ( 7.3- 8.9) 7.9 ( 7.1- 8.8) 10.3 ( 7.8- 13.5) ∼
Indiana 8.1 ( 7.0- 9.2) 8.2 ( 7.1- 9.4) ∼ ∼
Michigan 8.6 ( 7.7- 9.5) 8.7 ( 7.8- 9.7) 8.7 ( 6.1- 12.1) ∼
Ohio 9.3 ( 8.5- 10.2) 9.2 ( 8.4- 10.1) 10.9 ( 7.9- 15.0) ∼
Wisconsin 9.3 ( 8.1- 10.6) 8.9 ( 7.8- 10.2) ∼ ∼
West North Central 8.1 ( 7.5- 8.7) 8.0 ( 7.4- 8.7) 10.6 ( 7.1- 15.6) ∼
Iowa 9.2 ( 7.7- 10.9) 9.2 ( 7.7- 10.9) ∼ ∼
Kansas 5.9 ( 4.6- 7.5) 5.8 ( 4.5- 7.4) ∼ ∼
Minnesota 8.2 ( 7.0- 9.5) 8.1 ( 6.9- 9.4) ∼ ∼
Missouri 9.1 ( 7.9- 10.3) 9.1 ( 7.9- 10.5) 9.3 ( 5.4- 15.6) ∼
Nebraska 7.6 ( 5.8- 9.8) 7.9 ( 6.0- 10.1) ∼ ∼
North Dakota 5.7 ( 3.4- 9.1) 5.5 ( 3.2- 8.9) ∼ ∼
South Dakota 6.7 ( 4.4- 10.0) 6.8 ( 4.3- 10.2) ∼ ∼
South 7.4 ( 7.2- 7.7) 6.9 ( 6.7- 7.2) 11.4 ( 10.5- 12.3) 3.5 ( 2.8- 4.3)
South Atlantic 7.6 ( 7.3- 8.0) 7.0 ( 6.7- 7.4) 12.0 ( 10.8- 13.3) 3.3 ( 2.3- 4.6)
Delaware 9.8 ( 6.8- 13.9) 9.8 ( 6.6- 14.2) ∼ ∼
District of Columbia 12.6 ( 8.5- 18.2) ∼ 19.1 ( 12.8- 28.0) ∼
Florida 7.1 ( 6.6- 7.7) 7.0 ( 6.4- 7.6) 10.5 ( 8.2- 13.4) 3.4 ( 2.4- 4.8)
Georgia 7.5 ( 6.5- 8.6) 6.1 ( 5.1- 7.3) 13.5 ( 10.7- 17.1) ∼
Maryland 8.3 ( 7.2- 9.7) 8.4 ( 7.1- 9.9) 8.8 ( 6.1- 12.7) ∼
North Carolina 8.1 ( 7.1- 9.1) 7.3 ( 6.3- 8.4) 12.3 ( 9.4- 16.0) ∼
South Carolina 8.8 ( 7.4- 10.3) 7.1 ( 5.8- 8.8) 15.3 ( 11.6- 20.1) ∼
Virginia 7.1 ( 6.1- 8.1) 6.8 ( 5.8- 7.9) 9.9 ( 7.1- 13.6) ∼
West Virginia 7.8 ( 6.1- 10.0) 7.5 ( 5.8- 9.7) ∼ ∼
East South Central 7.7 ( 7.1- 8.4) 7.2 ( 6.5- 7.9) 11.5 ( 9.5- 13.8) ∼
Alabama 7.0 ( 5.9- 8.3) 6.3 ( 5.2- 7.7) 10.3 ( 7.4- 14.2) ∼
Kentucky 8.5 ( 7.2- 10.0) 8.3 ( 7.0- 9.8) ∼ ∼
Mississippi 8.6 ( 7.0- 10.5) 7.3 ( 5.6- 9.4) 12.0 ( 8.4- 16.7) ∼
Tennessee 7.3 ( 6.3- 8.5) 6.8 ( 5.8- 8.1) 12.5 ( 8.5- 18.0) ∼
West South Central 6.8 ( 6.3- 7.3) 6.6 ( 6.1- 7.1) 9.7 ( 8.1- 11.7) 3.8 ( 2.8- 5.0)
Arkansas 5.5 ( 4.3- 7.0) 5.0 ( 3.7- 6.5) ∼ ∼
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Table 2.8.1.2M: Esophagus. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 8.2 ( 6.9- 9.6) 7.7 ( 6.3- 9.4) 10.0 ( 7.3- 13.7) ∼
Oklahoma 7.3 ( 6.1- 8.8) 7.3 ( 5.9- 8.9) ∼ ∼
Texas 6.6 ( 6.0- 7.2) 6.5 ( 5.9- 7.1) 9.2 ( 7.0- 12.0) 3.8 ( 2.8- 5.1)
West 7.3 ( 6.9- 7.6) 7.7 ( 7.4- 8.1) 5.6 ( 4.2- 7.4) 4.8 ( 4.0- 5.7)
Mountain 7.7 ( 7.0- 8.3) 7.8 ( 7.2- 8.5) ∼ 5.0 ( 3.5- 7.1)
Arizona 7.8 ( 6.7- 9.0) 7.9 ( 6.8- 9.2) ∼ ∼
Colorado 7.1 ( 5.8- 8.6) 7.4 ( 6.0- 8.9) ∼ ∼
Idaho 9.0 ( 6.7- 11.9) 9.2 ( 6.8- 12.2) ∼ ∼
Montana 7.3 ( 5.0- 10.3) 7.5 ( 5.2- 10.7) ∼ ∼
Nevada 9.7 ( 7.8- 12.1) 10.4 ( 8.3- 13.0) ∼ ∼
New Mexico 6.6 ( 4.9- 8.7) 6.2 ( 4.6- 8.4) ∼ ∼
Utah 5.6 ( 4.0- 7.7) 5.8 ( 4.2- 7.9) ∼ ∼
Wyoming 10.2 ( 6.4- 15.9) 10.4 ( 6.5- 16.2) ∼ ∼
Pacific 7.1 ( 6.7- 7.5) 7.7 ( 7.2- 8.1) 5.7 ( 4.2- 7.8) 4.7 ( 3.8- 5.8)
Alaska ∼ ∼ ∼ ∼
California 6.8 ( 6.3- 7.2) 7.4 ( 6.9- 7.9) 6.0 ( 4.4- 8.2) 4.7 ( 3.7- 5.8)
Hawaii 6.1 ( 4.3- 8.5) ∼ ∼ ∼
Oregon 8.2 ( 6.9- 9.8) 8.5 ( 7.1- 10.1) ∼ ∼
Washington 8.3 ( 7.2- 9.5) 8.8 ( 7.6- 10.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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96 Table 2.8.1.2F: Esophagus. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 1.7 ( 1.7- 1.8) 1.6 ( 1.6- 1.7) 2.9 ( 2.7- 3.2) 0.9 ( 0.7- 1.1)
Northeast 1.9 ( 1.7- 2.0) 1.8 ( 1.6- 2.0) 2.7 ( 2.1- 3.3) 1.1 ( 0.6- 1.8)
New England 1.8 ( 1.6- 2.1) 1.9 ( 1.6- 2.2) ∼ ∼
Connecticut 1.7 ( 1.2- 2.4) 1.8 ( 1.2- 2.5) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 1.8 ( 1.4- 2.2) 1.8 ( 1.4- 2.3) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island 2.5 ( 1.5- 4.1) 2.5 ( 1.4- 4.2) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.9 ( 1.7- 2.1) 1.8 ( 1.6- 2.0) 2.8 ( 2.2- 3.5) ∼
New Jersey 2.0 ( 1.6- 2.4) 2.0 ( 1.6- 2.5) ∼ ∼
New York 1.9 ( 1.6- 2.1) 1.7 ( 1.5- 2.0) 2.9 ( 2.1- 3.9) ∼
Pennsylvania 1.8 ( 1.5- 2.1) 1.7 ( 1.4- 2.0) 3.2 ( 1.9- 4.9) ∼
Midwest 1.9 ( 1.8- 2.0) 1.8 ( 1.6- 1.9) 3.4 ( 2.7- 4.1) ∼
East North Central 2.0 ( 1.9- 2.2) 1.9 ( 1.7- 2.0) 3.5 ( 2.7- 4.3) ∼
Illinois 2.0 ( 1.7- 2.4) 1.8 ( 1.5- 2.2) 3.2 ( 2.1- 4.7) ∼
Indiana 1.8 ( 1.4- 2.3) 1.6 ( 1.2- 2.1) ∼ ∼
Michigan 2.0 ( 1.7- 2.4) 1.9 ( 1.5- 2.3) 3.0 ( 1.8- 4.7) ∼
Ohio 2.1 ( 1.8- 2.5) 2.0 ( 1.6- 2.4) 3.7 ( 2.4- 5.6) ∼
Wisconsin 2.0 ( 1.6- 2.6) 2.0 ( 1.5- 2.5) ∼ ∼
West North Central 1.6 ( 1.4- 1.9) 1.6 ( 1.3- 1.8) ∼ ∼
Iowa 1.7 ( 1.2- 2.5) 1.8 ( 1.2- 2.5) ∼ ∼
Kansas 1.5 ( 0.9- 2.2) 1.3 ( 0.8- 2.1) ∼ ∼
Minnesota 1.9 ( 1.4- 2.4) 1.8 ( 1.3- 2.4) ∼ ∼
Missouri 1.5 ( 1.1- 1.9) 1.4 ( 1.0- 1.9) ∼ ∼
Nebraska 2.1 ( 1.3- 3.2) 1.9 ( 1.1- 3.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 1.6 ( 1.5- 1.7) 1.4 ( 1.3- 1.5) 3.0 ( 2.6- 3.4) 0.7 ( 0.5- 1.1)
South Atlantic 1.8 ( 1.7- 2.0) 1.5 ( 1.3- 1.6) 3.6 ( 3.1- 4.2) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.5 ( 1.2- 1.7) 1.3 ( 1.1- 1.6) 2.6 ( 1.7- 3.9) ∼
Georgia 2.2 ( 1.7- 2.7) 1.4 ( 1.0- 1.9) 4.8 ( 3.4- 6.5) ∼
Maryland 2.0 ( 1.6- 2.6) 1.8 ( 1.3- 2.4) 3.2 ( 1.9- 5.1) ∼
North Carolina 1.8 ( 1.5- 2.3) 1.5 ( 1.2- 2.0) 3.1 ( 2.0- 4.6) ∼
South Carolina 1.7 ( 1.2- 2.3) 1.0 ( 0.6- 1.7) 3.5 ( 2.2- 5.5) ∼
Virginia 2.2 ( 1.7- 2.7) 1.9 ( 1.5- 2.5) 3.8 ( 2.4- 5.7) ∼
West Virginia 1.7 ( 1.0- 2.7) 1.6 ( 1.0- 2.6) ∼ ∼
East South Central 1.3 ( 1.1- 1.5) 1.2 ( 0.9- 1.4) 2.0 ( 1.3- 2.8) ∼
Alabama 1.5 ( 1.0- 2.0) 1.2 ( 0.8- 1.8) ∼ ∼
Kentucky 1.3 ( 0.9- 1.8) 1.3 ( 0.9- 1.9) ∼ ∼
Mississippi 1.2 ( 0.7- 1.9) ∼ ∼ ∼
Tennessee 1.2 ( 0.9- 1.6) 1.1 ( 0.8- 1.6) ∼ ∼
West South Central 1.5 ( 1.3- 1.7) 1.4 ( 1.2- 1.6) 2.1 ( 1.5- 2.8) ∼
Arkansas 1.3 ( 0.8- 2.0) ∼ ∼ ∼
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Table 2.8.1.2F: Esophagus. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 1.5 ( 1.0- 2.0) 1.6 ( 1.1- 2.3) ∼ ∼
Oklahoma 1.2 ( 0.7- 1.8) 1.1 ( 0.7- 1.8) ∼ ∼
Texas 1.6 ( 1.4- 1.9) 1.5 ( 1.3- 1.8) 2.7 ( 1.8- 4.0) ∼
West 1.7 ( 1.5- 1.8) 1.7 ( 1.6- 1.9) 2.5 ( 1.7- 3.5) 0.9 ( 0.6- 1.3)
Mountain 1.6 ( 1.3- 1.9) 1.6 ( 1.3- 1.9) ∼ ∼
Arizona 1.6 ( 1.2- 2.1) 1.7 ( 1.2- 2.2) ∼ ∼
Colorado 1.5 ( 1.0- 2.2) 1.5 ( 1.0- 2.1) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana 3.2 ( 1.9- 5.3) 3.2 ( 1.8- 5.3) ∼ ∼
Nevada 1.6 ( 1.0- 2.7) ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.7 ( 1.5- 1.9) 1.8 ( 1.6- 2.0) 2.5 ( 1.6- 3.6) 0.9 ( 0.6- 1.4)
Alaska ∼ ∼ ∼ ∼
California 1.6 ( 1.4- 1.8) 1.7 ( 1.4- 1.9) 2.4 ( 1.5- 3.6) 1.0 ( 0.6- 1.5)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.3 ( 1.7- 3.0) 2.3 ( 1.7- 3.1) ∼ ∼
Washington 2.0 ( 1.5- 2.6) 2.1 ( 1.6- 2.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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98 Table 2.9.1.1M: Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 3.1 ( 3.0- 3.2) 3.2 ( 3.1- 3.3) 2.7 ( 2.4- 3.0) 2.9 ( 2.5- 3.2)
Northeast 3.8 ( 3.5- 4.0) 3.9 ( 3.7- 4.2) 2.9 ( 2.3- 3.7) 3.9 ( 2.9- 5.2)
New England 3.8 ( 3.4- 4.3) 3.9 ( 3.5- 4.5) ∼ ∼
Connecticut 3.6 ( 2.7- 4.7) 3.5 ( 2.6- 4.6) ∼ ∼
Maine 5.6 ( 3.9- 7.8) 5.5 ( 3.8- 7.8) ∼ ∼
Massachusetts 3.6 ( 3.0- 4.4) 3.8 ( 3.1- 4.6) ∼ ∼
New Hampshire 4.7 ( 3.2- 6.9) 4.7 ( 3.2- 7.0) ∼ -
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.8 ( 3.5- 4.0) 3.9 ( 3.6- 4.2) 3.0 ( 2.4- 3.9) 3.8 ( 2.8- 5.2)
New Jersey 3.3 ( 2.8- 3.9) 3.7 ( 3.1- 4.4) ∼ 4.0 ( 2.2- 7.9)
New York 4.1 ( 3.7- 4.6) 4.4 ( 3.9- 4.9) 2.9 ( 2.1- 4.2) 3.8 ( 2.6- 5.7)
Pennsylvania 3.6 ( 3.1- 4.1) 3.5 ( 3.0- 4.0) 4.1 ( 2.7- 6.6) -
Midwest 3.2 ( 3.0- 3.4) 3.3 ( 3.1- 3.5) 2.4 ( 1.8- 3.1) 2.9 ( 1.8- 5.0)
East North Central 3.2 ( 3.0- 3.5) 3.3 ( 3.0- 3.6) 2.6 ( 2.0- 3.4) 3.1 ( 1.8- 5.7)
Illinois 3.1 ( 2.7- 3.6) 3.4 ( 2.9- 3.9) 2.0 ( 1.1- 3.6) 2.4 ( 1.4- 6.0)
Indiana 3.2 ( 2.5- 3.9) 3.2 ( 2.5- 4.0) ∼ ∼
Michigan 3.1 ( 2.6- 3.6) 3.2 ( 2.6- 3.8) 2.8 ( 1.6- 5.0) ∼
Detroit 3.8 ( 3.0- 4.9) 4.2 ( 3.2- 5.5) ∼ -
Ohio 3.1 ( 2.6- 3.6) 3.0 ( 2.5- 3.5) 2.9 ( 1.6- 5.2) ∼
Wisconsin 4.0 ( 3.3- 4.9) 4.2 ( 3.4- 5.1) ∼ -
West North Central 3.1 ( 2.8- 3.5) 3.2 ( 2.8- 3.6) ∼ ∼
Iowa 3.7 ( 2.8- 4.9) 3.7 ( 2.7- 4.9) ∼ ∼
Kansas 3.1 ( 2.2- 4.3) 3.3 ( 2.3- 4.5) ∼ ∼
Minnesota 3.0 ( 2.4- 3.8) 3.1 ( 2.4- 4.0) ∼ ∼
Missouri 3.2 ( 2.5- 3.9) 3.4 ( 2.7- 4.2) ∼ ∼
Nebraska 2.7 ( 1.7- 4.1) 2.7 ( 1.6- 4.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 4.1 ( 2.3- 7.0) ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 3.0 ( 2.6- 3.4) 3.1 ( 2.7- 3.6) 2.1 ( 1.3- 3.5) -
Georgia 2.9 ( 2.4- 3.6) 3.0 ( 2.4- 3.8) 2.9 ( 1.9- 4.5) ∼
Atlanta 3.5 ( 2.6- 4.9) 4.1 ( 2.9- 6.0) ∼ ∼
Maryland 2.7 ( 2.1- 3.4) 2.8 ( 2.1- 3.8) 2.4 ( 1.3- 4.7) ∼
North Carolina 2.7 ( 2.2- 3.3) 2.5 ( 2.0- 3.1) 3.6 ( 2.4- 5.6) ∼
South Carolina 2.4 ( 1.8- 3.3) 2.5 ( 1.7- 3.5) ∼ -
Virginia
West Virginia 3.3 ( 2.2- 4.8) 3.3 ( 2.2- 4.8) ∼ ∼
East South Central
Alabama 3.2 ( 2.5- 4.1) 3.2 ( 2.4- 4.3) 2.8 ( 1.6- 5.0) ∼
Kentucky 3.3 ( 2.6- 4.3) 3.3 ( 2.5- 4.3) ∼ -
Mississippi
Tennessee
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Table 2.9.1.1M: Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 3.1 ( 2.4- 4.0) 3.6 ( 2.7- 4.8) ∼ ∼
Oklahoma 2.7 ( 2.0- 3.6) 3.0 ( 2.2- 4.1) ∼ ∼
Texas 2.7 ( 2.4- 3.0) 2.7 ( 2.3- 3.0) 3.0 ( 2.1- 4.5) 2.2 ( 1.6- 3.1)
West 2.8 ( 2.6- 3.0) 2.9 ( 2.7- 3.1) 2.3 ( 1.7- 3.4) 3.0 ( 2.5- 3.6)
Mountain 2.7 ( 2.3- 3.0) 2.7 ( 2.4- 3.1) ∼ 3.2 ( 2.3- 4.6)
Arizona 2.3 ( 1.7- 3.0) 2.2 ( 1.6- 2.9) ∼ 3.3 ( 1.8- 6.8)
Colorado 3.0 ( 2.3- 3.9) 3.0 ( 2.3- 4.0) ∼ ∼
Idaho 2.8 ( 1.6- 4.5) 2.9 ( 1.7- 4.6) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.9 ( 2.0- 4.3) 3.4 ( 2.3- 5.0) ∼ ∼
New Mexico 3.1 ( 2.0- 4.6) 3.4 ( 2.2- 5.1) ∼ ∼
Utah 2.2 ( 1.4- 3.6) 2.3 ( 1.4- 3.7) ∼ ∼
Wyoming
Pacific 2.8 ( 2.6- 3.1) 3.0 ( 2.7- 3.3) 2.3 ( 1.6- 3.5) 2.9 ( 2.3- 3.7)
Alaska ∼ ∼ ∼ ∼
California 2.7 ( 2.5- 3.0) 2.9 ( 2.6- 3.2) 2.2 ( 1.4- 3.5) 2.8 ( 2.2- 3.6)
San Francisco-Oakland 2.6 ( 2.0- 3.5) 2.7 ( 1.9- 3.7) ∼ ∼
San Jose-Monterey 3.7 ( 2.7- 5.2) 4.3 ( 3.0- 6.1) ∼ ∼
Los Angeles 2.4 ( 2.0- 3.0) 2.7 ( 2.1- 3.3) ∼ 3.2 ( 2.2- 4.8)
Hawaii 2.6 ( 1.5- 4.3) ∼ ∼ -
Oregon 3.1 ( 2.3- 4.1) 3.2 ( 2.4- 4.3) ∼ ∼
Washington 3.3 ( 2.7- 4.1) 3.2 ( 2.6- 4.0) ∼ ∼
Seattle-Puget Sound 3.0 ( 2.3- 3.9) 3.1 ( 2.4- 4.1) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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100 Table 2.9.1.1F: Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 2.5 ( 2.4- 2.5) 2.6 ( 2.5- 2.7) 2.0 ( 1.8- 2.3) 1.9 ( 1.7- 2.1)
Northeast 3.0 ( 2.8- 3.2) 3.2 ( 3.0- 3.5) 2.2 ( 1.7- 2.7) 2.6 ( 1.9- 3.4)
New England 2.7 ( 2.4- 3.1) 2.7 ( 2.3- 3.2) ∼ ∼
Connecticut 3.4 ( 2.6- 4.5) 3.3 ( 2.4- 4.4) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 2.4 ( 1.9- 3.0) 2.4 ( 1.9- 3.1) ∼ ∼
New Hampshire 3.6 ( 2.2- 5.4) 3.7 ( 2.3- 5.6) ∼ -
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.1 ( 2.9- 3.4) 3.4 ( 3.1- 3.7) 2.0 ( 1.5- 2.6) 2.5 ( 1.9- 3.4)
New Jersey 3.2 ( 2.6- 3.7) 3.8 ( 3.1- 4.5) ∼ 3.3 ( 1.9- 5.6)
New York 3.0 ( 2.6- 3.3) 3.3 ( 2.9- 3.7) 2.1 ( 1.5- 2.9) 2.1 ( 1.3- 3.2)
Pennsylvania 3.3 ( 2.9- 3.8) 3.4 ( 3.0- 4.0) 2.5 ( 1.5- 4.1) -
Midwest 2.6 ( 2.4- 2.7) 2.6 ( 2.4- 2.8) 2.1 ( 1.7- 2.7) 2.3 ( 1.4- 3.7)
East North Central 2.6 ( 2.4- 2.9) 2.7 ( 2.5- 3.0) 2.2 ( 1.7- 2.9) 1.9 ( 1.1- 3.5)
Illinois 2.5 ( 2.1- 2.9) 2.6 ( 2.2- 3.1) 1.9 ( 1.2- 3.1) ∼
Indiana 2.6 ( 2.1- 3.3) 2.7 ( 2.1- 3.4) ∼ ∼
Michigan 3.0 ( 2.5- 3.5) 3.0 ( 2.5- 3.5) 2.8 ( 1.8- 4.4) ∼
Detroit 3.5 ( 2.7- 4.4) 3.6 ( 2.7- 4.8) 3.0 ( 1.7- 4.9) -
Ohio 2.6 ( 2.2- 3.1) 2.7 ( 2.3- 3.2) ∼ ∼
Wisconsin 2.5 ( 1.9- 3.2) 2.5 ( 1.9- 3.2) ∼ -
West North Central 2.4 ( 2.1- 2.7) 2.4 ( 2.1- 2.8) ∼ ∼
Iowa 3.1 ( 2.2- 4.1) 3.0 ( 2.1- 4.0) ∼ ∼
Kansas 1.8 ( 1.1- 2.7) 1.8 ( 1.1- 2.8) ∼ ∼
Minnesota 2.5 ( 1.9- 3.2) 2.4 ( 1.8- 3.1) ∼ ∼
Missouri 1.9 ( 1.5- 2.5) 2.1 ( 1.5- 2.7) ∼ ∼
Nebraska 3.0 ( 1.9- 4.4) 3.1 ( 2.0- 4.6) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.4 ( 2.1- 2.8) 2.7 ( 2.3- 3.1) 1.7 ( 1.0- 2.7) -
Georgia 1.9 ( 1.5- 2.3) 2.2 ( 1.7- 2.8) 1.5 ( 0.9- 2.5) ∼
Atlanta 2.1 ( 1.4- 3.0) 2.8 ( 1.8- 4.2) ∼ ∼
Maryland 2.0 ( 1.5- 2.6) 2.2 ( 1.6- 3.1) ∼ ∼
North Carolina 2.4 ( 2.0- 2.9) 2.5 ( 1.9- 3.1) 2.1 ( 1.3- 3.3) ∼
South Carolina 2.4 ( 1.8- 3.2) 2.3 ( 1.6- 3.2) 2.6 ( 1.5- 4.3) -
Virginia
West Virginia ∼ ∼ ∼ ∼
East South Central
Alabama 1.9 ( 1.4- 2.6) 1.9 ( 1.3- 2.7) ∼ ∼
Kentucky 3.1 ( 2.4- 3.9) 3.2 ( 2.5- 4.1) ∼ -
Mississippi
Tennessee
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Table 2.9.1.1F: Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 2.2 ( 1.6- 2.9) 2.1 ( 1.4- 3.0) 2.4 ( 1.4- 3.9) ∼
Oklahoma 2.5 ( 1.8- 3.3) 2.4 ( 1.7- 3.4) ∼ ∼
Texas 1.9 ( 1.7- 2.2) 1.9 ( 1.7- 2.2) 1.7 ( 1.0- 2.6) 2.1 ( 1.6- 2.7)
West 2.2 ( 2.1- 2.4) 2.4 ( 2.2- 2.6) 2.1 ( 1.5- 3.0) 1.3 ( 1.1- 1.7)
Mountain 2.2 ( 1.9- 2.6) 2.3 ( 2.0- 2.7) ∼ 1.3 ( 0.8- 2.1)
Arizona 1.8 ( 1.4- 2.4) 2.0 ( 1.5- 2.7) ∼ ∼
Colorado 2.2 ( 1.6- 2.9) 2.2 ( 1.6- 2.9) ∼ ∼
Idaho 3.3 ( 2.1- 5.0) 3.4 ( 2.1- 5.2) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.7 ( 1.8- 3.9) 2.9 ( 1.9- 4.2) ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah 2.3 ( 1.5- 3.4) 2.4 ( 1.5- 3.5) ∼ ∼
Wyoming
Pacific 2.2 ( 2.1- 2.4) 2.4 ( 2.2- 2.7) 2.4 ( 1.7- 3.4) 1.4 ( 1.0- 1.8)
Alaska ∼ ∼ ∼ ∼
California 2.1 ( 1.9- 2.4) 2.3 ( 2.1- 2.6) 2.2 ( 1.4- 3.2) 1.3 ( 1.0- 1.8)
San Francisco-Oakland 1.8 ( 1.3- 2.5) 2.1 ( 1.4- 3.1) ∼ ∼
San Jose-Monterey 2.6 ( 1.8- 3.8) 2.7 ( 1.7- 4.1) ∼ ∼
Los Angeles 1.8 ( 1.4- 2.2) 1.9 ( 1.5- 2.5) ∼ 1.2 ( 0.7- 2.0)
Hawaii ∼ ∼ ∼ -
Oregon 2.9 ( 2.1- 3.8) 2.9 ( 2.2- 3.9) ∼ ∼
Washington 2.6 ( 2.1- 3.3) 2.6 ( 2.0- 3.3) ∼ ∼
Seattle-Puget Sound 2.9 ( 2.2- 3.8) 3.0 ( 2.3- 4.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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102 Table 2.9.1.2M: Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 0.6 ( 0.5- 0.6) 0.6 ( 0.5- 0.6) 0.6 ( 0.4- 0.7) 0.5 ( 0.3- 0.7)
Northeast 0.6 ( 0.5- 0.8) 0.6 ( 0.5- 0.8) 0.7 ( 0.4- 1.2) ∼
New England 0.7 ( 0.5- 1.0) 0.7 ( 0.5- 0.9) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.9 ( 0.6- 1.3) 0.9 ( 0.5- 1.3) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.6 ( 0.5- 0.7) 0.6 ( 0.5- 0.8) ∼ ∼
New Jersey 0.6 ( 0.4- 0.9) 0.7 ( 0.4- 1.0) ∼ ∼
New York 0.6 ( 0.5- 0.8) 0.7 ( 0.5- 0.9) ∼ ∼
Pennsylvania 0.6 ( 0.4- 0.8) 0.5 ( 0.4- 0.8) ∼ ∼
Midwest 0.6 ( 0.5- 0.7) 0.6 ( 0.5- 0.7) ∼ ∼
East North Central 0.7 ( 0.5- 0.8) 0.7 ( 0.6- 0.8) ∼ ∼
Illinois 0.7 ( 0.5- 1.0) 0.7 ( 0.5- 1.0) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.5 ( 0.3- 0.8) 0.6 ( 0.4- 0.9) ∼ ∼
Ohio 0.7 ( 0.5- 0.9) 0.7 ( 0.5- 1.0) ∼ ∼
Wisconsin 0.8 ( 0.5- 1.3) 0.8 ( 0.5- 1.2) ∼ ∼
West North Central 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.6 ( 0.5- 0.7) 0.6 ( 0.5- 0.7) 0.5 ( 0.4- 0.8) ∼
South Atlantic 0.5 ( 0.4- 0.6) 0.6 ( 0.5- 0.7) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.6 ( 0.4- 0.8) 0.7 ( 0.5- 0.9) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina 0.6 ( 0.4- 1.0) 0.7 ( 0.4- 1.1) ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.8 ( 0.6- 1.0) 0.8 ( 0.6- 1.1) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky 1.0 ( 0.6- 1.7) 0.9 ( 0.5- 1.6) ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.6 ( 0.5- 0.7) 0.5 ( 0.4- 0.7) 1.0 ( 0.6- 1.8) ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.9.1.2M: Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.5 ( 0.4- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
West 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ 0.4 ( 0.2- 0.7)
Mountain 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) ∼ ∼
Arizona 0.6 ( 0.3- 1.0) ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.7) ∼ 0.5 ( 0.3- 1.0)
Alaska ∼ ∼ ∼ ∼
California 0.5 ( 0.4- 0.7) 0.6 ( 0.4- 0.7) ∼ 0.6 ( 0.3- 1.1)
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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104 Table 2.9.1.2F: Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.3 ( 0.2- 0.4) 0.4 ( 0.3- 0.5)
Northeast 0.4 ( 0.3- 0.5) 0.5 ( 0.4- 0.5) ∼ ∼
New England 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.5) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
New Jersey 0.5 ( 0.3- 0.8) 0.6 ( 0.4- 0.9) ∼ ∼
New York 0.4 ( 0.3- 0.6) 0.6 ( 0.4- 0.7) ∼ ∼
Pennsylvania 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Midwest 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) ∼ ∼
East North Central 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Illinois 0.4 ( 0.3- 0.6) 0.5 ( 0.3- 0.7) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.3 ( 0.2- 0.5) ∼ ∼ ∼
Ohio 0.4 ( 0.3- 0.6) 0.4 ( 0.2- 0.6) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri 0.5 ( 0.3- 0.8) ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.5) 0.3 ( 0.2- 0.4) ∼
South Atlantic 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.5) ∼ ∼
Georgia 0.4 ( 0.2- 0.7) ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia 0.5 ( 0.3- 0.8) ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.3 ( 0.2- 0.5) 0.4 ( 0.2- 0.5) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.9.1.2F: Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.5 ( 0.3- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼
West 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) ∼ 0.4 ( 0.2- 0.6)
Mountain 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.5) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ 0.3 ( 0.2- 0.6)
Alaska ∼ ∼ ∼ ∼
California 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ 0.4 ( 0.2- 0.7)
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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106 Table 2.10.1.1M: Kaposi Sarcoma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 0.8 ( 0.8- 0.9) 0.7 ( 0.6- 0.7) 1.9 ( 1.6- 2.1) 1.5 ( 1.3- 1.8)
Northeast 1.0 ( 0.9- 1.1) 0.7 ( 0.6- 0.8) 3.0 ( 2.5- 3.8) 1.5 ( 1.0- 2.5)
New England 0.5 ( 0.4- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.8 ( 0.5- 1.2) 0.6 ( 0.4- 1.0) ∼ ∼
New Hampshire ∼ ∼ ∼ -
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.2 ( 1.0- 1.3) 0.7 ( 0.6- 0.9) 3.4 ( 2.7- 4.2) 1.7 ( 1.0- 2.8)
New Jersey 1.2 ( 0.9- 1.6) 0.9 ( 0.6- 1.4) 2.8 ( 1.6- 5.3) ∼
New York 1.5 ( 1.3- 1.8) 1.0 ( 0.8- 1.3) 3.7 ( 2.9- 5.0) 2.0 ( 1.2- 3.5)
Pennsylvania 0.6 ( 0.4- 0.8) ∼ 2.8 ( 1.6- 5.1) -
Midwest 0.5 ( 0.4- 0.6) 0.3 ( 0.3- 0.4) 1.5 ( 1.1- 2.1) ∼
East North Central 0.5 ( 0.4- 0.6) 0.4 ( 0.3- 0.5) 1.6 ( 1.1- 2.3) ∼
Illinois 0.8 ( 0.5- 1.0) 0.5 ( 0.3- 0.8) 2.0 ( 1.1- 3.6) ∼
Indiana 0.6 ( 0.3- 1.0) ∼ ∼ ∼
Michigan 0.6 ( 0.4- 0.8) ∼ ∼ ∼
Detroit 0.9 ( 0.5- 1.5) ∼ ∼ -
Ohio 0.4 ( 0.2- 0.6) ∼ ∼ ∼
Wisconsin ∼ ∼ ∼ -
West North Central 0.4 ( 0.3- 0.6) 0.3 ( 0.2- 0.5) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.3 ( 1.1- 1.6) 1.2 ( 1.0- 1.5) 1.8 ( 1.1- 3.1) -
Georgia 1.6 ( 1.3- 2.2) 1.1 ( 0.8- 1.7) 2.5 ( 1.7- 4.0) ∼
Atlanta 3.5 ( 2.5- 5.0) 2.2 ( 1.4- 3.7) 4.8 ( 3.1- 9.4) ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ -
Virginia
West Virginia ∼ ∼ ∼ ∼
East South Central
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ -
Mississippi
Tennessee
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Table 2.10.1.1M: Kaposi Sarcoma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 0.9 ( 0.5- 1.5) ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.8 ( 0.6- 1.0) 0.7 ( 0.5- 0.9) 1.4 ( 0.8- 2.7) 0.9 ( 0.6- 1.6)
West 1.1 ( 1.0- 1.2) 0.9 ( 0.8- 1.1) 2.3 ( 1.6- 3.4) 1.7 ( 1.3- 2.2)
Mountain 0.6 ( 0.5- 0.8) 0.6 ( 0.4- 0.8) ∼ 1.0 ( 0.6- 2.1)
Arizona ∼ ∼ ∼ ∼
Colorado 0.8 ( 0.4- 1.3) ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 1.2 ( 1.1- 1.4) 1.1 ( 0.9- 1.3) 2.6 ( 1.9- 3.9) 1.9 ( 1.4- 2.5)
Alaska ∼ ∼ ∼ ∼
California 1.4 ( 1.3- 1.6) 1.3 ( 1.1- 1.5) 2.8 ( 2.0- 4.2) 1.7 ( 1.3- 2.3)
San Francisco-Oakland 2.3 ( 1.7- 3.1) 2.3 ( 1.6- 3.2) ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles 2.0 ( 1.6- 2.5) 1.9 ( 1.5- 2.4) ∼ 2.6 ( 1.8- 4.0)
Hawaii ∼ ∼ ∼ -
Oregon ∼ ∼ ∼ ∼
Washington 0.8 ( 0.5- 1.2) 0.7 ( 0.4- 1.1) ∼ ∼
Seattle-Puget Sound 0.8 ( 0.4- 1.3) ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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108 Table 2.10.1.1F: Kaposi Sarcoma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.2 ( 0.1- 0.3) 0.2 ( 0.2- 0.4)
Northeast 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.2) ∼ ∼
New England ∼ ∼ ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ -
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.2 ( 0.1- 0.2) 0.1 ( 0.1- 0.2) ∼ ∼
New Jersey ∼ ∼ ∼ ∼
New York 0.2 ( 0.2- 0.4) 0.2 ( 0.1- 0.3) ∼ ∼
Pennsylvania ∼ ∼ ∼ -
Midwest 0.0 ( 0.0- 0.1) ∼ ∼ ∼
East North Central ∼ ∼ ∼ ∼
Illinois ∼ ∼ ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan ∼ ∼ ∼ ∼
Detroit ∼ ∼ ∼ -
Ohio ∼ ∼ ∼ ∼
Wisconsin ∼ ∼ ∼ -
West North Central ∼ ∼ ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.2 ( 0.1- 0.3) ∼ ∼ -
Georgia ∼ ∼ ∼ ∼
Atlanta ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ -
Virginia
West Virginia ∼ ∼ ∼ ∼
East South Central
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ -
Mississippi
Tennessee
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Table 2.10.1.1F: Kaposi Sarcoma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas ∼ ∼ ∼ ∼
West 0.1 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) ∼ ∼
Mountain ∼ ∼ ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 0.1 ( 0.1- 0.1) ∼ ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.1 ( 0.1- 0.2) ∼ ∼ ∼
San Francisco-Oakland ∼ ∼ ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles ∼ ∼ ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
Seattle-Puget Sound ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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110 Table 2.11.1.1M: Kidney and Renal Pelvis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 18.0 ( 17.8- 18.2) 18.1 ( 17.8- 18.3) 18.8 ( 18.0- 19.7) 16.9 ( 16.0- 17.9)
Northeast 18.7 ( 18.2- 19.3) 18.9 ( 18.4- 19.5) 16.7 ( 15.0- 18.6) 12.0 ( 10.2- 14.3)
New England 18.4 ( 17.4- 19.5) 18.5 ( 17.4- 19.6) 15.5 ( 11.2- 21.9) 14.5 ( 8.8- 23.5)
Connecticut 19.0 ( 16.9- 21.2) 18.7 ( 16.6- 21.1) 16.1 ( 9.6- 29.1) ∼
Maine 18.7 ( 15.6- 22.4) 18.7 ( 15.5- 22.4) ∼ ∼
Massachusetts 18.2 ( 16.7- 19.9) 18.5 ( 16.9- 20.2) 15.4 ( 9.5- 25.6) ∼
New Hampshire 16.0 ( 12.9- 19.7) 16.0 ( 12.9- 19.8) ∼ -
Rhode Island 21.2 ( 17.4- 25.7) 21.6 ( 17.7- 26.3) ∼ ∼
Vermont 15.4 ( 11.2- 20.7) 15.3 ( 11.1- 20.7) ∼ ∼
Middle Atlantic 18.8 ( 18.2- 19.5) 19.1 ( 18.5- 19.8) 16.8 ( 15.0- 18.8) 11.6 ( 9.7- 14.0)
New Jersey 19.2 ( 17.9- 20.7) 19.5 ( 18.1- 21.1) 18.9 ( 14.8- 24.2) 13.4 ( 9.4- 19.2)
New York 18.2 ( 17.3- 19.2) 19.1 ( 18.1- 20.1) 13.0 ( 10.9- 15.5) 11.0 ( 8.8- 13.9)
Pennsylvania 19.5 ( 18.4- 20.6) 19.0 ( 17.9- 20.2) 24.2 ( 19.8- 29.5) -
Midwest 18.7 ( 18.2- 19.2) 18.2 ( 17.7- 18.7) 24.0 ( 21.9- 26.3) 13.3 ( 10.5- 17.0)
East North Central 18.7 ( 18.1- 19.3) 18.1 ( 17.5- 18.7) 23.8 ( 21.5- 26.3) 13.9 ( 10.8- 18.1)
Illinois 20.3 ( 19.1- 21.5) 19.7 ( 18.4- 21.1) 25.3 ( 21.3- 30.1) 12.3 ( 8.5- 18.2)
Indiana 19.0 ( 17.4- 20.7) 18.6 ( 16.9- 20.4) 25.6 ( 18.5- 35.3) ∼
Michigan 18.1 ( 16.9- 19.4) 17.1 ( 15.9- 18.5) 25.3 ( 20.8- 30.6) 19.6 ( 10.9- 36.8)
Detroit 22.2 ( 20.0- 24.5) 21.2 ( 18.8- 23.8) 25.8 ( 20.6- 32.2) -
Ohio 17.9 ( 16.8- 19.1) 17.4 ( 16.3- 18.7) 19.5 ( 15.6- 24.3) ∼
Wisconsin 17.5 ( 15.9- 19.2) 17.3 ( 15.7- 19.0) 22.0 ( 13.5- 39.5) -
West North Central 18.8 ( 17.9- 19.7) 18.3 ( 17.4- 19.3) 24.7 ( 19.6- 31.2) ∼
Iowa 19.4 ( 17.2- 21.9) 18.8 ( 16.6- 21.2) ∼ ∼
Kansas 14.4 ( 12.3- 16.7) 14.6 ( 12.5- 17.0) ∼ ∼
Minnesota 19.1 ( 17.3- 21.0) 18.5 ( 16.7- 20.4) ∼ ∼
Missouri 20.2 ( 18.5- 22.0) 19.8 ( 18.1- 21.7) 25.4 ( 19.0- 33.9) ∼
Nebraska 19.8 ( 16.8- 23.1) 19.0 ( 16.1- 22.4) ∼ ∼
North Dakota 16.6 ( 12.4- 21.8) 16.7 ( 12.5- 22.1) ∼ ∼
South Dakota
South
South Atlantic
Delaware 22.6 ( 18.0- 28.1) 21.9 ( 17.0- 28.0) 27.8 ( 15.6- 50.9) ∼
District of Columbia 21.1 ( 15.7- 28.1) 22.1 ( 12.7- 37.4) 21.7 ( 14.8- 31.1) ∼
Florida 17.3 ( 16.5- 18.2) 17.7 ( 16.8- 18.7) 12.8 ( 10.4- 15.9) -
Georgia 18.4 ( 16.9- 20.0) 18.6 ( 16.8- 20.4) 19.1 ( 15.6- 23.3) ∼
Atlanta 17.7 ( 15.1- 20.9) 18.0 ( 14.9- 21.7) 19.2 ( 13.4- 27.5) ∼
Maryland 16.0 ( 14.3- 17.7) 16.3 ( 14.4- 18.3) 15.7 ( 12.2- 20.4) ∼
North Carolina 16.7 ( 15.4- 18.1) 16.7 ( 15.2- 18.2) 17.9 ( 14.6- 22.0) ∼
South Carolina 20.3 ( 18.3- 22.5) 20.5 ( 18.2- 23.1) 19.6 ( 15.3- 24.8) -
Virginia
West Virginia 18.6 ( 16.0- 21.7) 18.5 ( 15.8- 21.6) ∼ ∼
East South Central
Alabama 17.6 ( 15.8- 19.5) 17.0 ( 15.1- 19.2) 19.5 ( 15.4- 24.5) ∼
Kentucky 19.7 ( 17.7- 22.0) 19.7 ( 17.7- 22.0) 20.2 ( 12.3- 32.5) -
Mississippi
Tennessee
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Table 2.11.1.1M: Kidney and Renal Pelvis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 22.0 ( 20.0- 24.3) 22.5 ( 20.1- 25.2) 21.8 ( 17.6- 26.9) ∼
Oklahoma 18.0 ( 16.0- 20.2) 17.5 ( 15.4- 19.8) 21.0 ( 12.5- 34.6) ∼
Texas 19.7 ( 18.7- 20.7) 20.0 ( 19.0- 21.1) 18.0 ( 14.9- 21.6) 22.6 ( 20.3- 25.3)
West 16.0 ( 15.6- 16.5) 16.6 ( 16.0- 17.1) 17.4 ( 14.9- 20.2) 17.4 ( 16.0- 19.0)
Mountain 16.2 ( 15.3- 17.1) 16.2 ( 15.3- 17.2) 13.2 ( 8.2- 21.8) 19.4 ( 16.3- 22.9)
Arizona 18.3 ( 16.7- 20.1) 18.2 ( 16.5- 20.0) ∼ 21.6 ( 15.8- 29.4)
Colorado 16.1 ( 14.3- 18.2) 16.1 ( 14.2- 18.2) ∼ 14.3 ( 9.3- 22.4)
Idaho 16.2 ( 13.1- 19.9) 16.2 ( 13.0- 19.9) ∼ ∼
Montana 16.8 ( 13.2- 21.1) 16.5 ( 12.9- 20.9) ∼ ∼
Nevada 15.1 ( 12.7- 18.0) 15.9 ( 13.3- 19.0) ∼ 21.8 ( 11.0- 43.0)
New Mexico 15.3 ( 12.8- 18.3) 15.5 ( 12.9- 18.7) ∼ 21.7 ( 16.3- 28.6)
Utah 11.7 ( 9.4- 14.5) 11.6 ( 9.3- 14.5) ∼ ∼
Wyoming
Pacific 16.0 ( 15.4- 16.5) 16.7 ( 16.1- 17.4) 18.2 ( 15.5- 21.4) 16.8 ( 15.1- 18.6)
Alaska 18.4 ( 12.8- 27.4) 17.2 ( 11.0- 27.6) ∼ ∼
California 15.8 ( 15.1- 16.5) 16.8 ( 16.0- 17.5) 18.7 ( 15.8- 22.1) 16.8 ( 15.1- 18.7)
San Francisco-Oakland 13.3 ( 11.7- 15.1) 14.0 ( 12.0- 16.2) 20.7 ( 14.3- 29.5) 12.2 ( 8.0- 19.1)
San Jose-Monterey 13.7 ( 11.4- 16.4) 14.8 ( 12.1- 18.0) ∼ 13.6 ( 8.6- 22.6)
Los Angeles 15.2 ( 14.0- 16.6) 16.4 ( 14.9- 18.1) 19.0 ( 14.6- 24.6) 16.6 ( 13.8- 19.8)
Hawaii 11.9 ( 9.3- 15.0) 13.7 ( 8.6- 21.5) ∼ -
Oregon 16.1 ( 14.3- 18.2) 15.7 ( 13.8- 17.8) ∼ ∼
Washington 17.6 ( 16.0- 19.3) 17.6 ( 16.0- 19.4) ∼ 17.9 ( 9.8- 34.0)
Seattle-Puget Sound 17.5 ( 15.6- 19.6) 17.8 ( 15.8- 20.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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112 Table 2.11.1.1F: Kidney and Renal Pelvis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 9.2 ( 9.1- 9.4) 9.2 ( 9.1- 9.4) 10.0 ( 9.5- 10.5) 9.0 ( 8.4- 9.6)
Northeast 9.5 ( 9.2- 9.9) 9.7 ( 9.3- 10.1) 8.0 ( 7.1- 9.0) 6.5 ( 5.4- 7.9)
New England 10.0 ( 9.3- 10.7) 10.0 ( 9.3- 10.7) 10.7 ( 7.6- 14.8) ∼
Connecticut 9.5 ( 8.2- 11.0) 9.5 ( 8.2- 11.1) ∼ ∼
Maine 9.7 ( 7.6- 12.2) 9.7 ( 7.6- 12.2) ∼ ∼
Massachusetts 10.3 ( 9.3- 11.4) 10.3 ( 9.2- 11.4) 12.5 ( 7.8- 19.2) ∼
New Hampshire 8.7 ( 6.6- 11.3) 8.8 ( 6.7- 11.5) ∼ -
Rhode Island 10.8 ( 8.3- 13.8) 10.6 ( 8.1- 13.8) ∼ ∼
Vermont 10.5 ( 7.4- 14.8) 10.6 ( 7.5- 15.0) ∼ ∼
Middle Atlantic 9.4 ( 9.0- 9.8) 9.6 ( 9.2- 10.1) 7.6 ( 6.7- 8.7) 6.7 ( 5.5- 8.2)
New Jersey 10.1 ( 9.2- 11.0) 10.6 ( 9.6- 11.7) 8.1 ( 5.9- 10.9) 10.0 ( 7.0- 14.1)
New York 8.6 ( 8.1- 9.2) 8.9 ( 8.3- 9.6) 6.5 ( 5.3- 7.8) 5.6 ( 4.3- 7.3)
Pennsylvania 10.1 ( 9.4- 10.9) 9.9 ( 9.2- 10.7) 10.4 ( 8.0- 13.2) -
Midwest 10.0 ( 9.7- 10.3) 9.7 ( 9.4- 10.1) 11.6 ( 10.4- 13.0) 10.4 ( 8.0- 13.4)
East North Central 10.1 ( 9.7- 10.5) 9.8 ( 9.4- 10.3) 11.7 ( 10.4- 13.2) 9.0 ( 6.6- 12.1)
Illinois 10.3 ( 9.5- 11.1) 10.4 ( 9.6- 11.3) 9.9 ( 7.9- 12.3) 8.6 ( 5.8- 12.8)
Indiana 11.4 ( 10.3- 12.7) 11.1 ( 10.0- 12.4) 14.1 ( 9.6- 19.9) ∼
Michigan 9.6 ( 8.8- 10.5) 9.2 ( 8.3- 10.1) 12.2 ( 9.7- 15.3) ∼
Detroit 10.6 ( 9.3- 12.1) 10.3 ( 8.8- 12.0) 12.3 ( 9.4- 15.9) -
Ohio 9.8 ( 9.1- 10.6) 9.4 ( 8.7- 10.2) 12.1 ( 9.5- 15.1) ∼
Wisconsin 9.7 ( 8.6- 10.9) 9.3 ( 8.2- 10.5) 16.2 ( 9.4- 27.1) -
West North Central 9.6 ( 9.1- 10.3) 9.5 ( 8.9- 10.1) 11.3 ( 8.4- 14.9) 16.5 ( 9.7- 26.7)
Iowa 10.1 ( 8.6- 11.7) 10.0 ( 8.6- 11.7) ∼ ∼
Kansas 7.6 ( 6.3- 9.2) 7.7 ( 6.3- 9.3) ∼ ∼
Minnesota 9.7 ( 8.5- 11.0) 9.5 ( 8.3- 10.8) ∼ ∼
Missouri 10.5 ( 9.4- 11.7) 10.3 ( 9.2- 11.5) 11.8 ( 8.2- 16.5) ∼
Nebraska 9.3 ( 7.5- 11.5) 8.9 ( 7.1- 11.1) ∼ ∼
North Dakota 9.1 ( 6.3- 13.0) 9.4 ( 6.5- 13.4) ∼ ∼
South Dakota
South
South Atlantic
Delaware 8.6 ( 6.1- 11.8) 9.0 ( 6.3- 12.8) ∼ ∼
District of Columbia 8.7 ( 5.8- 13.0) ∼ 9.3 ( 5.7- 15.3) ∼
Florida 8.9 ( 8.3- 9.5) 8.8 ( 8.2- 9.5) 9.7 ( 7.8- 11.8) -
Georgia 9.0 ( 8.1- 10.0) 8.8 ( 7.8- 9.9) 10.0 ( 8.0- 12.3) ∼
Atlanta 7.0 ( 5.6- 8.7) 6.4 ( 4.8- 8.3) 8.8 ( 5.9- 13.0) ∼
Maryland 7.6 ( 6.7- 8.7) 7.7 ( 6.6- 9.0) 8.7 ( 6.5- 11.4) ∼
North Carolina 9.0 ( 8.2- 9.9) 8.6 ( 7.7- 9.6) 11.3 ( 9.1- 13.8) ∼
South Carolina 8.9 ( 7.8- 10.3) 9.3 ( 7.9- 10.9) 7.6 ( 5.5- 10.2) -
Virginia
West Virginia 10.2 ( 8.5- 12.3) 10.4 ( 8.6- 12.6) ∼ ∼
East South Central
Alabama 8.6 ( 7.6- 9.9) 8.4 ( 7.2- 9.8) 9.0 ( 6.7- 11.9) ∼
Kentucky 10.3 ( 9.1- 11.8) 10.0 ( 8.7- 11.5) 16.4 ( 10.3- 25.0) -
Mississippi
Tennessee
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Table 2.11.1.1F: Kidney and Renal Pelvis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 11.5 ( 10.2- 12.9) 11.5 ( 10.0- 13.3) 11.5 ( 9.0- 14.5) ∼
Oklahoma 8.7 ( 7.4- 10.1) 8.4 ( 7.1- 10.0) ∼ ∼
Texas 10.6 ( 10.0- 11.3) 10.6 ( 9.9- 11.3) 12.4 ( 10.3- 14.8) 11.8 ( 10.4- 13.4)
West 7.8 ( 7.5- 8.1) 8.0 ( 7.7- 8.3) 10.0 ( 8.4- 11.9) 8.9 ( 8.0- 9.9)
Mountain 8.3 ( 7.8- 9.0) 8.3 ( 7.7- 9.0) 10.0 ( 6.0- 15.8) 11.5 ( 9.5- 13.9)
Arizona 9.3 ( 8.2- 10.5) 9.5 ( 8.3- 10.7) ∼ 12.1 ( 8.6- 16.7)
Colorado 8.5 ( 7.3- 9.8) 8.3 ( 7.1- 9.7) ∼ 13.9 ( 9.1- 20.5)
Idaho 10.5 ( 8.2- 13.3) 10.6 ( 8.2- 13.5) ∼ ∼
Montana 7.9 ( 5.7- 10.8) 7.8 ( 5.5- 10.8) ∼ ∼
Nevada 8.0 ( 6.4- 10.0) 8.0 ( 6.3- 10.1) ∼ ∼
New Mexico 7.2 ( 5.6- 9.1) 7.0 ( 5.4- 9.0) ∼ 10.2 ( 7.1- 14.4)
Utah 5.1 ( 3.7- 6.8) 5.2 ( 3.8- 6.9) ∼ ∼
Wyoming
Pacific 7.6 ( 7.2- 7.9) 7.9 ( 7.5- 8.3) 10.0 ( 8.3- 12.1) 8.0 ( 7.0- 9.1)
Alaska 8.9 ( 5.2- 14.5) ∼ ∼ ∼
California 7.4 ( 7.0- 7.8) 7.6 ( 7.2- 8.1) 9.9 ( 8.0- 12.0) 8.1 ( 7.1- 9.2)
San Francisco-Oakland 7.4 ( 6.3- 8.6) 7.9 ( 6.6- 9.5) 10.1 ( 6.3- 15.7) 7.6 ( 4.3- 12.4)
San Jose-Monterey 5.4 ( 4.2- 7.0) 6.3 ( 4.7- 8.2) ∼ ∼
Los Angeles 7.2 ( 6.5- 8.1) 7.5 ( 6.6- 8.5) 9.5 ( 6.9- 12.7) 7.7 ( 6.1- 9.5)
Hawaii 5.0 ( 3.5- 7.0) ∼ ∼ -
Oregon 8.5 ( 7.2- 9.9) 8.3 ( 7.0- 9.8) ∼ ∼
Washington 8.8 ( 7.8- 10.0) 8.8 ( 7.8- 10.0) ∼ ∼
Seattle-Puget Sound 8.8 ( 7.6- 10.2) 9.3 ( 8.0- 10.8) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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114 Table 2.11.1.2M: Kidney and Renal Pelvis. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 6.1 ( 6.0- 6.3) 6.3 ( 6.1- 6.4) 5.8 ( 5.4- 6.3) 5.3 ( 4.8- 5.9)
Northeast 5.7 ( 5.4- 6.0) 6.0 ( 5.7- 6.3) 4.0 ( 3.2- 5.1) 3.0 ( 1.9- 4.5)
New England 5.7 ( 5.2- 6.4) 5.9 ( 5.3- 6.6) ∼ ∼
Connecticut 5.0 ( 4.0- 6.3) 5.2 ( 4.1- 6.5) ∼ ∼
Maine 8.9 ( 6.7- 11.7) 9.0 ( 6.8- 11.8) ∼ ∼
Massachusetts 5.3 ( 4.5- 6.2) 5.6 ( 4.7- 6.5) ∼ ∼
New Hampshire 4.3 ( 2.7- 6.6) 4.3 ( 2.7- 6.6) ∼ ∼
Rhode Island 9.0 ( 6.5- 12.2) 9.2 ( 6.7- 12.5) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 5.7 ( 5.4- 6.1) 6.0 ( 5.6- 6.4) 4.2 ( 3.3- 5.4) 3.0 ( 1.9- 4.6)
New Jersey 7.0 ( 6.2- 7.9) 7.2 ( 6.3- 8.2) 6.7 ( 4.2- 10.6) ∼
New York 5.0 ( 4.6- 5.6) 5.4 ( 4.9- 6.0) 3.3 ( 2.2- 4.8) 2.8 ( 1.6- 4.8)
Pennsylvania 5.9 ( 5.3- 6.6) 6.0 ( 5.4- 6.7) 4.2 ( 2.4- 7.1) ∼
Midwest 6.7 ( 6.4- 7.0) 6.7 ( 6.4- 7.0) 6.8 ( 5.7- 8.2) 3.5 ( 2.0- 6.1)
East North Central 6.5 ( 6.2- 6.9) 6.5 ( 6.1- 6.9) 6.9 ( 5.6- 8.4) 3.2 ( 1.6- 6.0)
Illinois 6.3 ( 5.6- 7.0) 6.4 ( 5.7- 7.2) 6.1 ( 4.1- 9.0) ∼
Indiana 7.3 ( 6.3- 8.5) 7.4 ( 6.4- 8.6) ∼ ∼
Michigan 6.1 ( 5.4- 6.9) 5.8 ( 5.1- 6.7) 8.0 ( 5.5- 11.4) ∼
Ohio 6.4 ( 5.7- 7.1) 6.4 ( 5.7- 7.2) 6.3 ( 4.2- 9.5) ∼
Wisconsin 6.9 ( 5.9- 8.1) 6.8 ( 5.8- 8.0) ∼ ∼
West North Central 7.1 ( 6.5- 7.7) 7.1 ( 6.5- 7.7) 6.9 ( 4.2- 11.1) ∼
Iowa 8.3 ( 6.8- 9.9) 8.2 ( 6.8- 9.9) ∼ ∼
Kansas 6.9 ( 5.5- 8.5) 6.8 ( 5.4- 8.5) ∼ ∼
Minnesota 6.9 ( 5.8- 8.1) 6.9 ( 5.8- 8.2) ∼ ∼
Missouri 7.0 ( 6.0- 8.1) 7.1 ( 6.0- 8.3) ∼ ∼
Nebraska 7.1 ( 5.3- 9.2) 6.8 ( 5.0- 8.9) ∼ ∼
North Dakota 6.9 ( 4.3- 10.6) 6.8 ( 4.2- 10.5) ∼ ∼
South Dakota 4.9 ( 2.9- 7.8) 5.0 ( 3.0- 8.1) ∼ ∼
South 6.3 ( 6.1- 6.6) 6.4 ( 6.1- 6.7) 6.2 ( 5.5- 6.9) 6.3 ( 5.4- 7.4)
South Atlantic 5.9 ( 5.6- 6.2) 5.9 ( 5.6- 6.3) 6.0 ( 5.1- 6.9) 4.5 ( 3.4- 5.9)
Delaware 4.8 ( 2.8- 8.0) ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 5.4 ( 4.9- 5.9) 5.6 ( 5.1- 6.1) 3.8 ( 2.4- 5.9) 4.7 ( 3.5- 6.3)
Georgia 6.5 ( 5.6- 7.6) 6.4 ( 5.3- 7.6) 7.8 ( 5.5- 10.9) ∼
Maryland 5.7 ( 4.8- 6.9) 5.8 ( 4.7- 7.1) 6.5 ( 4.2- 10.0) ∼
North Carolina 6.3 ( 5.4- 7.2) 6.3 ( 5.4- 7.4) 6.0 ( 4.0- 8.8) ∼
South Carolina 6.4 ( 5.2- 7.8) 6.4 ( 5.1- 8.0) 6.9 ( 4.3- 10.6) ∼
Virginia 6.1 ( 5.3- 7.2) 6.3 ( 5.3- 7.4) 6.2 ( 4.1- 9.2) ∼
West Virginia 6.9 ( 5.2- 8.9) 7.0 ( 5.3- 9.0) ∼ ∼
East South Central 6.3 ( 5.7- 6.9) 6.4 ( 5.8- 7.1) 6.3 ( 4.8- 8.1) ∼
Alabama 5.5 ( 4.5- 6.7) 5.4 ( 4.3- 6.8) 5.8 ( 3.5- 9.2) ∼
Kentucky 6.6 ( 5.5- 8.0) 6.8 ( 5.6- 8.3) ∼ ∼
Mississippi 7.2 ( 5.7- 8.9) 7.7 ( 5.9- 9.9) 5.8 ( 3.4- 9.5) ∼
Tennessee 6.3 ( 5.3- 7.4) 6.2 ( 5.2- 7.4) 8.0 ( 5.0- 12.6) ∼
West South Central 7.2 ( 6.7- 7.7) 7.3 ( 6.8- 7.8) 6.7 ( 5.3- 8.3) 8.0 ( 6.6- 9.7)
Arkansas 6.9 ( 5.5- 8.5) 7.0 ( 5.5- 8.8) ∼ ∼
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Table 2.11.1.2M: Kidney and Renal Pelvis. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 6.8 ( 5.6- 8.1) 6.8 ( 5.5- 8.4) 6.7 ( 4.4- 9.9) ∼
Oklahoma 7.4 ( 6.1- 8.9) 7.2 ( 5.8- 8.7) ∼ ∼
Texas 7.3 ( 6.7- 7.9) 7.5 ( 6.9- 8.2) 6.7 ( 4.8- 9.3) 8.3 ( 6.8- 10.1)
West 5.6 ( 5.3- 5.9) 5.8 ( 5.5- 6.2) 5.7 ( 4.2- 7.8) 5.6 ( 4.8- 6.6)
Mountain 6.3 ( 5.7- 6.9) 6.2 ( 5.6- 6.8) ∼ 5.8 ( 4.2- 8.0)
Arizona 6.4 ( 5.5- 7.6) 6.2 ( 5.2- 7.4) ∼ 7.3 ( 4.3- 12.5)
Colorado 5.9 ( 4.7- 7.3) 5.9 ( 4.7- 7.3) ∼ ∼
Idaho 6.5 ( 4.6- 9.1) 6.5 ( 4.5- 9.0) ∼ ∼
Montana 7.6 ( 5.2- 10.7) 7.6 ( 5.2- 10.8) ∼ ∼
Nevada 6.1 ( 4.5- 8.1) 6.5 ( 4.8- 8.7) ∼ ∼
New Mexico 6.8 ( 5.1- 8.9) 6.5 ( 4.8- 8.7) ∼ 6.5 ( 3.7- 10.9)
Utah 5.5 ( 3.9- 7.6) 5.6 ( 3.9- 7.7) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 5.3 ( 5.0- 5.6) 5.7 ( 5.3- 6.1) 6.0 ( 4.3- 8.3) 5.5 ( 4.6- 6.7)
Alaska ∼ ∼ ∼ ∼
California 5.1 ( 4.7- 5.5) 5.5 ( 5.1- 6.0) 5.7 ( 3.9- 8.1) 5.6 ( 4.6- 6.8)
Hawaii 3.7 ( 2.3- 5.6) ∼ ∼ ∼
Oregon 6.0 ( 4.9- 7.4) 6.0 ( 4.9- 7.4) ∼ ∼
Washington 6.1 ( 5.2- 7.1) 6.1 ( 5.1- 7.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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116 Table 2.11.1.2F: Kidney and Renal Pelvis. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 2.8 ( 2.7- 2.8) 2.8 ( 2.7- 2.9) 2.8 ( 2.6- 3.1) 2.3 ( 2.0- 2.6)
Northeast 2.7 ( 2.5- 2.8) 2.8 ( 2.6- 3.0) 2.2 ( 1.7- 2.8) 1.2 ( 0.7- 1.9)
New England 2.6 ( 2.3- 3.0) 2.7 ( 2.3- 3.1) ∼ ∼
Connecticut 2.6 ( 1.9- 3.4) 2.5 ( 1.9- 3.4) ∼ ∼
Maine 3.8 ( 2.6- 5.5) 3.7 ( 2.5- 5.4) ∼ ∼
Massachusetts 2.3 ( 1.8- 2.8) 2.4 ( 1.9- 3.0) ∼ ∼
New Hampshire 3.2 ( 2.0- 4.9) 3.2 ( 2.0- 4.9) ∼ ∼
Rhode Island 3.2 ( 2.0- 4.9) 3.1 ( 1.9- 4.9) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.7 ( 2.5- 2.9) 2.8 ( 2.6- 3.1) 2.1 ( 1.6- 2.8) 1.4 ( 0.9- 2.2)
New Jersey 2.8 ( 2.4- 3.3) 3.0 ( 2.5- 3.6) ∼ ∼
New York 2.3 ( 2.0- 2.6) 2.5 ( 2.2- 2.9) 1.1 ( 0.7- 1.8) 1.5 ( 0.9- 2.5)
Pennsylvania 3.1 ( 2.7- 3.5) 3.1 ( 2.7- 3.6) 3.9 ( 2.5- 5.8) ∼
Midwest 3.0 ( 2.9- 3.2) 3.0 ( 2.9- 3.2) 3.5 ( 2.8- 4.3) ∼
East North Central 3.1 ( 2.9- 3.3) 3.0 ( 2.8- 3.3) 3.6 ( 2.9- 4.5) ∼
Illinois 2.9 ( 2.5- 3.3) 2.9 ( 2.5- 3.4) 3.3 ( 2.2- 4.8) ∼
Indiana 3.8 ( 3.2- 4.6) 3.6 ( 2.9- 4.3) 8.7 ( 5.2- 13.7) ∼
Michigan 2.7 ( 2.3- 3.2) 2.7 ( 2.3- 3.2) ∼ ∼
Ohio 3.0 ( 2.6- 3.5) 3.0 ( 2.6- 3.5) 4.0 ( 2.6- 5.9) ∼
Wisconsin 3.2 ( 2.6- 3.9) 3.3 ( 2.7- 4.0) ∼ ∼
West North Central 3.0 ( 2.7- 3.3) 3.0 ( 2.7- 3.4) ∼ ∼
Iowa 2.8 ( 2.1- 3.7) 2.8 ( 2.1- 3.7) ∼ ∼
Kansas 3.0 ( 2.2- 4.0) 3.1 ( 2.3- 4.2) ∼ ∼
Minnesota 2.4 ( 1.9- 3.1) 2.5 ( 1.9- 3.2) ∼ ∼
Missouri 2.9 ( 2.3- 3.5) 2.8 ( 2.3- 3.5) ∼ ∼
Nebraska 4.2 ( 3.1- 5.7) 4.4 ( 3.2- 6.0) ∼ ∼
North Dakota 4.5 ( 2.7- 7.3) 4.6 ( 2.7- 7.6) ∼ ∼
South Dakota 3.9 ( 2.2- 6.4) ∼ ∼ ∼
South 2.8 ( 2.6- 2.9) 2.8 ( 2.6- 2.9) 2.9 ( 2.5- 3.3) 2.4 ( 1.9- 2.9)
South Atlantic 2.4 ( 2.3- 2.6) 2.4 ( 2.2- 2.6) 2.7 ( 2.2- 3.2) 1.6 ( 1.1- 2.4)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.1 ( 1.9- 2.4) 2.2 ( 1.9- 2.5) 2.0 ( 1.2- 3.1) 1.7 ( 1.1- 2.5)
Georgia 3.0 ( 2.5- 3.6) 2.9 ( 2.4- 3.6) 3.3 ( 2.2- 4.8) ∼
Maryland 2.5 ( 1.9- 3.1) 2.3 ( 1.7- 3.1) 3.1 ( 1.8- 4.8) ∼
North Carolina 2.4 ( 2.0- 2.9) 2.2 ( 1.8- 2.8) 3.0 ( 1.9- 4.4) ∼
South Carolina 2.5 ( 1.9- 3.3) 2.7 ( 2.0- 3.6) ∼ ∼
Virginia 2.8 ( 2.3- 3.4) 2.8 ( 2.3- 3.5) 3.1 ( 1.9- 4.9) ∼
West Virginia 3.1 ( 2.2- 4.4) 3.1 ( 2.2- 4.4) ∼ ∼
East South Central 2.9 ( 2.6- 3.2) 2.8 ( 2.4- 3.2) 3.5 ( 2.7- 4.6) ∼
Alabama 2.6 ( 2.1- 3.3) 2.6 ( 1.9- 3.4) 3.0 ( 1.7- 4.8) ∼
Kentucky 3.0 ( 2.3- 3.8) 2.9 ( 2.2- 3.7) ∼ ∼
Mississippi 2.7 ( 2.0- 3.6) 2.4 ( 1.6- 3.6) 3.5 ( 2.0- 5.8) ∼
Tennessee 3.1 ( 2.6- 3.8) 3.0 ( 2.4- 3.7) 4.0 ( 2.3- 6.6) ∼
West South Central 3.3 ( 3.0- 3.6) 3.3 ( 3.0- 3.7) 2.9 ( 2.2- 3.8) 3.0 ( 2.3- 3.9)
Arkansas 2.4 ( 1.7- 3.2) 2.5 ( 1.7- 3.4) ∼ ∼
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Table 2.11.1.2F: Kidney and Renal Pelvis. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 3.3 ( 2.6- 4.1) 3.5 ( 2.7- 4.5) 2.5 ( 1.4- 4.1) ∼
Oklahoma 3.7 ( 2.9- 4.7) 3.7 ( 2.9- 4.8) ∼ ∼
Texas 3.3 ( 3.0- 3.7) 3.4 ( 3.0- 3.8) 3.6 ( 2.5- 5.0) 3.1 ( 2.4- 4.0)
West 2.5 ( 2.4- 2.7) 2.6 ( 2.4- 2.8) 2.7 ( 1.8- 3.7) 2.8 ( 2.2- 3.4)
Mountain 2.6 ( 2.3- 2.9) 2.4 ( 2.1- 2.8) ∼ 3.3 ( 2.2- 4.7)
Arizona 2.7 ( 2.2- 3.4) 2.7 ( 2.1- 3.4) ∼ ∼
Colorado 2.3 ( 1.7- 3.1) 2.1 ( 1.5- 2.9) ∼ ∼
Idaho 2.4 ( 1.4- 3.9) 2.5 ( 1.4- 4.0) ∼ ∼
Montana 3.3 ( 1.9- 5.4) 3.2 ( 1.9- 5.4) ∼ ∼
Nevada 2.1 ( 1.4- 3.3) 2.0 ( 1.2- 3.2) ∼ ∼
New Mexico 3.1 ( 2.1- 4.4) 2.9 ( 1.9- 4.3) ∼ ∼
Utah 2.2 ( 1.4- 3.5) 2.0 ( 1.1- 3.1) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 2.5 ( 2.3- 2.7) 2.7 ( 2.5- 2.9) 2.5 ( 1.7- 3.7) 2.6 ( 2.0- 3.3)
Alaska ∼ ∼ ∼ ∼
California 2.4 ( 2.2- 2.6) 2.6 ( 2.3- 2.8) 2.7 ( 1.8- 3.9) 2.6 ( 2.0- 3.3)
Hawaii ∼ ∼ ∼ ∼
Oregon 3.0 ( 2.3- 3.9) 3.1 ( 2.3- 4.0) ∼ ∼
Washington 3.0 ( 2.5- 3.7) 3.2 ( 2.6- 4.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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118 Table 2.12.1.1M: Larynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 7.2 ( 7.0- 7.3) 6.9 ( 6.7- 7.1) 11.1 ( 10.5- 11.8) 6.1 ( 5.6- 6.7)
Northeast 7.3 ( 6.9- 7.6) 7.1 ( 6.7- 7.4) 9.6 ( 8.3- 11.1) 7.9 ( 6.4- 9.8)
New England 7.1 ( 6.4- 7.8) 6.9 ( 6.3- 7.6) 13.1 ( 8.4- 20.1) ∼
Connecticut 7.7 ( 6.4- 9.2) 7.2 ( 5.9- 8.7) 17.1 ( 10.0- 31.0) ∼
Maine 6.8 ( 5.0- 9.2) 6.7 ( 4.9- 9.1) ∼ ∼
Massachusetts 7.0 ( 6.1- 8.0) 7.1 ( 6.1- 8.2) ∼ ∼
New Hampshire 6.5 ( 4.6- 9.1) 6.4 ( 4.5- 8.9) ∼ -
Rhode Island 7.0 ( 4.9- 9.8) 6.8 ( 4.6- 9.6) ∼ ∼
Vermont 5.8 ( 3.5- 9.4) 5.9 ( 3.5- 9.5) ∼ ∼
Middle Atlantic 7.4 ( 7.0- 7.8) 7.1 ( 6.7- 7.6) 9.2 ( 7.9- 10.7) 8.1 ( 6.5- 10.2)
New Jersey 7.2 ( 6.4- 8.1) 6.8 ( 6.0- 7.8) 11.0 ( 7.9- 15.3) 7.3 ( 4.6- 12.0)
New York 7.2 ( 6.6- 7.8) 7.1 ( 6.5- 7.7) 7.4 ( 5.9- 9.3) 8.1 ( 6.1- 10.8)
Pennsylvania 7.7 ( 7.0- 8.4) 7.4 ( 6.7- 8.1) 11.7 ( 8.7- 15.7) -
Midwest 7.4 ( 7.1- 7.7) 7.0 ( 6.6- 7.3) 12.4 ( 10.9- 14.1) 3.9 ( 2.4- 6.4)
East North Central 7.6 ( 7.3- 8.0) 7.1 ( 6.8- 7.5) 12.9 ( 11.2- 14.7) 3.8 ( 2.2- 6.6)
Illinois 8.5 ( 7.8- 9.4) 8.1 ( 7.3- 9.0) 13.5 ( 10.7- 17.1) ∼
Indiana 7.5 ( 6.5- 8.6) 7.2 ( 6.2- 8.3) 12.8 ( 8.1- 20.2) ∼
Michigan 7.1 ( 6.3- 7.9) 6.4 ( 5.7- 7.3) 13.3 ( 10.1- 17.2) ∼
Detroit 8.6 ( 7.3- 10.1) 7.4 ( 6.1- 9.0) 14.1 ( 10.4- 18.9) -
Ohio 7.8 ( 7.1- 8.6) 7.3 ( 6.5- 8.1) 12.1 ( 9.0- 16.2) ∼
Wisconsin 6.5 ( 5.5- 7.5) 6.2 ( 5.3- 7.3) ∼ -
West North Central 6.7 ( 6.2- 7.3) 6.5 ( 6.0- 7.1) 9.6 ( 6.4- 14.3) ∼
Iowa 7.0 ( 5.7- 8.5) 6.9 ( 5.6- 8.5) ∼ ∼
Kansas 6.6 ( 5.2- 8.2) 6.4 ( 5.0- 8.0) ∼ ∼
Minnesota 5.7 ( 4.7- 6.8) 5.4 ( 4.5- 6.5) ∼ ∼
Missouri 8.5 ( 7.4- 9.7) 8.4 ( 7.3- 9.7) 10.5 ( 6.4- 17.0) ∼
Nebraska 5.0 ( 3.6- 6.9) 5.0 ( 3.5- 6.8) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 11.4 ( 8.2- 15.6) 9.2 ( 6.2- 13.5) ∼ ∼
District of Columbia 12.2 ( 8.0- 17.9) ∼ 16.4 ( 10.5- 25.0) ∼
Florida 8.6 ( 8.0- 9.2) 8.5 ( 7.8- 9.1) 9.4 ( 7.4- 12.2) -
Georgia 8.8 ( 7.7- 10.0) 8.2 ( 7.1- 9.5) 10.8 ( 8.3- 14.0) ∼
Atlanta 7.2 ( 5.4- 9.4) 7.4 ( 5.3- 10.2) 5.7 ( 3.4- 11.0) ∼
Maryland 7.5 ( 6.4- 8.7) 6.9 ( 5.7- 8.2) 10.8 ( 7.8- 14.9) ∼
North Carolina 7.4 ( 6.6- 8.4) 6.3 ( 5.5- 7.3) 13.1 ( 10.3- 16.6) ∼
South Carolina 9.5 ( 8.1- 11.0) 8.6 ( 7.1- 10.3) 13.0 ( 9.7- 17.4) -
Virginia
West Virginia 9.7 ( 7.8- 11.9) 9.8 ( 7.9- 12.1) ∼ ∼
East South Central
Alabama 9.0 ( 7.7- 10.4) 8.1 ( 6.8- 9.6) 12.5 ( 9.2- 16.7) ∼
Kentucky 9.6 ( 8.2- 11.1) 9.7 ( 8.3- 11.3) ∼ -
Mississippi
Tennessee
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Table 2.12.1.1M: Larynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 10.4 ( 9.0- 12.0) 9.2 ( 7.7- 11.0) 14.7 ( 11.3- 18.9) ∼
Oklahoma 8.0 ( 6.6- 9.5) 7.8 ( 6.4- 9.4) ∼ ∼
Texas 7.3 ( 6.7- 7.9) 6.9 ( 6.3- 7.5) 12.8 ( 10.3- 15.9) 5.4 ( 4.2- 6.8)
West 5.3 ( 5.0- 5.5) 5.4 ( 5.1- 5.7) 7.8 ( 6.1- 9.8) 5.4 ( 4.6- 6.4)
Mountain 5.3 ( 4.8- 5.9) 5.4 ( 4.9- 6.0) ∼ 6.1 ( 4.5- 8.4)
Arizona 5.0 ( 4.2- 6.0) 5.1 ( 4.2- 6.1) ∼ ∼
Colorado 5.5 ( 4.4- 6.7) 5.5 ( 4.4- 6.8) ∼ ∼
Idaho 6.2 ( 4.4- 8.7) 6.3 ( 4.4- 8.8) ∼ ∼
Montana 5.8 ( 3.9- 8.5) 5.8 ( 3.8- 8.5) ∼ ∼
Nevada 6.2 ( 4.7- 8.2) 6.4 ( 4.9- 8.5) ∼ ∼
New Mexico 4.9 ( 3.5- 6.8) 5.0 ( 3.5- 6.9) ∼ 7.4 ( 4.4- 12.1)
Utah 4.5 ( 3.1- 6.4) 4.5 ( 3.1- 6.4) ∼ ∼
Wyoming
Pacific 5.2 ( 4.9- 5.6) 5.3 ( 5.0- 5.7) 8.1 ( 6.3- 10.4) 5.2 ( 4.2- 6.3)
Alaska ∼ ∼ ∼ ∼
California 5.5 ( 5.1- 5.9) 5.6 ( 5.2- 6.1) 8.4 ( 6.5- 10.9) 5.3 ( 4.3- 6.5)
San Francisco-Oakland 5.1 ( 4.1- 6.3) 5.1 ( 3.9- 6.5) ∼ ∼
San Jose-Monterey 3.4 ( 2.3- 4.9) 3.7 ( 2.4- 5.4) ∼ ∼
Los Angeles 5.9 ( 5.1- 6.8) 6.0 ( 5.1- 7.0) 9.0 ( 6.2- 13.1) 4.7 ( 3.2- 6.7)
Hawaii 5.2 ( 3.6- 7.4) 9.4 ( 5.3- 16.2) ∼ -
Oregon 5.2 ( 4.1- 6.4) 5.3 ( 4.3- 6.6) ∼ ∼
Washington 4.1 ( 3.4- 5.0) 4.0 ( 3.3- 4.9) ∼ ∼
Seattle-Puget Sound 4.3 ( 3.4- 5.4) 4.2 ( 3.3- 5.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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120 Table 2.12.1.1F: Larynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 1.5 ( 1.4- 1.6) 1.4 ( 1.4- 1.5) 2.3 ( 2.1- 2.6) 0.7 ( 0.6- 0.9)
Northeast 1.6 ( 1.5- 1.8) 1.6 ( 1.4- 1.7) 2.3 ( 1.8- 2.9) 1.1 ( 0.7- 1.8)
New England 1.4 ( 1.2- 1.7) 1.4 ( 1.2- 1.7) ∼ ∼
Connecticut 1.5 ( 1.0- 2.2) 1.5 ( 1.0- 2.2) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 1.4 ( 1.1- 1.9) 1.4 ( 1.1- 1.9) ∼ ∼
New Hampshire ∼ ∼ ∼ -
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.7 ( 1.5- 1.8) 1.6 ( 1.4- 1.8) 2.4 ( 1.9- 3.1) 1.2 ( 0.7- 1.9)
New Jersey 1.5 ( 1.2- 1.9) 1.5 ( 1.1- 1.9) 2.8 ( 1.6- 4.6) ∼
New York 1.6 ( 1.4- 1.9) 1.6 ( 1.3- 1.9) 2.0 ( 1.4- 2.8) ∼
Pennsylvania 1.8 ( 1.5- 2.2) 1.7 ( 1.4- 2.1) 3.0 ( 1.8- 4.7) -
Midwest 1.6 ( 1.5- 1.7) 1.5 ( 1.4- 1.6) 2.9 ( 2.3- 3.6) ∼
East North Central 1.6 ( 1.5- 1.8) 1.5 ( 1.3- 1.6) 2.8 ( 2.2- 3.6) ∼
Illinois 1.8 ( 1.5- 2.1) 1.5 ( 1.2- 1.9) 3.3 ( 2.2- 4.8) ∼
Indiana 1.9 ( 1.5- 2.4) 1.9 ( 1.4- 2.5) ∼ ∼
Michigan 1.6 ( 1.2- 1.9) 1.4 ( 1.1- 1.8) 2.4 ( 1.4- 4.0) ∼
Detroit 1.9 ( 1.3- 2.5) 1.7 ( 1.1- 2.5) ∼ -
Ohio 1.6 ( 1.3- 1.9) 1.4 ( 1.1- 1.8) 2.5 ( 1.5- 4.1) ∼
Wisconsin 1.2 ( 0.8- 1.7) 1.0 ( 0.7- 1.5) ∼ -
West North Central 1.6 ( 1.3- 1.8) 1.5 ( 1.3- 1.8) ∼ ∼
Iowa 2.0 ( 1.4- 2.8) 2.0 ( 1.3- 2.8) ∼ ∼
Kansas 1.6 ( 1.0- 2.4) 1.4 ( 0.8- 2.2) ∼ ∼
Minnesota 1.3 ( 0.9- 1.8) 1.1 ( 0.7- 1.6) ∼ ∼
Missouri 1.6 ( 1.2- 2.1) 1.6 ( 1.1- 2.1) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.7 ( 1.5- 2.0) 1.6 ( 1.4- 1.9) 2.3 ( 1.5- 3.5) -
Georgia 2.1 ( 1.7- 2.6) 2.0 ( 1.5- 2.6) 2.6 ( 1.6- 3.9) ∼
Atlanta 2.1 ( 1.3- 3.1) ∼ ∼ ∼
Maryland 1.6 ( 1.2- 2.1) 1.5 ( 1.0- 2.1) 2.2 ( 1.3- 3.8) ∼
North Carolina 1.5 ( 1.1- 1.9) 1.3 ( 0.9- 1.7) 2.1 ( 1.3- 3.4) ∼
South Carolina 1.7 ( 1.2- 2.3) 1.6 ( 1.1- 2.4) ∼ -
Virginia
West Virginia 2.2 ( 1.5- 3.4) 2.3 ( 1.5- 3.5) ∼ ∼
East South Central
Alabama 1.7 ( 1.3- 2.3) 1.9 ( 1.3- 2.6) ∼ ∼
Kentucky 2.0 ( 1.5- 2.7) 2.1 ( 1.5- 2.8) ∼ -
Mississippi
Tennessee
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Table 2.12.1.1F: Larynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 2.3 ( 1.7- 3.0) 1.8 ( 1.2- 2.6) 3.3 ( 2.0- 5.0) ∼
Oklahoma 2.3 ( 1.7- 3.1) 2.2 ( 1.5- 3.1) ∼ ∼
Texas 1.4 ( 1.1- 1.6) 1.3 ( 1.0- 1.5) 2.0 ( 1.3- 3.2) 0.8 ( 0.5- 1.4)
West 1.0 ( 0.9- 1.1) 1.0 ( 0.9- 1.2) 1.7 ( 1.1- 2.5) 0.4 ( 0.2- 0.7)
Mountain 1.1 ( 0.9- 1.4) 1.2 ( 1.0- 1.4) ∼ ∼
Arizona 0.9 ( 0.6- 1.3) 0.9 ( 0.6- 1.4) ∼ ∼
Colorado 1.5 ( 1.0- 2.2) 1.5 ( 1.0- 2.2) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 0.9 ( 0.8- 1.1) 1.0 ( 0.8- 1.1) 1.9 ( 1.2- 2.9) ∼
Alaska ∼ ∼ ∼ ∼
California 1.0 ( 0.9- 1.2) 1.0 ( 0.9- 1.2) 1.8 ( 1.1- 2.8) ∼
San Francisco-Oakland 0.9 ( 0.5- 1.4) ∼ ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles 0.9 ( 0.6- 1.2) 0.9 ( 0.6- 1.2) ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon 0.8 ( 0.5- 1.4) 0.9 ( 0.5- 1.5) ∼ ∼
Washington 0.9 ( 0.6- 1.3) 0.8 ( 0.5- 1.3) ∼ ∼
Seattle-Puget Sound 0.9 ( 0.5- 1.4) ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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122 Table 2.12.1.2M: Larynx. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 2.3 ( 2.2- 2.4) 2.1 ( 2.1- 2.2) 4.8 ( 4.4- 5.3) 1.8 ( 1.5- 2.1)
Northeast 2.6 ( 2.4- 2.8) 2.5 ( 2.3- 2.7) 4.8 ( 4.0- 6.0) 2.9 ( 2.0- 4.3)
New England 2.5 ( 2.1- 2.9) 2.5 ( 2.1- 2.9) ∼ ∼
Connecticut 2.5 ( 1.8- 3.5) 2.5 ( 1.8- 3.5) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 2.8 ( 2.2- 3.5) 2.9 ( 2.3- 3.7) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island 3.4 ( 2.0- 5.5) 3.4 ( 1.9- 5.5) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.7 ( 2.4- 2.9) 2.5 ( 2.2- 2.7) 5.1 ( 4.1- 6.3) 3.0 ( 1.9- 4.5)
New Jersey 2.4 ( 1.9- 2.9) 2.1 ( 1.6- 2.6) 5.4 ( 3.3- 9.0) ∼
New York 2.8 ( 2.4- 3.1) 2.6 ( 2.2- 3.0) 4.5 ( 3.3- 6.1) 3.4 ( 2.1- 5.6)
Pennsylvania 2.8 ( 2.4- 3.2) 2.5 ( 2.1- 3.0) 6.3 ( 4.2- 9.4) ∼
Midwest 2.2 ( 2.0- 2.4) 2.0 ( 1.9- 2.2) 4.9 ( 3.9- 6.0) ∼
East North Central 2.3 ( 2.1- 2.6) 2.1 ( 1.9- 2.3) 5.2 ( 4.2- 6.5) ∼
Illinois 2.6 ( 2.2- 3.1) 2.4 ( 2.0- 2.9) 4.4 ( 2.8- 6.9) ∼
Indiana 2.3 ( 1.8- 3.0) 2.0 ( 1.5- 2.7) ∼ ∼
Michigan 2.4 ( 2.0- 2.9) 2.0 ( 1.6- 2.5) 5.5 ( 3.6- 8.3) ∼
Ohio 2.5 ( 2.1- 3.0) 2.2 ( 1.8- 2.7) 5.6 ( 3.5- 8.6) ∼
Wisconsin 1.5 ( 1.0- 2.1) 1.4 ( 1.0- 2.0) ∼ ∼
West North Central 1.9 ( 1.6- 2.2) 1.9 ( 1.6- 2.2) ∼ ∼
Iowa 2.2 ( 1.5- 3.1) 2.1 ( 1.4- 3.1) ∼ ∼
Kansas 1.7 ( 1.1- 2.7) 1.8 ( 1.1- 2.8) ∼ ∼
Minnesota 1.4 ( 1.0- 2.1) 1.4 ( 0.9- 2.0) ∼ ∼
Missouri 2.5 ( 1.9- 3.2) 2.4 ( 1.8- 3.2) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.6 ( 2.5- 2.8) 2.3 ( 2.1- 2.4) 5.0 ( 4.5- 5.7) 1.7 ( 1.3- 2.3)
South Atlantic 2.7 ( 2.5- 2.9) 2.3 ( 2.1- 2.5) 5.5 ( 4.7- 6.4) 1.6 ( 1.0- 2.5)
Delaware ∼ ∼ ∼ ∼
District of Columbia 6.8 ( 3.8- 11.4) ∼ ∼ ∼
Florida 2.6 ( 2.2- 2.9) 2.4 ( 2.1- 2.8) 4.7 ( 3.3- 6.7) 1.8 ( 1.1- 2.9)
Georgia 3.0 ( 2.4- 3.8) 2.5 ( 1.9- 3.3) 5.3 ( 3.5- 7.9) ∼
Maryland 2.3 ( 1.7- 3.1) 2.0 ( 1.4- 2.8) 3.7 ( 2.2- 6.5) ∼
North Carolina 3.2 ( 2.6- 3.9) 2.3 ( 1.8- 3.0) 7.8 ( 5.5- 10.9) ∼
South Carolina 3.4 ( 2.6- 4.4) 2.8 ( 2.0- 3.9) 5.9 ( 3.6- 9.4) ∼
Virginia 2.2 ( 1.7- 2.8) 1.9 ( 1.4- 2.6) 3.4 ( 1.9- 5.8) ∼
West Virginia 2.7 ( 1.8- 4.1) 2.7 ( 1.7- 4.1) ∼ ∼
East South Central 2.5 ( 2.1- 2.9) 2.3 ( 1.9- 2.7) 4.0 ( 2.8- 5.5) ∼
Alabama 2.4 ( 1.7- 3.2) 2.0 ( 1.4- 2.9) ∼ ∼
Kentucky 3.1 ( 2.4- 4.1) 3.1 ( 2.3- 4.1) ∼ ∼
Mississippi 2.5 ( 1.6- 3.7) 2.1 ( 1.2- 3.6) ∼ ∼
Tennessee 2.1 ( 1.6- 2.8) 1.9 ( 1.4- 2.7) ∼ ∼
West South Central 2.5 ( 2.2- 2.8) 2.2 ( 1.9- 2.5) 4.9 ( 3.7- 6.3) 1.9 ( 1.2- 2.9)
Arkansas 2.3 ( 1.5- 3.3) 2.2 ( 1.4- 3.3) ∼ ∼
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Table 2.12.1.2M: Larynx. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 2.7 ( 2.0- 3.6) 2.1 ( 1.4- 3.1) 4.8 ( 2.9- 7.6) ∼
Oklahoma 2.3 ( 1.6- 3.2) 2.1 ( 1.4- 3.1) ∼ ∼
Texas 2.5 ( 2.2- 2.9) 2.3 ( 1.9- 2.7) 5.4 ( 3.7- 7.7) 2.0 ( 1.3- 3.0)
West 1.7 ( 1.6- 1.9) 1.8 ( 1.6- 2.0) 3.6 ( 2.5- 5.1) 1.6 ( 1.1- 2.2)
Mountain 1.4 ( 1.2- 1.7) 1.4 ( 1.1- 1.7) ∼ ∼
Arizona 1.9 ( 1.4- 2.6) 1.9 ( 1.4- 2.6) ∼ ∼
Colorado 1.2 ( 0.7- 2.0) 1.1 ( 0.7- 1.9) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.9 ( 1.7- 2.1) 2.0 ( 1.8- 2.2) 3.6 ( 2.4- 5.3) 1.6 ( 1.1- 2.3)
Alaska ∼ ∼ ∼ ∼
California 1.9 ( 1.7- 2.1) 1.9 ( 1.7- 2.2) 3.8 ( 2.5- 5.6) 1.6 ( 1.1- 2.3)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.1 ( 1.5- 3.0) 2.2 ( 1.5- 3.1) ∼ ∼
Washington 1.9 ( 1.4- 2.6) 2.0 ( 1.5- 2.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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124 Table 2.12.1.2F: Larynx. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 0.5 ( 0.5- 0.5) 0.5 ( 0.4- 0.5) 0.8 ( 0.7- 1.0) 0.3 ( 0.2- 0.4)
Northeast 0.6 ( 0.5- 0.7) 0.5 ( 0.5- 0.6) 1.1 ( 0.7- 1.5) ∼
New England 0.6 ( 0.5- 0.8) 0.6 ( 0.5- 0.9) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.7 ( 0.4- 1.0) 0.7 ( 0.5- 1.1) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.6 ( 0.5- 0.7) 0.5 ( 0.4- 0.6) 1.2 ( 0.8- 1.6) ∼
New Jersey 0.5 ( 0.4- 0.8) 0.5 ( 0.3- 0.8) ∼ ∼
New York 0.6 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) 1.1 ( 0.7- 1.8) ∼
Pennsylvania 0.5 ( 0.4- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Midwest 0.5 ( 0.5- 0.6) 0.5 ( 0.4- 0.6) 1.2 ( 0.8- 1.6) ∼
East North Central 0.6 ( 0.5- 0.7) 0.5 ( 0.4- 0.6) 0.9 ( 0.6- 1.4) ∼
Illinois 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Indiana 0.8 ( 0.6- 1.2) 0.8 ( 0.6- 1.2) ∼ ∼
Michigan 0.5 ( 0.3- 0.8) 0.5 ( 0.3- 0.8) ∼ ∼
Ohio 0.7 ( 0.5- 0.9) 0.6 ( 0.4- 0.8) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.5) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri 0.6 ( 0.4- 0.9) ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.5 ( 0.5- 0.6) 0.5 ( 0.4- 0.5) 0.7 ( 0.5- 0.9) ∼
South Atlantic 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) 0.8 ( 0.5- 1.1) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) ∼ ∼
Georgia 0.5 ( 0.3- 0.7) ∼ ∼ ∼
Maryland 0.7 ( 0.4- 1.1) ∼ ∼ ∼
North Carolina 0.4 ( 0.3- 0.7) ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia 0.6 ( 0.4- 0.9) ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.6 ( 0.5- 0.8) 0.6 ( 0.4- 0.8) ∼ ∼
Alabama 0.7 ( 0.4- 1.1) ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee 0.6 ( 0.4- 1.0) 0.6 ( 0.3- 1.0) ∼ ∼
West South Central 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.12.1.2F: Larynx. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.4 ( 0.3- 0.5) 0.4 ( 0.2- 0.5) ∼ ∼
West 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Mountain 0.4 ( 0.3- 0.6) 0.5 ( 0.3- 0.6) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington 0.5 ( 0.3- 0.8) ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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126 Table 2.13.1.1M: Leukemias. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 14.6 ( 14.4- 14.8) 15.0 ( 14.7- 15.2) 11.0 ( 10.3- 11.7) 11.7 ( 10.9- 12.5)
Northeast 15.3 ( 14.8- 15.8) 15.6 ( 15.1- 16.2) 10.7 ( 9.3- 12.3) 10.6 ( 8.8- 12.7)
New England 14.9 ( 13.9- 15.8) 15.1 ( 14.1- 16.1) 8.9 ( 5.1- 15.2) 8.5 ( 4.4- 16.1)
Connecticut 13.8 ( 12.0- 15.8) 14.0 ( 12.1- 16.1) ∼ ∼
Maine 19.7 ( 16.3- 23.5) 19.0 ( 15.7- 22.9) ∼ ∼
Massachusetts 13.4 ( 12.1- 14.8) 13.8 ( 12.4- 15.3) ∼ ∼
New Hampshire 19.0 ( 15.5- 23.1) 18.1 ( 14.7- 22.2) ∼ -
Rhode Island 15.0 ( 11.8- 18.9) 15.5 ( 12.1- 19.5) ∼ ∼
Vermont 16.5 ( 12.2- 22.1) 16.8 ( 12.4- 22.4) ∼ ∼
Middle Atlantic 15.5 ( 14.9- 16.1) 15.9 ( 15.2- 16.5) 11.0 ( 9.5- 12.7) 11.0 ( 9.1- 13.3)
New Jersey 15.7 ( 14.5- 17.1) 15.5 ( 14.2- 16.9) 13.5 ( 9.8- 18.5) 11.4 ( 7.6- 17.2)
New York 15.2 ( 14.3- 16.0) 15.9 ( 14.9- 16.8) 11.0 ( 9.0- 13.4) 10.6 ( 8.4- 13.5)
Pennsylvania 15.8 ( 14.9- 16.9) 16.1 ( 15.1- 17.2) 9.0 ( 6.4- 12.6) -
Midwest 15.5 ( 15.0- 15.9) 15.5 ( 15.1- 16.0) 11.2 ( 9.7- 12.8) 11.7 ( 9.0- 15.4)
East North Central 15.3 ( 14.7- 15.8) 15.5 ( 14.9- 16.1) 10.9 ( 9.3- 12.6) 11.8 ( 8.8- 16.0)
Illinois 16.5 ( 15.4- 17.7) 16.8 ( 15.6- 18.0) 12.3 ( 9.5- 15.9) 13.4 ( 8.9- 20.2)
Indiana 15.8 ( 14.3- 17.4) 16.0 ( 14.5- 17.8) 8.8 ( 5.0- 15.1) ∼
Michigan 13.6 ( 12.6- 14.8) 14.1 ( 12.9- 15.4) 8.7 ( 6.1- 12.1) ∼
Detroit 15.2 ( 13.4- 17.3) 16.9 ( 14.7- 19.3) 8.4 ( 5.6- 12.4) -
Ohio 14.0 ( 13.0- 15.1) 14.0 ( 12.9- 15.1) 11.2 ( 8.2- 15.2) ∼
Wisconsin 17.8 ( 16.2- 19.6) 17.8 ( 16.1- 19.6) ∼ -
West North Central 15.8 ( 15.0- 16.7) 15.7 ( 14.8- 16.6) 12.9 ( 9.0- 18.3) 11.1 ( 5.5- 21.6)
Iowa 17.8 ( 15.7- 20.2) 17.8 ( 15.6- 20.1) ∼ ∼
Kansas 14.3 ( 12.3- 16.6) 14.1 ( 12.0- 16.5) ∼ ∼
Minnesota 17.9 ( 16.2- 19.8) 17.5 ( 15.8- 19.5) ∼ ∼
Missouri 14.4 ( 13.0- 16.0) 14.2 ( 12.7- 15.9) 14.1 ( 9.1- 21.4) ∼
Nebraska 14.1 ( 11.6- 17.0) 14.1 ( 11.6- 17.1) ∼ ∼
North Dakota 14.8 ( 10.9- 19.8) 14.5 ( 10.6- 19.6) ∼ ∼
South Dakota
South
South Atlantic
Delaware 12.1 ( 8.8- 16.4) 12.8 ( 9.1- 17.6) ∼ ∼
District of Columbia 7.5 ( 4.4- 12.2) ∼ ∼ ∼
Florida 13.9 ( 13.2- 14.7) 14.3 ( 13.5- 15.2) 10.1 ( 7.8- 13.0) -
Georgia 13.3 ( 12.0- 14.7) 13.7 ( 12.2- 15.3) 11.7 ( 9.0- 15.2) ∼
Atlanta 14.1 ( 11.6- 17.1) 14.7 ( 11.8- 18.2) 13.8 ( 8.7- 21.9) ∼
Maryland 10.3 ( 9.0- 11.8) 10.6 ( 9.0- 12.3) 8.7 ( 6.1- 12.4) ∼
North Carolina 11.2 ( 10.1- 12.4) 11.8 ( 10.5- 13.2) 7.1 ( 5.0- 9.9) ∼
South Carolina 15.6 ( 13.7- 17.7) 15.8 ( 13.7- 18.2) 12.3 ( 8.9- 16.8) -
Virginia
West Virginia 13.0 ( 10.8- 15.6) 13.1 ( 10.8- 15.7) ∼ ∼
East South Central
Alabama 13.0 ( 11.4- 14.8) 13.9 ( 12.0- 15.9) 9.8 ( 6.8- 13.8) ∼
Kentucky 16.0 ( 14.1- 18.1) 16.1 ( 14.1- 18.3) ∼ -
Mississippi
Tennessee
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Table 2.13.1.1M: Leukemias. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 15.4 ( 13.6- 17.3) 16.7 ( 14.5- 19.1) 12.0 ( 9.0- 15.9) ∼
Oklahoma 14.9 ( 13.0- 16.9) 14.9 ( 12.9- 17.1) ∼ ∼
Texas 14.7 ( 13.8- 15.6) 14.9 ( 14.0- 15.9) 13.5 ( 10.7- 16.8) 10.8 ( 9.2- 12.7)
West 14.3 ( 13.8- 14.8) 14.7 ( 14.2- 15.2) 11.9 ( 9.7- 14.4) 12.3 ( 11.1- 13.6)
Mountain 14.3 ( 13.4- 15.2) 14.5 ( 13.6- 15.4) ∼ 13.5 ( 11.0- 16.5)
Arizona 11.5 ( 10.2- 12.9) 11.5 ( 10.1- 13.0) ∼ 10.2 ( 7.2- 15.1)
Colorado 15.7 ( 13.8- 17.9) 15.5 ( 13.5- 17.6) ∼ 19.3 ( 12.4- 29.4)
Idaho 16.5 ( 13.3- 20.3) 16.5 ( 13.3- 20.3) ∼ ∼
Montana 15.0 ( 11.6- 19.1) 14.9 ( 11.5- 19.2) ∼ ∼
Nevada 12.2 ( 10.0- 14.8) 13.0 ( 10.6- 15.9) ∼ ∼
New Mexico 17.8 ( 15.0- 21.1) 18.8 ( 15.8- 22.3) ∼ 14.7 ( 10.4- 20.5)
Utah 16.8 ( 14.0- 20.0) 17.1 ( 14.3- 20.5) ∼ ∼
Wyoming
Pacific 14.3 ( 13.8- 14.9) 14.9 ( 14.3- 15.5) 13.3 ( 10.9- 16.3) 11.8 ( 10.5- 13.4)
Alaska 10.3 ( 6.3- 17.9) 9.9 ( 5.4- 19.0) ∼ ∼
California 13.9 ( 13.3- 14.6) 14.5 ( 13.8- 15.3) 13.8 ( 11.2- 17.0) 11.7 ( 10.3- 13.3)
San Francisco-Oakland 12.1 ( 10.6- 13.9) 13.2 ( 11.3- 15.5) 10.4 ( 5.9- 17.7) 12.9 ( 7.8- 20.8)
San Jose-Monterey 14.2 ( 11.9- 17.0) 15.3 ( 12.5- 18.6) ∼ 8.8 ( 5.1- 16.4)
Los Angeles 13.4 ( 12.2- 14.6) 14.2 ( 12.8- 15.7) 14.6 ( 10.7- 19.7) 10.7 ( 8.6- 13.2)
Hawaii 13.0 ( 10.3- 16.3) 15.1 ( 9.7- 23.2) ∼ -
Oregon 12.8 ( 11.2- 14.7) 12.7 ( 11.0- 14.7) ∼ ∼
Washington 17.5 ( 15.9- 19.3) 17.8 ( 16.2- 19.7) ∼ 19.8 ( 9.1- 39.7)
Seattle-Puget Sound 18.1 ( 16.2- 20.3) 19.1 ( 16.9- 21.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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128 Table 2.13.1.1F: Leukemias. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 8.8 ( 8.7- 9.0) 8.9 ( 8.8- 9.1) 7.1 ( 6.7- 7.5) 7.7 ( 7.2- 8.2)
Northeast 9.1 ( 8.7- 9.4) 9.2 ( 8.8- 9.5) 6.7 ( 5.9- 7.7) 7.9 ( 6.7- 9.3)
New England 8.9 ( 8.3- 9.6) 9.0 ( 8.3- 9.7) 6.8 ( 4.3- 10.3) 8.8 ( 5.3- 14.1)
Connecticut 8.7 ( 7.4- 10.1) 9.0 ( 7.7- 10.5) ∼ ∼
Maine 9.1 ( 7.1- 11.6) 8.9 ( 6.9- 11.4) ∼ ∼
Massachusetts 9.1 ( 8.1- 10.1) 9.2 ( 8.2- 10.3) ∼ ∼
New Hampshire 7.5 ( 5.6- 9.9) 6.9 ( 5.1- 9.3) ∼ -
Rhode Island 9.8 ( 7.5- 12.7) 10.0 ( 7.6- 13.1) ∼ ∼
Vermont 9.5 ( 6.5- 13.7) 9.6 ( 6.6- 13.8) ∼ ∼
Middle Atlantic 9.1 ( 8.7- 9.5) 9.2 ( 8.8- 9.7) 6.7 ( 5.8- 7.8) 7.8 ( 6.5- 9.4)
New Jersey 9.5 ( 8.6- 10.4) 9.2 ( 8.3- 10.2) 7.7 ( 5.6- 10.4) 8.9 ( 6.3- 12.5)
New York 8.8 ( 8.3- 9.4) 9.1 ( 8.5- 9.8) 6.5 ( 5.3- 7.8) 6.9 ( 5.4- 8.6)
Pennsylvania 9.4 ( 8.7- 10.2) 9.4 ( 8.7- 10.2) 6.6 ( 4.8- 8.9) -
Midwest 9.3 ( 9.0- 9.6) 9.3 ( 9.0- 9.6) 7.6 ( 6.6- 8.6) 8.9 ( 7.0- 11.5)
East North Central 9.3 ( 8.9- 9.6) 9.3 ( 8.9- 9.7) 7.6 ( 6.6- 8.8) 8.9 ( 6.7- 11.8)
Illinois 9.6 ( 8.9- 10.4) 9.8 ( 9.0- 10.6) 8.5 ( 6.6- 10.7) 9.1 ( 6.3- 13.2)
Indiana 9.2 ( 8.2- 10.3) 9.3 ( 8.2- 10.4) 6.8 ( 3.9- 11.2) ∼
Michigan 9.2 ( 8.4- 10.0) 9.1 ( 8.3- 10.0) 7.1 ( 5.2- 9.5) ∼
Detroit 10.2 ( 8.9- 11.6) 10.7 ( 9.1- 12.4) 7.2 ( 5.0- 10.0) -
Ohio 8.3 ( 7.6- 9.1) 8.2 ( 7.5- 9.0) 7.0 ( 5.1- 9.4) ∼
Wisconsin 10.7 ( 9.6- 11.9) 10.7 ( 9.5- 12.0) ∼ -
West North Central 9.4 ( 8.8- 10.0) 9.3 ( 8.7- 9.9) 7.1 ( 4.9- 10.0) 9.3 ( 5.1- 16.6)
Iowa 10.7 ( 9.2- 12.4) 10.5 ( 9.0- 12.2) ∼ ∼
Kansas 8.5 ( 7.1- 10.1) 8.6 ( 7.1- 10.3) ∼ ∼
Minnesota 9.7 ( 8.5- 10.9) 9.6 ( 8.4- 10.9) ∼ ∼
Missouri 8.6 ( 7.6- 9.7) 8.5 ( 7.5- 9.7) 9.3 ( 6.2- 13.5) ∼
Nebraska 10.9 ( 8.9- 13.2) 10.5 ( 8.5- 12.8) ∼ ∼
North Dakota 7.6 ( 5.1- 11.1) 7.8 ( 5.2- 11.4) ∼ ∼
South Dakota
South
South Atlantic
Delaware 6.4 ( 4.3- 9.3) 5.3 ( 3.2- 8.5) ∼ ∼
District of Columbia 5.5 ( 3.2- 9.3) ∼ ∼ ∼
Florida 9.0 ( 8.4- 9.6) 9.2 ( 8.6- 9.9) 8.5 ( 6.8- 10.6) -
Georgia 8.7 ( 7.8- 9.7) 9.3 ( 8.2- 10.5) 6.9 ( 5.3- 8.9) ∼
Atlanta 8.1 ( 6.5- 9.9) 9.9 ( 7.8- 12.3) 4.7 ( 2.5- 8.1) ∼
Maryland 6.6 ( 5.7- 7.6) 7.1 ( 6.0- 8.3) 5.4 ( 3.8- 7.7) ∼
North Carolina 7.1 ( 6.3- 7.9) 7.2 ( 6.3- 8.2) 6.7 ( 5.0- 8.6) ∼
South Carolina 9.7 ( 8.5- 11.1) 9.4 ( 7.9- 11.0) 8.3 ( 6.1- 11.0) -
Virginia
West Virginia 7.3 ( 5.7- 9.1) 7.4 ( 5.9- 9.4) ∼ ∼
East South Central
Alabama 8.0 ( 7.0- 9.2) 8.8 ( 7.5- 10.3) 5.5 ( 3.8- 7.8) ∼
Kentucky 7.9 ( 6.8- 9.2) 7.9 ( 6.8- 9.2) ∼ -
Mississippi
Tennessee
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Table 2.13.1.1F: Leukemias. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 8.8 ( 7.7- 10.1) 9.2 ( 7.8- 10.8) 8.1 ( 6.0- 10.6) ∼
Oklahoma 9.1 ( 7.8- 10.6) 8.9 ( 7.5- 10.5) ∼ ∼
Texas 8.8 ( 8.3- 9.4) 9.1 ( 8.5- 9.7) 6.7 ( 5.2- 8.6) 6.9 ( 5.9- 8.1)
West 8.5 ( 8.2- 8.9) 8.7 ( 8.4- 9.1) 7.7 ( 6.3- 9.3) 7.1 ( 6.4- 7.9)
Mountain 8.7 ( 8.1- 9.4) 8.8 ( 8.2- 9.5) ∼ 6.9 ( 5.4- 8.6)
Arizona 7.2 ( 6.2- 8.2) 7.4 ( 6.4- 8.5) ∼ 7.0 ( 4.6- 10.5)
Colorado 9.1 ( 7.9- 10.5) 9.0 ( 7.7- 10.4) ∼ 7.9 ( 4.7- 12.9)
Idaho 12.3 ( 9.8- 15.2) 12.5 ( 10.0- 15.5) ∼ ∼
Montana 10.9 ( 8.2- 14.3) 9.5 ( 7.0- 12.8) ∼ ∼
Nevada 9.2 ( 7.4- 11.2) 9.1 ( 7.2- 11.3) ∼ ∼
New Mexico 9.2 ( 7.4- 11.3) 9.7 ( 7.7- 12.0) ∼ 7.3 ( 4.7- 11.0)
Utah 8.6 ( 6.8- 10.7) 8.8 ( 7.0- 11.0) ∼ ∼
Wyoming
Pacific 8.5 ( 8.1- 8.9) 8.7 ( 8.3- 9.1) 8.2 ( 6.6- 10.1) 7.2 ( 6.4- 8.1)
Alaska 7.9 ( 4.5- 13.4) ∼ ∼ ∼
California 8.4 ( 8.0- 8.9) 8.6 ( 8.1- 9.1) 8.8 ( 7.1- 10.8) 7.3 ( 6.4- 8.3)
San Francisco-Oakland 7.7 ( 6.6- 9.0) 8.1 ( 6.7- 9.7) ∼ 7.4 ( 4.5- 11.8)
San Jose-Monterey 6.9 ( 5.5- 8.6) 7.1 ( 5.5- 9.1) ∼ ∼
Los Angeles 9.0 ( 8.2- 9.9) 9.4 ( 8.4- 10.4) 9.4 ( 6.8- 12.6) 7.9 ( 6.5- 9.5)
Hawaii 7.0 ( 5.2- 9.4) ∼ ∼ -
Oregon 7.7 ( 6.5- 9.1) 7.8 ( 6.5- 9.2) ∼ ∼
Washington 9.6 ( 8.6- 10.8) 9.7 ( 8.6- 11.0) ∼ ∼
Seattle-Puget Sound 8.9 ( 7.7- 10.3) 9.2 ( 7.9- 10.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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130 Table 2.13.1.2M: Leukemias. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 10.1 ( 9.9- 10.3) 10.4 ( 10.2- 10.6) 8.8 ( 8.2- 9.4) 6.1 ( 5.6- 6.8)
Northeast 9.7 ( 9.3- 10.1) 10.1 ( 9.6- 10.5) 6.9 ( 5.8- 8.3) 4.4 ( 3.2- 6.0)
New England 9.4 ( 8.7- 10.2) 9.5 ( 8.7- 10.3) 9.3 ( 5.3- 16.0) ∼
Connecticut 8.9 ( 7.4- 10.5) 9.0 ( 7.5- 10.7) ∼ ∼
Maine 13.6 ( 10.8- 17.0) 13.5 ( 10.7- 16.9) ∼ ∼
Massachusetts 8.1 ( 7.1- 9.3) 8.1 ( 7.1- 9.3) ∼ ∼
New Hampshire 13.1 ( 10.2- 16.8) 13.2 ( 10.1- 16.9) ∼ ∼
Rhode Island 8.8 ( 6.3- 11.9) 8.7 ( 6.3- 11.9) ∼ ∼
Vermont 10.4 ( 6.9- 15.2) 10.5 ( 7.0- 15.4) ∼ ∼
Middle Atlantic 9.8 ( 9.3- 10.2) 10.3 ( 9.8- 10.8) 6.7 ( 5.5- 8.1) 4.2 ( 2.9- 5.9)
New Jersey 10.5 ( 9.5- 11.7) 10.7 ( 9.6- 12.0) 10.6 ( 7.3- 15.4) 3.8 ( 1.9- 7.8)
New York 9.2 ( 8.5- 9.9) 9.9 ( 9.1- 10.7) 5.7 ( 4.2- 7.6) 4.2 ( 2.6- 6.5)
Pennsylvania 10.1 ( 9.3- 11.0) 10.5 ( 9.7- 11.4) 5.6 ( 3.5- 8.8) ∼
Midwest 10.8 ( 10.4- 11.2) 10.9 ( 10.5- 11.3) 10.0 ( 8.6- 11.7) 4.5 ( 2.8- 7.2)
East North Central 10.6 ( 10.2- 11.1) 10.8 ( 10.3- 11.3) 9.5 ( 7.9- 11.2) 4.3 ( 2.6- 7.4)
Illinois 11.2 ( 10.2- 12.1) 11.6 ( 10.6- 12.6) 8.7 ( 6.2- 12.0) 5.6 ( 2.7- 11.0)
Indiana 10.4 ( 9.2- 11.8) 10.7 ( 9.4- 12.2) ∼ ∼
Michigan 10.4 ( 9.5- 11.5) 10.6 ( 9.5- 11.7) 9.7 ( 6.9- 13.4) ∼
Ohio 10.9 ( 10.0- 11.9) 11.0 ( 10.0- 12.0) 11.4 ( 8.1- 15.6) ∼
Wisconsin 9.4 ( 8.2- 10.7) 9.6 ( 8.3- 10.9) ∼ ∼
West North Central 11.1 ( 10.4- 11.8) 11.0 ( 10.3- 11.7) 13.2 ( 9.1- 18.6) ∼
Iowa 10.8 ( 9.2- 12.7) 10.7 ( 9.0- 12.6) ∼ ∼
Kansas 10.5 ( 8.7- 12.5) 10.3 ( 8.5- 12.4) ∼ ∼
Minnesota 11.0 ( 9.6- 12.5) 11.0 ( 9.6- 12.6) ∼ ∼
Missouri 11.5 ( 10.2- 13.0) 11.4 ( 10.0- 12.9) 14.0 ( 9.0- 21.4) ∼
Nebraska 10.2 ( 8.1- 12.8) 10.4 ( 8.2- 13.0) ∼ ∼
North Dakota 14.0 ( 10.2- 18.9) 13.6 ( 9.8- 18.6) ∼ ∼
South Dakota 10.9 ( 7.8- 14.9) 11.1 ( 7.9- 15.2) ∼ ∼
South 10.3 ( 10.0- 10.6) 10.5 ( 10.2- 10.9) 9.1 ( 8.2- 9.9) 6.9 ( 6.0- 8.0)
South Atlantic 10.0 ( 9.6- 10.4) 10.2 ( 9.8- 10.7) 8.8 ( 7.7- 9.9) 7.9 ( 6.4- 9.7)
Delaware 11.2 ( 8.0- 15.5) 11.2 ( 7.8- 15.8) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 9.8 ( 9.1- 10.4) 10.0 ( 9.3- 10.7) 7.6 ( 5.6- 10.3) 8.2 ( 6.6- 10.3)
Georgia 10.2 ( 9.0- 11.5) 10.5 ( 9.1- 12.0) 9.9 ( 7.2- 13.3) ∼
Maryland 10.9 ( 9.5- 12.4) 11.5 ( 9.8- 13.3) 8.4 ( 5.8- 12.3) ∼
North Carolina 9.6 ( 8.6- 10.8) 10.2 ( 8.9- 11.5) 7.1 ( 5.0- 10.1) ∼
South Carolina 10.3 ( 8.7- 12.1) 10.5 ( 8.7- 12.6) 9.4 ( 6.3- 13.6) ∼
Virginia 10.8 ( 9.6- 12.2) 11.0 ( 9.6- 12.6) 10.6 ( 7.6- 14.5) ∼
West Virginia 8.7 ( 6.9- 11.0) 8.6 ( 6.7- 11.0) ∼ ∼
East South Central 11.0 ( 10.2- 11.8) 11.2 ( 10.4- 12.1) 9.6 ( 7.7- 11.8) ∼
Alabama 10.4 ( 9.0- 12.1) 10.3 ( 8.7- 12.1) 10.5 ( 7.4- 14.6) ∼
Kentucky 11.9 ( 10.2- 13.7) 12.1 ( 10.4- 14.1) ∼ ∼
Mississippi 10.9 ( 9.1- 13.2) 11.3 ( 9.1- 14.1) 10.1 ( 6.7- 14.7) ∼
Tennessee 10.8 ( 9.5- 12.3) 11.2 ( 9.7- 12.8) 8.5 ( 5.1- 13.3) ∼
West South Central 10.4 ( 9.8- 11.0) 10.7 ( 10.0- 11.3) 9.6 ( 7.9- 11.6) 6.0 ( 4.8- 7.5)
Arkansas 12.0 ( 10.1- 14.2) 12.7 ( 10.6- 15.0) ∼ ∼
continued
C
ancer Incidence and M
ortality by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
131
Table 2.13.1.2M: Leukemias. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 9.9 ( 8.5- 11.6) 10.6 ( 8.8- 12.6) 7.9 ( 5.4- 11.5) ∼
Oklahoma 10.8 ( 9.2- 12.7) 11.4 ( 9.6- 13.4) ∼ ∼
Texas 10.1 ( 9.4- 10.9) 10.2 ( 9.4- 11.0) 10.8 ( 8.3- 13.9) 6.1 ( 4.9- 7.6)
West 9.5 ( 9.1- 9.8) 9.9 ( 9.5- 10.3) 8.7 ( 6.9- 11.0) 6.3 ( 5.4- 7.3)
Mountain 9.3 ( 8.6- 10.0) 9.6 ( 8.8- 10.3) ∼ 7.5 ( 5.5- 10.0)
Arizona 8.9 ( 7.7- 10.2) 8.9 ( 7.7- 10.3) ∼ 6.0 ( 3.3- 10.8)
Colorado 9.9 ( 8.3- 11.7) 10.3 ( 8.6- 12.1) ∼ 11.3 ( 6.3- 19.9)
Idaho 8.3 ( 6.1- 11.2) 8.5 ( 6.2- 11.4) ∼ ∼
Montana 9.9 ( 7.1- 13.4) 9.9 ( 7.1- 13.5) ∼ ∼
Nevada 7.9 ( 6.1- 10.1) 8.3 ( 6.4- 10.7) ∼ ∼
New Mexico 9.2 ( 7.0- 11.7) 9.7 ( 7.5- 12.5) ∼ 8.0 ( 4.6- 13.2)
Utah 12.0 ( 9.5- 14.9) 12.2 ( 9.7- 15.2) ∼ ∼
Wyoming 8.6 ( 5.1- 14.1) 8.8 ( 5.2- 14.4) ∼ ∼
Pacific 9.5 ( 9.1- 10.0) 10.0 ( 9.5- 10.6) 9.5 ( 7.4- 12.1) 5.8 ( 4.8- 7.0)
Alaska ∼ ∼ ∼ ∼
California 9.2 ( 8.6- 9.7) 9.6 ( 9.1- 10.3) 9.3 ( 7.2- 12.1) 6.0 ( 4.9- 7.2)
Hawaii 9.0 ( 6.8- 11.7) 11.7 ( 6.9- 19.1) ∼ ∼
Oregon 10.5 ( 8.9- 12.3) 10.7 ( 9.1- 12.5) ∼ ∼
Washington 11.1 ( 9.8- 12.5) 11.4 ( 10.0- 12.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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132 Table 2.13.1.2F: Leukemias. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 5.7 ( 5.6- 5.8) 5.8 ( 5.7- 5.9) 5.4 ( 5.0- 5.7) 4.1 ( 3.7- 4.5)
Northeast 5.5 ( 5.3- 5.8) 5.7 ( 5.5- 6.0) 4.3 ( 3.6- 5.1) 4.2 ( 3.3- 5.4)
New England 5.4 ( 4.9- 5.9) 5.4 ( 4.9- 5.9) 5.2 ( 2.9- 8.5) ∼
Connecticut 5.4 ( 4.5- 6.5) 5.5 ( 4.5- 6.6) ∼ ∼
Maine 4.9 ( 3.5- 6.8) 4.8 ( 3.4- 6.7) ∼ ∼
Massachusetts 5.3 ( 4.6- 6.0) 5.4 ( 4.6- 6.2) ∼ ∼
New Hampshire 6.1 ( 4.4- 8.2) 6.1 ( 4.4- 8.4) ∼ ∼
Rhode Island 4.4 ( 3.0- 6.4) 4.3 ( 2.9- 6.3) ∼ ∼
Vermont 7.4 ( 4.9- 11.0) 7.4 ( 4.9- 11.1) ∼ ∼
Middle Atlantic 5.6 ( 5.3- 5.9) 5.8 ( 5.5- 6.2) 4.2 ( 3.5- 5.0) 4.0 ( 3.1- 5.2)
New Jersey 6.1 ( 5.4- 6.8) 6.4 ( 5.6- 7.2) 4.0 ( 2.5- 6.2) ∼
New York 5.4 ( 5.0- 5.8) 5.7 ( 5.3- 6.3) 4.0 ( 3.1- 5.1) 4.4 ( 3.2- 6.0)
Pennsylvania 5.6 ( 5.1- 6.1) 5.7 ( 5.1- 6.2) 5.0 ( 3.4- 7.0) ∼
Midwest 6.2 ( 6.0- 6.5) 6.3 ( 6.0- 6.5) 6.0 ( 5.1- 7.0) 3.7 ( 2.4- 5.6)
East North Central 6.2 ( 5.9- 6.5) 6.3 ( 6.0- 6.7) 6.1 ( 5.1- 7.1) 3.4 ( 2.0- 5.6)
Illinois 6.2 ( 5.6- 6.8) 6.3 ( 5.7- 7.0) 6.0 ( 4.5- 8.0) 4.2 ( 2.2- 7.6)
Indiana 6.4 ( 5.6- 7.3) 6.6 ( 5.7- 7.5) ∼ ∼
Michigan 6.2 ( 5.5- 6.9) 6.1 ( 5.4- 6.8) 6.8 ( 4.9- 9.2) ∼
Ohio 6.1 ( 5.5- 6.7) 6.2 ( 5.6- 6.8) 5.7 ( 4.0- 7.9) ∼
Wisconsin 6.6 ( 5.8- 7.6) 6.7 ( 5.8- 7.7) ∼ ∼
West North Central 6.1 ( 5.7- 6.6) 6.2 ( 5.7- 6.6) 5.8 ( 3.8- 8.6) ∼
Iowa 6.0 ( 5.0- 7.2) 6.1 ( 5.0- 7.3) ∼ ∼
Kansas 5.7 ( 4.6- 7.0) 5.9 ( 4.8- 7.3) ∼ ∼
Minnesota 6.5 ( 5.6- 7.6) 6.6 ( 5.6- 7.6) ∼ ∼
Missouri 6.4 ( 5.6- 7.3) 6.4 ( 5.5- 7.4) 7.5 ( 4.7- 11.4) ∼
Nebraska 5.7 ( 4.4- 7.4) 5.8 ( 4.4- 7.5) ∼ ∼
North Dakota 4.5 ( 2.8- 7.3) 4.4 ( 2.7- 7.2) ∼ ∼
South Dakota 5.3 ( 3.4- 8.1) 5.3 ( 3.3- 8.1) ∼ ∼
South 5.7 ( 5.5- 5.9) 5.8 ( 5.6- 6.0) 5.5 ( 5.0- 6.0) 4.4 ( 3.8- 5.1)
South Atlantic 5.6 ( 5.4- 5.9) 5.7 ( 5.4- 6.0) 5.3 ( 4.7- 6.0) 4.9 ( 3.9- 6.0)
Delaware 6.2 ( 4.1- 9.0) 6.1 ( 3.9- 9.3) ∼ ∼
District of Columbia 6.7 ( 4.2- 10.6) ∼ ∼ ∼
Florida 5.4 ( 5.0- 5.9) 5.5 ( 5.1- 6.0) 5.3 ( 4.0- 7.1) 5.1 ( 4.0- 6.5)
Georgia 5.3 ( 4.6- 6.1) 5.4 ( 4.6- 6.3) 5.2 ( 3.8- 6.9) ∼
Maryland 5.9 ( 5.0- 6.8) 6.2 ( 5.2- 7.3) 4.9 ( 3.3- 7.1) ∼
North Carolina 5.7 ( 5.0- 6.4) 5.8 ( 5.0- 6.6) 5.1 ( 3.7- 6.9) ∼
South Carolina 6.0 ( 5.1- 7.1) 5.8 ( 4.8- 7.1) 6.4 ( 4.5- 8.9) ∼
Virginia 6.1 ( 5.4- 7.0) 6.6 ( 5.7- 7.5) 4.6 ( 3.1- 6.6) ∼
West Virginia 5.3 ( 4.0- 6.8) 5.4 ( 4.1- 7.0) ∼ ∼
East South Central 5.9 ( 5.4- 6.4) 6.0 ( 5.5- 6.6) 5.1 ( 4.0- 6.3) ∼
Alabama 5.6 ( 4.8- 6.6) 5.8 ( 4.8- 7.0) 4.6 ( 3.0- 6.8) ∼
Kentucky 5.2 ( 4.3- 6.2) 5.2 ( 4.3- 6.3) ∼ ∼
Mississippi 7.5 ( 6.3- 9.0) 7.5 ( 6.0- 9.3) 7.2 ( 5.0- 10.1) ∼
Tennessee 5.8 ( 5.0- 6.7) 6.2 ( 5.3- 7.2) ∼ ∼
West South Central 5.8 ( 5.4- 6.1) 5.7 ( 5.3- 6.2) 6.2 ( 5.1- 7.4) 3.8 ( 3.1- 4.8)
Arkansas 6.7 ( 5.5- 8.1) 6.4 ( 5.1- 7.8) 9.0 ( 5.2- 14.6) ∼
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Table 2.13.1.2F: Leukemias. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 5.3 ( 4.5- 6.3) 5.1 ( 4.1- 6.3) 6.0 ( 4.3- 8.3) ∼
Oklahoma 6.0 ( 5.0- 7.2) 6.2 ( 5.1- 7.6) ∼ ∼
Texas 5.7 ( 5.2- 6.2) 5.7 ( 5.2- 6.2) 6.1 ( 4.7- 8.0) 3.9 ( 3.1- 4.9)
West 5.2 ( 5.0- 5.5) 5.4 ( 5.1- 5.7) 5.7 ( 4.5- 7.2) 3.8 ( 3.3- 4.5)
Mountain 5.2 ( 4.8- 5.7) 5.3 ( 4.8- 5.8) ∼ 3.0 ( 2.0- 4.4)
Arizona 5.0 ( 4.3- 5.9) 5.1 ( 4.3- 6.1) ∼ 4.3 ( 2.2- 7.6)
Colorado 5.2 ( 4.3- 6.3) 5.2 ( 4.2- 6.3) ∼ ∼
Idaho 6.5 ( 4.7- 8.8) 6.6 ( 4.8- 9.0) ∼ ∼
Montana 5.0 ( 3.3- 7.5) 5.3 ( 3.5- 7.9) ∼ ∼
Nevada 5.7 ( 4.3- 7.4) 5.6 ( 4.1- 7.4) ∼ ∼
New Mexico 4.8 ( 3.6- 6.5) 5.1 ( 3.7- 6.9) ∼ ∼
Utah 5.2 ( 3.8- 6.9) 5.1 ( 3.8- 6.9) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 5.2 ( 4.9- 5.5) 5.5 ( 5.2- 5.8) 6.0 ( 4.7- 7.7) 4.1 ( 3.4- 4.9)
Alaska ∼ ∼ ∼ ∼
California 5.2 ( 4.8- 5.5) 5.4 ( 5.1- 5.8) 6.0 ( 4.6- 7.8) 4.1 ( 3.4- 4.9)
Hawaii 4.9 ( 3.4- 6.8) ∼ ∼ ∼
Oregon 5.4 ( 4.4- 6.5) 5.4 ( 4.4- 6.6) ∼ ∼
Washington 5.8 ( 5.0- 6.7) 5.9 ( 5.0- 6.8) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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134 Table 2.14.1.1M: Liver and Intrahepatic Bile Duct. Age-Adjusted Invasive Cancer Incidence Rates∗ and
95% Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race
and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 7.9 ( 7.8- 8.1) 7.0 ( 6.8- 7.2) 10.9 ( 10.3- 11.6) 14.5 ( 13.6- 15.4)
Northeast 8.6 ( 8.2- 9.0) 7.5 ( 7.1- 7.8) 12.8 ( 11.3- 14.4) 15.9 ( 13.8- 18.5)
New England 7.3 ( 6.7- 8.0) 6.9 ( 6.3- 7.6) 7.0 ( 4.1- 12.3) 19.1 ( 12.6- 28.7)
Connecticut 7.0 ( 5.8- 8.4) 6.9 ( 5.7- 8.4) ∼ ∼
Maine 5.1 ( 3.5- 7.3) 4.9 ( 3.3- 7.1) ∼ ∼
Massachusetts 8.5 ( 7.5- 9.6) 7.8 ( 6.8- 9.0) ∼ 18.6 ( 10.7- 33.3)
New Hampshire 6.1 ( 4.2- 8.6) 5.9 ( 4.0- 8.4) ∼ -
Rhode Island 8.4 ( 6.0- 11.4) 8.2 ( 5.8- 11.3) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 9.1 ( 8.6- 9.5) 7.7 ( 7.3- 8.1) 13.5 ( 11.9- 15.3) 15.5 ( 13.2- 18.2)
New Jersey 8.5 ( 7.6- 9.5) 7.3 ( 6.4- 8.3) 10.3 ( 7.4- 14.6) 10.2 ( 6.7- 15.8)
New York 10.0 ( 9.3- 10.7) 8.6 ( 7.9- 9.3) 11.9 ( 9.9- 14.3) 16.5 ( 13.6- 20.0)
Pennsylvania 8.2 ( 7.5- 8.9) 6.9 ( 6.2- 7.6) 20.6 ( 16.7- 25.5) -
Midwest 6.5 ( 6.2- 6.8) 5.8 ( 5.5- 6.1) 12.2 ( 10.7- 13.8) 16.7 ( 13.4- 21.0)
East North Central 6.8 ( 6.5- 7.2) 6.1 ( 5.7- 6.5) 11.6 ( 10.1- 13.4) 16.1 ( 12.6- 20.9)
Illinois 7.9 ( 7.1- 8.7) 7.0 ( 6.3- 7.9) 11.2 ( 8.6- 14.6) 14.5 ( 10.2- 20.9)
Indiana 5.3 ( 4.5- 6.3) 5.0 ( 4.2- 6.0) 9.7 ( 5.9- 16.1) ∼
Michigan 6.7 ( 6.0- 7.5) 5.8 ( 5.1- 6.7) 12.7 ( 9.8- 16.6) ∼
Detroit 8.3 ( 7.0- 9.7) 7.1 ( 5.7- 8.7) 12.6 ( 9.2- 17.2) -
Ohio 6.1 ( 5.4- 6.8) 5.3 ( 4.6- 6.0) 11.2 ( 8.3- 15.2) ∼
Wisconsin 8.0 ( 6.9- 9.2) 7.3 ( 6.3- 8.5) ∼ -
West North Central 5.8 ( 5.4- 6.4) 5.1 ( 4.6- 5.6) 15.2 ( 11.2- 20.5) 19.2 ( 11.2- 32.1)
Iowa 5.3 ( 4.1- 6.6) 5.0 ( 3.9- 6.3) ∼ ∼
Kansas 5.1 ( 3.9- 6.5) 4.5 ( 3.4- 6.0) ∼ ∼
Minnesota 5.8 ( 4.9- 7.0) 5.0 ( 4.1- 6.0) ∼ ∼
Missouri 7.0 ( 6.0- 8.1) 6.0 ( 5.0- 7.0) 17.0 ( 11.8- 24.4) ∼
Nebraska 5.1 ( 3.7- 7.0) 4.3 ( 3.0- 6.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 5.2 ( 3.2- 8.4) 5.2 ( 3.0- 8.6) ∼ ∼
District of Columbia 12.1 ( 8.1- 17.6) ∼ 14.4 ( 9.0- 22.3) ∼
Florida 7.9 ( 7.4- 8.5) 7.8 ( 7.2- 8.4) 7.4 ( 5.6- 9.9) -
Georgia 6.6 ( 5.7- 7.6) 5.8 ( 4.9- 6.9) 8.2 ( 6.0- 11.0) ∼
Atlanta 7.3 ( 5.6- 9.5) 4.5 ( 3.0- 6.8) 12.3 ( 7.6- 19.9) ∼
Maryland 7.9 ( 6.7- 9.2) 7.6 ( 6.3- 9.0) 7.8 ( 5.4- 11.3) ∼
North Carolina 6.2 ( 5.4- 7.1) 5.6 ( 4.7- 6.5) 7.7 ( 5.5- 10.6) ∼
South Carolina 7.6 ( 6.4- 9.1) 6.9 ( 5.6- 8.5) 9.3 ( 6.5- 13.1) -
Virginia
West Virginia 4.8 ( 3.5- 6.6) 5.0 ( 3.6- 6.8) ∼ ∼
East South Central
Alabama 6.9 ( 5.8- 8.2) 6.8 ( 5.6- 8.3) 6.7 ( 4.4- 10.0) ∼
Kentucky 5.9 ( 4.9- 7.2) 5.5 ( 4.4- 6.8) ∼ -
Mississippi
Tennessee
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Table 2.14.1.1M: Liver and Intrahepatic Bile Duct. Age-Adjusted Invasive Cancer Incidence Rates∗ and
95% Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race
and Ethnicity, United States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 8.9 ( 7.6- 10.4) 7.7 ( 6.3- 9.4) 11.7 ( 8.8- 15.5) ∼
Oklahoma 6.1 ( 4.9- 7.4) 5.7 ( 4.6- 7.2) ∼ ∼
Texas 11.1 ( 10.4- 11.9) 10.4 ( 9.6- 11.2) 13.7 ( 11.1- 16.8) 18.8 ( 16.6- 21.1)
West 8.7 ( 8.4- 9.1) 7.2 ( 6.8- 7.5) 12.9 ( 10.7- 15.4) 14.1 ( 12.8- 15.5)
Mountain 7.4 ( 6.8- 8.0) 7.0 ( 6.4- 7.6) 11.7 ( 7.1- 20.1) 16.4 ( 13.7- 19.7)
Arizona 8.2 ( 7.1- 9.4) 8.2 ( 7.1- 9.5) ∼ 18.3 ( 13.5- 25.0)
Colorado 8.1 ( 6.7- 9.6) 7.1 ( 5.9- 8.6) ∼ 16.7 ( 11.1- 25.3)
Idaho 3.9 ( 2.4- 5.9) 3.9 ( 2.5- 6.0) ∼ ∼
Montana 5.3 ( 3.3- 8.0) 5.0 ( 3.1- 7.8) ∼ ∼
Nevada 7.8 ( 6.1- 9.9) 7.0 ( 5.4- 9.1) ∼ ∼
New Mexico 10.4 ( 8.4- 13.0) 10.3 ( 8.1- 13.0) ∼ 18.5 ( 13.5- 25.0)
Utah 3.3 ( 2.2- 4.9) 3.1 ( 1.9- 4.7) ∼ ∼
Wyoming
Pacific 9.3 ( 8.9- 9.8) 7.3 ( 6.8- 7.7) 13.1 ( 10.7- 15.9) 13.3 ( 11.8- 14.9)
Alaska ∼ ∼ ∼ ∼
California 9.9 ( 9.4- 10.4) 7.8 ( 7.3- 8.3) 13.2 ( 10.7- 16.2) 13.5 ( 12.0- 15.2)
San Francisco-Oakland 11.2 ( 9.7- 12.9) 6.9 ( 5.6- 8.5) 14.8 ( 9.3- 23.0) 12.0 ( 7.4- 19.3)
San Jose-Monterey 10.7 ( 8.8- 13.1) 7.9 ( 6.0- 10.2) ∼ 18.2 ( 11.6- 28.9)
Los Angeles 11.6 ( 10.6- 12.8) 9.0 ( 7.9- 10.3) 14.6 ( 10.8- 19.7) 13.8 ( 11.3- 16.8)
Hawaii 13.0 ( 10.3- 16.2) ∼ ∼ -
Oregon 5.2 ( 4.2- 6.4) 4.3 ( 3.3- 5.4) ∼ ∼
Washington 8.2 ( 7.2- 9.4) 7.2 ( 6.2- 8.3) ∼ ∼
Seattle-Puget Sound 9.6 ( 8.2- 11.2) 8.2 ( 6.9- 9.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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136 Table 2.14.1.1F: Liver and Intrahepatic Bile Duct. Age-Adjusted Invasive Cancer Incidence Rates∗ and
95% Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race
and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 2.8 ( 2.8- 2.9) 2.6 ( 2.5- 2.6) 3.6 ( 3.3- 3.9) 5.8 ( 5.3- 6.3)
Northeast 2.7 ( 2.5- 2.9) 2.4 ( 2.2- 2.6) 3.6 ( 3.0- 4.4) 4.9 ( 3.9- 6.2)
New England 2.2 ( 1.9- 2.5) 2.2 ( 1.8- 2.5) ∼ ∼
Connecticut 2.4 ( 1.7- 3.1) 2.3 ( 1.7- 3.2) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 2.3 ( 1.9- 2.9) 2.3 ( 1.8- 2.9) ∼ ∼
New Hampshire ∼ ∼ ∼ -
Rhode Island 2.2 ( 1.2- 3.7) 2.3 ( 1.3- 4.0) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.9 ( 2.7- 3.1) 2.5 ( 2.3- 2.8) 3.8 ( 3.1- 4.6) 5.0 ( 3.8- 6.3)
New Jersey 2.7 ( 2.2- 3.2) 2.5 ( 2.1- 3.1) ∼ ∼
New York 3.1 ( 2.8- 3.5) 2.8 ( 2.4- 3.2) 3.6 ( 2.8- 4.7) 5.6 ( 4.2- 7.4)
Pennsylvania 2.6 ( 2.2- 2.9) 2.2 ( 1.9- 2.6) 5.5 ( 3.9- 7.7) -
Midwest 2.4 ( 2.3- 2.6) 2.2 ( 2.1- 2.4) 3.7 ( 3.0- 4.5) 5.1 ( 3.4- 7.6)
East North Central 2.6 ( 2.4- 2.8) 2.5 ( 2.3- 2.7) 3.7 ( 3.0- 4.5) 4.3 ( 2.6- 6.8)
Illinois 2.7 ( 2.3- 3.1) 2.3 ( 2.0- 2.8) 4.5 ( 3.1- 6.2) ∼
Indiana 2.2 ( 1.8- 2.8) 2.1 ( 1.6- 2.7) ∼ ∼
Michigan 2.8 ( 2.4- 3.3) 2.7 ( 2.2- 3.2) 3.5 ( 2.2- 5.3) ∼
Detroit 2.9 ( 2.3- 3.7) 2.8 ( 2.1- 3.7) ∼ -
Ohio 2.5 ( 2.2- 3.0) 2.5 ( 2.1- 2.9) 2.6 ( 1.5- 4.2) ∼
Wisconsin 2.9 ( 2.3- 3.5) 2.7 ( 2.1- 3.4) ∼ -
West North Central 1.9 ( 1.6- 2.2) 1.8 ( 1.5- 2.0) 3.9 ( 2.3- 6.4) ∼
Iowa 1.9 ( 1.3- 2.7) 1.9 ( 1.3- 2.6) ∼ ∼
Kansas 1.5 ( 0.9- 2.3) 1.4 ( 0.8- 2.2) ∼ ∼
Minnesota 1.9 ( 1.4- 2.5) 1.7 ( 1.2- 2.3) ∼ ∼
Missouri 1.9 ( 1.4- 2.4) 1.8 ( 1.3- 2.3) ∼ ∼
Nebraska 2.5 ( 1.6- 3.8) 2.3 ( 1.4- 3.6) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.5 ( 2.3- 2.9) 2.4 ( 2.1- 2.7) 3.3 ( 2.3- 4.7) -
Georgia 2.5 ( 2.0- 3.0) 2.2 ( 1.7- 2.8) 2.6 ( 1.7- 4.0) ∼
Atlanta 2.2 ( 1.4- 3.2) ∼ ∼ ∼
Maryland 3.2 ( 2.6- 4.0) 3.0 ( 2.3- 3.8) 4.0 ( 2.6- 6.0) ∼
North Carolina 2.3 ( 1.9- 2.8) 2.2 ( 1.7- 2.7) 2.6 ( 1.6- 4.0) ∼
South Carolina 2.3 ( 1.7- 3.0) 1.9 ( 1.3- 2.7) 3.2 ( 1.9- 5.1) -
Virginia
West Virginia 2.0 ( 1.3- 3.1) 2.1 ( 1.3- 3.2) ∼ ∼
East South Central
Alabama 3.1 ( 2.5- 3.9) 2.9 ( 2.2- 3.7) 3.7 ( 2.3- 5.7) ∼
Kentucky 2.5 ( 1.9- 3.2) 2.4 ( 1.8- 3.1) ∼ -
Mississippi
Tennessee
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Table 2.14.1.1F: Liver and Intrahepatic Bile Duct. Age-Adjusted Invasive Cancer Incidence Rates∗ and
95% Confidence Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race
and Ethnicity, United States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 2.9 ( 2.3- 3.7) 2.5 ( 1.8- 3.4) 3.7 ( 2.4- 5.6) ∼
Oklahoma 3.2 ( 2.4- 4.1) 3.0 ( 2.2- 3.9) ∼ ∼
Texas 3.9 ( 3.5- 4.3) 3.7 ( 3.3- 4.1) 4.5 ( 3.3- 6.1) 7.5 ( 6.3- 8.9)
West 3.5 ( 3.3- 3.7) 2.9 ( 2.7- 3.1) 4.5 ( 3.5- 5.9) 6.4 ( 5.6- 7.3)
Mountain 2.4 ( 2.1- 2.8) 2.3 ( 2.0- 2.6) ∼ 4.9 ( 3.6- 6.6)
Arizona 2.2 ( 1.7- 2.9) 2.0 ( 1.5- 2.6) ∼ 5.1 ( 2.8- 8.7)
Colorado 2.3 ( 1.7- 3.0) 2.1 ( 1.5- 2.8) ∼ ∼
Idaho 2.3 ( 1.3- 3.8) 2.3 ( 1.3- 3.9) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 3.1 ( 2.1- 4.4) 3.0 ( 2.0- 4.3) ∼ ∼
New Mexico 3.1 ( 2.1- 4.5) 3.1 ( 2.1- 4.6) ∼ ∼
Utah 1.8 ( 1.0- 2.9) 1.7 ( 1.0- 2.9) ∼ ∼
Wyoming
Pacific 3.9 ( 3.7- 4.2) 3.2 ( 2.9- 3.4) 4.9 ( 3.7- 6.4) 6.9 ( 5.9- 7.9)
Alaska ∼ ∼ ∼ ∼
California 4.2 ( 3.9- 4.5) 3.4 ( 3.1- 3.7) 4.8 ( 3.6- 6.4) 7.0 ( 6.0- 8.1)
San Francisco-Oakland 4.7 ( 3.8- 5.7) 3.2 ( 2.4- 4.3) ∼ 7.7 ( 4.4- 12.7)
San Jose-Monterey 3.6 ( 2.6- 4.9) 2.6 ( 1.6- 3.9) ∼ ∼
Los Angeles 5.6 ( 4.9- 6.3) 4.6 ( 3.9- 5.4) 4.2 ( 2.5- 6.5) 7.5 ( 5.9- 9.4)
Hawaii 4.4 ( 3.0- 6.3) ∼ ∼ -
Oregon 2.4 ( 1.8- 3.3) 2.3 ( 1.7- 3.1) ∼ ∼
Washington 3.2 ( 2.6- 3.9) 2.6 ( 2.0- 3.3) ∼ ∼
Seattle-Puget Sound 3.7 ( 2.9- 4.6) 2.8 ( 2.1- 3.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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138 Table 2.14.1.2M: Liver and Intrahepatic Bile Duct. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 7.2 ( 7.0- 7.3) 6.5 ( 6.4- 6.7) 10.0 ( 9.4- 10.6) 10.9 ( 10.1- 11.7)
Northeast 7.0 ( 6.7- 7.4) 6.5 ( 6.2- 6.9) 9.3 ( 8.0- 10.7) 11.0 ( 9.1- 13.2)
New England 7.0 ( 6.3- 7.6) 6.7 ( 6.0- 7.4) 10.0 ( 6.3- 16.1) 8.1 ( 4.7- 14.7)
Connecticut 6.4 ( 5.2- 7.7) 5.9 ( 4.8- 7.3) ∼ ∼
Maine 5.9 ( 4.1- 8.2) 5.9 ( 4.1- 8.3) ∼ ∼
Massachusetts 7.6 ( 6.6- 8.7) 7.2 ( 6.3- 8.4) ∼ ∼
New Hampshire 7.9 ( 5.8- 10.8) 7.8 ( 5.6- 10.6) ∼ ∼
Rhode Island 6.7 ( 4.6- 9.4) 6.4 ( 4.4- 9.2) ∼ ∼
Vermont 5.5 ( 3.2- 9.2) 5.2 ( 2.9- 8.7) ∼ ∼
Middle Atlantic 7.1 ( 6.7- 7.5) 6.5 ( 6.1- 6.9) 9.2 ( 7.8- 10.8) 11.3 ( 9.3- 13.8)
New Jersey 6.5 ( 5.7- 7.4) 6.0 ( 5.2- 6.9) 8.2 ( 5.6- 12.1) 10.1 ( 6.2- 16.2)
New York 7.7 ( 7.1- 8.3) 7.2 ( 6.6- 7.9) 8.0 ( 6.3- 10.1) 11.8 ( 9.4- 14.9)
Pennsylvania 6.5 ( 5.9- 7.2) 5.8 ( 5.2- 6.5) 13.1 ( 9.9- 17.2) ∼
Midwest 6.5 ( 6.2- 6.8) 5.9 ( 5.6- 6.2) 12.9 ( 11.3- 14.7) 10.0 ( 7.4- 13.5)
East North Central 6.7 ( 6.3- 7.1) 6.1 ( 5.7- 6.5) 12.3 ( 10.7- 14.2) 8.8 ( 6.2- 12.7)
Illinois 7.0 ( 6.3- 7.7) 6.2 ( 5.5- 7.0) 12.2 ( 9.4- 15.7) 6.8 ( 4.1- 11.9)
Indiana 5.7 ( 4.8- 6.7) 5.2 ( 4.4- 6.2) 11.7 ( 7.1- 18.9) ∼
Michigan 6.7 ( 6.0- 7.6) 6.0 ( 5.3- 6.9) 11.4 ( 8.4- 15.4) ∼
Ohio 6.6 ( 5.9- 7.4) 6.1 ( 5.4- 6.9) 12.4 ( 9.2- 16.5) ∼
Wisconsin 7.3 ( 6.3- 8.5) 6.7 ( 5.7- 7.9) ∼ ∼
West North Central 6.1 ( 5.6- 6.6) 5.4 ( 4.9- 6.0) 16.0 ( 11.9- 21.4) ∼
Iowa 4.4 ( 3.4- 5.7) 4.2 ( 3.2- 5.5) ∼ ∼
Kansas 6.6 ( 5.2- 8.2) 6.2 ( 4.9- 7.9) ∼ ∼
Minnesota 6.3 ( 5.3- 7.4) 5.3 ( 4.4- 6.5) ∼ ∼
Missouri 7.5 ( 6.5- 8.6) 6.6 ( 5.6- 7.7) 15.9 ( 10.9- 23.2) ∼
Nebraska 5.2 ( 3.7- 7.1) 4.6 ( 3.2- 6.5) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 4.4 ( 2.5- 7.3) ∼ ∼ ∼
South 7.4 ( 7.2- 7.7) 7.0 ( 6.7- 7.3) 9.1 ( 8.3- 9.9) 10.6 ( 9.4- 11.9)
South Atlantic 6.8 ( 6.5- 7.2) 6.4 ( 6.1- 6.8) 8.0 ( 7.1- 9.1) 5.8 ( 4.6- 7.4)
Delaware 8.1 ( 5.4- 11.9) 7.8 ( 5.0- 11.9) ∼ ∼
District of Columbia 9.7 ( 6.2- 14.8) ∼ 12.3 ( 7.4- 19.8) ∼
Florida 6.9 ( 6.4- 7.5) 6.9 ( 6.3- 7.5) 6.7 ( 4.8- 9.3) 6.3 ( 4.9- 8.1)
Georgia 6.7 ( 5.8- 7.7) 6.2 ( 5.2- 7.4) 6.8 ( 4.9- 9.3) ∼
Maryland 7.2 ( 6.1- 8.5) 6.4 ( 5.2- 7.7) 9.6 ( 6.8- 13.6) ∼
North Carolina 6.5 ( 5.7- 7.4) 6.0 ( 5.1- 7.0) 7.8 ( 5.7- 10.7) ∼
South Carolina 7.3 ( 6.1- 8.8) 6.7 ( 5.4- 8.3) 9.5 ( 6.5- 13.5) ∼
Virginia 6.2 ( 5.3- 7.2) 5.6 ( 4.7- 6.7) 7.9 ( 5.6- 11.1) ∼
West Virginia 5.9 ( 4.5- 7.8) 5.9 ( 4.4- 7.8) ∼ ∼
East South Central 7.7 ( 7.1- 8.4) 7.5 ( 6.8- 8.2) 8.3 ( 6.6- 10.3) ∼
Alabama 8.0 ( 6.8- 9.4) 7.8 ( 6.5- 9.4) 8.3 ( 5.6- 12.0) ∼
Kentucky 7.6 ( 6.3- 9.1) 7.4 ( 6.1- 9.0) ∼ ∼
Mississippi 7.4 ( 5.9- 9.2) 7.8 ( 6.0- 10.0) 5.8 ( 3.4- 9.4) ∼
Tennessee 7.7 ( 6.6- 8.9) 7.3 ( 6.2- 8.5) 10.3 ( 6.7- 15.3) ∼
West South Central 8.5 ( 8.0- 9.0) 7.8 ( 7.2- 8.3) 12.3 ( 10.5- 14.5) 14.8 ( 12.8- 17.0)
Arkansas 6.4 ( 5.1- 8.0) 6.1 ( 4.7- 7.7) ∼ ∼
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Table 2.14.1.2M: Liver and Intrahepatic Bile Duct. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 9.0 ( 7.7- 10.6) 7.8 ( 6.4- 9.5) 12.9 ( 9.7- 17.0) ∼
Oklahoma 5.3 ( 4.2- 6.5) 5.0 ( 3.9- 6.3) ∼ ∼
Texas 9.4 ( 8.7- 10.1) 8.6 ( 7.9- 9.3) 13.2 ( 10.7- 16.4) 15.3 ( 13.3- 17.6)
West 7.5 ( 7.2- 7.8) 6.4 ( 6.1- 6.7) 10.8 ( 8.8- 13.1) 11.1 ( 9.9- 12.5)
Mountain 6.3 ( 5.8- 6.9) 6.1 ( 5.5- 6.7) 9.0 ( 4.9- 16.8) 11.7 ( 9.3- 14.6)
Arizona 7.1 ( 6.1- 8.3) 7.1 ( 6.0- 8.3) ∼ 12.0 ( 8.2- 17.7)
Colorado 5.3 ( 4.2- 6.6) 4.9 ( 3.8- 6.2) ∼ 8.2 ( 4.3- 15.5)
Idaho 4.4 ( 2.8- 6.6) 4.4 ( 2.8- 6.7) ∼ ∼
Montana 6.4 ( 4.3- 9.3) 6.2 ( 4.1- 9.2) ∼ ∼
Nevada 7.0 ( 5.4- 9.0) 6.5 ( 4.9- 8.6) ∼ ∼
New Mexico 9.6 ( 7.6- 12.1) 9.2 ( 7.1- 11.7) ∼ 15.3 ( 10.8- 21.5)
Utah 4.1 ( 2.7- 5.9) 3.8 ( 2.5- 5.6) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 8.0 ( 7.6- 8.4) 6.6 ( 6.2- 7.0) 11.1 ( 9.0- 13.8) 10.9 ( 9.5- 12.5)
Alaska ∼ ∼ ∼ ∼
California 8.3 ( 7.8- 8.8) 6.9 ( 6.4- 7.4) 11.0 ( 8.7- 13.8) 11.0 ( 9.6- 12.7)
Hawaii 10.7 ( 8.3- 13.7) ∼ ∼ ∼
Oregon 5.3 ( 4.3- 6.6) 4.5 ( 3.5- 5.7) ∼ ∼
Washington 7.3 ( 6.3- 8.5) 6.6 ( 5.6- 7.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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140 Table 2.14.1.2F: Liver and Intrahepatic Bile Duct. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 3.0 ( 2.9- 3.1) 2.8 ( 2.7- 2.9) 3.6 ( 3.3- 3.9) 4.9 ( 4.5- 5.4)
Northeast 2.6 ( 2.4- 2.7) 2.5 ( 2.3- 2.7) 3.1 ( 2.5- 3.8) 3.6 ( 2.7- 4.6)
New England 2.3 ( 2.0- 2.7) 2.3 ( 2.0- 2.7) ∼ ∼
Connecticut 2.2 ( 1.7- 3.0) 2.1 ( 1.5- 3.0) ∼ ∼
Maine 2.6 ( 1.6- 4.0) 2.6 ( 1.6- 4.1) ∼ ∼
Massachusetts 2.4 ( 2.0- 3.0) 2.5 ( 2.0- 3.1) ∼ ∼
New Hampshire 2.1 ( 1.2- 3.6) 2.2 ( 1.2- 3.6) ∼ ∼
Rhode Island 2.3 ( 1.3- 4.0) 2.4 ( 1.4- 4.2) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.7 ( 2.5- 2.9) 2.5 ( 2.3- 2.8) 3.2 ( 2.6- 3.9) 3.7 ( 2.7- 4.9)
New Jersey 2.5 ( 2.1- 3.0) 2.5 ( 2.0- 3.0) ∼ ∼
New York 2.9 ( 2.6- 3.2) 2.8 ( 2.4- 3.1) 3.2 ( 2.4- 4.2) 4.5 ( 3.3- 6.1)
Pennsylvania 2.5 ( 2.1- 2.8) 2.3 ( 2.0- 2.7) 3.9 ( 2.6- 5.8) ∼
Midwest 2.7 ( 2.5- 2.8) 2.5 ( 2.4- 2.7) 3.9 ( 3.2- 4.7) 3.3 ( 1.9- 5.3)
East North Central 2.9 ( 2.7- 3.1) 2.7 ( 2.5- 3.0) 4.0 ( 3.2- 4.8) ∼
Illinois 2.9 ( 2.5- 3.3) 2.6 ( 2.2- 3.1) 4.4 ( 3.1- 6.1) ∼
Indiana 2.7 ( 2.2- 3.3) 2.6 ( 2.1- 3.2) ∼ ∼
Michigan 3.2 ( 2.7- 3.7) 3.0 ( 2.6- 3.6) 3.6 ( 2.3- 5.4) ∼
Ohio 2.6 ( 2.3- 3.1) 2.6 ( 2.2- 3.0) 3.6 ( 2.2- 5.4) ∼
Wisconsin 3.0 ( 2.5- 3.7) 3.0 ( 2.4- 3.7) ∼ ∼
West North Central 2.2 ( 2.0- 2.5) 2.1 ( 1.9- 2.4) ∼ ∼
Iowa 2.3 ( 1.7- 3.2) 2.3 ( 1.6- 3.2) ∼ ∼
Kansas 2.3 ( 1.7- 3.3) 2.1 ( 1.5- 3.1) ∼ ∼
Minnesota 2.1 ( 1.6- 2.7) 2.0 ( 1.5- 2.6) ∼ ∼
Missouri 2.2 ( 1.7- 2.8) 2.1 ( 1.6- 2.7) ∼ ∼
Nebraska 2.1 ( 1.3- 3.2) 2.2 ( 1.4- 3.3) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 3.2 ( 3.0- 3.3) 3.0 ( 2.8- 3.1) 3.7 ( 3.3- 4.2) 5.1 ( 4.4- 5.9)
South Atlantic 2.7 ( 2.5- 2.9) 2.5 ( 2.3- 2.7) 3.5 ( 3.0- 4.0) 3.1 ( 2.3- 4.1)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.6 ( 2.3- 2.9) 2.4 ( 2.1- 2.8) 3.3 ( 2.3- 4.7) 3.1 ( 2.2- 4.2)
Georgia 2.9 ( 2.4- 3.5) 2.9 ( 2.3- 3.5) 2.6 ( 1.7- 4.0) ∼
Maryland 2.8 ( 2.2- 3.5) 2.5 ( 1.9- 3.3) 3.9 ( 2.5- 5.9) ∼
North Carolina 2.6 ( 2.1- 3.1) 2.3 ( 1.9- 2.9) 3.6 ( 2.4- 5.2) ∼
South Carolina 3.0 ( 2.4- 3.8) 2.2 ( 1.5- 3.0) 5.6 ( 3.8- 7.9) ∼
Virginia 2.4 ( 1.9- 2.9) 2.3 ( 1.8- 2.9) ∼ ∼
West Virginia 3.2 ( 2.3- 4.5) 3.3 ( 2.3- 4.6) ∼ ∼
East South Central 3.4 ( 3.0- 3.8) 3.3 ( 2.9- 3.7) 3.6 ( 2.8- 4.7) ∼
Alabama 4.2 ( 3.5- 5.0) 4.1 ( 3.3- 5.1) 4.5 ( 3.0- 6.7) ∼
Kentucky 3.0 ( 2.3- 3.8) 3.0 ( 2.3- 3.8) ∼ ∼
Mississippi 3.9 ( 3.0- 5.0) 4.1 ( 3.0- 5.5) ∼ ∼
Tennessee 2.8 ( 2.3- 3.5) 2.7 ( 2.1- 3.4) 4.0 ( 2.3- 6.5) ∼
West South Central 3.9 ( 3.7- 4.3) 3.8 ( 3.5- 4.1) 4.5 ( 3.5- 5.5) 6.9 ( 5.8- 8.3)
Arkansas 3.6 ( 2.8- 4.7) 3.2 ( 2.3- 4.3) ∼ ∼
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Table 2.14.1.2F: Liver and Intrahepatic Bile Duct. Age-Adjusted Cancer Death Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 4.6 ( 3.8- 5.6) 4.8 ( 3.9- 6.0) 3.7 ( 2.3- 5.6) ∼
Oklahoma 2.3 ( 1.7- 3.1) 2.0 ( 1.4- 2.8) ∼ ∼
Texas 4.2 ( 3.8- 4.6) 4.1 ( 3.7- 4.5) 4.5 ( 3.3- 6.1) 7.0 ( 5.8- 8.4)
West 3.6 ( 3.4- 3.9) 3.3 ( 3.1- 3.5) 3.7 ( 2.7- 4.9) 5.6 ( 4.9- 6.5)
Mountain 3.0 ( 2.6- 3.3) 2.8 ( 2.5- 3.2) ∼ 4.9 ( 3.6- 6.6)
Arizona 2.7 ( 2.2- 3.4) 2.5 ( 2.0- 3.2) ∼ ∼
Colorado 2.5 ( 1.8- 3.2) 2.6 ( 1.9- 3.4) ∼ ∼
Idaho 3.8 ( 2.5- 5.7) 3.6 ( 2.3- 5.4) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 4.1 ( 2.9- 5.5) 3.8 ( 2.7- 5.3) ∼ ∼
New Mexico 4.6 ( 3.3- 6.1) 4.4 ( 3.1- 6.0) ∼ 5.9 ( 3.5- 9.4)
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 3.9 ( 3.7- 4.2) 3.5 ( 3.3- 3.8) 3.9 ( 2.8- 5.2) 5.9 ( 5.0- 6.9)
Alaska ∼ ∼ ∼ ∼
California 4.1 ( 3.8- 4.4) 3.7 ( 3.4- 4.0) 3.9 ( 2.8- 5.3) 5.9 ( 5.0- 6.9)
Hawaii 3.6 ( 2.4- 5.4) ∼ ∼ ∼
Oregon 2.7 ( 2.0- 3.5) 2.6 ( 1.9- 3.4) ∼ ∼
Washington 3.9 ( 3.2- 4.7) 3.4 ( 2.7- 4.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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142 Table 2.15.1.1M: Lung and Bronchus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 86.4 ( 85.8- 86.9) 85.6 ( 85.0- 86.1) 105.7 (103.5- 107.8) 50.6 ( 48.8- 52.4)
Northeast 84.6 ( 83.4- 85.7) 84.6 ( 83.4- 85.8) 91.4 ( 87.0- 95.9) 51.2 ( 46.9- 56.0)
New England 84.8 ( 82.5- 87.1) 85.4 ( 83.1- 87.8) 72.2 ( 60.8- 85.6) 60.9 ( 47.8- 77.1)
Connecticut 81.9 ( 77.5- 86.5) 82.0 ( 77.5- 86.8) 81.7 ( 63.3- 106.1) 64.7 ( 43.6- 94.7)
Maine 97.1 ( 89.6- 105.1) 95.9 ( 88.5- 103.9) ∼ ∼
Massachusetts 84.3 ( 80.9- 87.8) 85.6 ( 82.1- 89.2) 62.1 ( 47.4- 81.0) 51.3 ( 34.5- 75.2)
New Hampshire 77.9 ( 70.6- 85.8) 77.7 ( 70.4- 85.7) ∼ -
Rhode Island 94.8 ( 86.4- 103.9) 96.8 ( 88.1- 106.1) ∼ ∼
Vermont 74.2 ( 64.4- 85.2) 73.8 ( 64.0- 84.8) ∼ ∼
Middle Atlantic 84.5 ( 83.2- 85.9) 84.3 ( 82.9- 85.8) 93.6 ( 89.0- 98.5) 49.9 ( 45.4- 54.9)
New Jersey 82.9 ( 80.0- 85.9) 81.9 ( 78.8- 85.1) 102.1 ( 91.5- 113.9) 49.8 ( 40.9- 60.6)
New York 80.2 ( 78.2- 82.1) 81.7 ( 79.5- 83.8) 77.0 ( 71.4- 83.0) 47.9 ( 42.4- 54.0)
Pennsylvania 91.3 ( 88.9- 93.7) 88.8 ( 86.4- 91.3) 125.6 (114.8- 137.4) -
Midwest 90.3 ( 89.2- 91.4) 88.0 ( 86.9- 89.2) 121.1 (116.1- 126.2) 44.5 ( 38.2- 51.7)
East North Central 92.6 ( 91.2- 93.9) 90.0 ( 88.6- 91.4) 120.9 (115.6- 126.5) 41.2 ( 34.5- 49.1)
Illinois 93.6 ( 91.0- 96.3) 91.5 ( 88.7- 94.4) 116.1 (107.2- 125.7) 39.2 ( 30.6- 50.0)
Indiana 103.9 (100.0- 107.9) 102.3 ( 98.2- 106.4) 128.6 (111.0- 148.6) ∼
Michigan 89.5 ( 86.7- 92.4) 86.0 ( 83.0- 89.0) 121.3 (111.0- 132.5) 45.1 ( 28.5- 70.3)
Detroit 101.5 ( 96.7- 106.6) 97.7 ( 92.4- 103.3) 122.2 (110.3- 135.3) -
Ohio 94.3 ( 91.7- 97.0) 91.2 ( 88.4- 94.0) 121.0 (110.5- 132.4) 39.4 ( 21.7- 69.1)
Wisconsin 80.3 ( 76.8- 84.0) 78.8 ( 75.2- 82.4) 139.2 (109.3- 177.5) -
West North Central 85.3 ( 83.3- 87.2) 83.9 ( 81.9- 85.9) 121.7 (109.0- 135.7) 58.2 ( 42.8- 78.2)
Iowa 83.5 ( 78.9- 88.4) 83.1 ( 78.4- 88.1) 116.1 ( 67.1- 194.5) ∼
Kansas 78.7 ( 73.8- 83.9) 78.2 ( 73.1- 83.5) 98.8 ( 71.2- 134.6) ∼
Minnesota 71.4 ( 67.8- 75.1) 70.4 ( 66.9- 74.2) 114.1 ( 75.4- 171.8) ∼
Missouri 103.4 ( 99.5- 107.5) 101.4 ( 97.4- 105.6) 131.5 (115.1- 150.1) 83.7 ( 48.9- 140.0)
Nebraska 79.3 ( 73.2- 85.8) 78.2 ( 72.0- 84.8) 105.6 ( 62.8- 174.7) ∼
North Dakota 77.6 ( 68.2- 88.0) 76.7 ( 67.3- 87.2) ∼ ∼
South Dakota
South
South Atlantic
Delaware 86.7 ( 77.4- 97.0) 86.7 ( 76.8- 97.8) 82.9 ( 57.4- 119.1) ∼
District of Columbia 92.1 ( 80.1- 105.7) 55.6 ( 39.8- 77.0) 110.7 ( 94.2- 129.6) ∼
Florida 91.2 ( 89.3- 93.1) 91.6 ( 89.5- 93.6) 90.4 ( 83.3- 98.1) -
Georgia 108.0 (104.1- 111.9) 108.0 (103.7- 112.4) 111.0 (102.1- 120.5) 52.2 ( 31.6- 83.9)
Atlanta 85.8 ( 79.2- 92.8) 81.3 ( 73.9- 89.3) 107.5 ( 91.7- 125.9) ∼
Maryland 79.7 ( 75.9- 83.5) 79.0 ( 74.8- 83.4) 86.8 ( 78.0- 96.7) 44.1 ( 25.3- 74.8)
North Carolina 93.4 ( 90.1- 96.7) 91.2 ( 87.7- 94.9) 106.1 ( 97.4- 115.4) ∼
South Carolina 103.4 ( 98.6- 108.4) 102.0 ( 96.6- 107.6) 108.7 ( 98.1- 120.3) -
Virginia
West Virginia 112.2 (105.5- 119.3) 112.5 (105.7- 119.7) 113.9 ( 73.5- 170.5) ∼
East South Central
Alabama 105.6 (101.1- 110.3) 105.6 (100.6- 110.8) 105.1 ( 94.6- 116.5) ∼
Kentucky 133.8 (128.4- 139.4) 133.2 (127.7- 139.0) 149.3 (125.0- 177.9) -
Mississippi
Tennessee
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Table 2.15.1.1M: Lung and Bronchus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 105.7 (101.0- 110.6) 101.1 ( 95.8- 106.7) 122.2 (111.7- 133.5) 106.7 ( 73.3- 154.1)
Oklahoma 110.2 (105.0- 115.5) 108.1 (102.7- 113.7) 137.9 (111.8- 168.9) 73.3 ( 42.6- 124.3)
Texas 88.5 ( 86.4- 90.7) 86.2 ( 83.9- 88.4) 122.3 (113.7- 131.5) 51.5 ( 47.6- 55.7)
West 69.4 ( 68.3- 70.4) 69.8 ( 68.7- 71.0) 95.5 ( 89.3- 102.2) 46.3 ( 43.6- 49.1)
Mountain 67.2 ( 65.4- 69.1) 68.0 ( 66.1- 70.0) 73.4 ( 60.4- 89.7) 52.8 ( 47.3- 58.8)
Arizona 68.3 ( 65.1- 71.7) 69.6 ( 66.3- 73.1) 64.5 ( 44.7- 94.4) 48.0 ( 39.3- 58.7)
Colorado 66.7 ( 62.6- 71.0) 66.2 ( 62.1- 70.6) 87.4 ( 60.1- 127.1) 66.2 ( 52.8- 82.7)
Idaho 67.4 ( 60.7- 74.7) 67.8 ( 61.0- 75.1) ∼ ∼
Montana 76.8 ( 68.8- 85.4) 75.2 ( 67.2- 84.0) ∼ ∼
Nevada 90.4 ( 84.3- 97.0) 92.8 ( 86.3- 99.8) 72.8 ( 49.9- 110.8) 50.9 ( 33.5- 77.7)
New Mexico 61.0 ( 55.7- 66.8) 64.4 ( 58.7- 70.6) ∼ 48.5 ( 39.7- 58.9)
Utah 38.1 ( 33.7- 42.9) 38.5 ( 34.1- 43.4) ∼ ∼
Wyoming
Pacific 70.2 ( 69.0- 71.4) 70.7 ( 69.3- 72.0) 99.5 ( 92.6- 106.9) 44.0 ( 41.0- 47.1)
Alaska 74.8 ( 61.9- 90.8) 74.8 ( 60.0- 93.6) ∼ ∼
California 66.9 ( 65.5- 68.3) 67.1 ( 65.6- 68.7) 96.7 ( 89.6- 104.4) 43.2 ( 40.2- 46.4)
San Francisco-Oakland 64.4 ( 60.7- 68.4) 61.6 ( 57.2- 66.2) 105.7 ( 89.7- 124.2) 57.3 ( 45.2- 72.1)
San Jose-Monterey 58.1 ( 53.0- 63.6) 59.7 ( 53.9- 66.0) 83.9 ( 42.8- 164.3) 60.3 ( 45.8- 78.9)
Los Angeles 61.7 ( 59.0- 64.4) 58.8 ( 55.9- 61.9) 98.9 ( 88.1- 110.8) 37.8 ( 33.3- 42.8)
Hawaii 66.7 ( 60.3- 73.6) 66.2 ( 54.0- 80.7) ∼ -
Oregon 80.5 ( 76.1- 85.0) 79.8 ( 75.3- 84.4) 156.2 (100.2- 240.3) ∼
Washington 81.5 ( 78.0- 85.2) 81.5 ( 77.8- 85.3) 125.5 ( 94.5- 165.9) 66.4 ( 44.5- 96.8)
Seattle-Puget Sound 84.6 ( 80.2- 89.2) 85.5 ( 80.9- 90.4) 131.7 ( 97.9- 176.6) 54.4 ( 29.1- 98.0)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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144 Table 2.15.1.1F: Lung and Bronchus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 53.7 ( 53.3- 54.1) 54.9 ( 54.5- 55.3) 50.3 ( 49.1- 51.5) 25.2 ( 24.2- 26.2)
Northeast 55.5 ( 54.7- 56.3) 56.9 ( 56.1- 57.8) 49.0 ( 46.6- 51.5) 25.8 ( 23.4- 28.4)
New England 59.9 ( 58.3- 61.6) 60.6 ( 58.9- 62.4) 51.6 ( 44.0- 60.3) 28.3 ( 21.3- 37.1)
Connecticut 58.5 ( 55.3- 61.9) 59.1 ( 55.7- 62.7) 57.6 ( 45.5- 72.2) 32.7 ( 20.6- 50.0)
Maine 61.3 ( 56.1- 67.0) 61.5 ( 56.2- 67.3) ∼ ∼
Massachusetts 60.8 ( 58.4- 63.4) 62.0 ( 59.4- 64.7) 43.1 ( 33.4- 54.9) 20.9 ( 12.8- 33.1)
New Hampshire 60.1 ( 54.4- 66.2) 59.7 ( 54.0- 65.9) ∼ -
Rhode Island 64.9 ( 58.8- 71.6) 65.4 ( 59.1- 72.3) 78.0 ( 45.1- 131.1) ∼
Vermont 46.4 ( 39.6- 54.3) 46.8 ( 40.0- 54.8) ∼ ∼
Middle Atlantic 54.0 ( 53.1- 55.0) 55.6 ( 54.5- 56.6) 48.7 ( 46.1- 51.3) 25.4 ( 22.9- 28.1)
New Jersey 55.1 ( 53.1- 57.2) 57.3 ( 55.0- 59.6) 51.6 ( 45.7- 58.1) 23.8 ( 19.0- 29.7)
New York 52.7 ( 51.4- 54.1) 56.4 ( 54.8- 58.0) 38.5 ( 35.6- 41.7) 24.3 ( 21.3- 27.5)
Pennsylvania 55.2 ( 53.6- 56.9) 53.5 ( 51.9- 55.2) 72.6 ( 66.1- 79.6) -
Midwest 55.2 ( 54.5- 56.0) 54.5 ( 53.7- 55.3) 64.8 ( 61.9- 67.9) 31.2 ( 26.8- 36.2)
East North Central 56.9 ( 56.0- 57.8) 56.1 ( 55.1- 57.1) 65.4 ( 62.2- 68.7) 31.3 ( 26.4- 36.9)
Illinois 57.4 ( 55.6- 59.2) 56.8 ( 54.9- 58.8) 66.6 ( 61.1- 72.4) 26.8 ( 20.9- 34.1)
Indiana 61.7 ( 59.1- 64.4) 61.2 ( 58.5- 64.0) 70.3 ( 59.6- 82.4) 53.5 ( 32.7- 83.8)
Michigan 56.5 ( 54.5- 58.5) 55.2 ( 53.1- 57.3) 65.8 ( 59.5- 72.4) 20.9 ( 11.8- 35.4)
Detroit 62.2 ( 59.0- 65.6) 62.2 ( 58.5- 66.0) 65.0 ( 57.9- 72.7) -
Ohio 56.4 ( 54.6- 58.2) 55.6 ( 53.8- 57.6) 61.0 ( 55.0- 67.5) 42.9 ( 27.0- 65.6)
Wisconsin 52.4 ( 49.8- 55.0) 51.6 ( 49.0- 54.3) 68.0 ( 52.7- 87.0) -
West North Central 51.4 ( 50.1- 52.8) 51.1 ( 49.7- 52.5) 61.5 ( 54.3- 69.5) 31.3 ( 21.8- 43.9)
Iowa 50.4 ( 47.1- 53.8) 50.6 ( 47.3- 54.1) ∼ ∼
Kansas 47.4 ( 43.9- 51.0) 47.7 ( 44.1- 51.5) 45.4 ( 30.1- 66.0) ∼
Minnesota 49.3 ( 46.6- 52.1) 48.8 ( 46.1- 51.7) 66.1 ( 41.6- 101.9) ∼
Missouri 58.2 ( 55.6- 60.9) 57.8 ( 55.1- 60.7) 65.1 ( 56.1- 75.3) ∼
Nebraska 45.8 ( 41.6- 50.3) 45.3 ( 41.1- 49.9) ∼ ∼
North Dakota 42.4 ( 36.0- 49.8) 41.6 ( 35.1- 49.1) ∼ ∼
South Dakota
South
South Atlantic
Delaware 58.9 ( 52.1- 66.4) 59.8 ( 52.4- 68.1) 56.7 ( 39.5- 79.4) ∼
District of Columbia 45.9 ( 38.7- 54.2) 41.6 ( 28.8- 59.9) 48.4 ( 39.6- 59.2) ∼
Florida 59.5 ( 58.1- 61.0) 61.9 ( 60.4- 63.5) 38.3 ( 34.6- 42.5) -
Georgia 53.5 ( 51.3- 55.8) 57.4 ( 54.8- 60.2) 41.7 ( 37.6- 46.3) 27.6 ( 15.5- 46.9)
Atlanta 48.7 ( 44.7- 52.9) 49.2 ( 44.5- 54.4) 50.4 ( 42.6- 59.4) ∼
Maryland 54.5 ( 51.9- 57.3) 56.1 ( 53.0- 59.4) 52.1 ( 46.6- 58.1) ∼
North Carolina 48.8 ( 46.8- 50.9) 50.9 ( 48.6- 53.3) 39.3 ( 35.2- 43.9) ∼
South Carolina 50.3 ( 47.4- 53.3) 53.0 ( 49.6- 56.5) 40.7 ( 35.6- 46.3) -
Virginia
West Virginia 66.9 ( 62.3- 71.7) 67.4 ( 62.8- 72.4) 54.2 ( 31.7- 88.0) ∼
East South Central
Alabama 53.4 ( 50.6- 56.3) 56.5 ( 53.3- 59.8) 40.3 ( 35.2- 46.0) ∼
Kentucky 73.0 ( 69.6- 76.6) 73.6 ( 70.0- 77.3) 68.5 ( 55.0- 84.3) -
Mississippi
Tennessee
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Table 2.15.1.1F: Lung and Bronchus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 54.2 ( 51.3- 57.3) 56.8 ( 53.3- 60.4) 47.9 ( 42.6- 53.7) 47.2 ( 29.1- 72.7)
Oklahoma 63.8 ( 60.3- 67.4) 63.2 ( 59.5- 67.0) 63.6 ( 49.0- 81.4) ∼
Texas 49.0 ( 47.6- 50.3) 49.0 ( 47.5- 50.5) 52.6 ( 48.1- 57.5) 20.6 ( 18.6- 22.8)
West 48.2 ( 47.4- 48.9) 50.4 ( 49.5- 51.2) 47.9 ( 44.2- 51.8) 23.5 ( 21.9- 25.1)
Mountain 45.4 ( 44.0- 46.8) 46.0 ( 44.6- 47.5) 48.5 ( 38.7- 60.0) 25.0 ( 21.9- 28.5)
Arizona 46.3 ( 43.9- 48.8) 47.7 ( 45.1- 50.3) 38.6 ( 23.7- 60.0) 20.9 ( 16.0- 26.9)
Colorado 45.7 ( 42.8- 48.8) 45.4 ( 42.4- 48.5) 55.3 ( 37.3- 79.5) 34.6 ( 26.5- 44.6)
Idaho 43.4 ( 38.5- 48.7) 42.9 ( 38.0- 48.3) ∼ ∼
Montana 52.7 ( 46.7- 59.4) 51.8 ( 45.7- 58.6) ∼ ∼
Nevada 68.5 ( 63.6- 73.7) 71.0 ( 65.7- 76.6) 58.2 ( 38.6- 85.7) 42.3 ( 28.8- 61.3)
New Mexico 36.6 ( 32.9- 40.6) 39.8 ( 35.8- 44.2) ∼ 18.6 ( 14.0- 24.2)
Utah 20.9 ( 18.0- 24.2) 20.7 ( 17.8- 24.0) ∼ ∼
Wyoming
Pacific 49.3 ( 48.4- 50.2) 52.3 ( 51.3- 53.4) 48.0 ( 44.0- 52.3) 22.9 ( 21.2- 24.8)
Alaska 50.5 ( 41.0- 61.8) 42.7 ( 32.9- 54.9) ∼ ∼
California 47.4 ( 46.3- 48.4) 50.4 ( 49.2- 51.6) 48.4 ( 44.2- 52.9) 22.4 ( 20.6- 24.3)
San Francisco-Oakland 48.3 ( 45.4- 51.2) 51.0 ( 47.5- 54.7) 68.5 ( 57.6- 80.9) 34.6 ( 27.1- 43.6)
San Jose-Monterey 43.8 ( 39.9- 47.9) 48.4 ( 43.9- 53.3) ∼ 32.2 ( 23.9- 42.8)
Los Angeles 39.0 ( 37.2- 40.9) 41.5 ( 39.4- 43.8) 42.3 ( 36.7- 48.6) 17.6 ( 15.2- 20.4)
Hawaii 36.1 ( 31.8- 40.8) 47.5 ( 37.7- 59.9) ∼ -
Oregon 58.2 ( 54.8- 61.7) 58.8 ( 55.3- 62.4) ∼ 57.3 ( 34.9- 90.3)
Washington 57.3 ( 54.7- 60.1) 58.0 ( 55.2- 60.9) 55.6 ( 37.8- 79.3) 32.1 ( 19.0- 51.8)
Seattle-Puget Sound 60.5 ( 57.2- 64.0) 62.7 ( 59.1- 66.4) 62.3 ( 42.4- 88.9) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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146 Table 2.15.1.2M: Lung and Bronchus. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 73.5 ( 73.0- 74.0) 72.7 ( 72.2- 73.2) 95.7 ( 93.8- 97.7) 36.7 ( 35.2- 38.2)
Northeast 67.3 ( 66.3- 68.4) 67.5 ( 66.4- 68.6) 76.3 ( 72.3- 80.5) 34.1 ( 30.5- 38.0)
New England 68.7 ( 66.7- 70.8) 69.2 ( 67.1- 71.3) 68.0 ( 56.8- 81.4) 37.2 ( 26.9- 50.9)
Connecticut 61.4 ( 57.6- 65.5) 61.5 ( 57.5- 65.6) 67.5 ( 50.1- 91.0) ∼
Maine 81.6 ( 74.7- 89.0) 80.9 ( 74.0- 88.4) ∼ ∼
Massachusetts 69.9 ( 66.8- 73.0) 70.7 ( 67.5- 74.0) 68.3 ( 52.6- 88.3) 48.3 ( 31.6- 72.2)
New Hampshire 66.5 ( 59.7- 73.9) 66.8 ( 60.0- 74.3) ∼ ∼
Rhode Island 75.1 ( 67.6- 83.2) 75.4 ( 67.7- 83.7) ∼ ∼
Vermont 62.1 ( 53.1- 72.4) 62.7 ( 53.6- 73.0) ∼ ∼
Middle Atlantic 66.8 ( 65.7- 68.1) 66.9 ( 65.6- 68.2) 77.3 ( 73.1- 81.7) 33.7 ( 29.9- 37.9)
New Jersey 64.9 ( 62.3- 67.6) 64.6 ( 61.9- 67.4) 79.9 ( 70.5- 90.6) 30.1 ( 23.2- 38.9)
New York 62.8 ( 61.1- 64.6) 64.1 ( 62.2- 66.0) 64.6 ( 59.4- 70.1) 32.7 ( 28.2- 37.8)
Pennsylvania 73.3 ( 71.2- 75.5) 71.5 ( 69.3- 73.7) 105.1 ( 95.1- 116.0) 56.0 ( 39.2- 79.3)
Midwest 76.3 ( 75.3- 77.3) 74.9 ( 73.9- 76.0) 102.3 ( 97.7- 107.0) 30.6 ( 25.5- 36.6)
East North Central 78.0 ( 76.8- 79.3) 76.5 ( 75.2- 77.8) 101.9 ( 96.9- 107.1) 30.3 ( 24.6- 37.2)
Illinois 75.9 ( 73.5- 78.4) 74.2 ( 71.7- 76.8) 99.2 ( 91.0- 108.1) 28.9 ( 21.6- 38.5)
Indiana 88.3 ( 84.7- 92.1) 86.8 ( 83.1- 90.7) 120.6 (103.6- 140.1) ∼
Michigan 75.4 ( 72.7- 78.1) 72.8 ( 70.0- 75.6) 101.2 ( 91.7- 111.6) 30.5 ( 17.6- 52.0)
Ohio 83.9 ( 81.4- 86.5) 83.0 ( 80.3- 85.7) 99.9 ( 90.4- 110.4) 54.1 ( 33.1- 86.7)
Wisconsin 64.1 ( 60.9- 67.4) 63.5 ( 60.3- 66.8) 90.0 ( 66.3- 122.3) ∼
West North Central 72.5 ( 70.7- 74.3) 71.7 ( 69.9- 73.6) 104.0 ( 92.3- 117.1) 32.2 ( 21.3- 47.7)
Iowa 74.0 ( 69.6- 78.6) 73.6 ( 69.2- 78.3) 126.9 ( 73.6- 210.3) ∼
Kansas 71.3 ( 66.6- 76.3) 70.7 ( 65.9- 75.8) 100.5 ( 73.0- 136.0) ∼
Minnesota 59.9 ( 56.6- 63.3) 60.3 ( 57.0- 63.8) 53.0 ( 29.5- 96.0) ∼
Missouri 86.9 ( 83.3- 90.6) 85.2 ( 81.5- 89.0) 113.8 ( 98.5- 131.2) ∼
Nebraska 67.0 ( 61.4- 73.1) 67.2 ( 61.5- 73.4) ∼ ∼
North Dakota 62.1 ( 53.7- 71.5) 62.1 ( 53.6- 71.6) ∼ ∼
South Dakota 63.6 ( 55.7- 72.4) 62.5 ( 54.5- 71.4) ∼ ∼
South 84.3 ( 83.4- 85.2) 82.4 ( 81.5- 83.4) 102.9 (100.2- 105.8) 42.0 ( 39.5- 44.6)
South Atlantic 79.1 ( 78.0- 80.2) 77.3 ( 76.1- 78.5) 95.2 ( 91.7- 98.7) 41.1 ( 37.5- 45.0)
Delaware 76.4 ( 67.5- 86.2) 75.3 ( 66.0- 85.8) 86.5 ( 60.0- 123.6) ∼
District of Columbia 86.8 ( 75.0- 100.1) 45.8 ( 31.4- 65.9) 111.4 ( 94.8- 130.4) ∼
Florida 71.0 ( 69.3- 72.8) 71.1 ( 69.3- 72.9) 77.1 ( 70.3- 84.5) 43.3 ( 39.4- 47.7)
Georgia 90.2 ( 86.6- 93.9) 88.3 ( 84.4- 92.4) 102.0 ( 93.4- 111.4) ∼
Maryland 74.5 ( 70.9- 78.3) 72.4 ( 68.3- 76.6) 88.1 ( 78.9- 98.4) ∼
North Carolina 87.0 ( 83.8- 90.3) 83.9 ( 80.5- 87.5) 106.5 ( 97.6- 116.0) ∼
South Carolina 90.3 ( 85.8- 95.1) 89.2 ( 84.1- 94.6) 94.3 ( 84.4- 105.3) ∼
Virginia 79.4 ( 76.1- 82.8) 76.2 ( 72.6- 79.9) 105.7 ( 95.9- 116.4) ∼
West Virginia 96.0 ( 89.8- 102.6) 96.8 ( 90.4- 103.5) 83.5 ( 49.1- 134.6) ∼
East South Central 103.0 (100.6- 105.4) 101.8 ( 99.3- 104.4) 113.9 (107.2- 120.9) 32.0 ( 18.2- 54.1)
Alabama 96.1 ( 91.7- 100.6) 93.2 ( 88.5- 98.2) 110.4 ( 99.5- 122.3) ∼
Kentucky 112.6 (107.6- 117.8) 112.9 (107.7- 118.3) 119.5 ( 97.2- 146.2) ∼
Mississippi 101.7 ( 95.9- 107.8) 98.4 ( 91.8- 105.4) 114.5 (102.4- 127.8) ∼
Tennessee 102.3 ( 98.2- 106.5) 101.2 ( 96.9- 105.6) 116.4 (103.3- 130.8) ∼
West South Central 83.7 ( 82.0- 85.3) 81.3 ( 79.6- 83.1) 114.4 (108.4- 120.7) 43.1 ( 39.6- 46.9)
Arkansas 103.4 ( 97.8- 109.2) 101.8 ( 96.0- 107.9) 119.8 (100.8- 141.7) ∼
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Table 2.15.1.2M: Lung and Bronchus. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 96.0 ( 91.5- 100.8) 89.3 ( 84.2- 94.6) 118.7 (108.2- 130.0) ∼
Oklahoma 90.5 ( 85.8- 95.4) 91.2 ( 86.2- 96.4) 122.7 ( 97.9- 152.5) ∼
Texas 76.3 ( 74.3- 78.3) 74.4 ( 72.3- 76.6) 110.1 (101.9- 118.9) 43.7 ( 40.1- 47.6)
West 58.0 ( 57.0- 58.9) 59.0 ( 58.0- 60.0) 81.6 ( 75.7- 87.9) 33.4 ( 31.1- 35.8)
Mountain 56.0 ( 54.3- 57.8) 56.9 ( 55.1- 58.6) 72.1 ( 58.1- 89.5) 37.6 ( 33.0- 42.8)
Arizona 59.5 ( 56.5- 62.7) 61.0 ( 57.8- 64.3) 71.0 ( 48.4- 104.2) 36.8 ( 29.1- 46.4)
Colorado 54.7 ( 51.0- 58.6) 54.9 ( 51.1- 58.9) 74.0 ( 49.0- 111.7) 37.6 ( 27.7- 50.6)
Idaho 57.5 ( 51.3- 64.3) 57.8 ( 51.5- 64.6) ∼ ∼
Montana 64.7 ( 57.4- 72.8) 62.9 ( 55.5- 70.9) ∼ ∼
Nevada 66.3 ( 60.9- 72.1) 69.0 ( 63.3- 75.2) 58.2 ( 35.7- 97.2) 29.6 ( 17.1- 52.0)
New Mexico 52.2 ( 47.2- 57.7) 53.9 ( 48.6- 59.7) ∼ 41.9 ( 33.5- 51.9)
Utah 32.2 ( 28.1- 36.7) 32.4 ( 28.3- 37.0) ∼ ∼
Wyoming 61.1 ( 51.0- 72.9) 61.5 ( 51.2- 73.5) ∼ ∼
Pacific 58.8 ( 57.7- 59.9) 60.0 ( 58.8- 61.3) 83.5 ( 77.0- 90.5) 31.8 ( 29.2- 34.6)
Alaska 65.3 ( 52.6- 81.2) 62.7 ( 48.5- 81.1) ∼ ∼
California 56.8 ( 55.5- 58.1) 57.7 ( 56.3- 59.2) 81.9 ( 75.2- 89.2) 30.9 ( 28.3- 33.7)
Hawaii 46.9 ( 41.6- 52.7) 49.7 ( 39.1- 62.8) ∼ ∼
Oregon 66.5 ( 62.6- 70.7) 66.8 ( 62.8- 71.1) ∼ ∼
Washington 67.0 ( 63.8- 70.4) 67.0 ( 63.7- 70.5) 116.3 ( 86.6- 155.3) 43.8 ( 25.7- 71.2)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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148 Table 2.15.1.2F: Lung and Bronchus. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 41.5 ( 41.2- 41.8) 42.6 ( 42.2- 42.9) 40.2 ( 39.3- 41.3) 14.8 ( 14.0- 15.6)
Northeast 41.1 ( 40.5- 41.8) 42.4 ( 41.6- 43.1) 36.2 ( 34.2- 38.4) 13.7 ( 11.9- 15.7)
New England 44.4 ( 43.0- 45.9) 45.3 ( 43.8- 46.8) 33.5 ( 27.2- 40.8) 14.1 ( 9.1- 21.1)
Connecticut 39.8 ( 37.1- 42.6) 40.6 ( 37.8- 43.5) 33.2 ( 23.9- 45.0) ∼
Maine 50.0 ( 45.3- 55.1) 49.9 ( 45.2- 55.0) ∼ ∼
Massachusetts 45.0 ( 42.9- 47.2) 46.2 ( 44.0- 48.5) 33.1 ( 24.5- 44.0) 17.6 ( 9.8- 30.0)
New Hampshire 48.6 ( 43.5- 54.1) 48.8 ( 43.7- 54.3) ∼ ∼
Rhode Island 46.7 ( 41.7- 52.3) 47.4 ( 42.2- 53.3) ∼ ∼
Vermont 39.5 ( 33.2- 46.8) 39.6 ( 33.3- 47.0) ∼ ∼
Middle Atlantic 40.0 ( 39.2- 40.8) 41.3 ( 40.4- 42.2) 36.6 ( 34.4- 38.9) 13.7 ( 11.8- 15.8)
New Jersey 40.8 ( 39.1- 42.6) 42.0 ( 40.1- 43.9) 41.0 ( 35.8- 46.8) 12.1 ( 8.6- 16.7)
New York 38.5 ( 37.3- 39.6) 41.3 ( 40.0- 42.6) 29.1 ( 26.6- 31.9) 14.1 ( 11.8- 16.7)
Pennsylvania 41.6 ( 40.3- 43.1) 40.9 ( 39.5- 42.4) 52.1 ( 46.6- 58.1) ∼
Midwest 43.1 ( 42.5- 43.8) 42.8 ( 42.1- 43.5) 51.3 ( 48.7- 54.0) 13.5 ( 10.6- 16.9)
East North Central 44.6 ( 43.8- 45.4) 44.2 ( 43.3- 45.1) 52.2 ( 49.3- 55.2) 13.0 ( 10.0- 16.8)
Illinois 42.8 ( 41.2- 44.3) 41.9 ( 40.2- 43.6) 55.4 ( 50.4- 60.7) 10.2 ( 6.8- 14.9)
Indiana 48.7 ( 46.4- 51.1) 48.1 ( 45.7- 50.5) 62.7 ( 52.6- 74.2) ∼
Michigan 44.4 ( 42.7- 46.2) 44.3 ( 42.4- 46.2) 47.5 ( 42.3- 53.3) ∼
Ohio 46.7 ( 45.1- 48.3) 46.9 ( 45.2- 48.6) 47.5 ( 42.2- 53.3) ∼
Wisconsin 39.8 ( 37.6- 42.1) 39.0 ( 36.7- 41.3) 60.0 ( 45.7- 78.2) ∼
West North Central 39.9 ( 38.7- 41.1) 39.8 ( 38.6- 41.0) 46.4 ( 40.1- 53.5) 15.0 ( 8.5- 24.9)
Iowa 35.6 ( 32.9- 38.4) 35.6 ( 32.9- 38.5) ∼ ∼
Kansas 40.1 ( 37.0- 43.4) 40.4 ( 37.2- 43.9) 34.7 ( 21.5- 53.5) ∼
Minnesota 38.8 ( 36.4- 41.2) 39.3 ( 36.9- 41.8) ∼ ∼
Missouri 46.2 ( 43.9- 48.6) 46.2 ( 43.8- 48.7) 50.4 ( 42.5- 59.5) ∼
Nebraska 35.8 ( 32.2- 39.8) 34.9 ( 31.2- 38.9) ∼ ∼
North Dakota 27.4 ( 22.4- 33.4) 26.5 ( 21.5- 32.6) ∼ ∼
South Dakota 35.9 ( 30.5- 42.1) 36.2 ( 30.6- 42.5) ∼ ∼
South 42.9 ( 42.4- 43.5) 44.2 ( 43.6- 44.8) 37.7 ( 36.4- 39.1) 14.5 ( 13.3- 15.9)
South Atlantic 41.8 ( 41.1- 42.6) 43.4 ( 42.6- 44.2) 35.4 ( 33.8- 37.1) 15.3 ( 13.4- 17.3)
Delaware 40.6 ( 35.1- 46.9) 41.7 ( 35.7- 48.7) 38.4 ( 24.2- 58.2) ∼
District of Columbia 38.5 ( 32.1- 46.1) 33.9 ( 23.0- 50.2) 41.4 ( 33.4- 51.5) ∼
Florida 42.3 ( 41.2- 43.5) 43.9 ( 42.7- 45.3) 29.4 ( 26.1- 33.1) 16.5 ( 14.4- 18.7)
Georgia 38.9 ( 36.9- 40.9) 41.9 ( 39.7- 44.3) 29.2 ( 25.7- 33.0) ∼
Maryland 45.1 ( 42.7- 47.6) 44.9 ( 42.1- 47.8) 49.3 ( 43.9- 55.3) ∼
North Carolina 40.7 ( 38.8- 42.5) 41.9 ( 39.9- 44.1) 36.4 ( 32.4- 40.8) ∼
South Carolina 39.0 ( 36.6- 41.7) 41.7 ( 38.8- 44.9) 30.5 ( 26.1- 35.5) ∼
Virginia 42.0 ( 40.0- 44.1) 43.3 ( 41.1- 45.7) 39.5 ( 34.8- 44.7) ∼
West Virginia 50.0 ( 46.1- 54.2) 50.2 ( 46.2- 54.5) 50.7 ( 29.6- 82.8) ∼
East South Central 47.1 ( 45.8- 48.5) 48.6 ( 47.1- 50.1) 40.2 ( 37.0- 43.5) ∼
Alabama 41.0 ( 38.6- 43.5) 42.5 ( 39.7- 45.4) 36.0 ( 31.2- 41.4) ∼
Kentucky 57.5 ( 54.5- 60.7) 58.1 ( 54.9- 61.4) 54.4 ( 42.5- 68.7) ∼
Mississippi 43.8 ( 40.6- 47.2) 46.0 ( 42.1- 50.2) 38.1 ( 32.5- 44.4) ∼
Tennessee 46.3 ( 44.1- 48.7) 47.0 ( 44.5- 49.6) 43.6 ( 37.3- 50.6) ∼
West South Central 42.6 ( 41.6- 43.6) 43.1 ( 42.1- 44.2) 41.8 ( 38.9- 44.9) 13.8 ( 12.2- 15.6)
Arkansas 48.3 ( 45.0- 51.8) 50.4 ( 46.9- 54.3) 34.6 ( 26.5- 44.4) ∼
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Table 2.15.1.2F: Lung and Bronchus. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 45.5 ( 42.9- 48.3) 46.5 ( 43.4- 49.8) 43.0 ( 38.0- 48.5) ∼
Oklahoma 47.6 ( 44.6- 50.7) 48.2 ( 45.0- 51.6) 43.7 ( 31.8- 58.8) ∼
Texas 40.0 ( 38.7- 41.2) 40.3 ( 39.0- 41.7) 42.3 ( 38.3- 46.8) 13.7 ( 12.0- 15.5)
West 37.8 ( 37.1- 38.5) 39.8 ( 39.1- 40.6) 41.8 ( 38.3- 45.6) 15.8 ( 14.5- 17.1)
Mountain 35.9 ( 34.7- 37.2) 36.5 ( 35.3- 37.8) 40.9 ( 32.0- 51.7) 19.3 ( 16.5- 22.5)
Arizona 38.3 ( 36.1- 40.5) 39.3 ( 37.0- 41.7) 45.5 ( 29.2- 68.2) 17.8 ( 13.3- 23.6)
Colorado 33.8 ( 31.4- 36.5) 34.2 ( 31.6- 36.9) 43.4 ( 27.3- 65.9) 25.4 ( 18.5- 34.2)
Idaho 32.1 ( 27.9- 36.7) 32.4 ( 28.2- 37.1) ∼ ∼
Montana 44.6 ( 39.1- 50.8) 43.7 ( 38.1- 49.9) ∼ ∼
Nevada 50.8 ( 46.6- 55.4) 52.4 ( 47.8- 57.2) 46.8 ( 29.3- 72.4) ∼
New Mexico 30.0 ( 26.7- 33.7) 32.1 ( 28.5- 36.0) ∼ 18.7 ( 14.1- 24.4)
Utah 18.7 ( 16.0- 21.8) 18.4 ( 15.6- 21.5) ∼ ∼
Wyoming 40.0 ( 32.8- 48.6) 40.5 ( 33.1- 49.2) ∼ ∼
Pacific 38.6 ( 37.8- 39.4) 41.4 ( 40.5- 42.3) 42.1 ( 38.3- 46.2) 14.6 ( 13.1- 16.1)
Alaska 38.9 ( 30.4- 49.3) 39.5 ( 29.9- 51.6) ∼ ∼
California 36.9 ( 36.0- 37.8) 39.2 ( 38.2- 40.3) 42.3 ( 38.3- 46.5) 14.4 ( 12.9- 16.0)
Hawaii 18.7 ( 15.7- 22.2) 28.7 ( 21.1- 38.9) ∼ ∼
Oregon 49.4 ( 46.4- 52.6) 50.5 ( 47.3- 53.8) ∼ ∼
Washington 45.3 ( 42.9- 47.7) 46.4 ( 44.0- 49.0) 45.8 ( 29.8- 67.7) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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150 Table 2.16.1.1M: Melanomas of the Skin. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 20.9 ( 20.6- 21.1) 22.8 ( 22.5- 23.1) 0.9 ( 0.7- 1.1) 4.5 ( 4.1- 5.1)
Northeast 21.0 ( 20.5- 21.6) 22.7 ( 22.1- 23.3) 0.8 ( 0.5- 1.4) 3.2 ( 2.3- 4.6)
New England 26.5 ( 25.3- 27.8) 26.9 ( 25.6- 28.2) ∼ ∼
Connecticut 24.1 ( 21.8- 26.6) 24.9 ( 22.4- 27.5) ∼ ∼
Maine 24.1 ( 20.5- 28.3) 24.1 ( 20.5- 28.3) ∼ ∼
Massachusetts 25.0 ( 23.2- 26.9) 25.1 ( 23.2- 27.0) ∼ ∼
New Hampshire 32.5 ( 28.0- 37.5) 32.5 ( 28.0- 37.6) ∼ -
Rhode Island 35.9 ( 30.9- 41.7) 37.4 ( 32.1- 43.4) ∼ ∼
Vermont 31.7 ( 25.6- 39.1) 32.2 ( 26.0- 39.7) ∼ ∼
Middle Atlantic 19.1 ( 18.4- 19.7) 21.1 ( 20.4- 21.8) 0.8 ( 0.5- 1.5) 3.2 ( 2.2- 4.8)
New Jersey 26.6 ( 25.0- 28.3) 30.5 ( 28.6- 32.4) ∼ ∼
New York 14.7 ( 13.9- 15.5) 16.5 ( 15.6- 17.5) ∼ 3.1 ( 1.8- 5.1)
Pennsylvania 20.5 ( 19.4- 21.7) 21.3 ( 20.1- 22.5) ∼ -
Midwest 18.7 ( 18.2- 19.2) 19.4 ( 18.9- 19.9) 1.0 ( 0.6- 1.6) 4.8 ( 3.1- 7.6)
East North Central 18.9 ( 18.3- 19.5) 19.9 ( 19.3- 20.6) ∼ 5.1 ( 3.1- 8.4)
Illinois 16.7 ( 15.6- 17.9) 18.3 ( 17.1- 19.6) ∼ ∼
Indiana 19.7 ( 18.0- 21.5) 20.6 ( 18.9- 22.5) ∼ ∼
Michigan 20.6 ( 19.2- 21.9) 22.5 ( 21.1- 24.1) ∼ ∼
Detroit 20.9 ( 18.8- 23.2) 26.8 ( 24.1- 29.8) ∼ -
Ohio 20.0 ( 18.8- 21.2) 19.9 ( 18.7- 21.3) ∼ ∼
Wisconsin 17.6 ( 16.0- 19.3) 18.1 ( 16.4- 19.8) ∼ -
West North Central 18.3 ( 17.4- 19.3) 18.2 ( 17.3- 19.2) ∼ ∼
Iowa 19.6 ( 17.4- 22.0) 18.1 ( 15.9- 20.5) ∼ ∼
Kansas 22.2 ( 19.6- 25.0) 21.9 ( 19.2- 24.8) ∼ ∼
Minnesota 19.8 ( 18.0- 21.7) 19.8 ( 17.9- 21.7) ∼ ∼
Missouri 14.8 ( 13.3- 16.3) 15.9 ( 14.3- 17.6) ∼ ∼
Nebraska 19.3 ( 16.4- 22.6) 17.1 ( 14.3- 20.3) ∼ ∼
North Dakota 14.0 ( 10.2- 18.9) 14.5 ( 10.6- 19.5) ∼ ∼
South Dakota
South
South Atlantic
Delaware 19.8 ( 15.6- 25.1) 22.3 ( 17.5- 28.4) ∼ ∼
District of Columbia 8.2 ( 5.1- 12.8) 16.9 ( 9.4- 30.3) ∼ ∼
Florida 19.3 ( 18.4- 20.2) 21.4 ( 20.4- 22.5) ∼ -
Georgia 22.7 ( 21.0- 24.5) 28.1 ( 26.0- 30.3) ∼ ∼
Atlanta 28.9 ( 25.4- 33.0) 39.3 ( 34.5- 44.7) ∼ ∼
Maryland 44.7 ( 42.1- 47.6) 59.3 ( 55.7- 63.0) ∼ ∼
North Carolina 18.5 ( 17.1- 20.0) 22.5 ( 20.8- 24.4) ∼ ∼
South Carolina 23.3 ( 21.1- 25.7) 30.1 ( 27.3- 33.3) ∼ -
Virginia
West Virginia 18.8 ( 16.1- 21.9) 19.5 ( 16.6- 22.7) ∼ ∼
East South Central
Alabama 16.3 ( 14.6- 18.3) 20.1 ( 17.9- 22.5) ∼ ∼
Kentucky 22.8 ( 20.6- 25.1) 22.6 ( 20.4- 25.0) ∼ -
Mississippi
Tennessee
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Table 2.16.1.1M: Melanomas of the Skin. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 13.1 ( 11.5- 14.9) 17.1 ( 15.0- 19.5) ∼ ∼
Oklahoma 18.7 ( 16.7- 21.0) 19.9 ( 17.6- 22.4) ∼ ∼
Texas 16.9 ( 16.0- 17.8) 17.0 ( 16.1- 18.0) ∼ 3.4 ( 2.6- 4.6)
West 23.6 ( 23.0- 24.2) 26.1 ( 25.4- 26.8) ∼ 4.7 ( 3.9- 5.6)
Mountain 22.9 ( 21.8- 23.9) 24.2 ( 23.1- 25.4) ∼ 4.2 ( 2.8- 6.3)
Arizona 22.1 ( 20.3- 24.0) 23.4 ( 21.5- 25.5) ∼ 5.1 ( 2.6- 9.8)
Colorado 23.8 ( 21.6- 26.3) 25.3 ( 23.0- 27.9) ∼ ∼
Idaho 27.1 ( 23.1- 31.6) 27.4 ( 23.3- 32.1) ∼ ∼
Montana 16.9 ( 13.3- 21.2) 17.0 ( 13.3- 21.4) ∼ ∼
Nevada 20.7 ( 18.0- 23.9) 22.9 ( 19.8- 26.4) ∼ ∼
New Mexico 21.9 ( 18.8- 25.4) 23.8 ( 20.4- 27.7) ∼ ∼
Utah 26.1 ( 22.6- 30.0) 27.1 ( 23.5- 31.1) ∼ ∼
Wyoming
Pacific 23.9 ( 23.2- 24.6) 27.0 ( 26.2- 27.8) ∼ 4.9 ( 4.0- 6.0)
Alaska 12.0 ( 7.4- 20.0) 14.9 ( 9.2- 25.0) ∼ ∼
California 23.5 ( 22.7- 24.3) 26.4 ( 25.4- 27.3) ∼ 5.0 ( 4.0- 6.1)
San Francisco-Oakland 18.9 ( 16.9- 21.0) 24.6 ( 22.0- 27.5) ∼ ∼
San Jose-Monterey 20.7 ( 17.9- 23.9) 23.8 ( 20.3- 27.7) ∼ ∼
Los Angeles 18.3 ( 16.9- 19.8) 22.3 ( 20.6- 24.2) ∼ 4.3 ( 2.9- 6.3)
Hawaii 20.4 ( 17.0- 24.4) 66.3 ( 54.3- 80.8) ∼ -
Oregon 26.7 ( 24.3- 29.3) 26.6 ( 24.2- 29.3) ∼ ∼
Washington 26.1 ( 24.2- 28.1) 28.5 ( 26.4- 30.7) ∼ ∼
Seattle-Puget Sound 26.3 ( 23.9- 28.8) 29.5 ( 26.9- 32.3) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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152 Table 2.16.1.1F: Melanomas of the Skin. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 13.6 ( 13.4- 13.8) 15.2 ( 15.0- 15.4) 0.9 ( 0.7- 1.1) 3.9 ( 3.6- 4.3)
Northeast 14.0 ( 13.6- 14.5) 15.6 ( 15.1- 16.1) 0.7 ( 0.5- 1.1) 3.2 ( 2.5- 4.2)
New England 19.3 ( 18.3- 20.3) 20.0 ( 18.9- 21.0) ∼ ∼
Connecticut 17.5 ( 15.7- 19.5) 19.0 ( 17.0- 21.2) ∼ ∼
Maine 18.8 ( 15.8- 22.3) 18.9 ( 15.8- 22.4) ∼ ∼
Massachusetts 19.2 ( 17.8- 20.7) 19.6 ( 18.1- 21.2) ∼ ∼
New Hampshire 23.5 ( 20.0- 27.5) 23.8 ( 20.2- 27.9) ∼ -
Rhode Island 19.2 ( 15.9- 23.2) 20.3 ( 16.7- 24.6) ∼ ∼
Vermont 22.2 ( 17.4- 28.2) 22.4 ( 17.5- 28.5) ∼ ∼
Middle Atlantic 12.2 ( 11.7- 12.6) 13.8 ( 13.3- 14.4) 0.8 ( 0.5- 1.2) 3.0 ( 2.2- 4.0)
New Jersey 16.3 ( 15.2- 17.5) 19.3 ( 18.0- 20.8) ∼ 3.3 ( 1.9- 5.9)
New York 9.0 ( 8.5- 9.6) 10.4 ( 9.7- 11.1) ∼ 2.3 ( 1.5- 3.4)
Pennsylvania 14.4 ( 13.5- 15.3) 15.1 ( 14.1- 16.1) ∼ -
Midwest 13.0 ( 12.7- 13.4) 13.8 ( 13.3- 14.2) 0.8 ( 0.5- 1.2) 4.6 ( 3.3- 6.5)
East North Central 13.0 ( 12.5- 13.4) 14.0 ( 13.5- 14.5) 0.9 ( 0.6- 1.4) 4.3 ( 3.0- 6.3)
Illinois 10.1 ( 9.3- 10.9) 11.3 ( 10.5- 12.3) ∼ 3.4 ( 1.9- 6.2)
Indiana 13.1 ( 11.9- 14.4) 14.1 ( 12.7- 15.5) ∼ ∼
Michigan 15.6 ( 14.5- 16.7) 17.7 ( 16.5- 19.0) ∼ ∼
Detroit 15.9 ( 14.3- 17.7) 21.5 ( 19.3- 24.0) ∼ -
Ohio 13.8 ( 12.8- 14.7) 13.7 ( 12.8- 14.8) ∼ ∼
Wisconsin 13.0 ( 11.7- 14.4) 13.8 ( 12.4- 15.3) ∼ -
West North Central 13.2 ( 12.5- 13.9) 13.1 ( 12.4- 13.9) ∼ ∼
Iowa 17.3 ( 15.2- 19.5) 16.1 ( 14.1- 18.3) ∼ ∼
Kansas 14.0 ( 12.1- 16.1) 13.8 ( 11.8- 16.0) ∼ ∼
Minnesota 15.2 ( 13.7- 16.7) 15.6 ( 14.0- 17.2) ∼ ∼
Missouri 9.1 ( 8.0- 10.2) 9.9 ( 8.7- 11.1) ∼ ∼
Nebraska 15.5 ( 13.0- 18.4) 12.2 ( 10.0- 14.9) ∼ ∼
North Dakota 6.9 ( 4.3- 10.5) 7.0 ( 4.3- 10.9) ∼ ∼
South Dakota
South
South Atlantic
Delaware 11.6 ( 8.7- 15.4) 13.3 ( 9.7- 17.9) ∼ ∼
District of Columbia 7.1 ( 4.5- 11.0) 18.4 ( 10.6- 32.1) ∼ ∼
Florida 11.9 ( 11.2- 12.6) 13.6 ( 12.8- 14.5) ∼ -
Georgia 13.2 ( 12.2- 14.4) 17.1 ( 15.6- 18.6) ∼ ∼
Atlanta 13.6 ( 11.7- 15.7) 20.6 ( 17.7- 23.9) ∼ ∼
Maryland 29.5 ( 27.6- 31.5) 42.7 ( 39.9- 45.7) ∼ ∼
North Carolina 12.6 ( 11.6- 13.7) 16.1 ( 14.8- 17.5) ∼ ∼
South Carolina 13.6 ( 12.1- 15.3) 18.5 ( 16.4- 20.8) ∼ -
Virginia
West Virginia 13.6 ( 11.4- 16.1) 14.1 ( 11.9- 16.8) ∼ ∼
East South Central
Alabama 10.8 ( 9.6- 12.2) 14.3 ( 12.6- 16.1) ∼ ∼
Kentucky 15.2 ( 13.6- 16.9) 15.7 ( 14.0- 17.6) ∼ -
Mississippi
Tennessee
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Table 2.16.1.1F: Melanomas of the Skin. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 7.6 ( 6.5- 8.8) 10.5 ( 8.9- 12.2) ∼ ∼
Oklahoma 11.1 ( 9.7- 12.7) 12.0 ( 10.4- 13.9) ∼ ∼
Texas 9.9 ( 9.3- 10.5) 9.7 ( 9.0- 10.4) ∼ 2.5 ( 1.9- 3.2)
West 14.9 ( 14.5- 15.3) 16.7 ( 16.2- 17.2) 1.1 ( 0.6- 1.9) 4.2 ( 3.6- 4.8)
Mountain 14.4 ( 13.6- 15.2) 15.5 ( 14.7- 16.4) ∼ 3.8 ( 2.7- 5.2)
Arizona 12.6 ( 11.3- 14.0) 13.7 ( 12.2- 15.2) ∼ 3.6 ( 2.0- 6.5)
Colorado 17.3 ( 15.6- 19.1) 18.5 ( 16.7- 20.5) ∼ ∼
Idaho 14.6 ( 11.8- 17.8) 14.8 ( 12.0- 18.1) ∼ ∼
Montana 14.5 ( 11.2- 18.4) 14.7 ( 11.4- 18.9) ∼ ∼
Nevada 12.9 ( 10.8- 15.3) 14.8 ( 12.4- 17.5) ∼ ∼
New Mexico 11.4 ( 9.3- 13.8) 12.7 ( 10.4- 15.4) ∼ ∼
Utah 16.6 ( 14.1- 19.5) 17.3 ( 14.7- 20.3) ∼ ∼
Wyoming
Pacific 15.1 ( 14.6- 15.6) 17.2 ( 16.6- 17.8) ∼ 4.3 ( 3.7- 5.1)
Alaska 9.3 ( 6.1- 14.2) 12.0 ( 7.8- 18.5) ∼ ∼
California 14.2 ( 13.6- 14.7) 16.0 ( 15.3- 16.7) ∼ 4.2 ( 3.5- 5.0)
San Francisco-Oakland 11.1 ( 9.7- 12.5) 15.4 ( 13.5- 17.6) ∼ ∼
San Jose-Monterey 11.7 ( 9.8- 13.9) 13.4 ( 11.1- 16.1) ∼ ∼
Los Angeles 10.8 ( 9.9- 11.8) 13.5 ( 12.3- 14.8) ∼ 3.7 ( 2.8- 5.0)
Hawaii 13.5 ( 10.9- 16.7) 37.4 ( 28.6- 48.8) ∼ -
Oregon 20.3 ( 18.3- 22.5) 20.5 ( 18.5- 22.8) ∼ ∼
Washington 18.2 ( 16.7- 19.8) 20.5 ( 18.8- 22.3) ∼ ∼
Seattle-Puget Sound 18.4 ( 16.7- 20.4) 21.4 ( 19.3- 23.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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154 Table 2.16.1.2M: Melanomas of the Skin. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 3.8 ( 3.7- 3.9) 4.2 ( 4.1- 4.4) 0.5 ( 0.4- 0.7) 0.8 ( 0.6- 1.1)
Northeast 3.5 ( 3.3- 3.8) 4.0 ( 3.7- 4.3) ∼ ∼
New England 4.4 ( 3.9- 4.9) 4.6 ( 4.1- 5.2) ∼ ∼
Connecticut 4.1 ( 3.1- 5.2) 4.3 ( 3.3- 5.6) ∼ ∼
Maine 5.9 ( 4.1- 8.2) 5.9 ( 4.2- 8.3) ∼ ∼
Massachusetts 4.0 ( 3.3- 4.8) 4.2 ( 3.5- 5.1) ∼ ∼
New Hampshire 5.5 ( 3.7- 7.9) 5.6 ( 3.8- 8.1) ∼ ∼
Rhode Island 3.6 ( 2.1- 5.8) 3.8 ( 2.2- 6.1) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.3 ( 3.0- 3.5) 3.7 ( 3.4- 4.1) ∼ ∼
New Jersey 4.0 ( 3.4- 4.7) 4.6 ( 3.9- 5.5) ∼ ∼
New York 2.6 ( 2.3- 3.0) 3.1 ( 2.7- 3.6) ∼ ∼
Pennsylvania 3.7 ( 3.2- 4.2) 4.0 ( 3.5- 4.5) ∼ ∼
Midwest 3.6 ( 3.4- 3.8) 3.9 ( 3.7- 4.1) ∼ ∼
East North Central 3.6 ( 3.4- 3.9) 4.0 ( 3.7- 4.3) ∼ ∼
Illinois 3.5 ( 3.0- 4.1) 4.0 ( 3.4- 4.6) ∼ ∼
Indiana 3.6 ( 2.9- 4.4) 3.8 ( 3.1- 4.7) ∼ ∼
Michigan 3.6 ( 3.0- 4.2) 4.0 ( 3.3- 4.7) ∼ ∼
Ohio 3.6 ( 3.1- 4.2) 4.0 ( 3.5- 4.6) ∼ ∼
Wisconsin 4.1 ( 3.3- 5.0) 4.3 ( 3.5- 5.2) ∼ ∼
West North Central 3.5 ( 3.1- 3.9) 3.6 ( 3.2- 4.1) ∼ ∼
Iowa 3.0 ( 2.2- 4.1) 3.1 ( 2.2- 4.2) ∼ ∼
Kansas 2.9 ( 2.0- 4.1) 3.1 ( 2.2- 4.3) ∼ ∼
Minnesota 3.7 ( 2.9- 4.6) 3.8 ( 3.0- 4.7) ∼ ∼
Missouri 3.7 ( 3.0- 4.6) 4.0 ( 3.2- 4.9) ∼ ∼
Nebraska 4.9 ( 3.4- 6.7) 4.9 ( 3.5- 6.8) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 4.0 ( 3.8- 4.2) 4.6 ( 4.4- 4.8) 0.6 ( 0.4- 0.9) 0.8 ( 0.5- 1.2)
South Atlantic 4.0 ( 3.8- 4.3) 4.7 ( 4.4- 5.0) ∼ ∼
Delaware 4.5 ( 2.5- 7.6) 5.2 ( 3.0- 8.8) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.3 ( 3.9- 4.8) 4.8 ( 4.3- 5.3) ∼ ∼
Georgia 3.4 ( 2.7- 4.1) 4.2 ( 3.4- 5.1) ∼ ∼
Maryland 4.7 ( 3.8- 5.7) 5.9 ( 4.8- 7.2) ∼ ∼
North Carolina 4.1 ( 3.5- 4.9) 4.9 ( 4.1- 5.8) ∼ ∼
South Carolina 3.7 ( 2.8- 4.8) 4.5 ( 3.4- 5.9) ∼ ∼
Virginia 3.8 ( 3.1- 4.6) 4.6 ( 3.8- 5.6) ∼ ∼
West Virginia 3.7 ( 2.6- 5.3) 3.9 ( 2.7- 5.5) ∼ ∼
East South Central 4.3 ( 3.8- 4.8) 4.9 ( 4.4- 5.5) ∼ ∼
Alabama 4.0 ( 3.1- 5.0) 4.8 ( 3.7- 6.1) ∼ ∼
Kentucky 5.0 ( 4.0- 6.2) 5.3 ( 4.3- 6.6) ∼ ∼
Mississippi 4.0 ( 2.9- 5.4) 5.3 ( 3.8- 7.2) ∼ ∼
Tennessee 4.1 ( 3.4- 5.1) 4.5 ( 3.7- 5.6) ∼ ∼
West South Central 3.8 ( 3.5- 4.2) 4.3 ( 3.9- 4.7) ∼ 0.9 ( 0.5- 1.7)
Arkansas 3.0 ( 2.1- 4.2) 3.4 ( 2.4- 4.8) ∼ ∼
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Table 2.16.1.2M: Melanomas of the Skin. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 3.7 ( 2.8- 4.7) 4.6 ( 3.5- 5.9) ∼ ∼
Oklahoma 5.4 ( 4.3- 6.7) 5.8 ( 4.6- 7.2) ∼ ∼
Texas 3.7 ( 3.3- 4.2) 4.1 ( 3.6- 4.6) ∼ 0.9 ( 0.5- 1.7)
West 3.8 ( 3.5- 4.0) 4.3 ( 4.0- 4.5) ∼ 1.1 ( 0.7- 1.6)
Mountain 4.1 ( 3.7- 4.6) 4.3 ( 3.8- 4.8) ∼ ∼
Arizona 4.4 ( 3.6- 5.3) 4.6 ( 3.8- 5.6) ∼ ∼
Colorado 3.3 ( 2.5- 4.4) 3.5 ( 2.6- 4.6) ∼ ∼
Idaho 5.6 ( 3.8- 8.0) 5.7 ( 3.9- 8.2) ∼ ∼
Montana 4.0 ( 2.4- 6.5) 4.0 ( 2.3- 6.5) ∼ ∼
Nevada 4.1 ( 2.9- 5.9) 4.6 ( 3.3- 6.5) ∼ ∼
New Mexico 3.3 ( 2.1- 4.9) 3.5 ( 2.2- 5.2) ∼ ∼
Utah 4.7 ( 3.3- 6.5) 4.8 ( 3.4- 6.8) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 3.6 ( 3.3- 3.9) 4.2 ( 3.9- 4.6) ∼ 1.1 ( 0.7- 1.7)
Alaska ∼ ∼ ∼ ∼
California 3.6 ( 3.2- 3.9) 4.2 ( 3.9- 4.6) ∼ 1.1 ( 0.7- 1.8)
Hawaii ∼ ∼ ∼ ∼
Oregon 4.8 ( 3.7- 6.0) 4.9 ( 3.9- 6.2) ∼ ∼
Washington 3.5 ( 2.8- 4.3) 3.7 ( 2.9- 4.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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156 Table 2.16.1.2F: Melanomas of the Skin. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 1.7 ( 1.7- 1.8) 2.0 ( 1.9- 2.0) 0.3 ( 0.2- 0.4) 0.7 ( 0.5- 0.9)
Northeast 1.8 ( 1.7- 2.0) 2.1 ( 1.9- 2.2) ∼ ∼
New England 1.7 ( 1.5- 2.0) 1.8 ( 1.5- 2.2) ∼ ∼
Connecticut 1.3 ( 0.9- 1.9) 1.4 ( 1.0- 2.1) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 1.7 ( 1.3- 2.2) 1.8 ( 1.4- 2.4) ∼ ∼
New Hampshire 2.4 ( 1.4- 4.0) 2.4 ( 1.4- 4.0) ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.9 ( 1.7- 2.0) 2.1 ( 2.0- 2.4) ∼ ∼
New Jersey 1.7 ( 1.3- 2.1) 1.9 ( 1.5- 2.4) ∼ ∼
New York 1.8 ( 1.6- 2.1) 2.2 ( 1.9- 2.5) ∼ ∼
Pennsylvania 2.0 ( 1.7- 2.4) 2.2 ( 1.9- 2.6) ∼ ∼
Midwest 1.7 ( 1.6- 1.8) 1.8 ( 1.7- 2.0) ∼ ∼
East North Central 1.7 ( 1.6- 1.9) 1.9 ( 1.7- 2.1) ∼ ∼
Illinois 1.7 ( 1.4- 2.0) 2.0 ( 1.6- 2.4) ∼ ∼
Indiana 2.5 ( 2.0- 3.1) 2.7 ( 2.1- 3.3) ∼ ∼
Michigan 1.5 ( 1.2- 1.8) 1.6 ( 1.3- 2.0) ∼ ∼
Ohio 1.8 ( 1.4- 2.1) 1.9 ( 1.6- 2.3) ∼ ∼
Wisconsin 1.2 ( 0.9- 1.7) 1.3 ( 0.9- 1.8) ∼ ∼
West North Central 1.6 ( 1.4- 1.9) 1.8 ( 1.5- 2.0) ∼ ∼
Iowa 1.7 ( 1.1- 2.4) 1.7 ( 1.1- 2.5) ∼ ∼
Kansas 1.3 ( 0.8- 2.1) 1.4 ( 0.9- 2.2) ∼ ∼
Minnesota 1.2 ( 0.8- 1.7) 1.3 ( 0.9- 1.8) ∼ ∼
Missouri 2.2 ( 1.7- 2.8) 2.5 ( 1.9- 3.1) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 1.7 ( 1.6- 1.8) 2.0 ( 1.9- 2.1) 0.3 ( 0.2- 0.4) 0.8 ( 0.6- 1.2)
South Atlantic 1.7 ( 1.6- 1.9) 2.1 ( 1.9- 2.3) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.6 ( 1.3- 1.8) 1.7 ( 1.5- 2.1) ∼ ∼
Georgia 2.0 ( 1.6- 2.4) 2.6 ( 2.1- 3.2) ∼ ∼
Maryland 1.4 ( 1.0- 1.9) 1.9 ( 1.4- 2.6) ∼ ∼
North Carolina 1.8 ( 1.4- 2.2) 2.2 ( 1.8- 2.8) ∼ ∼
South Carolina 1.8 ( 1.3- 2.4) 2.2 ( 1.6- 3.1) ∼ ∼
Virginia 2.2 ( 1.7- 2.7) 2.6 ( 2.1- 3.2) ∼ ∼
West Virginia 1.8 ( 1.1- 2.8) 1.8 ( 1.1- 2.9) ∼ ∼
East South Central 1.6 ( 1.4- 1.9) 1.9 ( 1.6- 2.3) ∼ ∼
Alabama 2.0 ( 1.5- 2.6) 2.4 ( 1.7- 3.2) ∼ ∼
Kentucky 1.7 ( 1.2- 2.3) 1.7 ( 1.2- 2.4) ∼ ∼
Mississippi 1.1 ( 0.6- 1.7) 1.5 ( 0.9- 2.6) ∼ ∼
Tennessee 1.6 ( 1.2- 2.2) 1.9 ( 1.4- 2.5) ∼ ∼
West South Central 1.7 ( 1.5- 1.9) 1.9 ( 1.7- 2.1) ∼ 0.8 ( 0.5- 1.3)
Arkansas 1.5 ( 0.9- 2.2) 1.7 ( 1.1- 2.5) ∼ ∼
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Table 2.16.1.2F: Melanomas of the Skin. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 1.5 ( 1.1- 2.1) 1.9 ( 1.3- 2.7) ∼ ∼
Oklahoma 2.0 ( 1.4- 2.7) 2.2 ( 1.5- 3.0) ∼ ∼
Texas 1.7 ( 1.4- 1.9) 1.8 ( 1.6- 2.2) ∼ 0.8 ( 0.4- 1.3)
West 1.7 ( 1.6- 1.9) 2.0 ( 1.8- 2.1) ∼ 0.6 ( 0.4- 1.0)
Mountain 1.9 ( 1.6- 2.2) 2.0 ( 1.7- 2.3) ∼ ∼
Arizona 1.9 ( 1.4- 2.5) 2.0 ( 1.5- 2.6) ∼ ∼
Colorado 2.2 ( 1.6- 2.9) 2.2 ( 1.6- 3.0) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 1.8 ( 1.0- 2.8) 2.0 ( 1.2- 3.2) ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah 2.3 ( 1.4- 3.5) 2.4 ( 1.5- 3.7) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.7 ( 1.5- 1.8) 2.0 ( 1.8- 2.2) ∼ 0.7 ( 0.4- 1.1)
Alaska ∼ ∼ ∼ ∼
California 1.6 ( 1.4- 1.8) 1.9 ( 1.7- 2.1) ∼ 0.7 ( 0.4- 1.1)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.2 ( 1.6- 3.0) 2.3 ( 1.7- 3.1) ∼ ∼
Washington 1.9 ( 1.5- 2.5) 2.0 ( 1.6- 2.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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158 Table 2.17.1.1M: Mesothelioma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 2.0 ( 2.0- 2.1) 2.2 ( 2.1- 2.3) 1.0 ( 0.8- 1.2) 1.5 ( 1.2- 1.8)
Northeast 2.4 ( 2.2- 2.6) 2.5 ( 2.3- 2.7) 1.4 ( 0.9- 2.1) ∼
New England 2.7 ( 2.3- 3.1) 2.7 ( 2.3- 3.2) ∼ ∼
Connecticut 3.0 ( 2.2- 4.0) 3.0 ( 2.2- 4.1) ∼ ∼
Maine 3.2 ( 1.9- 5.0) 3.2 ( 1.9- 5.1) ∼ ∼
Massachusetts 2.8 ( 2.2- 3.5) 2.9 ( 2.3- 3.6) ∼ ∼
New Hampshire ∼ ∼ ∼ -
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.3 ( 2.1- 2.5) 2.4 ( 2.2- 2.7) 1.3 ( 0.8- 2.1) ∼
New Jersey 2.8 ( 2.3- 3.4) 3.1 ( 2.5- 3.8) ∼ ∼
New York 2.1 ( 1.8- 2.4) 2.3 ( 2.0- 2.7) ∼ ∼
Pennsylvania 2.2 ( 1.9- 2.6) 2.2 ( 1.9- 2.7) ∼ -
Midwest 2.1 ( 1.9- 2.3) 2.2 ( 2.0- 2.4) ∼ ∼
East North Central 2.3 ( 2.1- 2.5) 2.4 ( 2.2- 2.7) ∼ ∼
Illinois 2.4 ( 2.0- 2.9) 2.8 ( 2.3- 3.3) ∼ ∼
Indiana 1.9 ( 1.4- 2.6) 2.0 ( 1.5- 2.7) ∼ ∼
Michigan 1.9 ( 1.5- 2.4) 2.1 ( 1.6- 2.6) ∼ ∼
Detroit 1.7 ( 1.1- 2.5) 2.0 ( 1.3- 3.0) ∼ -
Ohio 2.4 ( 2.0- 2.9) 2.5 ( 2.1- 3.0) ∼ ∼
Wisconsin 2.6 ( 2.0- 3.3) 2.6 ( 2.0- 3.4) ∼ -
West North Central 1.7 ( 1.4- 2.0) 1.7 ( 1.4- 2.0) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota 2.4 ( 1.8- 3.2) 2.4 ( 1.8- 3.2) ∼ ∼
Missouri 1.7 ( 1.2- 2.3) 1.8 ( 1.3- 2.4) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.9 ( 1.6- 2.2) 1.9 ( 1.7- 2.3) ∼ -
Georgia 1.0 ( 0.6- 1.5) 1.2 ( 0.8- 1.8) ∼ ∼
Atlanta ∼ ∼ ∼ ∼
Maryland 2.5 ( 1.8- 3.3) 2.7 ( 2.0- 3.7) ∼ ∼
North Carolina 1.4 ( 1.1- 2.0) 1.6 ( 1.2- 2.2) ∼ ∼
South Carolina 1.6 ( 1.0- 2.4) 1.6 ( 1.0- 2.6) ∼ -
Virginia
West Virginia 2.7 ( 1.7- 4.1) 2.8 ( 1.8- 4.2) ∼ ∼
East South Central
Alabama 2.0 ( 1.4- 2.8) 2.1 ( 1.4- 3.0) ∼ ∼
Kentucky 1.7 ( 1.1- 2.5) 1.8 ( 1.2- 2.7) ∼ -
Mississippi
Tennessee
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Table 2.17.1.1M: Mesothelioma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 1.6 ( 1.0- 2.3) 1.8 ( 1.2- 2.8) ∼ ∼
Oklahoma 1.5 ( 1.0- 2.3) 1.7 ( 1.1- 2.6) ∼ ∼
Texas 1.7 ( 1.4- 2.1) 1.8 ( 1.5- 2.2) ∼ 1.3 ( 0.8- 2.2)
West 2.1 ( 1.9- 2.2) 2.3 ( 2.1- 2.5) ∼ 2.1 ( 1.6- 2.8)
Mountain 1.9 ( 1.6- 2.2) 1.9 ( 1.6- 2.3) ∼ ∼
Arizona 1.6 ( 1.1- 2.2) 1.6 ( 1.2- 2.3) ∼ ∼
Colorado 2.5 ( 1.7- 3.4) 2.4 ( 1.7- 3.5) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.5 ( 1.5- 3.9) 2.6 ( 1.6- 4.1) ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 2.1 ( 1.9- 2.4) 2.4 ( 2.2- 2.7) ∼ 2.2 ( 1.6- 3.1)
Alaska ∼ ∼ ∼ ∼
California 1.9 ( 1.6- 2.1) 2.1 ( 1.9- 2.4) ∼ 2.3 ( 1.7- 3.2)
San Francisco-Oakland 1.8 ( 1.2- 2.6) 2.1 ( 1.4- 3.2) ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles 1.6 ( 1.2- 2.1) 2.1 ( 1.5- 2.7) ∼ 2.3 ( 1.3- 3.9)
Hawaii ∼ ∼ ∼ -
Oregon 3.1 ( 2.3- 4.2) 3.3 ( 2.4- 4.3) ∼ ∼
Washington 3.2 ( 2.5- 4.0) 3.2 ( 2.5- 4.0) ∼ ∼
Seattle-Puget Sound 3.1 ( 2.3- 4.1) 3.2 ( 2.4- 4.3) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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160 Table 2.17.1.1F: Mesothelioma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.2 ( 0.1- 0.3) 0.4 ( 0.2- 0.5)
Northeast 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
New England 0.4 ( 0.3- 0.6) 0.5 ( 0.3- 0.6) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ -
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
New Jersey 0.6 ( 0.4- 0.8) 0.7 ( 0.4- 1.0) ∼ ∼
New York 0.3 ( 0.2- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Pennsylvania 0.6 ( 0.4- 0.8) 0.5 ( 0.4- 0.7) ∼ -
Midwest 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
East North Central 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) ∼ ∼
Illinois 0.4 ( 0.2- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.6 ( 0.4- 0.8) 0.6 ( 0.4- 0.9) ∼ ∼
Detroit ∼ ∼ ∼ -
Ohio 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.5) ∼ ∼
Wisconsin 0.6 ( 0.4- 1.0) 0.6 ( 0.4- 1.0) ∼ -
West North Central 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) ∼ -
Georgia ∼ ∼ ∼ ∼
Atlanta ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ -
Virginia
West Virginia ∼ ∼ ∼ ∼
East South Central
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ -
Mississippi
Tennessee
continued
C
ancer Incidence and M
ortality by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
161
Table 2.17.1.1F: Mesothelioma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 0.7 ( 0.4- 1.1) ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.2 ( 0.2- 0.4) 0.2 ( 0.2- 0.4) ∼ ∼
West 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) ∼ ∼
Mountain 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼
San Francisco-Oakland ∼ ∼ ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles 0.4 ( 0.3- 0.7) 0.5 ( 0.3- 0.9) ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
Seattle-Puget Sound ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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162 Table 2.17.1.2M: Mesothelioma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 1.7 ( 1.6- 1.8) 1.8 ( 1.7- 1.9) 0.8 ( 0.6- 1.0) 1.0 ( 0.8- 1.3)
Northeast 2.0 ( 1.8- 2.2) 2.1 ( 2.0- 2.4) 1.0 ( 0.6- 1.7) ∼
New England 2.1 ( 1.8- 2.5) 2.2 ( 1.9- 2.6) ∼ ∼
Connecticut 1.7 ( 1.1- 2.5) 1.8 ( 1.1- 2.6) ∼ ∼
Maine 3.0 ( 1.8- 4.7) 3.0 ( 1.8- 4.8) ∼ ∼
Massachusetts 2.2 ( 1.7- 2.9) 2.3 ( 1.8- 3.0) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.0 ( 1.8- 2.2) 2.1 ( 1.9- 2.4) 1.0 ( 0.6- 1.8) ∼
New Jersey 2.8 ( 2.2- 3.4) 3.0 ( 2.4- 3.6) ∼ ∼
New York 1.5 ( 1.3- 1.8) 1.7 ( 1.4- 2.1) ∼ ∼
Pennsylvania 2.1 ( 1.7- 2.5) 2.1 ( 1.8- 2.6) ∼ ∼
Midwest 1.8 ( 1.6- 1.9) 1.9 ( 1.7- 2.1) ∼ ∼
East North Central 1.8 ( 1.7- 2.1) 2.0 ( 1.8- 2.2) ∼ ∼
Illinois 2.1 ( 1.7- 2.5) 2.3 ( 1.8- 2.8) ∼ ∼
Indiana 1.8 ( 1.3- 2.4) 1.9 ( 1.4- 2.6) ∼ ∼
Michigan 1.6 ( 1.2- 2.0) 1.8 ( 1.4- 2.3) ∼ ∼
Ohio 1.7 ( 1.3- 2.1) 1.8 ( 1.4- 2.2) ∼ ∼
Wisconsin 2.3 ( 1.7- 3.0) 2.3 ( 1.7- 3.0) ∼ ∼
West North Central 1.6 ( 1.4- 1.9) 1.7 ( 1.4- 2.0) ∼ ∼
Iowa 1.7 ( 1.1- 2.6) 1.8 ( 1.1- 2.6) ∼ ∼
Kansas 1.7 ( 1.1- 2.7) 1.8 ( 1.1- 2.8) ∼ ∼
Minnesota 1.6 ( 1.1- 2.3) 1.7 ( 1.2- 2.4) ∼ ∼
Missouri 1.5 ( 1.1- 2.1) 1.6 ( 1.1- 2.3) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 1.5 ( 1.4- 1.6) 1.6 ( 1.5- 1.7) 0.8 ( 0.6- 1.1) 0.7 ( 0.4- 1.1)
South Atlantic 1.6 ( 1.4- 1.7) 1.7 ( 1.5- 1.9) 0.8 ( 0.5- 1.3) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.5 ( 1.2- 1.7) 1.5 ( 1.3- 1.8) ∼ ∼
Georgia 1.0 ( 0.7- 1.6) 1.2 ( 0.8- 1.9) ∼ ∼
Maryland 2.0 ( 1.4- 2.7) 2.1 ( 1.5- 3.0) ∼ ∼
North Carolina 1.2 ( 0.9- 1.7) 1.4 ( 1.0- 1.9) ∼ ∼
South Carolina 1.4 ( 0.9- 2.2) 1.7 ( 1.0- 2.7) ∼ ∼
Virginia 2.4 ( 1.9- 3.2) 2.6 ( 1.9- 3.4) ∼ ∼
West Virginia 2.4 ( 1.5- 3.7) 2.5 ( 1.5- 3.9) ∼ ∼
East South Central 1.4 ( 1.1- 1.7) 1.5 ( 1.2- 1.9) ∼ ∼
Alabama 1.6 ( 1.1- 2.3) 1.8 ( 1.2- 2.7) ∼ ∼
Kentucky 1.3 ( 0.8- 2.0) 1.3 ( 0.7- 2.0) ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee 1.5 ( 1.0- 2.1) 1.6 ( 1.1- 2.3) ∼ ∼
West South Central 1.3 ( 1.1- 1.5) 1.3 ( 1.1- 1.6) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.17.1.2M: Mesothelioma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 1.5 ( 1.0- 2.3) 1.5 ( 0.9- 2.4) ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 1.4 ( 1.1- 1.7) 1.5 ( 1.2- 1.8) ∼ ∼
West 1.7 ( 1.5- 1.8) 1.8 ( 1.7- 2.0) ∼ 1.5 ( 1.1- 2.1)
Mountain 1.8 ( 1.5- 2.1) 1.8 ( 1.5- 2.2) ∼ ∼
Arizona 1.2 ( 0.8- 1.8) 1.3 ( 0.9- 1.9) ∼ ∼
Colorado 1.7 ( 1.1- 2.6) 1.8 ( 1.2- 2.7) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 1.8 ( 1.0- 3.1) ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah 3.1 ( 1.9- 4.8) 3.2 ( 2.0- 4.9) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.6 ( 1.4- 1.8) 1.8 ( 1.6- 2.1) ∼ 1.5 ( 1.0- 2.2)
Alaska ∼ ∼ ∼ ∼
California 1.4 ( 1.2- 1.7) 1.7 ( 1.4- 1.9) ∼ 1.5 ( 1.0- 2.2)
Hawaii ∼ ∼ ∼ ∼
Oregon 1.4 ( 0.9- 2.2) 1.5 ( 0.9- 2.3) ∼ ∼
Washington 2.8 ( 2.1- 3.6) 2.8 ( 2.2- 3.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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164 Table 2.17.1.2F: Mesothelioma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 0.3 ( 0.2- 0.3) 0.3 ( 0.3- 0.3) 0.1 ( 0.1- 0.2) 0.2 ( 0.1- 0.3)
Northeast 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼
New England 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
New Jersey 0.4 ( 0.2- 0.6) 0.4 ( 0.3- 0.7) ∼ ∼
New York 0.2 ( 0.1- 0.3) 0.2 ( 0.2- 0.4) ∼ ∼
Pennsylvania 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Midwest 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) ∼ ∼
East North Central 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) ∼ ∼
Illinois 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.4 ( 0.3- 0.6) 0.4 ( 0.2- 0.6) ∼ ∼
Ohio 0.4 ( 0.2- 0.5) 0.4 ( 0.2- 0.6) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.3) ∼ ∼
South Atlantic 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.3) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.2 ( 0.1- 0.3) 0.2 ( 0.1- 0.3) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.2 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.2 ( 0.1- 0.3) 0.2 ( 0.1- 0.3) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.17.1.2F: Mesothelioma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas ∼ ∼ ∼ ∼
West 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼
Mountain 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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166 Table 2.18.1.1M: Multiple Myeloma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 6.5 ( 6.3- 6.6) 6.0 ( 5.9- 6.2) 12.0 ( 11.3- 12.7) 5.6 ( 5.0- 6.2)
Northeast 7.0 ( 6.7- 7.3) 6.7 ( 6.3- 7.0) 10.5 ( 9.1- 12.2) 7.0 ( 5.4- 8.9)
New England 6.8 ( 6.2- 7.5) 6.5 ( 5.9- 7.2) 12.5 ( 8.2- 19.1) ∼
Connecticut 7.7 ( 6.4- 9.2) 7.1 ( 5.8- 8.7) ∼ ∼
Maine 7.7 ( 5.7- 10.3) 7.8 ( 5.8- 10.4) ∼ ∼
Massachusetts 6.9 ( 6.0- 7.9) 6.7 ( 5.7- 7.7) 12.8 ( 7.0- 23.1) ∼
New Hampshire 5.2 ( 3.5- 7.7) 4.8 ( 3.1- 7.2) ∼ -
Rhode Island 5.7 ( 3.8- 8.3) 5.5 ( 3.6- 8.1) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 7.1 ( 6.7- 7.5) 6.7 ( 6.3- 7.1) 10.2 ( 8.7- 12.0) 6.9 ( 5.2- 9.0)
New Jersey 7.4 ( 6.5- 8.3) 6.9 ( 6.0- 7.9) 13.1 ( 9.5- 18.1) 5.9 ( 3.3- 10.7)
New York 7.4 ( 6.8- 8.0) 7.0 ( 6.4- 7.7) 10.0 ( 8.0- 12.4) 7.1 ( 5.1- 9.9)
Pennsylvania 6.5 ( 5.8- 7.1) 6.3 ( 5.6- 6.9) 8.6 ( 6.0- 12.2) -
Midwest 6.6 ( 6.3- 6.9) 6.1 ( 5.8- 6.4) 13.6 ( 11.9- 15.5) 5.8 ( 3.9- 8.7)
East North Central 6.7 ( 6.3- 7.1) 6.0 ( 5.7- 6.4) 13.7 ( 11.9- 15.8) 6.7 ( 4.4- 10.2)
Illinois 7.5 ( 6.8- 8.3) 6.9 ( 6.2- 7.8) 12.5 ( 9.6- 16.1) 5.9 ( 3.4- 10.8)
Indiana 5.7 ( 4.8- 6.7) 5.4 ( 4.5- 6.5) ∼ ∼
Michigan 6.9 ( 6.2- 7.8) 6.0 ( 5.2- 6.8) 15.5 ( 11.9- 20.0) ∼
Detroit 9.9 ( 8.4- 11.5) 8.2 ( 6.7- 10.0) 17.0 ( 12.7- 22.5) -
Ohio 6.3 ( 5.6- 7.1) 5.6 ( 5.0- 6.4) 12.7 ( 9.3- 17.1) ∼
Wisconsin 6.3 ( 5.3- 7.4) 5.7 ( 4.8- 6.8) 31.7 ( 18.0- 54.8) -
West North Central 6.4 ( 5.8- 6.9) 6.1 ( 5.6- 6.7) 12.8 ( 9.0- 18.0) ∼
Iowa 7.3 ( 6.0- 8.9) 7.1 ( 5.8- 8.7) ∼ ∼
Kansas 6.3 ( 5.0- 7.9) 6.0 ( 4.7- 7.7) ∼ ∼
Minnesota 6.2 ( 5.2- 7.3) 6.0 ( 5.0- 7.2) ∼ ∼
Missouri 6.3 ( 5.4- 7.4) 5.7 ( 4.8- 6.8) 11.8 ( 7.5- 18.4) ∼
Nebraska 5.3 ( 3.8- 7.2) 5.4 ( 3.9- 7.4) ∼ ∼
North Dakota 6.4 ( 3.9- 10.0) 6.6 ( 4.0- 10.3) ∼ ∼
South Dakota
South
South Atlantic
Delaware 5.2 ( 3.1- 8.3) 4.8 ( 2.8- 8.2) ∼ ∼
District of Columbia 8.6 ( 5.3- 13.5) ∼ 12.8 ( 7.7- 20.5) ∼
Florida 5.5 ( 5.0- 6.0) 4.9 ( 4.5- 5.4) 11.7 ( 9.1- 14.8) -
Georgia 7.4 ( 6.4- 8.5) 6.6 ( 5.5- 7.8) 11.0 ( 8.4- 14.3) ∼
Atlanta 8.9 ( 6.9- 11.5) 8.1 ( 5.8- 11.0) 12.4 ( 7.7- 19.8) ∼
Maryland 4.8 ( 4.0- 5.9) 4.4 ( 3.4- 5.6) 6.5 ( 4.4- 9.9) ∼
North Carolina 5.7 ( 5.0- 6.6) 5.0 ( 4.2- 5.9) 10.0 ( 7.5- 13.4) ∼
South Carolina 7.5 ( 6.2- 9.0) 5.1 ( 3.9- 6.5) 14.8 ( 10.9- 19.7) -
Virginia
West Virginia 6.1 ( 4.6- 8.0) 5.9 ( 4.4- 7.8) ∼ ∼
East South Central
Alabama 6.1 ( 5.1- 7.4) 5.2 ( 4.2- 6.5) 10.4 ( 7.4- 14.5) ∼
Kentucky 7.6 ( 6.3- 9.1) 7.2 ( 6.0- 8.8) ∼ -
Mississippi
Tennessee
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Table 2.18.1.1M: Multiple Myeloma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 8.5 ( 7.1- 10.0) 6.6 ( 5.3- 8.2) 14.5 ( 11.0- 19.0) ∼
Oklahoma 6.7 ( 5.5- 8.2) 6.2 ( 4.9- 7.7) ∼ ∼
Texas 6.4 ( 5.8- 7.0) 5.7 ( 5.2- 6.3) 13.9 ( 11.1- 17.3) 5.2 ( 4.1- 6.6)
West 6.2 ( 5.9- 6.5) 6.0 ( 5.7- 6.4) 13.0 ( 10.7- 15.7) 6.2 ( 5.3- 7.3)
Mountain 5.9 ( 5.4- 6.5) 5.8 ( 5.3- 6.4) 10.0 ( 5.5- 18.3) 6.4 ( 4.6- 8.9)
Arizona 5.1 ( 4.2- 6.1) 4.9 ( 4.1- 6.0) ∼ ∼
Colorado 6.9 ( 5.6- 8.3) 6.2 ( 5.0- 7.7) ∼ ∼
Idaho 7.1 ( 5.1- 9.8) 7.3 ( 5.2- 10.0) ∼ ∼
Montana 6.6 ( 4.4- 9.6) 6.9 ( 4.6- 10.0) ∼ ∼
Nevada 5.1 ( 3.7- 6.9) 5.3 ( 3.9- 7.3) ∼ ∼
New Mexico 6.3 ( 4.6- 8.4) 6.3 ( 4.5- 8.5) ∼ 7.5 ( 4.3- 12.5)
Utah 6.2 ( 4.5- 8.3) 6.2 ( 4.6- 8.4) ∼ ∼
Wyoming
Pacific 6.3 ( 5.9- 6.7) 6.1 ( 5.7- 6.5) 13.5 ( 11.0- 16.6) 6.1 ( 5.1- 7.4)
Alaska ∼ ∼ ∼ ∼
California 6.0 ( 5.6- 6.5) 5.7 ( 5.3- 6.2) 13.8 ( 11.1- 17.0) 6.2 ( 5.1- 7.5)
San Francisco-Oakland 5.1 ( 4.1- 6.4) 4.6 ( 3.4- 6.0) ∼ ∼
San Jose-Monterey 6.5 ( 4.9- 8.5) 6.4 ( 4.6- 8.7) ∼ ∼
Los Angeles 6.1 ( 5.3- 7.0) 5.6 ( 4.7- 6.6) 13.7 ( 9.8- 18.9) 5.7 ( 4.0- 8.0)
Hawaii 4.2 ( 2.7- 6.2) ∼ ∼ -
Oregon 6.6 ( 5.4- 8.0) 6.8 ( 5.5- 8.2) ∼ ∼
Washington 8.0 ( 6.9- 9.2) 7.6 ( 6.5- 8.9) ∼ ∼
Seattle-Puget Sound 7.9 ( 6.6- 9.4) 7.7 ( 6.3- 9.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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168 Table 2.18.1.1F: Multiple Myeloma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 4.2 ( 4.1- 4.3) 3.7 ( 3.6- 3.8) 8.4 ( 8.0- 8.9) 4.3 ( 3.9- 4.7)
Northeast 4.6 ( 4.3- 4.8) 4.0 ( 3.7- 4.2) 9.4 ( 8.4- 10.5) 4.7 ( 3.7- 5.9)
New England 4.2 ( 3.8- 4.6) 4.0 ( 3.6- 4.5) 7.3 ( 4.6- 11.0) ∼
Connecticut 3.9 ( 3.1- 4.8) 3.6 ( 2.8- 4.6) ∼ ∼
Maine 4.3 ( 3.0- 6.1) 4.4 ( 3.1- 6.2) ∼ ∼
Massachusetts 4.0 ( 3.4- 4.7) 3.9 ( 3.3- 4.6) ∼ ∼
New Hampshire 5.4 ( 3.8- 7.5) 5.2 ( 3.6- 7.2) ∼ -
Rhode Island 5.4 ( 3.8- 7.6) 5.3 ( 3.6- 7.6) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 4.7 ( 4.4- 5.0) 4.0 ( 3.7- 4.2) 9.6 ( 8.5- 10.8) 4.4 ( 3.4- 5.7)
New Jersey 4.7 ( 4.1- 5.4) 4.1 ( 3.5- 4.7) 10.1 ( 7.6- 13.2) ∼
New York 4.8 ( 4.4- 5.3) 3.9 ( 3.5- 4.4) 9.4 ( 7.9- 11.0) 4.6 ( 3.4- 6.2)
Pennsylvania 4.5 ( 4.0- 5.0) 3.9 ( 3.5- 4.4) 9.9 ( 7.6- 12.7) -
Midwest 4.2 ( 4.0- 4.4) 3.8 ( 3.6- 4.0) 8.6 ( 7.5- 9.7) 4.0 ( 2.6- 6.2)
East North Central 4.4 ( 4.1- 4.6) 3.9 ( 3.6- 4.1) 8.6 ( 7.4- 9.8) 3.7 ( 2.1- 6.1)
Illinois 4.9 ( 4.4- 5.5) 4.2 ( 3.7- 4.8) 9.5 ( 7.5- 11.8) ∼
Indiana 3.8 ( 3.2- 4.5) 3.5 ( 2.9- 4.2) 8.7 ( 5.3- 13.7) ∼
Michigan 4.6 ( 4.0- 5.2) 3.8 ( 3.3- 4.4) 8.9 ( 6.8- 11.6) ∼
Detroit 5.5 ( 4.6- 6.5) 4.5 ( 3.6- 5.6) 9.1 ( 6.6- 12.3) -
Ohio 3.9 ( 3.5- 4.4) 3.5 ( 3.1- 4.0) 7.3 ( 5.4- 9.8) ∼
Wisconsin 4.5 ( 3.8- 5.3) 4.3 ( 3.6- 5.2) ∼ -
West North Central 3.9 ( 3.5- 4.3) 3.6 ( 3.2- 4.0) 8.7 ( 6.1- 12.0) ∼
Iowa 3.6 ( 2.8- 4.6) 3.4 ( 2.6- 4.4) ∼ ∼
Kansas 3.7 ( 2.8- 4.9) 3.1 ( 2.2- 4.2) ∼ ∼
Minnesota 4.0 ( 3.3- 4.8) 3.7 ( 3.0- 4.5) ∼ ∼
Missouri 3.8 ( 3.2- 4.6) 3.7 ( 3.0- 4.4) ∼ ∼
Nebraska 3.6 ( 2.5- 5.0) 3.5 ( 2.4- 4.9) ∼ ∼
North Dakota 5.7 ( 3.5- 9.0) 5.9 ( 3.7- 9.4) ∼ ∼
South Dakota
South
South Atlantic
Delaware 3.8 ( 2.2- 6.1) ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 3.8 ( 3.5- 4.2) 3.3 ( 2.9- 3.7) 8.6 ( 6.8- 10.7) -
Georgia 4.7 ( 4.1- 5.5) 3.6 ( 3.0- 4.4) 7.9 ( 6.2- 10.0) ∼
Atlanta 4.9 ( 3.7- 6.4) 4.2 ( 2.9- 5.9) 6.9 ( 4.3- 10.8) ∼
Maryland 4.7 ( 3.9- 5.6) 3.9 ( 3.1- 4.9) 7.7 ( 5.7- 10.3) ∼
North Carolina 3.5 ( 3.0- 4.1) 3.0 ( 2.5- 3.6) 6.2 ( 4.6- 8.2) ∼
South Carolina 5.0 ( 4.2- 6.0) 4.1 ( 3.2- 5.2) 7.2 ( 5.1- 9.8) -
Virginia
West Virginia 4.3 ( 3.2- 5.7) 3.7 ( 2.7- 5.1) ∼ ∼
East South Central
Alabama 4.7 ( 3.9- 5.6) 3.8 ( 3.0- 4.8) 8.1 ( 5.9- 10.9) ∼
Kentucky 4.6 ( 3.8- 5.6) 4.3 ( 3.4- 5.2) ∼ -
Mississippi
Tennessee
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Table 2.18.1.1F: Multiple Myeloma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 5.0 ( 4.1- 5.9) 3.5 ( 2.7- 4.5) 9.1 ( 6.9- 11.8) ∼
Oklahoma 3.9 ( 3.1- 4.9) 3.5 ( 2.7- 4.5) ∼ ∼
Texas 4.1 ( 3.7- 4.5) 3.7 ( 3.3- 4.1) 7.6 ( 5.9- 9.6) 4.1 ( 3.3- 5.2)
West 3.8 ( 3.6- 4.0) 3.6 ( 3.3- 3.8) 9.2 ( 7.6- 11.1) 4.4 ( 3.7- 5.1)
Mountain 3.6 ( 3.2- 4.0) 3.4 ( 3.0- 3.8) 10.1 ( 6.0- 16.1) 4.3 ( 3.1- 6.0)
Arizona 2.7 ( 2.1- 3.4) 2.7 ( 2.1- 3.4) ∼ ∼
Colorado 3.8 ( 3.0- 4.8) 3.5 ( 2.7- 4.4) ∼ ∼
Idaho 5.5 ( 3.9- 7.6) 5.5 ( 3.8- 7.6) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 4.9 ( 3.6- 6.5) 3.9 ( 2.7- 5.4) ∼ ∼
New Mexico 4.6 ( 3.3- 6.1) 4.3 ( 3.1- 6.0) ∼ 6.6 ( 4.0- 10.2)
Utah 3.2 ( 2.1- 4.6) 3.3 ( 2.2- 4.8) ∼ ∼
Wyoming
Pacific 3.9 ( 3.7- 4.2) 3.6 ( 3.4- 3.9) 9.1 ( 7.4- 11.1) 4.4 ( 3.6- 5.2)
Alaska ∼ ∼ ∼ ∼
California 3.9 ( 3.6- 4.2) 3.5 ( 3.2- 3.9) 9.3 ( 7.5- 11.4) 4.2 ( 3.4- 5.0)
San Francisco-Oakland 4.2 ( 3.4- 5.2) 3.7 ( 2.8- 4.8) 10.8 ( 6.9- 16.4) ∼
San Jose-Monterey 3.7 ( 2.6- 5.0) 4.1 ( 2.9- 5.7) ∼ ∼
Los Angeles 4.1 ( 3.5- 4.7) 3.6 ( 3.0- 4.3) 9.4 ( 6.8- 12.7) 3.8 ( 2.7- 5.3)
Hawaii 3.0 ( 1.9- 4.6) ∼ ∼ -
Oregon 4.1 ( 3.2- 5.1) 3.7 ( 2.9- 4.7) ∼ ∼
Washington 4.2 ( 3.5- 5.0) 4.3 ( 3.6- 5.1) ∼ ∼
Seattle-Puget Sound 4.0 ( 3.2- 5.0) 4.1 ( 3.3- 5.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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170 Table 2.18.1.2M: Multiple Myeloma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 4.8 ( 4.6- 4.9) 4.5 ( 4.4- 4.7) 8.3 ( 7.7- 8.9) 4.3 ( 3.8- 4.8)
Northeast 4.5 ( 4.2- 4.8) 4.4 ( 4.2- 4.7) 5.9 ( 4.8- 7.2) 4.0 ( 2.9- 5.6)
New England 4.7 ( 4.1- 5.2) 4.7 ( 4.1- 5.3) ∼ ∼
Connecticut 4.1 ( 3.2- 5.3) 3.8 ( 2.9- 5.0) ∼ ∼
Maine 5.0 ( 3.4- 7.2) 5.1 ( 3.4- 7.2) ∼ ∼
Massachusetts 4.9 ( 4.1- 5.8) 5.0 ( 4.2- 5.9) ∼ ∼
New Hampshire 5.3 ( 3.5- 7.8) 5.4 ( 3.6- 7.9) ∼ ∼
Rhode Island 4.7 ( 3.0- 7.2) 4.7 ( 2.9- 7.2) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 4.4 ( 4.1- 4.8) 4.3 ( 4.0- 4.7) 5.9 ( 4.8- 7.3) 4.1 ( 2.9- 5.9)
New Jersey 4.6 ( 4.0- 5.4) 4.5 ( 3.8- 5.3) 6.1 ( 3.8- 9.9) ∼
New York 4.4 ( 3.9- 4.9) 4.4 ( 3.9- 4.9) 5.4 ( 4.1- 7.3) 4.1 ( 2.6- 6.3)
Pennsylvania 4.4 ( 3.9- 4.9) 4.3 ( 3.7- 4.9) 6.5 ( 4.1- 9.9) ∼
Midwest 5.0 ( 4.7- 5.3) 4.7 ( 4.4- 5.0) 9.9 ( 8.4- 11.5) 4.7 ( 2.9- 7.6)
East North Central 5.1 ( 4.8- 5.5) 4.7 ( 4.4- 5.1) 9.9 ( 8.4- 11.7) 5.2 ( 3.1- 8.7)
Illinois 4.9 ( 4.3- 5.6) 4.5 ( 3.9- 5.2) 9.0 ( 6.5- 12.4) ∼
Indiana 5.0 ( 4.2- 6.0) 4.7 ( 3.9- 5.7) ∼ ∼
Michigan 5.8 ( 5.1- 6.6) 5.5 ( 4.8- 6.4) 9.1 ( 6.3- 12.7) ∼
Ohio 5.0 ( 4.3- 5.6) 4.5 ( 3.9- 5.2) 10.3 ( 7.3- 14.3) ∼
Wisconsin 4.7 ( 3.8- 5.6) 4.3 ( 3.5- 5.2) ∼ ∼
West North Central 4.7 ( 4.3- 5.2) 4.6 ( 4.2- 5.1) 9.4 ( 6.0- 14.2) ∼
Iowa 4.5 ( 3.5- 5.8) 4.4 ( 3.4- 5.7) ∼ ∼
Kansas 4.5 ( 3.4- 5.9) 4.2 ( 3.1- 5.6) ∼ ∼
Minnesota 5.3 ( 4.3- 6.4) 5.2 ( 4.3- 6.4) ∼ ∼
Missouri 4.2 ( 3.5- 5.2) 4.0 ( 3.2- 4.9) ∼ ∼
Nebraska 5.0 ( 3.6- 6.9) 5.1 ( 3.6- 7.0) ∼ ∼
North Dakota 6.0 ( 3.6- 9.5) 6.1 ( 3.7- 9.7) ∼ ∼
South Dakota 5.2 ( 3.1- 8.1) 5.3 ( 3.2- 8.5) ∼ ∼
South 4.8 ( 4.6- 5.0) 4.3 ( 4.1- 4.5) 8.7 ( 7.9- 9.6) 3.8 ( 3.1- 4.7)
South Atlantic 4.6 ( 4.3- 4.8) 4.0 ( 3.7- 4.3) 8.6 ( 7.5- 9.8) 3.3 ( 2.4- 4.7)
Delaware ∼ ∼ ∼ ∼
District of Columbia 7.8 ( 4.5- 12.7) ∼ ∼ ∼
Florida 3.8 ( 3.4- 4.2) 3.6 ( 3.2- 4.0) 6.3 ( 4.4- 8.8) 3.5 ( 2.4- 4.9)
Georgia 4.9 ( 4.0- 5.8) 3.8 ( 3.0- 4.8) 9.7 ( 7.1- 13.1) ∼
Maryland 4.4 ( 3.6- 5.4) 3.9 ( 3.0- 5.0) 6.6 ( 4.2- 10.1) ∼
North Carolina 5.4 ( 4.6- 6.3) 4.2 ( 3.4- 5.1) 12.2 ( 9.2- 16.1) ∼
South Carolina 5.7 ( 4.5- 7.0) 5.2 ( 4.0- 6.7) 7.5 ( 4.9- 11.4) ∼
Virginia 4.8 ( 4.0- 5.8) 4.1 ( 3.3- 5.1) 9.8 ( 6.9- 13.7) ∼
West Virginia 5.4 ( 3.9- 7.3) 5.5 ( 4.0- 7.5) ∼ ∼
East South Central 5.4 ( 4.8- 5.9) 4.8 ( 4.3- 5.4) 8.9 ( 7.1- 11.1) ∼
Alabama 5.7 ( 4.6- 7.0) 4.8 ( 3.8- 6.2) 9.4 ( 6.3- 13.4) ∼
Kentucky 4.6 ( 3.6- 5.8) 4.6 ( 3.6- 5.8) ∼ ∼
Mississippi 5.3 ( 4.0- 6.8) 3.9 ( 2.6- 5.5) 9.7 ( 6.3- 14.4) ∼
Tennessee 5.6 ( 4.7- 6.7) 5.3 ( 4.4- 6.5) 8.5 ( 5.2- 13.4) ∼
West South Central 4.9 ( 4.5- 5.4) 4.5 ( 4.1- 5.0) 8.9 ( 7.2- 10.8) 4.4 ( 3.3- 5.8)
Arkansas 4.8 ( 3.7- 6.3) 4.7 ( 3.5- 6.2) ∼ ∼
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Table 2.18.1.2M: Multiple Myeloma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 5.9 ( 4.8- 7.2) 4.6 ( 3.5- 6.0) 10.8 ( 7.7- 14.9) ∼
Oklahoma 3.9 ( 2.9- 5.0) 3.7 ( 2.7- 4.9) ∼ ∼
Texas 5.0 ( 4.5- 5.5) 4.7 ( 4.2- 5.3) 8.7 ( 6.5- 11.5) 4.6 ( 3.4- 6.0)
West 4.6 ( 4.4- 4.9) 4.8 ( 4.5- 5.1) 7.4 ( 5.6- 9.6) 4.6 ( 3.8- 5.6)
Mountain 4.6 ( 4.1- 5.1) 4.6 ( 4.1- 5.2) ∼ 5.8 ( 4.0- 8.2)
Arizona 5.0 ( 4.1- 6.0) 5.0 ( 4.1- 6.1) ∼ ∼
Colorado 4.7 ( 3.7- 6.0) 4.7 ( 3.6- 6.0) ∼ ∼
Idaho 3.7 ( 2.2- 5.8) 3.8 ( 2.3- 5.9) ∼ ∼
Montana 4.2 ( 2.5- 6.6) 3.9 ( 2.3- 6.4) ∼ ∼
Nevada 4.1 ( 2.8- 5.9) 4.4 ( 3.0- 6.4) ∼ ∼
New Mexico 4.7 ( 3.3- 6.6) 4.6 ( 3.2- 6.6) ∼ ∼
Utah 5.0 ( 3.5- 7.1) 5.2 ( 3.6- 7.3) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 4.7 ( 4.3- 5.0) 4.9 ( 4.6- 5.3) 7.8 ( 5.8- 10.3) 4.2 ( 3.3- 5.3)
Alaska ∼ ∼ ∼ ∼
California 4.5 ( 4.1- 4.9) 4.7 ( 4.3- 5.1) 8.0 ( 5.9- 10.7) 4.1 ( 3.2- 5.2)
Hawaii 2.9 ( 1.7- 4.7) ∼ ∼ ∼
Oregon 5.4 ( 4.3- 6.7) 5.6 ( 4.4- 6.9) ∼ ∼
Washington 5.6 ( 4.7- 6.7) 5.6 ( 4.7- 6.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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172 Table 2.18.1.2F: Multiple Myeloma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 3.1 ( 3.0- 3.2) 2.9 ( 2.8- 2.9) 6.0 ( 5.6- 6.4) 2.7 ( 2.4- 3.1)
Northeast 3.1 ( 2.9- 3.3) 2.8 ( 2.6- 3.0) 5.9 ( 5.1- 6.8) 2.4 ( 1.7- 3.4)
New England 3.2 ( 2.8- 3.6) 3.0 ( 2.7- 3.4) 6.9 ( 4.3- 10.7) ∼
Connecticut 3.3 ( 2.6- 4.2) 3.0 ( 2.3- 3.9) ∼ ∼
Maine 2.6 ( 1.7- 4.1) 2.7 ( 1.7- 4.2) ∼ ∼
Massachusetts 3.5 ( 2.9- 4.1) 3.4 ( 2.9- 4.1) ∼ ∼
New Hampshire 2.9 ( 1.8- 4.5) 2.9 ( 1.8- 4.6) ∼ ∼
Rhode Island 2.9 ( 1.7- 4.6) 2.5 ( 1.5- 4.3) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.0 ( 2.8- 3.3) 2.8 ( 2.5- 3.0) 5.8 ( 4.9- 6.8) 2.4 ( 1.7- 3.4)
New Jersey 3.1 ( 2.7- 3.7) 2.8 ( 2.4- 3.4) 6.0 ( 4.1- 8.6) ∼
New York 2.9 ( 2.6- 3.2) 2.5 ( 2.2- 2.9) 5.7 ( 4.6- 7.0) 2.3 ( 1.4- 3.5)
Pennsylvania 3.2 ( 2.8- 3.6) 3.0 ( 2.6- 3.4) 5.9 ( 4.2- 8.2) ∼
Midwest 3.3 ( 3.1- 3.5) 3.1 ( 2.9- 3.3) 6.1 ( 5.2- 7.1) ∼
East North Central 3.3 ( 3.1- 3.5) 3.0 ( 2.8- 3.3) 5.9 ( 4.9- 6.9) ∼
Illinois 3.1 ( 2.7- 3.5) 2.8 ( 2.4- 3.3) 5.1 ( 3.6- 6.9) ∼
Indiana 3.1 ( 2.5- 3.7) 3.1 ( 2.5- 3.7) ∼ ∼
Michigan 3.7 ( 3.2- 4.3) 3.4 ( 2.9- 4.0) 6.4 ( 4.6- 8.7) ∼
Ohio 3.5 ( 3.0- 3.9) 3.0 ( 2.6- 3.5) 7.5 ( 5.5- 10.0) ∼
Wisconsin 2.9 ( 2.3- 3.5) 2.8 ( 2.3- 3.5) ∼ ∼
West North Central 3.3 ( 3.0- 3.7) 3.1 ( 2.8- 3.5) 7.5 ( 5.1- 10.7) ∼
Iowa 3.2 ( 2.5- 4.2) 3.3 ( 2.5- 4.2) ∼ ∼
Kansas 3.5 ( 2.6- 4.5) 3.1 ( 2.3- 4.2) ∼ ∼
Minnesota 2.9 ( 2.3- 3.6) 2.8 ( 2.2- 3.6) ∼ ∼
Missouri 3.6 ( 3.0- 4.3) 3.3 ( 2.7- 4.0) 6.9 ( 4.1- 10.8) ∼
Nebraska 2.9 ( 1.9- 4.2) 3.0 ( 2.0- 4.3) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 4.1 ( 2.5- 6.5) 3.7 ( 2.2- 6.2) ∼ ∼
South 3.2 ( 3.0- 3.3) 2.8 ( 2.6- 2.9) 5.8 ( 5.3- 6.4) 2.6 ( 2.1- 3.2)
South Atlantic 3.0 ( 2.8- 3.2) 2.5 ( 2.4- 2.7) 5.7 ( 5.0- 6.4) 2.3 ( 1.6- 3.2)
Delaware 3.3 ( 1.9- 5.5) ∼ ∼ ∼
District of Columbia 6.1 ( 3.7- 9.9) ∼ 7.9 ( 4.7- 13.4) ∼
Florida 2.2 ( 2.0- 2.5) 2.0 ( 1.8- 2.3) 4.8 ( 3.5- 6.5) 2.5 ( 1.7- 3.5)
Georgia 3.5 ( 3.0- 4.2) 2.9 ( 2.3- 3.5) 5.9 ( 4.4- 7.8) ∼
Maryland 3.5 ( 2.9- 4.3) 3.1 ( 2.5- 4.0) 5.0 ( 3.4- 7.2) ∼
North Carolina 3.7 ( 3.2- 4.3) 3.2 ( 2.7- 3.9) 6.1 ( 4.5- 8.0) ∼
South Carolina 3.0 ( 2.4- 3.8) 2.4 ( 1.8- 3.3) 5.1 ( 3.4- 7.4) ∼
Virginia 3.4 ( 2.9- 4.0) 2.9 ( 2.3- 3.6) 6.3 ( 4.5- 8.6) ∼
West Virginia 3.0 ( 2.1- 4.1) 2.9 ( 2.0- 4.1) ∼ ∼
East South Central 3.8 ( 3.4- 4.2) 3.3 ( 2.9- 3.7) 6.4 ( 5.1- 7.8) ∼
Alabama 4.0 ( 3.2- 4.8) 3.2 ( 2.5- 4.1) 6.8 ( 4.8- 9.4) ∼
Kentucky 3.5 ( 2.8- 4.4) 3.3 ( 2.6- 4.2) ∼ ∼
Mississippi 4.0 ( 3.1- 5.2) 3.4 ( 2.4- 4.7) 6.0 ( 3.9- 8.9) ∼
Tennessee 3.6 ( 3.0- 4.3) 3.4 ( 2.7- 4.1) 5.6 ( 3.5- 8.6) ∼
West South Central 3.2 ( 2.9- 3.5) 2.9 ( 2.6- 3.1) 5.9 ( 4.9- 7.2) 2.9 ( 2.1- 3.8)
Arkansas 2.7 ( 2.0- 3.7) 2.4 ( 1.7- 3.4) ∼ ∼
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Table 2.18.1.2F: Multiple Myeloma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 3.5 ( 2.8- 4.3) 3.1 ( 2.3- 4.0) 4.5 ( 2.9- 6.6) ∼
Oklahoma 3.0 ( 2.3- 3.9) 2.8 ( 2.1- 3.7) ∼ ∼
Texas 3.3 ( 2.9- 3.6) 2.9 ( 2.6- 3.3) 6.7 ( 5.1- 8.7) 2.9 ( 2.1- 3.8)
West 2.9 ( 2.7- 3.1) 2.8 ( 2.6- 3.0) 7.4 ( 6.0- 9.1) 3.0 ( 2.4- 3.6)
Mountain 2.5 ( 2.2- 2.8) 2.4 ( 2.1- 2.7) ∼ 2.8 ( 1.8- 4.2)
Arizona 2.2 ( 1.7- 2.8) 2.2 ( 1.7- 2.8) ∼ ∼
Colorado 2.5 ( 1.9- 3.3) 2.3 ( 1.7- 3.1) ∼ ∼
Idaho 3.3 ( 2.0- 5.0) 2.8 ( 1.7- 4.5) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 3.9 ( 2.7- 5.3) 3.4 ( 2.3- 4.9) ∼ ∼
New Mexico 2.3 ( 1.5- 3.5) 2.3 ( 1.4- 3.6) ∼ ∼
Utah 2.1 ( 1.2- 3.3) 2.1 ( 1.3- 3.4) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 3.1 ( 2.9- 3.3) 3.0 ( 2.8- 3.3) 7.3 ( 5.8- 9.1) 3.0 ( 2.4- 3.8)
Alaska ∼ ∼ ∼ ∼
California 2.9 ( 2.6- 3.1) 2.7 ( 2.4- 3.0) 7.2 ( 5.6- 9.1) 3.0 ( 2.3- 3.8)
Hawaii ∼ ∼ ∼ ∼
Oregon 4.1 ( 3.3- 5.1) 3.9 ( 3.1- 4.9) ∼ ∼
Washington 3.8 ( 3.2- 4.6) 3.9 ( 3.2- 4.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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174 Table 2.19.1.1M: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 22.0 ( 21.7- 22.3) 22.4 ( 22.1- 22.6) 16.4 ( 15.6- 17.2) 19.8 ( 18.8- 20.8)
Northeast 23.7 ( 23.1- 24.3) 23.9 ( 23.3- 24.6) 18.2 ( 16.5- 20.1) 24.4 ( 21.6- 27.5)
New England 22.9 ( 21.8- 24.1) 22.8 ( 21.6- 24.0) 19.7 ( 14.3- 27.2) 23.4 ( 16.3- 33.6)
Connecticut 24.2 ( 21.9- 26.8) 24.9 ( 22.5- 27.6) ∼ 31.8 ( 18.1- 54.5)
Maine 22.6 ( 19.1- 26.7) 22.5 ( 18.9- 26.6) ∼ ∼
Massachusetts 23.0 ( 21.3- 24.8) 22.7 ( 20.9- 24.6) 27.7 ( 18.5- 41.3) 18.7 ( 10.6- 33.6)
New Hampshire 21.8 ( 18.1- 26.1) 21.1 ( 17.5- 25.4) ∼ -
Rhode Island 20.7 ( 16.9- 25.2) 20.7 ( 16.9- 25.3) ∼ ∼
Vermont 21.1 ( 16.0- 27.5) 21.0 ( 15.9- 27.4) ∼ ∼
Middle Atlantic 24.0 ( 23.3- 24.7) 24.3 ( 23.6- 25.1) 18.1 ( 16.3- 20.1) 24.5 ( 21.5- 27.9)
New Jersey 24.9 ( 23.3- 26.5) 25.3 ( 23.6- 27.1) 20.4 ( 16.3- 25.8) 26.4 ( 20.3- 34.3)
New York 22.9 ( 21.9- 23.9) 23.4 ( 22.3- 24.6) 16.3 ( 14.1- 18.9) 24.3 ( 20.7- 28.5)
Pennsylvania 24.8 ( 23.6- 26.1) 24.8 ( 23.6- 26.2) 20.0 ( 16.0- 25.0) -
Midwest 22.6 ( 22.1- 23.2) 22.8 ( 22.2- 23.4) 15.8 ( 14.1- 17.6) 24.2 ( 20.0- 29.4)
East North Central 22.4 ( 21.7- 23.0) 22.5 ( 21.8- 23.2) 16.3 ( 14.4- 18.3) 24.5 ( 19.7- 30.4)
Illinois 23.0 ( 21.8- 24.4) 23.9 ( 22.5- 25.4) 14.1 ( 11.3- 17.6) 24.0 ( 17.9- 32.2)
Indiana 23.5 ( 21.7- 25.4) 23.0 ( 21.2- 25.0) 24.9 ( 17.8- 34.4) 26.6 ( 13.9- 52.4)
Michigan 21.8 ( 20.5- 23.3) 22.0 ( 20.6- 23.6) 16.0 ( 12.6- 20.2) ∼
Detroit 22.7 ( 20.5- 25.2) 23.6 ( 21.0- 26.4) 18.3 ( 14.1- 23.6) -
Ohio 21.7 ( 20.5- 23.0) 21.5 ( 20.2- 22.9) 15.8 ( 12.3- 20.2) ∼
Wisconsin 22.0 ( 20.2- 24.0) 21.8 ( 20.0- 23.8) 17.5 ( 9.4- 34.9) -
West North Central 23.3 ( 22.3- 24.3) 23.5 ( 22.4- 24.5) 13.5 ( 9.7- 18.6) 23.3 ( 14.9- 36.1)
Iowa 22.1 ( 19.7- 24.6) 22.1 ( 19.7- 24.7) ∼ ∼
Kansas 21.5 ( 19.0- 24.3) 21.5 ( 18.9- 24.4) ∼ 33.7 ( 16.5- 67.2)
Minnesota 26.9 ( 24.8- 29.2) 26.5 ( 24.4- 28.9) ∼ ∼
Missouri 21.7 ( 19.9- 23.6) 22.7 ( 20.8- 24.8) 12.6 ( 8.0- 19.5) ∼
Nebraska 25.6 ( 22.2- 29.4) 25.1 ( 21.7- 29.0) ∼ ∼
North Dakota 18.2 ( 13.8- 23.7) 18.7 ( 14.2- 24.4) ∼ ∼
South Dakota
South
South Atlantic
Delaware 23.1 ( 18.4- 28.8) 23.4 ( 18.3- 29.7) ∼ ∼
District of Columbia 25.9 ( 19.8- 33.4) 20.2 ( 11.5- 35.0) 30.4 ( 22.1- 41.1) ∼
Florida 21.5 ( 20.5- 22.5) 21.5 ( 20.5- 22.6) 16.5 ( 13.8- 19.8) -
Georgia 19.2 ( 17.6- 20.9) 20.0 ( 18.2- 22.0) 15.6 ( 12.8- 19.1) ∼
Atlanta 19.8 ( 16.9- 23.2) 21.4 ( 17.9- 25.6) 15.7 ( 11.3- 22.6) ∼
Maryland 19.4 ( 17.6- 21.4) 21.2 ( 19.0- 23.5) 12.6 ( 9.7- 16.6) ∼
North Carolina 18.1 ( 16.7- 19.6) 18.6 ( 17.0- 20.3) 14.9 ( 11.9- 18.5) ∼
South Carolina 19.6 ( 17.5- 21.8) 21.3 ( 18.8- 24.0) 12.2 ( 8.9- 16.6) -
Virginia
West Virginia 19.6 ( 16.9- 22.8) 20.3 ( 17.5- 23.5) ∼ ∼
East South Central
Alabama 21.0 ( 19.0- 23.1) 23.0 ( 20.7- 25.5) 11.6 ( 8.5- 15.6) ∼
Kentucky 21.6 ( 19.5- 24.0) 21.7 ( 19.5- 24.2) 16.1 ( 9.0- 27.8) -
Mississippi
Tennessee
continued
C
ancer Incidence and M
ortality by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
175
Table 2.19.1.1M: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 21.4 ( 19.4- 23.8) 23.4 ( 20.9- 26.3) 14.1 ( 10.9- 18.2) ∼
Oklahoma 22.4 ( 20.1- 24.9) 22.2 ( 19.8- 24.9) 19.4 ( 10.9- 33.0) ∼
Texas 19.8 ( 18.8- 20.8) 19.8 ( 18.8- 20.9) 18.8 ( 15.8- 22.4) 17.2 ( 15.2- 19.5)
West 22.0 ( 21.5- 22.6) 22.5 ( 21.8- 23.1) 17.9 ( 15.4- 20.7) 17.9 ( 16.4- 19.6)
Mountain 20.4 ( 19.4- 21.4) 20.4 ( 19.4- 21.5) 16.2 ( 10.7- 25.1) 16.4 ( 13.7- 19.7)
Arizona 17.9 ( 16.3- 19.7) 18.2 ( 16.5- 20.0) ∼ 17.6 ( 12.8- 24.3)
Colorado 21.4 ( 19.2- 23.7) 21.2 ( 19.0- 23.7) ∼ 17.4 ( 11.3- 26.6)
Idaho 23.1 ( 19.3- 27.5) 23.5 ( 19.6- 27.9) ∼ ∼
Montana 22.1 ( 18.0- 27.0) 21.7 ( 17.5- 26.7) ∼ ∼
Nevada 23.6 ( 20.4- 27.2) 22.9 ( 19.6- 26.7) ∼ 17.1 ( 7.9- 36.9)
New Mexico 16.7 ( 14.0- 19.8) 16.9 ( 14.1- 20.2) ∼ 13.4 ( 9.2- 19.1)
Utah 23.0 ( 19.7- 26.7) 23.3 ( 19.9- 27.1) ∼ ∼
Wyoming
Pacific 22.7 ( 22.0- 23.4) 23.4 ( 22.6- 24.2) 18.2 ( 15.5- 21.4) 18.4 ( 16.6- 20.4)
Alaska 27.5 ( 19.4- 39.0) 30.8 ( 21.1- 44.8) ∼ ∼
California 22.1 ( 21.3- 22.9) 22.7 ( 21.9- 23.6) 19.2 ( 16.3- 22.6) 18.6 ( 16.8- 20.6)
San Francisco-Oakland 24.0 ( 21.8- 26.4) 25.9 ( 23.2- 28.9) 21.1 ( 14.6- 30.1) 27.7 ( 19.9- 38.4)
San Jose-Monterey 21.6 ( 18.7- 24.9) 23.1 ( 19.7- 27.0) ∼ 27.5 ( 18.2- 40.8)
Los Angeles 22.3 ( 20.8- 23.9) 22.9 ( 21.1- 24.8) 20.8 ( 16.2- 26.7) 17.6 ( 14.8- 20.8)
Hawaii 18.3 ( 15.1- 22.1) 22.7 ( 15.8- 32.1) ∼ -
Oregon 22.7 ( 20.5- 25.2) 22.9 ( 20.6- 25.5) ∼ ∼
Washington 26.7 ( 24.8- 28.8) 26.6 ( 24.6- 28.8) ∼ 20.6 ( 11.1- 38.3)
Seattle-Puget Sound 28.8 ( 26.4- 31.5) 30.1 ( 27.4- 33.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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176 Table 2.19.1.1F: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 15.5 ( 15.3- 15.7) 16.0 ( 15.7- 16.2) 10.5 ( 9.9- 11.0) 13.7 ( 12.9- 14.4)
Northeast 16.5 ( 16.1- 17.0) 17.1 ( 16.6- 17.5) 10.9 ( 9.8- 12.1) 13.6 ( 11.9- 15.5)
New England 17.2 ( 16.3- 18.1) 17.4 ( 16.5- 18.4) 13.3 ( 9.6- 18.0) 18.7 ( 13.3- 26.0)
Connecticut 15.9 ( 14.2- 17.8) 15.7 ( 14.0- 17.7) 17.5 ( 11.3- 26.2) ∼
Maine 18.3 ( 15.4- 21.6) 18.4 ( 15.5- 21.7) ∼ ∼
Massachusetts 17.6 ( 16.3- 19.0) 17.8 ( 16.4- 19.3) 12.0 ( 7.2- 18.9) 19.5 ( 11.8- 31.2)
New Hampshire 17.6 ( 14.7- 21.1) 17.5 ( 14.5- 21.0) ∼ -
Rhode Island 17.9 ( 14.7- 21.6) 19.0 ( 15.6- 22.9) ∼ ∼
Vermont 16.3 ( 12.4- 21.3) 16.5 ( 12.5- 21.6) ∼ ∼
Middle Atlantic 16.3 ( 15.8- 16.8) 16.9 ( 16.3- 17.5) 10.6 ( 9.5- 11.9) 12.9 ( 11.2- 14.8)
New Jersey 17.3 ( 16.2- 18.5) 18.0 ( 16.7- 19.3) 11.8 ( 9.2- 15.0) 14.6 ( 11.0- 19.1)
New York 15.5 ( 14.8- 16.3) 16.2 ( 15.4- 17.1) 10.3 ( 8.8- 11.9) 11.4 ( 9.5- 13.6)
Pennsylvania 16.6 ( 15.7- 17.6) 17.1 ( 16.2- 18.1) 10.3 ( 7.9- 13.1) -
Midwest 15.8 ( 15.4- 16.2) 16.1 ( 15.6- 16.5) 10.3 ( 9.2- 11.5) 14.3 ( 11.5- 17.8)
East North Central 15.5 ( 15.0- 16.0) 15.8 ( 15.3- 16.3) 10.4 ( 9.2- 11.7) 13.3 ( 10.3- 17.1)
Illinois 15.6 ( 14.7- 16.5) 16.3 ( 15.3- 17.4) 10.2 ( 8.2- 12.5) 13.2 ( 9.4- 18.4)
Indiana 14.1 ( 12.9- 15.5) 14.2 ( 12.9- 15.6) 9.7 ( 6.1- 14.6) ∼
Michigan 16.7 ( 15.7- 17.8) 17.1 ( 15.9- 18.3) 11.2 ( 8.8- 14.1) ∼
Detroit 17.3 ( 15.6- 19.1) 19.2 ( 17.2- 21.4) 9.8 ( 7.3- 13.0) -
Ohio 14.4 ( 13.5- 15.4) 14.4 ( 13.5- 15.4) 10.4 ( 8.1- 13.2) ∼
Wisconsin 17.0 ( 15.5- 18.5) 17.2 ( 15.8- 18.8) ∼ -
West North Central 16.6 ( 15.8- 17.4) 16.7 ( 15.9- 17.5) 9.9 ( 7.2- 13.3) 18.8 ( 11.7- 29.2)
Iowa 17.4 ( 15.6- 19.5) 17.4 ( 15.5- 19.5) ∼ ∼
Kansas 16.0 ( 14.0- 18.2) 15.8 ( 13.8- 18.1) ∼ ∼
Minnesota 18.3 ( 16.7- 20.0) 18.3 ( 16.6- 20.0) ∼ ∼
Missouri 15.3 ( 14.0- 16.8) 15.7 ( 14.3- 17.2) 10.6 ( 7.2- 15.1) ∼
Nebraska 16.3 ( 13.8- 19.1) 16.3 ( 13.8- 19.1) ∼ ∼
North Dakota 14.9 ( 11.2- 19.5) 14.3 ( 10.7- 19.0) ∼ ∼
South Dakota
South
South Atlantic
Delaware 15.1 ( 11.7- 19.2) 15.1 ( 11.5- 19.8) ∼ ∼
District of Columbia 12.4 ( 8.8- 17.3) ∼ 12.5 ( 8.0- 19.2) ∼
Florida 15.2 ( 14.5- 16.0) 15.4 ( 14.6- 16.3) 11.9 ( 9.9- 14.3) -
Georgia 13.9 ( 12.8- 15.1) 14.2 ( 12.9- 15.6) 11.4 ( 9.4- 13.7) ∼
Atlanta 14.2 ( 12.2- 16.5) 14.5 ( 12.0- 17.4) 12.3 ( 9.0- 16.7) ∼
Maryland 12.4 ( 11.1- 13.7) 13.6 ( 12.1- 15.2) 8.4 ( 6.4- 11.0) ∼
North Carolina 13.7 ( 12.6- 14.8) 14.8 ( 13.6- 16.1) 8.2 ( 6.4- 10.4) ∼
South Carolina 14.1 ( 12.6- 15.7) 15.8 ( 14.0- 17.8) 7.5 ( 5.5- 10.1) -
Virginia
West Virginia 16.9 ( 14.6- 19.5) 17.3 ( 14.9- 19.9) ∼ ∼
East South Central
Alabama 13.5 ( 12.1- 15.0) 14.8 ( 13.2- 16.6) 8.6 ( 6.3- 11.4) ∼
Kentucky 16.6 ( 15.0- 18.4) 16.6 ( 15.0- 18.5) ∼ -
Mississippi
Tennessee
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Table 2.19.1.1F: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 15.3 ( 13.7- 16.9) 16.4 ( 14.5- 18.4) 11.6 ( 9.1- 14.6) ∼
Oklahoma 15.4 ( 13.7- 17.2) 15.2 ( 13.4- 17.2) ∼ ∼
Texas 15.0 ( 14.2- 15.7) 15.4 ( 14.5- 16.2) 11.0 ( 9.0- 13.2) 13.2 ( 11.6- 14.9)
West 15.3 ( 14.9- 15.7) 15.8 ( 15.3- 16.3) 11.1 ( 9.4- 13.1) 13.4 ( 12.3- 14.6)
Mountain 15.2 ( 14.4- 16.0) 15.3 ( 14.5- 16.1) 10.7 ( 6.5- 16.9) 12.8 ( 10.7- 15.2)
Arizona 13.3 ( 12.0- 14.7) 13.4 ( 12.1- 14.9) ∼ 13.6 ( 10.1- 18.3)
Colorado 17.2 ( 15.4- 19.1) 17.0 ( 15.2- 18.9) ∼ 16.6 ( 11.2- 23.9)
Idaho 17.5 ( 14.5- 21.1) 17.6 ( 14.5- 21.2) ∼ ∼
Montana 16.2 ( 12.9- 20.1) 15.4 ( 12.2- 19.4) ∼ ∼
Nevada 15.5 ( 13.2- 18.2) 15.6 ( 13.1- 18.4) ∼ ∼
New Mexico 14.0 ( 11.7- 16.5) 14.8 ( 12.4- 17.6) ∼ 9.6 ( 6.5- 13.6)
Utah 16.0 ( 13.5- 18.8) 16.0 ( 13.5- 18.9) ∼ ∼
Wyoming
Pacific 15.3 ( 14.8- 15.8) 16.0 ( 15.4- 16.6) 11.3 ( 9.4- 13.4) 13.6 ( 12.3- 15.0)
Alaska 12.2 ( 7.9- 18.3) 14.2 ( 8.8- 22.1) ∼ ∼
California 14.8 ( 14.3- 15.4) 15.5 ( 14.9- 16.2) 11.3 ( 9.4- 13.5) 13.7 ( 12.3- 15.1)
San Francisco-Oakland 16.4 ( 14.8- 18.2) 17.6 ( 15.6- 19.9) 11.9 ( 7.7- 17.8) 18.1 ( 12.9- 24.7)
San Jose-Monterey 16.2 ( 13.9- 18.7) 16.5 ( 14.0- 19.5) ∼ 18.1 ( 12.1- 26.4)
Los Angeles 14.1 ( 13.1- 15.3) 15.5 ( 14.2- 16.9) 9.9 ( 7.4- 13.1) 12.4 ( 10.4- 14.7)
Hawaii 12.4 ( 9.9- 15.4) 15.1 ( 9.6- 23.3) ∼ -
Oregon 17.2 ( 15.4- 19.1) 17.4 ( 15.6- 19.4) ∼ ∼
Washington 17.7 ( 16.2- 19.2) 17.5 ( 15.9- 19.1) ∼ ∼
Seattle-Puget Sound 17.8 ( 16.1- 19.7) 18.4 ( 16.5- 20.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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178 Table 2.19.1.2M: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 9.6 ( 9.4- 9.8) 10.0 ( 9.8- 10.2) 6.9 ( 6.4- 7.4) 6.7 ( 6.1- 7.4)
Northeast 9.9 ( 9.5- 10.4) 10.2 ( 9.8- 10.7) 8.3 ( 7.1- 9.8) 5.6 ( 4.3- 7.4)
New England 10.1 ( 9.3- 10.9) 10.3 ( 9.5- 11.2) 7.4 ( 4.1- 13.2) ∼
Connecticut 9.7 ( 8.2- 11.4) 10.2 ( 8.7- 12.0) ∼ ∼
Maine 9.3 ( 7.0- 12.1) 9.4 ( 7.1- 12.2) ∼ ∼
Massachusetts 10.0 ( 8.9- 11.3) 10.1 ( 8.9- 11.4) ∼ ∼
New Hampshire 12.1 ( 9.3- 15.6) 12.3 ( 9.4- 15.8) ∼ ∼
Rhode Island 9.5 ( 6.9- 12.7) 9.7 ( 7.1- 13.1) ∼ ∼
Vermont 12.0 ( 8.2- 17.1) 11.8 ( 8.0- 17.0) ∼ ∼
Middle Atlantic 9.9 ( 9.4- 10.4) 10.2 ( 9.7- 10.7) 8.5 ( 7.2- 10.0) 6.2 ( 4.6- 8.2)
New Jersey 10.5 ( 9.5- 11.6) 10.7 ( 9.6- 11.9) 10.3 ( 7.2- 14.6) 5.9 ( 3.1- 10.9)
New York 9.2 ( 8.6- 9.9) 9.7 ( 9.0- 10.5) 7.5 ( 5.9- 9.5) 6.5 ( 4.5- 9.1)
Pennsylvania 10.4 ( 9.6- 11.2) 10.5 ( 9.7- 11.4) 9.2 ( 6.4- 13.1) ∼
Midwest 10.2 ( 9.8- 10.5) 10.4 ( 10.0- 10.8) 7.0 ( 5.9- 8.4) 5.9 ( 3.9- 8.8)
East North Central 10.0 ( 9.6- 10.5) 10.3 ( 9.9- 10.8) 7.0 ( 5.8- 8.5) 6.2 ( 3.9- 9.7)
Illinois 9.5 ( 8.7- 10.4) 10.1 ( 9.1- 11.1) 5.2 ( 3.5- 7.7) 5.5 ( 2.8- 10.7)
Indiana 10.7 ( 9.4- 12.0) 10.7 ( 9.4- 12.1) 9.8 ( 5.4- 17.0) ∼
Michigan 10.7 ( 9.7- 11.8) 11.1 ( 10.1- 12.3) 7.7 ( 5.3- 11.1) ∼
Ohio 9.9 ( 9.1- 10.9) 10.2 ( 9.3- 11.2) 7.0 ( 4.8- 10.2) ∼
Wisconsin 9.2 ( 8.0- 10.5) 9.2 ( 8.0- 10.6) ∼ ∼
West North Central 10.4 ( 9.8- 11.2) 10.6 ( 9.9- 11.4) 7.1 ( 4.2- 11.5) ∼
Iowa 11.3 ( 9.6- 13.2) 11.5 ( 9.7- 13.4) ∼ ∼
Kansas 9.6 ( 7.9- 11.5) 9.7 ( 8.0- 11.7) ∼ ∼
Minnesota 11.1 ( 9.7- 12.6) 11.3 ( 9.8- 12.9) ∼ ∼
Missouri 10.6 ( 9.3- 12.0) 10.9 ( 9.6- 12.4) ∼ ∼
Nebraska 10.0 ( 7.9- 12.5) 10.2 ( 8.1- 12.8) ∼ ∼
North Dakota 8.8 ( 5.8- 12.8) 8.6 ( 5.7- 12.7) ∼ ∼
South Dakota 8.2 ( 5.5- 11.7) 8.2 ( 5.5- 11.8) ∼ ∼
South 9.2 ( 9.0- 9.5) 9.7 ( 9.4- 10.1) 6.3 ( 5.6- 7.0) 6.5 ( 5.6- 7.6)
South Atlantic 9.1 ( 8.7- 9.5) 9.6 ( 9.1- 10.0) 6.1 ( 5.2- 7.0) 6.0 ( 4.7- 7.6)
Delaware 9.7 ( 6.6- 13.8) 10.0 ( 6.7- 14.6) ∼ ∼
District of Columbia 9.3 ( 5.7- 14.5) ∼ ∼ ∼
Florida 8.9 ( 8.3- 9.5) 9.2 ( 8.5- 9.9) 5.5 ( 3.9- 7.7) 6.7 ( 5.2- 8.5)
Georgia 8.4 ( 7.3- 9.6) 9.0 ( 7.7- 10.4) 5.4 ( 3.6- 7.9) ∼
Maryland 10.0 ( 8.7- 11.5) 11.3 ( 9.7- 13.1) 4.8 ( 2.8- 8.0) ∼
North Carolina 10.0 ( 8.9- 11.2) 10.6 ( 9.4- 12.0) 6.9 ( 4.8- 9.9) ∼
South Carolina 8.7 ( 7.3- 10.3) 9.7 ( 8.1- 11.6) 5.3 ( 3.1- 8.7) ∼
Virginia 9.0 ( 7.9- 10.2) 9.6 ( 8.3- 11.0) 6.5 ( 4.3- 9.7) ∼
West Virginia 8.9 ( 7.1- 11.2) 9.0 ( 7.1- 11.3) ∼ ∼
East South Central 9.9 ( 9.2- 10.7) 10.5 ( 9.7- 11.4) 6.2 ( 4.8- 8.0) ∼
Alabama 10.2 ( 8.7- 11.7) 11.0 ( 9.4- 12.9) 6.0 ( 3.8- 9.2) ∼
Kentucky 9.8 ( 8.4- 11.5) 9.8 ( 8.3- 11.6) ∼ ∼
Mississippi 9.7 ( 7.9- 11.7) 10.8 ( 8.7- 13.4) 6.2 ( 3.7- 10.0) ∼
Tennessee 9.9 ( 8.7- 11.3) 10.5 ( 9.1- 12.0) ∼ ∼
West South Central 9.2 ( 8.7- 9.8) 9.6 ( 9.0- 10.2) 7.1 ( 5.6- 8.8) 7.0 ( 5.7- 8.7)
Arkansas 9.7 ( 8.0- 11.7) 10.5 ( 8.6- 12.7) ∼ ∼
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Table 2.19.1.2M: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 10.2 ( 8.7- 11.9) 11.5 ( 9.7- 13.5) 6.4 ( 4.2- 9.6) ∼
Oklahoma 10.5 ( 8.9- 12.3) 11.0 ( 9.3- 13.0) ∼ ∼
Texas 8.6 ( 7.9- 9.3) 8.8 ( 8.1- 9.6) 7.6 ( 5.6- 10.3) 7.1 ( 5.7- 8.8)
West 9.2 ( 8.8- 9.6) 9.6 ( 9.2- 10.0) 6.7 ( 5.2- 8.7) 7.4 ( 6.4- 8.5)
Mountain 8.4 ( 7.8- 9.1) 8.6 ( 7.9- 9.4) ∼ 7.1 ( 5.2- 9.6)
Arizona 8.9 ( 7.7- 10.2) 9.0 ( 7.8- 10.3) ∼ 6.6 ( 3.8- 11.4)
Colorado 9.5 ( 8.0- 11.2) 9.8 ( 8.3- 11.6) ∼ ∼
Idaho 6.7 ( 4.7- 9.3) 6.9 ( 4.8- 9.5) ∼ ∼
Montana 8.0 ( 5.6- 11.2) 8.3 ( 5.8- 11.6) ∼ ∼
Nevada 8.1 ( 6.2- 10.6) 8.4 ( 6.3- 11.0) ∼ ∼
New Mexico 7.6 ( 5.8- 9.9) 7.6 ( 5.7- 10.0) ∼ 7.7 ( 4.5- 12.6)
Utah 8.2 ( 6.2- 10.7) 8.3 ( 6.3- 10.9) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 9.5 ( 9.1- 10.0) 10.1 ( 9.6- 10.6) 6.9 ( 5.2- 9.2) 7.5 ( 6.3- 8.9)
Alaska 10.6 ( 5.7- 19.3) ∼ ∼ ∼
California 9.2 ( 8.6- 9.7) 9.7 ( 9.1- 10.3) 7.2 ( 5.3- 9.6) 7.4 ( 6.2- 8.8)
Hawaii 6.7 ( 4.8- 9.1) ∼ ∼ ∼
Oregon 9.8 ( 8.3- 11.4) 10.0 ( 8.5- 11.8) ∼ ∼
Washington 12.1 ( 10.7- 13.6) 12.4 ( 10.9- 14.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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180 Table 2.19.1.2F: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 6.2 ( 6.0- 6.3) 6.4 ( 6.3- 6.5) 4.4 ( 4.1- 4.8) 5.3 ( 4.8- 5.8)
Northeast 6.1 ( 5.8- 6.4) 6.4 ( 6.1- 6.7) 4.1 ( 3.4- 4.9) 4.7 ( 3.6- 5.9)
New England 6.6 ( 6.1- 7.1) 6.7 ( 6.2- 7.3) 5.1 ( 2.9- 8.5) ∼
Connecticut 5.9 ( 4.9- 7.0) 5.9 ( 4.9- 7.1) ∼ ∼
Maine 6.5 ( 5.0- 8.6) 6.6 ( 5.0- 8.7) ∼ ∼
Massachusetts 6.8 ( 6.0- 7.7) 6.9 ( 6.1- 7.8) ∼ ∼
New Hampshire 8.3 ( 6.3- 10.8) 8.4 ( 6.4- 10.9) ∼ ∼
Rhode Island 6.1 ( 4.5- 8.3) 6.3 ( 4.6- 8.7) ∼ ∼
Vermont 6.1 ( 3.9- 9.4) 6.1 ( 3.9- 9.5) ∼ ∼
Middle Atlantic 5.9 ( 5.6- 6.2) 6.2 ( 5.9- 6.6) 4.0 ( 3.3- 4.8) 4.8 ( 3.7- 6.1)
New Jersey 6.3 ( 5.6- 7.0) 6.6 ( 5.9- 7.5) 3.8 ( 2.3- 5.9) ∼
New York 5.5 ( 5.1- 5.9) 5.8 ( 5.4- 6.4) 4.2 ( 3.3- 5.3) 5.0 ( 3.7- 6.7)
Pennsylvania 6.3 ( 5.8- 6.8) 6.5 ( 6.0- 7.1) 3.6 ( 2.3- 5.4) ∼
Midwest 6.7 ( 6.4- 6.9) 6.8 ( 6.5- 7.1) 5.0 ( 4.2- 5.9) 5.0 ( 3.2- 7.5)
East North Central 6.6 ( 6.3- 6.9) 6.8 ( 6.4- 7.1) 4.9 ( 4.1- 5.9) 5.7 ( 3.6- 8.7)
Illinois 6.4 ( 5.8- 7.0) 6.5 ( 5.9- 7.2) 5.3 ( 3.9- 7.1) 6.2 ( 3.4- 10.7)
Indiana 6.5 ( 5.7- 7.4) 6.6 ( 5.8- 7.6) ∼ ∼
Michigan 7.1 ( 6.4- 7.8) 7.4 ( 6.6- 8.1) 5.2 ( 3.6- 7.4) ∼
Ohio 6.6 ( 6.0- 7.2) 6.8 ( 6.2- 7.5) 4.3 ( 2.8- 6.3) ∼
Wisconsin 6.1 ( 5.3- 7.1) 6.2 ( 5.3- 7.1) ∼ ∼
West North Central 6.8 ( 6.4- 7.3) 6.9 ( 6.4- 7.4) 5.4 ( 3.5- 8.1) ∼
Iowa 7.6 ( 6.5- 9.0) 7.6 ( 6.4- 9.0) ∼ ∼
Kansas 6.6 ( 5.4- 8.0) 6.6 ( 5.4- 8.1) ∼ ∼
Minnesota 6.5 ( 5.6- 7.5) 6.6 ( 5.7- 7.6) ∼ ∼
Missouri 7.1 ( 6.3- 8.1) 7.2 ( 6.3- 8.2) 6.3 ( 3.8- 10.0) ∼
Nebraska 6.2 ( 4.8- 8.0) 6.3 ( 4.9- 8.1) ∼ ∼
North Dakota 6.8 ( 4.4- 10.1) 6.7 ( 4.3- 10.1) ∼ ∼
South Dakota 4.8 ( 3.0- 7.3) 4.9 ( 3.1- 7.6) ∼ ∼
South 6.0 ( 5.8- 6.2) 6.3 ( 6.1- 6.5) 4.4 ( 3.9- 4.8) 5.6 ( 4.9- 6.4)
South Atlantic 5.8 ( 5.6- 6.1) 6.1 ( 5.8- 6.4) 4.4 ( 3.9- 5.1) 5.1 ( 4.1- 6.3)
Delaware 5.9 ( 3.9- 8.6) 6.3 ( 4.1- 9.5) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 5.8 ( 5.4- 6.3) 5.8 ( 5.4- 6.3) 5.5 ( 4.2- 7.3) 5.3 ( 4.2- 6.7)
Georgia 6.0 ( 5.2- 6.8) 6.3 ( 5.4- 7.3) 4.8 ( 3.5- 6.6) ∼
Maryland 5.0 ( 4.2- 5.9) 5.4 ( 4.4- 6.4) 3.8 ( 2.4- 5.7) ∼
North Carolina 6.3 ( 5.6- 7.0) 6.6 ( 5.8- 7.5) 4.7 ( 3.3- 6.5) ∼
South Carolina 5.6 ( 4.6- 6.6) 6.4 ( 5.3- 7.7) 2.9 ( 1.7- 4.7) ∼
Virginia 5.9 ( 5.2- 6.8) 6.3 ( 5.4- 7.2) 4.3 ( 2.8- 6.2) ∼
West Virginia 6.7 ( 5.4- 8.4) 6.7 ( 5.3- 8.4) ∼ ∼
East South Central 6.4 ( 5.9- 6.9) 6.8 ( 6.3- 7.4) 3.9 ( 3.0- 5.0) ∼
Alabama 6.0 ( 5.1- 7.0) 6.7 ( 5.6- 7.9) 3.3 ( 2.0- 5.2) ∼
Kentucky 6.3 ( 5.4- 7.5) 6.5 ( 5.5- 7.6) ∼ ∼
Mississippi 6.0 ( 4.8- 7.3) 6.7 ( 5.3- 8.5) 3.6 ( 2.0- 5.9) ∼
Tennessee 6.9 ( 6.0- 7.8) 7.2 ( 6.2- 8.2) 5.1 ( 3.2- 7.9) ∼
West South Central 6.1 ( 5.8- 6.5) 6.4 ( 6.0- 6.8) 4.5 ( 3.6- 5.5) 6.1 ( 5.0- 7.4)
Arkansas 5.4 ( 4.3- 6.6) 5.6 ( 4.4- 6.9) ∼ ∼
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Table 2.19.1.2F: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 7.3 ( 6.2- 8.4) 7.8 ( 6.6- 9.3) 5.1 ( 3.5- 7.3) ∼
Oklahoma 5.2 ( 4.3- 6.3) 5.5 ( 4.5- 6.7) ∼ ∼
Texas 6.2 ( 5.7- 6.7) 6.4 ( 5.9- 6.9) 4.5 ( 3.2- 6.0) 6.1 ( 5.0- 7.4)
West 5.9 ( 5.7- 6.2) 6.2 ( 5.9- 6.5) 4.2 ( 3.1- 5.5) 5.3 ( 4.5- 6.1)
Mountain 6.0 ( 5.5- 6.5) 6.1 ( 5.6- 6.6) ∼ 5.3 ( 4.0- 7.0)
Arizona 6.8 ( 5.9- 7.8) 6.9 ( 6.0- 8.0) ∼ 4.9 ( 2.8- 8.2)
Colorado 6.6 ( 5.6- 7.9) 6.5 ( 5.4- 7.7) ∼ ∼
Idaho 5.0 ( 3.5- 7.0) 5.1 ( 3.6- 7.1) ∼ ∼
Montana 4.8 ( 3.1- 7.1) 5.0 ( 3.2- 7.4) ∼ ∼
Nevada 5.9 ( 4.5- 7.7) 6.4 ( 4.9- 8.3) ∼ ∼
New Mexico 5.5 ( 4.1- 7.2) 5.7 ( 4.2- 7.5) ∼ ∼
Utah 3.4 ( 2.3- 4.9) 3.6 ( 2.4- 5.0) ∼ ∼
Wyoming 7.9 ( 4.9- 12.3) 7.7 ( 4.7- 12.1) ∼ ∼
Pacific 5.9 ( 5.6- 6.2) 6.2 ( 5.9- 6.6) 4.3 ( 3.2- 5.8) 5.3 ( 4.4- 6.2)
Alaska ∼ ∼ ∼ ∼
California 5.8 ( 5.4- 6.1) 6.0 ( 5.6- 6.4) 4.5 ( 3.3- 6.1) 5.3 ( 4.4- 6.2)
Hawaii 4.3 ( 3.0- 6.2) ∼ ∼ ∼
Oregon 6.9 ( 5.8- 8.2) 7.1 ( 6.0- 8.4) ∼ ∼
Washington 6.3 ( 5.4- 7.2) 6.6 ( 5.7- 7.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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182 Table 2.20.1.1M: Oral Cavity and Pharynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 15.5 ( 15.3- 15.7) 15.3 ( 15.0- 15.5) 17.5 ( 16.7- 18.3) 10.4 ( 9.6- 11.1)
Northeast 14.8 ( 14.4- 15.3) 14.4 ( 13.9- 14.9) 17.7 ( 16.0- 19.6) 12.8 ( 10.9- 15.0)
New England 15.8 ( 14.9- 16.8) 15.5 ( 14.5- 16.5) 20.0 ( 14.7- 27.6) 10.7 ( 6.3- 18.3)
Connecticut 15.0 ( 13.2- 17.0) 14.8 ( 13.0- 16.9) 18.2 ( 9.9- 33.3) ∼
Maine 19.0 ( 15.8- 22.7) 18.5 ( 15.4- 22.2) ∼ ∼
Massachusetts 16.1 ( 14.7- 17.6) 15.7 ( 14.2- 17.2) 20.7 ( 13.6- 32.0) ∼
New Hampshire 14.8 ( 11.9- 18.4) 15.0 ( 12.0- 18.6) ∼ -
Rhode Island 14.5 ( 11.4- 18.3) 14.1 ( 10.9- 18.0) ∼ ∼
Vermont 13.8 ( 9.9- 18.8) 13.3 ( 9.6- 18.3) ∼ ∼
Middle Atlantic 14.5 ( 13.9- 15.0) 13.9 ( 13.4- 14.5) 17.4 ( 15.6- 19.4) 13.1 ( 11.0- 15.5)
New Jersey 14.2 ( 13.1- 15.4) 13.9 ( 12.6- 15.2) 18.1 ( 14.0- 23.5) 10.1 ( 7.0- 14.9)
New York 14.3 ( 13.5- 15.1) 13.9 ( 13.0- 14.8) 15.7 ( 13.5- 18.4) 12.6 ( 10.1- 15.7)
Pennsylvania 14.9 ( 14.0- 15.9) 14.1 ( 13.1- 15.1) 21.6 ( 17.7- 26.5) -
Midwest 15.3 ( 14.9- 15.8) 14.7 ( 14.3- 15.2) 19.0 ( 17.2- 21.0) 8.4 ( 6.3- 11.4)
East North Central 15.1 ( 14.6- 15.7) 14.5 ( 14.0- 15.1) 18.8 ( 16.9- 20.9) 8.9 ( 6.6- 12.4)
Illinois 16.1 ( 15.0- 17.2) 15.1 ( 14.0- 16.3) 22.8 ( 19.2- 27.0) 9.8 ( 6.6- 15.1)
Indiana 16.0 ( 14.5- 17.6) 15.9 ( 14.4- 17.5) 17.0 ( 11.3- 25.2) ∼
Michigan 16.4 ( 15.3- 17.6) 15.6 ( 14.4- 16.9) 18.2 ( 14.7- 22.4) ∼
Detroit 18.0 ( 16.1- 20.1) 17.1 ( 15.0- 19.5) 20.8 ( 16.5- 26.3) -
Ohio 13.1 ( 12.1- 14.1) 12.6 ( 11.6- 13.6) 14.4 ( 11.2- 18.6) ∼
Wisconsin 14.3 ( 12.9- 15.8) 14.0 ( 12.6- 15.6) 17.2 ( 9.9- 33.8) -
West North Central 15.7 ( 14.9- 16.6) 15.2 ( 14.4- 16.1) 20.4 ( 15.9- 26.2) ∼
Iowa 16.0 ( 14.0- 18.2) 15.7 ( 13.7- 17.9) ∼ ∼
Kansas 14.3 ( 12.2- 16.5) 13.1 ( 11.1- 15.4) ∼ ∼
Minnesota 15.2 ( 13.6- 16.9) 14.7 ( 13.1- 16.4) ∼ ∼
Missouri 16.6 ( 15.1- 18.3) 16.2 ( 14.6- 17.9) 21.8 ( 15.9- 29.8) ∼
Nebraska 14.3 ( 11.8- 17.2) 13.8 ( 11.3- 16.7) ∼ ∼
North Dakota 20.3 ( 15.7- 26.0) 20.5 ( 15.8- 26.3) ∼ ∼
South Dakota
South
South Atlantic
Delaware 16.1 ( 12.3- 20.9) 16.2 ( 12.1- 21.5) ∼ ∼
District of Columbia 16.9 ( 12.2- 23.1) ∼ 20.0 ( 13.6- 29.0) ∼
Florida 18.1 ( 17.3- 19.1) 18.7 ( 17.8- 19.7) 14.5 ( 12.0- 17.6) -
Georgia 18.0 ( 16.5- 19.5) 18.0 ( 16.3- 19.8) 19.7 ( 16.4- 23.7) ∼
Atlanta 16.4 ( 13.8- 19.5) 17.4 ( 14.3- 21.2) 14.8 ( 10.2- 22.0) ∼
Maryland 14.7 ( 13.2- 16.4) 15.0 ( 13.3- 16.9) 15.0 ( 11.8- 19.3) ∼
North Carolina 15.1 ( 13.8- 16.5) 14.1 ( 12.7- 15.5) 20.7 ( 17.2- 24.9) ∼
South Carolina 19.1 ( 17.1- 21.2) 17.8 ( 15.6- 20.2) 22.9 ( 18.6- 28.1) -
Virginia
West Virginia 15.2 ( 12.8- 17.9) 14.8 ( 12.4- 17.6) ∼ ∼
East South Central
Alabama 17.8 ( 16.1- 19.8) 18.6 ( 16.6- 20.9) 14.6 ( 11.1- 19.0) ∼
Kentucky 19.2 ( 17.2- 21.3) 19.0 ( 17.0- 21.2) 18.0 ( 11.0- 29.4) -
Mississippi
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Table 2.20.1.1M: Oral Cavity and Pharynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 19.6 ( 17.7- 21.8) 19.1 ( 16.9- 21.5) 20.8 ( 16.9- 25.5) ∼
Oklahoma 16.6 ( 14.7- 18.8) 17.0 ( 14.9- 19.3) ∼ ∼
Texas 15.5 ( 14.7- 16.4) 15.7 ( 14.8- 16.7) 14.3 ( 11.7- 17.5) 9.8 ( 8.2- 11.5)
West 14.4 ( 14.0- 14.9) 14.5 ( 14.0- 15.0) 14.9 ( 12.6- 17.5) 8.4 ( 7.4- 9.6)
Mountain 13.6 ( 12.8- 14.4) 13.7 ( 12.9- 14.6) 11.1 ( 6.9- 18.9) 9.2 ( 7.3- 11.8)
Arizona 12.1 ( 10.8- 13.5) 12.1 ( 10.7- 13.6) ∼ 9.4 ( 6.2- 14.6)
Colorado 14.1 ( 12.4- 16.0) 13.8 ( 12.1- 15.8) ∼ 8.7 ( 4.7- 15.9)
Idaho 13.2 ( 10.4- 16.5) 13.3 ( 10.5- 16.8) ∼ ∼
Montana 17.3 ( 13.7- 21.6) 17.2 ( 13.5- 21.6) ∼ ∼
Nevada 15.9 ( 13.5- 18.8) 16.3 ( 13.7- 19.4) ∼ ∼
New Mexico 14.0 ( 11.6- 16.8) 14.9 ( 12.3- 17.9) ∼ 9.6 ( 6.2- 14.6)
Utah 12.8 ( 10.4- 15.7) 13.0 ( 10.6- 15.9) ∼ ∼
Wyoming
Pacific 14.7 ( 14.2- 15.3) 14.8 ( 14.2- 15.4) 15.6 ( 13.1- 18.6) 8.1 ( 7.0- 9.5)
Alaska 10.7 ( 7.0- 17.8) 11.4 ( 7.1- 20.1) ∼ ∼
California 14.6 ( 14.0- 15.3) 14.8 ( 14.1- 15.5) 15.9 ( 13.2- 19.1) 8.4 ( 7.1- 9.8)
San Francisco-Oakland 15.3 ( 13.6- 17.2) 15.6 ( 13.6- 17.9) 15.1 ( 9.8- 23.1) 8.5 ( 4.8- 14.9)
San Jose-Monterey 14.3 ( 11.9- 17.0) 14.6 ( 12.0- 17.7) ∼ 13.2 ( 6.8- 24.1)
Los Angeles 13.3 ( 12.2- 14.6) 13.0 ( 11.6- 14.4) 18.6 ( 14.4- 24.1) 8.4 ( 6.5- 10.9)
Hawaii 17.4 ( 14.3- 21.0) 24.7 ( 18.0- 33.9) ∼ -
Oregon 14.5 ( 12.8- 16.5) 14.0 ( 12.3- 16.0) ∼ ∼
Washington 15.0 ( 13.6- 16.6) 14.8 ( 13.4- 16.4) ∼ ∼
Seattle-Puget Sound 16.6 ( 14.8- 18.6) 17.3 ( 15.3- 19.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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184 Table 2.20.1.1F: Oral Cavity and Pharynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 6.0 ( 5.9- 6.1) 6.0 ( 5.9- 6.1) 5.5 ( 5.1- 5.9) 3.7 ( 3.3- 4.1)
Northeast 6.0 ( 5.7- 6.3) 5.9 ( 5.6- 6.2) 6.6 ( 5.8- 7.6) 4.7 ( 3.7- 5.8)
New England 6.2 ( 5.7- 6.8) 6.2 ( 5.6- 6.8) 6.1 ( 3.7- 9.7) 5.7 ( 3.1- 10.3)
Connecticut 5.9 ( 4.9- 7.1) 5.7 ( 4.6- 7.0) ∼ ∼
Maine 6.5 ( 4.8- 8.6) 6.3 ( 4.7- 8.4) ∼ ∼
Massachusetts 6.4 ( 5.6- 7.3) 6.4 ( 5.6- 7.4) ∼ ∼
New Hampshire 6.9 ( 5.1- 9.2) 6.9 ( 5.0- 9.2) ∼ -
Rhode Island 5.4 ( 3.7- 7.6) 5.6 ( 3.8- 8.0) ∼ ∼
Vermont 5.7 ( 3.5- 9.1) 5.8 ( 3.6- 9.2) ∼ ∼
Middle Atlantic 5.9 ( 5.6- 6.3) 5.7 ( 5.4- 6.1) 6.7 ( 5.8- 7.7) 4.5 ( 3.5- 5.7)
New Jersey 5.8 ( 5.1- 6.5) 5.6 ( 4.9- 6.4) 6.5 ( 4.6- 9.1) 5.0 ( 2.9- 8.2)
New York 6.1 ( 5.7- 6.6) 6.0 ( 5.5- 6.5) 6.2 ( 5.1- 7.5) 4.4 ( 3.2- 5.9)
Pennsylvania 5.8 ( 5.3- 6.4) 5.6 ( 5.1- 6.2) 8.3 ( 6.2- 10.8) -
Midwest 6.1 ( 5.8- 6.3) 6.0 ( 5.8- 6.3) 5.2 ( 4.4- 6.1) 3.7 ( 2.3- 5.6)
East North Central 5.9 ( 5.6- 6.2) 5.9 ( 5.5- 6.2) 5.1 ( 4.3- 6.1) 3.5 ( 2.1- 5.7)
Illinois 6.3 ( 5.7- 6.9) 6.4 ( 5.7- 7.1) 5.3 ( 3.9- 7.0) ∼
Indiana 5.6 ( 4.8- 6.4) 5.5 ( 4.7- 6.4) ∼ ∼
Michigan 6.7 ( 6.0- 7.4) 6.7 ( 6.0- 7.5) 5.1 ( 3.6- 7.2) ∼
Detroit 7.3 ( 6.2- 8.5) 7.8 ( 6.5- 9.3) 5.2 ( 3.4- 7.6) -
Ohio 4.8 ( 4.3- 5.4) 4.7 ( 4.2- 5.3) 3.8 ( 2.4- 5.6) ∼
Wisconsin 6.5 ( 5.6- 7.4) 6.2 ( 5.3- 7.2) ∼ -
West North Central 6.5 ( 6.1- 7.0) 6.4 ( 5.9- 6.9) 5.9 ( 3.9- 8.6) ∼
Iowa 6.4 ( 5.2- 7.7) 6.2 ( 5.0- 7.5) ∼ ∼
Kansas 6.4 ( 5.2- 7.9) 6.3 ( 5.0- 7.8) ∼ ∼
Minnesota 7.4 ( 6.4- 8.5) 6.9 ( 6.0- 8.1) ∼ ∼
Missouri 5.3 ( 4.5- 6.1) 5.4 ( 4.6- 6.3) ∼ ∼
Nebraska 8.2 ( 6.5- 10.3) 7.8 ( 6.1- 9.9) ∼ ∼
North Dakota 8.5 ( 5.8- 12.4) 8.6 ( 5.7- 12.6) ∼ ∼
South Dakota
South
South Atlantic
Delaware 6.3 ( 4.2- 9.1) 6.6 ( 4.2- 9.9) ∼ ∼
District of Columbia 7.7 ( 4.9- 11.8) ∼ 8.1 ( 4.7- 13.9) ∼
Florida 7.1 ( 6.6- 7.6) 7.1 ( 6.6- 7.7) 6.6 ( 5.1- 8.4) -
Georgia 6.7 ( 5.9- 7.5) 6.9 ( 6.0- 7.9) 5.8 ( 4.4- 7.6) ∼
Atlanta 7.0 ( 5.6- 8.6) 6.8 ( 5.1- 8.8) 7.8 ( 5.0- 11.8) ∼
Maryland 5.3 ( 4.5- 6.2) 5.4 ( 4.4- 6.5) 4.8 ( 3.3- 6.9) ∼
North Carolina 5.9 ( 5.2- 6.7) 6.1 ( 5.3- 7.0) 5.3 ( 3.9- 7.1) ∼
South Carolina 6.2 ( 5.2- 7.3) 6.2 ( 5.1- 7.6) 5.6 ( 3.8- 7.9) -
Virginia
West Virginia 6.0 ( 4.7- 7.7) 6.0 ( 4.7- 7.7) ∼ ∼
East South Central
Alabama 6.3 ( 5.4- 7.4) 6.5 ( 5.5- 7.8) 5.1 ( 3.4- 7.3) ∼
Kentucky 5.3 ( 4.4- 6.3) 5.3 ( 4.3- 6.4) ∼ -
Mississippi
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Table 2.20.1.1F: Oral Cavity and Pharynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 5.7 ( 4.7- 6.7) 6.2 ( 5.1- 7.5) 4.3 ( 2.8- 6.2) ∼
Oklahoma 5.2 ( 4.3- 6.4) 5.5 ( 4.5- 6.8) ∼ ∼
Texas 5.2 ( 4.8- 5.7) 5.2 ( 4.8- 5.7) 5.1 ( 3.8- 6.6) 3.0 ( 2.3- 3.9)
West 6.0 ( 5.7- 6.3) 6.0 ( 5.8- 6.3) 4.4 ( 3.3- 5.6) 3.2 ( 2.7- 3.9)
Mountain 5.4 ( 5.0- 5.9) 5.4 ( 5.0- 6.0) ∼ 2.1 ( 1.3- 3.2)
Arizona 4.5 ( 3.7- 5.3) 4.5 ( 3.7- 5.4) ∼ ∼
Colorado 5.4 ( 4.4- 6.5) 5.2 ( 4.2- 6.3) ∼ ∼
Idaho 7.8 ( 5.9- 10.3) 7.8 ( 5.8- 10.3) ∼ ∼
Montana 6.1 ( 4.2- 8.7) 6.2 ( 4.2- 8.9) ∼ ∼
Nevada 5.0 ( 3.7- 6.5) 4.8 ( 3.5- 6.5) ∼ ∼
New Mexico 5.8 ( 4.4- 7.6) 6.5 ( 4.9- 8.5) ∼ ∼
Utah 5.9 ( 4.4- 7.7) 5.8 ( 4.3- 7.6) ∼ ∼
Wyoming
Pacific 6.2 ( 5.9- 6.5) 6.3 ( 6.0- 6.7) 4.9 ( 3.7- 6.4) 3.6 ( 2.9- 4.4)
Alaska ∼ ∼ ∼ ∼
California 6.0 ( 5.7- 6.4) 6.2 ( 5.7- 6.6) 4.8 ( 3.6- 6.3) 3.6 ( 2.9- 4.4)
San Francisco-Oakland 6.4 ( 5.4- 7.5) 6.3 ( 5.1- 7.7) ∼ ∼
San Jose-Monterey 5.6 ( 4.3- 7.2) 4.8 ( 3.5- 6.6) ∼ ∼
Los Angeles 5.9 ( 5.3- 6.7) 6.2 ( 5.4- 7.1) 5.5 ( 3.7- 8.1) 4.0 ( 2.9- 5.4)
Hawaii 6.0 ( 4.3- 8.1) 9.6 ( 5.5- 16.6) ∼ -
Oregon 6.9 ( 5.8- 8.2) 6.7 ( 5.6- 8.0) ∼ ∼
Washington 7.0 ( 6.1- 8.0) 6.8 ( 5.9- 7.8) ∼ ∼
Seattle-Puget Sound 7.4 ( 6.3- 8.6) 7.4 ( 6.2- 8.8) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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186 Table 2.20.1.2M: Oral Cavity and Pharynx. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 4.1 ( 4.0- 4.2) 3.9 ( 3.7- 4.0) 6.3 ( 5.8- 6.8) 2.7 ( 2.3- 3.1)
Northeast 3.8 ( 3.5- 4.0) 3.6 ( 3.3- 3.8) 5.8 ( 4.8- 7.0) 3.1 ( 2.2- 4.4)
New England 4.4 ( 3.9- 5.0) 4.3 ( 3.8- 4.9) ∼ ∼
Connecticut 4.1 ( 3.2- 5.3) 4.0 ( 3.1- 5.2) ∼ ∼
Maine 4.3 ( 2.8- 6.3) 4.3 ( 2.8- 6.3) ∼ ∼
Massachusetts 4.6 ( 3.8- 5.4) 4.3 ( 3.6- 5.2) ∼ ∼
New Hampshire 5.3 ( 3.6- 7.8) 5.4 ( 3.6- 7.9) ∼ ∼
Rhode Island 3.8 ( 2.3- 6.0) 4.0 ( 2.4- 6.3) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.6 ( 3.3- 3.8) 3.3 ( 3.0- 3.6) 5.9 ( 4.8- 7.1) 3.0 ( 2.1- 4.5)
New Jersey 3.6 ( 3.0- 4.3) 3.2 ( 2.6- 3.9) 6.8 ( 4.4- 10.6) ∼
New York 3.4 ( 3.0- 3.8) 3.2 ( 2.8- 3.6) 5.0 ( 3.7- 6.7) 3.0 ( 1.8- 4.9)
Pennsylvania 3.7 ( 3.3- 4.3) 3.5 ( 3.0- 4.0) 7.3 ( 5.0- 10.6) ∼
Midwest 3.8 ( 3.6- 4.1) 3.6 ( 3.4- 3.9) 5.9 ( 5.0- 7.1) ∼
East North Central 3.9 ( 3.6- 4.2) 3.6 ( 3.4- 3.9) 6.2 ( 5.1- 7.5) ∼
Illinois 3.7 ( 3.2- 4.3) 3.4 ( 2.9- 4.0) 6.3 ( 4.6- 8.8) ∼
Indiana 3.6 ( 3.0- 4.5) 3.7 ( 3.0- 4.5) ∼ ∼
Michigan 3.8 ( 3.3- 4.5) 3.3 ( 2.8- 4.0) 6.9 ( 4.7- 9.9) ∼
Ohio 4.1 ( 3.6- 4.7) 4.0 ( 3.4- 4.6) 6.0 ( 4.0- 9.0) ∼
Wisconsin 4.1 ( 3.3- 5.0) 3.9 ( 3.2- 4.8) ∼ ∼
West North Central 3.7 ( 3.3- 4.1) 3.6 ( 3.2- 4.1) ∼ ∼
Iowa 3.8 ( 2.9- 5.0) 3.8 ( 2.8- 5.0) ∼ ∼
Kansas 3.6 ( 2.6- 4.8) 3.5 ( 2.5- 4.8) ∼ ∼
Minnesota 3.8 ( 3.0- 4.7) 3.8 ( 3.0- 4.7) ∼ ∼
Missouri 3.7 ( 3.0- 4.5) 3.5 ( 2.8- 4.4) ∼ ∼
Nebraska 2.8 ( 1.8- 4.3) 2.8 ( 1.8- 4.3) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 4.3 ( 2.5- 7.1) ∼ ∼ ∼
South 4.5 ( 4.3- 4.7) 4.1 ( 3.9- 4.3) 6.8 ( 6.1- 7.5) 2.6 ( 2.0- 3.3)
South Atlantic 4.3 ( 4.0- 4.6) 3.9 ( 3.6- 4.2) 6.5 ( 5.6- 7.4) 3.2 ( 2.3- 4.5)
Delaware 5.0 ( 3.0- 8.1) 5.0 ( 2.8- 8.4) ∼ ∼
District of Columbia 6.8 ( 3.9- 11.2) ∼ 11.2 ( 6.5- 18.4) ∼
Florida 4.3 ( 3.9- 4.8) 4.2 ( 3.8- 4.7) 5.2 ( 3.7- 7.3) 3.6 ( 2.5- 5.1)
Georgia 3.6 ( 3.0- 4.4) 3.1 ( 2.5- 4.0) 5.7 ( 3.9- 8.1) ∼
Maryland 4.3 ( 3.4- 5.2) 3.7 ( 2.9- 4.8) 6.5 ( 4.4- 9.8) ∼
North Carolina 4.3 ( 3.7- 5.1) 3.9 ( 3.2- 4.8) 6.1 ( 4.3- 8.7) ∼
South Carolina 5.2 ( 4.2- 6.4) 4.2 ( 3.2- 5.5) 8.5 ( 6.0- 12.1) ∼
Virginia 4.0 ( 3.3- 4.8) 3.5 ( 2.7- 4.3) 7.3 ( 5.0- 10.5) ∼
West Virginia 4.9 ( 3.6- 6.6) 5.1 ( 3.7- 6.8) ∼ ∼
East South Central 4.8 ( 4.3- 5.3) 4.3 ( 3.8- 4.9) 7.3 ( 5.8- 9.1) ∼
Alabama 4.2 ( 3.3- 5.2) 4.1 ( 3.1- 5.3) 5.1 ( 3.1- 8.1) ∼
Kentucky 4.2 ( 3.3- 5.3) 4.2 ( 3.3- 5.4) ∼ ∼
Mississippi 5.4 ( 4.2- 7.0) 4.3 ( 3.1- 6.0) 8.2 ( 5.4- 12.3) ∼
Tennessee 5.3 ( 4.4- 6.3) 4.6 ( 3.8- 5.7) 10.2 ( 6.8- 15.0) ∼
West South Central 4.7 ( 4.3- 5.1) 4.4 ( 4.0- 4.8) 7.2 ( 5.8- 8.8) 2.0 ( 1.4- 3.0)
Arkansas 5.6 ( 4.4- 7.1) 5.1 ( 3.8- 6.7) ∼ ∼
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Table 2.20.1.2M: Oral Cavity and Pharynx. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 6.5 ( 5.4- 7.8) 6.2 ( 4.9- 7.7) 7.9 ( 5.4- 11.2) ∼
Oklahoma 3.6 ( 2.7- 4.7) 3.8 ( 2.9- 5.0) ∼ ∼
Texas 4.4 ( 3.9- 4.9) 4.1 ( 3.6- 4.6) 6.9 ( 5.1- 9.4) 2.0 ( 1.4- 3.0)
West 3.9 ( 3.7- 4.2) 3.9 ( 3.7- 4.2) 5.2 ( 3.9- 7.0) 2.6 ( 2.0- 3.4)
Mountain 3.5 ( 3.1- 3.9) 3.5 ( 3.0- 3.9) ∼ 1.8 ( 1.0- 3.2)
Arizona 3.8 ( 3.1- 4.7) 3.9 ( 3.1- 4.8) ∼ ∼
Colorado 3.1 ( 2.3- 4.1) 3.1 ( 2.3- 4.2) ∼ ∼
Idaho 4.1 ( 2.6- 6.2) 4.1 ( 2.6- 6.3) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 5.4 ( 3.9- 7.3) 5.6 ( 4.1- 7.7) ∼ ∼
New Mexico 3.3 ( 2.2- 4.9) 2.9 ( 1.9- 4.5) ∼ ∼
Utah 2.3 ( 1.3- 3.8) 2.2 ( 1.3- 3.7) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 4.1 ( 3.8- 4.4) 4.1 ( 3.8- 4.5) 5.2 ( 3.8- 7.1) 3.0 ( 2.2- 3.9)
Alaska ∼ ∼ ∼ ∼
California 4.2 ( 3.8- 4.5) 4.2 ( 3.8- 4.6) 5.4 ( 3.9- 7.5) 3.0 ( 2.2- 4.0)
Hawaii 4.0 ( 2.6- 6.0) ∼ ∼ ∼
Oregon 3.8 ( 2.9- 4.9) 3.8 ( 2.9- 4.9) ∼ ∼
Washington 4.2 ( 3.4- 5.1) 4.3 ( 3.5- 5.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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188 Table 2.20.1.2F: Oral Cavity and Pharynx. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 1.5 ( 1.5- 1.6) 1.5 ( 1.4- 1.6) 1.7 ( 1.5- 1.9) 0.7 ( 0.5- 0.9)
Northeast 1.4 ( 1.2- 1.5) 1.3 ( 1.2- 1.5) 1.4 ( 1.0- 1.9) ∼
New England 1.4 ( 1.2- 1.7) 1.4 ( 1.1- 1.7) ∼ ∼
Connecticut 0.9 ( 0.5- 1.4) 0.9 ( 0.6- 1.5) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 1.4 ( 1.1- 1.9) 1.3 ( 1.0- 1.8) ∼ ∼
New Hampshire 2.8 ( 1.7- 4.4) 2.8 ( 1.7- 4.5) ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.3 ( 1.2- 1.5) 1.3 ( 1.2- 1.5) 1.4 ( 1.0- 1.9) ∼
New Jersey 1.5 ( 1.2- 1.9) 1.4 ( 1.1- 1.8) ∼ ∼
New York 1.3 ( 1.1- 1.5) 1.3 ( 1.1- 1.6) 1.4 ( 0.9- 2.1) ∼
Pennsylvania 1.3 ( 1.0- 1.5) 1.2 ( 1.0- 1.5) ∼ ∼
Midwest 1.4 ( 1.3- 1.6) 1.4 ( 1.3- 1.6) 1.6 ( 1.2- 2.1) ∼
East North Central 1.5 ( 1.3- 1.6) 1.4 ( 1.3- 1.6) 1.8 ( 1.3- 2.4) ∼
Illinois 1.5 ( 1.2- 1.8) 1.4 ( 1.1- 1.7) 2.2 ( 1.4- 3.5) ∼
Indiana 1.1 ( 0.8- 1.6) 1.1 ( 0.8- 1.5) ∼ ∼
Michigan 1.4 ( 1.1- 1.8) 1.5 ( 1.2- 1.9) ∼ ∼
Ohio 1.5 ( 1.2- 1.8) 1.5 ( 1.2- 1.8) ∼ ∼
Wisconsin 1.7 ( 1.3- 2.3) 1.7 ( 1.2- 2.2) ∼ ∼
West North Central 1.4 ( 1.2- 1.6) 1.4 ( 1.2- 1.7) ∼ ∼
Iowa 1.3 ( 0.8- 2.0) 1.2 ( 0.7- 1.8) ∼ ∼
Kansas 1.2 ( 0.7- 1.9) 1.3 ( 0.8- 2.1) ∼ ∼
Minnesota 1.5 ( 1.1- 2.1) 1.6 ( 1.1- 2.1) ∼ ∼
Missouri 1.3 ( 0.9- 1.7) 1.4 ( 1.0- 1.9) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 1.6 ( 1.5- 1.7) 1.6 ( 1.5- 1.7) 1.9 ( 1.6- 2.2) 0.8 ( 0.5- 1.1)
South Atlantic 1.7 ( 1.6- 1.8) 1.6 ( 1.4- 1.8) 2.1 ( 1.7- 2.5) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.6 ( 1.4- 1.8) 1.5 ( 1.3- 1.8) 1.6 ( 0.9- 2.6) ∼
Georgia 2.1 ( 1.6- 2.6) 1.8 ( 1.4- 2.4) 2.7 ( 1.7- 4.0) ∼
Maryland 2.0 ( 1.5- 2.5) 2.0 ( 1.4- 2.7) ∼ ∼
North Carolina 1.7 ( 1.3- 2.1) 1.7 ( 1.3- 2.2) ∼ ∼
South Carolina 1.4 ( 1.0- 2.0) 1.2 ( 0.7- 1.9) ∼ ∼
Virginia 1.6 ( 1.2- 2.0) 1.5 ( 1.1- 2.0) ∼ ∼
West Virginia 1.4 ( 0.8- 2.3) 1.3 ( 0.8- 2.3) ∼ ∼
East South Central 1.6 ( 1.4- 1.9) 1.5 ( 1.3- 1.8) 1.9 ( 1.3- 2.8) ∼
Alabama 1.6 ( 1.2- 2.2) 1.6 ( 1.1- 2.3) ∼ ∼
Kentucky 1.5 ( 1.1- 2.1) 1.4 ( 1.0- 2.1) ∼ ∼
Mississippi 1.5 ( 0.9- 2.2) 1.7 ( 1.0- 2.7) ∼ ∼
Tennessee 1.7 ( 1.3- 2.2) 1.5 ( 1.1- 2.0) ∼ ∼
West South Central 1.5 ( 1.4- 1.7) 1.6 ( 1.4- 1.8) 1.3 ( 0.8- 1.9) 0.9 ( 0.5- 1.4)
Arkansas 1.4 ( 0.9- 2.1) 1.6 ( 1.0- 2.4) ∼ ∼
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Table 2.20.1.2F: Oral Cavity and Pharynx. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 1.8 ( 1.3- 2.4) 2.0 ( 1.4- 2.8) ∼ ∼
Oklahoma 1.4 ( 0.9- 2.1) 1.4 ( 0.9- 2.1) ∼ ∼
Texas 1.5 ( 1.3- 1.8) 1.6 ( 1.3- 1.9) ∼ 0.9 ( 0.5- 1.5)
West 1.7 ( 1.5- 1.8) 1.7 ( 1.5- 1.8) 1.9 ( 1.3- 2.8) 0.6 ( 0.4- 0.9)
Mountain 1.3 ( 1.0- 1.5) 1.3 ( 1.1- 1.5) ∼ ∼
Arizona 1.0 ( 0.6- 1.4) 1.0 ( 0.7- 1.5) ∼ ∼
Colorado 1.0 ( 0.6- 1.6) 1.1 ( 0.7- 1.6) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 1.7 ( 1.0- 2.7) 1.8 ( 1.0- 2.9) ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.9 ( 1.7- 2.0) 1.8 ( 1.6- 2.0) 2.3 ( 1.5- 3.3) 0.6 ( 0.3- 1.0)
Alaska ∼ ∼ ∼ ∼
California 1.8 ( 1.6- 2.0) 1.8 ( 1.6- 2.0) 2.2 ( 1.4- 3.3) 0.6 ( 0.4- 1.0)
Hawaii 2.5 ( 1.5- 4.1) ∼ ∼ ∼
Oregon 1.9 ( 1.3- 2.6) 1.9 ( 1.4- 2.7) ∼ ∼
Washington 2.0 ( 1.5- 2.6) 1.9 ( 1.4- 2.5) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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190 Table 2.21.1.1: Ovary. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 13.1 ( 12.9- 13.2) 13.5 ( 13.3- 13.7) 9.8 ( 9.3- 10.4) 11.0 ( 10.3- 11.6)
Northeast 13.9 ( 13.5- 14.3) 14.4 ( 14.0- 14.9) 9.8 ( 8.7- 10.9) 9.3 ( 7.9- 10.8)
New England 12.9 ( 12.1- 13.7) 13.2 ( 12.4- 14.0) 7.8 ( 5.1- 11.6) 7.8 ( 4.5- 13.0)
Connecticut 12.1 ( 10.6- 13.7) 12.5 ( 10.9- 14.3) ∼ ∼
Maine 12.0 ( 9.7- 14.8) 11.9 ( 9.6- 14.7) ∼ ∼
Massachusetts 14.0 ( 12.9- 15.3) 14.4 ( 13.2- 15.8) ∼ ∼
New Hampshire 11.9 ( 9.5- 14.8) 11.8 ( 9.4- 14.8) ∼ -
Rhode Island 12.0 ( 9.4- 15.2) 12.4 ( 9.6- 15.7) ∼ ∼
Vermont 11.3 ( 8.0- 15.6) 11.4 ( 8.1- 15.8) ∼ ∼
Middle Atlantic 14.3 ( 13.8- 14.8) 14.9 ( 14.4- 15.5) 10.0 ( 8.9- 11.2) 9.5 ( 8.1- 11.2)
New Jersey 15.0 ( 13.9- 16.1) 15.9 ( 14.7- 17.2) 9.9 ( 7.5- 12.9) 12.0 ( 8.7- 16.2)
New York 14.4 ( 13.7- 15.1) 15.2 ( 14.4- 16.1) 10.2 ( 8.7- 11.8) 8.8 ( 7.2- 10.8)
Pennsylvania 13.6 ( 12.8- 14.5) 13.9 ( 13.0- 14.9) 9.6 ( 7.3- 12.3) -
Midwest 12.8 ( 12.4- 13.2) 13.1 ( 12.7- 13.5) 9.3 ( 8.2- 10.5) 8.7 ( 6.7- 11.3)
East North Central 12.9 ( 12.4- 13.3) 13.2 ( 12.7- 13.7) 9.5 ( 8.4- 10.8) 9.1 ( 6.8- 12.1)
Illinois 13.3 ( 12.5- 14.2) 13.8 ( 12.8- 14.8) 9.8 ( 7.9- 12.2) 9.6 ( 6.6- 13.8)
Indiana 12.0 ( 10.9- 13.3) 12.4 ( 11.2- 13.8) ∼ ∼
Michigan 13.2 ( 12.2- 14.2) 13.5 ( 12.5- 14.6) 11.1 ( 8.7- 14.0) ∼
Detroit 13.5 ( 12.1- 15.2) 14.6 ( 12.9- 16.6) 10.7 ( 7.9- 14.0) -
Ohio 12.3 ( 11.5- 13.2) 12.5 ( 11.6- 13.5) 9.0 ( 6.8- 11.7) ∼
Wisconsin 13.4 ( 12.1- 14.8) 13.5 ( 12.2- 15.0) ∼ -
West North Central 12.6 ( 11.9- 13.3) 12.8 ( 12.1- 13.6) 8.0 ( 5.6- 11.2) ∼
Iowa 12.1 ( 10.5- 13.9) 12.2 ( 10.6- 14.0) ∼ ∼
Kansas 13.1 ( 11.3- 15.2) 13.3 ( 11.4- 15.4) ∼ ∼
Minnesota 13.3 ( 11.9- 14.7) 13.3 ( 11.9- 14.8) ∼ ∼
Missouri 12.4 ( 11.2- 13.7) 12.9 ( 11.6- 14.2) 7.9 ( 5.0- 12.0) ∼
Nebraska 11.4 ( 9.4- 13.9) 11.7 ( 9.6- 14.2) ∼ ∼
North Dakota 12.6 ( 9.3- 17.0) 12.8 ( 9.3- 17.3) ∼ ∼
South Dakota
South
South Atlantic
Delaware 12.8 ( 9.7- 16.6) 12.9 ( 9.6- 17.3) ∼ ∼
District of Columbia 12.2 ( 8.7- 16.9) ∼ 11.8 ( 7.7- 18.1) ∼
Florida 13.3 ( 12.6- 14.0) 13.7 ( 12.9- 14.5) 11.4 ( 9.4- 13.7) -
Georgia 13.2 ( 12.1- 14.4) 13.8 ( 12.5- 15.2) 11.6 ( 9.5- 14.0) ∼
Atlanta 13.5 ( 11.5- 15.8) 14.2 ( 11.8- 17.0) 11.9 ( 8.5- 16.5) ∼
Maryland 11.3 ( 10.2- 12.6) 12.6 ( 11.1- 14.2) 7.7 ( 5.7- 10.1) ∼
North Carolina 12.2 ( 11.2- 13.3) 12.4 ( 11.3- 13.6) 10.8 ( 8.7- 13.3) ∼
South Carolina 12.8 ( 11.3- 14.3) 13.1 ( 11.4- 15.0) 11.5 ( 8.9- 14.6) -
Virginia
West Virginia 13.8 ( 11.7- 16.2) 13.9 ( 11.8- 16.4) ∼ ∼
East South Central
Alabama 14.3 ( 12.9- 15.9) 15.6 ( 13.9- 17.4) 10.2 ( 7.7- 13.3) ∼
Kentucky 12.5 ( 11.1- 14.1) 12.6 ( 11.1- 14.2) 11.8 ( 6.8- 19.1) -
Mississippi
Tennessee
continued
C
ancer Incidence and M
ortality by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
191
Table 2.21.1.1: Ovary. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 11.9 ( 10.6- 13.4) 12.6 ( 11.0- 14.5) 10.4 ( 8.0- 13.3) ∼
Oklahoma 12.4 ( 10.9- 14.1) 12.8 ( 11.1- 14.7) ∼ ∼
Texas 11.4 ( 10.7- 12.1) 11.6 ( 10.9- 12.3) 10.5 ( 8.5- 12.7) 10.2 ( 8.9- 11.7)
West 13.3 ( 12.9- 13.7) 14.0 ( 13.5- 14.4) 6.7 ( 5.4- 8.3) 12.2 ( 11.2- 13.3)
Mountain 12.9 ( 12.1- 13.6) 13.2 ( 12.4- 14.0) ∼ 13.2 ( 11.1- 15.7)
Arizona 12.3 ( 11.1- 13.7) 12.6 ( 11.2- 14.0) ∼ 16.4 ( 12.3- 21.7)
Colorado 13.1 ( 11.6- 14.7) 13.4 ( 11.8- 15.1) ∼ 12.2 ( 8.0- 18.1)
Idaho 11.9 ( 9.4- 14.8) 12.1 ( 9.6- 15.2) ∼ ∼
Montana 15.1 ( 12.0- 19.0) 15.5 ( 12.2- 19.6) ∼ ∼
Nevada 14.4 ( 12.2- 16.9) 15.0 ( 12.6- 17.8) ∼ ∼
New Mexico 11.9 ( 9.9- 14.3) 12.3 ( 10.1- 14.9) ∼ 11.9 ( 8.4- 16.5)
Utah 13.3 ( 11.0- 15.9) 13.8 ( 11.4- 16.5) ∼ ∼
Wyoming
Pacific 13.5 ( 13.0- 14.0) 14.3 ( 13.8- 14.9) 7.1 ( 5.6- 8.8) 11.9 ( 10.7- 13.2)
Alaska 12.0 ( 7.8- 18.0) 12.3 ( 7.7- 19.4) ∼ ∼
California 13.1 ( 12.6- 13.7) 14.1 ( 13.5- 14.8) 6.9 ( 5.4- 8.7) 11.8 ( 10.6- 13.1)
San Francisco-Oakland 13.6 ( 12.1- 15.2) 14.9 ( 13.0- 17.0) ∼ 12.8 ( 8.6- 18.6)
San Jose-Monterey 14.0 ( 11.9- 16.3) 14.5 ( 12.1- 17.3) ∼ 10.0 ( 6.0- 16.4)
Los Angeles 13.0 ( 12.0- 14.1) 14.4 ( 13.2- 15.8) 7.3 ( 5.1- 10.2) 13.9 ( 11.9- 16.2)
Hawaii 12.6 ( 10.1- 15.6) 11.9 ( 7.4- 19.2) ∼ -
Oregon 13.1 ( 11.5- 14.8) 12.9 ( 11.3- 14.7) ∼ ∼
Washington 16.0 ( 14.6- 17.5) 16.3 ( 14.8- 17.9) ∼ 21.6 ( 12.3- 36.8)
Seattle-Puget Sound 15.7 ( 14.1- 17.5) 16.3 ( 14.5- 18.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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192 Table 2.21.1.2: Ovary. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 9.0 ( 8.9- 9.2) 9.4 ( 9.2- 9.5) 7.4 ( 7.0- 7.9) 6.0 ( 5.6- 6.6)
Northeast 9.3 ( 8.9- 9.6) 9.6 ( 9.3- 10.0) 7.0 ( 6.1- 8.0) 5.2 ( 4.1- 6.4)
New England 9.4 ( 8.7- 10.0) 9.6 ( 8.9- 10.3) 7.0 ( 4.3- 10.9) ∼
Connecticut 8.4 ( 7.2- 9.8) 8.7 ( 7.4- 10.2) ∼ ∼
Maine 11.1 ( 9.0- 13.8) 11.1 ( 8.9- 13.8) ∼ ∼
Massachusetts 9.7 ( 8.7- 10.8) 9.9 ( 8.9- 11.0) ∼ ∼
New Hampshire 9.2 ( 7.1- 11.8) 9.2 ( 7.1- 11.8) ∼ ∼
Rhode Island 8.3 ( 6.2- 10.9) 8.4 ( 6.3- 11.2) ∼ ∼
Vermont 9.8 ( 6.9- 14.0) 9.9 ( 6.9- 14.1) ∼ ∼
Middle Atlantic 9.2 ( 8.9- 9.6) 9.6 ( 9.2- 10.1) 7.0 ( 6.1- 8.1) 5.3 ( 4.2- 6.6)
New Jersey 10.1 ( 9.3- 11.0) 10.4 ( 9.5- 11.4) 9.4 ( 7.0- 12.4) ∼
New York 8.8 ( 8.3- 9.4) 9.4 ( 8.8- 10.1) 6.4 ( 5.2- 7.8) 5.8 ( 4.4- 7.6)
Pennsylvania 9.2 ( 8.6- 9.9) 9.5 ( 8.8- 10.2) 6.6 ( 4.8- 9.0) ∼
Midwest 9.2 ( 8.9- 9.6) 9.5 ( 9.2- 9.9) 6.7 ( 5.8- 7.8) 6.9 ( 4.9- 9.5)
East North Central 9.3 ( 8.9- 9.7) 9.6 ( 9.2- 10.1) 6.9 ( 5.9- 8.0) 6.3 ( 4.3- 9.1)
Illinois 8.9 ( 8.2- 9.6) 9.4 ( 8.6- 10.2) 6.8 ( 5.1- 8.8) 6.9 ( 4.2- 10.9)
Indiana 10.2 ( 9.1- 11.3) 10.4 ( 9.3- 11.6) 7.5 ( 4.3- 12.1) ∼
Michigan 9.6 ( 8.8- 10.4) 9.9 ( 9.1- 10.9) 7.0 ( 5.1- 9.4) ∼
Ohio 9.0 ( 8.3- 9.7) 9.2 ( 8.5- 10.1) 7.1 ( 5.1- 9.5) ∼
Wisconsin 9.5 ( 8.4- 10.7) 9.8 ( 8.7- 11.0) ∼ ∼
West North Central 9.1 ( 8.5- 9.7) 9.3 ( 8.7- 9.9) 6.0 ( 3.9- 8.9) ∼
Iowa 9.9 ( 8.5- 11.5) 10.0 ( 8.6- 11.6) ∼ ∼
Kansas 9.3 ( 7.8- 10.9) 9.4 ( 7.9- 11.1) ∼ ∼
Minnesota 8.7 ( 7.6- 9.9) 8.9 ( 7.8- 10.2) ∼ ∼
Missouri 8.8 ( 7.9- 9.9) 9.2 ( 8.1- 10.4) 6.4 ( 3.8- 10.2) ∼
Nebraska 8.9 ( 7.1- 11.0) 9.1 ( 7.3- 11.3) ∼ ∼
North Dakota 7.2 ( 4.8- 10.6) 6.9 ( 4.5- 10.3) ∼ ∼
South Dakota 10.9 ( 8.1- 14.5) 11.3 ( 8.4- 15.1) ∼ ∼
South 8.7 ( 8.5- 8.9) 9.0 ( 8.7- 9.2) 7.9 ( 7.3- 8.5) 6.1 ( 5.3- 6.9)
South Atlantic 8.8 ( 8.5- 9.2) 9.1 ( 8.7- 9.5) 7.8 ( 7.0- 8.6) 5.3 ( 4.3- 6.6)
Delaware 7.5 ( 5.2- 10.5) 7.9 ( 5.3- 11.4) ∼ ∼
District of Columbia 9.2 ( 6.2- 13.5) ∼ 8.6 ( 5.1- 14.3) ∼
Florida 8.7 ( 8.1- 9.2) 8.9 ( 8.3- 9.5) 7.9 ( 6.2- 9.9) 5.9 ( 4.7- 7.3)
Georgia 8.8 ( 7.9- 9.8) 9.1 ( 8.1- 10.3) 7.7 ( 6.0- 9.8) ∼
Maryland 9.2 ( 8.1- 10.3) 9.8 ( 8.5- 11.2) 7.7 ( 5.7- 10.3) ∼
North Carolina 9.3 ( 8.5- 10.2) 9.7 ( 8.7- 10.8) 7.8 ( 6.0- 10.0) ∼
South Carolina 8.0 ( 6.9- 9.2) 8.3 ( 7.0- 9.8) 6.9 ( 4.9- 9.5) ∼
Virginia 8.7 ( 7.8- 9.7) 9.0 ( 8.0- 10.1) 8.0 ( 6.0- 10.5) ∼
West Virginia 10.7 ( 8.9- 12.8) 10.5 ( 8.7- 12.6) ∼ ∼
East South Central 9.1 ( 8.5- 9.7) 9.3 ( 8.7- 10.0) 8.3 ( 6.9- 9.9) ∼
Alabama 9.2 ( 8.1- 10.4) 9.5 ( 8.2- 10.9) 8.4 ( 6.1- 11.2) ∼
Kentucky 9.4 ( 8.2- 10.7) 9.5 ( 8.3- 11.0) ∼ ∼
Mississippi 8.5 ( 7.1- 10.0) 8.1 ( 6.5- 10.0) 9.7 ( 7.0- 13.1) ∼
Tennessee 9.1 ( 8.1- 10.2) 9.5 ( 8.4- 10.7) 6.9 ( 4.5- 10.1) ∼
West South Central 8.3 ( 7.8- 8.7) 8.5 ( 8.0- 9.0) 7.7 ( 6.5- 9.1) 6.6 ( 5.5- 7.9)
Arkansas 9.1 ( 7.7- 10.7) 9.0 ( 7.5- 10.7) 10.8 ( 6.5- 16.9) ∼
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Table 2.21.1.2: Ovary. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 7.8 ( 6.7- 8.9) 8.2 ( 6.9- 9.6) 6.6 ( 4.8- 9.0) ∼
Oklahoma 8.5 ( 7.3- 9.9) 8.9 ( 7.6- 10.4) ∼ ∼
Texas 8.2 ( 7.6- 8.8) 8.4 ( 7.8- 9.0) 7.7 ( 6.1- 9.7) 6.8 ( 5.7- 8.1)
West 9.1 ( 8.8- 9.4) 9.6 ( 9.3- 10.0) 7.2 ( 5.8- 8.8) 6.2 ( 5.5- 7.1)
Mountain 9.1 ( 8.5- 9.7) 9.3 ( 8.7- 10.0) ∼ 5.5 ( 4.1- 7.2)
Arizona 8.3 ( 7.3- 9.4) 8.5 ( 7.5- 9.7) ∼ 6.5 ( 3.9- 10.4)
Colorado 10.1 ( 8.7- 11.5) 10.4 ( 9.0- 11.9) ∼ ∼
Idaho 9.3 ( 7.2- 12.0) 9.2 ( 7.0- 11.9) ∼ ∼
Montana 11.6 ( 8.9- 15.0) 12.1 ( 9.3- 15.6) ∼ ∼
Nevada 9.4 ( 7.6- 11.5) 9.6 ( 7.8- 11.9) ∼ ∼
New Mexico 7.2 ( 5.6- 9.1) 7.5 ( 5.8- 9.5) ∼ ∼
Utah 8.2 ( 6.4- 10.3) 8.5 ( 6.7- 10.7) ∼ ∼
Wyoming 12.7 ( 8.8- 17.9) 12.6 ( 8.7- 18.0) ∼ ∼
Pacific 9.1 ( 8.7- 9.5) 9.8 ( 9.3- 10.2) 7.1 ( 5.6- 8.9) 6.5 ( 5.6- 7.5)
Alaska 7.8 ( 4.3- 13.2) ∼ ∼ ∼
California 8.8 ( 8.4- 9.3) 9.4 ( 8.9- 10.0) 6.9 ( 5.4- 8.8) 6.6 ( 5.7- 7.7)
Hawaii 6.0 ( 4.4- 8.2) 9.7 ( 5.6- 16.5) ∼ ∼
Oregon 10.3 ( 9.0- 11.9) 10.7 ( 9.3- 12.3) ∼ ∼
Washington 10.7 ( 9.6- 12.0) 11.0 ( 9.8- 12.3) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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194 Table 2.22.1.1M: Pancreas. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 12.3 ( 12.1- 12.5) 12.1 ( 11.9- 12.3) 15.1 ( 14.3- 15.9) 10.8 ( 10.1- 11.7)
Northeast 13.4 ( 13.0- 13.9) 13.3 ( 12.8- 13.8) 15.4 ( 13.6- 17.3) 9.6 ( 7.8- 11.8)
New England 13.2 ( 12.3- 14.1) 13.0 ( 12.1- 13.9) 19.2 ( 13.4- 27.4) 11.0 ( 5.8- 19.9)
Connecticut 14.6 ( 12.8- 16.6) 14.3 ( 12.4- 16.3) 24.5 ( 15.0- 40.5) ∼
Maine 13.8 ( 11.1- 17.0) 13.9 ( 11.2- 17.2) ∼ ∼
Massachusetts 13.0 ( 11.7- 14.4) 12.8 ( 11.5- 14.3) 15.5 ( 8.3- 27.6) ∼
New Hampshire 10.9 ( 8.3- 14.3) 11.1 ( 8.4- 14.5) ∼ -
Rhode Island 11.3 ( 8.5- 14.8) 10.9 ( 8.1- 14.4) ∼ ∼
Vermont 13.4 ( 9.5- 18.6) 13.6 ( 9.6- 18.8) ∼ ∼
Middle Atlantic 13.5 ( 13.0- 14.0) 13.4 ( 12.8- 13.9) 14.9 ( 13.1- 16.9) 9.4 ( 7.5- 11.7)
New Jersey 13.1 ( 12.0- 14.4) 13.1 ( 11.9- 14.5) 14.9 ( 10.9- 20.2) 10.3 ( 6.6- 16.0)
New York 13.8 ( 13.0- 14.6) 13.7 ( 12.9- 14.6) 13.8 ( 11.6- 16.6) 9.1 ( 6.9- 12.0)
Pennsylvania 13.3 ( 12.4- 14.3) 13.1 ( 12.1- 14.0) 17.5 ( 13.6- 22.5) -
Midwest 12.1 ( 11.7- 12.5) 11.8 ( 11.4- 12.2) 16.0 ( 14.2- 17.9) 9.5 ( 7.0- 13.1)
East North Central 12.6 ( 12.1- 13.1) 12.3 ( 11.7- 12.8) 16.2 ( 14.3- 18.3) 9.5 ( 6.7- 13.6)
Illinois 13.5 ( 12.5- 14.6) 12.9 ( 11.9- 14.0) 19.1 ( 15.6- 23.4) 8.4 ( 4.9- 14.3)
Indiana 12.9 ( 11.5- 14.4) 12.5 ( 11.1- 14.0) 19.4 ( 12.9- 28.5) ∼
Michigan 12.8 ( 11.8- 13.9) 12.5 ( 11.4- 13.7) 15.2 ( 11.8- 19.5) ∼
Detroit 15.6 ( 13.8- 17.6) 15.7 ( 13.6- 18.0) 15.3 ( 11.4- 20.4) -
Ohio 11.2 ( 10.3- 12.2) 11.0 ( 10.0- 12.0) 12.9 ( 9.7- 17.1) ∼
Wisconsin 12.8 ( 11.4- 14.3) 12.8 ( 11.4- 14.4) ∼ -
West North Central 11.0 ( 10.3- 11.7) 10.8 ( 10.1- 11.6) 15.0 ( 10.9- 20.5) ∼
Iowa 11.1 ( 9.5- 13.0) 11.2 ( 9.5- 13.1) ∼ ∼
Kansas 10.1 ( 8.4- 12.1) 10.2 ( 8.4- 12.2) ∼ ∼
Minnesota 9.5 ( 8.3- 10.9) 9.0 ( 7.8- 10.4) ∼ ∼
Missouri 12.1 ( 10.8- 13.6) 12.0 ( 10.7- 13.5) 14.6 ( 9.6- 21.9) ∼
Nebraska 12.4 ( 10.1- 15.2) 12.6 ( 10.2- 15.4) ∼ ∼
North Dakota 10.1 ( 6.9- 14.4) 10.4 ( 7.1- 14.8) ∼ ∼
South Dakota
South
South Atlantic
Delaware 10.9 ( 7.8- 15.1) 9.4 ( 6.3- 13.7) ∼ ∼
District of Columbia 16.4 ( 11.5- 22.9) ∼ 18.0 ( 11.6- 27.0) ∼
Florida 12.0 ( 11.3- 12.8) 12.0 ( 11.2- 12.7) 12.3 ( 9.7- 15.4) -
Georgia 12.5 ( 11.2- 14.0) 11.8 ( 10.4- 13.4) 15.4 ( 12.3- 19.3) ∼
Atlanta 12.7 ( 10.2- 15.6) 12.6 ( 9.7- 16.1) 12.9 ( 8.3- 20.4) ∼
Maryland 12.4 ( 11.0- 14.0) 12.5 ( 10.8- 14.3) 13.0 ( 9.7- 17.4) ∼
North Carolina 11.5 ( 10.4- 12.8) 10.8 ( 9.6- 12.1) 16.0 ( 12.7- 20.2) ∼
South Carolina 12.4 ( 10.7- 14.4) 11.4 ( 9.6- 13.6) 15.5 ( 11.7- 20.5) -
Virginia
West Virginia 10.2 ( 8.2- 12.5) 10.0 ( 8.0- 12.5) ∼ ∼
East South Central
Alabama 11.3 ( 9.8- 12.9) 10.6 ( 9.1- 12.4) 14.6 ( 10.9- 19.4) ∼
Kentucky 11.9 ( 10.3- 13.7) 11.6 ( 10.0- 13.4) ∼ -
Mississippi
Tennessee
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Table 2.22.1.1M: Pancreas. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 15.4 ( 13.6- 17.4) 14.1 ( 12.1- 16.3) 20.7 ( 16.4- 25.8) ∼
Oklahoma 11.7 ( 10.1- 13.6) 11.8 ( 10.0- 13.8) ∼ ∼
Texas 11.8 ( 11.0- 12.6) 11.6 ( 10.8- 12.4) 14.1 ( 11.2- 17.5) 11.5 ( 9.8- 13.5)
West 11.8 ( 11.3- 12.2) 11.9 ( 11.5- 12.4) 12.5 ( 10.3- 15.0) 11.1 ( 9.8- 12.5)
Mountain 11.6 ( 10.8- 12.4) 11.7 ( 10.9- 12.5) 12.0 ( 7.2- 20.4) 13.3 ( 10.7- 16.5)
Arizona 10.8 ( 9.5- 12.2) 10.8 ( 9.5- 12.3) ∼ 12.5 ( 8.1- 19.1)
Colorado 12.2 ( 10.6- 14.1) 12.5 ( 10.8- 14.5) ∼ 14.1 ( 8.6- 22.8)
Idaho 13.6 ( 10.7- 17.1) 13.5 ( 10.6- 17.0) ∼ ∼
Montana 9.1 ( 6.5- 12.5) 9.0 ( 6.4- 12.5) ∼ ∼
Nevada 13.6 ( 11.2- 16.4) 13.6 ( 11.1- 16.6) ∼ ∼
New Mexico 10.3 ( 8.2- 12.8) 10.7 ( 8.5- 13.4) ∼ 14.8 ( 10.3- 21.0)
Utah 12.0 ( 9.6- 14.8) 12.2 ( 9.8- 15.2) ∼ ∼
Wyoming
Pacific 11.8 ( 11.4- 12.4) 12.0 ( 11.5- 12.6) 12.5 ( 10.2- 15.4) 10.3 ( 8.9- 11.8)
Alaska 13.8 ( 8.5- 22.6) 12.4 ( 7.0- 22.3) ∼ ∼
California 12.0 ( 11.4- 12.6) 12.2 ( 11.5- 12.9) 11.6 ( 9.3- 14.5) 10.4 ( 9.0- 12.0)
San Francisco-Oakland 11.2 ( 9.7- 12.9) 12.0 ( 10.2- 14.1) 10.8 ( 6.2- 18.1) 10.7 ( 6.0- 18.3)
San Jose-Monterey 10.9 ( 8.8- 13.4) 11.3 ( 8.9- 14.2) ∼ 12.3 ( 6.9- 21.9)
Los Angeles 11.5 ( 10.4- 12.8) 11.8 ( 10.4- 13.2) 10.8 ( 7.5- 15.4) 8.3 ( 6.3- 10.9)
Hawaii 9.3 ( 7.0- 12.1) ∼ ∼ -
Oregon 10.6 ( 9.0- 12.3) 10.5 ( 8.9- 12.3) ∼ ∼
Washington 12.4 ( 11.1- 13.9) 12.3 ( 10.9- 13.8) ∼ ∼
Seattle-Puget Sound 12.7 ( 11.0- 14.5) 12.6 ( 10.9- 14.5) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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196 Table 2.22.1.1F: Pancreas. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 9.5 ( 9.4- 9.7) 9.2 ( 9.0- 9.4) 12.9 ( 12.3- 13.5) 9.4 ( 8.7- 10.0)
Northeast 10.5 ( 10.2- 10.9) 10.3 ( 9.9- 10.7) 13.1 ( 11.9- 14.5) 8.3 ( 7.0- 9.9)
New England 10.2 ( 9.5- 10.9) 10.1 ( 9.4- 10.8) 12.3 ( 8.6- 17.1) 9.0 ( 5.0- 15.1)
Connecticut 9.7 ( 8.4- 11.1) 9.1 ( 7.8- 10.6) 16.4 ( 10.2- 25.3) ∼
Maine 10.2 ( 8.2- 12.8) 10.2 ( 8.2- 12.8) ∼ ∼
Massachusetts 10.6 ( 9.6- 11.7) 10.7 ( 9.6- 11.8) ∼ ∼
New Hampshire 9.9 ( 7.7- 12.6) 10.0 ( 7.8- 12.7) ∼ -
Rhode Island 11.0 ( 8.6- 13.9) 10.7 ( 8.3- 13.7) ∼ ∼
Vermont 7.6 ( 5.0- 11.3) 7.6 ( 5.1- 11.4) ∼ ∼
Middle Atlantic 10.6 ( 10.2- 11.1) 10.4 ( 9.9- 10.8) 13.2 ( 11.9- 14.7) 8.3 ( 6.8- 9.9)
New Jersey 10.7 ( 9.8- 11.6) 10.2 ( 9.3- 11.2) 15.6 ( 12.4- 19.4) 9.9 ( 6.8- 14.1)
New York 11.2 ( 10.6- 11.8) 11.3 ( 10.6- 12.0) 11.8 ( 10.2- 13.7) 8.0 ( 6.3- 10.0)
Pennsylvania 9.9 ( 9.2- 10.6) 9.3 ( 8.7- 10.1) 15.2 ( 12.3- 18.6) -
Midwest 9.4 ( 9.1- 9.7) 8.9 ( 8.6- 9.2) 14.5 ( 13.2- 16.0) 8.0 ( 5.8- 10.7)
East North Central 9.8 ( 9.4- 10.1) 9.2 ( 8.8- 9.6) 14.7 ( 13.2- 16.3) 8.9 ( 6.4- 12.3)
Illinois 10.5 ( 9.7- 11.3) 9.9 ( 9.1- 10.7) 15.5 ( 13.0- 18.5) 7.6 ( 4.6- 12.0)
Indiana 9.0 ( 8.1- 10.1) 8.6 ( 7.6- 9.7) 14.7 ( 10.1- 20.9) ∼
Michigan 10.0 ( 9.2- 10.9) 9.2 ( 8.4- 10.1) 15.8 ( 12.8- 19.3) ∼
Detroit 11.6 ( 10.2- 13.1) 10.5 ( 9.0- 12.1) 15.7 ( 12.3- 19.7) -
Ohio 8.9 ( 8.2- 9.7) 8.6 ( 7.8- 9.3) 11.9 ( 9.3- 14.9) ∼
Wisconsin 10.3 ( 9.2- 11.5) 9.9 ( 8.9- 11.1) 19.3 ( 11.1- 31.6) -
West North Central 8.5 ( 7.9- 9.0) 8.2 ( 7.7- 8.8) 13.7 ( 10.4- 17.8) ∼
Iowa 9.1 ( 7.7- 10.6) 8.7 ( 7.4- 10.2) ∼ ∼
Kansas 9.1 ( 7.6- 10.7) 8.7 ( 7.2- 10.3) ∼ ∼
Minnesota 7.9 ( 6.9- 9.1) 7.6 ( 6.6- 8.7) ∼ ∼
Missouri 8.3 ( 7.4- 9.4) 8.2 ( 7.2- 9.3) 10.9 ( 7.3- 15.6) ∼
Nebraska 8.4 ( 6.7- 10.5) 8.4 ( 6.7- 10.5) ∼ ∼
North Dakota 8.7 ( 6.0- 12.3) 8.5 ( 5.8- 12.1) ∼ ∼
South Dakota
South
South Atlantic
Delaware 6.6 ( 4.5- 9.5) 7.0 ( 4.7- 10.4) ∼ ∼
District of Columbia 12.0 ( 8.6- 16.7) ∼ 12.9 ( 8.6- 19.4) ∼
Florida 8.4 ( 7.8- 8.9) 8.1 ( 7.6- 8.7) 10.4 ( 8.4- 12.7) -
Georgia 9.7 ( 8.8- 10.8) 8.9 ( 7.9- 10.0) 12.7 ( 10.4- 15.3) ∼
Atlanta 9.9 ( 8.1- 11.9) 8.2 ( 6.3- 10.5) 15.0 ( 10.7- 20.5) ∼
Maryland 9.8 ( 8.7- 11.0) 9.9 ( 8.7- 11.4) 10.8 ( 8.3- 13.9) ∼
North Carolina 7.7 ( 6.9- 8.6) 7.2 ( 6.3- 8.1) 10.2 ( 8.2- 12.7) ∼
South Carolina 9.8 ( 8.6- 11.2) 8.2 ( 6.9- 9.6) 15.2 ( 12.1- 18.8) -
Virginia
West Virginia 7.0 ( 5.6- 8.7) 7.1 ( 5.7- 8.9) ∼ ∼
East South Central
Alabama 8.6 ( 7.6- 9.8) 8.2 ( 7.0- 9.6) 10.4 ( 7.9- 13.5) ∼
Kentucky 9.3 ( 8.1- 10.6) 9.3 ( 8.1- 10.7) ∼ -
Mississippi
Tennessee
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Table 2.22.1.1F: Pancreas. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 10.8 ( 9.5- 12.2) 9.4 ( 8.1- 11.0) 14.6 ( 11.7- 18.0) ∼
Oklahoma 9.1 ( 7.9- 10.5) 8.7 ( 7.4- 10.2) 22.3 ( 14.0- 34.0) ∼
Texas 8.9 ( 8.4- 9.5) 8.6 ( 8.0- 9.2) 12.0 ( 9.9- 14.4) 8.4 ( 7.1- 9.9)
West 9.6 ( 9.3- 10.0) 9.5 ( 9.2- 9.9) 13.6 ( 11.7- 15.9) 10.8 ( 9.7- 11.9)
Mountain 8.8 ( 8.3- 9.5) 8.7 ( 8.1- 9.3) 12.8 ( 8.0- 19.7) 9.6 ( 7.7- 11.9)
Arizona 8.3 ( 7.3- 9.4) 8.1 ( 7.1- 9.2) ∼ 7.3 ( 4.6- 11.3)
Colorado 9.1 ( 7.9- 10.5) 9.0 ( 7.7- 10.4) ∼ 13.7 ( 8.7- 20.7)
Idaho 10.0 ( 7.8- 12.7) 9.9 ( 7.7- 12.6) ∼ ∼
Montana 6.8 ( 4.8- 9.5) 6.3 ( 4.3- 9.0) ∼ ∼
Nevada 11.5 ( 9.5- 13.8) 11.2 ( 9.2- 13.7) ∼ ∼
New Mexico 8.5 ( 6.7- 10.5) 8.7 ( 6.8- 10.9) ∼ 10.8 ( 7.4- 15.3)
Utah 7.8 ( 6.1- 9.9) 8.0 ( 6.2- 10.1) ∼ ∼
Wyoming
Pacific 9.9 ( 9.5- 10.3) 9.9 ( 9.5- 10.4) 13.8 ( 11.7- 16.2) 11.1 ( 9.9- 12.5)
Alaska 8.2 ( 4.7- 13.7) ∼ ∼ ∼
California 9.7 ( 9.3- 10.2) 9.8 ( 9.2- 10.3) 14.0 ( 11.7- 16.6) 11.1 ( 9.9- 12.6)
San Francisco-Oakland 10.1 ( 8.8- 11.5) 9.9 ( 8.4- 11.6) 14.9 ( 10.1- 21.2) 8.3 ( 4.8- 13.5)
San Jose-Monterey 10.1 ( 8.4- 12.2) 10.9 ( 8.9- 13.4) ∼ 14.8 ( 9.1- 22.9)
Los Angeles 9.7 ( 8.8- 10.6) 9.3 ( 8.3- 10.4) 14.7 ( 11.4- 18.6) 9.6 ( 7.8- 11.7)
Hawaii 11.5 ( 9.1- 14.3) 12.6 ( 7.8- 20.2) ∼ -
Oregon 10.4 ( 9.1- 12.0) 10.5 ( 9.1- 12.1) ∼ ∼
Washington 10.4 ( 9.3- 11.6) 10.2 ( 9.1- 11.5) ∼ ∼
Seattle-Puget Sound 11.2 ( 9.8- 12.7) 11.1 ( 9.7- 12.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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198 Table 2.22.1.2M: Pancreas. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 12.2 ( 12.0- 12.4) 12.0 ( 11.8- 12.2) 15.4 ( 14.7- 16.3) 8.6 ( 7.9- 9.3)
Northeast 12.6 ( 12.1- 13.0) 12.6 ( 12.1- 13.1) 14.2 ( 12.5- 16.1) 7.3 ( 5.7- 9.3)
New England 12.9 ( 12.1- 13.9) 12.8 ( 11.9- 13.8) 18.8 ( 13.1- 26.8) ∼
Connecticut 13.4 ( 11.7- 15.4) 13.3 ( 11.5- 15.3) 19.4 ( 11.1- 34.5) ∼
Maine 12.6 ( 10.0- 15.8) 12.4 ( 9.8- 15.6) ∼ ∼
Massachusetts 13.5 ( 12.2- 15.0) 13.4 ( 12.0- 14.9) 20.2 ( 12.1- 32.8) ∼
New Hampshire 11.5 ( 8.8- 15.0) 11.5 ( 8.7- 14.9) ∼ ∼
Rhode Island 11.2 ( 8.4- 14.7) 11.7 ( 8.8- 15.4) ∼ ∼
Vermont 9.8 ( 6.5- 14.3) 9.9 ( 6.6- 14.5) ∼ ∼
Middle Atlantic 12.4 ( 11.9- 13.0) 12.5 ( 11.9- 13.1) 13.6 ( 11.9- 15.6) 6.8 ( 5.2- 8.9)
New Jersey 12.3 ( 11.2- 13.5) 12.4 ( 11.2- 13.7) 13.1 ( 9.5- 18.1) 8.6 ( 5.2- 14.1)
New York 12.3 ( 11.6- 13.1) 12.5 ( 11.7- 13.4) 13.1 ( 10.9- 15.8) 6.1 ( 4.2- 8.6)
Pennsylvania 12.6 ( 11.8- 13.6) 12.5 ( 11.6- 13.5) 15.2 ( 11.5- 20.0) ∼
Midwest 12.4 ( 12.0- 12.8) 12.2 ( 11.8- 12.7) 16.2 ( 14.4- 18.2) 8.5 ( 6.0- 12.0)
East North Central 12.6 ( 12.1- 13.1) 12.5 ( 12.0- 13.0) 15.6 ( 13.7- 17.7) 7.9 ( 5.3- 11.8)
Illinois 13.2 ( 12.2- 14.2) 13.0 ( 11.9- 14.1) 16.8 ( 13.4- 21.0) ∼
Indiana 12.8 ( 11.4- 14.3) 12.6 ( 11.2- 14.1) 17.9 ( 11.6- 26.9) ∼
Michigan 12.6 ( 11.6- 13.7) 12.6 ( 11.4- 13.8) 13.7 ( 10.5- 17.8) ∼
Ohio 11.9 ( 11.0- 12.9) 11.7 ( 10.7- 12.7) 15.4 ( 11.9- 20.0) ∼
Wisconsin 12.8 ( 11.4- 14.3) 12.8 ( 11.4- 14.4) ∼ ∼
West North Central 11.9 ( 11.2- 12.7) 11.7 ( 11.0- 12.5) 19.7 ( 14.9- 26.0) ∼
Iowa 11.7 ( 10.0- 13.7) 11.8 ( 10.1- 13.8) ∼ ∼
Kansas 11.6 ( 9.7- 13.7) 11.5 ( 9.7- 13.7) ∼ ∼
Minnesota 11.9 ( 10.5- 13.5) 11.7 ( 10.3- 13.3) ∼ ∼
Missouri 13.1 ( 11.7- 14.6) 12.4 ( 11.0- 13.9) 20.4 ( 14.5- 28.6) ∼
Nebraska 10.6 ( 8.4- 13.2) 10.6 ( 8.4- 13.3) ∼ ∼
North Dakota 10.1 ( 6.9- 14.4) 10.4 ( 7.1- 14.8) ∼ ∼
South Dakota 10.0 ( 7.1- 13.9) 10.4 ( 7.3- 14.4) ∼ ∼
South 12.2 ( 11.8- 12.5) 11.7 ( 11.4- 12.1) 15.9 ( 14.8- 17.0) 9.3 ( 8.2- 10.6)
South Atlantic 11.9 ( 11.5- 12.4) 11.4 ( 11.0- 11.9) 15.7 ( 14.3- 17.2) 9.2 ( 7.5- 11.2)
Delaware 11.7 ( 8.4- 16.1) 11.5 ( 8.0- 16.2) ∼ ∼
District of Columbia 14.5 ( 9.9- 20.7) ∼ 16.9 ( 10.7- 25.6) ∼
Florida 11.3 ( 10.6- 12.0) 11.3 ( 10.6- 12.0) 13.4 ( 10.6- 16.8) 9.1 ( 7.3- 11.3)
Georgia 12.7 ( 11.3- 14.1) 11.5 ( 10.1- 13.2) 17.4 ( 13.9- 21.6) ∼
Maryland 12.9 ( 11.4- 14.5) 12.3 ( 10.7- 14.2) 15.5 ( 11.9- 20.4) ∼
North Carolina 12.9 ( 11.7- 14.2) 12.2 ( 10.9- 13.6) 18.4 ( 14.8- 22.9) ∼
South Carolina 13.0 ( 11.3- 15.0) 12.3 ( 10.4- 14.5) 15.7 ( 11.7- 20.9) ∼
Virginia 11.7 ( 10.5- 13.1) 11.5 ( 10.1- 13.0) 14.2 ( 10.9- 18.4) ∼
West Virginia 11.0 ( 8.9- 13.5) 11.0 ( 8.9- 13.5) ∼ ∼
East South Central 12.8 ( 12.0- 13.7) 12.1 ( 11.2- 13.0) 18.1 ( 15.5- 21.1) ∼
Alabama 13.4 ( 11.8- 15.2) 12.9 ( 11.1- 14.9) 15.9 ( 11.9- 20.9) ∼
Kentucky 11.9 ( 10.3- 13.7) 11.6 ( 10.0- 13.4) 20.2 ( 11.8- 33.4) ∼
Mississippi 13.3 ( 11.3- 15.7) 11.1 ( 8.9- 13.7) 20.7 ( 15.7- 26.9) ∼
Tennessee 12.8 ( 11.4- 14.4) 12.3 ( 10.9- 14.0) 17.9 ( 12.9- 24.5) ∼
West South Central 12.2 ( 11.6- 12.9) 12.1 ( 11.4- 12.8) 14.4 ( 12.3- 16.8) 9.6 ( 8.1- 11.5)
Arkansas 12.7 ( 10.8- 14.9) 12.7 ( 10.6- 15.0) 14.2 ( 8.3- 23.1) ∼
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Table 2.22.1.2M: Pancreas. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 13.8 ( 12.1- 15.7) 13.1 ( 11.2- 15.2) 16.5 ( 12.7- 21.2) ∼
Oklahoma 11.8 ( 10.1- 13.7) 11.6 ( 9.9- 13.6) ∼ ∼
Texas 11.8 ( 11.0- 12.7) 11.8 ( 11.0- 12.7) 13.1 ( 10.4- 16.6) 9.9 ( 8.2- 11.8)
West 11.5 ( 11.1- 12.0) 11.7 ( 11.3- 12.2) 13.7 ( 11.4- 16.5) 8.4 ( 7.3- 9.6)
Mountain 11.3 ( 10.6- 12.1) 11.5 ( 10.7- 12.3) 10.2 ( 5.5- 18.8) 12.4 ( 9.9- 15.5)
Arizona 10.0 ( 8.8- 11.4) 10.1 ( 8.8- 11.5) ∼ 11.1 ( 7.1- 17.1)
Colorado 12.1 ( 10.4- 14.0) 12.5 ( 10.7- 14.5) ∼ 14.2 ( 8.7- 23.0)
Idaho 11.4 ( 8.8- 14.7) 11.6 ( 8.9- 14.9) ∼ ∼
Montana 10.1 ( 7.3- 13.6) 10.0 ( 7.2- 13.6) ∼ ∼
Nevada 13.4 ( 11.1- 16.3) 13.2 ( 10.8- 16.2) ∼ ∼
New Mexico 10.5 ( 8.4- 13.1) 11.3 ( 9.0- 14.0) ∼ 13.1 ( 8.8- 18.9)
Utah 13.3 ( 10.7- 16.3) 13.6 ( 11.0- 16.6) ∼ ∼
Wyoming 11.8 ( 7.5- 17.9) 11.5 ( 7.3- 17.6) ∼ ∼
Pacific 11.6 ( 11.1- 12.1) 11.9 ( 11.3- 12.4) 14.4 ( 11.8- 17.5) 6.9 ( 5.8- 8.2)
Alaska 11.3 ( 6.5- 19.8) 10.0 ( 5.1- 19.6) ∼ ∼
California 11.5 ( 10.9- 12.1) 11.7 ( 11.1- 12.4) 13.9 ( 11.3- 17.1) 6.9 ( 5.8- 8.2)
Hawaii 10.1 ( 7.7- 13.0) 12.6 ( 7.4- 20.5) ∼ ∼
Oregon 12.7 ( 11.0- 14.6) 12.7 ( 11.0- 14.7) ∼ ∼
Washington 11.9 ( 10.6- 13.4) 11.9 ( 10.5- 13.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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200 Table 2.22.1.2F: Pancreas. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 9.2 ( 9.0- 9.3) 8.9 ( 8.8- 9.1) 12.3 ( 11.8- 12.9) 7.5 ( 6.9- 8.0)
Northeast 9.7 ( 9.3- 10.0) 9.6 ( 9.2- 9.9) 11.0 ( 9.9- 12.3) 6.3 ( 5.1- 7.7)
New England 9.6 ( 9.0- 10.3) 9.6 ( 9.0- 10.3) 10.9 ( 7.4- 15.4) ∼
Connecticut 9.6 ( 8.3- 11.0) 9.3 ( 8.0- 10.8) 13.3 ( 7.8- 21.4) ∼
Maine 9.8 ( 7.9- 12.3) 9.9 ( 7.9- 12.4) ∼ ∼
Massachusetts 10.1 ( 9.1- 11.1) 10.2 ( 9.2- 11.3) ∼ ∼
New Hampshire 8.5 ( 6.5- 11.0) 8.6 ( 6.6- 11.2) ∼ ∼
Rhode Island 9.5 ( 7.3- 12.2) 9.4 ( 7.2- 12.3) ∼ ∼
Vermont 6.9 ( 4.5- 10.5) 6.9 ( 4.5- 10.5) ∼ ∼
Middle Atlantic 9.7 ( 9.3- 10.1) 9.6 ( 9.2- 10.0) 11.0 ( 9.8- 12.4) 6.1 ( 4.9- 7.6)
New Jersey 10.4 ( 9.5- 11.3) 10.2 ( 9.3- 11.2) 12.5 ( 9.6- 16.0) 7.1 ( 4.5- 10.7)
New York 9.8 ( 9.2- 10.4) 9.9 ( 9.3- 10.6) 10.0 ( 8.5- 11.7) 5.8 ( 4.4- 7.6)
Pennsylvania 9.2 ( 8.6- 9.9) 8.9 ( 8.2- 9.6) 12.9 ( 10.2- 16.0) ∼
Midwest 9.4 ( 9.1- 9.7) 9.1 ( 8.8- 9.4) 13.2 ( 11.9- 14.6) 5.4 ( 3.6- 7.9)
East North Central 9.6 ( 9.3- 10.0) 9.3 ( 8.9- 9.7) 13.5 ( 12.1- 15.1) 6.0 ( 3.8- 8.9)
Illinois 10.0 ( 9.2- 10.7) 9.3 ( 8.6- 10.1) 15.5 ( 12.9- 18.5) ∼
Indiana 9.8 ( 8.8- 10.9) 9.4 ( 8.4- 10.5) 16.2 ( 11.3- 22.6) ∼
Michigan 9.3 ( 8.6- 10.2) 8.9 ( 8.1- 9.8) 12.4 ( 9.8- 15.5) ∼
Ohio 9.1 ( 8.4- 9.9) 8.9 ( 8.2- 9.7) 11.0 ( 8.5- 13.9) ∼
Wisconsin 10.4 ( 9.3- 11.6) 10.3 ( 9.2- 11.5) ∼ ∼
West North Central 8.8 ( 8.3- 9.4) 8.7 ( 8.1- 9.2) 11.4 ( 8.4- 15.2) ∼
Iowa 9.8 ( 8.4- 11.3) 9.5 ( 8.2- 11.1) ∼ ∼
Kansas 7.2 ( 6.0- 8.7) 6.8 ( 5.5- 8.2) ∼ ∼
Minnesota 9.4 ( 8.3- 10.6) 9.5 ( 8.4- 10.8) ∼ ∼
Missouri 8.4 ( 7.5- 9.5) 8.2 ( 7.2- 9.2) 10.2 ( 6.8- 14.7) ∼
Nebraska 8.7 ( 7.0- 10.8) 8.8 ( 7.1- 10.9) ∼ ∼
North Dakota 8.3 ( 5.7- 11.9) 8.1 ( 5.5- 11.8) ∼ ∼
South Dakota 10.3 ( 7.5- 13.8) 10.0 ( 7.3- 13.7) ∼ ∼
South 8.9 ( 8.6- 9.1) 8.4 ( 8.1- 8.6) 12.4 ( 11.6- 13.2) 6.8 ( 5.9- 7.7)
South Atlantic 8.6 ( 8.3- 9.0) 8.1 ( 7.8- 8.5) 11.5 ( 10.6- 12.5) 5.6 ( 4.5- 6.8)
Delaware 7.8 ( 5.5- 10.9) 8.1 ( 5.5- 11.5) ∼ ∼
District of Columbia 11.5 ( 8.2- 16.1) ∼ 12.1 ( 8.0- 18.4) ∼
Florida 7.9 ( 7.4- 8.4) 7.8 ( 7.3- 8.4) 8.3 ( 6.5- 10.4) 5.8 ( 4.6- 7.2)
Georgia 9.2 ( 8.3- 10.2) 8.5 ( 7.5- 9.6) 11.2 ( 9.1- 13.7) ∼
Maryland 8.9 ( 7.9- 10.1) 8.3 ( 7.2- 9.6) 11.8 ( 9.3- 15.0) ∼
North Carolina 9.2 ( 8.3- 10.1) 8.7 ( 7.7- 9.6) 12.1 ( 9.9- 14.8) ∼
South Carolina 10.2 ( 9.0- 11.6) 9.2 ( 7.8- 10.7) 13.8 ( 10.8- 17.3) ∼
Virginia 8.8 ( 7.9- 9.8) 7.9 ( 6.9- 8.9) 13.9 ( 11.1- 17.1) ∼
West Virginia 8.3 ( 6.8- 10.1) 8.2 ( 6.6- 10.0) ∼ ∼
East South Central 9.5 ( 8.9- 10.1) 8.8 ( 8.2- 9.5) 13.5 ( 11.7- 15.5) ∼
Alabama 8.2 ( 7.2- 9.4) 7.8 ( 6.7- 9.1) 10.2 ( 7.7- 13.2) ∼
Kentucky 9.5 ( 8.3- 10.9) 9.4 ( 8.2- 10.8) 12.9 ( 7.5- 20.8) ∼
Mississippi 10.6 ( 9.0- 12.3) 8.8 ( 7.2- 10.7) 15.4 ( 12.0- 19.6) ∼
Tennessee 9.9 ( 8.9- 11.0) 9.1 ( 8.0- 10.3) 16.3 ( 12.6- 20.9) ∼
West South Central 9.0 ( 8.5- 9.5) 8.5 ( 8.0- 9.0) 13.5 ( 11.9- 15.3) 7.7 ( 6.5- 9.1)
Arkansas 8.9 ( 7.6- 10.5) 8.4 ( 7.0- 10.1) 11.7 ( 7.4- 17.7) ∼
continued
C
ancer Incidence and M
ortality by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
201
Table 2.22.1.2F: Pancreas. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 10.9 ( 9.6- 12.2) 9.3 ( 8.0- 10.9) 15.0 ( 12.1- 18.5) ∼
Oklahoma 8.0 ( 6.8- 9.3) 8.2 ( 6.9- 9.6) ∼ ∼
Texas 8.8 ( 8.2- 9.4) 8.4 ( 7.8- 9.0) 12.9 ( 10.7- 15.5) 7.8 ( 6.5- 9.2)
West 9.0 ( 8.7- 9.4) 9.0 ( 8.6- 9.3) 13.2 ( 11.2- 15.4) 9.0 ( 8.0- 10.1)
Mountain 8.6 ( 8.0- 9.2) 8.4 ( 7.8- 9.1) 15.9 ( 10.4- 23.4) 9.4 ( 7.5- 11.8)
Arizona 7.9 ( 6.9- 8.9) 7.8 ( 6.8- 8.9) ∼ 7.2 ( 4.6- 11.2)
Colorado 9.7 ( 8.4- 11.1) 9.5 ( 8.1- 10.9) ∼ 11.6 ( 7.0- 18.2)
Idaho 8.4 ( 6.4- 10.9) 8.1 ( 6.1- 10.6) ∼ ∼
Montana 7.5 ( 5.4- 10.2) 7.3 ( 5.3- 10.1) ∼ ∼
Nevada 10.2 ( 8.3- 12.4) 9.7 ( 7.8- 12.0) ∼ ∼
New Mexico 9.3 ( 7.5- 11.4) 9.3 ( 7.4- 11.5) ∼ 9.8 ( 6.5- 14.3)
Utah 7.0 ( 5.4- 8.9) 7.2 ( 5.5- 9.2) ∼ ∼
Wyoming 6.5 ( 3.8- 10.6) 6.7 ( 3.9- 10.9) ∼ ∼
Pacific 9.2 ( 8.8- 9.6) 9.3 ( 8.8- 9.7) 12.8 ( 10.7- 15.1) 8.9 ( 7.7- 10.1)
Alaska 9.0 ( 5.2- 14.7) ∼ ∼ ∼
California 9.1 ( 8.6- 9.5) 9.1 ( 8.7- 9.7) 13.0 ( 10.9- 15.5) 8.9 ( 7.8- 10.2)
Hawaii 10.1 ( 7.9- 12.7) ∼ ∼ ∼
Oregon 9.5 ( 8.3- 11.0) 9.5 ( 8.2- 11.0) ∼ ∼
Washington 9.6 ( 8.6- 10.8) 9.6 ( 8.5- 10.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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202 Table 2.23.1.1: Prostate. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 161.2 (160.4- 161.9) 151.5 (150.7- 152.2) 234.1 (230.9- 237.3) 135.1 (132.4- 137.9)
Northeast 177.2 (175.5- 178.8) 167.9 (166.2- 169.6) 242.4 (235.5- 249.5) 165.5 (157.8- 173.5)
New England 173.7 (170.5- 176.9) 170.0 (166.8- 173.3) 227.6 (208.1- 249.2) 186.4 (163.9- 211.8)
Connecticut 177.4 (170.9- 184.0) 171.2 (164.6- 178.0) 248.2 (216.9- 284.9) 184.0 (148.7- 227.4)
Maine 164.2 (154.5- 174.4) 163.8 (154.1- 174.1) ∼ ∼
Massachusetts 174.1 (169.4- 179.0) 171.3 (166.4- 176.3) 218.4 (191.4- 249.3) 186.5 (154.3- 225.1)
New Hampshire 173.6 (162.9- 185.0) 164.6 (154.1- 175.8) ∼ -
Rhode Island 180.1 (168.4- 192.3) 179.0 (167.1- 191.5) 175.5 (114.0- 277.8) 195.7 (129.8- 297.6)
Vermont 161.3 (147.1- 176.7) 162.7 (148.3- 178.2) ∼ ∼
Middle Atlantic 178.4 (176.5- 180.3) 167.1 (165.1- 169.1) 243.9 (236.6- 251.5) 162.7 (154.6- 171.3)
New Jersey 213.1 (208.5- 217.8) 199.5 (194.7- 204.4) 275.6 (258.5- 293.8) 222.2 (203.0- 243.1)
New York 165.6 (162.8- 168.4) 154.1 (151.2- 157.0) 224.7 (215.2- 234.5) 139.4 (130.3- 149.1)
Pennsylvania 174.3 (171.1- 177.6) 164.2 (160.9- 167.6) 263.7 (248.1- 280.2) -
Midwest 161.8 (160.4- 163.3) 149.6 (148.1- 151.1) 229.0 (222.2- 236.0) 119.9 (110.1- 130.5)
East North Central 163.6 (161.8- 165.4) 148.7 (147.0- 150.6) 234.6 (227.1- 242.3) 121.2 (110.2- 133.2)
Illinois 162.4 (158.9- 165.9) 152.5 (148.9- 156.2) 210.2 (198.1- 223.0) 116.8 (102.7- 132.9)
Indiana 132.8 (128.4- 137.3) 127.7 (123.3- 132.3) 178.3 (157.6- 201.4) 104.3 ( 73.4- 147.6)
Michigan 195.2 (191.0- 199.4) 171.9 (167.8- 176.1) 296.8 (280.6- 313.9) 115.1 ( 88.6- 149.3)
Detroit 228.3 (221.1- 235.7) 199.9 (192.3- 207.7) 323.7 (304.1- 344.4) -
Ohio 153.6 (150.3- 157.1) 131.5 (128.3- 134.9) 219.8 (205.8- 234.8) 142.0 (107.8- 186.6)
Wisconsin 164.3 (159.3- 169.4) 159.9 (154.9- 165.1) 253.4 (215.8- 298.5) -
West North Central 157.7 (155.0- 160.4) 151.4 (148.7- 154.1) 196.3 (180.3- 213.6) 114.9 ( 93.9- 140.2)
Iowa 154.1 (147.7- 160.7) 149.7 (143.4- 156.3) 128.5 ( 80.6- 203.7) ∼
Kansas 160.5 (153.4- 167.9) 148.2 (141.2- 155.4) 205.1 (164.6- 253.5) 100.2 ( 66.1- 149.6)
Minnesota 193.4 (187.5- 199.4) 185.9 (180.0- 191.9) 265.3 (206.2- 341.8) 132.0 ( 80.3- 212.2)
Missouri 127.7 (123.4- 132.1) 122.8 (118.5- 127.4) 190.3 (170.5- 212.1) 97.1 ( 61.4- 153.1)
Nebraska 150.0 (141.6- 158.8) 140.9 (132.6- 149.6) 184.5 (125.7- 268.7) 150.0 ( 91.5- 241.5)
North Dakota 182.7 (168.1- 198.3) 182.1 (167.4- 197.9) ∼ ∼
South Dakota
South
South Atlantic
Delaware 188.7 (175.0- 203.3) 176.1 (161.8- 191.4) 275.5 (228.8- 331.8) ∼
District of Columbia 217.1 (198.3- 237.4) 138.3 (113.2- 168.7) 258.4 (232.6- 286.5) ∼
Florida 147.2 (144.8- 149.7) 140.2 (137.7- 142.7) 218.6 (207.7- 230.2) -
Georgia 173.6 (168.8- 178.5) 151.6 (146.5- 156.7) 266.8 (253.0- 281.3) 124.5 ( 93.3- 165.5)
Atlanta 194.1 (184.6- 204.1) 171.2 (160.9- 182.1) 286.9 (261.8- 314.4) 135.8 ( 88.2- 207.4)
Maryland 186.7 (181.1- 192.6) 172.2 (166.0- 178.5) 259.0 (243.2- 275.8) 124.1 ( 90.9- 168.3)
North Carolina 146.6 (142.6- 150.7) 131.9 (127.7- 136.1) 221.7 (209.0- 235.1) 80.8 ( 53.2- 120.9)
South Carolina 181.9 (175.6- 188.4) 151.5 (145.1- 158.3) 278.3 (261.1- 296.4) -
Virginia
West Virginia 148.0 (140.2- 156.0) 146.7 (138.9- 154.9) 214.3 (157.0- 287.4) ∼
East South Central
Alabama 142.3 (137.0- 147.6) 123.4 (118.1- 129.0) 221.6 (206.3- 237.9) ∼
Kentucky 154.7 (148.9- 160.7) 143.5 (137.8- 149.5) 260.4 (227.7- 297.3) -
Mississippi
Tennessee
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Table 2.23.1.1: Prostate. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 190.5 (184.1- 197.0) 174.3 (167.3- 181.5) 247.0 (231.7- 263.1) 178.8 (136.0- 234.9)
Oklahoma 151.4 (145.3- 157.6) 145.1 (138.8- 151.6) 200.9 (169.9- 236.7) 126.0 ( 81.9- 190.5)
Texas 136.2 (133.6- 138.8) 130.2 (127.6- 133.0) 187.9 (177.3- 199.0) 107.8 (102.2- 113.6)
West 155.6 (154.1- 157.1) 151.8 (150.2- 153.4) 221.3 (212.0- 230.9) 133.2 (128.9- 137.7)
Mountain 146.2 (143.5- 148.9) 143.5 (140.7- 146.3) 173.8 (153.3- 197.4) 118.1 (110.3- 126.4)
Arizona 106.1 (102.2- 110.3) 103.7 ( 99.6- 107.9) 141.8 (110.0- 183.6) 85.0 ( 73.7- 98.1)
Colorado 158.2 (152.2- 164.5) 148.3 (142.3- 154.5) 170.2 (134.7- 216.8) 131.7 (113.1- 153.3)
Idaho 168.7 (158.2- 179.8) 169.5 (158.9- 180.8) ∼ ∼
Montana 186.5 (174.3- 199.5) 178.1 (166.0- 191.1) ∼ ∼
Nevada 167.4 (159.0- 176.2) 163.9 (155.2- 173.1) 210.4 (164.8- 270.6) 152.6 (121.0- 193.1)
New Mexico 146.9 (138.7- 155.5) 152.9 (144.2- 162.0) 184.4 (117.7- 286.5) 132.8 (118.9- 148.1)
Utah 190.4 (180.5- 200.6) 193.9 (183.9- 204.5) ∼ 153.1 (108.0- 217.2)
Wyoming
Pacific 159.6 (157.8- 161.4) 155.8 (153.8- 157.8) 230.6 (220.3- 241.3) 138.7 (133.6- 144.0)
Alaska 164.5 (145.1- 187.0) 170.2 (148.2- 195.8) ∼ ∼
California 159.4 (157.3- 161.6) 153.6 (151.3- 155.9) 231.6 (220.8- 243.0) 140.0 (134.7- 145.5)
San Francisco-Oakland 162.0 (156.1- 168.1) 163.9 (156.9- 171.2) 202.3 (180.3- 226.8) 144.7 (125.9- 166.1)
San Jose-Monterey 164.4 (156.0- 173.2) 169.5 (160.0- 179.6) 235.7 (171.9- 332.1) 133.3 (112.7- 157.6)
Los Angeles 158.8 (154.6- 163.1) 145.9 (141.3- 150.7) 242.9 (226.4- 260.6) 143.9 (135.2- 153.1)
Hawaii 113.4 (105.1- 122.3) 124.5 (107.7- 143.7) ∼ -
Oregon 153.4 (147.4- 159.5) 150.7 (144.7- 157.0) 145.5 ( 92.6- 226.3) 136.4 ( 96.5- 190.8)
Washington 174.8 (169.7- 180.0) 170.9 (165.7- 176.3) 250.2 (209.2- 299.5) 135.3 (106.4- 171.5)
Seattle-Puget Sound 175.0 (168.7- 181.4) 177.3 (170.7- 184.2) 262.1 (217.9- 316.1) 80.9 ( 52.0- 126.4)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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204 Table 2.23.1.2: Prostate. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 28.1 ( 27.8- 28.4) 25.8 ( 25.5- 26.2) 63.0 ( 61.2- 64.8) 22.0 ( 20.7- 23.3)
Northeast 27.6 ( 26.9- 28.3) 25.9 ( 25.2- 26.6) 56.9 ( 53.1- 61.0) 23.8 ( 20.4- 27.7)
New England 27.9 ( 26.5- 29.3) 27.6 ( 26.3- 29.1) 47.7 ( 36.9- 61.1) 19.3 ( 11.1- 31.4)
Connecticut 29.4 ( 26.7- 32.3) 28.9 ( 26.1- 31.8) 43.6 ( 28.3- 65.9) ∼
Maine 26.4 ( 22.2- 31.1) 26.1 ( 22.0- 30.8) ∼ ∼
Massachusetts 27.9 ( 25.9- 30.0) 27.8 ( 25.7- 30.0) 47.0 ( 32.3- 66.7) ∼
New Hampshire 29.5 ( 24.7- 35.1) 29.8 ( 25.0- 35.4) ∼ ∼
Rhode Island 24.8 ( 20.5- 29.9) 24.0 ( 19.6- 29.1) ∼ ∼
Vermont 25.5 ( 19.5- 32.9) 25.7 ( 19.6- 33.1) ∼ ∼
Middle Atlantic 27.5 ( 26.7- 28.4) 25.2 ( 24.4- 26.0) 58.0 ( 53.9- 62.4) 24.5 ( 20.8- 28.7)
New Jersey 26.0 ( 24.3- 27.8) 23.8 ( 22.1- 25.6) 58.1 ( 48.8- 68.9) 27.5 ( 19.8- 37.4)
New York 27.4 ( 26.2- 28.6) 24.6 ( 23.4- 25.9) 55.6 ( 50.3- 61.4) 23.7 ( 19.4- 28.8)
Pennsylvania 28.6 ( 27.2- 30.0) 26.6 ( 25.2- 28.0) 63.6 ( 55.2- 73.1) ∼
Midwest 28.3 ( 27.7- 29.0) 26.6 ( 25.9- 27.3) 57.8 ( 53.9- 61.8) 15.3 ( 11.5- 20.2)
East North Central 28.7 ( 27.9- 29.5) 26.4 ( 25.6- 27.2) 58.5 ( 54.3- 62.9) 16.9 ( 12.5- 22.7)
Illinois 29.1 ( 27.6- 30.8) 25.6 ( 24.1- 27.3) 66.0 ( 58.4- 74.4) 17.3 ( 11.5- 25.6)
Indiana 28.2 ( 26.0- 30.5) 26.3 ( 24.1- 28.6) 62.9 ( 49.5- 79.1) ∼
Michigan 27.5 ( 25.8- 29.2) 25.5 ( 23.8- 27.3) 47.2 ( 40.3- 55.2) ∼
Ohio 28.8 ( 27.3- 30.5) 26.2 ( 24.6- 27.8) 62.7 ( 54.5- 71.9) ∼
Wisconsin 29.8 ( 27.5- 32.1) 29.7 ( 27.5- 32.1) ∼ ∼
West North Central 27.6 ( 26.4- 28.8) 27.0 ( 25.8- 28.2) 53.0 ( 43.7- 63.8) ∼
Iowa 29.0 ( 26.2- 32.0) 28.9 ( 26.1- 31.9) ∼ ∼
Kansas 27.9 ( 24.9- 31.2) 26.8 ( 23.8- 30.1) 65.9 ( 42.2- 98.6) ∼
Minnesota 31.1 ( 28.6- 33.7) 31.3 ( 28.8- 33.9) ∼ ∼
Missouri 23.9 ( 21.9- 26.0) 22.1 ( 20.1- 24.2) 51.5 ( 40.1- 65.3) ∼
Nebraska 24.8 ( 21.4- 28.7) 24.1 ( 20.6- 28.0) ∼ ∼
North Dakota 27.7 ( 22.2- 34.2) 27.8 ( 22.2- 34.4) ∼ ∼
South Dakota 30.9 ( 25.4- 37.3) 31.1 ( 25.5- 37.6) ∼ ∼
South 29.1 ( 28.6- 29.7) 24.5 ( 23.9- 25.0) 67.9 ( 65.4- 70.4) 20.8 ( 18.9- 22.9)
South Atlantic 28.7 ( 27.9- 29.4) 23.6 ( 22.9- 24.3) 69.9 ( 66.5- 73.4) 21.2 ( 18.4- 24.3)
Delaware 26.9 ( 21.3- 33.7) 24.1 ( 18.4- 31.1) 49.9 ( 28.0- 84.2) ∼
District of Columbia 51.8 ( 42.2- 63.1) ∼ 72.6 ( 58.3- 89.5) ∼
Florida 23.9 ( 22.9- 24.9) 21.7 ( 20.7- 22.7) 64.4 ( 57.4- 72.2) 22.9 ( 19.7- 26.4)
Georgia 33.0 ( 30.6- 35.6) 24.5 ( 22.2- 27.0) 74.4 ( 66.0- 83.5) ∼
Maryland 31.0 ( 28.4- 33.7) 23.5 ( 21.0- 26.1) 72.9 ( 63.0- 83.9) ∼
North Carolina 32.1 ( 30.0- 34.4) 25.4 ( 23.3- 27.6) 72.2 ( 64.0- 81.2) ∼
South Carolina 35.2 ( 32.0- 38.6) 27.2 ( 24.0- 30.7) 67.1 ( 57.7- 77.6) ∼
Virginia 33.7 ( 31.3- 36.2) 27.9 ( 25.6- 30.4) 71.9 ( 63.2- 81.6) ∼
West Virginia 26.2 ( 22.7- 30.1) 25.7 ( 22.2- 29.6) ∼ ∼
East South Central 32.5 ( 31.0- 34.0) 26.3 ( 24.8- 27.7) 72.5 ( 66.8- 78.6) ∼
Alabama 34.8 ( 31.9- 37.9) 26.8 ( 24.0- 29.8) 70.4 ( 61.2- 80.7) ∼
Kentucky 28.1 ( 25.4- 31.1) 26.6 ( 23.8- 29.5) 59.5 ( 43.2- 80.6) ∼
Mississippi 40.9 ( 36.9- 45.2) 25.5 ( 21.8- 29.6) 85.0 ( 73.9- 97.3) ∼
Tennessee 29.6 ( 27.3- 32.2) 26.0 ( 23.6- 28.6) 63.6 ( 53.2- 75.6) ∼
West South Central 28.1 ( 27.0- 29.1) 25.3 ( 24.2- 26.3) 58.7 ( 53.9- 63.7) 21.0 ( 18.2- 24.0)
Arkansas 30.2 ( 27.0- 33.6) 26.6 ( 23.4- 30.1) 67.2 ( 52.3- 85.2) ∼
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Table 2.23.1.2: Prostate. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 33.2 ( 30.2- 36.3) 27.0 ( 23.9- 30.3) 56.9 ( 49.0- 65.8) ∼
Oklahoma 25.7 ( 23.0- 28.6) 24.1 ( 21.4- 27.1) 66.5 ( 46.8- 91.9) ∼
Texas 27.0 ( 25.7- 28.4) 25.0 ( 23.6- 26.3) 56.8 ( 50.3- 64.0) 21.4 ( 18.6- 24.6)
West 26.7 ( 26.0- 27.4) 27.1 ( 26.4- 27.8) 56.8 ( 51.3- 62.9) 23.5 ( 21.4- 25.8)
Mountain 27.7 ( 26.5- 29.1) 27.7 ( 26.4- 29.1) 49.3 ( 35.8- 66.9) 29.6 ( 25.0- 34.8)
Arizona 24.7 ( 22.6- 26.9) 24.7 ( 22.6- 27.0) 45.8 ( 25.5- 78.4) 33.2 ( 24.8- 43.9)
Colorado 28.7 ( 25.8- 31.8) 28.5 ( 25.6- 31.7) ∼ 27.7 ( 18.4- 40.5)
Idaho 29.9 ( 25.3- 35.1) 30.3 ( 25.6- 35.7) ∼ ∼
Montana 27.4 ( 22.5- 33.1) 27.2 ( 22.3- 33.0) ∼ ∼
Nevada 30.6 ( 26.4- 35.3) 29.4 ( 25.2- 34.2) 71.0 ( 37.5- 124.5) ∼
New Mexico 29.6 ( 25.6- 34.1) 30.1 ( 25.9- 34.8) ∼ 30.1 ( 22.7- 39.4)
Utah 28.6 ( 24.5- 33.1) 29.0 ( 24.9- 33.6) ∼ ∼
Wyoming 32.0 ( 24.2- 41.7) 32.5 ( 24.6- 42.4) ∼ ∼
Pacific 26.3 ( 25.5- 27.1) 26.8 ( 26.0- 27.7) 58.3 ( 52.2- 64.9) 21.3 ( 19.0- 23.9)
Alaska 41.0 ( 28.5- 57.6) 49.4 ( 34.2- 69.6) ∼ ∼
California 25.8 ( 24.9- 26.8) 25.9 ( 24.9- 27.0) 58.9 ( 52.5- 65.8) 21.2 ( 18.8- 23.9)
Hawaii 17.6 ( 14.3- 21.4) 26.4 ( 18.2- 37.5) ∼ ∼
Oregon 29.4 ( 26.7- 32.3) 29.6 ( 26.8- 32.6) ∼ ∼
Washington 28.0 ( 25.9- 30.4) 28.5 ( 26.3- 30.9) 45.1 ( 25.2- 76.0) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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206 Table 2.24.1.1M: Stomach. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 10.1 ( 9.9- 10.3) 9.1 ( 9.0- 9.3) 16.6 ( 15.7- 17.5) 14.8 ( 13.8- 15.7)
Northeast 12.0 ( 11.6- 12.5) 11.2 ( 10.7- 11.6) 18.4 ( 16.4- 20.6) 17.2 ( 14.7- 20.1)
New England 10.9 ( 10.1- 11.7) 10.5 ( 9.7- 11.4) 22.7 ( 16.3- 31.5) 17.9 ( 11.0- 28.3)
Connecticut 12.8 ( 11.1- 14.8) 11.9 ( 10.2- 13.8) 29.8 ( 18.8- 47.4) ∼
Maine 10.0 ( 7.7- 12.9) 9.8 ( 7.5- 12.7) ∼ ∼
Massachusetts 10.4 ( 9.3- 11.7) 10.3 ( 9.1- 11.6) 17.5 ( 9.8- 30.0) 21.3 ( 10.8- 39.4)
New Hampshire 7.2 ( 5.1- 9.9) 7.3 ( 5.2- 10.0) ∼ -
Rhode Island 11.8 ( 8.9- 15.3) 11.6 ( 8.8- 15.2) ∼ ∼
Vermont 10.4 ( 6.9- 15.2) 10.2 ( 6.7- 15.0) ∼ ∼
Middle Atlantic 12.5 ( 12.0- 13.0) 11.5 ( 10.9- 12.0) 17.8 ( 15.8- 20.1) 17.1 ( 14.4- 20.2)
New Jersey 14.1 ( 12.9- 15.4) 13.1 ( 11.9- 14.4) 20.0 ( 15.3- 26.1) 17.7 ( 13.0- 24.2)
New York 12.8 ( 12.0- 13.6) 11.7 ( 10.9- 12.5) 16.0 ( 13.4- 19.0) 15.7 ( 12.6- 19.6)
Pennsylvania 11.0 ( 10.2- 11.9) 10.2 ( 9.4- 11.1) 20.0 ( 15.7- 25.4) -
Midwest 9.2 ( 8.8- 9.5) 8.4 ( 8.1- 8.8) 17.3 ( 15.4- 19.4) 13.1 ( 9.9- 17.3)
East North Central 9.6 ( 9.2- 10.1) 8.8 ( 8.4- 9.2) 16.6 ( 14.6- 18.8) 11.4 ( 8.3- 15.8)
Illinois 11.5 ( 10.6- 12.5) 10.5 ( 9.6- 11.5) 17.1 ( 13.7- 21.2) 14.8 ( 9.9- 21.9)
Indiana 8.0 ( 7.0- 9.2) 7.4 ( 6.3- 8.6) 16.2 ( 10.5- 24.6) ∼
Michigan 10.1 ( 9.2- 11.1) 9.2 ( 8.3- 10.3) 16.6 ( 12.9- 21.3) ∼
Detroit 13.0 ( 11.3- 14.9) 12.6 ( 10.7- 14.7) 15.1 ( 11.1- 20.3) -
Ohio 8.4 ( 7.6- 9.2) 7.5 ( 6.7- 8.3) 16.5 ( 12.6- 21.4) ∼
Wisconsin 9.1 ( 7.9- 10.4) 8.9 ( 7.7- 10.2) ∼ -
West North Central 8.2 ( 7.6- 8.8) 7.6 ( 7.0- 8.2) 21.4 ( 16.0- 28.1) 19.4 ( 10.8- 33.2)
Iowa 7.6 ( 6.2- 9.2) 7.3 ( 6.0- 8.9) ∼ ∼
Kansas 7.6 ( 6.1- 9.3) 7.2 ( 5.7- 8.9) ∼ ∼
Minnesota 8.6 ( 7.4- 9.9) 8.2 ( 7.0- 9.6) ∼ ∼
Missouri 8.5 ( 7.4- 9.8) 7.3 ( 6.2- 8.5) 23.1 ( 16.2- 32.5) ∼
Nebraska 7.5 ( 5.7- 9.8) 7.5 ( 5.7- 9.8) ∼ ∼
North Dakota 8.8 ( 5.8- 12.8) 8.7 ( 5.7- 12.8) ∼ ∼
South Dakota
South
South Atlantic
Delaware 8.5 ( 5.7- 12.4) 6.7 ( 4.1- 10.7) ∼ ∼
District of Columbia 12.6 ( 8.4- 18.3) ∼ 15.7 ( 9.9- 24.1) ∼
Florida 9.8 ( 9.2- 10.4) 9.2 ( 8.6- 9.9) 16.0 ( 13.1- 19.6) -
Georgia 8.9 ( 7.8- 10.1) 7.2 ( 6.1- 8.5) 15.6 ( 12.4- 19.5) ∼
Atlanta 8.0 ( 6.2- 10.3) 5.9 ( 4.1- 8.4) 13.5 ( 8.9- 20.9) ∼
Maryland 8.0 ( 6.8- 9.3) 6.5 ( 5.3- 7.9) 12.3 ( 8.8- 17.0) ∼
North Carolina 7.6 ( 6.6- 8.6) 6.8 ( 5.8- 7.9) 11.6 ( 8.7- 15.2) ∼
South Carolina 9.6 ( 8.2- 11.3) 6.2 ( 4.9- 7.8) 21.1 ( 16.6- 26.7) -
Virginia
West Virginia 9.0 ( 7.1- 11.4) 8.7 ( 6.8- 11.0) ∼ ∼
East South Central
Alabama 9.4 ( 8.1- 10.9) 7.1 ( 5.9- 8.7) 19.7 ( 15.3- 25.1) ∼
Kentucky 9.3 ( 7.9- 10.9) 9.0 ( 7.6- 10.7) ∼ -
Mississippi
Tennessee
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Table 2.24.1.1M: Stomach. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 11.6 ( 10.0- 13.4) 9.2 ( 7.6- 11.1) 19.8 ( 15.6- 25.0) ∼
Oklahoma 7.9 ( 6.5- 9.5) 7.8 ( 6.4- 9.4) ∼ ∼
Texas 9.9 ( 9.2- 10.7) 9.4 ( 8.6- 10.1) 14.8 ( 11.9- 18.3) 15.9 ( 13.8- 18.2)
West 10.2 ( 9.8- 10.6) 9.0 ( 8.7- 9.5) 15.1 ( 12.5- 18.0) 14.8 ( 13.3- 16.3)
Mountain 8.0 ( 7.3- 8.6) 7.6 ( 7.0- 8.3) 12.8 ( 7.3- 22.1) 14.3 ( 11.6- 17.7)
Arizona 8.5 ( 7.3- 9.7) 8.2 ( 7.1- 9.5) ∼ 18.2 ( 12.8- 25.6)
Colorado 6.8 ( 5.6- 8.3) 6.6 ( 5.3- 8.1) ∼ 11.9 ( 6.6- 20.7)
Idaho 7.3 ( 5.3- 9.9) 6.9 ( 5.0- 9.5) ∼ ∼
Montana 9.0 ( 6.5- 12.3) 8.7 ( 6.2- 12.0) ∼ ∼
Nevada 8.3 ( 6.5- 10.7) 7.5 ( 5.7- 9.9) ∼ ∼
New Mexico 9.7 ( 7.6- 12.1) 9.1 ( 7.0- 11.6) ∼ 13.1 ( 8.7- 19.1)
Utah 7.2 ( 5.4- 9.5) 7.2 ( 5.4- 9.5) ∼ ∼
Wyoming
Pacific 11.1 ( 10.6- 11.6) 9.7 ( 9.2- 10.2) 15.5 ( 12.7- 18.8) 14.9 ( 13.2- 16.8)
Alaska 13.0 ( 7.3- 22.5) ∼ ∼ ∼
California 11.5 ( 10.9- 12.1) 10.2 ( 9.6- 10.8) 15.9 ( 12.9- 19.4) 15.1 ( 13.4- 17.0)
San Francisco-Oakland 13.1 ( 11.4- 15.0) 10.7 ( 8.9- 12.7) 13.3 ( 8.1- 21.1) 14.3 ( 8.6- 23.0)
San Jose-Monterey 13.2 ( 10.9- 15.9) 11.9 ( 9.4- 14.8) ∼ 20.9 ( 12.8- 33.3)
Los Angeles 13.5 ( 12.3- 14.9) 11.8 ( 10.5- 13.2) 17.9 ( 13.3- 23.8) 17.0 ( 14.1- 20.6)
Hawaii 18.0 ( 14.7- 21.7) 11.1 ( 6.3- 18.7) ∼ -
Oregon 7.9 ( 6.6- 9.4) 7.6 ( 6.3- 9.2) ∼ ∼
Washington 9.6 ( 8.4- 10.9) 9.1 ( 7.9- 10.4) ∼ ∼
Seattle-Puget Sound 9.6 ( 8.2- 11.3) 9.2 ( 7.7- 10.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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208 Table 2.24.1.1F: Stomach. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 4.8 ( 4.7- 4.9) 4.2 ( 4.0- 4.3) 8.6 ( 8.1- 9.1) 8.7 ( 8.1- 9.3)
Northeast 5.4 ( 5.2- 5.7) 4.8 ( 4.6- 5.1) 9.1 ( 8.0- 10.2) 9.5 ( 8.1- 11.2)
New England 4.6 ( 4.2- 5.1) 4.4 ( 3.9- 4.9) 8.7 ( 5.7- 12.9) 8.4 ( 4.9- 13.9)
Connecticut 5.0 ( 4.1- 6.1) 4.8 ( 3.9- 5.9) ∼ ∼
Maine 3.1 ( 2.1- 4.7) 3.2 ( 2.1- 4.8) ∼ ∼
Massachusetts 5.1 ( 4.4- 5.9) 4.8 ( 4.1- 5.5) ∼ ∼
New Hampshire 2.3 ( 1.3- 3.8) 2.3 ( 1.3- 3.9) ∼ -
Rhode Island 5.5 ( 3.9- 7.6) 5.2 ( 3.6- 7.3) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 5.7 ( 5.4- 6.0) 5.0 ( 4.7- 5.3) 9.1 ( 8.0- 10.3) 9.6 ( 8.1- 11.4)
New Jersey 5.6 ( 4.9- 6.3) 5.1 ( 4.4- 5.8) 8.0 ( 5.7- 10.9) 9.9 ( 6.7- 14.1)
New York 6.4 ( 6.0- 6.9) 5.4 ( 5.0- 5.9) 9.4 ( 7.9- 11.0) 9.4 ( 7.5- 11.5)
Pennsylvania 4.9 ( 4.4- 5.4) 4.4 ( 3.9- 4.9) 9.4 ( 7.2- 12.2) -
Midwest 4.2 ( 4.0- 4.4) 3.7 ( 3.5- 3.9) 9.1 ( 8.0- 10.3) 8.2 ( 6.0- 10.9)
East North Central 4.4 ( 4.2- 4.7) 3.8 ( 3.5- 4.0) 9.4 ( 8.2- 10.8) 7.9 ( 5.6- 11.0)
Illinois 5.3 ( 4.8- 5.9) 4.6 ( 4.1- 5.2) 8.5 ( 6.7- 10.8) 10.6 ( 7.1- 15.7)
Indiana 3.5 ( 2.9- 4.1) 3.1 ( 2.5- 3.8) 7.4 ( 4.2- 12.1) ∼
Michigan 4.6 ( 4.1- 5.2) 3.6 ( 3.1- 4.2) 11.5 ( 9.0- 14.5) ∼
Detroit 6.0 ( 5.1- 7.1) 4.3 ( 3.4- 5.4) 12.6 ( 9.6- 16.2) -
Ohio 4.1 ( 3.6- 4.6) 3.4 ( 3.0- 3.9) 9.2 ( 7.0- 12.0) ∼
Wisconsin 4.2 ( 3.5- 5.0) 3.9 ( 3.2- 4.7) ∼ -
West North Central 3.6 ( 3.3- 4.0) 3.4 ( 3.1- 3.8) 7.3 ( 4.9- 10.4) ∼
Iowa 3.5 ( 2.7- 4.5) 3.5 ( 2.7- 4.5) ∼ ∼
Kansas 3.3 ( 2.5- 4.4) 3.2 ( 2.4- 4.3) ∼ ∼
Minnesota 3.8 ( 3.1- 4.6) 3.6 ( 2.9- 4.4) ∼ ∼
Missouri 3.7 ( 3.1- 4.5) 3.4 ( 2.8- 4.1) 7.5 ( 4.6- 11.5) ∼
Nebraska 3.5 ( 2.5- 5.0) 3.4 ( 2.3- 4.8) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 6.2 ( 4.1- 9.0) 4.7 ( 2.8- 7.7) ∼ ∼
District of Columbia 7.9 ( 5.2- 11.9) ∼ 9.3 ( 5.8- 15.0) ∼
Florida 4.5 ( 4.1- 4.9) 3.8 ( 3.5- 4.2) 9.8 ( 7.9- 12.0) -
Georgia 5.0 ( 4.4- 5.8) 3.9 ( 3.2- 4.7) 8.1 ( 6.4- 10.2) ∼
Atlanta 5.9 ( 4.6- 7.5) 4.1 ( 2.9- 5.8) 9.3 ( 6.2- 13.6) ∼
Maryland 4.1 ( 3.4- 4.9) 3.4 ( 2.7- 4.3) 5.1 ( 3.5- 7.3) ∼
North Carolina 4.0 ( 3.5- 4.7) 3.3 ( 2.8- 4.0) 6.7 ( 5.0- 8.7) ∼
South Carolina 5.1 ( 4.2- 6.1) 3.7 ( 2.9- 4.8) 9.0 ( 6.7- 11.9) -
Virginia
West Virginia 3.6 ( 2.6- 4.8) 3.5 ( 2.6- 4.9) ∼ ∼
East South Central
Alabama 4.8 ( 4.0- 5.7) 4.5 ( 3.7- 5.6) 5.4 ( 3.7- 7.8) ∼
Kentucky 3.5 ( 2.8- 4.3) 3.3 ( 2.6- 4.2) ∼ -
Mississippi
Tennessee
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Table 2.24.1.1F: Stomach. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 6.9 ( 5.9- 8.0) 4.4 ( 3.5- 5.6) 13.4 ( 10.7- 16.7) ∼
Oklahoma 3.7 ( 2.9- 4.6) 3.2 ( 2.4- 4.2) ∼ ∼
Texas 4.6 ( 4.2- 5.1) 4.2 ( 3.8- 4.6) 8.1 ( 6.3- 10.1) 8.1 ( 6.9- 9.5)
West 5.1 ( 4.9- 5.4) 4.4 ( 4.2- 4.7) 8.5 ( 6.9- 10.3) 9.2 ( 8.2- 10.2)
Mountain 4.0 ( 3.6- 4.5) 3.8 ( 3.4- 4.3) ∼ 8.0 ( 6.3- 10.1)
Arizona 3.3 ( 2.7- 4.1) 3.3 ( 2.7- 4.1) ∼ 6.4 ( 3.9- 10.2)
Colorado 4.4 ( 3.6- 5.4) 4.0 ( 3.1- 4.9) ∼ 12.1 ( 7.7- 18.5)
Idaho 4.4 ( 3.0- 6.3) 4.2 ( 2.8- 6.1) ∼ ∼
Montana 5.2 ( 3.5- 7.7) 5.5 ( 3.6- 8.0) ∼ ∼
Nevada 3.9 ( 2.8- 5.4) 3.8 ( 2.7- 5.4) ∼ ∼
New Mexico 4.6 ( 3.4- 6.2) 4.0 ( 2.8- 5.5) ∼ 8.3 ( 5.4- 12.3)
Utah 3.9 ( 2.7- 5.4) 3.9 ( 2.7- 5.5) ∼ ∼
Wyoming
Pacific 5.5 ( 5.2- 5.9) 4.7 ( 4.4- 5.0) 8.8 ( 7.1- 10.7) 9.6 ( 8.5- 10.8)
Alaska ∼ ∼ ∼ ∼
California 5.7 ( 5.4- 6.1) 5.0 ( 4.7- 5.4) 8.6 ( 6.8- 10.6) 9.6 ( 8.5- 10.9)
San Francisco-Oakland 5.6 ( 4.7- 6.7) 4.1 ( 3.1- 5.2) 9.7 ( 5.9- 15.2) 7.2 ( 4.1- 11.9)
San Jose-Monterey 6.9 ( 5.5- 8.7) 6.3 ( 4.7- 8.2) ∼ 10.6 ( 6.0- 17.7)
Los Angeles 7.9 ( 7.1- 8.7) 7.2 ( 6.3- 8.1) 7.2 ( 5.0- 10.1) 11.0 ( 9.1- 13.2)
Hawaii 9.4 ( 7.3- 11.9) ∼ ∼ -
Oregon 4.0 ( 3.1- 5.0) 3.5 ( 2.7- 4.5) ∼ ∼
Washington 4.6 ( 3.8- 5.4) 3.9 ( 3.2- 4.7) ∼ ∼
Seattle-Puget Sound 5.0 ( 4.1- 6.1) 4.2 ( 3.3- 5.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
U
nited States C
ancer Statistics: 2002 Incidence and M
ortality
210 Table 2.24.1.2M: Stomach. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 5.9 ( 5.8- 6.1) 5.2 ( 5.1- 5.4) 12.0 ( 11.3- 12.8) 8.9 ( 8.2- 9.7)
Northeast 6.7 ( 6.4- 7.0) 6.2 ( 5.8- 6.5) 12.1 ( 10.5- 14.0) 8.9 ( 7.1- 11.2)
New England 6.7 ( 6.1- 7.4) 6.4 ( 5.8- 7.1) 15.1 ( 10.0- 22.7) ∼
Connecticut 7.4 ( 6.1- 8.9) 6.7 ( 5.4- 8.2) 17.3 ( 9.4- 32.0) ∼
Maine 6.4 ( 4.5- 8.9) 6.5 ( 4.6- 8.9) ∼ ∼
Massachusetts 6.6 ( 5.7- 7.6) 6.3 ( 5.4- 7.4) ∼ ∼
New Hampshire 5.9 ( 4.0- 8.5) 5.9 ( 4.0- 8.5) ∼ ∼
Rhode Island 8.0 ( 5.7- 11.0) 8.1 ( 5.7- 11.2) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 6.7 ( 6.3- 7.1) 6.1 ( 5.7- 6.5) 11.8 ( 10.1- 13.7) 8.7 ( 6.8- 11.1)
New Jersey 7.5 ( 6.7- 8.5) 6.8 ( 5.9- 7.8) 15.0 ( 11.0- 20.3) 8.7 ( 5.2- 14.3)
New York 6.9 ( 6.4- 7.6) 6.2 ( 5.6- 6.9) 11.1 ( 8.9- 13.8) 8.5 ( 6.2- 11.6)
Pennsylvania 5.8 ( 5.2- 6.5) 5.5 ( 4.9- 6.1) 10.4 ( 7.3- 14.5) ∼
Midwest 5.2 ( 4.9- 5.4) 4.7 ( 4.4- 4.9) 11.5 ( 9.9- 13.2) 7.1 ( 4.7- 10.5)
East North Central 5.5 ( 5.2- 5.9) 5.0 ( 4.6- 5.3) 11.1 ( 9.5- 13.0) 7.3 ( 4.5- 11.4)
Illinois 6.4 ( 5.7- 7.2) 5.9 ( 5.2- 6.7) 9.9 ( 7.4- 13.2) 9.2 ( 5.0- 16.0)
Indiana 4.5 ( 3.7- 5.4) 4.2 ( 3.4- 5.1) ∼ ∼
Michigan 5.9 ( 5.2- 6.7) 5.2 ( 4.5- 6.0) 11.9 ( 8.7- 16.0) ∼
Ohio 5.6 ( 4.9- 6.3) 4.9 ( 4.3- 5.6) 13.1 ( 9.6- 17.8) ∼
Wisconsin 3.9 ( 3.1- 4.8) 3.7 ( 2.9- 4.6) ∼ ∼
West North Central 4.5 ( 4.0- 4.9) 4.1 ( 3.7- 4.5) 13.4 ( 9.2- 19.2) ∼
Iowa 4.6 ( 3.6- 5.9) 4.6 ( 3.5- 5.9) ∼ ∼
Kansas 3.9 ( 2.9- 5.2) 3.2 ( 2.3- 4.5) ∼ ∼
Minnesota 4.6 ( 3.7- 5.6) 4.3 ( 3.4- 5.3) ∼ ∼
Missouri 4.6 ( 3.8- 5.6) 4.0 ( 3.2- 4.9) 12.6 ( 7.6- 20.2) ∼
Nebraska 3.3 ( 2.1- 4.8) 3.4 ( 2.2- 5.0) ∼ ∼
North Dakota 5.7 ( 3.4- 9.1) 5.2 ( 3.0- 8.6) ∼ ∼
South Dakota 5.5 ( 3.4- 8.6) 4.8 ( 2.8- 7.8) ∼ ∼
South 5.9 ( 5.7- 6.2) 5.0 ( 4.8- 5.2) 12.3 ( 11.3- 13.3) 8.3 ( 7.3- 9.6)
South Atlantic 5.7 ( 5.4- 6.0) 4.7 ( 4.4- 5.0) 12.4 ( 11.1- 13.8) 6.3 ( 5.0- 8.0)
Delaware 4.5 ( 2.6- 7.6) ∼ ∼ ∼
District of Columbia 12.5 ( 8.3- 18.3) ∼ 16.7 ( 10.6- 25.4) ∼
Florida 5.4 ( 4.9- 5.9) 4.9 ( 4.5- 5.4) 12.1 ( 9.4- 15.5) 6.5 ( 5.0- 8.4)
Georgia 5.9 ( 5.0- 6.9) 4.3 ( 3.4- 5.3) 12.4 ( 9.4- 16.1) ∼
Maryland 5.5 ( 4.6- 6.7) 4.4 ( 3.5- 5.6) 9.9 ( 7.0- 14.1) ∼
North Carolina 5.5 ( 4.7- 6.4) 4.6 ( 3.8- 5.6) 10.6 ( 7.9- 14.2) ∼
South Carolina 6.4 ( 5.2- 7.8) 4.7 ( 3.6- 6.2) 12.2 ( 8.8- 16.8) ∼
Virginia 6.3 ( 5.4- 7.4) 4.6 ( 3.7- 5.6) 16.4 ( 12.5- 21.2) ∼
West Virginia 6.6 ( 5.0- 8.6) 6.5 ( 4.9- 8.6) ∼ ∼
East South Central 5.8 ( 5.2- 6.4) 4.9 ( 4.4- 5.6) 10.9 ( 8.9- 13.2) ∼
Alabama 5.3 ( 4.3- 6.5) 4.2 ( 3.2- 5.4) 10.4 ( 7.3- 14.5) ∼
Kentucky 6.0 ( 4.9- 7.4) 5.6 ( 4.5- 7.0) ∼ ∼
Mississippi 6.7 ( 5.2- 8.5) 5.2 ( 3.7- 7.2) 10.5 ( 7.0- 15.2) ∼
Tennessee 5.5 ( 4.6- 6.6) 4.8 ( 3.9- 6.0) 10.8 ( 7.1- 16.0) ∼
West South Central 6.4 ( 5.9- 6.9) 5.6 ( 5.1- 6.0) 13.0 ( 11.0- 15.4) 10.4 ( 8.7- 12.3)
Arkansas 6.4 ( 5.0- 8.0) 5.3 ( 4.0- 6.9) 16.3 ( 9.8- 25.7) ∼
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Table 2.24.1.2M: Stomach. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 7.1 ( 5.9- 8.6) 5.0 ( 3.8- 6.4) 14.0 ( 10.5- 18.4) ∼
Oklahoma 5.5 ( 4.4- 6.8) 4.8 ( 3.7- 6.1) ∼ ∼
Texas 6.4 ( 5.8- 7.0) 5.9 ( 5.3- 6.5) 11.3 ( 8.6- 14.6) 10.6 ( 8.9- 12.6)
West 6.1 ( 5.8- 6.4) 5.4 ( 5.1- 5.8) 11.6 ( 9.4- 14.4) 9.8 ( 8.6- 11.2)
Mountain 4.9 ( 4.4- 5.4) 4.7 ( 4.2- 5.2) ∼ 10.0 ( 7.7- 12.9)
Arizona 5.5 ( 4.6- 6.6) 5.3 ( 4.4- 6.3) ∼ 12.9 ( 8.4- 19.4)
Colorado 3.9 ( 3.0- 5.1) 3.4 ( 2.5- 4.6) ∼ ∼
Idaho 3.3 ( 2.0- 5.3) 3.2 ( 1.9- 5.2) ∼ ∼
Montana 6.4 ( 4.2- 9.4) 6.4 ( 4.2- 9.5) ∼ ∼
Nevada 4.6 ( 3.3- 6.4) 4.5 ( 3.2- 6.4) ∼ ∼
New Mexico 7.1 ( 5.3- 9.3) 6.9 ( 5.1- 9.3) ∼ 9.8 ( 6.1- 15.1)
Utah 3.7 ( 2.4- 5.5) 3.8 ( 2.5- 5.7) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 6.6 ( 6.2- 7.0) 5.8 ( 5.4- 6.2) 11.6 ( 9.2- 14.5) 9.8 ( 8.4- 11.4)
Alaska ∼ ∼ ∼ ∼
California 6.9 ( 6.5- 7.4) 6.2 ( 5.7- 6.7) 11.6 ( 9.1- 14.6) 9.9 ( 8.4- 11.6)
Hawaii 7.6 ( 5.5- 10.1) ∼ ∼ ∼
Oregon 4.9 ( 3.9- 6.2) 4.8 ( 3.8- 6.0) ∼ ∼
Washington 5.4 ( 4.5- 6.4) 4.7 ( 3.9- 5.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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212 Table 2.24.1.2F: Stomach. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 3.0 ( 2.9- 3.1) 2.5 ( 2.5- 2.6) 6.1 ( 5.7- 6.5) 5.1 ( 4.6- 5.6)
Northeast 3.3 ( 3.1- 3.5) 3.0 ( 2.8- 3.2) 6.1 ( 5.3- 7.1) 4.4 ( 3.4- 5.7)
New England 3.4 ( 3.1- 3.9) 3.2 ( 2.9- 3.6) 7.2 ( 4.5- 11.0) ∼
Connecticut 3.4 ( 2.7- 4.3) 2.9 ( 2.2- 3.8) ∼ ∼
Maine 3.0 ( 2.0- 4.6) 3.0 ( 2.0- 4.6) ∼ ∼
Massachusetts 3.8 ( 3.2- 4.4) 3.7 ( 3.1- 4.4) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island 4.2 ( 2.8- 6.1) 3.7 ( 2.4- 5.6) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.3 ( 3.1- 3.5) 2.9 ( 2.7- 3.1) 6.0 ( 5.1- 7.0) 4.7 ( 3.6- 6.0)
New Jersey 3.5 ( 3.0- 4.1) 3.3 ( 2.8- 3.9) 6.0 ( 4.1- 8.6) ∼
New York 3.6 ( 3.3- 4.0) 3.1 ( 2.8- 3.5) 5.7 ( 4.6- 7.0) 5.2 ( 3.9- 7.0)
Pennsylvania 2.7 ( 2.4- 3.1) 2.4 ( 2.0- 2.7) 6.8 ( 4.9- 9.1) ∼
Midwest 2.6 ( 2.4- 2.7) 2.2 ( 2.1- 2.4) 6.5 ( 5.6- 7.6) 3.7 ( 2.3- 5.8)
East North Central 2.7 ( 2.5- 2.9) 2.3 ( 2.1- 2.5) 6.6 ( 5.6- 7.7) 4.5 ( 2.8- 7.1)
Illinois 3.0 ( 2.6- 3.5) 2.5 ( 2.1- 2.9) 6.6 ( 5.0- 8.6) 4.6 ( 2.4- 8.3)
Indiana 2.3 ( 1.8- 2.9) 2.1 ( 1.6- 2.7) ∼ ∼
Michigan 2.6 ( 2.2- 3.1) 2.1 ( 1.7- 2.5) 6.9 ( 4.9- 9.3) ∼
Ohio 2.8 ( 2.4- 3.2) 2.4 ( 2.1- 2.8) 6.7 ( 4.8- 9.2) ∼
Wisconsin 2.1 ( 1.7- 2.7) 2.1 ( 1.6- 2.7) ∼ ∼
West North Central 2.3 ( 2.0- 2.6) 2.1 ( 1.8- 2.4) 6.3 ( 4.1- 9.3) ∼
Iowa 2.1 ( 1.5- 2.9) 2.1 ( 1.5- 2.9) ∼ ∼
Kansas 2.3 ( 1.6- 3.2) 2.2 ( 1.5- 3.2) ∼ ∼
Minnesota 2.5 ( 2.0- 3.2) 2.3 ( 1.8- 2.9) ∼ ∼
Missouri 2.6 ( 2.1- 3.2) 2.1 ( 1.6- 2.7) 7.3 ( 4.5- 11.3) ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.9 ( 2.8- 3.1) 2.4 ( 2.2- 2.5) 6.0 ( 5.5- 6.6) 4.7 ( 4.1- 5.5)
South Atlantic 2.8 ( 2.6- 3.0) 2.2 ( 2.1- 2.4) 5.8 ( 5.1- 6.5) 3.2 ( 2.4- 4.2)
Delaware ∼ ∼ ∼ ∼
District of Columbia 5.1 ( 3.0- 8.4) ∼ 6.3 ( 3.6- 11.4) ∼
Florida 2.7 ( 2.4- 3.0) 2.3 ( 2.0- 2.7) 6.8 ( 5.2- 8.8) 3.4 ( 2.5- 4.5)
Georgia 3.0 ( 2.5- 3.6) 2.2 ( 1.7- 2.8) 5.9 ( 4.4- 7.8) ∼
Maryland 2.8 ( 2.3- 3.5) 2.2 ( 1.7- 3.0) 4.6 ( 3.0- 6.6) ∼
North Carolina 2.6 ( 2.2- 3.1) 2.1 ( 1.7- 2.6) 4.5 ( 3.2- 6.2) ∼
South Carolina 3.3 ( 2.7- 4.2) 2.3 ( 1.7- 3.2) 6.8 ( 4.8- 9.3) ∼
Virginia 2.8 ( 2.3- 3.4) 2.2 ( 1.7- 2.7) 5.8 ( 4.0- 8.0) ∼
West Virginia 2.3 ( 1.5- 3.4) 2.2 ( 1.5- 3.4) ∼ ∼
East South Central 2.9 ( 2.5- 3.2) 2.4 ( 2.0- 2.7) 5.3 ( 4.3- 6.6) ∼
Alabama 3.2 ( 2.6- 4.0) 2.8 ( 2.1- 3.7) 4.7 ( 3.1- 6.8) ∼
Kentucky 2.2 ( 1.7- 2.9) 2.0 ( 1.5- 2.7) ∼ ∼
Mississippi 3.0 ( 2.2- 4.0) 2.3 ( 1.5- 3.4) 4.8 ( 3.0- 7.2) ∼
Tennessee 2.9 ( 2.4- 3.6) 2.3 ( 1.8- 2.9) 7.0 ( 4.6- 10.1) ∼
West South Central 3.2 ( 2.9- 3.5) 2.6 ( 2.3- 2.8) 7.3 ( 6.1- 8.7) 6.1 ( 5.1- 7.4)
Arkansas 2.1 ( 1.5- 3.0) 1.3 ( 0.8- 2.1) ∼ ∼
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Table 2.24.1.2F: Stomach. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 3.7 ( 3.0- 4.5) 2.0 ( 1.4- 2.8) 8.6 ( 6.4- 11.3) ∼
Oklahoma 2.0 ( 1.4- 2.7) 1.7 ( 1.2- 2.5) ∼ ∼
Texas 3.5 ( 3.1- 3.9) 3.1 ( 2.7- 3.4) 7.2 ( 5.5- 9.2) 6.4 ( 5.3- 7.7)
West 3.3 ( 3.1- 3.5) 2.8 ( 2.6- 3.0) 5.3 ( 4.1- 6.7) 5.9 ( 5.2- 6.8)
Mountain 2.3 ( 2.0- 2.6) 2.1 ( 1.8- 2.4) ∼ 5.4 ( 4.0- 7.2)
Arizona 2.3 ( 1.8- 2.9) 2.0 ( 1.5- 2.6) ∼ 4.9 ( 2.7- 8.3)
Colorado 2.2 ( 1.7- 3.0) 2.1 ( 1.5- 2.9) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.8 ( 1.8- 4.0) 2.9 ( 1.9- 4.2) ∼ ∼
New Mexico 3.1 ( 2.1- 4.4) 2.6 ( 1.6- 3.9) ∼ ∼
Utah 2.3 ( 1.4- 3.5) 2.2 ( 1.4- 3.5) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 3.7 ( 3.4- 3.9) 3.1 ( 2.8- 3.3) 5.5 ( 4.2- 7.1) 6.1 ( 5.2- 7.1)
Alaska ∼ ∼ ∼ ∼
California 3.9 ( 3.6- 4.2) 3.4 ( 3.1- 3.7) 5.5 ( 4.1- 7.2) 6.1 ( 5.2- 7.1)
Hawaii 7.0 ( 5.3- 9.3) ∼ ∼ ∼
Oregon 2.4 ( 1.8- 3.2) 2.1 ( 1.5- 2.9) ∼ ∼
Washington 2.5 ( 1.9- 3.1) 2.2 ( 1.7- 2.8) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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214 Table 2.25.1.1: Testis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 5.1 ( 5.0- 5.2) 5.8 ( 5.6- 5.9) 1.4 ( 1.2- 1.6) 3.5 ( 3.2- 3.8)
Northeast 5.7 ( 5.5- 6.0) 6.6 ( 6.2- 6.9) 1.7 ( 1.2- 2.3) 3.3 ( 2.6- 4.3)
New England 6.3 ( 5.7- 6.9) 6.8 ( 6.2- 7.5) ∼ ∼
Connecticut 6.0 ( 4.9- 7.3) 6.7 ( 5.4- 8.2) ∼ ∼
Maine 6.1 ( 4.3- 8.4) 6.2 ( 4.4- 8.7) ∼ ∼
Massachusetts 6.8 ( 6.0- 7.8) 7.6 ( 6.6- 8.7) ∼ ∼
New Hampshire 5.7 ( 4.0- 8.1) 5.8 ( 4.0- 8.2) ∼ -
Rhode Island 5.1 ( 3.3- 7.5) 5.7 ( 3.7- 8.4) ∼ ∼
Vermont 5.8 ( 3.4- 9.5) ∼ ∼ ∼
Middle Atlantic 5.5 ( 5.2- 5.9) 6.4 ( 6.1- 6.9) 1.6 ( 1.1- 2.3) 3.4 ( 2.7- 4.5)
New Jersey 6.1 ( 5.4- 6.9) 7.3 ( 6.4- 8.3) ∼ 4.8 ( 3.4- 8.2)
New York 4.8 ( 4.4- 5.3) 5.7 ( 5.2- 6.3) 1.2 ( 0.7- 2.1) 3.0 ( 2.1- 4.5)
Pennsylvania 6.4 ( 5.7- 7.0) 6.9 ( 6.2- 7.7) ∼ -
Midwest 5.4 ( 5.1- 5.7) 5.8 ( 5.5- 6.1) 1.5 ( 1.1- 2.1) 3.2 ( 2.3- 5.0)
East North Central 5.3 ( 5.0- 5.6) 5.8 ( 5.5- 6.2) 1.5 ( 1.1- 2.2) 3.8 ( 2.7- 6.1)
Illinois 5.1 ( 4.5- 5.7) 5.7 ( 5.0- 6.4) ∼ 3.9 ( 2.2- 7.9)
Indiana 4.9 ( 4.1- 5.7) 5.3 ( 4.5- 6.3) ∼ ∼
Michigan 5.3 ( 4.7- 6.0) 6.1 ( 5.3- 6.9) ∼ ∼
Detroit 5.3 ( 4.3- 6.4) 6.7 ( 5.4- 8.3) ∼ -
Ohio 5.2 ( 4.6- 5.8) 5.4 ( 4.7- 6.1) ∼ ∼
Wisconsin 6.6 ( 5.7- 7.7) 7.0 ( 6.0- 8.2) ∼ -
West North Central 5.6 ( 5.2- 6.2) 5.9 ( 5.4- 6.4) ∼ ∼
Iowa 6.1 ( 4.9- 7.6) 6.1 ( 4.8- 7.6) ∼ ∼
Kansas 4.1 ( 3.1- 5.3) 4.0 ( 2.9- 5.3) ∼ ∼
Minnesota 7.1 ( 6.1- 8.2) 7.3 ( 6.2- 8.5) ∼ ∼
Missouri 5.0 ( 4.2- 6.0) 5.6 ( 4.7- 6.7) ∼ ∼
Nebraska 5.1 ( 3.7- 6.9) 5.2 ( 3.7- 7.1) ∼ ∼
North Dakota 5.5 ( 3.2- 9.0) 5.9 ( 3.4- 9.6) ∼ ∼
South Dakota
South
South Atlantic
Delaware 4.4 ( 2.5- 7.3) 5.3 ( 3.0- 8.9) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.6 ( 4.1- 5.1) 5.3 ( 4.8- 5.9) ∼ -
Georgia 4.0 ( 3.5- 4.7) 5.2 ( 4.4- 6.1) 1.4 ( 0.8- 2.8) ∼
Atlanta 3.8 ( 3.0- 5.2) 5.5 ( 4.2- 7.5) ∼ ∼
Maryland 4.6 ( 3.8- 5.5) 6.3 ( 5.2- 7.6) ∼ ∼
North Carolina 3.9 ( 3.4- 4.6) 4.7 ( 4.0- 5.6) ∼ ∼
South Carolina 3.3 ( 2.5- 4.2) 4.3 ( 3.3- 5.6) ∼ -
Virginia
West Virginia 4.3 ( 3.0- 6.0) 4.5 ( 3.2- 6.3) ∼ ∼
East South Central
Alabama 4.1 ( 3.3- 5.1) 5.0 ( 3.9- 6.2) ∼ ∼
Kentucky 5.2 ( 4.2- 6.3) 5.4 ( 4.4- 6.7) ∼ -
Mississippi
Tennessee
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Table 2.25.1.1: Testis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 4.4 ( 3.6- 5.5) 5.9 ( 4.7- 7.4) ∼ ∼
Oklahoma 4.6 ( 3.6- 5.8) 5.1 ( 3.9- 6.5) ∼ ∼
Texas 4.5 ( 4.1- 4.9) 5.0 ( 4.5- 5.4) 1.8 ( 1.0- 3.1) 3.5 ( 3.0- 4.3)
West 5.3 ( 5.0- 5.5) 5.9 ( 5.6- 6.2) 1.2 ( 0.7- 2.1) 3.7 ( 3.3- 4.2)
Mountain 5.4 ( 5.0- 5.9) 5.8 ( 5.3- 6.3) ∼ 3.9 ( 3.0- 5.2)
Arizona 4.7 ( 3.9- 5.6) 4.9 ( 4.1- 5.9) ∼ 3.5 ( 2.2- 6.9)
Colorado 5.5 ( 4.6- 6.5) 5.8 ( 4.8- 6.9) ∼ 4.2 ( 2.5- 9.2)
Idaho 5.4 ( 3.8- 7.7) 5.3 ( 3.7- 7.6) ∼ ∼
Montana 6.8 ( 4.6- 9.9) 7.0 ( 4.6- 10.3) ∼ ∼
Nevada 3.8 ( 2.8- 5.3) 4.2 ( 3.0- 5.9) ∼ ∼
New Mexico 6.3 ( 4.8- 8.3) 6.9 ( 5.2- 9.2) ∼ 5.4 ( 3.3- 9.0)
Utah 7.9 ( 6.3- 9.9) 8.4 ( 6.7- 10.5) ∼ ∼
Wyoming
Pacific 5.2 ( 4.9- 5.5) 6.0 ( 5.7- 6.4) 1.3 ( 0.8- 2.4) 3.6 ( 3.2- 4.3)
Alaska 8.0 ( 5.2- 14.3) 8.4 ( 5.1- 16.2) ∼ ∼
California 4.9 ( 4.5- 5.2) 5.7 ( 5.3- 6.1) ∼ 3.7 ( 3.2- 4.3)
San Francisco-Oakland 5.1 ( 4.2- 6.2) 7.0 ( 5.7- 8.5) ∼ 3.7 ( 2.2- 8.1)
San Jose-Monterey 4.3 ( 3.2- 5.7) 5.5 ( 4.1- 7.3) ∼ 3.8 ( 2.0- 10.1)
Los Angeles 4.0 ( 3.5- 4.6) 4.9 ( 4.2- 5.7) ∼ 2.7 ( 2.1- 3.9)
Hawaii 4.0 ( 2.6- 6.0) ∼ ∼ -
Oregon 7.1 ( 5.9- 8.5) 7.2 ( 6.0- 8.7) ∼ ∼
Washington 6.3 ( 5.5- 7.3) 6.7 ( 5.7- 7.7) ∼ ∼
Seattle-Puget Sound 6.4 ( 5.4- 7.6) 7.4 ( 6.2- 8.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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216 Table 2.25.1.2: Testis. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.2 ( 0.1- 0.3) 0.3 ( 0.2- 0.4)
Northeast 0.3 ( 0.2- 0.4) 0.3 ( 0.3- 0.4) ∼ ∼
New England 0.4 ( 0.2- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼
New Jersey ∼ ∼ ∼ ∼
New York 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Pennsylvania ∼ ∼ ∼ ∼
Midwest 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼
East North Central 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Illinois ∼ ∼ ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan ∼ ∼ ∼ ∼
Ohio 0.3 ( 0.2- 0.5) 0.4 ( 0.2- 0.6) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.2 ( 0.1- 0.3) 0.3 ( 0.2- 0.6)
South Atlantic 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.5) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central ∼ ∼ ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.3 ( 0.2- 0.4) 0.4 ( 0.3- 0.5) ∼ 0.4 ( 0.2- 0.9)
Arkansas ∼ ∼ ∼ ∼
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Table 2.25.1.2: Testis. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.3 ( 0.2- 0.5) 0.4 ( 0.2- 0.5) ∼ 0.4 ( 0.2- 0.9)
West 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ 0.4 ( 0.3- 0.8)
Mountain 0.4 ( 0.2- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ 0.3 ( 0.1- 0.7)
Alaska ∼ ∼ ∼ ∼
California 0.3 ( 0.2- 0.4) 0.4 ( 0.3- 0.5) ∼ 0.3 ( 0.1- 0.7)
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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218 Table 2.26.1.1M: Thyroid. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 4.3 ( 4.2- 4.4) 4.5 ( 4.3- 4.6) 2.2 ( 1.9- 2.5) 3.6 ( 3.3- 4.0)
Northeast 5.4 ( 5.1- 5.7) 5.6 ( 5.3- 5.9) 2.4 ( 1.8- 3.1) 3.2 ( 2.4- 4.4)
New England 5.0 ( 4.5- 5.6) 5.1 ( 4.6- 5.7) ∼ ∼
Connecticut 4.5 ( 3.6- 5.7) 4.6 ( 3.6- 5.9) ∼ ∼
Maine 4.0 ( 2.7- 5.9) 3.9 ( 2.6- 5.8) ∼ ∼
Massachusetts 5.3 ( 4.5- 6.1) 5.5 ( 4.6- 6.4) ∼ ∼
New Hampshire 3.3 ( 2.0- 5.2) 3.4 ( 2.1- 5.4) ∼ -
Rhode Island 8.8 ( 6.5- 11.9) 8.9 ( 6.5- 12.1) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 5.5 ( 5.2- 5.8) 5.8 ( 5.4- 6.1) 2.5 ( 1.9- 3.3) 3.5 ( 2.5- 4.8)
New Jersey 5.8 ( 5.1- 6.6) 6.1 ( 5.3- 7.0) ∼ 3.3 ( 1.8- 6.9)
New York 5.0 ( 4.6- 5.5) 5.4 ( 4.9- 6.0) 2.2 ( 1.4- 3.4) 3.1 ( 2.0- 4.8)
Pennsylvania 6.0 ( 5.4- 6.6) 6.0 ( 5.4- 6.7) ∼ -
Midwest 4.1 ( 3.9- 4.3) 4.2 ( 3.9- 4.4) 2.4 ( 1.8- 3.2) 2.5 ( 1.5- 4.5)
East North Central 3.9 ( 3.6- 4.1) 3.9 ( 3.6- 4.2) 2.3 ( 1.6- 3.1) 1.8 ( 1.0- 4.0)
Illinois 4.3 ( 3.8- 4.9) 4.6 ( 4.0- 5.2) ∼ 2.4 ( 1.3- 6.1)
Indiana 3.8 ( 3.1- 4.6) 3.9 ( 3.2- 4.8) ∼ ∼
Michigan 3.7 ( 3.1- 4.3) 3.6 ( 3.1- 4.3) 3.3 ( 1.8- 5.8) ∼
Detroit 4.5 ( 3.5- 5.6) 4.7 ( 3.7- 6.1) ∼ -
Ohio 3.4 ( 3.0- 4.0) 3.3 ( 2.8- 3.9) ∼ ∼
Wisconsin 4.2 ( 3.4- 5.1) 4.4 ( 3.6- 5.3) ∼ -
West North Central 4.7 ( 4.3- 5.2) 4.8 ( 4.3- 5.3) ∼ ∼
Iowa 5.4 ( 4.3- 6.8) 5.4 ( 4.2- 6.7) ∼ ∼
Kansas 4.6 ( 3.5- 5.9) 4.5 ( 3.4- 5.9) ∼ ∼
Minnesota 4.5 ( 3.7- 5.4) 4.4 ( 3.6- 5.4) ∼ ∼
Missouri 4.9 ( 4.1- 5.8) 5.3 ( 4.4- 6.3) ∼ ∼
Nebraska 4.5 ( 3.1- 6.2) 4.3 ( 3.0- 6.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 5.2 ( 3.1- 8.3) 5.0 ( 2.8- 8.4) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 3.8 ( 3.4- 4.2) 4.1 ( 3.6- 4.6) ∼ -
Georgia 3.5 ( 2.9- 4.2) 3.9 ( 3.2- 4.8) ∼ ∼
Atlanta 3.8 ( 2.7- 5.3) 4.4 ( 3.0- 6.3) ∼ ∼
Maryland 4.6 ( 3.8- 5.5) 5.3 ( 4.3- 6.5) ∼ ∼
North Carolina 2.5 ( 2.0- 3.1) 2.6 ( 2.0- 3.2) ∼ ∼
South Carolina 3.7 ( 2.9- 4.8) 4.1 ( 3.1- 5.5) ∼ -
Virginia
West Virginia 3.8 ( 2.6- 5.4) 3.8 ( 2.7- 5.4) ∼ ∼
East South Central
Alabama 3.8 ( 3.0- 4.8) 4.2 ( 3.3- 5.4) ∼ ∼
Kentucky 3.4 ( 2.6- 4.4) 3.6 ( 2.8- 4.7) ∼ -
Mississippi
Tennessee
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Table 2.26.1.1M: Thyroid. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 3.5 ( 2.8- 4.5) 4.6 ( 3.6- 5.9) ∼ ∼
Oklahoma 3.2 ( 2.4- 4.2) 3.6 ( 2.7- 4.7) ∼ ∼
Texas 4.1 ( 3.7- 4.5) 4.1 ( 3.6- 4.5) 3.4 ( 2.2- 5.3) 3.5 ( 2.7- 4.5)
West 4.3 ( 4.0- 4.5) 4.4 ( 4.1- 4.6) 1.7 ( 1.1- 2.7) 3.5 ( 3.0- 4.2)
Mountain 5.2 ( 4.7- 5.7) 5.3 ( 4.8- 5.8) ∼ 4.8 ( 3.6- 6.6)
Arizona 4.6 ( 3.8- 5.6) 4.8 ( 4.0- 5.8) ∼ 4.2 ( 2.1- 8.4)
Colorado 5.1 ( 4.2- 6.3) 5.2 ( 4.2- 6.4) ∼ ∼
Idaho 4.4 ( 2.9- 6.5) 4.6 ( 3.0- 6.7) ∼ ∼
Montana 4.7 ( 2.9- 7.2) 4.4 ( 2.7- 7.0) ∼ ∼
Nevada 4.7 ( 3.5- 6.4) 4.6 ( 3.3- 6.4) ∼ ∼
New Mexico 7.2 ( 5.5- 9.3) 7.6 ( 5.8- 9.9) ∼ 6.9 ( 4.3- 11.1)
Utah 6.4 ( 4.8- 8.4) 6.6 ( 5.0- 8.7) ∼ ∼
Wyoming
Pacific 3.9 ( 3.6- 4.2) 4.0 ( 3.7- 4.3) 1.5 ( 0.9- 2.6) 3.1 ( 2.5- 3.9)
Alaska ∼ ∼ ∼ ∼
California 3.9 ( 3.6- 4.2) 4.0 ( 3.7- 4.4) 1.4 ( 0.8- 2.6) 3.0 ( 2.4- 3.8)
San Francisco-Oakland 4.0 ( 3.2- 5.0) 4.1 ( 3.1- 5.3) ∼ ∼
San Jose-Monterey 3.6 ( 2.6- 5.1) 3.3 ( 2.1- 4.9) ∼ ∼
Los Angeles 4.2 ( 3.6- 5.0) 4.5 ( 3.8- 5.4) ∼ 3.3 ( 2.3- 4.8)
Hawaii 4.8 ( 3.2- 6.9) ∼ ∼ -
Oregon 3.4 ( 2.6- 4.4) 3.4 ( 2.6- 4.4) ∼ ∼
Washington 4.3 ( 3.6- 5.2) 4.2 ( 3.4- 5.1) ∼ ∼
Seattle-Puget Sound 4.5 ( 3.6- 5.6) 4.7 ( 3.7- 5.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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220 Table 2.26.1.1F: Thyroid. Age-Adjusted Invasive Cancer Incidence Rates
∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 12.1 ( 11.9- 12.3) 12.5 ( 12.3- 12.7) 7.4 ( 6.9- 7.8) 12.1 ( 11.5- 12.7)
Northeast 15.0 ( 14.5- 15.4) 15.5 ( 15.0- 16.0) 8.3 ( 7.3- 9.3) 11.4 ( 10.0- 12.9)
New England 14.2 ( 13.4- 15.1) 14.4 ( 13.5- 15.3) 7.4 ( 5.0- 10.8) 14.5 ( 10.6- 19.9)
Connecticut 13.9 ( 12.2- 15.7) 14.5 ( 12.7- 16.5) ∼ 17.0 ( 10.5- 28.0)
Maine 15.2 ( 12.4- 18.5) 15.0 ( 12.2- 18.4) ∼ ∼
Massachusetts 15.0 ( 13.7- 16.3) 15.2 ( 13.9- 16.7) ∼ 11.5 ( 6.8- 20.1)
New Hampshire 10.4 ( 8.1- 13.2) 10.1 ( 7.8- 12.9) ∼ -
Rhode Island 15.6 ( 12.5- 19.2) 15.4 ( 12.2- 19.3) ∼ ∼
Vermont 11.8 ( 8.4- 16.4) 11.8 ( 8.3- 16.4) ∼ ∼
Middle Atlantic 15.3 ( 14.7- 15.8) 15.9 ( 15.3- 16.5) 8.4 ( 7.4- 9.5) 10.8 ( 9.4- 12.5)
New Jersey 15.6 ( 14.4- 16.8) 16.8 ( 15.5- 18.2) 7.9 ( 5.9- 10.5) 12.0 ( 9.3- 15.5)
New York 13.2 ( 12.5- 13.9) 13.6 ( 12.8- 14.4) 6.6 ( 5.5- 7.9) 9.8 ( 8.1- 11.7)
Pennsylvania 18.3 ( 17.3- 19.4) 18.4 ( 17.3- 19.6) 13.8 ( 11.1- 17.0) -
Midwest 11.2 ( 10.9- 11.6) 11.7 ( 11.3- 12.1) 6.9 ( 6.0- 7.9) 11.3 ( 9.2- 14.0)
East North Central 10.9 ( 10.5- 11.4) 11.4 ( 11.0- 11.9) 6.7 ( 5.8- 7.8) 11.5 ( 9.1- 14.5)
Illinois 13.0 ( 12.2- 13.9) 14.1 ( 13.1- 15.1) 7.7 ( 6.0- 9.7) 10.1 ( 7.4- 14.0)
Indiana 10.7 ( 9.6- 12.0) 11.1 ( 9.9- 12.4) 7.5 ( 4.5- 11.9) ∼
Michigan 10.9 ( 10.0- 11.8) 11.3 ( 10.4- 12.4) 6.9 ( 5.0- 9.1) ∼
Detroit 11.5 ( 10.1- 13.1) 13.5 ( 11.7- 15.5) 6.5 ( 4.5- 9.2) -
Ohio 9.1 ( 8.4- 10.0) 9.3 ( 8.5- 10.2) 5.4 ( 3.8- 7.5) ∼
Wisconsin 10.5 ( 9.3- 11.8) 11.1 ( 9.8- 12.4) ∼ -
West North Central 12.0 ( 11.3- 12.7) 12.2 ( 11.5- 13.0) 7.8 ( 5.5- 10.7) 10.6 ( 6.5- 17.7)
Iowa 13.4 ( 11.6- 15.5) 13.5 ( 11.6- 15.6) ∼ ∼
Kansas 13.2 ( 11.3- 15.3) 13.4 ( 11.4- 15.6) ∼ ∼
Minnesota 10.7 ( 9.4- 12.0) 10.4 ( 9.1- 11.8) ∼ ∼
Missouri 11.3 ( 10.1- 12.6) 12.0 ( 10.6- 13.4) 7.0 ( 4.4- 10.8) ∼
Nebraska 14.2 ( 11.8- 17.0) 14.7 ( 12.2- 17.6) ∼ ∼
North Dakota 12.2 ( 8.6- 16.8) 12.0 ( 8.4- 16.8) ∼ ∼
South Dakota
South
South Atlantic
Delaware 16.3 ( 12.7- 20.6) 17.2 ( 13.0- 22.4) ∼ ∼
District of Columbia 14.4 ( 10.5- 19.6) 17.3 ( 9.9- 30.6) 11.4 ( 7.1- 18.0) ∼
Florida 11.4 ( 10.7- 12.1) 12.2 ( 11.4- 13.0) 6.6 ( 5.2- 8.3) -
Georgia 10.5 ( 9.6- 11.6) 11.6 ( 10.4- 12.9) 8.0 ( 6.4- 9.9) 15.6 ( 8.1- 29.9)
Atlanta 13.0 ( 11.2- 15.0) 16.1 ( 13.6- 19.0) 8.5 ( 6.0- 12.2) ∼
Maryland 13.1 ( 11.8- 14.5) 14.2 ( 12.6- 16.0) 10.6 ( 8.5- 13.3) 20.7 ( 12.3- 34.8)
North Carolina 7.1 ( 6.3- 7.9) 7.5 ( 6.6- 8.5) 5.5 ( 4.1- 7.3) ∼
South Carolina 8.4 ( 7.2- 9.8) 9.5 ( 8.0- 11.3) 5.5 ( 3.8- 7.8) -
Virginia
West Virginia 12.9 ( 10.7- 15.4) 13.1 ( 10.9- 15.7) ∼ ∼
East South Central
Alabama 8.6 ( 7.5- 9.9) 9.0 ( 7.6- 10.6) 7.8 ( 5.7- 10.4) ∼
Kentucky 10.7 ( 9.4- 12.2) 10.8 ( 9.4- 12.3) ∼ -
Mississippi
Tennessee
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Table 2.26.1.1F: Thyroid. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 11.1 ( 9.8- 12.6) 14.1 ( 12.3- 16.2) 5.6 ( 4.0- 7.8) ∼
Oklahoma 8.6 ( 7.3- 10.1) 8.8 ( 7.4- 10.5) ∼ ∼
Texas 11.5 ( 10.9- 12.2) 11.9 ( 11.2- 12.7) 6.2 ( 4.8- 7.9) 11.9 ( 10.6- 13.4)
West 12.2 ( 11.8- 12.6) 12.3 ( 11.8- 12.7) 7.0 ( 5.8- 8.5) 11.6 ( 10.8- 12.6)
Mountain 13.9 ( 13.2- 14.7) 14.1 ( 13.3- 15.0) 11.8 ( 7.8- 17.5) 12.8 ( 11.0- 15.0)
Arizona 11.3 ( 10.1- 12.7) 11.7 ( 10.3- 13.2) ∼ 11.1 ( 8.3- 15.0)
Colorado 12.9 ( 11.5- 14.5) 12.8 ( 11.3- 14.4) ∼ 14.1 ( 10.2- 19.6)
Idaho 13.9 ( 11.2- 17.2) 14.3 ( 11.4- 17.6) ∼ ∼
Montana 16.7 ( 13.2- 21.0) 17.8 ( 14.0- 22.4) ∼ ∼
Nevada 15.4 ( 13.2- 18.0) 15.1 ( 12.7- 17.9) ∼ 14.1 ( 8.7- 24.5)
New Mexico 16.8 ( 14.3- 19.7) 17.3 ( 14.6- 20.5) ∼ 12.0 ( 8.7- 16.3)
Utah 17.4 ( 14.9- 20.3) 17.7 ( 15.1- 20.6) ∼ ∼
Wyoming
Pacific 11.6 ( 11.1- 12.0) 11.4 ( 10.9- 11.9) 6.1 ( 4.8- 7.7) 11.3 ( 10.3- 12.4)
Alaska 12.3 ( 8.5- 17.7) 9.0 ( 5.7- 14.6) ∼ ∼
California 11.1 ( 10.6- 11.6) 11.4 ( 10.8- 12.0) 5.4 ( 4.2- 7.0) 11.3 ( 10.2- 12.4)
San Francisco-Oakland 10.3 ( 9.0- 11.7) 9.5 ( 8.0- 11.3) ∼ 13.1 ( 9.3- 18.4)
San Jose-Monterey 10.6 ( 8.8- 12.6) 11.9 ( 9.8- 14.5) ∼ 12.1 ( 8.1- 18.1)
Los Angeles 12.0 ( 11.0- 13.0) 12.5 ( 11.3- 13.7) 6.2 ( 4.2- 8.8) 10.4 ( 8.9- 12.2)
Hawaii 15.3 ( 12.4- 18.6) 12.3 ( 7.5- 20.0) ∼ -
Oregon 10.6 ( 9.1- 12.2) 9.7 ( 8.3- 11.4) ∼ 16.3 ( 8.5- 33.7)
Washington 13.7 ( 12.4- 15.1) 12.8 ( 11.5- 14.3) ∼ 12.2 ( 6.3- 24.0)
Seattle-Puget Sound 12.8 ( 11.3- 14.4) 13.2 ( 11.6- 15.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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222 Table 2.26.1.2M: Thyroid. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.3- 0.5) 0.6 ( 0.4- 0.8)
Northeast 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
New England 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
New Jersey 0.4 ( 0.3- 0.7) ∼ ∼ ∼
New York 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Pennsylvania 0.4 ( 0.2- 0.6) 0.4 ( 0.2- 0.6) ∼ ∼
Midwest 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
East North Central 0.6 ( 0.5- 0.7) 0.6 ( 0.5- 0.7) ∼ ∼
Illinois 0.5 ( 0.4- 0.8) 0.6 ( 0.4- 0.9) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.6 ( 0.4- 1.0) 0.6 ( 0.4- 1.0) ∼ ∼
Ohio 0.6 ( 0.4- 0.8) 0.6 ( 0.4- 0.9) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.2- 0.6) 0.7 ( 0.4- 1.2)
South Atlantic 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.6 ( 0.5- 0.8) 0.7 ( 0.5- 0.9) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.26.1.2M: Thyroid. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.7 ( 0.5- 0.9) 0.7 ( 0.5- 1.0) ∼ ∼
West 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) ∼ 0.6 ( 0.4- 1.0)
Mountain 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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224 Table 2.26.1.2F: Thyroid. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) 0.6 ( 0.5- 0.8)
Northeast 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) ∼ ∼
New England 0.4 ( 0.3- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.4 ( 0.2- 0.7) ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
New Jersey 0.4 ( 0.2- 0.6) 0.4 ( 0.2- 0.6) ∼ ∼
New York 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼
Pennsylvania 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Midwest 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
East North Central 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
Illinois 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Indiana 0.4 ( 0.3- 0.7) 0.5 ( 0.3- 0.8) ∼ ∼
Michigan 0.6 ( 0.4- 0.8) 0.6 ( 0.4- 0.8) ∼ ∼
Ohio 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Wisconsin 0.5 ( 0.3- 0.8) ∼ ∼ ∼
West North Central 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.6) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri 0.5 ( 0.3- 0.9) 0.5 ( 0.3- 0.8) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.7) 0.4 ( 0.2- 0.7)
South Atlantic 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.2- 0.6) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina 0.4 ( 0.2- 0.6) ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia 0.5 ( 0.3- 0.8) 0.5 ( 0.3- 0.9) ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.5 ( 0.4- 0.7) 0.5 ( 0.3- 0.6) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee 0.6 ( 0.3- 0.9) 0.5 ( 0.3- 0.9) ∼ ∼
West South Central 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.26.1.2F: Thyroid. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 0.8 ( 0.5- 1.2) ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼
West 0.6 ( 0.5- 0.6) 0.5 ( 0.4- 0.6) ∼ 0.8 ( 0.5- 1.1)
Mountain 0.6 ( 0.4- 0.8) 0.6 ( 0.4- 0.7) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.5 ( 0.5- 0.7) 0.5 ( 0.4- 0.6) ∼ 0.7 ( 0.4- 1.1)
Alaska ∼ ∼ ∼ ∼
California 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.6) ∼ 0.7 ( 0.4- 1.2)
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington 0.6 ( 0.3- 0.9) 0.5 ( 0.3- 0.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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226 Table 2.27.1.1M: Urinary Bladder. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2002
Area All Races White Black Hispanic§‖
United States 37.0 ( 36.7- 37.4) 39.0 ( 38.6- 39.4) 17.7 ( 16.8- 18.7) 19.9 ( 18.8- 21.0)
Northeast 43.0 ( 42.1- 43.8) 45.6 ( 44.7- 46.5) 15.9 ( 14.1- 18.0) 21.9 ( 18.9- 25.3)
New England 45.4 ( 43.7- 47.1) 46.3 ( 44.6- 48.1) 17.8 ( 12.0- 26.1) 30.4 ( 21.4- 42.7)
Connecticut 41.6 ( 38.5- 44.9) 42.6 ( 39.4- 46.1) ∼ 27.8 ( 14.4- 50.7)
Maine 45.8 ( 40.7- 51.5) 45.7 ( 40.5- 51.3) ∼ ∼
Massachusetts 47.1 ( 44.5- 49.7) 48.6 ( 46.0- 51.3) 19.3 ( 11.4- 31.9) 22.8 ( 12.6- 40.2)
New Hampshire 49.2 ( 43.4- 55.7) 48.8 ( 42.9- 55.3) ∼ -
Rhode Island 49.2 ( 43.2- 55.9) 49.9 ( 43.6- 56.8) ∼ ∼
Vermont 33.9 ( 27.4- 41.6) 34.3 ( 27.7- 42.0) ∼ ∼
Middle Atlantic 42.1 ( 41.2- 43.1) 45.4 ( 44.3- 46.4) 15.7 ( 13.7- 17.9) 20.7 ( 17.6- 24.3)
New Jersey 43.2 ( 41.1- 45.4) 46.5 ( 44.2- 49.0) 14.6 ( 10.7- 19.8) 27.9 ( 20.8- 37.1)
New York 40.4 ( 39.1- 41.9) 44.7 ( 43.2- 46.4) 14.2 ( 11.8- 17.2) 16.7 ( 13.3- 20.7)
Pennsylvania 43.9 ( 42.2- 45.6) 45.5 ( 43.7- 47.3) 20.2 ( 15.9- 25.5) -
Midwest 38.1 ( 37.4- 38.9) 39.0 ( 38.2- 39.8) 19.4 ( 17.3- 21.6) 20.5 ( 16.4- 25.4)
East North Central 38.7 ( 37.8- 39.6) 39.9 ( 38.9- 40.8) 19.7 ( 17.5- 22.2) 21.6 ( 16.9- 27.4)
Illinois 41.7 ( 39.9- 43.5) 44.6 ( 42.6- 46.6) 18.5 ( 14.8- 23.0) 20.1 ( 14.3- 28.2)
Indiana 34.1 ( 31.8- 36.5) 34.2 ( 31.9- 36.7) 20.2 ( 13.4- 29.8) ∼
Michigan 40.3 ( 38.4- 42.3) 41.6 ( 39.5- 43.8) 22.6 ( 18.2- 27.9) 28.0 ( 14.8- 50.5)
Detroit 43.1 ( 40.0- 46.5) 49.3 ( 45.5- 53.4) 18.6 ( 14.1- 24.3) -
Ohio 38.3 ( 36.5- 40.0) 38.7 ( 36.9- 40.6) 18.6 ( 14.4- 23.9) 35.0 ( 18.6- 63.5)
Wisconsin 35.7 ( 33.3- 38.2) 36.3 ( 33.9- 38.8) ∼ -
West North Central 36.8 ( 35.5- 38.1) 37.2 ( 35.8- 38.6) 17.0 ( 12.6- 22.7) 15.9 ( 8.8- 27.7)
Iowa 37.3 ( 34.2- 40.7) 37.1 ( 34.0- 40.5) ∼ ∼
Kansas 35.5 ( 32.2- 39.1) 35.5 ( 32.1- 39.2) ∼ ∼
Minnesota 38.8 ( 36.2- 41.6) 38.7 ( 36.0- 41.5) ∼ ∼
Missouri 35.7 ( 33.4- 38.2) 37.1 ( 34.6- 39.7) 16.0 ( 10.7- 23.6) ∼
Nebraska 35.9 ( 31.8- 40.4) 35.6 ( 31.4- 40.2) ∼ ∼
North Dakota 36.6 ( 30.3- 44.0) 37.4 ( 30.9- 45.0) ∼ ∼
South Dakota
South
South Atlantic
Delaware 39.1 ( 32.9- 46.3) 40.9 ( 34.0- 48.9) ∼ ∼
District of Columbia 24.2 ( 18.1- 31.8) 36.1 ( 23.8- 54.0) 18.4 ( 11.9- 27.7) ∼
Florida 38.2 ( 37.0- 39.5) 39.9 ( 38.6- 41.2) 17.8 ( 14.4- 22.0) -
Georgia 32.2 ( 30.1- 34.5) 36.0 ( 33.5- 38.7) 16.8 ( 13.4- 21.0) ∼
Atlanta 27.6 ( 23.9- 31.9) 31.5 ( 26.9- 36.8) 13.8 ( 8.8- 21.5) ∼
Maryland 34.5 ( 32.0- 37.1) 38.6 ( 35.6- 41.8) 22.4 ( 17.3- 28.6) ∼
North Carolina 31.8 ( 29.9- 33.8) 35.1 ( 32.9- 37.5) 14.7 ( 11.4- 18.8) ∼
South Carolina 31.6 ( 28.9- 34.6) 35.3 ( 32.0- 38.8) 17.3 ( 13.0- 22.7) -
Virginia
West Virginia 39.7 ( 35.7- 44.2) 40.2 ( 36.1- 44.7) ∼ ∼
East South Central
Alabama 30.7 ( 28.3- 33.4) 34.0 ( 31.2- 37.1) 16.4 ( 12.3- 21.5) ∼
Kentucky 38.2 ( 35.3- 41.4) 38.9 ( 35.9- 42.2) 24.4 ( 14.9- 38.8) -
Mississippi
Tennessee
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Table 2.27.1.1M: Urinary Bladder. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 33.2 ( 30.5- 36.1) 38.2 ( 34.9- 41.8) 17.0 ( 13.1- 21.9) ∼
Oklahoma 31.2 ( 28.4- 34.2) 32.5 ( 29.5- 35.7) ∼ ∼
Texas 28.3 ( 27.1- 29.5) 29.4 ( 28.1- 30.7) 18.1 ( 14.8- 22.0) 15.3 ( 13.2- 17.8)
West 35.0 ( 34.3- 35.7) 37.1 ( 36.3- 37.9) 19.1 ( 16.2- 22.4) 17.4 ( 15.7- 19.1)
Mountain 35.3 ( 33.9- 36.7) 36.2 ( 34.8- 37.7) ∼ 16.0 ( 13.1- 19.6)
Arizona 35.9 ( 33.5- 38.4) 36.8 ( 34.4- 39.4) ∼ 11.7 ( 7.6- 18.0)
Colorado 34.9 ( 31.9- 38.0) 35.7 ( 32.7- 39.0) ∼ 17.5 ( 11.2- 27.0)
Idaho 39.9 ( 34.7- 45.6) 39.9 ( 34.7- 45.7) ∼ ∼
Montana 41.7 ( 35.9- 48.3) 41.1 ( 35.2- 47.7) ∼ ∼
Nevada 41.0 ( 36.7- 45.7) 42.5 ( 38.0- 47.5) ∼ ∼
New Mexico 27.9 ( 24.3- 31.9) 29.9 ( 26.0- 34.3) ∼ 17.0 ( 12.0- 23.8)
Utah 27.4 ( 23.7- 31.7) 28.0 ( 24.2- 32.3) ∼ ∼
Wyoming
Pacific 34.9 ( 34.0- 35.7) 37.5 ( 36.5- 38.5) 20.5 ( 17.3- 24.2) 17.9 ( 15.9- 20.0)
Alaska 32.3 ( 23.9- 44.0) 40.5 ( 29.8- 55.2) ∼ ∼
California 33.4 ( 32.4- 34.4) 36.1 ( 35.0- 37.3) 20.8 ( 17.4- 24.8) 18.1 ( 16.1- 20.3)
San Francisco-Oakland 29.8 ( 27.3- 32.6) 34.0 ( 30.8- 37.4) 17.3 ( 10.9- 26.6) 21.2 ( 14.1- 31.3)
San Jose-Monterey 31.8 ( 28.0- 36.1) 33.7 ( 29.3- 38.5) ∼ 25.6 ( 16.7- 38.6)
Los Angeles 31.6 ( 29.7- 33.6) 35.0 ( 32.6- 37.4) 23.8 ( 18.5- 30.4) 17.6 ( 14.4- 21.4)
Hawaii 26.5 ( 22.6- 31.0) 40.8 ( 31.2- 53.0) ∼ -
Oregon 40.6 ( 37.5- 43.9) 39.7 ( 36.6- 43.1) ∼ ∼
Washington 41.0 ( 38.4- 43.6) 41.8 ( 39.1- 44.5) ∼ ∼
Seattle-Puget Sound 43.2 ( 40.0- 46.6) 45.5 ( 42.1- 49.1) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Includes invasive and in situ.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1M. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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228 Table 2.27.1.1F: Urinary Bladder. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2002
Area All Races White Black Hispanic§‖
United States 9.4 ( 9.3- 9.6) 9.8 ( 9.6- 10.0) 7.1 ( 6.7- 7.6) 5.6 ( 5.1- 6.1)
Northeast 11.4 ( 11.1- 11.8) 12.1 ( 11.7- 12.5) 7.4 ( 6.4- 8.4) 6.6 ( 5.4- 8.0)
New England 12.7 ( 11.9- 13.4) 13.0 ( 12.2- 13.8) 7.0 ( 4.3- 11.0) ∼
Connecticut 12.0 ( 10.5- 13.6) 12.3 ( 10.8- 14.1) ∼ ∼
Maine 12.4 ( 10.2- 15.2) 12.4 ( 10.1- 15.2) ∼ ∼
Massachusetts 12.7 ( 11.6- 13.9) 13.1 ( 12.0- 14.4) ∼ ∼
New Hampshire 14.3 ( 11.6- 17.4) 14.3 ( 11.6- 17.5) ∼ -
Rhode Island 13.6 ( 10.9- 16.8) 14.3 ( 11.5- 17.8) ∼ ∼
Vermont 12.4 ( 9.1- 16.8) 12.5 ( 9.1- 17.0) ∼ ∼
Middle Atlantic 11.0 ( 10.6- 11.4) 11.7 ( 11.2- 12.2) 7.4 ( 6.4- 8.5) 6.6 ( 5.3- 8.1)
New Jersey 12.1 ( 11.1- 13.1) 12.5 ( 11.5- 13.6) 11.2 ( 8.5- 14.6) 9.2 ( 6.1- 13.3)
New York 10.7 ( 10.1- 11.3) 11.7 ( 11.0- 12.4) 6.1 ( 4.9- 7.4) 5.2 ( 3.9- 6.9)
Pennsylvania 10.9 ( 10.2- 11.7) 11.3 ( 10.5- 12.1) 7.7 ( 5.7- 10.2) -
Midwest 9.6 ( 9.3- 9.9) 9.7 ( 9.4- 10.0) 7.6 ( 6.6- 8.7) 5.7 ( 3.9- 8.2)
East North Central 9.7 ( 9.3- 10.1) 9.8 ( 9.4- 10.2) 7.5 ( 6.4- 8.7) 5.8 ( 3.7- 8.7)
Illinois 9.9 ( 9.2- 10.7) 10.0 ( 9.2- 10.8) 9.3 ( 7.3- 11.7) 5.7 ( 3.2- 9.8)
Indiana 8.7 ( 7.7- 9.7) 8.7 ( 7.8- 9.8) ∼ ∼
Michigan 9.5 ( 8.7- 10.3) 9.7 ( 8.8- 10.6) 7.6 ( 5.6- 10.1) ∼
Detroit 10.3 ( 9.0- 11.7) 11.3 ( 9.8- 13.0) 7.3 ( 5.1- 10.2) -
Ohio 10.4 ( 9.6- 11.2) 10.4 ( 9.6- 11.2) 6.4 ( 4.6- 8.8) ∼
Wisconsin 9.2 ( 8.2- 10.3) 9.4 ( 8.4- 10.6) ∼ -
West North Central 9.4 ( 8.9- 10.0) 9.5 ( 8.9- 10.1) 8.2 ( 5.7- 11.5) ∼
Iowa 10.3 ( 8.9- 11.9) 10.2 ( 8.8- 11.8) ∼ ∼
Kansas 7.3 ( 6.1- 8.8) 7.4 ( 6.0- 8.9) ∼ ∼
Minnesota 10.3 ( 9.1- 11.6) 10.3 ( 9.1- 11.6) ∼ ∼
Missouri 9.3 ( 8.3- 10.3) 9.4 ( 8.3- 10.5) 8.2 ( 5.2- 12.3) ∼
Nebraska 9.6 ( 7.8- 11.8) 9.7 ( 7.9- 12.0) ∼ ∼
North Dakota 9.7 ( 6.8- 13.6) 10.0 ( 7.0- 14.0) ∼ ∼
South Dakota
South
South Atlantic
Delaware 9.1 ( 6.6- 12.3) 9.7 ( 6.9- 13.5) ∼ ∼
District of Columbia 7.0 ( 4.5- 10.9) ∼ 7.4 ( 4.3- 12.8) ∼
Florida 10.0 ( 9.4- 10.6) 10.4 ( 9.8- 11.0) 5.8 ( 4.4- 7.6) -
Georgia 7.8 ( 7.0- 8.7) 8.0 ( 7.0- 9.1) 7.4 ( 5.7- 9.6) ∼
Atlanta 8.0 ( 6.5- 9.9) 7.4 ( 5.6- 9.5) 10.3 ( 6.8- 15.1) ∼
Maryland 8.0 ( 7.0- 9.1) 8.3 ( 7.2- 9.6) 7.6 ( 5.6- 10.2) ∼
North Carolina 8.1 ( 7.3- 9.0) 8.6 ( 7.6- 9.6) 6.5 ( 4.9- 8.5) ∼
South Carolina 7.2 ( 6.2- 8.4) 7.5 ( 6.3- 9.0) 6.4 ( 4.4- 8.8) -
Virginia
West Virginia 12.9 ( 11.0- 15.2) 13.2 ( 11.2- 15.5) ∼ ∼
East South Central
Alabama 7.7 ( 6.7- 8.9) 8.5 ( 7.3- 9.9) 5.3 ( 3.6- 7.7) ∼
Kentucky 9.2 ( 8.0- 10.5) 9.2 ( 7.9- 10.5) ∼ -
Mississippi
Tennessee
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Table 2.27.1.1F: Urinary Bladder. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Confidence
Intervals by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2002
Area All Races White Black Hispanic§‖
West South Central
Arkansas
Louisiana 8.2 ( 7.1- 9.4) 8.3 ( 7.0- 9.8) 7.8 ( 5.7- 10.3) ∼
Oklahoma 7.7 ( 6.5- 9.0) 7.7 ( 6.5- 9.1) ∼ ∼
Texas 6.7 ( 6.2- 7.3) 6.7 ( 6.2- 7.3) 6.6 ( 5.0- 8.5) 3.8 ( 3.0- 4.8)
West 8.7 ( 8.3- 9.0) 9.3 ( 8.9- 9.6) 7.5 ( 6.1- 9.2) 5.5 ( 4.7- 6.3)
Mountain 8.8 ( 8.2- 9.4) 9.0 ( 8.4- 9.7) ∼ 5.9 ( 4.4- 7.8)
Arizona 9.0 ( 7.9- 10.1) 9.3 ( 8.2- 10.5) ∼ 6.1 ( 3.6- 9.8)
Colorado 9.6 ( 8.3- 11.1) 9.7 ( 8.3- 11.2) ∼ ∼
Idaho 7.3 ( 5.4- 9.6) 7.4 ( 5.5- 9.8) ∼ ∼
Montana 9.8 ( 7.4- 12.9) 9.5 ( 7.1- 12.7) ∼ ∼
Nevada 11.5 ( 9.6- 13.8) 12.1 ( 10.0- 14.6) ∼ ∼
New Mexico 6.3 ( 4.9- 8.2) 6.9 ( 5.3- 8.9) ∼ ∼
Utah 6.4 ( 4.8- 8.2) 6.6 ( 5.0- 8.5) ∼ ∼
Wyoming
Pacific 8.6 ( 8.2- 9.0) 9.4 ( 8.9- 9.8) 7.9 ( 6.3- 9.8) 5.3 ( 4.5- 6.3)
Alaska ∼ ∼ ∼ ∼
California 8.3 ( 7.9- 8.7) 9.0 ( 8.5- 9.5) 7.8 ( 6.2- 9.8) 5.3 ( 4.4- 6.3)
San Francisco-Oakland 9.8 ( 8.5- 11.1) 11.8 ( 10.1- 13.6) 10.1 ( 6.3- 15.6) 11.1 ( 7.0- 16.8)
San Jose-Monterey 7.9 ( 6.4- 9.8) 9.9 ( 7.9- 12.2) ∼ ∼
Los Angeles 7.6 ( 6.9- 8.5) 8.4 ( 7.4- 9.4) 7.8 ( 5.5- 10.8) 4.8 ( 3.6- 6.4)
Hawaii 3.7 ( 2.5- 5.5) ∼ ∼ -
Oregon 10.3 ( 8.9- 11.8) 10.4 ( 9.0- 12.0) ∼ ∼
Washington 10.7 ( 9.6- 12.0) 11.1 ( 9.9- 12.4) ∼ ∼
Seattle-Puget Sound 11.6 ( 10.2- 13.2) 12.2 ( 10.7- 13.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
‡ Includes invasive and in situ.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Technical Notes) for each of those cancers. U.S rates are as presented in Table 1.1.1.1F. Michigan, Georgia,
California, and Washington state rates each include cases from the SEER metropolitan areas.
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230 Table 2.27.1.2M: Urinary Bladder. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2002
Area All Races White Black Hispanic‡§
United States 7.5 ( 7.3- 7.7) 7.8 ( 7.7- 8.0) 5.5 ( 5.0- 6.1) 4.2 ( 3.7- 4.8)
Northeast 8.1 ( 7.8- 8.5) 8.5 ( 8.1- 8.9) 4.7 ( 3.7- 6.0) 6.0 ( 4.3- 8.1)
New England 8.7 ( 8.0- 9.5) 8.7 ( 8.0- 9.5) 10.3 ( 5.7- 17.8) ∼
Connecticut 9.3 ( 7.9- 11.0) 9.5 ( 7.9- 11.2) ∼ ∼
Maine 8.4 ( 6.3- 11.2) 8.5 ( 6.3- 11.3) ∼ ∼
Massachusetts 8.0 ( 7.0- 9.1) 8.0 ( 6.9- 9.2) ∼ ∼
New Hampshire 9.4 ( 6.9- 12.7) 9.3 ( 6.8- 12.6) ∼ ∼
Rhode Island 8.8 ( 6.3- 12.0) 8.7 ( 6.2- 11.9) ∼ ∼
Vermont 11.4 ( 7.6- 16.5) 11.5 ( 7.6- 16.7) ∼ ∼
Middle Atlantic 7.9 ( 7.5- 8.4) 8.4 ( 8.0- 8.9) 4.1 ( 3.1- 5.4) 5.5 ( 3.8- 7.7)
New Jersey 8.2 ( 7.3- 9.3) 8.8 ( 7.8- 10.0) ∼ ∼
New York 7.7 ( 7.1- 8.4) 8.4 ( 7.7- 9.1) 3.7 ( 2.4- 5.4) 4.6 ( 2.8- 7.3)
Pennsylvania 8.0 ( 7.2- 8.7) 8.2 ( 7.5- 9.0) 4.9 ( 2.8- 8.1) ∼
Midwest 7.7 ( 7.4- 8.0) 8.0 ( 7.6- 8.3) 4.9 ( 3.9- 6.2) ∼
East North Central 7.8 ( 7.4- 8.2) 8.1 ( 7.6- 8.5) 5.0 ( 3.8- 6.4) ∼
Illinois 7.2 ( 6.5- 8.1) 7.8 ( 6.9- 8.7) 4.0 ( 2.3- 6.5) ∼
Indiana 6.5 ( 5.5- 7.6) 6.8 ( 5.8- 8.0) ∼ ∼
Michigan 7.8 ( 6.9- 8.7) 8.0 ( 7.0- 9.0) 6.4 ( 4.0- 9.8) ∼
Ohio 8.7 ( 7.8- 9.6) 9.0 ( 8.1- 10.0) 5.5 ( 3.3- 9.0) ∼
Wisconsin 8.3 ( 7.1- 9.5) 8.3 ( 7.2- 9.6) ∼ ∼
West North Central 7.5 ( 6.9- 8.1) 7.6 ( 7.0- 8.3) ∼ ∼
Iowa 7.0 ( 5.7- 8.6) 7.1 ( 5.8- 8.7) ∼ ∼
Kansas 8.2 ( 6.6- 10.0) 8.4 ( 6.8- 10.3) ∼ ∼
Minnesota 8.4 ( 7.2- 9.8) 8.6 ( 7.3- 10.0) ∼ ∼
Missouri 7.1 ( 6.0- 8.2) 7.1 ( 6.1- 8.4) ∼ ∼
Nebraska 6.9 ( 5.1- 9.0) 7.0 ( 5.3- 9.3) ∼ ∼
North Dakota 6.9 ( 4.3- 10.6) 7.0 ( 4.4- 10.8) ∼ ∼
South Dakota 7.3 ( 4.7- 10.7) 7.2 ( 4.6- 10.7) ∼ ∼
South 7.3 ( 7.0- 7.6) 7.5 ( 7.2- 7.8) 5.9 ( 5.2- 6.7) 4.5 ( 3.6- 5.5)
South Atlantic 7.4 ( 7.1- 7.8) 7.7 ( 7.3- 8.1) 6.2 ( 5.2- 7.2) 6.0 ( 4.6- 7.8)
Delaware 9.6 ( 6.6- 13.8) 10.4 ( 7.0- 15.0) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 7.5 ( 6.9- 8.1) 7.7 ( 7.1- 8.3) 6.5 ( 4.4- 9.3) 6.7 ( 5.1- 8.7)
Georgia 6.6 ( 5.6- 7.8) 6.8 ( 5.6- 8.2) 6.1 ( 4.0- 9.1) ∼
Maryland 8.1 ( 6.9- 9.5) 8.3 ( 6.9- 9.9) 8.0 ( 5.2- 12.2) ∼
North Carolina 7.2 ( 6.2- 8.3) 7.6 ( 6.6- 8.9) 5.0 ( 3.1- 7.8) ∼
South Carolina 7.5 ( 6.2- 9.1) 8.0 ( 6.4- 9.9) 5.8 ( 3.3- 9.5) ∼
Virginia 7.3 ( 6.3- 8.5) 7.7 ( 6.5- 9.1) 5.5 ( 3.4- 8.6) ∼
West Virginia 8.2 ( 6.3- 10.5) 8.3 ( 6.4- 10.7) ∼ ∼
East South Central 7.3 ( 6.6- 8.0) 7.6 ( 6.9- 8.4) 5.2 ( 3.8- 7.0) ∼
Alabama 6.9 ( 5.7- 8.3) 7.5 ( 6.1- 9.2) ∼ ∼
Kentucky 7.7 ( 6.4- 9.3) 7.9 ( 6.5- 9.5) ∼ ∼
Mississippi 7.6 ( 6.0- 9.6) 8.6 ( 6.6- 11.0) ∼ ∼
Tennessee 7.1 ( 6.0- 8.3) 7.1 ( 6.0- 8.5) 7.2 ( 4.1- 11.9) ∼
West South Central 7.0 ( 6.5- 7.6) 7.2 ( 6.7- 7.8) 6.0 ( 4.5- 7.7) 3.4 ( 2.4- 4.7)
Arkansas 7.9 ( 6.3- 9.7) 8.0 ( 6.3- 9.9) ∼ ∼
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Table 2.27.1.2M: Urinary Bladder. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2002
Area All Races White Black Hispanic‡§
Louisiana 6.2 ( 5.0- 7.7) 6.8 ( 5.3- 8.5) ∼ ∼
Oklahoma 8.1 ( 6.7- 9.8) 8.5 ( 7.0- 10.3) ∼ ∼
Texas 6.8 ( 6.2- 7.5) 6.9 ( 6.3- 7.6) 6.6 ( 4.6- 9.3) 3.4 ( 2.4- 4.8)
West 7.0 ( 6.7- 7.4) 7.5 ( 7.1- 7.9) 6.1 ( 4.4- 8.4) 3.5 ( 2.7- 4.4)
Mountain 7.2 ( 6.5- 7.8) 7.3 ( 6.7- 8.0) ∼ 3.3 ( 1.9- 5.5)
Arizona 6.9 ( 5.8- 8.1) 7.1 ( 6.0- 8.3) ∼ ∼
Colorado 7.5 ( 6.1- 9.2) 7.8 ( 6.3- 9.5) ∼ ∼
Idaho 7.6 ( 5.4- 10.5) 7.6 ( 5.4- 10.4) ∼ ∼
Montana 6.5 ( 4.3- 9.5) 6.5 ( 4.3- 9.6) ∼ ∼
Nevada 8.9 ( 6.8- 11.5) 9.3 ( 7.1- 12.1) ∼ ∼
New Mexico 6.4 ( 4.6- 8.6) 6.8 ( 4.9- 9.1) ∼ ∼
Utah 6.3 ( 4.5- 8.6) 6.4 ( 4.6- 8.7) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 7.0 ( 6.6- 7.4) 7.6 ( 7.2- 8.1) 5.9 ( 4.1- 8.4) 3.5 ( 2.7- 4.6)
Alaska ∼ ∼ ∼ ∼
California 7.0 ( 6.6- 7.5) 7.6 ( 7.1- 8.2) 6.0 ( 4.1- 8.6) 3.7 ( 2.8- 4.8)
Hawaii ∼ ∼ ∼ ∼
Oregon 8.8 ( 7.4- 10.5) 9.1 ( 7.6- 10.8) ∼ ∼
Washington 6.9 ( 5.8- 8.0) 7.0 ( 5.9- 8.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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232 Table 2.27.1.2F: Urinary Bladder. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2002
Area All Races White Black Hispanic‡§
United States 2.4 ( 2.3- 2.4) 2.3 ( 2.3- 2.4) 3.0 ( 2.8- 3.3) 1.5 ( 1.3- 1.8)
Northeast 2.7 ( 2.5- 2.9) 2.8 ( 2.6- 2.9) 2.9 ( 2.3- 3.6) 1.3 ( 0.8- 2.1)
New England 2.8 ( 2.5- 3.2) 2.9 ( 2.5- 3.3) ∼ ∼
Connecticut 2.3 ( 1.7- 3.0) 2.2 ( 1.6- 3.0) ∼ ∼
Maine 2.7 ( 1.7- 4.2) 2.7 ( 1.7- 4.2) ∼ ∼
Massachusetts 3.2 ( 2.7- 3.9) 3.4 ( 2.8- 4.0) ∼ ∼
New Hampshire 2.3 ( 1.3- 3.8) 2.3 ( 1.3- 3.9) ∼ ∼
Rhode Island 2.7 ( 1.7- 4.3) 2.8 ( 1.7- 4.5) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.7 ( 2.5- 2.9) 2.7 ( 2.5- 2.9) 2.9 ( 2.3- 3.7) 1.3 ( 0.8- 2.1)
New Jersey 2.8 ( 2.4- 3.3) 2.8 ( 2.3- 3.3) 3.8 ( 2.3- 6.0) ∼
New York 2.6 ( 2.3- 2.9) 2.7 ( 2.4- 3.1) 2.3 ( 1.6- 3.2) ∼
Pennsylvania 2.7 ( 2.4- 3.1) 2.6 ( 2.3- 3.0) 3.8 ( 2.4- 5.7) ∼
Midwest 2.3 ( 2.2- 2.5) 2.3 ( 2.1- 2.5) 3.1 ( 2.5- 3.9) ∼
East North Central 2.4 ( 2.2- 2.6) 2.4 ( 2.2- 2.6) 3.2 ( 2.5- 4.1) ∼
Illinois 2.2 ( 1.9- 2.6) 2.1 ( 1.8- 2.5) 3.6 ( 2.4- 5.2) ∼
Indiana 2.6 ( 2.1- 3.2) 2.7 ( 2.1- 3.3) ∼ ∼
Michigan 2.3 ( 2.0- 2.8) 2.1 ( 1.8- 2.6) 4.3 ( 2.8- 6.3) ∼
Ohio 2.7 ( 2.3- 3.1) 2.7 ( 2.4- 3.2) ∼ ∼
Wisconsin 2.2 ( 1.7- 2.8) 2.2 ( 1.7- 2.8) ∼ ∼
West North Central 2.1 ( 1.9- 2.4) 2.1 ( 1.9- 2.4) ∼ ∼
Iowa 2.0 ( 1.5- 2.8) 2.0 ( 1.4- 2.7) ∼ ∼
Kansas 2.3 ( 1.6- 3.1) 2.1 ( 1.5- 3.0) ∼ ∼
Minnesota 2.6 ( 2.0- 3.3) 2.5 ( 2.0- 3.2) ∼ ∼
Missouri 2.0 ( 1.6- 2.5) 2.0 ( 1.5- 2.6) ∼ ∼
Nebraska 1.9 ( 1.2- 2.9) 1.9 ( 1.2- 3.0) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.3 ( 2.2- 2.4) 2.2 ( 2.0- 2.3) 3.1 ( 2.8- 3.5) 1.5 ( 1.1- 2.0)
South Atlantic 2.5 ( 2.3- 2.6) 2.3 ( 2.1- 2.5) 3.4 ( 2.9- 4.0) 1.8 ( 1.2- 2.6)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.4 ( 2.1- 2.7) 2.4 ( 2.1- 2.7) 2.8 ( 1.8- 4.1) 1.6 ( 1.0- 2.4)
Georgia 2.8 ( 2.3- 3.3) 2.4 ( 1.9- 3.0) 4.0 ( 2.8- 5.7) ∼
Maryland 2.7 ( 2.1- 3.4) 2.4 ( 1.8- 3.1) 4.6 ( 3.0- 6.8) ∼
North Carolina 2.3 ( 1.9- 2.8) 2.1 ( 1.6- 2.6) 3.2 ( 2.1- 4.7) ∼
South Carolina 2.2 ( 1.7- 2.9) 2.2 ( 1.6- 3.1) ∼ ∼
Virginia 2.2 ( 1.8- 2.8) 2.0 ( 1.6- 2.6) 3.5 ( 2.2- 5.3) ∼
West Virginia 2.9 ( 2.0- 4.1) 2.9 ( 2.0- 4.1) ∼ ∼
East South Central 2.1 ( 1.9- 2.4) 2.1 ( 1.8- 2.4) 2.3 ( 1.6- 3.1) ∼
Alabama 1.5 ( 1.1- 2.1) 1.6 ( 1.1- 2.3) ∼ ∼
Kentucky 2.5 ( 1.9- 3.2) 2.4 ( 1.8- 3.1) ∼ ∼
Mississippi 2.0 ( 1.4- 2.9) 2.0 ( 1.3- 3.0) ∼ ∼
Tennessee 2.4 ( 1.9- 3.0) 2.3 ( 1.8- 3.0) ∼ ∼
West South Central 2.0 ( 1.8- 2.3) 1.9 ( 1.7- 2.1) 3.2 ( 2.5- 4.2) 1.3 ( 0.8- 1.9)
Arkansas 2.2 ( 1.6- 3.0) 1.9 ( 1.3- 2.8) ∼ ∼
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Table 2.27.1.2F: Urinary Bladder. Age-Adjusted Cancer Death Rates∗ and 95% Confidence Intervals by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2002
Area All Races White Black Hispanic‡§
Louisiana 2.0 ( 1.4- 2.6) 1.8 ( 1.3- 2.6) ∼ ∼
Oklahoma 2.3 ( 1.7- 3.1) 2.1 ( 1.5- 2.9) ∼ ∼
Texas 2.0 ( 1.7- 2.2) 1.8 ( 1.6- 2.1) 3.3 ( 2.2- 4.7) 1.2 ( 0.7- 1.9)
West 2.2 ( 2.0- 2.4) 2.3 ( 2.1- 2.5) 2.6 ( 1.7- 3.6) 1.7 ( 1.2- 2.2)
Mountain 2.0 ( 1.7- 2.3) 2.0 ( 1.7- 2.3) ∼ 1.8 ( 1.0- 2.9)
Arizona 1.8 ( 1.4- 2.4) 1.8 ( 1.4- 2.4) ∼ ∼
Colorado 2.1 ( 1.5- 2.9) 2.2 ( 1.6- 3.0) ∼ ∼
Idaho 2.3 ( 1.4- 3.8) 2.4 ( 1.4- 3.9) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.6 ( 1.7- 3.8) 2.6 ( 1.7- 4.0) ∼ ∼
New Mexico 2.2 ( 1.4- 3.4) 2.3 ( 1.4- 3.6) ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 2.3 ( 2.1- 2.5) 2.4 ( 2.2- 2.6) 2.9 ( 1.9- 4.1) 1.6 ( 1.1- 2.2)
Alaska ∼ ∼ ∼ ∼
California 2.3 ( 2.1- 2.5) 2.4 ( 2.2- 2.7) 2.9 ( 1.9- 4.2) 1.7 ( 1.2- 2.3)
Hawaii ∼ ∼ ∼ ∼
Oregon 3.1 ( 2.4- 3.9) 3.1 ( 2.4- 4.0) ∼ ∼
Washington 1.9 ( 1.5- 2.5) 2.0 ( 1.5- 2.5) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.

State and Metropolitan Area 
Incidence Rates and State Death Rates 
for the Most Common Cancers
Figure 3.1.M.1
Consecutive numbering of states 
in alphabetical order beginning 
with the United States
M = males
F = females
1 = incidence rate
2 = death rate
3 = figures that display data for states
Figures 1 and 2 are maps of the 
United States.

Figures 3.1.M1–3.58.F2
United States Cancer Statistics: 2002 Incidence and Mortality
236
Figure 3.1.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10
Primary Sites with the Highest Rates within Race- and Ethnic-Specific
Categories
United States,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information. Rates cover
cover approximately 93% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 1.1.1.1M for 95%
confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or if the population of the
specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.1.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
United States,∗ Males, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 1.1.1.2M for 95%
confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or if the population of the
specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.1.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10
Primary Sites with the Highest Rates within Race- and Ethnic-Specific
Categories
United States,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information. Rates cover
cover approximately 93% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 1.1.1.1F for 95%
confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or if the population of the
specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.1.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
United States,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 1.1.1.2F for 95%
confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or if the population of the
specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.2.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Alabama,∗† Males, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.2.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Alabama,∗ Males, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.2.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Alabama,∗† Females, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.2.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Alabama,∗ Females, 2002
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.3.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Alaska,∗† Males, 2002
Melanomas of the Skin
Esophagus
Stomach
Pancreas
Kidney & Renal Pelvis
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
12.0
12.4
13.0
13.8
18.4
27.5
32.3
52.0
74.8
164.5
Leukemias
Oral Cavity & Pharynx
Pancreas
Melanomas of the Skin
Kidney & Renal Pelvis
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
9.9
11.4
12.4
14.9
17.2
30.8
40.5
51.4
74.8
170.2
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
68.1
79.9
89.6
0 50 100 150 200 250 300
Incidence rates were not
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.3.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Alaska,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.3.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Alaska,∗† Females, 2002
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ranked when the population
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.3.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Alaska,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.4.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Arizona,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.4.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Arizona,∗ Males, 2002
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size was less than 50,000
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.4.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Arizona,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.4.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Arizona,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.5.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Arkansas,∗ Males, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.5.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Arkansas,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.6.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
California,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.6.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
California,∗ Males, 2002
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.6.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
California,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.6.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
California,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.7.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Los Angeles,∗† Males, 2002
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.7.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Los Angeles,∗† Females, 2002
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ranked when the population
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or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
State and Metropolitan Area Incidence Rates and State Death Rates for the Most Common Cancers
263
Mortality data are not presented for metropolitan areas.
United States Cancer Statistics: 2002 Incidence and Mortality
264
Figure 3.8.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
San Francisco-Oakland,∗† Males, 2002
Leukemias
Stomach
Kidney & Renal Pelvis
Oral Cavity & Pharynx
Melanomas of the Skin
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
12.1
13.1
13.3
15.3
18.9
24.0
29.8
56.5
64.4
162.0
Pancreas
Leukemias
Kidney & Renal Pelvis
Oral Cavity & Pharynx
Melanomas of the Skin
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
12.0
13.2
14.0
15.6
24.6
25.9
34.0
55.4
61.6
163.9
Pancreas
Stomach
Liver & IBD
Oral Cavity & Pharynx
Urinary Bladder
Kidney & Renal Pelvis
Non-Hodgkin Lymphoma
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
10.8
13.3
14.8
15.1
17.3
20.7
21.1
62.9
105.7
202.3
Pancreas
Leukemias
Oral Cavity & Pharynx
Non-Hodgkin Lymphoma
Urinary Bladder
Stomach
Liver & IBD
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
7.9
7.9
13.7
15.4
18.0
21.5
23.4
53.2
56.5
104.3
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.8.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
San Francisco-Oakland,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.9.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
San Jose-Monterey,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.9.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
San Jose-Monterey,∗† Females, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.10.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Colorado,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.10.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Colorado,∗ Males, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.10.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Colorado,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.10.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Colorado,∗ Females, 2002
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Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.11.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Connecticut,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Urinary Bladder
Non-Hodgkin Lymphoma
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
27.8
31.8
56.7
64.7
184.0
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
State and Metropolitan Area Incidence Rates and State Death Rates for the Most Common Cancers
277
Figure 3.11.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Connecticut,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.11.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Connecticut,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.11.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Connecticut,∗ Females, 2002
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.12.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Delaware,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.12.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Delaware,∗ Males, 2002
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2002 Incidence and Mortality
282
Figure 3.12.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Delaware,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.12.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Delaware,∗ Females, 2002
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.13.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
District of Columbia,∗† Males, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.13.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
District of Columbia,∗ Males, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.13.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
District of Columbia,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.13.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
District of Columbia,∗ Females, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.14.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Florida,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
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ranked at state’s request.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.14.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Florida,∗ Males, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.14.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Florida,∗† Females, 2002
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ranked when the population
size was less than 50,000
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.14.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Florida,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.15.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Georgia,∗† Males, 2002
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Incidence rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.15.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Georgia,∗ Males, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.15.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Georgia,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.15.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Georgia,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.16.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Atlanta,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Mortality data are not presented for metropolitan areas.
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Figure 3.16.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Atlanta,∗† Females, 2002
Cervix Uteri
Pancreas
Thyroid
Ovary
Melanomas of the Skin
Non-Hodgkin Lymphoma
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
8.3
9.9
13.0
13.5
13.6
14.2
19.2
46.9
48.7
128.2
Pancreas
Leukemias
Ovary
Non-Hodgkin Lymphoma
Thyroid
Corpus & Uterus, NOS
Melanomas of the Skin
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
8.2
9.9
14.2
14.5
16.1
19.6
20.6
43.8
49.2
133.2
Stomach
Urinary Bladder
Ovary
Non-Hodgkin Lymphoma
Cervix Uteri
Pancreas
Corpus & Uterus, NOS
Lung & Bronchus
Colon & Rectum
Breast
0 50 100 150 200 250 300
9.3
10.3
11.9
12.3
13.3
15.0
18.5
50.4
56.2
120.1 Breast
0 50 100 150 200 250 300
71.8
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Mortality data are not presented for metropolitan areas.
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Figure 3.17.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Hawaii,∗† Males, 2002
Liver & IBD
Leukemias
Oral Cavity & Pharynx
Stomach
Non-Hodgkin Lymphoma
Melanomas of the Skin
Urinary Bladder
Lung & Bronchus
Colon & Rectum
Prostate
0 50 100 150 200 250 300
13.0
13.0
17.4
18.0
18.3
20.4
26.5
66.7
67.0
113.4
Stomach
Kidney & Renal Pelvis
Leukemias
Non-Hodgkin Lymphoma
Oral Cavity & Pharynx
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Melanomas of the Skin
Prostate
0 50 100 150 200 250 300
11.1
13.7
15.1
22.7
24.7
40.8
54.6
66.2
66.3
124.5
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.17.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Hawaii,∗ Males, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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Death rates were not
ranked when the population
size was less than 50,000
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than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.17.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Hawaii,∗† Females, 2002
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Incidence rates were not
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or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.17.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Hawaii,∗ Females, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Death rates were not
ranked when the population
size was less than 50,000
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.18.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Idaho,∗† Males, 2002
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Incidence rates were not
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size was less than 50,000
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.18.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Idaho,∗ Males, 2002
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.18.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Idaho,∗† Females, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.18.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Idaho,∗ Females, 2002
Multiple Myeloma
Brain & ONS
Liver & IBD
Non-Hodgkin Lymphoma
Leukemias
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.3
3.8
3.8
5.0
6.5
8.4
9.3
12.9
25.0
32.1
Corpus & Uterus, NOS
Liver & IBD
Brain & ONS
Non-Hodgkin Lymphoma
Leukemias
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.1
3.6
3.9
5.1
6.6
8.1
9.2
12.8
25.0
32.4
0 50 100 150
Death rates were not
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than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.19.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Illinois,∗† Males, 2002
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.19.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Illinois,∗ Males, 2002
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Death rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2002 Incidence and Mortality
310
Figure 3.19.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Illinois,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.19.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Illinois,∗ Females, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories. Leukemias
Stomach
Non-Hodgkin Lymphoma
Ovary
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150
4.2
4.6
6.2
6.9
8.7
10.2
16.6
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.20.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Indiana,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Non-Hodgkin Lymphoma
Colon & Rectum
Prostate
0 50 100 150 200 250 300
26.6
31.2
104.3
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.20.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Indiana,∗ Males, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.20.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Indiana,∗† Females, 2002
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ranked when the population
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.20.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Indiana,∗ Females, 2002
Kidney & Renal Pelvis
Brain & ONS
Corpus & Uterus, NOS
Leukemias
Non-Hodgkin Lymphoma
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.8
4.2
5.1
6.4
6.5
9.8
10.2
17.9
25.6
48.7
Kidney & Renal Pelvis
Brain & ONS
Corpus & Uterus, NOS
Leukemias
Non-Hodgkin Lymphoma
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.6
4.4
4.8
6.6
6.6
9.4
10.4
17.5
24.9
48.1
Ovary
Kidney & Renal Pelvis
Corpus & Uterus, NOS
Pancreas
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
7.5
8.7
10.0
16.2
24.9
35.0
62.7
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.21.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Iowa,∗† Males, 2002
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categories.
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.21.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Iowa,∗ Males, 2002
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.21.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Iowa,∗† Females, 2002
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or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.21.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Iowa,∗ Females, 2002
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ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.22.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Kansas,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.22.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Kansas,∗ Males, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.22.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Kansas,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.22.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Kansas,∗ Females, 2002
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Death rates were not
ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.23.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Kentucky,∗† Males, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
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or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates are
suppressed and not
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.23.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Kentucky,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.23.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Kentucky,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.23.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Kentucky,∗ Females, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.24.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Louisiana,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.24.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Louisiana,∗ Males, 2002
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ranked when the population
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.24.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Louisiana,∗† Females, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.24.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Louisiana,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.25.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Maine,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.25.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Maine,∗ Males, 2002
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than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.25.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Maine,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.25.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Maine,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.26.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Maryland,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.26.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Maryland,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.26.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Maryland,∗† Females, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.26.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Maryland,∗ Females, 2002
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Death rates were not
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.27.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Massachusetts,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.27.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Massachusetts,∗ Males, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.27.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Massachusetts,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.27.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Massachusetts,∗ Females, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.28.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Michigan,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.28.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Michigan,∗ Males, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
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Death rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.28.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Michigan,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.28.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Michigan,∗ Females, 2002
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or case counts were fewer
than 16 in each of the site
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.29.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Detroit,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Mortality data are not presented for metropolitan areas.
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Figure 3.29.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Detroit,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Mortality data are not presented for metropolitan areas.
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Figure 3.30.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Minnesota,∗† Males, 2002
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ranked when the population
size was less than 50,000
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.30.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Minnesota,∗ Males, 2002
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than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.30.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Minnesota,∗† Females, 2002
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ranked when the population
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or case counts were fewer
than 16 in each of the site
categories.
Breast
0 50 100 150 200 250 300
101.6
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.30.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Minnesota,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.31.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Mississippi,∗ Males, 2002
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ranked when the population
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or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.31.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Mississippi,∗ Females, 2002
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ranked when the population
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than 16 in each of the site
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.32.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Missouri,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.32.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Missouri,∗ Males, 2002
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.32.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Missouri,∗† Females, 2002
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size was less than 50,000
or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.32.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Missouri,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.33.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Montana,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.33.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Montana,∗ Males, 2002
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ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2002 Incidence and Mortality
366
Figure 3.33.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Montana,∗† Females, 2002
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than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.33.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Montana,∗ Females, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
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than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.34.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Nebraska,∗† Males, 2002
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size was less than 50,000
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.34.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Nebraska,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.34.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Nebraska,∗† Females, 2002
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.34.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Nebraska,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.35.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Nevada,∗† Males, 2002
Leukemias
Pancreas
Kidney & Renal Pelvis
Oral Cavity & Pharynx
Melanomas of the Skin
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
12.2
13.6
15.1
15.9
20.7
23.6
41.0
63.7
90.4
167.4
Leukemias
Pancreas
Kidney & Renal Pelvis
Oral Cavity & Pharynx
Non-Hodgkin Lymphoma
Melanomas of the Skin
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
13.0
13.6
15.9
16.3
22.9
22.9
42.5
62.6
92.8
163.9
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
66.6
72.8
210.4
Prostate
Colon & Rectum
0 50 100 150 200 250 300
69.7
82.5
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.35.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Nevada,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.35.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Nevada,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.35.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Nevada,∗ Females, 2002
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Death rates were not
ranked when the population
size was less than 50,000
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0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.36.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
New Hampshire,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.36.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
New Hampshire,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.36.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
New Hampshire,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.36.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
New Hampshire,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.37.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
New Jersey,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.37.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
New Jersey,∗ Males, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.37.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
New Jersey,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.37.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
New Jersey,∗ Females, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.38.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
New Mexico,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.38.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
New Mexico,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.38.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
New Mexico,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.38.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
New Mexico,∗ Females, 2002
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.39.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
New York,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.39.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
New York,∗ Males, 2002
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Death rates were not
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or case counts were fewer
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2002 Incidence and Mortality
390
Figure 3.39.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
New York,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.39.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
New York,∗ Females, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.40.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
North Carolina,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.40.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
North Carolina,∗ Males, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.40.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
North Carolina,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.40.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
North Carolina,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.41.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
North Dakota,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.41.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
North Dakota,∗ Males, 2002
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categories.
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.41.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
North Dakota,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.41.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
North Dakota,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.42.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Ohio,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.42.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Ohio,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.42.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Ohio,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.42.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Ohio,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.43.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Oklahoma,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.43.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Oklahoma,∗ Males, 2002
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size was less than 50,000
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.43.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Oklahoma,∗† Females, 2002
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
State and Metropolitan Area Incidence Rates and State Death Rates for the Most Common Cancers
407
Figure 3.43.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Oklahoma,∗ Females, 2002
Kidney & Renal Pelvis
Corpus & Uterus, NOS
Brain & ONS
Non-Hodgkin Lymphoma
Leukemias
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.7
4.2
4.2
5.2
6.0
8.0
8.5
16.2
27.0
47.6
Kidney & Renal Pelvis
Corpus & Uterus, NOS
Brain & ONS
Non-Hodgkin Lymphoma
Leukemias
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.7
3.8
4.8
5.5
6.2
8.2
8.9
15.2
26.7
48.2
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
28.3
42.6
43.7
0 50 100 150
Death rates were not
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.44.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Oregon,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.44.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Oregon,∗ Males, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.44.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Oregon,∗† Females, 2002
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Incidence rates were not
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size was less than 50,000
or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.44.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Oregon,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.45.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Pennsylvania,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.45.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Pennsylvania,∗ Males, 2002
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.45.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Pennsylvania,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.45.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Pennsylvania,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.46.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Rhode Island,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.46.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Rhode Island,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.46.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Rhode Island,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.46.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Rhode Island,∗ Females, 2002
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.47.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
South Carolina,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.47.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
South Carolina,∗ Males, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.47.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
South Carolina,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.47.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
South Carolina,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.48.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
South Dakota,∗ Males, 2002
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.48.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
South Dakota,∗ Females, 2002
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
State and Metropolitan Area Incidence Rates and State Death Rates for the Most Common Cancers
429
Figure 3.49.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Tennessee,∗ Males, 2002
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than 16 in each of the site
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size was less than 50,000
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.49.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Tennessee,∗ Females, 2002
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than 16 in each of the site
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.50.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Texas,∗† Males, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.50.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Texas,∗ Males, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Multiple Myeloma
Leukemias
Non-Hodgkin Lymphoma
Kidney & Renal Pelvis
Pancreas
Stomach
Liver & IBD
Colon & Rectum
Prostate
Lung & Bronchus
0 50 100 150
4.6
6.1
7.1
8.3
9.9
10.6
15.3
17.8
21.4
43.7
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.50.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Texas,∗† Females, 2002
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.50.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Texas,∗ Females, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.51.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Utah,∗† Males, 2002
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or case counts were fewer
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.51.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Utah,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.51.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Utah,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.51.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Utah,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.52.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Vermont,∗† Males, 2002
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Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.52.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Vermont,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.52.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Vermont,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.52.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Vermont,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.53.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Virginia,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.53.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Virginia,∗ Females, 2002
Brain & ONS
Multiple Myeloma
Corpus & Uterus, NOS
Non-Hodgkin Lymphoma
Leukemias
Ovary
Pancreas
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.1
3.4
3.6
5.9
6.1
8.7
8.8
17.1
26.8
42.0
Multiple Myeloma
Brain & ONS
Corpus & Uterus, NOS
Non-Hodgkin Lymphoma
Leukemias
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
2.9
3.2
3.4
6.3
6.6
7.9
9.0
15.9
24.8
43.3
Non-Hodgkin Lymphoma
Corpus & Uterus, NOS
Leukemias
Stomach
Multiple Myeloma
Ovary
Pancreas
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
4.3
4.5
4.6
5.8
6.3
8.0
13.9
23.9
36.3
39.5
Breast
Lung & Bronchus
0 50 100 150
20.0
23.2
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.54.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Washington,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.54.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Washington,∗ Males, 2002
Brain & ONS
Urinary Bladder
Liver & IBD
Esophagus
Leukemias
Pancreas
Non-Hodgkin Lymphoma
Colon & Rectum
Prostate
Lung & Bronchus
0 50 100 150
6.6
6.9
7.3
8.3
11.1
11.9
12.1
19.3
28.0
67.0
Liver & IBD
Brain & ONS
Urinary Bladder
Esophagus
Leukemias
Pancreas
Non-Hodgkin Lymphoma
Colon & Rectum
Prostate
Lung & Bronchus
0 50 100 150
6.6
6.8
7.0
8.8
11.4
11.9
12.4
19.4
28.5
67.0
Prostate
Lung & Bronchus
0 50 100 150
45.1
116.3
Stomach
Liver & IBD
Lung & Bronchus
0 50 100 150
15.5
21.2
43.0
Lung & Bronchus
0 50 100 150
58.4 Lung & Bronchus
0 50 100 150
43.8
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.54.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Washington,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.54.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Washington,∗ Females, 2002
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.55.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Seattle-Puget Sound,∗† Males, 2002
Pancreas
Oral Cavity & Pharynx
Kidney & Renal Pelvis
Leukemias
Melanomas of the Skin
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
12.7
16.6
17.5
18.1
26.3
28.8
43.2
53.3
84.6
175.0
Pancreas
Oral Cavity & Pharynx
Kidney & Renal Pelvis
Leukemias
Melanomas of the Skin
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
12.6
17.3
17.8
19.1
29.5
30.1
45.5
53.7
85.5
177.3
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
56.4
131.7
262.1
Stomach
Non-Hodgkin Lymphoma
Urinary Bladder
Liver & IBD
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
15.1
18.2
18.4
29.7
36.5
55.8
81.0
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
54.4
80.9
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Mortality data are not presented for metropolitan areas.
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Figure 3.55.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Seattle-Puget Sound,∗† Females, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Breast
0 50 100 150 200 250 300
65.3
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Mortality data are not presented for metropolitan areas.
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Figure 3.56.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
West Virginia,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.56.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
West Virginia,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.56.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
West Virginia,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.56.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
West Virginia,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.57.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Wisconsin,∗† Males, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.57.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Wisconsin,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.57.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Specific Categories
Wisconsin,∗† Females, 2002
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All Races White
Black Asian/Pacific Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if cases are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.57.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Wisconsin,∗ Females, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.58.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Wyoming,∗ Males, 2002
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All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.58.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Specific Categories
Wyoming,∗ Females, 2002
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
All Races White
Black Asian/Pacific Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.26.1.2F
and Appendix F.1-F.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if deaths are fewer than 16 or
if the population of a specific category (race, ethnicity) is less than 50,000.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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A–1
Registries in bold contributed data to this report.
Alabama
Alabama Statewide Cancer Registry
Alabama Department of Public Health
P.O. Box 303017
Montgomery, AL 36130-3017
Phone: (334) 206-5557
Fax: (334) 206-3823
http://www.adph.org/cancer_registry
Alaska
Alaska Cancer Registry
3601 C Street, Suite 540
P.O. Box 240249
Anchorage, AK 99524-0249
Phone: (907) 269-8000
Fax: (907) 561-1896
http://www.epi.hss.state.ak.us/cd/cancer.stm
Arizona
Arizona Cancer Registry
Arizona Department of Health Services
150 North 18th Avenue, Suite 550
Phoenix, AZ 85007-3248
Phone: (602) 542-7320
Fax: (602) 542-7362
http://www.hs.state.az.us/phs/phstats/acr/index.htm
Arkansas
Arkansas Central Cancer Registry
Arkansas Department of Health
4815 West Markham Street, Slot 7
Little Rock, AR 72205-3866
Phone: (501) 661-2392
Fax: (501) 661-2891
http://www.healthyarkansas.com/arkcancer/arkcancer.html
State and Metropolitan Area Cancer Registries
National Program of Cancer Registries (NPCR) and
Surveillance, Epidemiology, and End Results (SEER) Program 
California
California Cancer Registry
1700 Tribute Road, Suite 100
Sacramento, CA 95815-4402
Phone: (916) 779-0300
Fax: (916) 779-0264
http://www.ccrcal.org/index.htm
San Francisco-Oakland and San Jose-Monterey
Greater Bay Area Cancer Registry 
2201 Walnut Avenue, Suite 300
Freemont, CA  94538-2334
Phone: (510) 608-5000
Fax: (510) 608-5095
http://www.nccc.org
Los Angeles
Los Angeles Cancer Surveillance Program
1540 Alcazar Street, Suite 204
Los Angeles, CA 90089-9007
Phone: (323) 442-2300
Fax: (323) 442-2301
http://www.usc.edu/schools/medicine/departments/preventive_medicine/divisions/
epidemiology/research/csp/index.html
Colorado
Colorado Department of Public Health and Environment
Prevention Services Division
Colorado Central Cancer Registry 
4300 Cherry Creek Drive South
PSD-CR-A5
Denver, CO 80246-1530
Phone: (303) 692-2540
Fax: (303) 691-7721
http://www.cdphe.state.co.us/pp/cccr/cccrhom.asp
Connecticut
Connecticut Tumor Registry
410 Capitol Avenue, MS # 13-TMR
P.O. Box 340308
Hartford, CT 06134-0308
Phone: (860) 509-7163
Fax: (860) 509-7161
http://www.dph.state.ct.us/OPPE/hptumor.htm
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Registries in bold contributed data to this report.
Delaware
Delaware Cancer Registry
Delaware Department of Health and Social Services
Division of Public Health
P.O. Box 637
Dover, DE 19903-0637
Phone: (302) 739-5617
Fax: (302) 739-6617
http://www.dhss.delaware.gov/dhss/dph/dpc/registry.html
District of Columbia
District of Columbia Cancer Registry
District of Columbia Department of Health
825 North Capitol Street, NE
Room 3145
Washington, DC 20002-4210
Phone: (202) 442-5905
Fax: (202) 442-9432
http://doh.dc.gov/doh/site/default.asp
Florida
Florida Cancer Data System
Sylvester Comprehensive Cancer Center
University of Miami School of Medicine
P.O. Box 016960 (D4-11)
Miami, FL 33101-6960
Phone: (305) 243-4600
Fax: (305) 243-4871
http://fcds.med.miami.edu
Georgia
Georgia Comprehensive Cancer Registry
Georgia Department of Human Resources
2 Peachtree Street, NW
14th Floor
Atlanta, GA 30303-3181
Phone: (404) 657-1943
Fax: (404) 657-7517
http://health.state.ga.us/programs/gccr/index.asp
Atlanta
Georgia Center for Cancer Statistics
1518 Clifton Road, NE
Atlanta, GA 30322-4201
Phone: (404) 727-8700
Fax: (404) 727-7261
http://www.sph.emory.edu/GCCS
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Registries in bold contributed data to this report.
Hawaii
Hawaii Tumor Registry
1236 Lauhala Street
Honolulu, HI 96813-2424
Phone: (808) 586-9750
Fax: (808) 587-0024
http://www.crch.org/SerHTR.htm
Idaho
Cancer Data Registry of Idaho
615 North 7th Street
P.O. Box 1278
Boise, ID 83701-1278
Phone: (208) 338-5100
Fax: (208) 338-7800
http://www.idcancer.org
Illinois
Illinois State Cancer Registry
Illinois Department of Public Health
605 West Jefferson Street
Springfield, IL 62761-0001
Phone: (217) 785-1873
Fax: (217) 524-1770
http://www.idph.state.il.us/cancer/statistics.htm
Indiana
Indiana State Department of Health
State Cancer Registry
2 North Meridian Street, Section 7-D
Indianapolis, IN 46204-3010
Phone: (317) 233-7158
Fax: (317) 233-7722
http://www.in.gov/isdh/dataandstats/cancer.htm
Iowa
State Health Registry of Iowa
250 FB Building
The University of Iowa
Iowa City, IA 52242-2001
Phone: (319) 335-8609
Fax: (319) 335-8610
http://www.public-health.uiowa.edu/shri
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Registries in bold contributed data to this report.
Kansas
Kansas Cancer Registry
University of Kansas Medical Center
3901 Rainbow Boulevard
Kansas City, KS 66160-7312
Phone: (913) 588-4722
Fax: (913) 588-2780
http://www2.kumc.edu/kcr
Kentucky
Kentucky Cancer Registry
2365 Harrodsburg Road, Suite A230
Lexington, KY 40504-3381
Phone: (859) 219-0773
Fax: (859) 219-0557
http://web.kcr.uky.edu
Louisiana
Louisiana Tumor Registry
Louisiana State University Health Sciences Center—New Orleans
1600 Canal Street, Suite 900A
New Orleans, LA 70112-2896
Phone: (504) 568-4716
Fax: (504) 568-2493
http://www.lcltfb.org/registry.html
Maine
Department of Health and Human Services
Bureau of Health
Maine Cancer Registry
Key Plaza, 4th Floor
286 Water Street
11 State House Station
Augusta, ME 04333-0011
Phone: (207) 287-5272
Fax: (207) 287-4631
http://www.maine.gov/dhhs/bohdcfh/mcr/index2.htm
Maryland
Maryland Cancer Registry
201 West Preston Street, Suite 300
Baltimore, MD 21201-2301
Phone: (410) 767-4055
Fax: (410) 333-5218
http://www.fha.state.md.us/cancer/registry
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Registries in bold contributed data to this report.
Massachusetts
Massachusetts Department of Public Health
Center for Health Information, Statistics, Research, and Evaluation
Massachusetts Cancer Registry
250 Washington Street, 6th Floor
Boston, MA 02108-4619
Phone: (617) 624-5600
Fax: (617) 624-5695
http://www.mass.gov/dph/bhsre/mcr/canreg.htm
Michigan
Michigan Cancer Surveillance Program
Division for Vital Records and Health Statistics
3423 North Martin Luther King, Jr., Boulevard
P.O. Box 30691
Lansing, MI 48909-8191
Phone: (517) 335-8702
Fax: (517) 335-9964
http://www.michigan.gov/mdch
Detroit
Metropolitan Detroit Cancer Surveillance System
Wayne State University
110 East Warren Avenue
Detroit, MI 48201-1312
Phone: (313) 833-0715
Fax: (313) 831-7806
http://www.karmanos.org/epid
Minnesota
Minnesota Cancer Surveillance System
Minnesota Department of Health
Chronic Disease and Environmental Epidemiology
P.O. Box 9441
Minneapolis, MN 55440-9441
Phone: (612) 676-5374
Fax: (612) 676-5099
http://www.health.state.mn.us/divs/hpcd/cdee/mcss
Mississippi
Mississippi Cancer Registry
University of Mississippi Medical Center
2500 North State Street
Jackson, MS 39216-4500
Phone: (601) 815-5482
Fax: (601) 815-5483
http://www.health.ms.gov/cancer
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Registries in bold contributed data to this report.
Missouri
Missouri Cancer Registry
University of Missouri—Columbia
324 Clark Hall
Columbia, MO 65211-4380
Phone: (573) 882-7775
Fax: (573) 884-9655
http://mcr.umh.edu
Montana 
Montana Central Tumor Registry
Public Health and Safety Division
Montana Department of Public Health and Human Services
Cogswell Building
1400 Broadway
P.O. Box 202952
Helena, MT 59620-2952
Phone: (406) 444-2618
Fax: (406) 444-6557
http://www.dphhs.mt.gov/PHSD/Breast-Cervical/tumor-registry-index.shtml
Nebraska
Nebraska Cancer Registry
Nebraska Department of Health and Human Services Regulation and Licensure
302 Centennial Mall South
P.O. Box 95007
Lincoln, NE 68509-5007
Phone: (402) 471-0147
Fax: (402) 471-9727
http://www.hhs.state.ne.us/ced/cancer
Nevada
Nevada State Cancer Registry
Bureau of Health Planning and Statistics
3811 West Charleston Boulevard, Suite 208
Las Vegas, NV 89102-1846
Phone: (702) 486-6260
Fax: (702) 486-7602
http://www.health2k.state.nv.us/cancer
New Hampshire
New Hampshire State Cancer Registry
P.O. Box 186
Hanover, NH 03755-0186
Phone: (603) 653-1032
Fax: (603) 653-1050
http://www.dartmouth.edu/~nhscr
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Registries in bold contributed data to this report.
New Jersey
New Jersey State Cancer Registry
Cancer Epidemiology Services
New Jersey State Department of Health and Senior Services
P.O. Box 369
Trenton, NJ 08625-0369
Phone: (609) 588-3500
Fax: (609) 588-3638
http://www.state.nj.us/health/cancer/njscr1b.htm
New Mexico
New Mexico Tumor Registry
2325 Camino de Salud, NE
Albuquerque, NM 87131-5306
Phone: (505) 272-5541
Fax: (505) 272-8572
http://hsc.unm.edu/epiccpro
New York
New York State Cancer Registry
Corning Tower, Room 536
Empire State Plaza
Albany, NY 12237-0679
Phone: (518) 474-2255
Fax: (518) 473-6789
http://www.health.state.ny.us/nysdoh/cancer/nyscr/nyscr.htm
North Carolina
North Carolina Central Cancer Registry
State Center for Health Statistics
North Carolina Department of Health and Human Services
1908 Mail Service Center
Raleigh, NC 27699-1908
Phone: (919) 715-4555
Fax: (919) 733-8485
http://www.schs.state.nc.us/SCHS/CCR
North Dakota
North Dakota Department of Health
Division of Health Promotion and Education
600 East Boulevard Avenue, Department 301
Bismarck, ND 58505-0200
Phone: (701) 328-2333
Fax: (701) 328-2036
http://www.health.state.nd.us/cancerregistry
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Registries in bold contributed data to this report.
Ohio
Ohio Department of Health
Cancer Incidence Surveillance System
246 North High Street
P.O. Box 118
Columbus, OH 43266-0118
Phone: (614) 752-2689
Fax: (614) 644-1909
http://www2.odh.ohio.gov/ODHPrograms/CI_SURV/ci_surv1.htm
Oklahoma
Oklahoma Central Cancer Registry
Chronic Disease Service
Oklahoma Department of Health
1000 Northeast 10th Street
Oklahoma City, OK 73117-1299
Phone: (405) 271-4072
Fax: (405) 271-5181
http://www.health.state.ok.us/program/cds/cancereg.html
Oregon
Oregon State Cancer Registry
Department of Human Services
800 Northeast Oregon Street, Suite 730
Portland, OR 97232-2195
Phone: (971) 673-0986
Fax: (971) 673-0996
http://oregon.gov/DHS/ph/oscar/index.shtml
Pennsylvania
Pennsylvania Cancer Registry
Bureau of Health Statistics and Research
Pennsylvania Department of Health
555 Walnut Street, 6th Floor
Harrisburg, PA 17101-1914
Phone: (717) 783-2548
Fax: (717) 772-3258
http://www.health.state.pa.us/stats
Puerto Rico
Departamento de Salud de Puerto Rico
Registro Central de Puerto Rico
P.O. Box 70184
San Juan, PR 00926-8184
Phone: (787) 274-7866
Fax: (787) 274-3347
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Registries in bold contributed data to this report.
Republic of Palau
Ministry of Health, Republic of Palau
P.O. Box 6027
Koror, PW 96940-0845
Phone: 011-(680) 488-4612
Fax: 011-(680) 488-1211
Rhode Island
Rhode Island Department of Health
3 Capitol Hill
Providence, RI 02908-5097
Phone: (401) 222-1172
Fax: (401) 222-3551
http://www.health.ri.gov/disease/cancer/registry.php
South Carolina
South Carolina Department of Health and Environmental Control
South Carolina Central Cancer Registry
2600 Bull Street
Columbia, SC 29201-1708
Phone: (803) 898-3696
Fax: (803) 898-3599
http://www.scdhec.gov/co/phsis/biostatistics/SCCCR/scccrmain.htm
South Dakota
South Dakota Cancer Registry
Office of Health Promotion, Health, and Medical Services
Department of Health
615 East 4th Street
Pierre, SD 57501-1700
Phone: (605) 773-5740
Fax: (605) 773-5509
Tennessee
Tennessee Cancer Registry
Cordell Hull Building, 6th Floor North
425 5th Avenue, North
Nashville, TN 37247-0001
Phone: (615) 253-5937
Fax: (615) 532-7904
http://www2.state.tn.us/health/TCR
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Registries in bold contributed data to this report.
Texas
Texas Cancer Registry
Cancer Epidemiology and Surveillance Branch
Texas Department of State Health Services
1100 West 49th Street
Austin, TX 78756-3199
Phone: (512) 458-7523
Fax: (512) 458-7681
http://www.dshs.state.tx.us/tcr/default.shtm
Utah
Utah Cancer Registry
546 Chipeta Way, Suite 410
Salt Lake City, UT 84108-3572
Phone: (801) 581-8407
Fax: (801) 581-4560
http://uuhsc.utah.edu/ucr
Vermont
Vermont Cancer Registry
Vermont Department of Health
P.O. Box 70
108 Cherry Street
Burlington, VT 05402-0070
Phone: (802) 865-7749
Fax: (802) 651-1787
http://www.healthyvermonters.info/hs/epi/cdepi/cancer/registry/cancerreg.shtml
Virgin Islands (U.S.)
Virgin Islands Department of Health
3500 Estate Richmond
Charles Harwood Complex
Christiansted, St. Croix, VI 00820-4370
Phone: (340) 773-1311, ext. 3082
Fax: (340) 773-0850
Virginia
Virginia Cancer Registry
Office of Family Health Services
109 Governor Street, 10th Floor
Richmond, VA 23219-3623
Phone: (804) 864-7866
Fax: (804) 864-7870
http://www.vdh.state.va.us/epi/cancer/index.asp
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Washington
Washington State Cancer Registry
Airdustrial Park, Building 10
P.O. Box 47835
Olympia, WA 98504-7835
Phone: (360) 236-3676
Fax: (360) 586-2714
http://www3.doh.wa.gov/WSCR
Seattle-Puget Sound
Seattle-Puget Sound Cancer Surveillance System
1100 Fairview Avenue North
P.O. Box 19024
Seattle, WA 98109-1024
Phone: (206) 667-4719
Fax: (206) 667-4870
http://www.fhcrc.org/science/phs/css
West Virginia
West Virginia Department of Health and Human Resources
Bureau for Public Health
West Virginia Cancer Registry
350 Capitol Street, Room 125
Charleston, WV 25301-3715
Phone: (304) 558-6421
Fax: (304) 558-4463
http://www.wvdhhr.org/idep/cancerrep.htm
Wisconsin
Wisconsin Cancer Reporting System 
Wisconsin Department of Health and Family Services
Bureau of Health Information and Policy
Division of Public Health
P.O. Box 2659
Madison, WI 53701-2659
Phone: (608) 266-8926
Fax: (608) 264-9881
http://dhfs.wisconsin.gov/wcrs/index.htm
Wyoming
Wyoming Cancer Surveillance Program
Wyoming Central Tumor Registry
6101 Yellowstone Road, Room 259A
Cheyenne, WY 82002-0001
Phone: (307) 777-3477
Fax: (307) 777-3419
http://wdhfs.state.wy.us/cancer
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National Program of Cancer Registries
Scientific Working Group Members
Mark E. Allen, MS, California Cancer Registry
Virginia C. Andrews, MSPH, South Carolina Central Cancer Registry
Vivien W. Chen, PhD, Louisiana Tumor Registry  
Catherine N. Correa, PhD, MPH, Louisiana Tumor Registry 
Susan T. Gershman, MS, MPH, PhD, CTR, Massachusetts Cancer Registry
Georgette G. Haydu, MS, Ohio Cancer Incidence Surveillance System
Jeannette Jackson-Thompson, PhD, MSPH, Missouri Cancer Registry
Alison T. Johnson, CTR, Vermont Cancer Registry 
Amy Kahn, MS, CTR, New York State Cancer Registry
Karen L. Knight, MS, North Carolina Central Cancer Registry
Betsy A. Kohler, MPH, CTR, New Jersey State Cancer Registry
Sue Min Lai, PhD, MS, MBA, Kansas Cancer Registry
Jill A. MacKinnon, CTR, Florida Cancer Data System
Howard J. Martin, PhD, Virginia Cancer Registry
Stacey Neloms, MPH, Maryland Cancer Registry
Xiaoling Niu, MS, New Jersey State Cancer Registry
Patricia Reese, CTR, Wyoming Central Tumor Registry
Maria J. Schymura, PhD, New York State Cancer Registry
Tiefu Shen, MD, PhD, Illinois State Cancer Registry
Laura Stephenson, BA, Wisconsin Cancer Reporting System 
Thomas C. Tucker, PhD, MPH, Kentucky Cancer Registry
Lydia Voti, MS, Florida Cancer Data System
Nancy S. Weiss, PhD, Texas Cancer Registry
Melanie Williams, PhD, Texas Cancer Registry
Brian D. Wright, BS, Pennsylvania Cancer Registry  
William E. Wright, PhD, California Cancer Registry
Xiao Cheng Wu, MD, MPH, CTR, Louisiana Tumor Registry
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National Partner Organizations
National partner organizations are crucial to the success of cancer registration and cancer surveillance in
the United States. This document, and many advances in cancer surveillance in the United States, would
not have been possible without the tireless efforts and many achievements of the following organizations:
American Cancer Society (ACS)
1599 Clifton Road, NE
Atlanta, GA 30329-4251
Phone: (404) 329-5738
Fax: (404) 327-6450
http://www.cancer.org
American College of Surgeons (ACoS) Commission on Cancer (CoC)
633 North Saint Clair Street
Chicago, IL 60611-3211
Phone: (312) 202-5085
Fax: (312) 202-5009 
http://www.facs.org/dept/cancer/index.html
American Joint Committee on Cancer (AJCC)
633 North Saint Clair Street
Chicago, IL 60611-3211
Phone: (312) 202-5290
Fax: (312) 202-5009
http://www.cancerstaging.org
National Cancer Registrars Association (NCRA)
1310 Braddock Place
Suite 102
Alexandria, VA 22314-1648
Phone: (703) 299-6640
Fax: (703) 299-6620
http://www.ncra-usa.org
North American Association of Central Cancer Registries (NAACCR)
2121 West White Oaks Drive
Suite C
Springfield, IL 62704-6495
Phone: (217) 698-0800
Fax: (217) 698-0188
http://www.naaccr.org
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–2 Table D.1.1M: Invasive Cancer Incidence Counts by Primary Site and Race and Ethnicity, United
States∗†
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 641,341 552,027 61,360 12,660 2,115 35,822
Oral Cavity and Pharynx 19,086 16,239 1,999 498 73 947
Lip 1,656 1,584 ∼ ∼ ∼ 47
Tongue 4,928 4,328 426 84 18 235
Salivary Gland 1,760 1,573 105 45 ∼ 102
Floor of Mouth 1,350 1,119 186 ∼ ∼ 52
Gum and Other Mouth 2,249 1,893 266 51 ∼ 120
Nasopharynx 1,024 636 155 207 ∼ 70
Tonsil 3,150 2,729 327 45 18 160
Oropharynx 776 612 151 ∼ ∼ 42
Hypopharynx 1,592 1,273 269 30 ∼ 85
Other Oral Cavity and Pharynx 601 492 100 ∼ ∼ 34
Digestive System 124,014 105,434 12,611 4,037 497 8,370
Esophagus 9,861 8,500 1,100 133 39 428
Stomach 11,596 9,221 1,540 673 63 1,176
Small Intestine 2,508 2,080 341 50 ∼ 137
Colon and Rectum 70,651 61,221 6,471 1,804 262 4,020
Colon excluding Rectum 49,329 42,578 4,855 1,132 173 2,633
Rectum and Rectosigmoid Junction 21,322 18,643 1,616 672 89 1,387
Anus, Anal Canal and Anorectum 1,453 1,235 177 ∼ ∼ 100
Liver and Intrahepatic Bile Duct 9,582 7,296 1,209 869 62 1,309
Gallbladder 906 767 78 43 ∼ 100
Other Biliary 2,205 1,937 142 89 ∼ 155
Pancreas 14,201 12,269 1,458 329 38 855
Retroperitoneum 486 437 26 ∼ ∼ 51
Peritoneum, Omentum and Mesentery 102 85 ∼ ∼ ∼ ∼
Other Digestive Organs 463 386 54 19 ∼ 31
Respiratory System 110,192 95,728 11,517 1,895 390 4,323
Nose, Nasal Cavity and Middle Ear 1,049 899 110 23 ∼ 78
Larynx 8,659 7,253 1,175 110 30 505
Lung and Bronchus 100,099 87,232 10,205 1,755 355 3,687
Pleura 62 56 ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 323 288 23 ∼ ∼ 49
Bones and Joints 1,387 1,158 152 39 ∼ 181
Soft Tissue including Heart 4,205 3,604 390 105 ∼ 375
Skin excluding Basal and Squamous 27,268 25,713 199 92 38 506
Melanomas of the Skin 25,196 23,864 92 63 34 420
Other Non-Epithelial Skin 2,072 1,849 107 29 ∼ 86
Breast 1,646 1,407 176 29 ∼ 67
Male Genital System 198,176 164,418 23,111 3,210 577 11,297
Prostate 190,096 156,997 22,788 3,093 522 10,382
Testis 6,852 6,351 217 95 48 792
Penis 985 860 91 ∼ ∼ 109
Other Male Genital Organs 243 210 ∼ ∼ ∼ ∼
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Table D.1.1M: Invasive Cancer Incidence Counts by Primary Site and Race and Ethnicity, United
States∗† (continued)
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
Urinary System 64,822 59,176 3,640 860 182 3,003
Urinary Bladder‖ 41,736 38,936 1,563 529 59 1,414
Kidney and Renal Pelvis 21,690 18,957 2,023 301 119 1,537
Ureter 976 914 23 24 ∼ 31
Other Urinary Organs 420 369 31 ∼ ∼ 21
Eye and Orbit 1,120 1,027 44 ∼ ∼ 79
Brain and Other Nervous System 9,643 8,708 567 200 38 790
Brain 9,164 8,297 534 185 35 750
Cranial Nerves and Other Nervous System 479 411 33 ∼ ∼ 40
Endocrine System 6,356 5,566 382 245 17 532
Thyroid 5,444 4,827 266 205 16 439
Other Endocrine including Thymus 912 739 116 40 ∼ 93
Lymphomas 30,174 26,505 2,312 665 100 2,365
Hodgkin Lymphoma 4,043 3,467 395 77 ∼ 436
Non-Hodgkin Lymphoma 26,131 23,038 1,917 588 85 1,929
Multiple Myeloma 7,507 6,103 1,148 124 31 448
Leukemias 17,119 15,175 1,161 347 65 1,374
Acute Lymphocytic 2,118 1,822 157 79 21 497
Chronic Lymphocytic 5,321 4,769 332 32 ∼ 177
Acute Myeloid 5,249 4,673 357 144 20 384
Chronic Myeloid 1,979 1,718 155 50 ∼ 163
Other Leukemias 2,452 2,193 160 42 ∼ 153
Mesothelioma 2,279 2,165 86 ∼ ∼ 108
Kaposi Sarcoma 1,055 695 280 24 ∼ 212
Miscellaneous 15,292 13,206 1,585 263 64 845
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix
I for data quality criteria and registry-specific data quality information. Case counts cover approximately 93% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
‖ Includes invasive and in situ.
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Notes: Incidence counts cover approximately 93% of the U.S. population; death counts cover 100% of the U.S. population. Use caution when comparing incidence
and death counts.
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–4 Table D.1.1F: Invasive Cancer Incidence Counts by Primary Site and Race and Ethnicity, United
States∗†
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 598,705 518,948 54,793 14,120 2,170 35,150
Oral Cavity and Pharynx 8,906 7,645 820 266 30 410
Lip 529 501 ∼ ∼ ∼ 16
Tongue 2,313 2,020 176 67 ∼ 116
Salivary Gland 1,322 1,103 126 54 ∼ 87
Floor of Mouth 620 544 54 ∼ ∼ ∼
Gum and Other Mouth 1,843 1,612 164 36 ∼ 94
Nasopharynx 473 317 70 80 ∼ 33
Tonsil 814 712 83 ∼ ∼ 22
Oropharynx 312 258 46 ∼ ∼ ∼
Hypopharynx 440 369 62 ∼ ∼ ∼
Other Oral Cavity and Pharynx 240 209 28 ∼ ∼ ∼
Digestive System 109,272 92,201 12,293 3,217 445 6,836
Esophagus 3,057 2,476 481 59 ∼ 114
Stomach 7,388 5,592 1,193 480 42 883
Small Intestine 2,241 1,848 320 38 ∼ 144
Colon and Rectum 68,883 58,925 7,249 1,673 249 3,503
Colon excluding Rectum 52,585 44,942 5,741 1,165 177 2,561
Rectum and Rectosigmoid Junction 16,298 13,983 1,508 508 72 942
Anus, Anal Canal and Anorectum 2,250 2,008 189 28 ∼ 168
Liver and Intrahepatic Bile Duct 4,309 3,372 511 362 22 560
Gallbladder 2,030 1,699 234 63 22 272
Other Biliary 2,083 1,777 179 104 ∼ 164
Pancreas 14,676 12,412 1,759 352 59 883
Retroperitoneum 545 446 70 17 ∼ 44
Peritoneum, Omentum and Mesentery 1,342 1,248 58 26 ∼ 64
Other Digestive Organs 468 398 50 ∼ ∼ 37
Respiratory System 83,285 73,735 7,436 1,327 309 2,637
Nose, Nasal Cavity and Middle Ear 740 642 57 22 ∼ 61
Larynx 2,186 1,809 335 ∼ ∼ 79
Lung and Bronchus 80,163 71,114 7,024 1,290 300 2,482
Pleura 33 27 ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 163 143 ∼ ∼ ∼ ∼
Bones and Joints 1,078 896 116 31 ∼ 118
Soft Tissue including Heart 3,541 2,958 429 84 19 322
Skin excluding Basal and Squamous 20,981 19,480 262 108 28 611
Melanomas of the Skin 19,386 18,137 130 71 23 524
Other Non-Epithelial Skin 1,595 1,343 132 37 ∼ 87
Breast 182,125 157,828 16,439 4,535 607 10,317
Female Genital System 71,190 61,212 6,687 1,907 273 5,469
Cervix 12,085 9,394 1,930 451 63 1,813
Corpus 33,338 29,236 2,631 802 121 1,988
Uterus, NOS 1,140 890 205 20 ∼ 68
Ovary 19,177 16,958 1,428 535 57 1,281
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Table D.1.1F: Invasive Cancer Incidence Counts by Primary Site and Race and Ethnicity, United
States∗† (continued)
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
Vagina 1,069 861 153 31 ∼ 82
Vulva 3,411 3,051 248 39 ∼ 168
Other Female Genital Organs 970 822 92 29 ∼ 69
Urinary System 28,838 25,553 2,475 336 101 1,543
Urinary Bladder‖ 14,466 13,147 968 132 28 533
Kidney and Renal Pelvis 13,613 11,734 1,445 186 72 983
Ureter 571 526 28 ∼ ∼ 19
Other Urinary Organs 188 146 34 ∼ ∼ ∼
Eye and Orbit 916 849 31 ∼ ∼ 75
Brain and Other Nervous System 7,845 7,040 522 173 25 662
Brain 7,246 6,540 459 156 24 598
Cranial Nerves and Other Nervous System 599 500 63 17 ∼ 64
Endocrine System 17,477 14,864 1,285 823 70 1,861
Thyroid 16,690 14,229 1,180 787 68 1,781
Other Endocrine including Thymus 787 635 105 36 ∼ 80
Lymphomas 26,517 23,512 1,911 575 88 1,814
Hodgkin Lymphoma 3,391 2,899 349 67 ∼ 308
Non-Hodgkin Lymphoma 23,126 20,613 1,562 508 80 1,506
Multiple Myeloma 6,361 4,911 1,188 120 34 427
Leukemias 13,130 11,438 1,048 299 53 1,085
Acute Lymphocytic 1,632 1,385 124 77 ∼ 376
Chronic Lymphocytic 3,830 3,386 250 31 ∼ 115
Acute Myeloid 4,265 3,714 372 125 17 345
Chronic Myeloid 1,514 1,312 129 38 ∼ 102
Other Leukemias 1,889 1,641 173 28 ∼ 147
Mesothelioma 587 548 27 ∼ ∼ 39
Kaposi Sarcoma 142 100 32 ∼ ∼ 24
Miscellaneous 16,514 14,178 1,792 300 80 900
Breast, in situ ¶ 41,125 35,326 3,515 1,315 120 2,176
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix
I for data quality criteria and registry-specific data quality information. Case counts cover approximately 93% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
‖ Includes invasive and in situ.
¶ Case counts for in situ female breast cancer are listed separately and are not included in the "all sites" category.
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Notes: Incidence counts cover approximately 93% of the U.S. population; death counts cover 100% of the U.S. population. Use caution when comparing incidence
and death counts.
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–6 Table D.1.2M: Cancer Death Counts by Primary Site and Race and Ethnicity, United States∗
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander† Alaska Native† Hispanic†‡
All Sites 288,763 249,864 32,625 5,193 1,081 12,235
Oral Cavity and Pharynx 5,184 4,256 766 135 27 215
Lip 54 52 ∼ ∼ ∼ ∼
Tongue 1,220 1,032 157 22 ∼ 60
Salivary Gland 455 426 24 ∼ ∼ ∼
Floor of Mouth 112 94 16 ∼ ∼ ∼
Gum and Other Mouth 648 543 96 ∼ ∼ 20
Nasopharynx 388 255 54 73 ∼ 17
Tonsil 476 399 74 ∼ ∼ 21
Oropharynx 431 327 91 ∼ ∼ 21
Hypopharynx 253 207 42 ∼ ∼ ∼
Other Oral Cavity and Pharynx 1,147 921 211 ∼ ∼ 41
Digestive System 71,968 60,816 8,739 2,077 336 3,995
Esophagus 9,789 8,510 1,133 109 37 329
Stomach 7,133 5,542 1,194 352 45 671
Small Intestine 530 441 72 ∼ ∼ 22
Colon and Rectum 28,471 24,416 3,343 582 130 1,279
Colon excluding Rectum 23,669 20,258 2,853 463 95 1,065
Rectum and Rectosigmoid Junction 4,802 4,158 490 119 35 214
Anus, Anal Canal and Anorectum 213 184 27 ∼ ∼ ∼
Liver and Intrahepatic Bile Duct 9,011 7,114 1,165 672 60 891
Gallbladder 562 477 57 24 ∼ 53
Other Biliary 726 642 54 27 ∼ 41
Pancreas 14,876 12,921 1,616 289 50 667
Retroperitoneum 112 101 ∼ ∼ ∼ ∼
Peritoneum, Omentum and Mesentery 68 60 ∼ ∼ ∼ ∼
Other Digestive Organs 477 408 62 ∼ ∼ 24
Respiratory System 93,531 81,206 10,656 1,353 316 2,780
Nose, Nasal Cavity and Middle Ear 275 243 27 ∼ ∼ ∼
Larynx 2,921 2,351 541 18 ∼ 139
Lung and Bronchus 90,121 78,423 10,069 1,325 304 2,616
Pleura 40 39 ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 174 150 18 ∼ ∼ ∼
Bones and Joints 664 574 75 ∼ ∼ 69
Soft Tissue including Heart 1,762 1,528 193 33 ∼ 126
Skin excluding Basal and Squamous 6,371 6,159 170 29 ∼ 129
Melanomas of the Skin 4,725 4,639 52 25 ∼ 77
Other Non-Epithelial Skin 1,646 1,520 118 ∼ ∼ 52
Breast 369 300 64 ∼ ∼ ∼
Male Genital System 31,084 25,485 5,200 308 91 1,297
Prostate 30,446 24,918 5,145 298 85 1,209
Testis 393 357 28 ∼ ∼ 57
Penis 209 180 22 ∼ ∼ 30
Other Male Genital Organs 36 30 ∼ ∼ ∼ ∼
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Table D.1.2M: Cancer Death Counts by Primary Site and Race and Ethnicity, United States∗
(continued)
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander† Alaska Native† Hispanic†‡
Urinary System 16,447 15,039 1,129 196 83 687
Urinary Bladder 8,503 7,907 481 98 17 252
Kidney and Renal Pelvis 7,587 6,803 630 91 63 426
Ureter 166 156 ∼ ∼ ∼ ∼
Other Urinary Organs 191 173 ∼ ∼ ∼ ∼
Eye and Orbit 117 111 ∼ ∼ ∼ ∼
Brain and Other Nervous System 7,125 6,554 409 139 23 359
Endocrine System 1,007 868 101 34 ∼ 76
Thyroid 558 503 40 ∼ ∼ 45
Other Endocrine including Thymus 449 365 61 20 ∼ 31
Lymphoma 12,289 11,190 857 213 29 602
Hodgkin Lymphoma 751 655 82 ∼ ∼ 53
Non-Hodgkin Lymphoma 11,538 10,535 775 199 29 549
Multiple Myeloma 5,671 4,764 822 66 19 306
Leukemias 12,058 10,868 932 218 40 602
Acute Lymphocytic 816 716 63 29 ∼ 136
Chronic Lymphocytic 2,555 2,343 202 ∼ ∼ 41
Acute Myeloid 4,415 4,012 287 100 16 211
Chronic Myeloid 749 626 99 20 ∼ 41
Other Leukemias 3,523 3,171 281 61 ∼ 173
Mesothelioma 2,004 1,912 76 ∼ ∼ 70
Miscellaneous 21,081 18,212 2,424 361 84 896
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Notes: Incidence counts cover approximately 93% of the U.S. population; death counts cover 100% of the U.S. population. Use caution when comparing
incidence and death counts.
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–8 Table D.1.2F: Cancer Death Counts by Primary Site and Race and Ethnicity, United States∗
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander† Alaska Native† Hispanic†‡
All Sites 268,501 232,613 29,989 4,805 1,094 10,906
Oral Cavity and Pharynx 2,553 2,176 278 83 16 69
Lip 20 17 ∼ ∼ ∼ ∼
Tongue 667 589 55 19 ∼ 23
Salivary Gland 267 232 26 ∼ ∼ ∼
Floor of Mouth 37 32 ∼ ∼ ∼ ∼
Gum and Other Mouth 504 463 36 ∼ ∼ ∼
Nasopharynx 240 159 39 39 ∼ ∼
Tonsil 162 141 17 ∼ ∼ ∼
Oropharynx 175 141 28 ∼ ∼ ∼
Hypopharynx 70 62 ∼ ∼ ∼ ∼
Other Oral Cavity and Pharynx 411 340 62 ∼ ∼ ∼
Digestive System 60,573 50,955 7,788 1,544 286 3,100
Esophagus 2,911 2,400 456 45 ∼ 82
Stomach 5,065 3,777 937 305 46 514
Small Intestine 487 401 78 ∼ ∼ ∼
Colon and Rectum 28,132 24,018 3,520 479 115 1,067
Colon excluding Rectum 24,318 20,725 3,103 393 97 921
Rectum and Rectosigmoid Junction 3,814 3,293 417 86 18 146
Anus, Anal Canal and Anorectum 326 301 24 ∼ ∼ ∼
Liver and Intrahepatic Bile Duct 5,036 4,136 569 297 34 472
Gallbladder 1,345 1,122 181 32 ∼ 145
Other Biliary 775 704 54 16 ∼ 45
Pancreas 15,387 13,110 1,877 338 62 696
Retroperitoneum 107 95 ∼ ∼ ∼ ∼
Peritoneum, Omentum and Mesentery 548 500 36 ∼ ∼ 22
Other Digestive Organs 454 391 48 ∼ ∼ 24
Respiratory System 68,617 61,108 6,394 860 255 1,471
Nose, Nasal Cavity and Middle Ear 169 155 ∼ ∼ ∼ 19
Larynx 801 661 133 ∼ ∼ 26
Lung and Bronchus 67,509 60,167 6,237 853 252 1,421
Pleura 33 30 ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 105 95 ∼ ∼ ∼ ∼
Bones and Joints 530 456 61 ∼ ∼ 38
Soft Tissue including Heart 1,792 1,526 223 36 ∼ 110
Skin excluding Basal and Squamous 3,533 3,410 91 23 ∼ 88
Melanomas of the Skin 2,788 2,713 50 17 ∼ 70
Other Non-Epithelial Skin 745 697 41 ∼ ∼ 18
Breast 41,514 35,082 5,572 712 148 1,724
Female Genital System 27,091 23,177 3,248 544 122 1,413
Cervix 3,952 2,967 829 122 34 388
Corpus 3,187 2,613 493 69 ∼ 150
Uterus, NOS 3,666 2,954 626 66 20 187
Ovary 14,682 13,202 1,163 267 50 622
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Table D.1.2F: Cancer Death Counts by Primary Site and Race and Ethnicity, United States∗
(continued)
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander† Alaska Native† Hispanic†‡
Vagina 378 326 46 ∼ ∼ 16
Vulva 794 742 43 ∼ ∼ 33
Other Female Genital Organs 432 373 48 ∼ ∼ 17
Urinary System 8,996 7,908 937 102 49 373
Urinary Bladder 4,124 3,604 459 47 ∼ 135
Kidney and Renal Pelvis 4,578 4,053 439 51 35 233
Ureter 131 123 ∼ ∼ ∼ ∼
Other Urinary Organs 163 128 34 ∼ ∼ ∼
Eye and Orbit 123 115 ∼ ∼ ∼ ∼
Brain and Other Nervous System 5,705 5,240 372 75 18 290
Endocrine System 1,224 1,041 135 43 ∼ 86
Thyroid 809 697 78 31 ∼ 62
Other Endocrine including Thymus 415 344 57 ∼ ∼ 24
Lymphoma 10,973 9,999 747 202 25 565
Hodgkin Lymphoma 601 538 48 ∼ ∼ 46
Non-Hodgkin Lymphoma 10,372 9,461 699 188 24 519
Multiple Myeloma 5,242 4,214 917 88 23 254
Leukemias 9,523 8,472 853 165 33 488
Acute Lymphocytic 616 536 55 19 ∼ 108
Chronic Lymphocytic 1,888 1,710 163 ∼ ∼ 32
Acute Myeloid 3,499 3,123 289 73 ∼ 169
Chronic Myeloid 618 525 74 16 ∼ 31
Other Leukemias 2,902 2,578 272 46 ∼ 148
Mesothelioma 426 400 19 ∼ ∼ 17
Miscellaneous 20,063 17,313 2,347 312 91 808
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Notes: Incidence counts cover approximately 93% of the U.S. population; death counts cover 100% of the U.S. population. Use caution when comparing
incidence and death counts.
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–10 Table D.2.1M: Invasive Cancer Incidence Counts for Ages 0-19 by International Classification of Childhood
Cancer (ICCC∗) Group and Subgroup, Race and Ethnicity, United States†
Males, 2002
Asian/Pacific American Indian/
ICCC Group and Subgroup All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All ICCC Groups Combined 6,673 5,569 654 223 59 1,309
I Leukemia 1,722 1,442 143 71 21 438
I(a) Lymphoid leukemia 1,294 1,101 96 52 ∼ 353
Acute lymphocytic leukemia (ALL) 1,251 1,064 93 49 ∼ 340
Lymphoid excluding ALL 43 37 ∼ ∼ ∼ ∼
I(b) Acute non-lymphocytic leukemia 317 252 35 ∼ ∼ 61
I(c) Chronic myeloid leukemia 52 39 ∼ ∼ ∼ ∼
I(d) Other specified leukemia ∼ ∼ ∼ ∼ ∼ ∼
I(e) Unspecified leukemia 49 41 ∼ ∼ ∼ ∼
II Lymphoma and reticuloendothelial neoplasms 1,020 849 112 30 ∼ 195
II(a) Hodgkin lymphoma 460 378 51 ∼ ∼ 76
II(b) Non-Hodgkin lymphoma 385 321 47 ∼ ∼ 81
II(c) Burkitt lymphoma 155 134 ∼ ∼ ∼ 32
II(d) Miscellaneous lymphoreticular neoplasms ∼ ∼ ∼ ∼ ∼ ∼
II(e) Unspecified lymphoma ∼ ∼ ∼ ∼ ∼ ∼
III CNS and misc intracranial and intraspinal neoplasms 1,188 1,007 126 22 ∼ 199
III(a) Ependymoma 123 104 ∼ ∼ ∼ 26
III(b) Astrocytoma 567 487 54 ∼ ∼ 86
III(c) Primitive neuroectodermal tumors 262 223 25 ∼ ∼ 42
III(d) Other gliomas 189 159 23 ∼ ∼ 35
III(e) Misc intracranial and intraspinal neoplasms ∼ ∼ ∼ ∼ ∼ ∼
III(f) Unspecified intracranial and intraspinal neoplasm 37 28 ∼ ∼ ∼ ∼
IV Sympathetic nervous system tumors 329 268 40 ∼ ∼ 50
IV(a) Neuroblastoma and ganglioneuroblastoma 320 262 37 ∼ ∼ 48
IV(b) Other sympathetic nervous system tumors ∼ ∼ ∼ ∼ ∼ ∼
V Retinoblastoma 115 80 23 ∼ ∼ 23
VI Renal tumors 238 189 37 ∼ ∼ 39
VI(a) Wilms tumor, rhabdoid and clear cell sarcoma 217 178 29 ∼ ∼ 37
VI(b) Renal carcinoma 20 ∼ ∼ ∼ ∼ ∼
VI(c) Unspecified malignant renal tumors ∼ ∼ ∼ ∼ ∼ ∼
VII Hepatic tumors 83 60 ∼ ∼ ∼ ∼
VII(a) Hepatoblastoma 61 45 ∼ ∼ ∼ ∼
VII(b) Hepatic carcinoma 21 ∼ ∼ ∼ ∼ ∼
VII(c) Unspecified malignant hepatic tumors ∼ ∼ ∼ ∼ ∼ ∼
VIII Malignant bone tumors 420 349 46 ∼ ∼ 84
VIII(a) Osteosarcoma 231 184 31 ∼ ∼ 53
VIII(b) Chrondosarcoma 23 19 ∼ ∼ ∼ ∼
VIII(c) Ewing sarcoma 141 126 ∼ ∼ ∼ 21
VIII(d) Other specified malignant bone tumors 18 16 ∼ ∼ ∼ ∼
VIII(e) Unspecified malignant bone tumors ∼ ∼ ∼ ∼ ∼ ∼
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Table D.2.1M: Invasive Cancer Incidence Counts for Ages 0-19 by International Classification of Childhood
Cancer (ICCC∗) Group and Subgroup, Race and Ethnicity, United States† (continued)
Males, 2002
Asian/Pacific American Indian/
ICCC Group and Subgroup All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
IX Soft-tissue sarcomas 527 422 64 21 ∼ 84
IX(a) Rhabdomyosarcoma and embryonal sarcoma 228 186 29 ∼ ∼ 36
IX(b) Fibrosarcoma, neurofibrosar and other fibromatous
neoplasms 80 62 ∼ ∼ ∼ ∼
IX(c) Kaposi sarcoma ∼ ∼ ∼ ∼ ∼ ∼
IX(d) Other specified soft-tissue sarcomas 164 131 19 ∼ ∼ 28
IX(d) excluding misclassification from III(c) 146 115 18 ∼ ∼ 26
PNET - not in brain/CNS/bone 18 16 ∼ ∼ ∼ ∼
IX(e) Unspecified soft-tissue sarcomas 55 43 ∼ ∼ ∼ ∼
X Germ-cell, trophoblastic and other gonadal neoplasms 512 464 18 ∼ ∼ 122
X(a) Intracranial and intraspinal germ-cell tumors 84 69 ∼ ∼ ∼ ∼
X(b) Other and unspecified non-gonadal germ-cell tumors 45 38 ∼ ∼ ∼ 16
X(c) Gonadal germ-cell tumors 378 352 ∼ ∼ ∼ 90
X(d) Gonadal carcinomas ∼ ∼ ∼ ∼ ∼ ∼
X(e) Other and unspecified malignant gonadal tumors ∼ ∼ ∼ ∼ ∼ ∼
XI Carcinomas and other malignant epithelial neoplasms 460 393 30 ∼ ∼ 49
XI(a) Adrenocortical carcinoma ∼ ∼ ∼ ∼ ∼ ∼
XI(b) Thyroid carcinoma 82 71 ∼ ∼ ∼ ∼
XI(c) Nasopharyngeal carcinoma 30 ∼ ∼ ∼ ∼ ∼
XI(d) Malignant melanoma 220 205 ∼ ∼ ∼ ∼
XI(e) Skin carcinoma ∼ ∼ ∼ ∼ ∼ ∼
XI(f) Other and unspecified carcinomas 119 96 ∼ ∼ ∼ ∼
XII Other and unspecified malignant neoplasms 34 25 ∼ ∼ ∼ ∼
XII(a) Other specified malignant tumors ∼ ∼ ∼ ∼ ∼ ∼
XII(b) Other unspecified malignant tumors 23 17 ∼ ∼ ∼ ∼
Not classified by ICCC 25 21 ∼ ∼ ∼ ∼
∗ SEER modification of the 1996 International Classification of Childhood Cancer based on ICD-0-2. See Technical Notes.
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for
data quality criteria and registry-specific data quality information. Case counts cover approximately 93% of the U.S. population.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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–12 Table D.2.1F: Invasive Cancer Incidence Counts for Ages 0-19 by International Classification of Childhood
Cancer (ICCC∗) Group and Subgroup, Race and Ethnicity, United States†
Females, 2002
Asian/Pacific American Indian/
ICCC Group and Subgroup All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All ICCC Groups Combined 5,485 4,466 633 198 51 976
I Leukemia 1,363 1,109 133 68 19 352
I(a) Lymphoid leukemia 986 822 75 51 ∼ 275
Acute lymphocytic leukemia (ALL) 957 795 74 50 ∼ 260
Lymphoid excluding ALL 29 27 ∼ ∼ ∼ ∼
I(b) Acute non-lymphocytic leukemia 282 216 46 ∼ ∼ 54
I(c) Chronic myeloid leukemia 45 35 ∼ ∼ ∼ ∼
I(d) Other specified leukemia ∼ ∼ ∼ ∼ ∼ ∼
I(e) Unspecified leukemia 40 28 ∼ ∼ ∼ ∼
II Lymphoma and reticuloendothelial neoplasms 724 586 92 32 ∼ 100
II(a) Hodgkin lymphoma 439 366 48 16 ∼ 48
II(b) Non-Hodgkin lymphoma 225 169 41 ∼ ∼ 41
II(c) Burkitt lymphoma 43 36 ∼ ∼ ∼ ∼
II(d) Miscellaneous lymphoreticular neoplasms ∼ ∼ ∼ ∼ ∼ ∼
II(e) Unspecified lymphoma ∼ ∼ ∼ ∼ ∼ ∼
III CNS and misc intracranial and intraspinal neoplasms 912 753 105 26 ∼ 148
III(a) Ependymoma 92 71 16 ∼ ∼ 19
III(b) Astrocytoma 438 370 44 ∼ ∼ 64
III(c) Primitive neuroectodermal tumors 173 140 21 ∼ ∼ 29
III(d) Other gliomas 174 141 21 ∼ ∼ 32
III(e) Misc intracranial and intraspinal neoplasms ∼ ∼ ∼ ∼ ∼ ∼
III(f) Unspecified intracranial and intraspinal neoplasm 26 24 ∼ ∼ ∼ ∼
IV Sympathetic nervous system tumors 265 223 27 ∼ ∼ 37
IV(a) Neuroblastoma and ganglioneuroblastoma 257 218 25 ∼ ∼ 36
IV(b) Other sympathetic nervous system tumors ∼ ∼ ∼ ∼ ∼ ∼
V Retinoblastoma 93 72 ∼ ∼ ∼ 26
VI Renal tumors 230 165 46 ∼ ∼ 34
VI(a) Wilms tumor, rhabdoid and clear cell sarcoma 218 157 42 ∼ ∼ 34
VI(b) Renal carcinoma ∼ ∼ ∼ ∼ ∼ ∼
VI(c) Unspecified malignant renal tumors ∼ ∼ ∼ ∼ ∼ ∼
VII Hepatic tumors 44 40 ∼ ∼ ∼ ∼
VII(a) Hepatoblastoma 28 26 ∼ ∼ ∼ ∼
VII(b) Hepatic carcinoma 16 ∼ ∼ ∼ ∼ ∼
VII(c) Unspecified malignant hepatic tumors ∼ ∼ ∼ ∼ ∼ ∼
VIII Malignant bone tumors 277 232 33 ∼ ∼ 48
VIII(a) Osteosarcoma 142 104 29 ∼ ∼ 23
VIII(b) Chrondosarcoma ∼ ∼ ∼ ∼ ∼ ∼
VIII(c) Ewing sarcoma 99 97 ∼ ∼ ∼ ∼
VIII(d) Other specified malignant bone tumors ∼ ∼ ∼ ∼ ∼ ∼
VIII(e) Unspecified malignant bone tumors ∼ ∼ ∼ ∼ ∼ ∼
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Table D.2.1F: Invasive Cancer Incidence Counts for Ages 0-19 by International Classification of Childhood
Cancer (ICCC∗) Group and Subgroup, Race and Ethnicity, United States† (continued)
Females, 2002
Asian/Pacific American Indian/
ICCC Group and Subgroup All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
IX Soft-tissue sarcomas 377 286 65 ∼ ∼ 60
IX(a) Rhabdomyosarcoma and embryonal sarcoma 132 99 28 ∼ ∼ 22
IX(b) Fibrosarcoma, neurofibrosar and other fibromatous
neoplasms 78 60 ∼ ∼ ∼ ∼
IX(c) Kaposi sarcoma ∼ ∼ ∼ ∼ ∼ ∼
IX(d) Other specified soft-tissue sarcomas 122 96 ∼ ∼ ∼ 21
IX(d) excluding misclassification from III(c) 105 83 ∼ ∼ ∼ 20
PNET - not in brain/CNS/bone 17 ∼ ∼ ∼ ∼ ∼
IX(e) Unspecified soft-tissue sarcomas 45 31 ∼ ∼ ∼ ∼
X Germ-cell, trophoblastic and other gonadal neoplasms 307 237 44 ∼ ∼ 67
X(a) Intracranial and intraspinal germ-cell tumors 38 32 ∼ ∼ ∼ ∼
X(b) Other and unspecified non-gonadal germ-cell tumors 66 46 ∼ ∼ ∼ ∼
X(c) Gonadal germ-cell tumors 163 127 23 ∼ ∼ 43
X(d) Gonadal carcinomas 24 21 ∼ ∼ ∼ ∼
X(e) Other and unspecified malignant gonadal tumors 16 ∼ ∼ ∼ ∼ ∼
XI Carcinomas and other malignant epithelial neoplasms 815 704 57 23 ∼ 83
XI(a) Adrenocortical carcinoma ∼ ∼ ∼ ∼ ∼ ∼
XI(b) Thyroid carcinoma 331 294 ∼ ∼ ∼ 35
XI(c) Nasopharyngeal carcinoma 20 ∼ ∼ ∼ ∼ ∼
XI(d) Malignant melanoma 255 237 ∼ ∼ ∼ ∼
XI(e) Skin carcinoma ∼ ∼ ∼ ∼ ∼ ∼
XI(f) Other and unspecified carcinomas 191 147 33 ∼ ∼ 31
XII Other and unspecified malignant neoplasms 53 40 ∼ ∼ ∼ ∼
XII(a) Other specified malignant tumors 33 25 ∼ ∼ ∼ ∼
XII(b) Other unspecified malignant tumors 20 ∼ ∼ ∼ ∼ ∼
Not classified by ICCC 25 19 ∼ ∼ ∼ ∼
∗ SEER modification of the 1996 International Classification of Childhood Cancer based on ICD-0-2. See Technical Notes.
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for
data quality criteria and registry-specific data quality information. Case counts cover approximately 93% of the U.S. population.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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∗)
Group and Subgroup, and Age, United States†
All Races, Males and Females, 2002
Age (years)
ICCC Group and Subgroup 0-14 0-19 <1 1-4 5-9 10-14 15-19
All ICCC Groups Combined 8,208 12,158 865 2,893 2,098 2,352 3,950
I Leukemia 2,551 3,085 154 1,184 691 522 534
I(a) Lymphoid leukemia 1,970 2,280 63 992 568 347 310
Acute lymphocytic leukemia (ALL) 1,912 2,208 62 972 546 332 296
Lymphoid excluding ALL 58 72 ∼ 20 22 ∼ ∼
I(b) Acute non-lymphocytic leukemia 432 599 64 149 82 137 167
I(c) Chronic myeloid leukemia 65 97 ∼ 16 ∼ 24 32
I(d) Other specified leukemia ∼ 20 ∼ ∼ ∼ ∼ ∼
I(e) Unspecified leukemia 71 89 ∼ 23 22 ∼ 18
II Lymphoma and reticuloendothelial neoplasms 811 1,744 17 114 230 450 933
II(a) Hodgkin lymphoma 296 899 ∼ ∼ 58 229 603
II(b) Non-Hodgkin lymphoma 345 610 ∼ 70 107 157 265
II(c) Burkitt lymphoma 147 198 ∼ 29 59 58 51
II(d) Miscellaneous lymphoreticular neoplasms ∼ ∼ ∼ ∼ ∼ ∼ ∼
II(e) Unspecified lymphoma ∼ 25 ∼ ∼ ∼ ∼ ∼
III CNS and misc intracranial and intraspinal neoplasms 1,729 2,100 121 568 600 440 371
III(a) Ependymoma 197 215 25 89 40 43 18
III(b) Astrocytoma 790 1,005 43 235 279 233 215
III(c) Primitive neuroectodermal tumors 385 435 25 136 145 79 50
III(d) Other gliomas 288 363 ∼ 80 126 72 75
III(e) Misc intracranial and intraspinal neoplasms ∼ 19 ∼ ∼ ∼ ∼ ∼
III(f) Unspecified intracranial and intraspinal neoplasm 55 63 17 24 ∼ ∼ ∼
IV Sympathetic nervous system tumors 579 594 219 271 66 23 ∼
IV(a) Neuroblastoma and ganglioneuroblastoma 572 577 219 267 66 20 ∼
IV(b) Other sympathetic nervous system tumors ∼ 17 ∼ ∼ ∼ ∼ ∼
V Retinoblastoma 208 208 86 119 ∼ ∼ ∼
VI Renal tumors 447 468 63 278 85 21 21
VI(a) Wilms tumor, rhabdoid and clear cell sarcoma 433 435 63 276 80 ∼ ∼
VI(b) Renal carcinoma ∼ 32 ∼ ∼ ∼ ∼ 19
VI(c) Unspecified malignant renal tumors ∼ ∼ ∼ ∼ ∼ ∼ ∼
VII Hepatic tumors 108 127 26 62 ∼ ∼ 19
VII(a) Hepatoblastoma 88 89 25 58 ∼ ∼ ∼
VII(b) Hepatic carcinoma 19 37 ∼ ∼ ∼ ∼ 18
VII(c) Unspecified malignant hepatic tumors ∼ ∼ ∼ ∼ ∼ ∼ ∼
VIII Malignant bone tumors 400 697 ∼ 23 111 264 297
VIII(a) Osteosarcoma 211 373 ∼ ∼ 49 155 162
VIII(b) Chrondosarcoma ∼ 38 ∼ ∼ ∼ ∼ 29
VIII(c) Ewing sarcoma 153 240 ∼ ∼ 52 86 87
VIII(d) Other specified malignant bone tumors 18 33 ∼ ∼ ∼ ∼ ∼
VIII(e) Unspecified malignant bone tumors ∼ ∼ ∼ ∼ ∼ ∼ ∼
IX Soft-tissue sarcomas 620 904 64 167 174 215 284
IX(a) Rhabdomyosarcoma and embryonal sarcoma 295 360 26 120 91 58 65
IX(b) Fibrosarcoma, neurofibrosar and other fibromatous
neoplasms 101 158 20 ∼ 24 44 57
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Table D.3.1: Invasive Cancer Incidence Counts by International Classification of Childhood Cancer (ICCC∗)
Group and Subgroup, and Age, United States† (continued)
All Races, Males and Females, 2002
Age (years)
ICCC Group and Subgroup 0-14 0-19 <1 1-4 5-9 10-14 15-19
IX(c) Kaposi sarcoma ∼ ∼ ∼ ∼ ∼ ∼ ∼
IX(d) Other specified soft-tissue sarcomas 161 286 ∼ 26 41 80 125
IX(d) excluding misclassification from III(c) 142 251 ∼ 20 37 71 109
PNET - not in brain/CNS/bone 19 35 ∼ ∼ ∼ ∼ 16
IX(e) Unspecified soft-tissue sarcomas 63 100 ∼ ∼ 18 33 37
X Germ-cell, trophoblastic and other gonadal neoplasms 304 819 83 45 49 127 515
X(a) Intracranial and intraspinal germ-cell tumors 81 122 ∼ ∼ 20 50 41
X(b) Other and unspecified non-gonadal germ-cell tumors 80 111 55 18 ∼ ∼ 31
X(c) Gonadal germ-cell tumors 132 541 21 22 24 65 409
X(d) Gonadal carcinomas ∼ 25 ∼ ∼ ∼ ∼ 19
X(e) Other and unspecified malignant gonadal tumors ∼ 20 ∼ ∼ ∼ ∼ ∼
XI Carcinomas and other malignant epithelial neoplasms 358 1,275 ∼ 33 70 246 917
XI(a) Adrenocortical carcinoma ∼ 19 ∼ ∼ ∼ ∼ ∼
XI(b) Thyroid carcinoma 101 413 ∼ ∼ 18 80 312
XI(c) Nasopharyngeal carcinoma ∼ 50 ∼ ∼ ∼ ∼ 36
XI(d) Malignant melanoma 127 475 ∼ 16 31 74 348
XI(e) Skin carcinoma ∼ ∼ ∼ ∼ ∼ ∼ ∼
XI(f) Other and unspecified carcinomas 95 310 ∼ ∼ ∼ 73 215
XII Other and unspecified malignant neoplasms 46 87 ∼ ∼ ∼ 23 41
XII(a) Other specified malignant tumors 24 44 ∼ ∼ ∼ ∼ 20
XII(b) Other unspecified malignant tumors 22 43 ∼ ∼ ∼ ∼ 21
Not classified by ICCC 47 50 16 18 ∼ ∼ ∼
∗ SEER modification of the 1996 International Classification of Childhood Cancer based on ICD-0-2. See Technical Notes.
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for
data quality criteria and registry-specific data quality information. Case counts cover approximately 93% of the U.S. population.
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, age).
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–16 Table D.4.1M: Childhood Invasive Cancer Incidence Counts for Ages 0-19 by Primary Site and Race
and Ethnicity, United States∗
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander† Alaska Native† Hispanic†‡
All Sites 6,673 5,569 654 223 59 1,309
Bones and Joints 416 344 47 ∼ ∼ 84
Brain and Other Nervous System 1,237 1,046 129 27 ∼ 209
Hodgkin Lymphoma 460 378 51 ∼ ∼ 76
Kidney and Renal Pelvis 249 198 39 ∼ ∼ 41
Leukemia 1,722 1,442 143 71 21 438
Acute Lymphocytic 1,274 1,084 94 51 ∼ 345
Acute Myeloid 280 218 33 ∼ ∼ 52
Non-Hodgkin Lymphoma 551 463 61 18 ∼ 117
Soft Tissue 398 323 35 22 ∼ 72
Other 1,640 1,375 149 55 17 272
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Case counts cover approximately 93% of the U.S. population.
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Table D.4.2M: Childhood Cancer Death Counts for Ages 0-19 by Primary Site and Race and Ethnicity,
United States∗
Males, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander† Alaska Native† Hispanic†‡
All Sites 1,282 1,006 210 53 ∼ 234
Bones and Joints 96 79 ∼ ∼ ∼ 16
Brain and Other Nervous System 327 249 58 ∼ ∼ 52
Hodgkin Lymphoma 20 17 ∼ ∼ ∼ ∼
Kidney and Renal Pelvis 22 17 ∼ ∼ ∼ ∼
Leukemia 382 310 52 17 ∼ 91
Acute Lymphocytic 188 158 21 ∼ ∼ 47
Acute Myeloid 109 86 18 ∼ ∼ 26
Non-Hodgkin Lymphoma 78 61 ∼ ∼ ∼ ∼
Soft Tissue 82 59 19 ∼ ∼ ∼
Other 275 214 47 ∼ ∼ 46
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Notes: Incidence counts cover approximately 93% of the U.S. population; death counts cover 100% of the U.S. population. Use caution when
comparing incidence and death counts.
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Table D.4.1F: Childhood Invasive Cancer Incidence Counts for Ages 0-19 by Primary Site and Race
and Ethnicity, United States∗
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander† Alaska Native† Hispanic†‡
All Sites 5,485 4,466 633 198 51 976
Bones and Joints 277 231 34 ∼ ∼ 45
Brain and Other Nervous System 939 778 105 27 ∼ 158
Hodgkin Lymphoma 439 366 48 16 ∼ 48
Kidney and Renal Pelvis 237 169 48 ∼ ∼ 36
Leukemia 1,362 1,108 133 68 19 351
Acute Lymphocytic 967 804 75 50 ∼ 262
Acute Myeloid 243 187 38 ∼ ∼ 45
Non-Hodgkin Lymphoma 282 218 44 ∼ ∼ 51
Soft Tissue 344 265 51 ∼ ∼ 55
Other 1,605 1,331 170 45 ∼ 232
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Case counts cover approximately 93% of the U.S. population.
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Table D.4.2F: Childhood Cancer Death Counts for Ages 0-19 by Primary Site and Race and Ethnicity,
United States∗
Females, 2002
Asian/Pacific American Indian/
Primary Site All Races White Black Islander† Alaska Native† Hispanic†‡
All Sites 989 776 163 38 ∼ 187
Bones and Joints 83 72 ∼ ∼ ∼ 16
Brain and Other Nervous System 244 191 42 ∼ ∼ 38
Hodgkin Lymphoma ∼ ∼ ∼ ∼ ∼ ∼
Kidney and Renal Pelvis 27 24 ∼ ∼ ∼ ∼
Leukemia 296 236 39 18 ∼ 73
Acute Lymphocytic 135 115 ∼ ∼ ∼ 44
Acute Myeloid 100 76 19 ∼ ∼ 19
Non-Hodgkin Lymphoma 40 27 ∼ ∼ ∼ ∼
Soft Tissue 71 59 ∼ ∼ ∼ ∼
Other 215 158 47 ∼ ∼ 35
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
Notes: Incidence counts cover approximately 93% of the U.S. population; death counts cover 100% of the U.S. population. Use caution when
comparing incidence and death counts.
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–18 Table D.5.1: Childhood Invasive Cancer Incidence Counts by Primary Site and Age, United States
∗
All Races, Males and Females, 2002
Age (years)
Primary Site 0-14 0-19 <1 1-4 5-9 10-14 15-19
All Sites 8,208 12,158 865 2,893 2,098 2,352 3,950
Bones and Joints 402 693 ∼ 24 110 262 291
Brain and Other Nervous System 1,791 2,176 139 575 613 464 385
Hodgkin Lymphoma 296 899 ∼ ∼ 58 229 603
Kidney and Renal Pelvis 463 486 67 284 88 24 23
Leukemia 2,551 3,084 154 1,184 691 522 533
Acute Lymphocytic 1,939 2,241 62 980 555 342 302
Acute Myeloid 366 523 47 119 73 127 157
Non-Hodgkin Lymphoma 503 833 ∼ 103 170 218 330
Soft Tissue 542 742 112 163 110 157 200
Other 1,660 3,245 374 552 258 476 1,585
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Case counts cover approximately 93% of the U.S. population.
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, age).
Table D.5.2: Childhood Cancer Death Counts by Primary Site and Age, United States∗
All Races, Males and Females, 2002
Age (years)
Primary Site 0-14 0-19 <1 1-4 5-9 10-14 15-19
All Sites 1,548 2,271 74 402 537 535 723
Bones and Joints 85 179 ∼ ∼ 21 61 94
Brain and Other Nervous System 463 571 ∼ 114 202 135 108
Hodgkin Lymphoma ∼ 33 ∼ ∼ ∼ ∼ 27
Kidney and Renal Pelvis 42 49 ∼ ∼ 23 ∼ ∼
Leukemia 441 678 21 104 148 168 237
Acute Lymphocytic 217 323 ∼ 34 82 91 106
Acute Myeloid 131 209 ∼ 46 34 44 78
Non-Hodgkin Lymphoma 74 118 ∼ ∼ ∼ 42 44
Soft Tissue 95 153 ∼ 23 28 41 58
Other 342 490 31 136 97 78 148
∗ Data are from the National Vital Statistics System (NVSS).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (site, age).
Notes: Incidence counts cover approximately 93% of the U.S. population; death counts cover 100% of the U.S. population. Use caution when comparing
incidence and death counts.
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Table D.6.1: Invasive Cancer of the Brain and Other Nervous System Incidence Counts by Standard
Histology Group and Subgroup∗, Age, and Sex, United States†
All Races, 2002
0-19 years 20+ years
Histology Group and Subgroup Male Female Male Female
Total 1,312 981 9,081 7,471
Tumors of Neuroepithelial Tissue 1,182 908 7,738 6,042
Pilocytic astrocytoma 278 244 121 109
Diffuse astrocytoma 20 22 104 101
Anaplastic astrocytoma 50 21 630 481
Unique astrocytoma variants ∼ ∼ ∼ 24
Astrocytoma, NOS 118 64 586 483
Glioblastoma 56 36 4,708 3,483
Oligodendroglioma 42 31 635 498
Ependymoma 113 80 197 214
Mixed glioma 16 ∼ 251 202
Glioma malignant, NOS 161 167 344 347
Choroid plexus ∼ ∼ ∼ ∼
Neuroepithelial ∼ ∼ ∼ 17
Neuronal/glial, neuronal 22 19 ∼ ∼
Pineal parenchymal ∼ 20 ∼ ∼
Embryonal/primitive/medulloblastoma 268 167 115 58
Tumors of Cranial and Spinal Nerves ∼ ∼ 30 24
Tumors of the Meninges ∼ ∼ 141 288
Meningioma ∼ ∼ 117 258
Other mesenchymal ∼ ∼ 24 30
Lymphomas and Hematopoietic Neoplasms ∼ ∼ 610 524
Germ Cell Tumors 84 38 46 ∼
Tumors of Sellar Region ∼ ∼ 18 ∼
Local Extensions from Regional Tumors ∼ ∼ 25 23
Unclassified Tumors ∼ 16 473 549
Hemangioma ∼ ∼ ∼ ∼
Neoplasm, unspecified ∼ 16 466 544
All other ∼ ∼ ∼ ∼
∗ As determined by the Consensus Conference on Cancer Registration of Brain and Central Nervous System Tumors. See Technical Notes and Appendix J.
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information. Rates cover approximately 93% of the U.S. population.
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (histology, age, sex).
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E–2 Table E.1.1: All Cancer Sites Combined. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 146,630 128,044 12,785 6,365 140,295 123,371 11,980 5,957
New England 38,613 36,284 1,386 909 37,289 35,248 1,254 883
Connecticut 9,443 8,593 631 358 9,080 8,333 586 386
Maine 3,957 3,897 17 ∼ 3,575 3,531 ∼ 16
Massachusetts 17,233 16,077 646 416 17,138 16,074 572 369
New Hampshire 3,293 3,172 ∼ - 3,107 3,045 ∼ -
Rhode Island 3,095 2,968 76 94 2,915 2,802 78 84
Vermont 1,592 1,577 ∼ ∼ 1,474 1,463 ∼ ∼
Middle Atlantic 108,017 91,760 11,399 ∼ 103,006 88,123 10,726 ∼
New Jersey 24,272 20,444 2,609 1,577 22,193 19,082 2,301 1,374
New York 46,910 38,368 5,760 3,361 46,412 38,140 5,642 3,241
Pennsylvania 36,835 32,948 3,030 - 34,401 30,901 2,783 -
Midwest
East North Central 111,775 96,481 11,214 ∼ 105,720 92,524 10,396 ∼
Illinois 30,141 25,328 3,722 1,170 29,056 24,408 3,757 1,223
Indiana 14,231 13,014 993 163 14,132 13,002 964 184
Michigan 25,916 21,592 3,313 278 23,371 19,908 2,829 231
Detroit 11,354 8,522 2,543 - 10,086 7,775 2,129 -
Ohio 27,959 23,797 2,631 208 26,509 23,209 2,410 250
Wisconsin 13,528 12,750 555 - 12,652 11,997 436 -
West North Central
Iowa 7,802 7,517 105 51 7,616 7,393 84 52
Kansas 6,244 5,693 266 129 5,957 5,529 257 138
Minnesota 12,272 11,485 247 86 11,154 10,554 194 84
Missouri 13,694 12,320 1,228 124 13,087 11,779 1,160 117
Nebraska 4,156 3,877 114 76 4,113 3,915 87 90
North Dakota 1,702 1,657 ∼ ∼ 1,430 1,370 ∼ ∼
South Dakota
South
South Atlantic
Delaware 2,185 1,807 331 29 1,913 1,592 269 22
District of Columbia 1,430 361 1,011 33 1,298 369 862 43
Florida 49,973 45,015 4,259 - 44,122 39,592 3,837 -
Georgia 17,886 13,500 4,119 251 16,278 12,260 3,713 246
Atlanta 5,346 3,611 1,594 128 5,108 3,439 1,519 137
Maryland 13,345 10,187 2,835 174 12,571 9,588 2,656 245
North Carolina 17,767 14,144 3,317 152 16,527 13,376 2,841 184
South Carolina 10,566 7,727 2,637 - 8,867 6,667 2,052 -
Virginia
West Virginia 5,260 5,115 131 ∼ 4,844 4,719 117 17
East South Central
Alabama 10,755 8,472 2,187 56 9,804 7,787 1,896 73
Kentucky 10,942 10,054 684 - 9,893 9,184 595 -
Mississippi
Tennessee
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Table E.1.1: All Cancer Sites Combined. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 11,244 8,195 2,934 219 9,483 6,841 2,554 226
Oklahoma 8,683 7,595 463 130 7,895 6,812 436 135
Texas 40,984 35,431 4,303 6,472 37,902 32,781 3,842 6,401
West
Mountain
Arizona 11,016 10,360 242 1,089 10,270 9,736 150 1,086
Colorado 8,725 8,064 252 787 8,391 7,846 203 750
Idaho 3,064 3,017 ∼ 76 2,664 2,620 ∼ 85
Montana 2,512 2,348 ∼ 26 2,081 1,953 ∼ 16
Nevada 5,389 4,887 240 329 4,427 3,962 210 321
New Mexico 3,938 3,752 64 1,138 3,379 3,186 41 914
Utah 3,768 3,702 21 147 3,189 3,110 ∼ 155
Wyoming
Pacific 97,634 81,220 5,359 ∼ 93,535 78,532 ∼ 10,580
Alaska 1,053 841 26 16 874 637 25 ∼
California 70,584 58,096 4,817 9,700 67,668 56,683 3,951 10,049
San Francisco-Oakland 9,172 6,649 894 758 9,388 6,886 873 864
San Jose-Monterey 4,541 3,660 142 622 4,251 3,545 71 636
Los Angeles 17,701 13,095 2,184 3,575 17,532 13,417 1,844 3,912
Hawaii 2,804 889 38 - 2,635 752 ∼ -
Oregon 8,564 8,065 106 166 8,439 7,916 82 211
Washington 14,629 13,329 372 321 13,919 12,544 273 296
Seattle-Puget Sound 10,020 9,179 345 141 9,728 8,856 254 96
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary
bladder.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
U
nited States C
ancer Statistics: 2002 Incidence and M
ortality
E–4 Table E.1.2: All Cancer Sites Combined. Cancer Death Counts by U.S. Census Region and Division, State,
Sex, and Race and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 57,231 50,991 5,356 1,829 57,544 51,343 5,475 1,656
New England 15,338 14,625 570 229 15,101 14,439 529 190
Connecticut 3,612 3,356 238 89 3,551 3,289 233 71
Maine 1,685 1,667 ∼ ∼ 1,521 1,511 ∼ ∼
Massachusetts 6,875 6,496 285 106 7,039 6,707 256 102
New Hampshire 1,333 1,321 ∼ ∼ 1,196 1,191 ∼ ∼
Rhode Island 1,200 1,156 38 26 1,203 1,154 36 ∼
Vermont 633 629 ∼ ∼ 591 587 ∼ ∼
Middle Atlantic 41,893 36,366 4,786 1,600 42,443 36,904 4,946 1,466
New Jersey 8,722 7,489 1,047 404 9,105 7,898 1,074 329
New York 18,072 15,192 2,407 1,047 18,588 15,678 2,520 1,027
Pennsylvania 15,099 13,685 1,332 149 14,750 13,328 1,352 110
Midwest 68,389 61,452 6,334 737 64,854 58,254 6,039 615
East North Central 47,910 42,189 5,341 594 45,678 40,161 5,174 504
Illinois 12,577 10,583 1,818 325 12,160 10,119 1,895 302
Indiana 6,580 6,034 537 56 6,285 5,759 513 38
Michigan 10,266 8,798 1,366 97 9,719 8,338 1,284 77
Ohio 12,920 11,462 1,412 77 12,253 10,914 1,296 62
Wisconsin 5,567 5,312 208 39 5,261 5,031 186 25
West North Central 20,479 19,263 993 143 19,176 18,093 865 111
Iowa 3,342 3,278 50 ∼ 3,131 3,079 44 ∼
Kansas 2,753 2,560 163 37 2,609 2,447 128 33
Minnesota 4,751 4,586 94 22 4,459 4,338 60 23
Missouri 6,414 5,741 635 41 5,908 5,281 590 28
Nebraska 1,747 1,685 49 28 1,686 1,624 42 16
North Dakota 670 650 ∼ ∼ 623 597 ∼ ∼
South Dakota 802 763 ∼ ∼ 760 727 ∼ ∼
South 108,861 89,682 18,244 4,801 95,444 78,415 16,037 4,148
South Atlantic 57,922 47,183 10,291 2,003 51,299 41,666 9,145 1,716
Delaware 880 738 135 ∼ 741 624 112 ∼
District of Columbia 673 125 541 ∼ 623 142 467 ∼
Florida 21,001 19,039 1,863 1,752 18,138 16,327 1,704 1,495
Georgia 7,420 5,455 1,910 60 6,555 4,802 1,689 47
Maryland 5,275 3,885 1,301 45 5,120 3,757 1,287 45
North Carolina 8,550 6,704 1,768 37 7,660 6,043 1,530 35
South Carolina 4,547 3,322 1,209 20 3,786 2,753 1,013 ∼
Virginia 7,117 5,528 1,493 72 6,483 5,098 1,271 70
West Virginia 2,459 2,387 71 ∼ 2,193 2,120 72 ∼
East South Central 20,404 16,822 3,528 45 17,319 14,250 3,000 55
Alabama 5,291 4,053 1,223 ∼ 4,407 3,382 1,011 ∼
Kentucky 5,084 4,755 319 21 4,354 4,047 296 16
Mississippi 3,305 2,233 1,060 ∼ 2,764 1,869 879 ∼
Tennessee 6,724 5,781 926 ∼ 5,794 4,952 814 21
West South Central 30,535 25,677 4,425 2,753 26,826 22,499 3,892 2,377
Arkansas 3,435 2,999 422 ∼ 2,847 2,433 393 ∼
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Table E.1.2: All Cancer Sites Combined. Cancer Death Counts by U.S. Census Region and Division, State,
Sex, and Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 5,042 3,492 1,520 39 4,399 3,041 1,328 41
Oklahoma 3,967 3,532 270 44 3,507 3,101 207 34
Texas 18,091 15,654 2,213 2,669 16,073 13,924 1,964 2,301
West 54,282 47,739 2,691 4,868 50,659 44,601 2,438 4,487
Mountain 15,962 15,228 372 1,427 14,069 13,278 328 1,180
Arizona 5,094 4,859 127 487 4,265 4,033 94 376
Colorado 3,275 3,127 106 293 3,109 2,948 99 255
Idaho 1,128 1,117 ∼ ∼ 1,010 990 ∼ 17
Montana 967 921 ∼ ∼ 944 896 ∼ ∼
Nevada 2,102 1,949 97 83 1,835 1,651 110 77
New Mexico 1,653 1,547 33 486 1,414 1,312 ∼ 401
Utah 1,302 1,274 ∼ 46 1,074 1,038 ∼ 33
Wyoming 441 434 ∼ 16 418 410 ∼ ∼
Pacific 38,320 32,511 2,319 ∼ 36,590 31,323 2,110 ∼
Alaska 398 293 ∼ ∼ 317 233 ∼ ∼
California 27,564 23,148 2,101 3,253 26,579 22,482 1,946 3,154
Hawaii 1,094 320 ∼ 60 851 242 ∼ 33
Oregon 3,682 3,553 49 40 3,567 3,444 44 36
Washington 5,582 5,197 145 80 5,276 4,922 110 76
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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E–6 Table E.2.1: Brain and Other Nervous System. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 2,047 1,849 103 110 1,704 1,533 110 100
New England 559 532 ∼ 24 436 419 ∼ 20
Connecticut 139 132 ∼ ∼ 89 82 ∼ ∼
Maine 65 65 ∼ ∼ 44 43 ∼ ∼
Massachusetts 240 221 ∼ ∼ 214 206 ∼ ∼
New Hampshire 46 46 ∼ - 37 36 ∼ -
Rhode Island 42 41 ∼ ∼ 35 35 ∼ ∼
Vermont 27 27 ∼ ∼ 17 17 ∼ ∼
Middle Atlantic 1,488 1,317 89 ∼ 1,268 1,114 102 ∼
New Jersey 308 269 17 25 245 207 25 20
New York 692 593 52 52 579 491 57 55
Pennsylvania 488 455 20 - 444 416 20 -
Midwest
East North Central 1,626 1,486 95 54 1,367 1,259 78 45
Illinois 367 330 26 35 362 318 28 30
Indiana 222 207 ∼ ∼ 186 174 ∼ ∼
Michigan 382 345 27 ∼ 318 292 23 ∼
Detroit 155 131 20 - 132 115 ∼ -
Ohio 429 387 27 ∼ 339 319 ∼ ∼
Wisconsin 226 217 ∼ - 162 156 ∼ -
West North Central
Iowa 118 115 ∼ ∼ 100 97 ∼ ∼
Kansas 115 112 ∼ ∼ 66 63 ∼ ∼
Minnesota 203 189 ∼ ∼ 158 146 ∼ ∼
Missouri 203 191 ∼ ∼ 189 172 ∼ ∼
Nebraska 71 69 ∼ ∼ 44 43 ∼ ∼
North Dakota 19 18 ∼ ∼ 19 19 ∼ ∼
South Dakota
South
South Atlantic
Delaware 25 20 ∼ ∼ 23 20 ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 667 610 50 - 569 520 40 -
Georgia 274 216 50 ∼ 215 173 40 ∼
Atlanta 88 63 22 ∼ 65 49 16 ∼
Maryland 186 159 21 ∼ 146 128 16 ∼
North Carolina 296 260 27 ∼ 237 192 37 ∼
South Carolina 133 116 ∼ - 124 105 18 -
Virginia
West Virginia 79 77 ∼ ∼ 53 53 ∼ ∼
East South Central
Alabama 163 137 25 ∼ 136 117 ∼ ∼
Kentucky 134 126 ∼ - 132 125 ∼ -
Mississippi
Tennessee
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Table E.2.1: Brain and Other Nervous System. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 145 118 24 ∼ 91 70 21 ∼
Oklahoma 129 110 ∼ ∼ 124 116 ∼ ∼
Texas 733 651 53 152 581 506 54 103
West
Mountain
Arizona 190 179 ∼ 25 135 130 ∼ 27
Colorado 154 149 ∼ 23 117 110 ∼ ∼
Idaho 65 64 ∼ ∼ 43 43 ∼ ∼
Montana 50 48 ∼ ∼ 35 31 ∼ ∼
Nevada 79 74 ∼ ∼ 62 53 ∼ ∼
New Mexico 62 59 ∼ 20 43 40 ∼ 20
Utah 83 82 ∼ ∼ 60 59 ∼ ∼
Wyoming
Pacific 1,584 ∼ 46 246 ∼ 1,113 40 229
Alaska 21 18 ∼ ∼ ∼ ∼ ∼ ∼
California 1,141 1,018 44 233 910 798 35 224
San Francisco-Oakland 124 103 ∼ ∼ 115 83 ∼ ∼
San Jose-Monterey 75 66 ∼ ∼ 63 52 ∼ 18
Los Angeles 275 242 16 80 237 206 ∼ 88
Hawaii 26 ∼ ∼ - 28 ∼ ∼ -
Oregon 148 143 ∼ ∼ 107 103 ∼ ∼
Washington 248 232 ∼ ∼ 204 192 ∼ ∼
Seattle-Puget Sound 165 154 ∼ ∼ 132 124 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–8 Table E.2.2: Brain and Other Nervous System. Cancer Death Counts by U.S. Census Region and Division,
State, Sex, and Race and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 1,287 1,206 59 44 ∼ ∼ 62 32
New England 391 381 ∼ ∼ ∼ ∼ ∼ ∼
Connecticut 87 85 ∼ ∼ 59 54 ∼ ∼
Maine 45 45 ∼ ∼ 32 32 ∼ ∼
Massachusetts 165 157 ∼ ∼ 123 116 ∼ ∼
New Hampshire 44 44 ∼ ∼ 27 27 ∼ ∼
Rhode Island 32 32 ∼ ∼ 26 25 ∼ ∼
Vermont 18 18 ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 896 825 52 36 753 688 51 29
New Jersey 178 159 ∼ ∼ 145 136 ∼ ∼
New York 417 381 27 21 344 296 36 23
Pennsylvania 301 285 ∼ ∼ 264 256 ∼ ∼
Midwest 1,689 1,593 79 27 1,367 1,298 59 ∼
East North Central 1,155 1,074 71 20 910 856 49 ∼
Illinois 263 239 19 ∼ 204 182 20 ∼
Indiana 160 156 ∼ ∼ 142 136 ∼ ∼
Michigan 272 248 22 ∼ 215 202 ∼ ∼
Ohio 306 281 23 ∼ 236 226 ∼ ∼
Wisconsin 154 150 ∼ ∼ 113 110 ∼ ∼
West North Central 534 519 ∼ ∼ 457 442 ∼ ∼
Iowa 84 79 ∼ ∼ 78 78 ∼ ∼
Kansas 87 85 ∼ ∼ 68 67 ∼ ∼
Minnesota 126 125 ∼ ∼ 108 107 ∼ ∼
Missouri 143 139 ∼ ∼ 124 115 ∼ ∼
Nebraska 48 48 ∼ ∼ 41 40 ∼ ∼
North Dakota 17 17 ∼ ∼ 21 19 ∼ ∼
South Dakota 29 26 ∼ ∼ 17 16 ∼ ∼
South 2,586 2,325 240 145 2,116 1,881 221 114
South Atlantic 1,318 1,168 139 62 1,066 936 124 46
Delaware 21 17 ∼ ∼ 19 17 ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 478 448 28 47 380 358 22 37
Georgia 179 149 27 ∼ 139 119 20 ∼
Maryland 113 93 19 ∼ 94 80 ∼ ∼
North Carolina 208 187 19 ∼ 173 141 30 ∼
South Carolina 106 93 ∼ ∼ 92 78 ∼ ∼
Virginia 146 120 24 ∼ 119 98 20 ∼
West Virginia 58 57 ∼ ∼ 42 42 ∼ ∼
East South Central 478 425 52 ∼ 425 378 44 ∼
Alabama 119 105 ∼ ∼ 100 87 ∼ ∼
Kentucky 109 107 ∼ ∼ 85 80 ∼ ∼
Mississippi 68 50 18 ∼ 81 71 ∼ ∼
Tennessee 182 163 18 ∼ 159 140 17 ∼
West South Central 790 732 49 83 625 567 53 67
Arkansas 77 74 ∼ ∼ 77 71 ∼ ∼
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Table E.2.2: Brain and Other Nervous System. Cancer Death Counts by U.S. Census Region and Division,
State, Sex, and Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 99 79 20 ∼ 80 62 17 ∼
Oklahoma 103 98 ∼ ∼ 83 80 ∼ ∼
Texas 511 481 22 78 385 354 29 66
West 1,563 1,430 31 143 1,189 1,106 30 130
Mountain 422 410 ∼ 38 316 303 ∼ 21
Arizona 132 128 ∼ ∼ 83 82 ∼ ∼
Colorado 87 85 ∼ ∼ 87 83 ∼ ∼
Idaho 34 34 ∼ ∼ 25 25 ∼ ∼
Montana 22 22 ∼ ∼ 24 19 ∼ ∼
Nevada 43 42 ∼ ∼ 36 34 ∼ ∼
New Mexico 40 39 ∼ ∼ 22 21 ∼ ∼
Utah 54 50 ∼ ∼ 32 32 ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 1,020 27 105 873 803 26 109
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 803 720 27 100 606 553 22 103
Hawaii 26 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon 121 116 ∼ ∼ 102 98 ∼ ∼
Washington 180 168 ∼ ∼ 143 136 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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continued
Table E.3.1: Breast. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 40,587 35,584 3,448 1,703
New England 11,018 10,395 399 254
Connecticut 2,739 2,503 184 112
Maine 1,012 1,004 ∼ ∼
Massachusetts 5,000 4,677 191 99
New Hampshire 969 951 ∼ -
Rhode Island 823 789 17 30
Vermont 475 471 ∼ ∼
Middle Atlantic 29,569 25,189 3,049 ∼
New Jersey 6,385 5,458 664 390
New York 13,502 11,045 1,589 939
Pennsylvania 9,682 8,686 796 -
Midwest
East North Central 31,583 27,680 3,058 ∼
Illinois 8,622 7,229 1,117 366
Indiana 4,163 3,828 293 56
Michigan 6,988 6,007 795 76
Detroit 2,904 2,252 601 -
Ohio 7,932 6,940 719 61
Wisconsin 3,878 3,676 134 -
West North Central
Iowa 2,247 2,183 27 ∼
Kansas 1,934 1,803 71 37
Minnesota 3,599 3,423 56 32
Missouri 3,975 3,608 335 36
Nebraska 1,312 1,275 22 26
North Dakota 449 419 ∼ ∼
South Dakota
South
South Atlantic
Delaware 559 470 75 ∼
District of Columbia 406 142 244 ∼
Florida 12,841 11,445 1,153 -
Georgia 5,188 3,915 1,176 65
Atlanta 1,718 1,163 501 37
Maryland 3,573 2,679 790 57
North Carolina 5,260 4,253 916 46
South Carolina 2,723 2,096 592 -
Virginia
West Virginia 1,241 1,206 31 ∼
East South Central
Alabama 2,982 2,375 580 16
Kentucky 2,788 2,576 178 -
Mississippi
Tennessee
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Table E.3.1: Breast. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 2,830 2,004 807 77
Oklahoma 2,450 2,117 143 40
Texas 11,935 10,383 1,144 1,877
West
Mountain
Arizona 3,212 3,065 45 311
Colorado 2,785 2,601 69 215
Idaho 881 868 ∼ 29
Montana 607 574 ∼ ∼
Nevada 1,326 1,181 61 103
New Mexico 1,075 1,029 ∼ 278
Utah 1,036 1,012 ∼ 58
Wyoming
Pacific 30,741 25,862 1,395 3,142
Alaska 299 235 ∼ ∼
California 22,164 18,653 1,273 2,990
San Francisco-Oakland 3,246 2,482 266 301
San Jose-Monterey 1,424 1,189 27 177
Los Angeles 5,633 4,296 599 1,120
Hawaii 889 265 ∼ -
Oregon 2,732 2,540 33 55
Washington 4,657 4,169 81 92
Seattle-Puget Sound 3,274 3,008 75 33
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–12 Table E.3.2: Breast. Cancer Death Counts by U.S. Census Region and Division, State, and Race and Ethnicity,United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 9,009 7,886 1,021 273
New England 2,228 2,118 90 34
Connecticut 551 508 39 ∼
Maine 201 200 ∼ ∼
Massachusetts 1,055 999 43 18
New Hampshire 176 175 ∼ ∼
Rhode Island 164 156 ∼ ∼
Vermont 81 80 ∼ ∼
Middle Atlantic 6,781 5,768 931 239
New Jersey 1,476 1,246 204 57
New York 2,988 2,467 469 161
Pennsylvania 2,317 2,055 258 21
Midwest 9,916 8,737 1,090 103
East North Central 7,016 6,039 918 87
Illinois 1,897 1,531 341 59
Indiana 900 815 80 ∼
Michigan 1,516 1,259 240 ∼
Ohio 1,913 1,679 227 ∼
Wisconsin 790 755 30 ∼
West North Central 2,900 2,698 172 16
Iowa 483 475 ∼ ∼
Kansas 419 383 30 ∼
Minnesota 641 625 ∼ ∼
Missouri 893 774 112 ∼
Nebraska 252 238 ∼ ∼
North Dakota 103 99 ∼ ∼
South Dakota 109 104 ∼ ∼
South 14,797 11,617 3,019 670
South Atlantic 7,990 6,154 1,747 270
Delaware 110 86 24 ∼
District of Columbia 110 25 83 ∼
Florida 2,668 2,313 339 235
Georgia 1,042 727 305 ∼
Maryland 879 606 257 ∼
North Carolina 1,221 912 294 ∼
South Carolina 627 435 190 ∼
Virginia 1,059 786 245 ∼
West Virginia 274 264 ∼ ∼
East South Central 2,617 2,074 531 ∼
Alabama 681 513 167 ∼
Kentucky 652 597 51 ∼
Mississippi 419 247 172 ∼
Tennessee 865 717 141 ∼
West South Central 4,190 3,389 741 397
Arkansas 416 337 76 ∼
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Table E.3.2: Breast. Cancer Death Counts by U.S. Census Region and Division, State, and Race and Ethnicity,
United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 718 453 262 ∼
Oklahoma 546 470 45 ∼
Texas 2,510 2,129 358 383
West 7,792 6,842 442 678
Mountain 2,234 2,110 65 191
Arizona 659 615 24 66
Colorado 493 474 ∼ 31
Idaho 173 170 ∼ ∼
Montana 150 143 ∼ ∼
Nevada 270 241 18 ∼
New Mexico 216 203 ∼ 66
Utah 220 213 ∼ ∼
Wyoming 53 51 ∼ ∼
Pacific 5,558 4,732 377 487
Alaska 47 36 ∼ ∼
California 4,133 3,465 349 463
Hawaii 115 34 ∼ ∼
Oregon 501 483 ∼ ∼
Washington 762 714 20 ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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E–14 Table E.4.1: Breast, In Situ . Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 10,638 9,375 766 476
New England 3,408 3,233 78 98
Connecticut 830 774 35 49
Maine 285 281 ∼ ∼
Massachusetts 1,710 1,604 40 38
New Hampshire 278 276 ∼ -
Rhode Island 181 174 ∼ ∼
Vermont 124 124 ∼ ∼
Middle Atlantic 7,230 6,142 688 ∼
New Jersey 1,690 1,483 138 113
New York 3,253 2,622 354 232
Pennsylvania 2,287 2,037 196 -
Midwest
East North Central 7,372 6,416 734 143
Illinois 1,901 1,622 211 85
Indiana 915 841 63 ∼
Michigan 1,925 1,617 241 17
Detroit 926 714 190 -
Ohio 1,886 1,656 176 21
Wisconsin 745 680 43 -
West North Central
Iowa 421 405 ∼ ∼
Kansas 347 318 ∼ ∼
Minnesota 702 659 ∼ ∼
Missouri 792 711 72 ∼
Nebraska 268 254 ∼ ∼
North Dakota 58 58 ∼ ∼
South Dakota
South
South Atlantic
Delaware 161 138 22 ∼
District of Columbia 94 39 49 ∼
Florida 2,853 2,527 265 -
Georgia 1,137 876 243 ∼
Atlanta 436 322 105 ∼
Maryland 781 579 167 17
North Carolina 1,034 842 184 ∼
South Carolina 627 486 135 -
Virginia
West Virginia 294 290 ∼ ∼
East South Central
Alabama 699 574 119 ∼
Kentucky 534 492 34 -
Mississippi
Tennessee
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Table E.4.1: Breast, In Situ . Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 509 379 121 16
Oklahoma 439 374 30 ∼
Texas 2,384 2,024 244 318
West
Mountain
Arizona 640 605 ∼ 58
Colorado 690 629 16 50
Idaho 158 156 ∼ ∼
Montana 151 143 ∼ ∼
Nevada 285 252 ∼ 16
New Mexico 217 210 ∼ 39
Utah 202 197 ∼ ∼
Wyoming
Pacific 6,638 5,318 254 619
Alaska 98 66 ∼ ∼
California 4,638 3,755 235 582
San Francisco-Oakland 715 485 47 47
San Jose-Monterey 313 234 ∼ 34
Los Angeles 1,152 868 99 218
Hawaii 281 54 ∼ -
Oregon 563 518 ∼ ∼
Washington 1,058 925 ∼ 26
Seattle-Puget Sound 767 686 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† In situ cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–16 Table E.5.1: Cervix Uteri. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 2,411 1,818 433 284
New England 514 455 38 33
Connecticut 114 95 16 ∼
Maine 51 49 ∼ ∼
Massachusetts 234 199 20 21
New Hampshire 51 51 ∼ -
Rhode Island 36 33 ∼ ∼
Vermont 28 28 ∼ ∼
Middle Atlantic 1,897 1,363 395 ∼
New Jersey 434 321 83 78
New York 908 586 228 148
Pennsylvania 555 456 84 -
Midwest
East North Central 1,927 1,552 ∼ 112
Illinois 602 452 128 76
Indiana 272 242 26 ∼
Michigan 387 292 77 ∼
Detroit 182 118 58 -
Ohio 467 389 59 ∼
Wisconsin 199 177 ∼ -
West North Central
Iowa 119 115 ∼ ∼
Kansas 91 74 ∼ ∼
Minnesota 172 145 ∼ ∼
Missouri 237 193 38 ∼
Nebraska 75 70 ∼ ∼
North Dakota 23 21 ∼ ∼
South Dakota
South
South Atlantic
Delaware 32 22 ∼ ∼
District of Columbia 33 ∼ 24 ∼
Florida 916 724 162 -
Georgia 412 259 143 ∼
Atlanta 120 54 57 ∼
Maryland 522 355 151 27
North Carolina 323 229 81 ∼
South Carolina 220 140 78 -
Virginia
West Virginia 96 93 ∼ ∼
East South Central
Alabama 256 154 92 ∼
Kentucky 224 202 18 -
Mississippi
Tennessee
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Table E.5.1: Cervix Uteri. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 229 121 103 ∼
Oklahoma 156 118 17 ∼
Texas 990 813 138 377
West
Mountain
Arizona 189 164 ∼ 45
Colorado 164 144 ∼ 35
Idaho 51 48 ∼ ∼
Montana 36 35 ∼ ∼
Nevada 95 80 ∼ ∼
New Mexico 75 68 ∼ 29
Utah 68 62 ∼ ∼
Wyoming
Pacific 1,943 ∼ 100 629
Alaska 21 18 ∼ ∼
California 1,540 1,253 88 606
San Francisco-Oakland 146 93 16 26
San Jose-Monterey 88 75 ∼ 40
Los Angeles 532 419 38 286
Hawaii 47 ∼ ∼ -
Oregon 127 114 ∼ ∼
Washington 208 171 ∼ ∼
Seattle-Puget Sound 156 128 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–18 Table E.5.2: Cervix Uteri. Cancer Death Counts by U.S. Census Region and Division, State, and Race and
Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast ∼ ∼ 150 59
New England ∼ ∼ ∼ ∼
Connecticut 35 28 ∼ ∼
Maine 17 17 ∼ ∼
Massachusetts 56 48 ∼ ∼
New Hampshire 16 16 ∼ ∼
Rhode Island 18 18 ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 595 436 139 54
New Jersey 116 82 30 ∼
New York 294 207 74 32
Pennsylvania 185 147 35 ∼
Midwest 865 683 162 22
East North Central 632 483 135 19
Illinois 206 144 58 ∼
Indiana 79 67 ∼ ∼
Michigan 115 83 29 ∼
Ohio 183 149 30 ∼
Wisconsin 49 40 ∼ ∼
West North Central 233 200 27 ∼
Iowa 39 38 ∼ ∼
Kansas 35 29 ∼ ∼
Minnesota 35 31 ∼ ∼
Missouri 85 66 19 ∼
Nebraska 25 23 ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 1,617 1,126 466 141
South Atlantic 812 553 242 39
Delaware 16 ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 284 219 64 33
Georgia 129 77 48 ∼
Maryland 73 35 35 ∼
North Carolina 112 74 35 ∼
South Carolina 66 39 26 ∼
Virginia 89 62 23 ∼
West Virginia 35 34 ∼ ∼
East South Central 290 191 99 ∼
Alabama 77 43 34 ∼
Kentucky 54 50 ∼ ∼
Mississippi 62 28 34 ∼
Tennessee 97 70 27 ∼
West South Central 515 382 125 99
Arkansas 63 44 19 ∼
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Table E.5.2: Cervix Uteri. Cancer Death Counts by U.S. Census Region and Division, State, and Race and
Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 70 32 37 ∼
Oklahoma 53 43 ∼ ∼
Texas 329 263 66 96
West 725 587 51 166
Mountain 197 167 ∼ 32
Arizona 64 58 ∼ 18
Colorado 39 35 ∼ ∼
Idaho 18 18 ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 28 20 ∼ ∼
New Mexico 20 ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 528 420 43 134
Alaska ∼ ∼ ∼ ∼
California 416 326 38 129
Hawaii ∼ ∼ ∼ ∼
Oregon 45 42 ∼ ∼
Washington 46 40 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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E–20 Table E.6.1: Colon and Rectum. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 16,770 14,901 1,277 732 17,180 15,133 1,539 668
New England 4,415 4,189 130 80 4,428 4,196 149 86
Connecticut 1,095 1,005 64 37 1,105 1,015 69 40
Maine 479 476 ∼ ∼ 446 439 ∼ ∼
Massachusetts 1,966 1,853 59 38 2,015 1,896 71 30
New Hampshire 332 325 ∼ - 355 349 ∼ -
Rhode Island 362 350 ∼ ∼ 349 340 ∼ ∼
Vermont 181 180 ∼ ∼ 158 157 ∼ ∼
Middle Atlantic 12,355 10,712 1,147 ∼ 12,752 10,937 1,390 ∼
New Jersey 2,674 2,273 282 172 2,757 2,345 317 150
New York 5,399 4,536 556 419 5,694 4,689 728 377
Pennsylvania 4,282 3,903 309 - 4,301 3,903 345 -
Midwest
East North Central 12,628 11,072 1,240 ∼ 12,564 10,871 1,385 172
Illinois 3,597 3,053 442 151 3,550 2,943 517 96
Indiana 1,731 1,592 120 16 1,750 1,617 119 ∼
Michigan 2,612 2,206 345 35 2,644 2,196 381 18
Detroit 1,113 831 259 - 1,192 871 303 -
Ohio 3,179 2,807 270 17 3,188 2,744 323 29
Wisconsin 1,509 1,414 63 - 1,432 1,371 45 -
West North Central
Iowa 975 951 ∼ ∼ 1,038 1,008 ∼ ∼
Kansas 694 641 30 ∼ 711 655 37 ∼
Minnesota 1,276 1,201 22 ∼ 1,280 1,215 20 ∼
Missouri 1,653 1,505 135 18 1,543 1,370 164 ∼
Nebraska 518 492 17 ∼ 499 478 ∼ ∼
North Dakota 208 201 ∼ ∼ 179 174 ∼ ∼
South Dakota
South
South Atlantic
Delaware 213 172 35 ∼ 213 167 39 ∼
District of Columbia 140 24 111 ∼ 150 32 111 ∼
Florida 5,527 5,010 427 - 5,226 4,672 484 -
Georgia 1,883 1,436 421 22 1,829 1,299 509 27
Atlanta 497 318 159 ∼ 555 360 184 ∼
Maryland 1,255 941 268 21 1,290 932 325 18
North Carolina 1,914 1,510 379 19 1,874 1,451 386 ∼
South Carolina 1,137 843 279 - 1,029 705 315 -
Virginia
West Virginia 638 626 ∼ ∼ 675 646 28 ∼
East South Central
Alabama 1,192 945 238 ∼ 1,118 850 262 ∼
Kentucky 1,205 1,125 73 - 1,233 1,130 94 -
Mississippi
Tennessee
continued
A
ppendix E
E–21
Table E.6.1: Colon and Rectum. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 1,293 963 316 24 1,221 844 365 18
Oklahoma 985 872 48 ∼ 895 770 50 ∼
Texas 4,556 3,923 526 767 4,018 3,360 527 597
West
Mountain
Arizona 1,183 1,128 24 103 1,110 1,061 16 105
Colorado 820 767 24 94 846 800 ∼ 72
Idaho 310 306 ∼ ∼ 233 227 ∼ ∼
Montana 253 229 ∼ ∼ 229 214 ∼ ∼
Nevada 593 527 31 39 447 392 27 20
New Mexico 417 393 ∼ 140 317 291 ∼ 88
Utah 329 319 ∼ ∼ 361 353 ∼ 20
Wyoming
Pacific 10,086 8,198 517 1,047 9,575 7,825 521 912
Alaska 104 81 ∼ ∼ 95 57 ∼ ∼
California 7,359 6,012 461 1,008 6,938 5,666 483 868
San Francisco-Oakland 1,003 692 97 83 961 679 83 78
San Jose-Monterey 477 364 ∼ 55 418 336 ∼ 49
Los Angeles 1,911 1,413 202 355 1,913 1,353 267 336
Hawaii 411 90 ∼ - 315 71 ∼ -
Oregon 842 784 ∼ ∼ 878 823 ∼ 19
Washington 1,370 1,231 38 20 1,349 1,208 31 24
Seattle-Puget Sound 923 833 34 ∼ 944 848 29 ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–22 Table E.6.2: Colon and Rectum. Cancer Death Counts by U.S. Census Region and Division, State, Sex, andRace and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 6,123 5,479 546 209 6,387 5,713 617 178
New England 1,557 1,483 57 17 1,677 1,610 60 24
Connecticut 366 343 22 ∼ 383 360 21 ∼
Maine 171 169 ∼ ∼ 155 155 ∼ ∼
Massachusetts 704 662 31 ∼ 816 779 34 ∼
New Hampshire 117 115 ∼ ∼ 108 108 ∼ ∼
Rhode Island 126 122 ∼ ∼ 142 135 ∼ ∼
Vermont 73 72 ∼ ∼ 73 73 ∼ ∼
Middle Atlantic 4,566 3,996 489 ∼ 4,710 4,103 557 ∼
New Jersey 970 840 106 46 987 861 120 34
New York 1,996 1,696 248 133 2,094 1,759 298 113
Pennsylvania 1,600 1,460 135 ∼ 1,629 1,483 139 ∼
Midwest 6,838 6,100 656 76 6,996 6,272 670 54
East North Central 4,783 4,175 556 62 4,799 4,193 ∼ 44
Illinois 1,326 1,115 190 33 1,379 1,142 225 25
Indiana 656 599 55 ∼ 662 606 55 ∼
Michigan 988 830 150 ∼ 948 799 140 ∼
Ohio 1,283 1,123 145 ∼ 1,275 1,130 145 ∼
Wisconsin 530 508 16 ∼ 535 516 ∼ ∼
West North Central 2,055 1,925 100 ∼ 2,197 2,079 90 ∼
Iowa 334 328 ∼ ∼ 370 364 ∼ ∼
Kansas 276 254 17 ∼ 311 289 18 ∼
Minnesota 451 433 ∼ ∼ 482 464 ∼ ∼
Missouri 654 585 62 ∼ 636 579 53 ∼
Nebraska 195 185 ∼ ∼ 220 212 ∼ ∼
North Dakota 66 64 ∼ ∼ 87 83 ∼ ∼
South Dakota 79 76 ∼ ∼ 91 88 ∼ ∼
South 10,312 8,348 1,873 506 9,803 7,742 1,959 446
South Atlantic 5,506 4,463 1,003 225 5,315 4,182 1,091 233
Delaware 93 77 16 ∼ 77 61 ∼ ∼
District of Columbia 64 ∼ 49 ∼ 74 ∼ 60 ∼
Florida 2,009 1,817 181 210 1,883 1,663 213 209
Georgia 676 505 163 ∼ 654 431 213 ∼
Maryland 533 392 134 ∼ 531 389 137 ∼
North Carolina 769 589 176 ∼ 794 611 176 ∼
South Carolina 430 296 134 ∼ 381 266 114 ∼
Virginia 678 525 143 ∼ 679 515 154 ∼
West Virginia 254 247 ∼ ∼ 242 233 ∼ ∼
East South Central 1,853 1,498 348 ∼ 1,768 1,384 374 ∼
Alabama 453 331 120 ∼ 411 287 123 ∼
Kentucky 495 460 31 ∼ 497 449 47 ∼
Mississippi 308 211 96 ∼ 310 190 115 ∼
Tennessee 597 496 101 ∼ 550 458 89 ∼
West South Central 2,953 2,387 522 278 2,720 2,176 494 209
Arkansas 313 261 50 ∼ 297 246 48 ∼
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Table E.6.2: Colon and Rectum. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and
Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 535 350 182 ∼ 454 295 158 ∼
Oklahoma 381 333 28 ∼ 348 290 30 ∼
Texas 1,724 1,443 262 270 1,621 1,345 258 204
West 5,198 4,489 268 488 4,946 4,291 274 389
Mountain 1,593 1,515 34 170 1,397 1,315 44 124
Arizona 490 467 ∼ 49 407 387 ∼ 37
Colorado 340 324 ∼ 47 318 297 ∼ 27
Idaho 100 99 ∼ ∼ 91 89 ∼ ∼
Montana 101 93 ∼ ∼ 83 80 ∼ ∼
Nevada 223 209 ∼ ∼ 176 156 ∼ ∼
New Mexico 178 164 ∼ 57 141 131 ∼ 52
Utah 125 123 ∼ ∼ 124 118 ∼ ∼
Wyoming 36 36 ∼ ∼ 57 57 ∼ ∼
Pacific 3,605 2,974 234 318 3,549 2,976 230 265
Alaska 36 21 ∼ ∼ 30 17 ∼ ∼
California 2,606 2,134 213 309 2,618 2,176 214 253
Hawaii 134 40 ∼ ∼ 100 28 ∼ ∼
Oregon 354 338 ∼ ∼ 311 301 ∼ ∼
Washington 475 441 ∼ ∼ 490 454 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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E–24 Table E.7.1: Corpus and Uterus, NOS. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 9,104 8,141 658 378
New England 2,424 2,304 65 70
Connecticut 589 542 33 33
Maine 244 240 ∼ ∼
Massachusetts 1,124 1,069 26 30
New Hampshire 188 185 ∼ -
Rhode Island 173 164 ∼ ∼
Vermont 106 104 ∼ ∼
Middle Atlantic 6,680 5,837 593 ∼
New Jersey 1,392 1,221 128 76
New York 3,012 2,502 347 208
Pennsylvania 2,276 2,114 118 -
Midwest
East North Central 6,653 5,939 ∼ 135
Illinois 1,731 1,493 180 84
Indiana 912 858 48 ∼
Michigan 1,529 1,300 173 ∼
Detroit 616 476 128 -
Ohio 1,660 1,490 111 17
Wisconsin 821 798 ∼ -
West North Central
Iowa 462 452 ∼ ∼
Kansas 346 324 ∼ ∼
Minnesota 756 721 ∼ ∼
Missouri 775 704 60 ∼
Nebraska 252 240 ∼ ∼
North Dakota 88 86 ∼ ∼
South Dakota
South
South Atlantic
Delaware 141 120 18 ∼
District of Columbia 84 19 58 ∼
Florida 2,292 2,026 229 -
Georgia 788 599 173 16
Atlanta 249 171 69 ∼
Maryland 642 475 139 26
North Carolina 951 766 162 ∼
South Carolina 439 305 122 -
Virginia
West Virginia 315 313 ∼ ∼
East South Central
Alabama 386 294 86 ∼
Kentucky 506 471 27 -
Mississippi
Tennessee
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Table E.7.1: Corpus and Uterus, NOS. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 421 318 98 16
Oklahoma 347 306 ∼ ∼
Texas 1,836 1,619 171 360
West
Mountain
Arizona 551 510 ∼ 50
Colorado 417 390 ∼ 29
Idaho 145 144 ∼ ∼
Montana 118 108 ∼ ∼
Nevada 213 195 ∼ ∼
New Mexico 190 171 ∼ 45
Utah 194 188 ∼ ∼
Wyoming
Pacific 5,066 4,182 236 587
Alaska 41 30 ∼ ∼
California 3,670 3,051 209 560
San Francisco-Oakland 547 383 55 40
San Jose-Monterey 234 203 ∼ 32
Los Angeles 1,001 771 99 226
Hawaii 178 47 ∼ -
Oregon 453 420 ∼ ∼
Washington 724 634 17 16
Seattle-Puget Sound 504 451 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–26 Table E.7.2: Corpus and Uterus, NOS. Cancer Death Counts by U.S. Census Region and Division, State, andRace and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 1,634 1,385 230 52
New England 384 359 20 ∼
Connecticut 86 75 ∼ ∼
Maine 36 36 ∼ ∼
Massachusetts 184 170 ∼ ∼
New Hampshire 29 29 ∼ ∼
Rhode Island 22 22 ∼ ∼
Vermont 27 27 ∼ ∼
Middle Atlantic 1,250 1,026 210 51
New Jersey 277 225 47 ∼
New York 555 428 118 37
Pennsylvania 418 373 45 ∼
Midwest 1,736 1,504 214 20
East North Central 1,243 1,056 ∼ 18
Illinois 322 252 61 ∼
Indiana 182 160 22 ∼
Michigan 276 231 44 ∼
Ohio 312 268 44 ∼
Wisconsin 151 145 ∼ ∼
West North Central 493 448 38 ∼
Iowa 87 83 ∼ ∼
Kansas 61 54 ∼ ∼
Minnesota 114 109 ∼ ∼
Missouri 146 120 25 ∼
Nebraska 42 41 ∼ ∼
North Dakota 24 23 ∼ ∼
South Dakota 19 18 ∼ ∼
South 2,209 1,593 589 143
South Atlantic 1,228 883 332 67
Delaware 17 ∼ ∼ ∼
District of Columbia 32 ∼ 26 ∼
Florida 448 364 81 58
Georgia 138 78 59 ∼
Maryland 135 94 40 ∼
North Carolina 180 122 56 ∼
South Carolina 90 51 38 ∼
Virginia 141 109 29 ∼
West Virginia 47 47 ∼ ∼
East South Central 365 248 116 ∼
Alabama 101 54 46 ∼
Kentucky 76 70 ∼ ∼
Mississippi 61 25 36 ∼
Tennessee 127 99 28 ∼
West South Central 616 462 141 75
Arkansas 62 45 17 ∼
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Table E.7.2: Corpus and Uterus, NOS. Cancer Death Counts by U.S. Census Region and Division, State, and
Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 78 32 46 ∼
Oklahoma 86 70 ∼ ∼
Texas 390 315 72 73
West 1,274 1,085 86 122
Mountain 333 311 ∼ 36
Arizona 77 71 ∼ ∼
Colorado 81 78 ∼ ∼
Idaho 21 21 ∼ ∼
Montana 30 29 ∼ ∼
Nevada 38 32 ∼ ∼
New Mexico 42 37 ∼ ∼
Utah 33 32 ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific ∼ 774 78 86
Alaska ∼ ∼ ∼ ∼
California 701 577 73 82
Hawaii 26 ∼ ∼ ∼
Oregon 80 76 ∼ ∼
Washington 125 112 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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E–28 Table E.8.1: Esophagus. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 2,334 2,067 204 108 777 644 114 31
New England 720 685 27 19 230 215 ∼ ∼
Connecticut 155 140 ∼ ∼ 58 51 ∼ ∼
Maine 69 68 ∼ ∼ 20 20 ∼ ∼
Massachusetts 340 323 ∼ ∼ 110 102 ∼ ∼
New Hampshire 79 78 ∼ - 19 19 ∼ -
Rhode Island 49 48 ∼ ∼ ∼ ∼ ∼ ∼
Vermont 28 28 ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,614 1,382 177 ∼ 547 429 101 27
New Jersey 314 266 39 22 124 102 19 ∼
New York 716 590 94 53 264 197 57 ∼
Pennsylvania 584 526 44 - 159 130 25 -
Midwest
East North Central 1,835 1,613 188 29 589 482 92 ∼
Illinois 486 410 69 ∼ 161 123 34 ∼
Indiana 222 208 ∼ ∼ 80 66 ∼ ∼
Michigan 410 355 50 ∼ 129 104 23 ∼
Detroit 164 126 37 - 57 37 20 -
Ohio 464 403 43 ∼ 136 110 21 ∼
Wisconsin 253 237 ∼ - 83 79 ∼ -
West North Central
Iowa 128 126 ∼ ∼ 37 37 ∼ ∼
Kansas 72 63 ∼ ∼ 26 24 ∼ ∼
Minnesota 201 195 ∼ ∼ 47 43 ∼ ∼
Missouri 250 216 33 ∼ 65 54 ∼ ∼
Nebraska 66 62 ∼ ∼ 20 19 ∼ ∼
North Dakota 36 33 ∼ ∼ ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 40 36 ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 32 ∼ 23 ∼ ∼ ∼ ∼ ∼
Florida 721 635 80 - 231 188 41 -
Georgia 261 175 84 ∼ 85 45 39 ∼
Atlanta 69 40 27 ∼ 23 ∼ ∼ ∼
Maryland 196 154 41 ∼ 59 39 19 ∼
North Carolina 296 211 82 ∼ 77 53 20 ∼
South Carolina 188 108 78 - 63 38 25 -
Virginia
West Virginia 85 81 ∼ ∼ 21 21 ∼ ∼
East South Central
Alabama 166 116 49 ∼ 51 29 22 ∼
Kentucky 150 134 ∼ - 34 32 ∼ -
Mississippi
Tennessee
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Table E.8.1: Esophagus. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 170 120 50 ∼ 44 33 ∼ ∼
Oklahoma 145 127 ∼ ∼ 25 19 ∼ ∼
Texas 594 519 67 83 184 149 31 23
West
Mountain
Arizona 171 164 ∼ ∼ 45 41 ∼ ∼
Colorado 129 124 ∼ ∼ 41 37 ∼ ∼
Idaho 41 40 ∼ ∼ ∼ ∼ ∼ ∼
Montana 29 28 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 88 83 ∼ ∼ 21 19 ∼ ∼
New Mexico 47 45 ∼ ∼ ∼ ∼ ∼ ∼
Utah 46 46 ∼ ∼ ∼ ∼ ∼ ∼
Wyoming
Pacific 1,344 1,170 69 100 445 373 27 25
Alaska 21 ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 922 806 61 97 330 276 24 25
San Francisco-Oakland 125 103 ∼ ∼ 47 32 ∼ ∼
San Jose-Monterey 59 51 ∼ ∼ 18 ∼ ∼ ∼
Los Angeles 195 145 28 38 85 67 ∼ ∼
Hawaii 36 ∼ ∼ - ∼ ∼ ∼ -
Oregon 153 147 ∼ ∼ 36 36 ∼ ∼
Washington 212 194 ∼ ∼ 65 59 ∼ ∼
Seattle-Puget Sound 124 114 ∼ ∼ 38 33 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–30 Table E.8.2: Esophagus. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race andEthnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 2,083 1,870 194 59 662 571 84 17
New England 607 582 24 ∼ 172 167 ∼ ∼
Connecticut 121 111 ∼ ∼ 39 37 ∼ ∼
Maine 73 73 ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 285 271 ∼ ∼ 78 76 ∼ ∼
New Hampshire 62 62 ∼ ∼ ∼ ∼ ∼ ∼
Rhode Island 38 37 ∼ ∼ 19 18 ∼ ∼
Vermont 28 28 ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,476 1,288 170 51 490 404 ∼ ∼
New Jersey 284 248 33 ∼ 105 91 ∼ ∼
New York 605 505 88 33 225 174 48 ∼
Pennsylvania 587 535 49 ∼ 160 139 20 ∼
Midwest 2,438 2,222 205 21 741 636 95 ∼
East North Central 1,721 1,541 173 18 544 455 83 ∼
Illinois 417 353 61 ∼ 147 116 27 ∼
Indiana 216 204 ∼ ∼ 64 53 ∼ ∼
Michigan 382 342 40 ∼ 117 98 19 ∼
Ohio 476 430 45 ∼ 150 126 23 ∼
Wisconsin 230 212 ∼ ∼ 66 62 ∼ ∼
West North Central 717 681 32 ∼ 197 181 ∼ ∼
Iowa 134 131 ∼ ∼ 36 36 ∼ ∼
Kansas 73 67 ∼ ∼ 24 21 ∼ ∼
Minnesota 175 168 ∼ ∼ 55 52 ∼ ∼
Missouri 232 214 18 ∼ 51 44 ∼ ∼
Nebraska 60 60 ∼ ∼ 21 19 ∼ ∼
North Dakota 18 17 ∼ ∼ ∼ ∼ ∼ ∼
South Dakota 25 24 ∼ ∼ ∼ ∼ ∼ ∼
South 3,356 2,661 673 104 954 700 246 25
South Atlantic 1,892 1,467 413 43 577 395 177 ∼
Delaware 36 31 ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 31 ∼ 29 ∼ ∼ ∼ ∼ ∼
Florida 678 598 78 37 176 147 27 ∼
Georgia 237 148 87 ∼ 88 43 44 ∼
Maryland 186 143 40 ∼ 61 41 20 ∼
North Carolina 279 210 65 ∼ 85 58 26 ∼
South Carolina 158 98 60 ∼ 40 19 20 ∼
Virginia 215 170 44 ∼ 85 61 24 ∼
West Virginia 72 67 ∼ ∼ 21 20 ∼ ∼
East South Central 596 470 124 ∼ 131 101 30 ∼
Alabama 148 107 41 ∼ 40 26 ∼ ∼
Kentucky 156 144 ∼ ∼ 31 29 ∼ ∼
Mississippi 104 64 38 ∼ 19 ∼ ∼ ∼
Tennessee 188 155 33 ∼ 41 34 ∼ ∼
West South Central 868 724 136 61 246 204 39 ∼
Arkansas 72 58 ∼ ∼ 20 ∼ ∼ ∼
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Table E.8.2: Esophagus. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race and
Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 156 110 46 ∼ 36 29 ∼ ∼
Oklahoma 119 104 ∼ ∼ 24 21 ∼ ∼
Texas 521 452 65 58 166 139 26 ∼
West 1,912 1,757 61 145 554 493 31 29
Mountain 606 585 ∼ 41 151 144 ∼ ∼
Arizona 193 184 ∼ ∼ 49 48 ∼ ∼
Colorado 115 113 ∼ ∼ 31 29 ∼ ∼
Idaho 51 51 ∼ ∼ ∼ ∼ ∼ ∼
Montana 34 34 ∼ ∼ 17 16 ∼ ∼
Nevada 93 90 ∼ ∼ 17 ∼ ∼ ∼
New Mexico 54 47 ∼ ∼ ∼ ∼ ∼ ∼
Utah 43 43 ∼ ∼ ∼ ∼ ∼ ∼
Wyoming 23 23 ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 1,172 51 104 403 349 27 23
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 910 812 49 99 282 236 24 23
Hawaii 37 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon 136 135 ∼ ∼ 49 48 ∼ ∼
Washington 208 205 ∼ ∼ 65 62 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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E–32 Table E.9.1: Hodgkin Lymphoma. Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 988 851 90 87 856 745 79 63
New England 260 243 ∼ ∼ 203 182 ∼ ∼
Connecticut 59 50 ∼ ∼ 60 49 ∼ ∼
Maine 35 34 ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 111 105 ∼ ∼ 83 75 ∼ ∼
New Hampshire 30 29 ∼ - 23 23 ∼ -
Rhode Island ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 728 608 ∼ ∼ 653 563 ∼ ∼
New Jersey 138 121 ∼ 21 137 125 ∼ 19
New York 378 306 44 47 299 242 39 25
Pennsylvania 212 181 25 - 217 196 17 -
Midwest
East North Central 707 626 63 33 623 539 64 21
Illinois 191 169 18 19 161 136 19 ∼
Indiana 94 85 ∼ ∼ 83 76 ∼ ∼
Michigan 147 127 17 ∼ 152 125 22 ∼
Detroit 71 57 ∼ - 72 51 17 -
Ohio 168 143 16 ∼ 159 141 ∼ ∼
Wisconsin 107 102 ∼ - 68 61 ∼ -
West North Central
Iowa 53 50 ∼ ∼ 46 43 ∼ ∼
Kansas 41 39 ∼ ∼ 23 21 ∼ ∼
Minnesota 75 71 ∼ ∼ 64 56 ∼ ∼
Missouri 89 82 ∼ ∼ 56 51 ∼ ∼
Nebraska 23 21 ∼ ∼ 26 25 ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 16 ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 246 217 24 - 217 192 21 -
Georgia 121 87 31 ∼ 82 63 19 ∼
Atlanta 53 38 ∼ ∼ 32 24 ∼ ∼
Maryland 69 50 16 ∼ 56 40 ∼ ∼
North Carolina 110 77 30 ∼ 103 79 21 ∼
South Carolina 48 35 ∼ - 52 33 17 -
Virginia
West Virginia 29 28 ∼ ∼ ∼ ∼ ∼ ∼
East South Central
Alabama 70 53 16 ∼ 46 33 ∼ ∼
Kentucky 67 61 ∼ - 64 61 ∼ -
Mississippi
Tennessee
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Table E.9.1: Hodgkin Lymphoma. Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 65 52 ∼ ∼ 51 32 18 ∼
Oklahoma 45 42 ∼ ∼ 46 37 ∼ ∼
Texas 278 234 35 65 206 177 22 63
West
Mountain
Arizona 61 52 ∼ 19 52 50 ∼ ∼
Colorado 69 64 ∼ ∼ 49 45 ∼ ∼
Idaho 18 18 ∼ ∼ 22 22 ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nevada 32 32 ∼ ∼ 29 26 ∼ ∼
New Mexico 27 26 ∼ ∼ ∼ ∼ ∼ ∼
Utah 24 23 ∼ ∼ 29 28 ∼ ∼
Wyoming
Pacific ∼ 543 33 132 522 442 34 78
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 466 395 27 115 372 315 27 70
San Francisco-Oakland 57 39 ∼ ∼ 40 30 ∼ ∼
San Jose-Monterey 43 37 ∼ ∼ 31 23 ∼ ∼
Los Angeles 107 87 ∼ 45 87 68 ∼ 21
Hawaii 16 ∼ ∼ - ∼ ∼ ∼ -
Oregon 54 52 ∼ ∼ 51 48 ∼ ∼
Washington 99 84 ∼ ∼ 80 68 ∼ ∼
Seattle-Puget Sound 62 55 ∼ ∼ 61 53 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–34 Table E.9.2: Hodgkin Lymphoma. Cancer Death Counts by U.S. Census Region and Division, State, and Raceand Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 163 139 20 ∼ 126 119 ∼ ∼
New England 48 42 ∼ ∼ 24 23 ∼ ∼
Connecticut ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 26 23 ∼ ∼ ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 115 97 ∼ ∼ 102 96 ∼ ∼
New Jersey 25 21 ∼ ∼ 25 24 ∼ ∼
New York 55 47 ∼ ∼ 48 46 ∼ ∼
Pennsylvania 35 29 ∼ ∼ 29 26 ∼ ∼
Midwest 168 154 ∼ ∼ 129 119 ∼ ∼
East North Central ∼ ∼ ∼ ∼ 89 80 ∼ ∼
Illinois 38 32 ∼ ∼ 27 25 ∼ ∼
Indiana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Michigan 24 23 ∼ ∼ 17 ∼ ∼ ∼
Ohio 34 32 ∼ ∼ 26 21 ∼ ∼
Wisconsin 20 18 ∼ ∼ ∼ ∼ ∼ ∼
West North Central 37 35 ∼ ∼ 40 39 ∼ ∼
Iowa ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼ 16 ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South 274 231 42 ∼ 223 197 24 ∼
South Atlantic 133 118 ∼ ∼ 110 96 ∼ ∼
Delaware ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 52 51 ∼ ∼ 32 30 ∼ ∼
Georgia ∼ ∼ ∼ ∼ 18 ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Carolina 25 22 ∼ ∼ ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼ 19 ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
East South Central 59 49 ∼ ∼ 32 27 ∼ ∼
Alabama ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Kentucky 20 16 ∼ ∼ ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
West South Central 82 64 17 ∼ 81 74 ∼ ∼
Arkansas ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
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Table E.9.2: Hodgkin Lymphoma. Cancer Death Counts by U.S. Census Region and Division, State, and Race
and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Texas 48 38 ∼ ∼ 46 43 ∼ ∼
West 146 131 ∼ 21 123 103 ∼ 21
Mountain 42 40 ∼ ∼ 28 28 ∼ ∼
Arizona 16 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific 104 91 ∼ 21 95 75 ∼ 16
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 80 69 ∼ 21 74 57 ∼ 16
Hawaii ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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E–36 Table E.10.1: Kaposi Sarcoma. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 255 143 95 34 49 37 ∼ ∼
New England 35 29 ∼ ∼ ∼ ∼ ∼ ∼
Connecticut ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 24 18 ∼ ∼ ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ - ∼ ∼ ∼ -
Rhode Island ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 220 ∼ 91 31 38 28 ∼ ∼
New Jersey 49 30 16 ∼ ∼ ∼ ∼ ∼
New York 137 69 59 24 27 17 ∼ ∼
Pennsylvania 34 ∼ 16 - ∼ ∼ ∼ -
Midwest
East North Central ∼ 64 39 ∼ ∼ ∼ ∼ ∼
Illinois 43 24 16 ∼ ∼ ∼ ∼ ∼
Indiana 17 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Michigan 26 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Detroit 16 ∼ ∼ - ∼ ∼ ∼ -
Ohio 20 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Wisconsin ∼ ∼ ∼ - ∼ ∼ ∼ -
West North Central
Iowa ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 105 85 20 - 16 ∼ ∼ -
Georgia 67 33 30 ∼ ∼ ∼ ∼ ∼
Atlanta 53 22 27 ∼ ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ - ∼ ∼ ∼ -
Virginia
West Virginia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
East South Central
Alabama ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ - ∼ ∼ ∼ -
Mississippi
Tennessee
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Table E.10.1: Kaposi Sarcoma. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 18 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Texas 75 57 16 24 ∼ ∼ ∼ ∼
West
Mountain
Arizona ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Colorado 16 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Wyoming
Pacific 279 199 38 91 22 ∼ ∼ ∼
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 242 172 35 83 20 ∼ ∼ ∼
San Francisco-Oakland 49 33 ∼ ∼ ∼ ∼ ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Los Angeles 94 68 ∼ 49 ∼ ∼ ∼ ∼
Hawaii ∼ ∼ ∼ - ∼ ∼ ∼ -
Oregon ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Washington 24 18 ∼ ∼ ∼ ∼ ∼ ∼
Seattle-Puget Sound 16 ∼ ∼ ∼ ∼ ∼ ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
U
nited States C
ancer Statistics: 2002 Incidence and M
ortality
E–38 Table E.11.1: Kidney and Renal Pelvis. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 4,796 4,251 385 183 3,113 2,758 262 123
New England 1,238 1,165 47 30 829 780 40 ∼
Connecticut 314 283 20 ∼ 195 179 ∼ ∼
Maine 129 127 ∼ ∼ 78 77 ∼ ∼
Massachusetts 544 511 22 ∼ 390 363 23 ∼
New Hampshire 96 94 ∼ - 60 60 ∼ -
Rhode Island 108 104 ∼ ∼ 69 64 ∼ ∼
Vermont 47 46 ∼ ∼ 37 37 ∼ ∼
Middle Atlantic 3,558 3,086 338 ∼ 2,284 1,978 222 ∼
New Jersey 762 655 78 44 507 448 46 40
New York 1,576 1,341 149 99 964 805 110 64
Pennsylvania 1,220 1,090 111 - 813 725 66 -
Midwest
East North Central 3,852 3,332 432 85 2,572 2,217 296 54
Illinois 1,100 914 152 46 702 596 87 33
Indiana 525 476 45 ∼ 387 348 33 ∼
Michigan 830 687 122 17 530 438 81 ∼
Detroit 394 294 89 - 237 174 62 -
Ohio 950 834 91 ∼ 654 562 77 ∼
Wisconsin 447 421 22 - 299 273 18 -
West North Central
Iowa 281 266 ∼ ∼ 187 183 ∼ ∼
Kansas 178 170 ∼ ∼ 115 109 ∼ ∼
Minnesota 429 397 ∼ ∼ 259 244 ∼ ∼
Missouri 539 481 56 ∼ 343 303 35 ∼
Nebraska 159 147 ∼ ∼ 93 86 ∼ ∼
North Dakota 53 52 ∼ ∼ 34 34 ∼ ∼
South Dakota
South
South Atlantic
Delaware 86 70 16 ∼ 40 35 ∼ ∼
District of Columbia 51 17 32 ∼ 28 ∼ 20 ∼
Florida 1,609 1,477 109 - 977 864 103 -
Georgia 592 462 127 ∼ 365 267 93 ∼
Atlanta 183 128 52 ∼ 89 54 33 ∼
Maryland 370 284 78 ∼ 226 166 54 ∼
North Carolina 622 506 112 ∼ 410 310 96 ∼
South Carolina 378 292 79 - 207 160 44 -
Virginia
West Virginia 178 171 ∼ ∼ 120 118 ∼ ∼
East South Central
Alabama 367 286 80 ∼ 228 172 52 ∼
Kentucky 366 342 21 - 239 216 22 -
Mississippi
Tennessee
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Table E.11.1: Kidney and Renal Pelvis. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 422 320 100 ∼ 275 201 74 ∼
Oklahoma 296 252 20 ∼ 173 147 ∼ ∼
Texas 1,664 1,490 136 397 1,080 936 126 257
West
Mountain
Arizona 455 422 ∼ 60 270 255 ∼ 45
Colorado 290 273 ∼ 30 179 165 ∼ 30
Idaho 94 92 ∼ ∼ 70 69 ∼ ∼
Montana 77 72 ∼ ∼ 42 40 ∼ ∼
Nevada 148 139 ∼ 17 86 75 ∼ ∼
New Mexico 129 120 ∼ 58 72 63 ∼ 34
Utah 92 88 ∼ ∼ 48 47 ∼ ∼
Wyoming
Pacific 3,117 2,686 179 466 1,762 1,488 116 258
Alaska 45 32 ∼ ∼ 20 ∼ ∼ ∼
California 2,249 1,943 164 435 1,262 1,060 104 248
San Francisco-Oakland 251 183 36 30 170 127 21 17
San Jose-Monterey 132 111 ∼ 25 61 54 ∼ ∼
Los Angeles 558 449 69 159 330 251 46 95
Hawaii 74 23 ∼ - 36 ∼ ∼ -
Oregon 271 252 ∼ ∼ 166 155 ∼ ∼
Washington 478 436 ∼ 19 278 252 ∼ ∼
Seattle-Puget Sound 325 294 ∼ ∼ 189 176 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–40 Table E.11.2: Kidney and Renal Pelvis. Cancer Death Counts by U.S. Census Region and Division, State, Sex,
and Race and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast ∼ ∼ 86 30 ∼ ∼ 66 22
New England ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Connecticut 80 76 ∼ ∼ 58 53 ∼ ∼
Maine 56 56 ∼ ∼ 33 32 ∼ ∼
Massachusetts 151 149 ∼ ∼ 94 92 ∼ ∼
New Hampshire 23 23 ∼ ∼ 23 23 ∼ ∼
Rhode Island 44 43 ∼ ∼ 25 23 ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,037 943 79 26 691 628 ∼ 22
New Jersey 262 232 25 ∼ 146 131 ∼ ∼
New York 414 369 36 19 271 248 18 16
Pennsylvania 361 342 18 ∼ 274 249 25 ∼
Midwest 1,911 1,749 134 21 1,185 1,079 99 ∼
East North Central 1,286 1,155 113 16 821 729 87 ∼
Illinois 330 290 33 ∼ 210 182 27 ∼
Indiana 193 183 ∼ ∼ 137 118 19 ∼
Michigan 270 226 36 ∼ 156 139 ∼ ∼
Ohio 322 294 28 ∼ 214 189 25 ∼
Wisconsin 171 162 ∼ ∼ 104 101 ∼ ∼
West North Central 625 594 21 ∼ 364 350 ∼ ∼
Iowa 119 116 ∼ ∼ 59 58 ∼ ∼
Kansas 83 78 ∼ ∼ 50 49 ∼ ∼
Minnesota 148 143 ∼ ∼ 73 73 ∼ ∼
Missouri 180 167 ∼ ∼ 98 88 ∼ ∼
Nebraska 55 51 ∼ ∼ 47 47 ∼ ∼
North Dakota 22 21 ∼ ∼ 20 20 ∼ ∼
South Dakota 18 18 ∼ ∼ 17 ∼ ∼ ∼
South 2,794 2,419 354 188 1,619 1,364 239 92
South Atlantic 1,427 1,224 197 58 792 657 129 27
Delaware 17 ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 506 476 27 50 261 241 19 24
Georgia 190 147 43 ∼ 120 90 30 ∼
Maryland 128 99 29 ∼ 75 54 20 ∼
North Carolina 211 176 33 ∼ 113 86 25 ∼
South Carolina 113 90 23 ∼ 60 48 ∼ ∼
Virginia 187 156 30 ∼ 110 89 20 ∼
West Virginia 63 62 ∼ ∼ 39 38 ∼ ∼
East South Central 468 404 64 ∼ 293 237 55 ∼
Alabama 106 86 20 ∼ 73 55 17 ∼
Kentucky 115 111 ∼ ∼ 70 64 ∼ ∼
Mississippi 86 68 18 ∼ 44 28 16 ∼
Tennessee 161 139 22 ∼ 106 90 16 ∼
West South Central 899 791 93 128 534 470 55 64
Arkansas 87 78 ∼ ∼ 41 38 ∼ ∼
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Table E.11.2: Kidney and Renal Pelvis. Cancer Death Counts by U.S. Census Region and Division, State, Sex,
and Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 127 96 30 ∼ 81 65 16 ∼
Oklahoma 119 101 ∼ ∼ 77 68 ∼ ∼
Texas 566 516 47 127 335 299 34 63
West 1,478 1,332 56 187 842 751 35 106
Mountain 489 455 ∼ 51 247 221 ∼ 32
Arizona 157 143 ∼ 21 81 75 ∼ ∼
Colorado 97 91 ∼ ∼ 47 41 ∼ ∼
Idaho 37 36 ∼ ∼ 17 17 ∼ ∼
Montana 33 32 ∼ ∼ 18 17 ∼ ∼
Nevada 56 54 ∼ ∼ 23 19 ∼ ∼
New Mexico 56 49 ∼ 17 31 26 ∼ ∼
Utah 41 40 ∼ ∼ 20 17 ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 877 47 136 595 530 29 74
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 690 614 39 129 421 370 28 69
Hawaii 23 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon 101 96 ∼ ∼ 64 62 ∼ ∼
Washington 162 149 ∼ ∼ 96 94 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 1,861 1,593 214 108 521 438 75 22
New England 470 435 29 ∼ 121 114 ∼ ∼
Connecticut 127 108 18 ∼ 31 27 ∼ ∼
Maine 46 45 ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 205 194 ∼ ∼ 54 51 ∼ ∼
New Hampshire 38 37 ∼ - ∼ ∼ ∼ -
Rhode Island 35 32 ∼ ∼ ∼ ∼ ∼ ∼
Vermont 19 19 ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,391 1,158 185 ∼ 400 324 69 21
New Jersey 285 230 46 24 76 60 16 ∼
New York 619 499 88 64 177 139 34 ∼
Pennsylvania 487 429 51 - 147 125 19 -
Midwest
East North Central 1,585 1,327 ∼ 21 404 325 72 ∼
Illinois 463 375 83 ∼ 118 87 30 ∼
Indiana 208 184 23 ∼ 64 59 ∼ ∼
Michigan 329 262 64 ∼ 85 68 16 ∼
Detroit 157 105 50 - 42 29 ∼ -
Ohio 417 351 54 ∼ 102 82 16 ∼
Wisconsin 168 155 ∼ - 35 29 ∼ -
West North Central
Iowa 103 100 ∼ ∼ 34 33 ∼ ∼
Kansas 81 74 ∼ ∼ 22 18 ∼ ∼
Minnesota 126 116 ∼ ∼ 33 28 ∼ ∼
Missouri 226 204 21 ∼ 51 45 ∼ ∼
Nebraska 41 39 ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 44 30 ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 28 ∼ 24 ∼ ∼ ∼ ∼ ∼
Florida 797 706 77 - 185 158 25 -
Georgia 281 203 73 ∼ 84 60 23 ∼
Atlanta 69 47 20 ∼ 24 ∼ ∼ ∼
Maryland 173 120 51 ∼ 47 31 16 ∼
North Carolina 278 193 81 ∼ 66 46 19 ∼
South Carolina 182 127 55 - 41 29 ∼ -
Virginia
West Virginia 96 94 ∼ ∼ 26 26 ∼ ∼
East South Central
Alabama 191 139 51 ∼ 46 39 ∼ ∼
Kentucky 184 175 ∼ - 47 45 ∼ -
Mississippi
Tennessee
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Table E.12.1: Larynx. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 202 133 68 ∼ 54 30 22 ∼
Oklahoma 132 114 ∼ ∼ 44 37 ∼ ∼
Texas 611 504 100 85 137 111 22 17
West
Mountain
Arizona 126 119 ∼ ∼ 25 25 ∼ ∼
Colorado 98 94 ∼ ∼ 31 30 ∼ ∼
Idaho 37 37 ∼ ∼ ∼ ∼ ∼ ∼
Montana 28 27 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 63 60 ∼ ∼ ∼ ∼ ∼ ∼
New Mexico 41 38 ∼ 19 ∼ ∼ ∼ ∼
Utah 35 34 ∼ ∼ ∼ ∼ ∼ ∼
Wyoming
Pacific ∼ ∼ 76 117 214 183 22 ∼
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 760 633 71 113 169 143 19 ∼
San Francisco-Oakland 95 67 ∼ ∼ 19 ∼ ∼ ∼
San Jose-Monterey 34 28 ∼ ∼ ∼ ∼ ∼ ∼
Los Angeles 209 158 34 37 39 29 ∼ ∼
Hawaii 32 16 ∼ - ∼ ∼ ∼ -
Oregon 86 85 ∼ ∼ 16 16 ∼ ∼
Washington 110 100 ∼ ∼ 26 22 ∼ ∼
Seattle-Puget Sound 79 71 ∼ ∼ 18 ∼ ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–44 Table E.12.2: Larynx. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race andEthnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 651 541 108 35 193 159 33 ∼
New England 159 152 ∼ ∼ 54 53 ∼ ∼
Connecticut 42 38 ∼ ∼ ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 79 77 ∼ ∼ 27 26 ∼ ∼
New Hampshire ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Rhode Island 17 16 ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 492 389 101 30 139 106 32 ∼
New Jersey 90 67 21 ∼ 27 21 ∼ ∼
New York 231 179 52 22 66 47 18 ∼
Pennsylvania 171 143 28 ∼ 46 38 ∼ ∼
Midwest 637 536 99 ∼ 195 162 33 ∼
East North Central 469 378 90 ∼ ∼ ∼ 23 ∼
Illinois 136 110 26 ∼ 30 25 ∼ ∼
Indiana 59 49 ∼ ∼ 29 27 ∼ ∼
Michigan 108 80 27 ∼ 29 25 ∼ ∼
Ohio 129 105 24 ∼ 45 35 ∼ ∼
Wisconsin 37 34 ∼ ∼ ∼ ∼ ∼ ∼
West North Central 168 158 ∼ ∼ 50 40 ∼ ∼
Iowa 31 30 ∼ ∼ ∼ ∼ ∼ ∼
Kansas 21 21 ∼ ∼ ∼ ∼ ∼ ∼
Minnesota 30 28 ∼ ∼ ∼ ∼ ∼ ∼
Missouri 63 56 ∼ ∼ 21 ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South 1,168 863 295 52 293 231 60 ∼
South Atlantic 669 477 187 23 163 123 39 ∼
Delaware ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 16 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 240 202 38 21 58 53 ∼ ∼
Georgia 91 58 33 ∼ 18 ∼ ∼ ∼
Maryland 54 34 20 ∼ 21 ∼ ∼ ∼
North Carolina 108 65 40 ∼ 20 ∼ ∼ ∼
South Carolina 60 39 21 ∼ ∼ ∼ ∼ ∼
Virginia 65 47 16 ∼ 24 ∼ ∼ ∼
West Virginia 26 25 ∼ ∼ ∼ ∼ ∼ ∼
East South Central 189 149 40 ∼ 60 49 ∼ ∼
Alabama 48 34 ∼ ∼ 18 ∼ ∼ ∼
Kentucky 58 54 ∼ ∼ ∼ ∼ ∼ ∼
Mississippi 28 17 ∼ ∼ ∼ ∼ ∼ ∼
Tennessee 55 44 ∼ ∼ 21 17 ∼ ∼
West South Central 310 237 68 28 70 59 ∼ ∼
Arkansas 30 26 ∼ ∼ ∼ ∼ ∼ ∼
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Table E.12.2: Larynx. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race and
Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 50 29 21 ∼ ∼ ∼ ∼ ∼
Oklahoma 36 29 ∼ ∼ ∼ ∼ ∼ ∼
Texas 194 153 39 28 40 32 ∼ ∼
West 465 411 39 48 120 109 ∼ ∼
Mountain 114 104 ∼ ∼ 40 40 ∼ ∼
Arizona 48 44 ∼ ∼ ∼ ∼ ∼ ∼
Colorado 21 18 ∼ ∼ ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific 351 307 32 37 80 69 ∼ ∼
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 261 219 30 35 52 43 ∼ ∼
Hawaii ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon 35 35 ∼ ∼ ∼ ∼ ∼ ∼
Washington 51 49 ∼ ∼ 16 ∼ ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 3,806 3,395 243 194 2,963 2,602 224 170
New England 967 918 21 19 753 714 25 26
Connecticut 220 204 ∼ ∼ 182 172 ∼ ∼
Maine 124 119 ∼ ∼ 73 71 ∼ ∼
Massachusetts 392 372 ∼ ∼ 347 327 ∼ ∼
New Hampshire 107 101 ∼ - 53 48 ∼ -
Rhode Island 74 72 ∼ ∼ 65 63 ∼ ∼
Vermont 50 50 ∼ ∼ 33 33 ∼ ∼
Middle Atlantic 2,839 2,477 222 ∼ 2,210 1,888 199 ∼
New Jersey 607 506 55 45 476 393 47 42
New York 1,272 1,082 124 112 990 820 108 84
Pennsylvania 960 889 43 - 744 675 44 -
Midwest
East North Central 3,041 2,738 ∼ 90 2,398 2,116 ∼ 82
Illinois 862 747 74 54 679 580 72 53
Indiana 414 389 17 ∼ 318 296 16 ∼
Michigan 604 540 43 ∼ 503 428 47 ∼
Detroit 260 220 31 - 230 182 36 -
Ohio 721 644 52 ∼ 566 498 45 ∼
Wisconsin 440 418 ∼ - 332 314 ∼ -
West North Central
Iowa 254 247 ∼ ∼ 200 192 ∼ ∼
Kansas 176 163 ∼ ∼ 133 126 ∼ ∼
Minnesota 391 363 ∼ ∼ 269 256 ∼ ∼
Missouri 370 332 29 ∼ 288 257 29 ∼
Nebraska 112 108 ∼ ∼ 110 101 ∼ ∼
North Dakota 47 45 ∼ ∼ 31 31 ∼ ∼
South Dakota
South
South Atlantic
Delaware 45 41 ∼ ∼ 29 20 ∼ ∼
District of Columbia 18 ∼ ∼ ∼ 17 ∼ ∼ ∼
Florida 1,278 1,177 82 - 994 890 90 -
Georgia 416 328 79 ∼ 357 280 68 ∼
Atlanta 136 98 34 ∼ 102 81 17 ∼
Maryland 229 175 45 ∼ 196 152 36 ∼
North Carolina 398 339 44 ∼ 322 258 57 ∼
South Carolina 268 208 47 - 222 156 48 -
Virginia
West Virginia 121 118 ∼ ∼ 82 81 ∼ ∼
East South Central
Alabama 252 210 38 ∼ 208 174 32 ∼
Kentucky 273 257 ∼ - 185 172 ∼ -
Mississippi
Tennessee
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Table E.13.1: Leukemias. Cancer Incidence Counts by U.S. Census Region and Division, State and Metropolitan
Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 283 223 59 ∼ 213 158 52 ∼
Oklahoma 235 206 ∼ ∼ 182 156 ∼ ∼
Texas 1,210 1,078 99 256 918 820 70 191
West
Mountain
Arizona 291 268 ∼ 52 210 199 ∼ 36
Colorado 271 251 ∼ 38 194 181 ∼ 22
Idaho 96 94 ∼ ∼ 86 86 ∼ ∼
Montana 67 64 ∼ ∼ 56 48 ∼ ∼
Nevada 118 113 ∼ ∼ 93 82 ∼ ∼
New Mexico 148 140 ∼ 44 90 85 ∼ 25
Utah 140 138 ∼ ∼ 84 83 ∼ ∼
Wyoming
Pacific 2,765 2,353 124 446 2,000 1,673 98 340
Alaska 29 21 ∼ ∼ 17 ∼ ∼ ∼
California 1,992 1,689 114 419 1,479 1,224 95 321
San Francisco-Oakland 216 164 17 26 174 127 ∼ 23
San Jose-Monterey 137 112 ∼ 25 80 64 ∼ ∼
Los Angeles 510 408 52 149 428 333 46 137
Hawaii 80 25 ∼ - 48 ∼ ∼ -
Oregon 209 197 ∼ ∼ 151 143 ∼ ∼
Washington 455 421 ∼ 17 305 279 ∼ ∼
Seattle-Puget Sound 318 297 ∼ ∼ 193 176 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–48 Table E.13.2: Leukemias. Cancer Death Counts by U.S. Census Region and Division, State, and Race and
Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 2,324 2,148 139 66 1,945 1,782 137 81
New England 590 564 19 ∼ 490 470 17 ∼
Connecticut 139 131 ∼ ∼ 124 117 ∼ ∼
Maine 82 81 ∼ ∼ 41 40 ∼ ∼
Massachusetts 228 214 ∼ ∼ 220 210 ∼ ∼
New Hampshire 69 68 ∼ ∼ 44 44 ∼ ∼
Rhode Island 43 41 ∼ ∼ 33 31 ∼ ∼
Vermont 29 29 ∼ ∼ 28 28 ∼ ∼
Middle Atlantic 1,734 1,584 120 ∼ 1,455 1,312 120 66
New Jersey 387 340 38 16 325 296 23 ∼
New York 739 663 59 33 636 555 65 49
Pennsylvania 608 581 23 ∼ 494 461 32 ∼
Midwest 2,959 2,741 193 38 2,464 2,277 172 34
East North Central 2,008 1,841 152 31 1,693 1,538 146 25
Illinois 552 495 47 18 451 397 50 18
Indiana 260 249 ∼ ∼ 229 219 ∼ ∼
Michigan 436 389 43 ∼ 360 312 43 ∼
Ohio 535 488 46 ∼ 430 394 36 ∼
Wisconsin 225 220 ∼ ∼ 223 216 ∼ ∼
West North Central 951 900 41 ∼ 771 739 26 ∼
Iowa 153 149 ∼ ∼ 130 129 ∼ ∼
Kansas 125 116 ∼ ∼ 100 99 ∼ ∼
Minnesota 228 221 ∼ ∼ 196 191 ∼ ∼
Missouri 283 256 27 ∼ 229 207 22 ∼
Nebraska 78 77 ∼ ∼ 67 66 ∼ ∼
North Dakota 44 42 ∼ ∼ 23 22 ∼ ∼
South Dakota 40 39 ∼ ∼ 26 25 ∼ ∼
South 4,337 3,791 510 242 3,360 2,846 468 189
South Atlantic 2,326 2,021 289 114 1,806 1,518 266 89
Delaware 40 35 ∼ ∼ 29 24 ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ 22 ∼ ∼ ∼
Florida 908 848 58 91 648 592 52 73
Georgia 286 232 54 ∼ 217 165 51 ∼
Maryland 229 184 38 ∼ 176 141 31 ∼
North Carolina 313 271 41 ∼ 269 218 44 ∼
South Carolina 166 132 34 ∼ 142 104 37 ∼
Virginia 293 241 47 ∼ 239 206 30 ∼
West Virginia 76 73 ∼ ∼ 64 63 ∼ ∼
East South Central 767 664 99 ∼ 601 514 83 ∼
Alabama 195 153 41 ∼ 157 128 27 ∼
Kentucky 198 190 ∼ ∼ 123 116 ∼ ∼
Mississippi 122 91 30 ∼ 125 90 35 ∼
Tennessee 252 230 21 ∼ 196 180 ∼ ∼
West South Central 1,244 1,106 122 122 953 814 119 93
Arkansas 147 137 ∼ ∼ 114 96 17 ∼
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Table E.13.2: Leukemias. Cancer Death Counts by U.S. Census Region and Division, State, and Race and
Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 168 134 33 ∼ 132 93 38 ∼
Oklahoma 161 152 ∼ ∼ 125 114 ∼ ∼
Texas 768 683 73 119 582 511 60 89
West 2,438 2,188 90 256 1,754 1,567 76 184
Mountain 703 680 ∼ 67 500 476 ∼ 35
Arizona 212 200 ∼ 21 152 145 ∼ 16
Colorado 155 152 ∼ 20 110 104 ∼ ∼
Idaho 46 46 ∼ ∼ 44 44 ∼ ∼
Montana 43 42 ∼ ∼ 28 28 ∼ ∼
Nevada 74 70 ∼ ∼ 57 50 ∼ ∼
New Mexico 67 65 ∼ 18 48 46 ∼ ∼
Utah 88 87 ∼ ∼ 49 47 ∼ ∼
Wyoming 18 18 ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ ∼ 81 189 ∼ 1,091 69 149
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 1,229 1,058 74 182 915 793 63 141
Hawaii 55 19 ∼ ∼ 36 ∼ ∼ ∼
Oregon 163 159 ∼ ∼ 110 106 ∼ ∼
Washington 273 259 ∼ ∼ 186 175 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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E–50 Table E.14.1: Liver and Intrahepatic Bile Duct. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast ∼ ∼ 302 237 921 738 115 79
New England ∼ ∼ 20 37 196 182 ∼ ∼
Connecticut 115 105 ∼ ∼ 50 45 ∼ ∼
Maine 33 31 ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 252 215 ∼ 21 95 88 ∼ ∼
New Hampshire 35 33 ∼ - ∼ ∼ ∼ -
Rhode Island 42 39 ∼ ∼ 16 16 ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,715 1,241 282 ∼ 725 556 ∼ 71
New Jersey 332 242 45 32 140 116 ∼ ∼
New York 866 603 140 139 361 261 59 57
Pennsylvania 517 396 97 - 224 179 35 -
Midwest
East North Central 1,396 1,104 ∼ 87 694 581 89 20
Illinois 425 323 69 48 189 142 37 ∼
Indiana 151 130 20 ∼ 77 67 ∼ ∼
Michigan 308 231 66 ∼ 159 132 23 ∼
Detroit 150 98 48 - 67 50 ∼ -
Ohio 314 246 52 ∼ 176 156 16 ∼
Wisconsin 198 174 ∼ - 93 84 ∼ -
West North Central
Iowa 76 70 ∼ ∼ 36 35 ∼ ∼
Kansas 62 52 ∼ ∼ 23 20 ∼ ∼
Minnesota 130 105 ∼ ∼ 52 46 ∼ ∼
Missouri 190 146 37 ∼ 66 56 ∼ ∼
Nebraska 41 33 ∼ ∼ 25 22 ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 20 17 ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 30 ∼ 22 ∼ ∼ ∼ ∼ ∼
Florida 727 639 62 - 294 250 34 -
Georgia 218 144 59 ∼ 100 68 24 ∼
Atlanta 78 32 33 ∼ 27 ∼ ∼ ∼
Maryland 182 130 41 ∼ 96 66 26 ∼
North Carolina 218 159 46 ∼ 106 81 21 ∼
South Carolina 141 97 40 - 53 33 18 -
Virginia
West Virginia 44 44 ∼ ∼ 23 23 ∼ ∼
East South Central
Alabama 140 109 28 ∼ 83 61 21 ∼
Kentucky 110 94 ∼ - 57 51 ∼ -
Mississippi
Tennessee
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Table E.14.1: Liver and Intrahepatic Bile Duct. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 169 107 57 ∼ 71 45 24 ∼
Oklahoma 99 82 ∼ ∼ 64 52 ∼ ∼
Texas 940 768 114 327 391 329 46 142
West
Mountain
Arizona 204 189 ∼ 58 66 56 ∼ 16
Colorado 145 121 ∼ 32 47 41 ∼ ∼
Idaho 23 23 ∼ ∼ 16 16 ∼ ∼
Montana 24 22 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 80 64 ∼ ∼ 33 28 ∼ ∼
New Mexico 88 79 ∼ 50 31 28 ∼ ∼
Utah 27 24 ∼ ∼ 17 16 ∼ ∼
Wyoming
Pacific ∼ 1,186 124 359 ∼ 604 56 195
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 1,430 911 111 342 721 475 50 190
San Francisco-Oakland 213 94 24 25 107 55 ∼ 16
San Jose-Monterey 109 64 ∼ 29 41 23 ∼ ∼
Los Angeles 434 249 52 128 253 154 20 83
Hawaii 81 ∼ ∼ - 32 ∼ ∼ -
Oregon 91 71 ∼ ∼ 48 44 ∼ ∼
Washington 230 186 ∼ ∼ 102 77 ∼ ∼
Seattle-Puget Sound 181 140 ∼ ∼ 79 55 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–52 Table E.14.2: Liver and Intrahepatic Bile Duct. Cancer Death Counts by U.S. Census Region and Division,State, Sex, and Race and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 1,763 1,440 207 154 ∼ ∼ 96 59
New England 454 410 25 20 ∼ ∼ ∼ ∼
Connecticut 103 89 ∼ ∼ 49 43 ∼ ∼
Maine 36 36 ∼ ∼ 23 23 ∼ ∼
Massachusetts 219 195 ∼ ∼ 102 98 ∼ ∼
New Hampshire 45 43 ∼ ∼ 16 16 ∼ ∼
Rhode Island 34 31 ∼ ∼ 16 16 ∼ ∼
Vermont 17 16 ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,309 1,030 182 ∼ 699 580 ∼ 53
New Jersey 253 199 35 26 132 114 ∼ ∼
New York 653 503 88 96 344 273 51 45
Pennsylvania 403 328 59 ∼ 223 193 25 ∼
Midwest 1,871 1,536 270 60 1,055 921 110 19
East North Central 1,329 1,079 ∼ 45 786 673 95 ∼
Illinois 365 280 70 23 210 165 36 ∼
Indiana 153 130 21 ∼ 99 88 ∼ ∼
Michigan 293 231 52 ∼ 182 153 23 ∼
Ohio 339 280 56 ∼ 192 169 22 ∼
Wisconsin 179 158 ∼ ∼ 103 98 ∼ ∼
West North Central 542 457 56 ∼ 269 248 ∼ ∼
Iowa 64 60 ∼ ∼ 45 43 ∼ ∼
Kansas 80 71 ∼ ∼ 39 34 ∼ ∼
Minnesota 137 111 ∼ ∼ 60 56 ∼ ∼
Missouri 195 156 33 ∼ 79 69 ∼ ∼
Nebraska 41 35 ∼ ∼ 24 24 ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota 16 ∼ ∼ ∼ ∼ ∼ ∼ ∼
South 3,339 2,647 569 315 1,867 1,495 314 183
South Atlantic 1,672 1,317 298 79 868 667 172 51
Delaware 29 24 ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 24 ∼ 19 ∼ ∼ ∼ ∼ ∼
Florida 643 582 50 70 313 272 34 43
Georgia 208 145 50 ∼ 118 88 24 ∼
Maryland 163 107 46 ∼ 84 57 24 ∼
North Carolina 228 169 48 ∼ 122 90 30 ∼
South Carolina 131 93 37 ∼ 71 38 32 ∼
Virginia 189 138 41 ∼ 95 72 ∼ ∼
West Virginia 57 55 ∼ ∼ 40 39 ∼ ∼
East South Central 574 475 92 ∼ 347 286 57 ∼
Alabama 161 127 33 ∼ 115 89 26 ∼
Kentucky 131 120 ∼ ∼ 72 68 ∼ ∼
Mississippi 88 67 18 ∼ 63 48 ∼ ∼
Tennessee 194 161 30 ∼ 97 81 16 ∼
West South Central 1,093 855 179 234 652 542 85 131
Arkansas 82 69 ∼ ∼ 61 48 ∼ ∼
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Table E.14.2: Liver and Intrahepatic Bile Duct. Cancer Death Counts by U.S. Census Region and Division,
State, Sex, and Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 167 107 57 ∼ 116 90 23 ∼
Oklahoma 88 73 ∼ ∼ 50 39 ∼ ∼
Texas 756 606 105 231 425 365 45 126
West 2,038 1,491 119 362 1,204 939 49 211
Mountain 506 455 17 100 282 254 ∼ 47
Arizona 175 162 ∼ 36 82 72 ∼ ∼
Colorado 91 80 ∼ 16 51 50 ∼ ∼
Idaho 24 24 ∼ ∼ 26 24 ∼ ∼
Montana 29 27 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 70 58 ∼ ∼ 42 35 ∼ ∼
New Mexico 79 69 ∼ 40 45 39 ∼ 18
Utah 30 27 ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 1,036 102 262 ∼ 685 43 164
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 1,165 781 89 248 711 527 40 158
Hawaii 66 ∼ ∼ ∼ 27 ∼ ∼ ∼
Oregon 91 73 ∼ ∼ 56 52 ∼ ∼
Washington 195 161 ∼ ∼ 123 98 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 21,019 18,691 1,846 617 18,479 16,602 1,548 454
New England 5,474 5,228 165 93 5,080 4,853 168 64
Connecticut 1,306 1,212 79 37 1,237 1,149 80 26
Maine 636 622 ∼ ∼ 504 501 ∼ ∼
Massachusetts 2,416 2,301 69 39 2,329 2,219 69 24
New Hampshire 434 427 ∼ - 417 409 ∼ -
Rhode Island 469 456 ∼ ∼ 426 408 17 ∼
Vermont 213 210 ∼ ∼ 167 167 ∼ ∼
Middle Atlantic 15,545 13,463 1,681 ∼ 13,399 11,749 1,380 ∼
New Jersey 3,159 2,691 379 132 2,818 2,494 285 88
New York 6,693 5,663 784 334 5,993 5,188 637 259
Pennsylvania 5,693 5,109 518 - 4,588 4,067 458 -
Midwest
East North Central 18,284 15,989 2,035 162 14,658 12,870 1,582 ∼
Illinois 4,814 4,046 682 88 3,945 3,316 563 83
Indiana 2,721 2,498 203 ∼ 2,120 1,949 154 22
Michigan 3,893 3,304 535 28 3,149 2,687 414 16
Detroit 1,709 1,293 398 - 1,414 1,092 310 -
Ohio 4,875 4,276 519 16 3,829 3,397 380 23
Wisconsin 1,981 1,865 96 - 1,615 1,521 71 -
West North Central
Iowa 1,202 1,175 19 ∼ 918 903 ∼ ∼
Kansas 954 898 45 ∼ 721 684 28 ∼
Minnesota 1,529 1,459 34 ∼ 1,302 1,245 25 ∼
Missouri 2,693 2,423 249 19 1,937 1,735 187 ∼
Nebraska 623 594 21 ∼ 453 431 ∼ ∼
North Dakota 246 238 ∼ ∼ 159 152 ∼ ∼
South Dakota
South
South Atlantic
Delaware 326 280 38 ∼ 275 237 36 ∼
District of Columbia 214 43 162 ∼ 148 36 108 ∼
Florida 8,694 7,961 680 - 6,956 6,502 383 -
Georgia 3,261 2,568 668 27 2,144 1,748 381 17
Atlanta 733 494 228 ∼ 569 397 166 ∼
Maryland 1,793 1,356 402 19 1,608 1,240 339 ∼
North Carolina 3,270 2,640 595 ∼ 2,248 1,888 325 ∼
South Carolina 1,845 1,421 413 - 1,178 934 232 -
Virginia
West Virginia 1,070 1,042 25 ∼ 815 795 18 ∼
East South Central
Alabama 2,141 1,742 383 ∼ 1,420 1,181 221 ∼
Kentucky 2,416 2,266 140 - 1,713 1,618 90 -
Mississippi
Tennessee
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Table E.15.1: Lung and Bronchus. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 1,945 1,395 536 36 1,312 1,007 298 21
Oklahoma 1,758 1,535 105 19 1,294 1,130 65 ∼
Texas 6,882 5,941 832 716 4,888 4,301 504 394
West
Mountain
Arizona 1,703 1,635 38 125 1,385 1,335 21 66
Colorado 1,063 1,002 39 96 932 875 31 64
Idaho 378 373 ∼ ∼ 290 282 ∼ ∼
Montana 347 328 ∼ ∼ 282 266 ∼ ∼
Nevada 866 804 38 35 727 670 30 35
New Mexico 488 475 ∼ 112 360 357 ∼ 57
Utah 283 277 ∼ ∼ 187 179 ∼ ∼
Wyoming
Pacific 12,806 10,681 849 920 11,374 9,911 539 655
Alaska 146 110 ∼ ∼ 108 72 ∼ ∼
California 8,911 7,338 745 859 8,079 7,001 499 609
San Francisco-Oakland 1,135 763 162 85 1,108 813 142 75
San Jose-Monterey 500 404 17 67 485 422 ∼ 52
Los Angeles 2,104 1,496 332 286 1,760 1,386 205 193
Hawaii 405 108 ∼ - 262 81 ∼ -
Oregon 1,296 1,232 28 ∼ 1,149 1,110 ∼ 23
Washington 2,048 1,893 66 38 1,776 1,647 32 21
Seattle-Puget Sound 1,423 1,300 62 20 1,270 1,171 32 ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–56 Table E.15.2: Lung and Bronchus. Cancer Death Counts by U.S. Census Region and Division, State, Sex, andRace and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 16,540 14,790 1,520 396 14,001 12,723 1,139 227
New England 4,386 4,195 148 51 3,886 3,752 103 28
Connecticut 969 902 59 ∼ 878 829 44 ∼
Maine 528 519 ∼ ∼ 420 415 ∼ ∼
Massachusetts 1,982 1,886 72 31 1,780 1,715 50 16
New Hampshire 361 358 ∼ ∼ 341 338 ∼ ∼
Rhode Island 371 355 ∼ ∼ 324 313 ∼ ∼
Vermont 175 175 ∼ ∼ 143 142 ∼ ∼
Middle Atlantic 12,154 10,595 1,372 345 10,115 8,971 1,036 ∼
New Jersey 2,438 2,100 294 79 2,120 1,871 227 42
New York 5,180 4,408 651 224 4,435 3,884 480 144
Pennsylvania 4,536 4,087 427 42 3,560 3,216 329 ∼
Midwest 21,542 19,400 2,002 154 16,200 14,626 1,447 85
East North Central 15,184 13,403 1,689 122 11,637 10,308 1,251 68
Illinois 3,864 3,253 575 68 2,983 2,490 460 33
Indiana 2,274 2,083 190 ∼ 1,694 1,554 137 ∼
Michigan 3,218 2,749 436 19 2,495 2,178 297 ∼
Ohio 4,269 3,833 425 23 3,221 2,917 295 ∼
Wisconsin 1,559 1,485 63 ∼ 1,244 1,169 62 ∼
West North Central 6,358 5,997 313 32 4,563 4,318 196 17
Iowa 1,059 1,037 19 ∼ 673 662 ∼ ∼
Kansas 856 803 48 ∼ 623 593 21 ∼
Minnesota 1,261 1,230 20 ∼ 1,065 1,045 ∼ ∼
Missouri 2,227 2,003 213 ∼ 1,565 1,415 142 ∼
Nebraska 524 509 ∼ ∼ 365 343 ∼ ∼
North Dakota 197 193 ∼ ∼ 107 101 ∼ ∼
South Dakota 234 222 ∼ ∼ 165 159 ∼ ∼
South 37,136 31,125 5,750 1,163 24,934 21,622 3,114 532
South Atlantic 19,247 15,985 3,134 521 13,345 11,536 1,725 253
Delaware 280 238 39 ∼ 193 170 23 ∼
District of Columbia 198 34 162 ∼ 128 33 94 ∼
Florida 6,770 6,193 548 461 5,077 4,771 290 230
Georgia 2,639 2,040 586 ∼ 1,547 1,276 261 ∼
Maryland 1,634 1,217 393 ∼ 1,333 1,004 314 ∼
North Carolina 2,977 2,375 577 ∼ 1,891 1,579 299 ∼
South Carolina 1,564 1,204 354 ∼ 919 740 172 ∼
Virginia 2,280 1,797 457 ∼ 1,640 1,365 254 ∼
West Virginia 905 887 18 ∼ 617 598 18 ∼
East South Central 7,604 6,446 1,142 19 4,712 4,087 612 ∼
Alabama 1,887 1,488 392 ∼ 1,102 900 200 ∼
Kentucky 1,991 1,884 106 ∼ 1,356 1,283 72 ∼
Mississippi 1,201 863 337 ∼ 699 529 166 ∼
Tennessee 2,525 2,211 307 ∼ 1,555 1,375 174 ∼
West South Central 10,285 8,694 1,474 623 6,877 5,999 777 268
Arkansas 1,325 1,173 146 ∼ 806 741 63 ∼
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Table E.15.2: Lung and Bronchus. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and
Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 1,729 1,210 506 ∼ 1,108 836 267 ∼
Oklahoma 1,421 1,277 91 ∼ 976 876 45 ∼
Texas 5,810 5,034 731 600 3,987 3,546 402 253
West 14,903 13,108 797 903 12,374 11,196 537 577
Mountain 4,321 4,148 113 271 3,404 3,257 75 177
Arizona 1,466 1,416 37 94 1,154 1,113 25 54
Colorado 861 820 33 55 687 656 23 47
Idaho 316 312 ∼ ∼ 215 213 ∼ ∼
Montana 289 271 ∼ ∼ 242 228 ∼ ∼
Nevada 616 581 27 20 538 494 24 ∼
New Mexico 405 388 ∼ 91 294 288 ∼ 55
Utah 233 227 ∼ ∼ 167 159 ∼ ∼
Wyoming 135 133 ∼ ∼ 107 106 ∼ ∼
Pacific 10,582 8,960 684 632 8,970 7,939 462 400
Alaska 119 84 ∼ ∼ 79 64 ∼ ∼
California 7,451 6,234 603 583 6,338 5,512 427 377
Hawaii 286 79 ∼ ∼ 138 48 ∼ ∼
Oregon 1,061 1,025 ∼ ∼ 996 976 ∼ ∼
Washington 1,665 1,538 62 22 1,419 1,339 26 ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 5,341 5,049 19 50 4,327 4,051 23 71
New England 1,770 1,684 ∼ ∼ 1,540 1,466 ∼ ∼
Connecticut 399 376 ∼ ∼ 350 338 ∼ ∼
Maine 158 156 ∼ ∼ 141 139 ∼ ∼
Massachusetts 741 687 ∼ ∼ 700 645 ∼ ∼
New Hampshire 197 193 ∼ - 159 157 ∼ -
Rhode Island 180 177 ∼ ∼ 117 115 ∼ ∼
Vermont 95 95 ∼ ∼ 73 72 ∼ ∼
Middle Atlantic 3,571 3,365 16 42 2,787 2,585 22 ∼
New Jersey 1,042 1,013 ∼ ∼ 793 764 ∼ 17
New York 1,260 1,155 ∼ 24 979 874 ∼ 29
Pennsylvania 1,269 1,197 ∼ - 1,015 947 ∼ -
Midwest
East North Central 3,927 3,682 ∼ 28 3,151 2,937 23 40
Illinois 917 856 ∼ ∼ 668 615 ∼ 19
Indiana 541 525 ∼ ∼ 422 411 ∼ ∼
Michigan 946 901 ∼ ∼ 827 789 ∼ ∼
Detroit 379 374 ∼ - 346 336 ∼ -
Ohio 1,070 958 ∼ ∼ 857 751 ∼ ∼
Wisconsin 453 442 ∼ - 377 371 ∼ -
West North Central
Iowa 286 258 ∼ ∼ 273 248 ∼ ∼
Kansas 277 254 ∼ ∼ 201 183 ∼ ∼
Minnesota 453 432 ∼ ∼ 396 381 ∼ ∼
Missouri 390 380 ∼ ∼ 285 273 ∼ ∼
Nebraska 156 133 ∼ ∼ 137 102 ∼ ∼
North Dakota 45 45 ∼ ∼ 23 22 ∼ ∼
South Dakota
South
South Atlantic
Delaware 77 73 ∼ ∼ 51 46 ∼ ∼
District of Columbia 22 16 ∼ ∼ 23 18 ∼ ∼
Florida 1,756 1,732 ∼ - 1,206 1,180 ∼ -
Georgia 754 722 ∼ ∼ 560 516 ∼ ∼
Atlanta 291 283 ∼ ∼ 196 185 ∼ ∼
Maryland 1,078 1,064 ∼ ∼ 871 864 ∼ ∼
North Carolina 675 673 ∼ ∼ 560 550 ∼ ∼
South Carolina 430 424 ∼ - 303 292 ∼ -
Virginia
West Virginia 175 175 ∼ ∼ 142 142 ∼ ∼
East South Central
Alabama 331 324 ∼ ∼ 271 264 ∼ ∼
Kentucky 436 402 ∼ - 337 321 ∼ -
Mississippi
Tennessee
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Table E.16.1: Melanomas of the Skin. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 245 237 ∼ ∼ 180 171 ∼ ∼
Oklahoma 301 280 ∼ ∼ 215 197 ∼ ∼
Texas 1,452 1,278 ∼ 68 1,033 862 ∼ 68
West
Mountain
Arizona 551 543 ∼ 16 347 342 ∼ 16
Colorado 453 452 ∼ ∼ 389 384 ∼ ∼
Idaho 166 164 ∼ ∼ 97 96 ∼ ∼
Montana 79 75 ∼ ∼ 71 68 ∼ ∼
Nevada 214 210 ∼ ∼ 138 137 ∼ ∼
New Mexico 182 180 ∼ ∼ 108 107 ∼ ∼
Utah 216 216 ∼ ∼ 161 160 ∼ ∼
Wyoming
Pacific 4,728 4,391 ∼ 130 3,530 3,223 ∼ 181
Alaska 31 31 ∼ ∼ 28 27 ∼ ∼
California 3,399 3,107 ∼ 122 2,459 2,204 ∼ 164
San Francisco-Oakland 358 330 ∼ ∼ 254 239 ∼ ∼
San Jose-Monterey 204 180 ∼ ∼ 137 119 ∼ ∼
Los Angeles 682 624 ∼ 38 511 467 ∼ 59
Hawaii 128 112 ∼ - 92 62 ∼ -
Oregon 452 428 ∼ ∼ 379 359 ∼ ∼
Washington 718 713 ∼ ∼ 572 571 ∼ ∼
Seattle-Puget Sound 487 486 ∼ ∼ 400 398 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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and Race and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast ∼ ∼ ∼ ∼ 614 600 ∼ ∼
New England ∼ ∼ ∼ ∼ 151 150 ∼ ∼
Connecticut 65 64 ∼ ∼ 30 30 ∼ ∼
Maine 38 38 ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 115 114 ∼ ∼ 69 68 ∼ ∼
New Hampshire 32 32 ∼ ∼ 17 17 ∼ ∼
Rhode Island 17 17 ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 602 598 ∼ ∼ 463 450 ∼ ∼
New Jersey 154 154 ∼ ∼ 86 84 ∼ ∼
New York 222 219 ∼ ∼ 208 199 ∼ ∼
Pennsylvania 226 225 ∼ ∼ 169 167 ∼ ∼
Midwest 1,043 1,029 ∼ ∼ 629 614 ∼ ∼
East North Central 733 722 ∼ ∼ 443 428 ∼ ∼
Illinois 186 182 ∼ ∼ 118 114 ∼ ∼
Indiana 97 95 ∼ ∼ 86 84 ∼ ∼
Michigan 157 153 ∼ ∼ 82 77 ∼ ∼
Ohio 191 190 ∼ ∼ 117 113 ∼ ∼
Wisconsin 102 102 ∼ ∼ 40 40 ∼ ∼
West North Central 310 307 ∼ ∼ 186 186 ∼ ∼
Iowa 44 44 ∼ ∼ 30 30 ∼ ∼
Kansas 36 36 ∼ ∼ 21 21 ∼ ∼
Minnesota 79 79 ∼ ∼ 33 33 ∼ ∼
Missouri 96 94 ∼ ∼ 76 76 ∼ ∼
Nebraska 39 38 ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South 1,778 1,737 33 28 970 942 22 32
South Atlantic 976 959 ∼ ∼ 535 521 ∼ ∼
Delaware 16 16 ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 390 386 ∼ ∼ 173 169 ∼ ∼
Georgia 108 105 ∼ ∼ 81 80 ∼ ∼
Maryland 102 99 ∼ ∼ 43 42 ∼ ∼
North Carolina 146 142 ∼ ∼ 81 81 ∼ ∼
South Carolina 62 60 ∼ ∼ 41 38 ∼ ∼
Virginia 115 114 ∼ ∼ 86 82 ∼ ∼
West Virginia 35 35 ∼ ∼ 21 21 ∼ ∼
East South Central 317 309 ∼ ∼ 162 157 ∼ ∼
Alabama 76 74 ∼ ∼ 51 47 ∼ ∼
Kentucky 91 91 ∼ ∼ 39 38 ∼ ∼
Mississippi 47 45 ∼ ∼ 17 17 ∼ ∼
Tennessee 103 99 ∼ ∼ 55 55 ∼ ∼
West South Central 485 469 ∼ 18 273 264 ∼ 18
Arkansas 38 38 ∼ ∼ 25 25 ∼ ∼
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Table E.16.2: Melanomas of the Skin. Cancer Death Counts by U.S. Census Region and Division, State, Sex,
and Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 67 63 ∼ ∼ 38 35 ∼ ∼
Oklahoma 84 79 ∼ ∼ 40 38 ∼ ∼
Texas 296 289 ∼ 16 170 166 ∼ 17
West 1,020 995 ∼ 37 575 557 ∼ 25
Mountain 330 326 ∼ ∼ 181 177 ∼ ∼
Arizona 108 106 ∼ ∼ 56 55 ∼ ∼
Colorado 59 59 ∼ ∼ 47 45 ∼ ∼
Idaho 32 32 ∼ ∼ ∼ ∼ ∼ ∼
Montana 18 17 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 41 41 ∼ ∼ 18 18 ∼ ∼
New Mexico 25 24 ∼ ∼ ∼ ∼ ∼ ∼
Utah 37 37 ∼ ∼ 21 21 ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific 690 669 ∼ 27 394 380 ∼ 20
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 499 486 ∼ 25 277 268 ∼ 18
Hawaii ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon 77 76 ∼ ∼ 45 44 ∼ ∼
Washington 91 89 ∼ ∼ 61 59 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 573 543 24 ∼ 157 145 ∼ ∼
New England 166 161 ∼ ∼ 40 39 ∼ ∼
Connecticut 46 44 ∼ ∼ ∼ ∼ ∼ ∼
Maine 20 20 ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 79 76 ∼ ∼ ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ - ∼ ∼ ∼ -
Rhode Island ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 407 382 21 ∼ 117 106 ∼ ∼
New Jersey 103 99 ∼ ∼ 31 30 ∼ ∼
New York 168 156 ∼ ∼ 38 34 ∼ ∼
Pennsylvania 136 127 ∼ - 48 42 ∼ -
Midwest
East North Central 434 421 ∼ ∼ ∼ ∼ ∼ ∼
Illinois 120 119 ∼ ∼ 27 24 ∼ ∼
Indiana 48 47 ∼ ∼ ∼ ∼ ∼ ∼
Michigan 80 77 ∼ ∼ 33 30 ∼ ∼
Detroit 29 27 ∼ - ∼ ∼ ∼ -
Ohio 122 116 ∼ ∼ 19 19 ∼ ∼
Wisconsin 64 62 ∼ - 20 19 ∼ -
West North Central
Iowa ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Minnesota 51 50 ∼ ∼ ∼ ∼ ∼ ∼
Missouri 42 41 ∼ ∼ ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 180 174 ∼ - 55 52 ∼ -
Georgia 27 27 ∼ ∼ ∼ ∼ ∼ ∼
Atlanta ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Maryland 51 44 ∼ ∼ ∼ ∼ ∼ ∼
North Carolina 48 45 ∼ ∼ ∼ ∼ ∼ ∼
South Carolina 27 22 ∼ - ∼ ∼ ∼ -
Virginia
West Virginia 25 25 ∼ ∼ ∼ ∼ ∼ ∼
East South Central
Alabama 39 33 ∼ ∼ ∼ ∼ ∼ ∼
Kentucky 29 29 ∼ - ∼ ∼ ∼ -
Mississippi
Tennessee
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Table E.17.1: Mesothelioma. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 29 25 ∼ ∼ 16 ∼ ∼ ∼
Oklahoma 23 23 ∼ ∼ ∼ ∼ ∼ ∼
Texas 129 121 ∼ 18 24 22 ∼ ∼
West
Mountain
Arizona 39 39 ∼ ∼ ∼ ∼ ∼ ∼
Colorado 37 35 ∼ ∼ ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nevada 23 22 ∼ ∼ ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Wyoming
Pacific 379 356 ∼ 49 80 72 ∼ ∼
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 245 230 ∼ 48 66 60 ∼ ∼
San Francisco-Oakland 30 25 ∼ ∼ ∼ ∼ ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Los Angeles 55 53 ∼ 19 19 18 ∼ ∼
Hawaii ∼ ∼ ∼ - ∼ ∼ ∼ -
Oregon 50 50 ∼ ∼ ∼ ∼ ∼ ∼
Washington 75 70 ∼ ∼ ∼ ∼ ∼ ∼
Seattle-Puget Sound 49 47 ∼ ∼ ∼ ∼ ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–64 Table E.17.2: Mesothelioma. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race
and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 482 462 18 ∼ 96 91 ∼ ∼
New England 134 132 ∼ ∼ 24 24 ∼ ∼
Connecticut 27 26 ∼ ∼ ∼ ∼ ∼ ∼
Maine 19 19 ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 61 60 ∼ ∼ ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 348 330 16 ∼ 72 67 ∼ ∼
New Jersey 101 95 ∼ ∼ 21 20 ∼ ∼
New York 121 114 ∼ ∼ 24 22 ∼ ∼
Pennsylvania 126 121 ∼ ∼ 27 25 ∼ ∼
Midwest 489 477 ∼ ∼ 132 124 ∼ ∼
East North Central 348 339 ∼ ∼ 88 80 ∼ ∼
Illinois 102 98 ∼ ∼ 19 17 ∼ ∼
Indiana 43 43 ∼ ∼ ∼ ∼ ∼ ∼
Michigan 66 66 ∼ ∼ 23 20 ∼ ∼
Ohio 84 80 ∼ ∼ 26 24 ∼ ∼
Wisconsin 53 52 ∼ ∼ ∼ ∼ ∼ ∼
West North Central 141 138 ∼ ∼ 44 44 ∼ ∼
Iowa 25 25 ∼ ∼ ∼ ∼ ∼ ∼
Kansas 20 20 ∼ ∼ ∼ ∼ ∼ ∼
Minnesota 34 34 ∼ ∼ ∼ ∼ ∼ ∼
Missouri 38 37 ∼ ∼ ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South 623 578 44 21 108 100 ∼ ∼
South Atlantic 368 343 25 ∼ 54 51 ∼ ∼
Delaware ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 139 135 ∼ ∼ 21 20 ∼ ∼
Georgia 27 26 ∼ ∼ ∼ ∼ ∼ ∼
Maryland 40 35 ∼ ∼ ∼ ∼ ∼ ∼
North Carolina 41 38 ∼ ∼ ∼ ∼ ∼ ∼
South Carolina 23 21 ∼ ∼ ∼ ∼ ∼ ∼
Virginia 65 57 ∼ ∼ ∼ ∼ ∼ ∼
West Virginia 22 22 ∼ ∼ ∼ ∼ ∼ ∼
East South Central 99 94 ∼ ∼ 24 23 ∼ ∼
Alabama 30 28 ∼ ∼ ∼ ∼ ∼ ∼
Kentucky 20 19 ∼ ∼ ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Tennessee 36 36 ∼ ∼ ∼ ∼ ∼ ∼
West South Central 156 141 ∼ ∼ 30 26 ∼ ∼
Arkansas ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
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Table E.17.2: Mesothelioma. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race
and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 26 19 ∼ ∼ ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Texas 103 97 ∼ ∼ ∼ ∼ ∼ ∼
West 410 395 ∼ 40 90 85 ∼ ∼
Mountain 129 128 ∼ ∼ 24 24 ∼ ∼
Arizona 30 30 ∼ ∼ ∼ ∼ ∼ ∼
Colorado 25 25 ∼ ∼ ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nevada 16 ∼ ∼ ∼ ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Utah 22 22 ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific 281 267 ∼ 31 66 61 ∼ ∼
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 182 175 ∼ 29 49 44 ∼ ∼
Hawaii ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon 22 22 ∼ ∼ ∼ ∼ ∼ ∼
Washington 65 62 ∼ ∼ ∼ ∼ ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast ∼ ∼ 217 88 ∼ ∼ 297 79
New England ∼ ∼ 31 ∼ ∼ ∼ 24 ∼
Connecticut 123 106 ∼ ∼ 83 72 ∼ ∼
Maine 50 50 ∼ ∼ 37 37 ∼ ∼
Massachusetts 199 180 16 ∼ 159 147 ∼ ∼
New Hampshire 29 26 ∼ - 39 37 ∼ -
Rhode Island 28 26 ∼ ∼ 38 35 ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,293 1,066 186 ∼ 1,185 863 273 67
New Jersey 283 227 49 19 245 182 56 ∼
New York 610 482 100 49 560 375 154 49
Pennsylvania 400 357 37 - 380 306 63 -
Midwest
East North Central 1,326 1,076 ∼ 34 1,150 917 ∼ 19
Illinois 393 311 71 19 347 259 81 ∼
Indiana 150 133 ∼ ∼ 131 112 19 ∼
Michigan 305 233 67 ∼ 260 193 58 ∼
Detroit 166 109 54 - 128 83 44 -
Ohio 322 262 51 ∼ 271 222 46 ∼
Wisconsin 156 137 19 - 141 131 ∼ -
West North Central
Iowa 105 100 ∼ ∼ 68 63 ∼ ∼
Kansas 76 69 ∼ ∼ 57 45 ∼ ∼
Minnesota 134 126 ∼ ∼ 110 98 ∼ ∼
Missouri 161 133 25 ∼ 133 116 ∼ ∼
Nebraska 41 41 ∼ ∼ 37 35 ∼ ∼
North Dakota 20 20 ∼ ∼ 22 22 ∼ ∼
South Dakota
South
South Atlantic
Delaware 20 16 ∼ ∼ 18 ∼ ∼ ∼
District of Columbia 21 ∼ 19 ∼ ∼ ∼ ∼ ∼
Florida 513 423 86 - 443 348 86 -
Georgia 222 150 72 ∼ 191 111 74 ∼
Atlanta 76 47 29 ∼ 58 34 23 ∼
Maryland 109 74 32 ∼ 139 88 48 ∼
North Carolina 203 146 55 ∼ 163 111 51 ∼
South Carolina 129 69 52 - 119 74 40 -
Virginia
West Virginia 58 55 ∼ ∼ 53 45 ∼ ∼
East South Central
Alabama 126 87 39 ∼ 126 81 44 ∼
Kentucky 132 118 ∼ - 108 93 ∼ -
Mississippi
Tennessee
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Table E.18.1: Multiple Myeloma. Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 151 89 61 ∼ 120 63 57 ∼
Oklahoma 105 85 ∼ ∼ 80 63 ∼ ∼
Texas 509 406 93 85 414 329 74 81
West
Mountain
Arizona 124 113 ∼ ∼ 80 74 ∼ ∼
Colorado 114 98 ∼ ∼ 79 68 ∼ ∼
Idaho 41 41 ∼ ∼ 37 36 ∼ ∼
Montana 29 29 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 51 48 ∼ ∼ 50 36 ∼ ∼
New Mexico 48 44 ∼ 17 45 39 ∼ 20
Utah 47 46 ∼ ∼ 28 28 ∼ ∼
Wyoming
Pacific ∼ 933 111 140 ∼ 696 101 129
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 809 629 102 134 664 494 95 118
San Francisco-Oakland 90 56 ∼ ∼ 98 61 23 ∼
San Jose-Monterey 59 45 ∼ ∼ 42 37 ∼ ∼
Los Angeles 209 142 45 43 185 121 44 43
Hawaii 26 ∼ ∼ - 22 ∼ ∼ -
Oregon 107 106 ∼ ∼ 82 72 ∼ ∼
Washington 204 178 ∼ ∼ 133 123 ∼ ∼
Seattle-Puget Sound 134 118 ∼ ∼ 87 79 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast ∼ ∼ 119 47 ∼ ∼ 181 41
New England ∼ ∼ ∼ ∼ ∼ ∼ 21 ∼
Connecticut 64 55 ∼ ∼ 76 66 ∼ ∼
Maine 32 32 ∼ ∼ 24 24 ∼ ∼
Massachusetts 135 130 ∼ ∼ 144 134 ∼ ∼
New Hampshire 29 29 ∼ ∼ 22 22 ∼ ∼
Rhode Island 23 22 ∼ ∼ 21 18 ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 784 671 106 41 798 629 160 36
New Jersey 170 142 23 ∼ 169 135 33 ∼
New York 349 289 59 27 344 249 89 24
Pennsylvania 265 240 24 ∼ 285 245 38 ∼
Midwest 1,383 1,196 179 26 1,298 1,115 171 ∼
East North Central 973 814 152 23 893 747 140 ∼
Illinois 245 194 47 ∼ 228 184 42 ∼
Indiana 127 112 ∼ ∼ 109 102 ∼ ∼
Michigan 244 206 37 ∼ 218 177 40 ∼
Ohio 246 204 41 ∼ 245 196 47 ∼
Wisconsin 111 98 ∼ ∼ 93 88 ∼ ∼
West North Central 410 382 27 ∼ 405 368 31 ∼
Iowa 64 62 ∼ ∼ 69 68 ∼ ∼
Kansas 54 48 ∼ ∼ 59 51 ∼ ∼
Minnesota 109 105 ∼ ∼ 85 80 ∼ ∼
Missouri 106 91 ∼ ∼ 126 105 19 ∼
Nebraska 39 38 ∼ ∼ 31 31 ∼ ∼
North Dakota 19 19 ∼ ∼ ∼ ∼ ∼ ∼
South Dakota 19 19 ∼ ∼ 21 19 ∼ ∼
South 2,034 1,561 455 102 1,891 1,398 473 93
South Atlantic 1,073 802 262 41 982 705 269 38
Delaware ∼ ∼ ∼ ∼ 16 ∼ ∼ ∼
District of Columbia 17 ∼ ∼ ∼ 20 ∼ 18 ∼
Florida 362 316 44 36 276 228 46 35
Georgia 135 83 51 ∼ 141 89 51 ∼
Maryland 95 65 29 ∼ 106 74 31 ∼
North Carolina 177 115 59 ∼ 178 126 50 ∼
South Carolina 95 68 26 ∼ 73 45 28 ∼
Virginia 133 93 39 ∼ 134 92 40 ∼
West Virginia 46 46 ∼ ∼ 38 36 ∼ ∼
East South Central 376 291 85 ∼ 384 286 96 ∼
Alabama 106 74 32 ∼ 109 70 38 ∼
Kentucky 78 72 ∼ ∼ 84 74 ∼ ∼
Mississippi 59 33 26 ∼ 66 40 26 ∼
Tennessee 133 112 21 ∼ 125 102 22 ∼
West South Central 585 468 108 61 525 407 108 54
Arkansas 59 50 ∼ ∼ 48 37 ∼ ∼
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Table E.18.2: Multiple Myeloma. Cancer Death Counts by U.S. Census Region and Division, State, and Race
and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 100 59 41 ∼ 86 58 27 ∼
Oklahoma 58 50 ∼ ∼ 64 53 ∼ ∼
Texas 368 309 57 60 327 259 62 52
West 1,178 1,059 69 131 963 803 92 106
Mountain 351 332 ∼ 39 240 217 ∼ 24
Arizona 121 115 ∼ ∼ 66 63 ∼ ∼
Colorado 74 69 ∼ ∼ 52 46 ∼ ∼
Idaho 20 20 ∼ ∼ 22 19 ∼ ∼
Montana 19 17 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 38 37 ∼ ∼ 39 31 ∼ ∼
New Mexico 37 33 ∼ ∼ 23 21 ∼ ∼
Utah 35 35 ∼ ∼ 19 19 ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 727 59 92 723 586 78 82
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 580 502 55 84 498 388 71 78
Hawaii 18 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon 86 85 ∼ ∼ 84 77 ∼ ∼
Washington 134 125 ∼ ∼ 122 114 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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and Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 5,988 5,289 455 387 5,460 4,922 362 265
New England 1,515 1,416 54 52 1,471 1,397 46 47
Connecticut 397 373 ∼ 25 340 310 26 ∼
Maine 147 144 ∼ ∼ 150 149 ∼ ∼
Massachusetts 678 619 34 21 677 637 20 25
New Hampshire 128 122 ∼ - 126 123 ∼ -
Rhode Island 105 99 ∼ ∼ 118 118 ∼ ∼
Vermont 60 59 ∼ ∼ 60 60 ∼ ∼
Middle Atlantic 4,473 3,873 401 ∼ 3,989 3,525 316 ∼
New Jersey 964 832 93 86 881 779 70 63
New York 1,973 1,631 215 226 1,748 1,472 180 131
Pennsylvania 1,536 1,410 93 - 1,360 1,274 66 -
Midwest
East North Central 4,523 4,051 318 136 4,022 3,649 ∼ 81
Illinois 1,226 1,084 97 81 1,088 968 90 49
Indiana 635 577 45 16 485 452 23 ∼
Michigan 975 857 83 ∼ 938 834 76 ∼
Detroit 395 315 68 - 391 333 49 -
Ohio 1,134 1,010 77 ∼ 975 877 67 ∼
Wisconsin 553 523 16 - 536 518 ∼ -
West North Central
Iowa 320 313 ∼ ∼ 332 325 ∼ ∼
Kansas 266 249 ∼ 16 243 225 ∼ ∼
Minnesota 595 564 ∼ ∼ 495 476 ∼ ∼
Missouri 561 533 26 ∼ 516 475 32 ∼
Nebraska 205 193 ∼ ∼ 165 159 ∼ ∼
North Dakota 58 58 ∼ ∼ 59 56 ∼ ∼
South Dakota
South
South Atlantic
Delaware 86 74 ∼ ∼ 69 58 ∼ ∼
District of Columbia 64 18 45 ∼ 40 ∼ 26 ∼
Florida 1,955 1,758 155 - 1,707 1,552 131 -
Georgia 618 482 128 ∼ 570 432 120 ∼
Atlanta 210 149 58 ∼ 183 120 56 ∼
Maryland 445 363 72 ∼ 369 299 60 ∼
North Carolina 648 538 96 ∼ 631 549 71 ∼
South Carolina 351 293 50 - 326 273 46 -
Virginia
West Virginia 187 187 ∼ ∼ 202 200 ∼ ∼
East South Central
Alabama 423 370 49 ∼ 360 308 49 ∼
Kentucky 398 374 17 - 389 365 ∼ -
Mississippi
Tennessee
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Table E.19.1: Non-Hodgkin Lymphoma. Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 398 320 70 ∼ 369 290 75 ∼
Oklahoma 354 308 17 ∼ 309 267 ∼ ∼
Texas 1,656 1,449 161 312 1,519 1,361 114 282
West
Mountain
Arizona 446 421 ∼ 58 387 364 ∼ 54
Colorado 384 358 ∼ 34 360 335 ∼ 33
Idaho 136 135 ∼ ∼ 117 115 ∼ ∼
Montana 100 94 ∼ ∼ 87 80 ∼ ∼
Nevada 222 191 ∼ 17 161 143 ∼ ∼
New Mexico 137 127 ∼ 36 139 133 ∼ 32
Utah 182 178 ∼ ∼ 146 141 ∼ ∼
Wyoming
Pacific 4,425 3,750 187 556 3,577 3,049 136 447
Alaska 55 46 ∼ ∼ 28 24 ∼ ∼
California 3,168 2,657 174 524 2,557 2,163 123 424
San Francisco-Oakland 454 348 36 53 377 280 25 42
San Jose-Monterey 211 173 ∼ 39 184 146 ∼ 32
Los Angeles 834 645 76 204 648 521 51 150
Hawaii 113 38 ∼ - 87 24 ∼ -
Oregon 376 362 ∼ ∼ 346 335 ∼ ∼
Washington 713 647 ∼ 22 559 503 ∼ ∼
Seattle-Puget Sound 519 483 ∼ ∼ 385 352 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–72 Table E.19.2: Non-Hodgkin Lymphoma. Cancer Death Counts by U.S. Census Region and Division, State, and
Race and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 2,403 2,197 184 76 2,173 2,022 131 78
New England 627 608 16 ∼ 617 599 16 ∼
Connecticut 151 149 ∼ ∼ 137 130 ∼ ∼
Maine 58 58 ∼ ∼ 59 59 ∼ ∼
Massachusetts 275 260 ∼ ∼ 288 277 ∼ ∼
New Hampshire 64 64 ∼ ∼ 60 60 ∼ ∼
Rhode Island 46 45 ∼ ∼ 49 49 ∼ ∼
Vermont 33 32 ∼ ∼ 24 24 ∼ ∼
Middle Atlantic 1,776 1,589 168 ∼ 1,556 1,423 115 71
New Jersey 389 341 44 16 340 311 21 ∼
New York 759 660 87 49 646 568 71 52
Pennsylvania 628 588 37 ∼ 570 544 23 ∼
Midwest 2,819 2,656 144 39 2,644 2,482 145 27
East North Central 1,916 1,779 ∼ 32 1,799 1,668 120 25
Illinois 475 436 31 16 468 418 45 16
Indiana 273 255 16 ∼ 233 223 ∼ ∼
Michigan 451 413 35 ∼ 417 381 33 ∼
Ohio 499 464 34 ∼ 472 443 27 ∼
Wisconsin 218 211 ∼ ∼ 209 203 ∼ ∼
West North Central 903 877 21 ∼ 845 814 25 ∼
Iowa 160 160 ∼ ∼ 159 157 ∼ ∼
Kansas 115 110 ∼ ∼ 109 105 ∼ ∼
Minnesota 231 227 ∼ ∼ 199 195 ∼ ∼
Missouri 261 247 ∼ ∼ 256 237 19 ∼
Nebraska 78 77 ∼ ∼ 68 67 ∼ ∼
North Dakota 28 27 ∼ ∼ 29 28 ∼ ∼
South Dakota 30 29 ∼ ∼ 25 25 ∼ ∼
South 3,969 3,563 375 200 3,566 3,160 369 209
South Atlantic 2,145 1,916 213 81 1,899 1,660 220 86
Delaware 34 30 ∼ ∼ 28 26 ∼ ∼
District of Columbia 21 ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 828 780 46 71 716 656 57 74
Georgia 234 194 36 ∼ 239 193 44 ∼
Maryland 210 183 23 ∼ 150 123 24 ∼
North Carolina 330 290 37 ∼ 298 256 38 ∼
South Carolina 150 131 19 ∼ 132 115 17 ∼
Virginia 256 222 31 ∼ 236 202 28 ∼
West Virginia 82 80 ∼ ∼ 86 83 ∼ ∼
East South Central 712 641 68 ∼ 654 590 62 ∼
Alabama 196 171 24 ∼ 167 147 19 ∼
Kentucky 167 157 ∼ ∼ 154 148 ∼ ∼
Mississippi 110 90 19 ∼ 98 81 16 ∼
Tennessee 239 223 ∼ ∼ 235 214 21 ∼
West South Central 1,112 1,006 94 116 1,013 910 87 119
Arkansas 116 112 ∼ ∼ 93 85 ∼ ∼
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Table E.19.2: Non-Hodgkin Lymphoma. Cancer Death Counts by U.S. Census Region and Division, State, and
Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 177 149 28 ∼ 179 145 32 ∼
Oklahoma 162 150 ∼ ∼ 112 105 ∼ ∼
Texas 657 595 54 112 629 575 45 113
West 2,347 2,119 72 234 1,989 1,797 54 205
Mountain 640 617 ∼ 58 573 548 ∼ 54
Arizona 212 202 ∼ 21 205 196 ∼ 18
Colorado 153 150 ∼ ∼ 137 127 ∼ ∼
Idaho 38 38 ∼ ∼ 36 36 ∼ ∼
Montana 36 36 ∼ ∼ 27 27 ∼ ∼
Nevada 67 63 ∼ ∼ 61 59 ∼ ∼
New Mexico 60 55 ∼ 19 54 51 ∼ ∼
Utah 59 58 ∼ ∼ 32 32 ∼ ∼
Wyoming ∼ ∼ ∼ ∼ 21 20 ∼ ∼
Pacific 1,707 1,502 61 176 ∼ 1,249 48 151
Alaska 19 ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 1,202 1,046 56 165 1,016 880 46 144
Hawaii 40 ∼ ∼ ∼ 32 ∼ ∼ ∼
Oregon 155 153 ∼ ∼ 150 148 ∼ ∼
Washington 291 276 ∼ ∼ 208 203 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 3,870 3,271 419 202 1,949 1,648 214 89
New England 1,084 997 53 24 516 478 20 16
Connecticut 251 228 17 ∼ 120 104 ∼ ∼
Maine 129 124 ∼ ∼ 53 51 ∼ ∼
Massachusetts 495 445 29 ∼ 241 223 ∼ ∼
New Hampshire 91 90 ∼ - 47 46 ∼ -
Rhode Island 74 68 ∼ ∼ 34 33 ∼ ∼
Vermont 44 42 ∼ ∼ 21 21 ∼ ∼
Middle Atlantic 2,786 2,274 366 ∼ 1,433 1,170 194 ∼
New Jersey 570 469 75 39 291 237 37 19
New York 1,272 994 186 111 688 539 104 49
Pennsylvania 944 811 105 - 454 394 53 -
Midwest
East North Central 3,192 2,719 370 59 1,504 1,323 131 23
Illinois 895 711 151 38 428 365 47 ∼
Indiana 450 414 30 ∼ 191 175 ∼ ∼
Michigan 770 635 101 ∼ 372 325 35 ∼
Detroit 332 241 82 - 165 133 27 -
Ohio 705 612 70 ∼ 320 282 24 ∼
Wisconsin 372 347 18 - 193 176 ∼ -
West North Central
Iowa 233 224 ∼ ∼ 116 110 ∼ ∼
Kansas 180 155 ∼ ∼ 94 86 ∼ ∼
Minnesota 345 320 ∼ ∼ 207 188 ∼ ∼
Missouri 449 396 48 ∼ 175 162 ∼ ∼
Nebraska 116 107 ∼ ∼ 80 73 ∼ ∼
North Dakota 65 64 ∼ ∼ 31 30 ∼ ∼
South Dakota
South
South Atlantic
Delaware 63 53 ∼ ∼ 29 25 ∼ ∼
District of Columbia 43 ∼ 31 ∼ 24 ∼ 17 ∼
Florida 1,649 1,506 128 - 769 685 70 -
Georgia 612 465 143 ∼ 275 211 58 ∼
Atlanta 174 125 46 ∼ 89 58 27 ∼
Maryland 370 278 85 ∼ 156 115 34 ∼
North Carolina 562 423 132 ∼ 271 223 45 ∼
South Carolina 372 261 105 - 144 108 33 -
Virginia
West Virginia 147 139 ∼ ∼ 72 70 ∼ ∼
East South Central
Alabama 381 317 62 ∼ 166 134 29 ∼
Kentucky 367 339 21 - 122 114 ∼ -
Mississippi
Tennessee
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Table E.20.1: Oral Cavity and Pharynx. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 389 278 106 ∼ 136 108 28 ∼
Oklahoma 273 244 ∼ ∼ 105 97 ∼ ∼
Texas 1,344 1,189 116 170 533 462 56 66
West
Mountain
Arizona 306 284 ∼ 33 131 123 ∼ ∼
Colorado 264 242 ∼ 16 116 104 ∼ ∼
Idaho 78 77 ∼ ∼ 54 53 ∼ ∼
Montana 82 78 ∼ ∼ 33 32 ∼ ∼
Nevada 162 148 ∼ ∼ 54 46 ∼ ∼
New Mexico 121 117 ∼ 26 57 57 ∼ ∼
Utah 103 101 ∼ ∼ 55 52 ∼ ∼
Wyoming
Pacific 2,948 2,434 152 225 ∼ ∼ 60 115
Alaska 32 27 ∼ ∼ ∼ ∼ ∼ ∼
California 2,135 1,754 138 218 1,036 852 54 109
San Francisco-Oakland 299 215 26 19 146 98 ∼ ∼
San Jose-Monterey 142 114 ∼ 17 64 42 ∼ ∼
Los Angeles 504 361 70 78 274 212 28 48
Hawaii 111 46 ∼ - 43 16 ∼ -
Oregon 249 229 ∼ ∼ 136 126 ∼ ∼
Washington 421 378 ∼ ∼ 222 196 ∼ ∼
Seattle-Puget Sound 314 290 ∼ ∼ 158 140 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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E–76 Table E.20.2: Oral Cavity and Pharynx. Cancer Death Counts by U.S. Census Region and Division, State, Sex,
and Race and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast ∼ ∼ 133 43 469 409 44 ∼
New England ∼ ∼ ∼ ∼ 128 118 ∼ ∼
Connecticut 67 60 ∼ ∼ 21 20 ∼ ∼
Maine 28 28 ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts 134 119 ∼ ∼ 58 50 ∼ ∼
New Hampshire 30 30 ∼ ∼ 20 20 ∼ ∼
Rhode Island 19 19 ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 666 526 119 37 341 291 41 ∼
New Jersey 139 106 28 ∼ 77 63 ∼ ∼
New York 294 222 57 24 156 131 23 ∼
Pennsylvania 233 198 34 ∼ 108 97 ∼ ∼
Midwest 1,127 972 135 ∼ 566 510 47 ∼
East North Central 796 664 120 ∼ 394 344 45 ∼
Illinois 202 156 43 ∼ 108 86 20 ∼
Indiana 100 93 ∼ ∼ 42 37 ∼ ∼
Michigan 175 133 35 ∼ 83 75 ∼ ∼
Ohio 217 188 29 ∼ 104 93 ∼ ∼
Wisconsin 102 94 ∼ ∼ 57 53 ∼ ∼
West North Central 331 308 ∼ ∼ 172 166 ∼ ∼
Iowa 55 54 ∼ ∼ 25 23 ∼ ∼
Kansas 44 41 ∼ ∼ 19 19 ∼ ∼
Minnesota 81 78 ∼ ∼ 45 45 ∼ ∼
Missouri 97 84 ∼ ∼ 46 45 ∼ ∼
Nebraska 23 22 ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota 16 ∼ ∼ ∼ ∼ ∼ ∼ ∼
South 2,045 1,587 437 73 959 786 160 30
South Atlantic 1,074 817 249 39 544 431 105 ∼
Delaware 19 16 ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 17 ∼ 17 ∼ ∼ ∼ ∼ ∼
Florida 400 353 43 36 188 167 17 ∼
Georgia 122 82 40 ∼ 85 58 26 ∼
Maryland 98 64 33 ∼ 60 46 ∼ ∼
North Carolina 154 113 40 ∼ 81 65 ∼ ∼
South Carolina 97 59 38 ∼ 34 22 ∼ ∼
Virginia 120 83 35 ∼ 63 48 ∼ ∼
West Virginia 47 47 ∼ ∼ 17 16 ∼ ∼
East South Central 368 284 83 ∼ 162 131 30 ∼
Alabama 85 65 20 ∼ 44 34 ∼ ∼
Kentucky 78 74 ∼ ∼ 37 33 ∼ ∼
Mississippi 67 40 27 ∼ 24 20 ∼ ∼
Tennessee 138 105 32 ∼ 57 44 ∼ ∼
West South Central 603 486 105 34 253 224 25 18
Arkansas 71 56 ∼ ∼ 23 23 ∼ ∼
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Table E.20.2: Oral Cavity and Pharynx. Cancer Death Counts by U.S. Census Region and Division, State, Sex,
and Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 122 86 36 ∼ 44 35 ∼ ∼
Oklahoma 59 55 ∼ ∼ 29 25 ∼ ∼
Texas 351 289 52 33 157 141 ∼ 18
West 1,056 903 61 85 559 471 27 23
Mountain 278 261 ∼ 17 119 115 ∼ ∼
Arizona 95 90 ∼ ∼ 30 30 ∼ ∼
Colorado 52 49 ∼ ∼ 21 21 ∼ ∼
Idaho 23 23 ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nevada 51 48 ∼ ∼ 17 16 ∼ ∼
New Mexico 28 23 ∼ ∼ ∼ ∼ ∼ ∼
Utah 17 16 ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 642 51 68 ∼ 356 27 18
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 576 466 48 65 314 251 24 18
Hawaii 25 ∼ ∼ ∼ 19 ∼ ∼ ∼
Oregon 62 59 ∼ ∼ 39 38 ∼ ∼
Washington 111 105 ∼ ∼ 64 56 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 4,489 4,011 320 180
New England 1,076 1,027 27 19
Connecticut 249 233 ∼ ∼
Maine 97 95 ∼ ∼
Massachusetts 531 505 ∼ ∼
New Hampshire 84 82 ∼ -
Rhode Island 75 72 ∼ ∼
Vermont 40 40 ∼ ∼
Middle Atlantic 3,413 2,984 293 ∼
New Jersey 752 666 58 50
New York 1,594 1,336 174 103
Pennsylvania 1,067 982 61 -
Midwest
East North Central 3,255 2,928 239 65
Illinois 903 778 88 42
Indiana 407 386 ∼ ∼
Michigan 733 646 72 ∼
Detroit 307 250 52 -
Ohio 810 733 57 ∼
Wisconsin 402 385 ∼ -
West North Central
Iowa 214 210 ∼ ∼
Kansas 196 186 ∼ ∼
Minnesota 349 334 ∼ ∼
Missouri 411 379 23 ∼
Nebraska 111 109 ∼ ∼
North Dakota 48 47 ∼ ∼
South Dakota
South
South Atlantic
Delaware 59 50 ∼ ∼
District of Columbia 41 ∼ 27 ∼
Florida 1,445 1,309 120 -
Georgia 544 422 114 ∼
Atlanta 173 122 46 ∼
Maryland 336 272 55 ∼
North Carolina 556 448 91 ∼
South Carolina 292 220 67 -
Virginia
West Virginia 159 155 ∼ ∼
East South Central
Alabama 375 313 57 ∼
Kentucky 291 273 17 -
Mississippi
Tennessee
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Table E.21.1: Ovary. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 286 218 66 ∼
Oklahoma 243 216 ∼ ∼
Texas 1,165 1,027 104 238
West
Mountain
Arizona 353 333 ∼ 58
Colorado 277 265 ∼ 29
Idaho 79 79 ∼ ∼
Montana 80 78 ∼ ∼
Nevada 153 140 ∼ ∼
New Mexico 117 108 ∼ 38
Utah 119 119 ∼ ∼
Wyoming
Pacific 3,134 2,695 82 433
Alaska 29 24 ∼ ∼
California 2,256 1,944 73 409
San Francisco-Oakland 307 230 ∼ 31
San Jose-Monterey 162 128 ∼ 21
Los Angeles 602 488 35 193
Hawaii 87 21 ∼ -
Oregon 260 245 ∼ ∼
Washington 502 461 ∼ 19
Seattle-Puget Sound 339 307 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 3,138 2,859 219 92
New England 819 789 21 ∼
Connecticut 183 174 ∼ ∼
Maine 93 92 ∼ ∼
Massachusetts 385 368 ∼ ∼
New Hampshire 66 65 ∼ ∼
Rhode Island 56 54 ∼ ∼
Vermont 36 36 ∼ ∼
Middle Atlantic 2,319 2,070 198 82
New Jersey 527 465 52 ∼
New York 1,014 874 104 62
Pennsylvania 778 731 42 ∼
Midwest 3,493 3,272 193 46
East North Central 2,441 2,253 ∼ 36
Illinois 619 553 58 24
Indiana 355 337 17 ∼
Michigan 548 495 44 ∼
Ohio 620 574 44 ∼
Wisconsin 299 294 ∼ ∼
West North Central 1,052 1,019 26 ∼
Iowa 191 189 ∼ ∼
Kansas 149 142 ∼ ∼
Minnesota 238 236 ∼ ∼
Missouri 300 281 18 ∼
Nebraska 90 89 ∼ ∼
North Dakota 31 29 ∼ ∼
South Dakota 53 53 ∼ ∼
South 5,059 4,360 657 234
South Atlantic 2,800 2,390 384 90
Delaware 35 31 ∼ ∼
District of Columbia 30 ∼ 19 ∼
Florida 1,009 928 76 82
Georgia 355 280 72 ∼
Maryland 272 217 52 ∼
North Carolina 438 368 65 ∼
South Carolina 188 146 39 ∼
Virginia 344 286 52 ∼
West Virginia 129 123 ∼ ∼
East South Central 914 785 128 ∼
Alabama 250 202 47 ∼
Kentucky 222 212 ∼ ∼
Mississippi 136 92 44 ∼
Tennessee 306 279 27 ∼
West South Central 1,345 1,185 145 139
Arkansas 150 130 19 ∼
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Table E.21.2: Ovary. Cancer Death Counts by U.S. Census Region and Division, State, and Race and Ethnicity,
United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 190 148 41 ∼
Oklahoma 178 163 ∼ ∼
Texas 827 744 76 137
West 2,992 2,711 94 250
Mountain 861 829 ∼ 54
Arizona 246 236 ∼ 20
Colorado 210 204 ∼ ∼
Idaho 63 61 ∼ ∼
Montana 64 64 ∼ ∼
Nevada 99 90 ∼ ∼
New Mexico 71 67 ∼ ∼
Utah 74 74 ∼ ∼
Wyoming 34 33 ∼ ∼
Pacific 2,131 ∼ 80 196
Alaska 17 ∼ ∼ ∼
California 1,518 1,324 71 191
Hawaii 44 17 ∼ ∼
Oregon 211 209 ∼ ∼
Washington 341 319 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 3,334 2,929 310 125 3,669 3,181 403 138
New England 858 802 43 18 908 853 37 16
Connecticut 238 214 23 ∼ 217 191 22 ∼
Maine 91 91 ∼ ∼ 87 86 ∼ ∼
Massachusetts 373 346 16 ∼ 428 405 ∼ ∼
New Hampshire 60 60 ∼ - 70 70 ∼ -
Rhode Island 56 51 ∼ ∼ 78 73 ∼ ∼
Vermont 40 40 ∼ ∼ 28 28 ∼ ∼
Middle Atlantic 2,476 2,127 267 ∼ 2,761 2,328 366 ∼
New Jersey 501 432 53 29 569 471 83 35
New York 1,149 949 143 70 1,327 1,102 187 82
Pennsylvania 826 746 71 - 865 755 96 -
Midwest
East North Central 2,501 2,186 ∼ 43 2,622 2,230 350 45
Illinois 701 576 111 21 755 614 128 23
Indiana 336 303 30 ∼ 320 285 32 ∼
Michigan 568 488 71 ∼ 579 469 98 ∼
Detroit 269 213 53 - 272 193 74 -
Ohio 582 516 57 ∼ 628 545 74 ∼
Wisconsin 314 303 ∼ - 340 317 18 -
West North Central
Iowa 161 159 ∼ ∼ 175 166 ∼ ∼
Kansas 122 116 ∼ ∼ 149 134 ∼ ∼
Minnesota 211 192 ∼ ∼ 215 200 ∼ ∼
Missouri 314 284 29 ∼ 292 259 30 ∼
Nebraska 97 95 ∼ ∼ 90 87 ∼ ∼
North Dakota 32 32 ∼ ∼ 37 36 ∼ ∼
South Dakota
South
South Atlantic
Delaware 41 30 ∼ ∼ 31 28 ∼ ∼
District of Columbia 37 ∼ 25 ∼ 41 ∼ 29 ∼
Florida 1,123 1,013 92 - 1,015 901 100 -
Georgia 362 262 98 ∼ 392 275 112 ∼
Atlanta 108 74 33 ∼ 111 65 44 ∼
Maryland 276 212 59 ∼ 291 222 66 ∼
North Carolina 400 310 84 ∼ 361 271 84 ∼
South Carolina 205 145 59 - 232 147 85 -
Virginia
West Virginia 94 90 ∼ ∼ 89 87 ∼ ∼
East South Central
Alabama 225 173 52 ∼ 237 177 58 ∼
Kentucky 211 194 ∼ - 221 207 ∼ -
Mississippi
Tennessee
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Table E.22.1: Pancreas. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 282 194 86 ∼ 265 173 88 ∼
Oklahoma 184 165 ∼ ∼ 189 160 22 ∼
Texas 913 796 95 178 903 763 115 157
West
Mountain
Arizona 263 247 ∼ 29 251 230 ∼ 23
Colorado 205 197 ∼ 24 189 176 ∼ 24
Idaho 76 74 ∼ ∼ 70 68 ∼ ∼
Montana 40 38 ∼ ∼ 38 34 ∼ ∼
Nevada 124 113 ∼ ∼ 118 104 ∼ ∼
New Mexico 85 81 ∼ 37 83 78 ∼ 33
Utah 90 89 ∼ ∼ 71 70 ∼ ∼
Wyoming
Pacific 2,193 ∼ 112 241 2,340 ∼ 149 301
Alaska 28 22 ∼ ∼ 18 ∼ ∼ ∼
California 1,618 1,352 96 231 1,691 1,395 139 288
San Francisco-Oakland 204 155 17 17 237 165 31 17
San Jose-Monterey 97 80 ∼ 17 115 98 ∼ 22
Los Angeles 394 302 37 71 442 318 70 101
Hawaii 56 ∼ ∼ - 84 21 ∼ -
Oregon 171 163 ∼ ∼ 216 208 ∼ ∼
Washington 320 292 ∼ ∼ 331 299 ∼ ∼
Seattle-Puget Sound 218 196 ∼ ∼ 241 214 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 3,076 2,744 282 85 3,447 3,057 337 103
New England 824 775 41 ∼ 881 841 33 ∼
Connecticut 215 197 18 ∼ 219 200 18 ∼
Maine 82 80 ∼ ∼ 86 86 ∼ ∼
Massachusetts 380 352 22 ∼ 421 403 ∼ ∼
New Hampshire 63 62 ∼ ∼ 61 61 ∼ ∼
Rhode Island 54 54 ∼ ∼ 68 65 ∼ ∼
Vermont 30 30 ∼ ∼ 26 26 ∼ ∼
Middle Atlantic 2,252 1,969 241 ∼ 2,566 2,216 304 ∼
New Jersey 458 399 46 24 564 488 66 26
New York 1,018 858 135 42 1,170 983 157 58
Pennsylvania 776 712 60 ∼ 832 745 81 ∼
Midwest 3,520 3,178 320 45 3,680 3,271 369 30
East North Central 2,472 2,200 ∼ 33 2,613 2,269 ∼ 27
Illinois 673 574 91 ∼ 719 584 129 ∼
Indiana 329 302 27 ∼ 351 316 35 ∼
Michigan 546 479 64 ∼ 547 463 76 ∼
Ohio 608 540 67 ∼ 651 577 68 ∼
Wisconsin 316 305 ∼ ∼ 345 329 ∼ ∼
West North Central 1,048 978 61 ∼ 1,067 1,002 48 ∼
Iowa 170 168 ∼ ∼ 195 188 ∼ ∼
Kansas 138 131 ∼ ∼ 124 111 ∼ ∼
Minnesota 257 243 ∼ ∼ 270 265 ∼ ∼
Missouri 333 288 41 ∼ 300 266 29 ∼
Nebraska 81 79 ∼ ∼ 95 93 ∼ ∼
North Dakota 32 32 ∼ ∼ 34 33 ∼ ∼
South Dakota 37 37 ∼ ∼ 49 46 ∼ ∼
South 5,296 4,371 875 273 5,261 4,202 1,006 244
South Atlantic 2,864 2,330 513 118 2,814 2,229 553 92
Delaware 42 35 ∼ ∼ 37 33 ∼ ∼
District of Columbia 33 ∼ 24 ∼ 40 ∼ 28 ∼
Florida 1,060 962 92 96 967 876 78 82
Georgia 361 255 103 ∼ 370 264 102 ∼
Maryland 282 207 68 ∼ 267 190 73 ∼
North Carolina 434 340 94 ∼ 438 336 99 ∼
South Carolina 214 157 56 ∼ 243 166 76 ∼
Virginia 336 266 67 ∼ 346 251 89 ∼
West Virginia 102 99 ∼ ∼ 106 101 ∼ ∼
East South Central 943 763 178 ∼ 966 758 206 ∼
Alabama 261 206 55 ∼ 228 171 57 ∼
Kentucky 208 190 18 ∼ 228 211 17 ∼
Mississippi 155 94 60 ∼ 175 106 68 ∼
Tennessee 319 273 45 ∼ 335 270 64 ∼
West South Central 1,489 1,278 184 153 1,481 1,215 247 147
Arkansas 159 141 18 ∼ 157 131 24 ∼
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Table E.22.2: Pancreas. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race
and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 246 176 68 ∼ 269 175 90 ∼
Oklahoma 184 162 ∼ ∼ 170 155 ∼ ∼
Texas 900 799 86 149 885 754 120 142
West 2,984 2,628 139 264 2,999 2,580 165 319
Mountain 880 846 16 97 817 761 27 85
Arizona 247 234 ∼ 28 239 224 ∼ 24
Colorado 192 188 ∼ 23 199 185 ∼ 20
Idaho 64 64 ∼ ∼ 59 56 ∼ ∼
Montana 45 43 ∼ ∼ 44 42 ∼ ∼
Nevada 123 111 ∼ ∼ 104 89 ∼ ∼
New Mexico 86 85 ∼ 32 92 85 ∼ 28
Utah 98 97 ∼ ∼ 63 63 ∼ ∼
Wyoming 25 24 ∼ ∼ 17 17 ∼ ∼
Pacific 2,104 1,782 123 167 2,182 1,819 138 234
Alaska 23 17 ∼ ∼ 19 ∼ ∼ ∼
California 1,517 1,275 109 158 1,582 1,316 130 225
Hawaii 61 19 ∼ ∼ 74 ∼ ∼ ∼
Oregon 205 197 ∼ ∼ 199 191 ∼ ∼
Washington 298 274 ∼ ∼ 308 284 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 44,821 37,602 5,096 2,042
New England 11,481 10,627 546 293
Connecticut 2,891 2,572 251 112
Maine 1,090 1,078 ∼ ∼
Massachusetts 5,105 4,694 256 138
New Hampshire 1,008 945 ∼ -
Rhode Island 899 851 27 31
Vermont 488 487 ∼ ∼
Middle Atlantic 33,340 26,975 4,550 ∼
New Jersey 8,261 6,637 1,074 588
New York 14,121 10,835 2,361 1,021
Pennsylvania 10,958 9,503 1,115 -
Midwest
East North Central 32,848 26,882 3,958 ∼
Illinois 8,516 6,880 1,216 300
Indiana 3,537 3,175 282 40
Michigan 8,665 6,758 1,315 74
Detroit 3,910 2,692 1,058 -
Ohio 8,013 6,221 959 65
Wisconsin 4,117 3,848 186 -
West North Central
Iowa 2,225 2,123 24 ∼
Kansas 1,940 1,700 93 30
Minnesota 4,188 3,891 86 25
Missouri 3,400 2,999 363 25
Nebraska 1,188 1,080 35 23
North Dakota 579 564 ∼ ∼
South Dakota
South
South Atlantic
Delaware 721 575 134 ∼
District of Columbia 502 111 373 ∼
Florida 14,173 12,267 1,660 -
Georgia 5,357 3,685 1,582 68
Atlanta 1,792 1,131 620 34
Maryland 4,284 3,013 1,165 54
North Carolina 5,276 3,941 1,216 33
South Carolina 3,304 2,162 1,050 -
Virginia
West Virginia 1,412 1,361 47 ∼
East South Central
Alabama 2,910 2,066 805 ∼
Kentucky 2,809 2,458 239 -
Mississippi
Tennessee
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Table E.23.1: Prostate. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 3,494 2,428 1,031 63
Oklahoma 2,418 2,065 158 30
Texas 10,927 9,270 1,294 1,557
West
Mountain
Arizona 2,699 2,475 75 234
Colorado 2,701 2,392 93 204
Idaho 971 957 ∼ ∼
Montana 873 805 ∼ ∼
Nevada 1,625 1,439 96 102
New Mexico 1,228 1,175 26 348
Utah 1,431 1,412 ∼ 44
Wyoming
Pacific 29,792 24,099 2,074 3,094
Alaska 336 279 ∼ ∼
California 21,719 17,160 1,869 2,956
San Francisco-Oakland 2,940 2,102 323 232
San Jose-Monterey 1,491 1,208 55 169
Los Angeles 5,547 3,804 858 1,146
Hawaii 690 208 ∼ -
Oregon 2,523 2,374 27 44
Washington 4,524 4,078 153 91
Seattle-Puget Sound 3,046 2,778 144 31
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 6,183 5,249 890 196
New England 1,625 1,547 75 18
Connecticut 440 409 31 ∼
Maine 148 146 ∼ ∼
Massachusetts 724 687 35 ∼
New Hampshire 136 136 ∼ ∼
Rhode Island 115 107 ∼ ∼
Vermont 62 62 ∼ ∼
Middle Atlantic 4,558 3,702 815 ∼
New Jersey 878 717 154 48
New York 2,030 1,556 443 119
Pennsylvania 1,650 1,429 218 ∼
Midwest 7,175 6,237 904 63
East North Central 4,943 4,137 ∼ 57
Illinois 1,331 1,026 295 33
Indiana 630 551 79 ∼
Michigan 1,021 844 170 ∼
Ohio 1,301 1,075 223 ∼
Wisconsin 660 641 ∼ ∼
West North Central 2,232 2,100 122 ∼
Iowa 399 393 ∼ ∼
Kansas 312 286 25 ∼
Minnesota 602 591 ∼ ∼
Missouri 538 462 75 ∼
Nebraska 183 173 ∼ ∼
North Dakota 88 87 ∼ ∼
South Dakota 110 108 ∼ ∼
South 11,000 8,019 2,926 452
South Atlantic 6,146 4,387 1,731 216
Delaware 82 64 16 ∼
District of Columbia 102 ∼ 91 ∼
Florida 2,241 1,897 335 200
Georgia 750 442 308 ∼
Maryland 570 344 220 ∼
North Carolina 894 589 298 ∼
South Carolina 478 288 190 ∼
Virginia 816 551 263 ∼
West Virginia 213 203 ∼ ∼
East South Central 1,969 1,358 606 ∼
Alabama 568 355 211 ∼
Kentucky 411 364 46 ∼
Mississippi 395 180 214 ∼
Tennessee 595 459 135 ∼
West South Central 2,885 2,274 589 233
Arkansas 336 266 70 ∼
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Table E.23.2: Prostate. Cancer Death Counts by U.S. Census Region and Division, State, and Race and
Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 495 302 192 ∼
Oklahoma 350 297 38 ∼
Texas 1,704 1,409 289 227
West 6,088 5,413 425 498
Mountain 1,833 1,752 52 163
Arizona 542 518 17 58
Colorado 374 356 ∼ 31
Idaho 150 150 ∼ ∼
Montana 110 107 ∼ ∼
Nevada 215 192 17 ∼
New Mexico 200 189 ∼ 58
Utah 183 181 ∼ ∼
Wyoming 59 59 ∼ ∼
Pacific 4,255 3,661 373 335
Alaska 40 39 ∼ ∼
California 3,058 2,572 344 318
Hawaii 102 34 ∼ ∼
Oregon 436 425 ∼ ∼
Washington 619 591 17 ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 2,969 2,448 346 211 ∼ ∼ 281 163
New England 695 637 47 27 ∼ ∼ 26 20
Connecticut 205 176 26 ∼ 114 101 ∼ ∼
Maine 64 62 ∼ ∼ 27 27 ∼ ∼
Massachusetts 298 275 17 16 219 196 ∼ ∼
New Hampshire 41 41 ∼ - 16 16 ∼ -
Rhode Island 58 55 ∼ ∼ 42 39 ∼ ∼
Vermont 29 28 ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 2,274 1,811 299 ∼ 1,477 1,117 255 ∼
New Jersey 535 427 67 56 295 233 42 35
New York 1,059 801 155 109 750 524 153 97
Pennsylvania 680 583 77 - 432 360 60 -
Midwest
East North Central 1,883 1,546 ∼ 57 1,199 918 ∼ 45
Illinois 592 464 98 40 380 284 70 34
Indiana 211 181 26 ∼ 123 103 16 ∼
Michigan 430 345 73 ∼ 268 186 73 ∼
Detroit 214 162 50 - 144 82 61 -
Ohio 425 345 66 ∼ 289 222 56 ∼
Wisconsin 225 211 ∼ - 139 123 ∼ -
West North Central
Iowa 109 103 ∼ ∼ 68 67 ∼ ∼
Kansas 93 83 ∼ ∼ 54 50 ∼ ∼
Minnesota 183 169 ∼ ∼ 108 100 ∼ ∼
Missouri 218 172 39 ∼ 132 109 21 ∼
Nebraska 59 57 ∼ ∼ 37 34 ∼ ∼
North Dakota 28 27 ∼ ∼ ∼ ∼ ∼ ∼
South Dakota
South
South Atlantic
Delaware 30 20 ∼ ∼ 29 19 ∼ ∼
District of Columbia 30 ∼ 23 ∼ 27 ∼ 22 ∼
Florida 915 784 120 - 527 416 96 -
Georgia 272 170 97 ∼ 204 119 76 ∼
Atlanta 77 38 35 ∼ 73 35 33 ∼
Maryland 176 109 49 ∼ 124 78 34 ∼
North Carolina 255 188 61 ∼ 188 126 56 ∼
South Carolina 172 85 82 - 119 66 51 -
Virginia
West Virginia 79 74 ∼ ∼ 46 44 ∼ ∼
East South Central
Alabama 186 113 71 ∼ 129 96 31 ∼
Kentucky 162 148 ∼ - 83 74 ∼ -
Mississippi
Tennessee
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Table E.24.1: Stomach. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 203 120 80 ∼ 169 81 84 ∼
Oklahoma 124 108 ∼ ∼ 76 59 ∼ ∼
Texas 785 653 101 251 470 373 78 164
West
Mountain
Arizona 209 191 ∼ 47 99 91 ∼ 21
Colorado 107 98 ∼ 17 93 79 ∼ 25
Idaho 44 41 ∼ ∼ 31 29 ∼ ∼
Montana 42 39 ∼ ∼ 29 29 ∼ ∼
Nevada 78 62 ∼ ∼ 40 35 ∼ ∼
New Mexico 78 67 ∼ 31 45 35 ∼ 26
Utah 56 54 ∼ ∼ 35 34 ∼ ∼
Wyoming
Pacific 2,051 ∼ 125 353 ∼ 907 96 289
Alaska 21 ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 1,551 1,133 116 337 1,000 720 86 274
San Francisco-Oakland 229 133 21 22 132 68 20 17
San Jose-Monterey 118 84 ∼ 27 79 57 ∼ 17
Los Angeles 467 307 55 141 360 244 35 127
Hawaii 108 16 ∼ - 70 ∼ ∼ -
Oregon 128 118 ∼ ∼ 80 66 ∼ ∼
Washington 243 211 ∼ ∼ 145 113 ∼ ∼
Seattle-Puget Sound 164 141 ∼ ∼ 109 82 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast ∼ ∼ 221 102 1,203 974 188 73
New England ∼ ∼ 31 ∼ 330 298 22 ∼
Connecticut 118 99 16 ∼ 82 67 ∼ ∼
Maine 39 39 ∼ ∼ 27 27 ∼ ∼
Massachusetts 185 166 ∼ ∼ 166 153 ∼ ∼
New Hampshire 33 32 ∼ ∼ ∼ ∼ ∼ ∼
Rhode Island 39 38 ∼ ∼ 32 28 ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,188 940 190 ∼ 873 676 166 67
New Jersey 278 217 51 25 189 154 32 ∼
New York 561 419 100 55 434 316 91 52
Pennsylvania 349 304 39 ∼ 250 206 43 ∼
Midwest 1,433 1,186 209 35 1,028 818 183 26
East North Central 1,045 848 174 28 739 571 156 25
Illinois 321 254 55 20 223 160 55 16
Indiana 116 101 ∼ ∼ 84 71 ∼ ∼
Michigan 244 190 49 ∼ 157 112 43 ∼
Ohio 271 219 50 ∼ 202 159 41 ∼
Wisconsin 93 84 ∼ ∼ 73 69 ∼ ∼
West North Central 388 338 35 ∼ 289 247 27 ∼
Iowa 66 64 ∼ ∼ 45 44 ∼ ∼
Kansas 47 37 ∼ ∼ 37 34 ∼ ∼
Minnesota 95 86 ∼ ∼ 76 67 ∼ ∼
Missouri 117 93 21 ∼ 94 70 21 ∼
Nebraska 25 25 ∼ ∼ ∼ ∼ ∼ ∼
North Dakota 18 16 ∼ ∼ ∼ ∼ ∼ ∼
South Dakota 20 17 ∼ ∼ ∼ ∼ ∼ ∼
South 2,528 1,821 660 243 1,735 1,179 500 179
South Atlantic 1,352 940 389 82 915 610 280 55
Delaware 17 ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 29 ∼ 24 ∼ 19 ∼ 16 ∼
Florida 502 419 79 67 323 256 61 48
Georgia 166 93 69 ∼ 123 68 53 ∼
Maryland 120 73 41 ∼ 86 52 29 ∼
North Carolina 181 125 55 ∼ 125 82 38 ∼
South Carolina 107 61 45 ∼ 81 42 39 ∼
Virginia 173 101 66 ∼ 114 71 37 ∼
West Virginia 57 55 ∼ ∼ 29 27 ∼ ∼
East South Central 412 300 110 ∼ 294 202 87 ∼
Alabama 104 66 38 ∼ 90 60 29 ∼
Kentucky 104 92 ∼ ∼ 53 45 ∼ ∼
Mississippi 73 42 30 ∼ 51 27 23 ∼
Tennessee 131 100 30 ∼ 100 70 28 ∼
West South Central 764 581 161 161 526 367 133 122
Arkansas 78 58 20 ∼ 37 20 ∼ ∼
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Table E.24.2: Stomach. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race and
Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 122 62 57 ∼ 91 37 52 ∼
Oklahoma 84 66 ∼ ∼ 43 35 ∼ ∼
Texas 480 395 71 157 355 275 66 121
West 1,562 1,213 104 291 1,099 806 66 236
Mountain 375 340 ∼ 80 222 192 ∼ 52
Arizona 132 120 ∼ 34 67 54 ∼ 16
Colorado 63 52 ∼ ∼ 48 43 ∼ ∼
Idaho 20 19 ∼ ∼ ∼ ∼ ∼ ∼
Montana 27 26 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 43 38 ∼ ∼ 28 26 ∼ ∼
New Mexico 54 49 ∼ 24 31 23 ∼ ∼
Utah 27 27 ∼ ∼ 21 20 ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 873 91 211 ∼ 614 59 184
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 916 676 83 203 683 495 54 175
Hawaii 45 ∼ ∼ ∼ 53 ∼ ∼ ∼
Oregon 79 74 ∼ ∼ 50 42 ∼ ∼
Washington 132 107 ∼ ∼ 81 68 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Table E.25.1: Testis. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 1,523 ∼ 53 105
New England 438 ∼ ∼ ∼
Connecticut 101 96 ∼ ∼
Maine 38 38 ∼ ∼
Massachusetts 220 213 ∼ ∼
New Hampshire 35 34 ∼ -
Rhode Island 26 26 ∼ ∼
Vermont 18 ∼ ∼ ∼
Middle Atlantic 1,085 992 44 ∼
New Jersey 256 238 ∼ 37
New York 458 404 19 49
Pennsylvania 371 350 ∼ -
Midwest
East North Central 1,196 1,119 40 61
Illinois 320 291 ∼ 36
Indiana 148 146 ∼ ∼
Michigan 261 248 ∼ ∼
Detroit 104 96 ∼ -
Ohio 286 258 ∼ ∼
Wisconsin 181 176 ∼ -
West North Central
Iowa 85 80 ∼ ∼
Kansas 55 48 ∼ ∼
Minnesota 181 169 ∼ ∼
Missouri 137 132 ∼ ∼
Nebraska 43 41 ∼ ∼
North Dakota 17 17 ∼ ∼
South Dakota
South
South Atlantic
Delaware 17 16 ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 363 341 ∼ -
Georgia 179 159 17 ∼
Atlanta 66 57 ∼ ∼
Maryland 122 112 ∼ ∼
North Carolina 167 152 ∼ ∼
South Carolina 66 60 ∼ -
Virginia
West Virginia 38 38 ∼ ∼
East South Central
Alabama 90 79 ∼ ∼
Kentucky 106 101 ∼ -
Mississippi
Tennessee
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Table E.25.1: Testis. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 94 84 ∼ ∼
Oklahoma 76 68 ∼ ∼
Texas 510 471 20 159
West
Mountain
Arizona 128 118 ∼ 26
Colorado 135 130 ∼ 20
Idaho 35 33 ∼ ∼
Montana 29 27 ∼ ∼
Nevada 43 40 ∼ ∼
New Mexico 56 52 ∼ 21
Utah 90 90 ∼ ∼
Wyoming
Pacific 1,262 ∼ 18 271
Alaska 26 21 ∼ ∼
California 887 826 ∼ 252
San Francisco-Oakland 116 107 ∼ 19
San Jose-Monterey 56 52 ∼ 16
Los Angeles 205 188 ∼ 73
Hawaii 25 ∼ ∼ -
Oregon 126 117 ∼ ∼
Washington 198 180 ∼ ∼
Seattle-Puget Sound 142 135 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 75 70 ∼ ∼
New England 26 26 ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 49 44 ∼ ∼
New Jersey ∼ ∼ ∼ ∼
New York 29 24 ∼ ∼
Pennsylvania ∼ ∼ ∼ ∼
Midwest 85 79 ∼ ∼
East North Central 59 55 ∼ ∼
Illinois ∼ ∼ ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan ∼ ∼ ∼ ∼
Ohio 18 17 ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 26 24 ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 125 108 17 24
South Atlantic 62 50 ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 22 20 ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central ∼ ∼ ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 49 46 ∼ 18
Arkansas ∼ ∼ ∼ ∼
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Table E.25.2: Testis. Cancer Death Counts by U.S. Census Region and Division, State, and Race and Ethnicity,
United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 34 33 ∼ 17
West 108 100 ∼ 28
Mountain 32 31 ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 76 69 ∼ 17
Alaska ∼ ∼ ∼ ∼
California 55 50 ∼ 16
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Table E.26.1: Thyroid. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast ∼ ∼ 61 66 4,371 3,724 293 283
New England ∼ ∼ ∼ ∼ 1,081 994 31 55
Connecticut 76 68 ∼ ∼ 259 235 ∼ 24
Maine 28 27 ∼ ∼ 105 102 ∼ ∼
Massachusetts 165 155 ∼ ∼ 518 470 ∼ 21
New Hampshire 21 21 ∼ - 70 67 ∼ -
Rhode Island 46 43 ∼ ∼ 90 82 ∼ ∼
Vermont ∼ ∼ ∼ ∼ 39 38 ∼ ∼
Middle Atlantic 1,076 935 57 ∼ 3,290 2,730 262 ∼
New Jersey 240 206 ∼ 17 715 609 52 71
New York 462 389 28 32 1,357 1,046 121 133
Pennsylvania 374 340 ∼ - 1,218 1,075 89 -
Midwest
East North Central 838 748 46 20 2,581 2,296 ∼ 104
Illinois 253 224 ∼ 16 845 736 71 57
Indiana 111 105 ∼ ∼ 336 312 19 ∼
Michigan 173 149 16 ∼ 563 486 48 ∼
Detroit 84 68 ∼ - 248 205 34 -
Ohio 189 161 ∼ ∼ 545 479 36 ∼
Wisconsin 112 109 ∼ - 292 283 ∼ -
West North Central
Iowa 79 75 ∼ ∼ 199 191 ∼ ∼
Kansas 59 54 ∼ ∼ 178 165 ∼ ∼
Minnesota 110 102 ∼ ∼ 272 246 ∼ ∼
Missouri 133 128 ∼ ∼ 335 307 22 ∼
Nebraska 37 34 ∼ ∼ 125 121 ∼ ∼
North Dakota ∼ ∼ ∼ ∼ 40 38 ∼ ∼
South Dakota
South
South Atlantic
Delaware 20 16 ∼ ∼ 70 57 ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ 46 18 22 ∼
Florida 329 310 ∼ - 1,018 901 81 -
Georgia 132 112 ∼ ∼ 456 346 94 19
Atlanta 50 38 ∼ ∼ 200 146 44 ∼
Maryland 120 100 ∼ ∼ 384 275 86 20
North Carolina 96 78 ∼ ∼ 309 246 51 ∼
South Carolina 70 57 ∼ - 182 143 34 -
Virginia
West Virginia 36 35 ∼ ∼ 128 125 ∼ ∼
East South Central
Alabama 79 69 ∼ ∼ 204 155 46 ∼
Kentucky 64 64 ∼ - 230 211 ∼ -
Mississippi
Tennessee
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Table E.26.1: Thyroid. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 73 69 ∼ ∼ 256 215 39 ∼
Oklahoma 54 52 ∼ ∼ 153 130 ∼ ∼
Texas 382 329 29 79 1,208 1,060 73 330
West
Mountain
Arizona 119 113 ∼ 19 302 279 ∼ 60
Colorado 108 101 ∼ ∼ 292 266 ∼ 47
Idaho 28 28 ∼ ∼ 89 88 ∼ ∼
Montana 22 20 ∼ ∼ 79 78 ∼ ∼
Nevada 52 44 ∼ ∼ 165 138 ∼ 24
New Mexico 64 60 ∼ 22 159 143 ∼ 43
Utah 57 56 ∼ ∼ 176 170 ∼ ∼
Wyoming
Pacific ∼ 695 19 117 2,683 2,097 81 540
Alaska ∼ ∼ ∼ ∼ 38 23 ∼ ∼
California 613 512 16 107 1,932 1,544 65 504
San Francisco-Oakland 83 60 ∼ ∼ 230 140 ∼ 41
San Jose-Monterey 40 27 ∼ ∼ 128 105 ∼ 34
Los Angeles 176 140 ∼ 43 569 432 32 181
Hawaii 30 ∼ ∼ - 98 20 ∼ -
Oregon 60 56 ∼ ∼ 191 163 ∼ 17
Washington 125 108 ∼ ∼ 424 347 ∼ 17
Seattle-Puget Sound 90 81 ∼ ∼ 276 241 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Invasive cancers only.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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Table E.26.2: Thyroid. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race and
Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 107 96 ∼ ∼ 157 138 ∼ ∼
New England 33 31 ∼ ∼ 33 28 ∼ ∼
Connecticut ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼ 17 ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 74 ∼ ∼ ∼ 124 110 ∼ ∼
New Jersey 17 ∼ ∼ ∼ 20 18 ∼ ∼
New York 35 31 ∼ ∼ 59 52 ∼ ∼
Pennsylvania 22 20 ∼ ∼ 45 40 ∼ ∼
Midwest 134 124 ∼ ∼ 191 176 ∼ ∼
East North Central 106 99 ∼ ∼ 127 ∼ ∼ ∼
Illinois 27 26 ∼ ∼ 35 31 ∼ ∼
Indiana ∼ ∼ ∼ ∼ 16 16 ∼ ∼
Michigan 27 24 ∼ ∼ 35 31 ∼ ∼
Ohio 29 27 ∼ ∼ 24 23 ∼ ∼
Wisconsin ∼ ∼ ∼ ∼ 17 ∼ ∼ ∼
West North Central 28 25 ∼ ∼ 64 60 ∼ ∼
Iowa ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼ 20 17 ∼ ∼
Nebraska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
South 196 177 18 19 277 233 41 16
South Atlantic 82 74 ∼ ∼ 144 123 19 ∼
Delaware ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 30 28 ∼ ∼ 59 54 ∼ ∼
Georgia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼ 19 ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼ 19 17 ∼ ∼
West Virginia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
East South Central 34 30 ∼ ∼ 51 40 ∼ ∼
Alabama ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼ 20 17 ∼ ∼
West South Central 80 73 ∼ ∼ 82 70 ∼ ∼
Arkansas ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
continued
A
ppendix E
E–101
Table E.26.2: Thyroid. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and Race and
Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana ∼ ∼ ∼ ∼ 19 ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Texas 53 49 ∼ ∼ 49 44 ∼ ∼
West 121 106 ∼ 20 184 150 ∼ 30
Mountain 33 32 ∼ ∼ 56 51 ∼ ∼
Arizona ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific 88 74 ∼ ∼ 128 99 ∼ 21
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 70 59 ∼ ∼ 95 72 ∼ 21
Hawaii ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼ 18 16 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Table E.27.1: Urinary Bladder. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
Northeast 10,475 9,941 299 241 3,936 3,644 223 109
New England 2,890 2,804 37 47 1,110 1,079 20 ∼
Connecticut 660 630 ∼ 16 259 246 ∼ ∼
Maine 295 291 ∼ ∼ 106 105 ∼ ∼
Massachusetts 1,328 1,290 20 18 506 490 ∼ ∼
New Hampshire 266 260 ∼ - 100 99 ∼ -
Rhode Island 242 234 ∼ ∼ 92 92 ∼ ∼
Vermont 99 99 ∼ ∼ 47 47 ∼ ∼
Middle Atlantic 7,585 7,137 262 ∼ 2,826 2,565 203 ∼
New Jersey 1,610 1,507 53 65 635 564 58 32
New York 3,286 3,051 129 103 1,248 1,114 96 53
Pennsylvania 2,689 2,579 80 - 943 887 49 -
Midwest
East North Central 7,450 6,933 ∼ 92 2,601 2,353 178 28
Illinois 2,085 1,939 92 48 713 617 76 17
Indiana 874 818 30 ∼ 312 293 ∼ ∼
Michigan 1,704 1,560 97 16 548 490 46 ∼
Detroit 713 644 60 - 244 209 34 -
Ohio 1,924 1,771 71 16 728 658 40 ∼
Wisconsin 863 845 ∼ - 300 295 ∼ -
West North Central
Iowa 534 522 ∼ ∼ 203 199 ∼ ∼
Kansas 422 401 ∼ ∼ 121 115 ∼ ∼
Minnesota 824 795 ∼ ∼ 295 286 ∼ ∼
Missouri 897 856 31 ∼ 326 300 23 ∼
Nebraska 278 267 ∼ ∼ 99 97 ∼ ∼
North Dakota 117 117 ∼ ∼ 38 38 ∼ ∼
South Dakota
South
South Atlantic
Delaware 144 129 ∼ ∼ 43 39 ∼ ∼
District of Columbia 55 29 25 ∼ 24 ∼ 17 ∼
Florida 3,640 3,477 108 - 1,203 1,134 55 -
Georgia 929 820 96 ∼ 313 246 64 ∼
Atlanta 226 185 33 ∼ 95 62 29 ∼
Maryland 737 646 80 ∼ 236 184 49 ∼
North Carolina 1,056 975 73 ∼ 381 325 53 ∼
South Carolina 520 455 59 - 171 133 36 -
Virginia
West Virginia 365 358 ∼ ∼ 162 160 ∼ ∼
East South Central
Alabama 598 539 56 ∼ 211 180 30 ∼
Kentucky 657 630 21 - 217 203 ∼ -
Mississippi
Tennessee
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Table E.27.1: Urinary Bladder. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race and Ethnicity, United States,∗† 2002 (continued)
Male Female
Area All Races White Black Hispanic‡§ All Races White Black Hispanic‡§
West South Central
Arkansas
Louisiana 579 507 67 ∼ 200 150 47 ∼
Oklahoma 479 446 ∼ ∼ 163 145 ∼ ∼
Texas 2,130 1,973 115 215 678 598 61 71
West
Mountain
Arizona 880 854 ∼ 29 270 262 ∼ 19
Colorado 549 533 ∼ 29 195 185 ∼ ∼
Idaho 218 214 ∼ ∼ 51 51 ∼ ∼
Montana 186 178 ∼ ∼ 56 52 ∼ ∼
Nevada 367 349 ∼ ∼ 121 113 ∼ ∼
New Mexico 220 218 ∼ 39 63 63 ∼ ∼
Utah 199 197 ∼ ∼ 60 60 ∼ ∼
Wyoming
Pacific 6,231 5,577 165 367 ∼ 1,826 86 150
Alaska 61 60 ∼ ∼ ∼ ∼ ∼ ∼
California 4,355 3,894 148 353 1,438 1,279 78 141
San Francisco-Oakland 518 423 24 35 228 193 21 23
San Jose-Monterey 266 224 ∼ 30 90 89 ∼ ∼
Los Angeles 1,044 871 74 121 351 288 37 52
Hawaii 160 64 ∼ - 28 ∼ ∼ -
Oregon 644 606 ∼ ∼ 211 204 ∼ ∼
Washington 1,011 953 ∼ ∼ 345 328 ∼ ∼
Seattle-Puget Sound 711 678 ∼ ∼ 252 238 ∼ ∼
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix I for data quality criteria and registry-specific data quality information.
† Includes invasive and in situ.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
- Counts are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
division is suppressed due to a count of less than 16. Michigan, Georgia, California, and Washington state counts each include cases from the SEER
metropolitan areas.
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Table E.27.2: Urinary Bladder. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and
Race and Ethnicity, United States,∗ 2002
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Northeast 1,877 1,779 78 51 ∼ ∼ 85 21
New England 529 507 16 ∼ ∼ ∼ ∼ ∼
Connecticut 142 135 ∼ ∼ 55 51 ∼ ∼
Maine 52 52 ∼ ∼ 24 24 ∼ ∼
Massachusetts 217 205 ∼ ∼ 144 142 ∼ ∼
New Hampshire 47 46 ∼ ∼ 17 17 ∼ ∼
Rhode Island 42 40 ∼ ∼ 22 22 ∼ ∼
Vermont 29 29 ∼ ∼ ∼ ∼ ∼ ∼
Middle Atlantic 1,348 1,272 ∼ 39 735 651 79 18
New Jersey 287 273 ∼ ∼ 158 138 19 ∼
New York 589 545 31 24 318 278 36 ∼
Pennsylvania 472 454 17 ∼ 259 235 24 ∼
Midwest 2,027 1,938 82 ∼ 966 878 85 ∼
East North Central 1,402 1,329 70 ∼ 687 612 74 ∼
Illinois 342 322 19 ∼ 169 141 28 ∼
Indiana 156 153 ∼ ∼ 98 93 ∼ ∼
Michigan 307 282 23 ∼ 142 115 26 ∼
Ohio 406 386 20 ∼ 200 186 ∼ ∼
Wisconsin 191 186 ∼ ∼ 78 77 ∼ ∼
West North Central 625 609 ∼ ∼ 279 266 ∼ ∼
Iowa 98 98 ∼ ∼ 46 45 ∼ ∼
Kansas 93 91 ∼ ∼ 42 39 ∼ ∼
Minnesota 165 164 ∼ ∼ 77 73 ∼ ∼
Missouri 169 157 ∼ ∼ 74 69 ∼ ∼
Nebraska 52 52 ∼ ∼ 23 23 ∼ ∼
North Dakota 22 22 ∼ ∼ ∼ ∼ ∼ ∼
South Dakota 26 25 ∼ ∼ ∼ ∼ ∼ ∼
South 2,911 2,615 277 104 1,392 1,120 257 51
South Atlantic 1,664 1,490 165 64 825 656 162 29
Delaware 33 31 ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Florida 704 669 32 61 312 285 25 22
Georgia 158 131 27 ∼ 112 76 35 ∼
Maryland 161 131 29 ∼ 81 55 26 ∼
North Carolina 220 197 22 ∼ 111 81 27 ∼
South Carolina 115 97 17 ∼ 54 41 ∼ ∼
Virginia 189 163 23 ∼ 89 66 23 ∼
West Virginia 69 68 ∼ ∼ 37 36 ∼ ∼
East South Central 486 437 48 ∼ 225 188 36 ∼
Alabama 122 108 ∼ ∼ 43 36 ∼ ∼
Kentucky 124 118 ∼ ∼ 61 55 ∼ ∼
Mississippi 79 67 ∼ ∼ 35 25 ∼ ∼
Tennessee 161 144 17 ∼ 86 72 ∼ ∼
West South Central 761 688 64 40 342 276 59 22
Arkansas 92 84 ∼ ∼ 40 31 ∼ ∼
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Table E.27.2: Urinary Bladder. Cancer Death Counts by U.S. Census Region and Division, State, Sex, and
Race and Ethnicity, United States,∗ 2002 (continued)
Male Female
Area All Races White Black Hispanic†‡ All Races White Black Hispanic†‡
Louisiana 95 80 ∼ ∼ 50 35 ∼ ∼
Oklahoma 116 110 ∼ ∼ 53 44 ∼ ∼
Texas 458 414 39 38 199 166 31 20
West 1,688 1,575 44 86 756 686 32 57
Mountain 499 486 ∼ 20 192 186 ∼ 16
Arizona 156 152 ∼ ∼ 57 54 ∼ ∼
Colorado 103 102 ∼ ∼ 45 45 ∼ ∼
Idaho 40 39 ∼ ∼ 17 17 ∼ ∼
Montana 28 27 ∼ ∼ ∼ ∼ ∼ ∼
Nevada 69 66 ∼ ∼ 26 24 ∼ ∼
New Mexico 47 46 ∼ ∼ 22 21 ∼ ∼
Utah 42 41 ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Pacific 1,189 1,089 36 66 564 500 31 41
Alaska ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
California 868 792 33 66 415 367 29 41
Hawaii ∼ ∼ ∼ ∼ ∼ ∼ ∼ ∼
Oregon 135 134 ∼ ∼ 67 65 ∼ ∼
Washington 161 152 ∼ ∼ 67 64 ∼ ∼
∗ Data are from the National Vital Statistics System (NVSS).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Counts are suppressed if fewer than 16 cases were reported in a specific category (area, sex, race, ethnicity).
Notes: Region/division counts are suppressed if the count for exactly one state in the region or division is suppressed due to a count of less than 16.
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Table F.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Confidence Intervals for Asian/Pacific
Islanders† by State and Metropolitan Area, Primary Site, and Sex, United States, 2002
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
United States
Prostate 84.0 (81.0- 87.2) 10.3 ( 9.1-11.6)
Breast ∼ 79.8 ( 77.4- 82.2) ∼ 12.9 (11.9-13.9)
Lung & Bronchus 48.7 (46.3- 51.1) 26.7 ( 25.2- 28.2) 36.6 (34.6-38.8) 17.6 (16.4-18.9)
Colon & Rectum 46.6 (44.4- 49.0) 34.3 ( 32.6- 36.1) 15.9 (14.5-17.3) 10.1 ( 9.2-11.1)
Liver & IBD 20.3 (18.9- 21.8) 7.4 ( 6.7- 8.3) 15.9 (14.6-17.2) 6.1 ( 5.4- 6.9)
Stomach 18.1 (16.7- 19.6) 10.0 ( 9.1- 11.0) 9.8 ( 8.8-11.0) 6.4 ( 5.7- 7.2)
Urinary Bladder 15.4 (14.1- 16.9) ∼ 3.1 ( 2.5- 3.8) ∼
Corpus & Uterus, NOS 14.5 ( 13.5- 15.5) 2.6 ( 2.1- 3.1)
Non-Hodgkin Lymphoma 14.4 (13.1- 15.7) 9.8 ( 9.0- 10.8) 5.3 ( 4.5- 6.1) 3.8 ( 3.3- 4.5)
Thyroid ∼ 12.4 ( 11.6- 13.4) ∼ ∼
Oral Cavity & Pharynx 10.7 ( 9.8- 11.8) ∼ 3.2 ( 2.7- 3.9) ∼
Ovary 9.5 ( 8.7- 10.4) 5.1 ( 4.5- 5.7)
Pancreas 8.9 ( 7.9- 9.9) ∼ 7.8 ( 6.9- 8.8) 7.2 ( 6.4- 8.0)
Leukemias 7.7 ( 6.9- 8.6) ∼ 5.2 ( 4.5- 6.0) 3.1 ( 2.6- 3.6)
Cervix Uteri 7.7 ( 7.0- 8.5) ∼
Arizona
Prostate 57.3 (32.8- 99.0) ∼
Breast ∼ 45.7 ( 29.5- 72.7) ∼ ∼
California
Prostate 92.8 (87.9- 97.9) 10.4 ( 8.7-12.5)
Breast ∼ 89.7 ( 85.8- 93.8) ∼ 14.5 (12.9-16.2)
Lung & Bronchus 50.9 (47.2- 54.8) 26.6 ( 24.3- 29.0) 39.9 (36.6-43.4) 19.4 (17.5-21.5)
Colon & Rectum 49.7 (46.2- 53.5) 36.3 ( 33.7- 39.1) 17.0 (14.9-19.4) 11.1 ( 9.6-12.7)
Liver & IBD 22.8 (20.5- 25.3) 9.2 ( 7.9- 10.6) 17.5 (15.5-19.8) 7.1 ( 6.0- 8.4)
Stomach 19.6 (17.3- 22.1) 9.4 ( 8.1- 10.9) 11.1 ( 9.3-13.1) 6.8 ( 5.6- 8.1)
Urinary Bladder 16.5 (14.4- 18.9) ∼ 3.2 ( 2.3- 4.4) ∼
Non-Hodgkin Lymphoma 16.1 (14.1- 18.3) 10.6 ( 9.2- 12.1) 6.5 ( 5.2- 8.0) 4.4 ( 3.5- 5.5)
Corpus & Uterus, NOS 15.3 ( 13.7- 17.1) ∼
Thyroid ∼ 12.6 ( 11.2- 14.2) ∼ ∼
Oral Cavity & Pharynx 11.7 (10.1- 13.5) ∼ 3.6 ( 2.7- 4.7) ∼
Ovary 10.4 ( 9.1- 11.9) 5.4 ( 4.5- 6.6)
Pancreas 10.1 ( 8.5- 11.9) ∼ 8.8 ( 7.3-10.5) 6.8 ( 5.6- 8.1)
Leukemias 8.2 ( 6.8- 9.7) ∼ 5.4 ( 4.3- 6.7) 2.7 ( 2.0- 3.6)
Cervix Uteri 7.9 ( 6.8- 9.2) 2.4 ( 1.8- 3.2)
Los Angeles
Breast ∼ 94.9 ( 87.9-102.4)
Prostate 90.1 (81.9- 99.0)
Colon & Rectum 55.8 (49.4- 62.9) 42.4 ( 37.6- 47.8)
Lung & Bronchus 52.3 (46.1- 59.3) 25.3 ( 21.5- 29.5)
Liver & IBD 23.4 (19.5- 28.1) 11.6 ( 9.1- 14.6)
Stomach 21.2 (17.2- 25.9) 12.3 ( 9.7- 15.4)
Urinary Bladder 18.8 (15.0- 23.4) ∼
Non-Hodgkin Lymphoma 18.1 (14.6- 22.3) 9.3 ( 7.1- 12.0)
Corpus & Uterus, NOS 16.7 ( 13.9- 20.0)
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Table F.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Confidence Intervals for Asian/Pacific
Islanders† by State and Metropolitan Area, Primary Site, and Sex, United States, 2002 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Thyroid ∼ 13.9 ( 11.3- 16.9)
Oral Cavity & Pharynx 11.4 ( 8.8- 14.7) ∼
Ovary 11.1 ( 8.7- 13.9)
Pancreas 10.6 ( 7.9- 14.1) ∼
Cervix Uteri 10.2 ( 8.0- 12.9)
Leukemias 7.0 ( 4.9- 9.9) ∼
San Francisco-Oakland
Prostate 104.3 (93.8-115.7)
Breast ∼ 93.7 ( 85.4-102.7)
Lung & Bronchus 56.5 (48.7- 65.3) 31.1 ( 26.3- 36.7)
Colon & Rectum 53.2 (45.8- 61.6) 41.0 ( 35.4- 47.3)
Liver & IBD 23.4 (18.8- 29.2) 7.3 ( 5.1- 10.2)
Stomach 21.5 (16.8- 27.4) 9.0 ( 6.5- 12.3)
Corpus & Uterus, NOS 19.9 ( 16.1- 24.3)
Urinary Bladder 18.0 (13.6- 23.4) ∼
Non-Hodgkin Lymphoma 15.4 (11.4- 20.4) 13.9 ( 10.7- 17.8)
Thyroid ∼ 14.0 ( 10.9- 17.7)
Oral Cavity & Pharynx 13.7 (10.3- 18.3) ∼
Ovary 12.6 ( 9.6- 16.2)
Leukemias 7.9 ( 5.3- 11.6) ∼
Pancreas 7.9 ( 5.3- 11.6) 7.7 ( 5.4- 10.6)
San Jose-Monterey
Prostate 96.7 (82.1-113.8)
Breast ∼ 79.9 ( 69.0- 92.5)
Colon & Rectum 50.9 (40.7- 63.5) 32.3 ( 25.1- 41.3)
Lung & Bronchus 47.5 (36.9- 60.8) 24.8 ( 18.4- 33.2)
Liver & IBD 22.7 (16.2- 31.8) 8.3 ( 4.8- 13.8)
Stomach 20.0 (13.3- 29.4) 9.6 ( 5.8- 15.3)
Urinary Bladder 19.1 (12.4- 28.6) ∼
Non-Hodgkin Lymphoma 12.4 ( 7.9- 19.5) 13.3 ( 8.9- 19.5)
Oral Cavity & Pharynx 12.5 ( 7.6- 20.0) 8.1 ( 4.7- 13.3)
Ovary 11.8 ( 7.9- 17.5)
Pancreas 10.5 ( 5.9- 18.0) ∼
Leukemias 8.2 ( 4.7- 14.3) ∼
Corpus & Uterus, NOS 8.1 ( 4.8- 13.4)
Thyroid ∼ 7.5 ( 4.5- 12.3)
Colorado
Breast ∼ 67.7 ( 46.0-100.4) ∼ ∼
Prostate 60.7 (34.1-109.7) ∼
Connecticut
Breast ∼ 85.8 ( 55.3-133.5) ∼ ∼
Prostate 63.1 (34.5-122.2) ∼
Florida
Prostate 76.3 (58.3- 99.8) ∼
Breast ∼ 62.2 ( 50.4- 77.4) ∼ ∼
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Table F.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Confidence Intervals for Asian/Pacific
Islanders† by State and Metropolitan Area, Primary Site, and Sex, United States, 2002 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Colon & Rectum 26.0 (16.7- 41.0) 26.0 ( 17.4- 38.5) ∼ ∼
Lung & Bronchus 25.5 (15.0- 42.3) 26.0 ( 17.5- 38.4) 27.9 (16.2-46.1) ∼
Thyroid ∼ 11.5 ( 6.9- 19.9) ∼ ∼
Cervix Uteri 9.8 ( 5.6- 18.0) ∼
Corpus & Uterus, NOS 9.5 ( 5.6- 17.4) ∼
Georgia
Breast ∼ 69.6 ( 52.8- 95.6) ∼ ∼
Prostate 68.8 (44.5-109.4) ∼
Lung & Bronchus 41.7 (21.6- 80.1) ∼ ∼ ∼
Colon & Rectum 37.4 (19.6- 73.2) ∼ ∼ ∼
Atlanta
Breast ∼ 71.8 ( 50.7-109.1)
Prostate 63.5 (36.4-118.0)
Colon & Rectum 45.0 (20.4- 99.4) ∼
Hawaii
Breast ∼ 118.1 (108.8-128.0) ∼ 14.9 (11.8-18.7)
Prostate 100.6 (91.4-110.5) 14.9 (11.5-19.0)
Colon & Rectum 69.7 (62.1- 78.0) 43.1 ( 37.8- 49.1) 21.3 (17.2-26.2) 12.6 ( 9.8-16.0)
Lung & Bronchus 64.7 (57.4- 72.7) 31.9 ( 27.4- 37.1) 46.1 (40.0-52.9) 15.9 (12.7-19.6)
Corpus & Uterus, NOS 25.2 ( 21.0- 30.1) 4.4 ( 2.8- 6.6)
Stomach 20.9 (16.8- 25.7) 10.9 ( 8.3- 14.1) 8.0 ( 5.5-11.1) 8.4 ( 6.2-11.2)
Urinary Bladder 20.5 (16.5- 25.3) ∼ ∼ ∼
Liver & IBD 15.7 (12.2- 19.9) ∼ 12.2 ( 9.2-16.0) 3.8 ( 2.4- 5.9)
Non-Hodgkin Lymphoma 15.4 (11.9- 19.6) 10.2 ( 7.7- 13.4) 6.5 ( 4.3- 9.4) 4.1 ( 2.6- 6.3)
Thyroid ∼ 15.3 ( 11.9- 19.3) ∼ ∼
Oral Cavity & Pharynx 14.3 (11.0- 18.4) ∼ ∼ ∼
Ovary 12.4 ( 9.6- 16.0) 4.9 ( 3.2- 7.2)
Kidney & Renal Pelvis 11.3 ( 8.4- 15.0) ∼ ∼ ∼
Pancreas ∼ 11.3 ( 8.6- 14.6) 9.4 ( 6.7-12.7) 10.9 ( 8.3-14.1)
Leukemias 11.0 ( 8.1- 14.6) ∼ 8.2 ( 5.7-11.4) 4.4 ( 2.8- 6.6)
Cervix Uteri 7.0 ( 4.8- 9.8) ∼
Brain & ONS ∼ ∼ 4.6 ( 2.8- 7.1) ∼
Esophagus ∼ ∼ 5.9 ( 3.8- 8.7) ∼
Illinois
Breast ∼ 70.3 ( 59.4- 83.0) ∼ 11.6 ( 7.3-18.1)
Prostate 58.1 (45.7- 74.3) ∼
Lung & Bronchus 47.7 (35.5- 63.9) 25.1 ( 17.9- 34.7) 27.8 (18.1-42.0) 19.9 (13.4-28.9)
Colon & Rectum 39.8 (29.2- 54.2) 31.6 ( 23.6- 41.8) 16.0 ( 9.3-27.2) ∼
Liver & IBD 19.4 (11.9- 31.3) ∼ ∼ ∼
Stomach 16.7 ( 9.9- 27.7) 12.6 ( 7.5- 20.1) ∼ ∼
Non-Hodgkin Lymphoma 15.9 ( 9.4- 26.7) ∼ ∼ ∼
Ovary 12.8 ( 8.4- 19.3) ∼
Corpus & Uterus, NOS 11.7 ( 7.6- 17.9) ∼
Oral Cavity & Pharynx 9.7 ( 5.3- 18.5) ∼ ∼ ∼
Thyroid ∼ 9.1 ( 5.6- 14.7) ∼ ∼
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Table F.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Confidence Intervals for Asian/Pacific
Islanders† by State and Metropolitan Area, Primary Site, and Sex, United States, 2002 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Maryland
Prostate 62.6 (45.1- 87.6) ∼
Breast ∼ 53.1 ( 40.8- 69.5) ∼ ∼
Lung & Bronchus 28.7 (18.0- 47.4) 19.8 ( 11.7- 32.6) 28.9 (16.6-49.7) ∼
Colon & Rectum 26.7 (15.3- 46.6) ∼ ∼ ∼
Thyroid ∼ 13.2 ( 7.6- 23.2) ∼ ∼
Massachusetts
Breast ∼ 69.6 ( 53.8- 89.7) ∼ ∼
Prostate 69.0 (49.8- 95.3) ∼
Lung & Bronchus 50.2 (33.0- 75.0) 35.8 ( 23.4- 53.2) 42.8 (26.5-67.1) ∼
Colon & Rectum 40.5 (25.9- 62.6) 38.9 ( 26.1- 56.7) ∼ ∼
Liver & IBD 24.2 (14.7- 40.9) ∼ ∼ ∼
Thyroid ∼ 19.5 ( 12.3- 31.1) ∼ ∼
Corpus & Uterus, NOS 16.5 ( 9.2- 28.5) ∼
Michigan
Prostate 102.9 (72.1-147.1) ∼
Breast ∼ 62.5 ( 45.2- 87.5) ∼ ∼
Lung & Bronchus 41.8 (22.8- 75.8) ∼ ∼ ∼
Colon & Rectum 41.6 (23.8- 73.7) 31.0 ( 16.8- 54.3) ∼ ∼
Detroit
Prostate 91.1 (59.1-143.1)
Breast ∼ 46.9 ( 29.5- 76.4)
Minnesota
Breast ∼ 47.5 ( 30.4- 75.3) ∼ ∼
Nevada
Colon & Rectum 82.5 (49.1-135.9) 39.8 ( 23.1- 69.3) ∼ ∼
Breast ∼ 80.7 ( 57.1-116.0) ∼ ∼
Prostate 69.7 (45.0-112.4) ∼
Lung & Bronchus ∼ 31.2 ( 16.9- 58.5) ∼ 28.3 (15.6-53.9)
New Jersey
Prostate 102.6 (85.1-123.8) ∼
Breast ∼ 72.0 ( 61.5- 84.6) ∼ 10.0 ( 6.1-16.5)
Colon & Rectum 48.2 (36.5- 63.9) 29.6 ( 21.7- 40.0) 15.4 ( 9.1-26.1) ∼
Lung & Bronchus 46.2 (34.6- 61.8) 16.4 ( 10.6- 24.8) 29.5 (19.8-43.6) 11.4 ( 6.5-19.1)
Liver & IBD 19.8 (12.6- 31.2) ∼ 12.1 ( 6.8-21.8) ∼
Stomach 16.9 (10.8- 27.0) 10.6 ( 5.9- 18.2) ∼ ∼
Urinary Bladder 15.1 ( 8.7- 25.9) ∼ ∼ ∼
Thyroid ∼ 11.3 ( 7.6- 17.3) ∼ ∼
Non-Hodgkin Lymphoma 8.7 ( 4.5- 17.3) 8.3 ( 4.4- 14.9) ∼ ∼
Oral Cavity & Pharynx 7.9 ( 4.5- 15.6) ∼ ∼ ∼
Leukemias ∼ 7.7 ( 4.1- 14.0) ∼ ∼
Corpus & Uterus, NOS 7.0 ( 4.1- 12.4) ∼
New York
Prostate 66.3 (57.9- 75.8) 8.7 ( 5.5-13.4)
Breast ∼ 63.1 ( 56.6- 70.4) ∼ 10.3 ( 7.5-13.8)
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Table F.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Confidence Intervals for Asian/Pacific
Islanders† by State and Metropolitan Area, Primary Site, and Sex, United States, 2002 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Lung & Bronchus 45.0 (37.9- 53.4) 20.4 ( 16.4- 25.2) 35.1 (28.7-42.9) 14.5 (11.1-18.8)
Colon & Rectum 43.2 (36.4- 51.2) 32.8 ( 27.6- 38.7) 14.8 (10.5-20.4) 7.1 ( 4.8-10.3)
Stomach 23.4 (18.4- 29.7) 9.7 ( 7.0- 13.2) 11.2 ( 7.8-15.9) 5.9 ( 3.8- 8.9)
Liver & IBD 21.6 (17.1- 27.2) 6.1 ( 4.0- 9.0) 14.5 (10.8-19.5) 4.3 ( 2.5- 6.9)
Non-Hodgkin Lymphoma 13.8 (10.2- 18.6) 9.3 ( 6.7- 12.6) ∼ ∼
Thyroid ∼ 13.5 ( 10.7- 17.1) ∼ ∼
Urinary Bladder 11.6 ( 8.0- 16.5) ∼ ∼ ∼
Corpus & Uterus, NOS 11.2 ( 8.6- 14.6) ∼
Pancreas 10.5 ( 7.2- 15.1) ∼ 6.2 ( 3.8- 9.9) 6.6 ( 4.3- 9.9)
Oral Cavity & Pharynx 10.0 ( 7.4- 13.8) ∼ ∼ ∼
Cervix Uteri 9.3 ( 6.8- 12.4) ∼
Ovary 8.8 ( 6.4- 11.9) 7.1 ( 4.8-10.2)
Kidney & Renal Pelvis 8.0 ( 5.5- 11.7) ∼ ∼ ∼
Leukemias ∼ ∼ 4.4 ( 2.3- 7.9) ∼
North Carolina
Breast ∼ 59.6 ( 40.5- 92.9) ∼ ∼
Lung & Bronchus ∼ 46.7 ( 25.1- 84.9) ∼ ∼
Ohio
Breast ∼ 60.8 ( 42.1- 88.1) ∼ ∼
Prostate 54.9 (33.3- 91.0) ∼
Oregon
Breast ∼ 85.6 ( 62.3-116.7) ∼ ∼
Lung & Bronchus 54.1 (30.7- 92.1) ∼ ∼ ∼
Prostate 46.3 (26.5- 79.9) ∼
Colon & Rectum ∼ 32.2 ( 18.4- 54.5) ∼ ∼
Pennsylvania
Breast ∼ 66.9 ( 50.3- 88.5) ∼ ∼
Prostate 63.8 (44.1- 91.9) ∼
Lung & Bronchus 38.0 (22.6- 62.7) 31.2 ( 19.4- 48.7) 28.5 (15.5-51.0) ∼
Colon & Rectum 30.9 (17.4- 53.8) 21.6 ( 12.1- 36.7) ∼ ∼
Thyroid ∼ 17.1 ( 10.4- 28.8) ∼ ∼
Corpus & Uterus, NOS 16.4 ( 8.9- 29.2) ∼
Liver & IBD ∼ ∼ 19.5 (10.1-38.0) ∼
Texas
Prostate 46.7 (35.7- 61.4) ∼
Breast ∼ 45.8 ( 37.9- 55.6) ∼ 8.2 ( 4.9-13.9)
Lung & Bronchus 36.2 (26.5- 49.6) 20.2 ( 14.1- 28.7) 28.3 (19.2-41.4) 17.2 (11.4-25.5)
Colon & Rectum 30.8 (20.7- 45.0) 26.9 ( 19.6- 36.6) 8.7 ( 4.3-17.4) 11.7 ( 6.6-19.6)
Liver & IBD 18.1 (11.4- 28.7) ∼ 24.3 (16.4-36.2) ∼
Stomach 11.6 ( 6.1- 21.5) ∼ ∼ ∼
Thyroid ∼ 10.0 ( 6.5- 15.8) ∼ ∼
Oral Cavity & Pharynx 9.2 ( 5.1- 17.5) ∼ ∼ ∼
Corpus & Uterus, NOS 9.1 ( 5.3- 15.3) ∼
Non-Hodgkin Lymphoma 8.0 ( 4.0- 16.3) ∼ ∼ ∼
Virginia
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Table F.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Confidence Intervals for Asian/Pacific
Islanders† by State and Metropolitan Area, Primary Site, and Sex, United States, 2002 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Breast ∼ ∼ ∼ 20.0 (12.9-31.6)
Lung & Bronchus ∼ ∼ 36.4 (22.0-59.9) 23.2 (13.3-38.3)
Washington
Breast ∼ 91.1 ( 78.0-106.4) ∼ 14.2 ( 8.8-22.3)
Prostate 84.2 (67.2-105.1) ∼
Lung & Bronchus 53.0 (39.4- 70.5) 33.5 ( 25.2- 44.1) 43.0 (31.2-58.7) 21.5 (15.0-30.3)
Colon & Rectum 36.2 (25.7- 50.5) 37.4 ( 28.2- 49.1) ∼ 14.6 ( 8.8-23.1)
Liver & IBD 27.1 (18.0- 40.1) 10.3 ( 5.9- 17.4) 21.2 (13.3-33.1) 10.6 ( 6.0-17.9)
Non-Hodgkin Lymphoma 17.8 (10.8- 28.8) 12.3 ( 7.5- 19.7) ∼ ∼
Urinary Bladder 16.8 ( 9.8- 28.1) ∼ ∼ ∼
Corpus & Uterus, NOS 16.5 ( 11.2- 24.2) ∼
Stomach 15.0 ( 8.3- 25.9) 11.2 ( 6.8- 18.2) 15.5 ( 8.3-27.2) ∼
Thyroid ∼ 12.5 ( 8.3- 19.1) ∼ ∼
Pancreas ∼ 11.4 ( 6.4- 19.3) ∼ 10.5 ( 5.9-17.7)
Ovary 11.4 ( 7.0- 18.3) ∼
Seattle-Puget Sound
Breast ∼ 89.1 ( 75.6-104.9)
Prostate 81.0 (63.8-102.4)
Lung & Bronchus 55.8 (41.2- 74.9) 33.7 ( 25.0- 45.0)
Colon & Rectum 36.5 (25.8- 51.5) 36.0 ( 26.7- 48.0)
Liver & IBD 29.7 (19.7- 44.0) 11.4 ( 6.5- 19.1)
Urinary Bladder 18.4 (10.7- 30.6) ∼
Non-Hodgkin Lymphoma 18.2 (10.8- 30.2) 13.0 ( 7.8- 20.9)
Corpus & Uterus, NOS 17.8 ( 12.0- 26.2)
Stomach 15.1 ( 8.1- 26.9) 10.9 ( 6.4- 18.2)
Ovary 13.6 ( 8.4- 21.4)
Thyroid ∼ 11.5 ( 7.2- 18.3)
Cervix Uteri 8.6 ( 4.8- 15.0)
Wisconsin
Breast ∼ 61.4 ( 35.4-104.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population.
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined that have an
Asian/Pacific Islander population of at least 50,000. See Appendix I for data quality criteria and registry-specific data quality information.
§ Data are from the National Vital Statistics System (NVSS).
∼ Rates are suppressed if cases are fewer than 16 or if the Asian/Pacific Islander population of a specific category (area, sex) is less than 50,000.
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Table F.2: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Confidence Intervals for American
Indian/Alaska Natives† by State and Metropolitan Area, Primary Site, and Sex, United States, 2002
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
United States
Prostate 74.2 ( 67.5- 81.5) 15.7 (12.4- 19.8)
Breast ∼ 56.7 (52.1- 61.6) ∼ 13.9 (11.7-16.5)
Lung & Bronchus 47.9 ( 42.6- 53.8) 32.9 (29.2- 37.0) 42.1 (37.2- 47.7) 27.5 (24.1-31.2)
Colon & Rectum 34.1 ( 29.8- 39.2) 26.8 (23.4- 30.5) 16.1 (13.2- 19.6) 12.7 (10.4-15.4)
Kidney & Renal Pelvis 14.1 ( 11.4- 17.3) 7.2 ( 5.6- 9.3) 8.0 ( 6.0- 10.6) 3.5 ( 2.4- 5.0)
Corpus & Uterus, NOS 12.3 (10.2- 14.8) 3.2 ( 2.2- 4.7)
Non-Hodgkin Lymphoma 9.7 ( 7.5- 12.5) 8.1 ( 6.4- 10.2) ∼ ∼
Urinary Bladder 9.3 ( 6.9- 12.5) ∼ ∼ ∼
Stomach 7.9 ( 5.9- 10.6) ∼ 6.4 ( 4.5- 8.9) 4.9 ( 3.5- 6.6)
Oral Cavity & Pharynx 7.7 ( 5.8- 10.1) ∼ 3.2 ( 2.0- 5.0) ∼
Liver & IBD 6.7 ( 5.0- 9.1) ∼ 7.2 ( 5.4- 9.8) 3.9 ( 2.7- 5.6)
Pancreas ∼ 6.7 ( 5.0- 8.7) 6.4 ( 4.6- 8.9) 6.8 ( 5.2- 8.8)
Leukemias 6.1 ( 4.5- 8.4) ∼ 4.9 ( 3.3- 7.1) 3.2 ( 2.2- 4.6)
Thyroid ∼ 5.5 ( 4.2- 7.1) ∼ ∼
Ovary 5.4 ( 4.0- 7.1) 4.9 ( 3.6- 6.6)
Cervix Uteri 4.9 ( 3.7- 6.4) ∼
Esophagus ∼ ∼ 5.5 ( 3.8- 8.0) ∼
Alaska
Breast ∼ 113.6 (80.4-158.9) ∼ ∼
Colon & Rectum 68.1 ( 38.6-128.7) 101.7 (67.6-149.0) ∼ ∼
Prostate 89.6 ( 52.3-157.8) ∼
Lung & Bronchus 79.9 ( 51.5-137.7) 83.2 (53.2-126.4) 87.7 (52.0-154.1) ∼
Arizona
Prostate 34.4 ( 19.8- 57.0) ∼
Kidney & Renal Pelvis 27.4 ( 16.1- 46.0) ∼ ∼ ∼
Breast ∼ 24.9 (16.0- 38.1) ∼ ∼
Corpus & Uterus, NOS 15.4 ( 8.8- 26.3) ∼
New Mexico
Prostate 48.9 ( 30.3- 76.6) ∼
Colon & Rectum 32.5 ( 17.7- 56.5) ∼ ∼ ∼
Breast ∼ 29.3 (17.9- 46.8) ∼ ∼
North Carolina
Prostate 134.9 ( 95.3-193.1) ∼
Breast ∼ 78.9 (55.1-110.7) ∼ ∼
Lung & Bronchus 66.3 ( 41.3-110.8) ∼ 66.1 (37.8-115.1) ∼
Colon & Rectum ∼ 43.0 (25.1- 69.7) ∼ ∼
Oklahoma
Prostate 167.6 (139.7-200.7) ∼
Lung & Bronchus 120.3 ( 97.3-148.4) 74.7 (59.7- 92.5) 58.2 (42.1- 79.7) 41.5 (30.6-55.2)
Breast ∼ 104.9 (87.7-124.8) ∼ 25.1 (17.0-36.1)
Colon & Rectum 60.3 ( 44.5- 81.5) 53.0 (40.6- 68.2) 22.0 (13.0- 36.8) 21.2 (13.6-31.6)
Non-Hodgkin Lymphoma 26.2 ( 15.9- 42.2) 22.5 (14.7- 33.3) ∼ ∼
Urinary Bladder 25.7 ( 15.7- 41.4) ∼ ∼ ∼
Kidney & Renal Pelvis 21.6 ( 13.5- 35.1) ∼ ∼ ∼
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Table F.2: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Confidence Intervals for American
Indian/Alaska Natives† by State and Metropolitan Area, Primary Site, and Sex, United States, 2002 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Corpus & Uterus, NOS 21.2 (13.6- 31.6) ∼
Cervix Uteri 12.8 ( 7.4- 21.0) ∼
Washington
Prostate 132.9 ( 87.9-198.8) ∼
Breast ∼ 128.2 (92.6-176.0) ∼ ∼
Lung & Bronchus 64.5 ( 33.9-117.8) 62.3 (35.7-103.0) 58.4 (30.7-108.3) 54.6 (30.5-92.7)
Colon & Rectum 49.7 ( 26.0- 95.1) ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population.
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined that have an
American Indian/Alaska Native population of at least 50,000. See Appendix I for data quality criteria and registry-specific data quality information.
§ Data are from the National Vital Statistics System (NVSS).
∼ Rates are suppressed if cases are fewer than 16 or if the American Indian/Alaska Native population of a specific category (area, sex) is less than 50,000.
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Table H.1: State, Metropolitan Area, and Territory Cancer Registries by Federal
Funding Source and First Diagnosis Year* for Which Cancer Cases Were
Reportable to CDC’s NPCR or NCI’s SEER Program
Alabama 1996 NPCR
Alaska 1996 NPCR
Arizona 1995 NPCR
Arkansas 1996 NPCR
California 1995/2000 NPCR/SEER
Los Angeles 1992 SEER
San Francisco-Oakland 1973 SEER
San Jose-Monterey 1992 SEER
Colorado 1995 NPCR
Connecticut 1973 SEER
Delaware 1997 NPCR
District of Columbia 1996 NPCR
Florida 1995 NPCR
Georgia 1995 NPCR
Atlanta 1975 SEER
Hawaii 1973 SEER
Idaho 1995 NPCR
Illinois 1995 NPCR
Indiana 1995 NPCR
Iowa 1973 SEER
Kansas 1995 NPCR
Kentucky 1995/2000 NPCR/SEER
Louisiana 1995/2000 NPCR/SEER
Maine 1995 NPCR
Maryland 1996 NPCR
Massachusetts 1995 NPCR
Michigan 1995 NPCR
Detroit 1973 SEER
Minnesota 1995 NPCR
Mississippi 1996 NPCR
Missouri 1996 NPCR
Montana 1995 NPCR
Nebraska 1995 NPCR
Nevada 1995 NPCR
New Hampshire 1995 NPCR
New Jersey 1995/2000 NPCR/SEER
New Mexico 1973 SEER
New York 1996 NPCR
North Carolina 1995 NPCR
North Dakota 1997 NPCR
Ohio 1996 NPCR
Oklahoma 1997 NPCR
Oregon 1996 NPCR
Palau                                                          1999 NPCR
Pennsylvania 1995 NPCR
Puerto Rico 1998 NPCR
Rhode Island 1995 NPCR
First Diagnosis Year for Which 
State, Metropolitan Cancer Cases Were Reportable Federal Funding 
Area, or Territory to NPCR or SEER* Source 2005
continued
South Carolina 1996 NPCR
South Dakota 2001 NPCR
Tennessee 1999 NPCR
Texas 1995 NPCR
Utah 1973 SEER
Vermont 1996 NPCR
Virgin Islands (U.S.) 1999 NPCR
Virginia 1996 NPCR
Washington 1995 NPCR
Seattle-Puget Sound 1974 SEER
West Virginia 1995 NPCR
Wisconsin 1995 NPCR
Wyoming 1996 NPCR
Table H.1: State, Metropolitan Area, and Territory Cancer Registries by Federal
Funding Source and First Diagnosis Year* for Which Cancer Cases Were
Reportable to CDC’s NPCR or NCI’s SEER Program (continued)
H–2
United States Cancer Statistics: 2002 Incidence and Mortality
* Diagnosis year is the year during which a reported cancer case was first diagnosed.
CDC = Centers for Disease Control and Prevention.
NCI = National Cancer Institute.
NPCR = National Program of Cancer Registries.
SEER = Surveillance, Epidemiology, and End Results.
First Diagnosis Year for Which 
State, Metropolitan Cancer Cases Were Reportable Federal Funding 
Area, or Territory to NPCR or SEER* Source 2005
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Tables I.1 and I.2
United States Cancer Statistics: 2002 Incidence and Mortality
I–2
Alabama ≥95 100.0 2.1 0.00 0.43 0.00
Alaska ≥95 100.0 0.3 0.00 1.39 0.00
Arizona 90-94 100.0 2.0 0.00 1.57 0.02
Arkansas <90 99.9 0.1 0.02 0.92 0.00
California ≥95 100.0 1.2 0.01 1.89 0.03
Greater Bay# ≥95 100.0 1.1 0.02 1.86 0.02
Los Angeles ≥95 100.0 0.8 0.01 2.29 0.03
Colorado ≥95 100.0 2.8 0.00 2.76 0.05
Connecticut ≥95 100.0 1.4 0.02 0.87 0.00
Delaware 90-94 100.0 1.2 0.00 1.35 0.00
District of Columbia 90-94 99.5 3.1 0.22 1.74 0.04
Florida ≥95 100.0 2.9 0.02 0.56 0.00
Georgia ≥95 100.0 2.3 0.00 0.59 0.00
Atlanta ≥95 100.0 1.2 0.00 0.62 0.00
Hawaii ≥95 100.0 0.8 0.00 3.37 0.00
Idaho ≥95 100.0 2.7 0.00 0.39 0.00
Illinois ≥95 100.0 2.9 0.00 1.39 0.00
Indiana >95 100.0 2.4 0.00 0.89 0.00
Iowa ≥95 100.0 1.5 0.00 2.02 0.00
Kansas 90-94 100.0 0.4 0.00 2.53 0.00
Kentucky ≥95 100.0 0.8 0.00 1.27 0.00
Louisiana ≥95 100.0 1.2 0.00 0.26 0.00
Maine ≥95 100.0 1.4 0.00 0.45 0.00
Maryland ≥95 100.0 0.7 0.00 0.01 0.06
Massachusetts ≥95 100.0 1.6 0.00 1.26 0.00
Michigan ≥95 100.0 1.1 0.05 2.27 0.01
Detroit ≥95 100.0 1.1 0.02 2.35 0.02
Minnesota ≥95 100.0 1.6 0.00 2.16 0.00
Mississippi
Missouri ≥95 100.0 2.8 0.00 0.40 0.01
Montana 90-94 100.0 4.9 0.00 2.47 0.00
Nebraska ≥95 100.0 2.1 0.00 2.32 0.00
Nevada ≥95 100.0 1.5 0.00 1.18 0.01
New Hampshire ≥95 100.0 1.1 0.09 1.99 0.00
New Jersey ≥95 100.0 1.6 0.02 1.53 0.02
New Mexico ≥95 100.0 2.0 0.00 0.00 0.01
New York ≥95 100.0 1.6 0.00 2.19 0.00
North Carolina 90-94 100.0 0.5 0.02 0.26 0.00
North Dakota 90-94 100.0 1.6 0.00 0.03 0.00
Ohio 90-94 100.0 3.1 0.00 3.68 0.00
Oklahoma ≥95 100.0 2.6 0.00 0.82 0.03
Oregon ≥95 100.0 1.0 0.00 2.51 0.00
Pennsylvania ≥95 100.0 2.0 0.00 1.41 0.01
Rhode Island ≥95 100.0 2.2 0.00 0.51 0.00
South Carolina ≥95 100.0 2.3 0.01 0.99 0.00
Table I.1: Achievement of Selected Data Quality Criteria* by State and SEER
Metropolitan Area Cancer Registries, 2002
Only data from the shaded states and metropolitan areas are included in United States
Cancer Statistics: 2002 Incidence and Mortality.†
% Case % Passing % % Missing % Missing % Missing
Cancer Registry Ascertainment‡ Edits§ DCOs¶ Sex Race Age
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South Dakota ≥95 100.0 NDC** 0.00 3.26 0.00
Tennessee
Texas 90-94 100.0 4.0 0.00 1.17 0.00
Utah ≥95 100.0 0.3 0.00 0.00 0.01
Vermont ≥95 100.0 1.3 0.06 0.49 0.00
Virginia <90 100.0 0.9 0.00 0.73 0.00
Washington ≥95 100.0 0.4 0.00 2.75 0.00
Seattle-Puget Sound ≥95 100.0 0.5 0.00 0.45 0.00
West Virginia ≥95 100.0 2.0 0.00 0.00 0.00
Wisconsin ≥95 100.0 3.0 0.01 0.61 0.00
Wyoming
Table I.1: Achievement of Selected Data Quality Criteria* by State and SEER
Metropolitan Area Cancer Registries, 2002 (continued)
Only data from the shaded states and metropolitan areas are included in United States
Cancer Statistics: 2002 Incidence and Mortality.†
% Case % Passing % % Missing % Missing % Missing
Cancer Registry Ascertainment‡ Edits§ DCOs¶ Sex Race Age
Note: Cancer incidence data included in this report are from statewide or metropolitan area cancer registries that meet the
following data quality criteria for all cancer sites combined:
• Case ascertainment is 90% or more complete.
• No more than 5% of cases are ascertained solely on the basis of a death certificate.
• No more than 3% of cases are missing information on sex.
• No more than 3% of cases are missing information on age.
• No more that 5% of cases are missing information on race.
• At least 97% of the registry’s records passed a set of single-field and interfield computerized edits.
* National Program of Cancer Registries (including California, Kentucky, Louisiana, and New Jersey) data quality based
on January 2005 data submission; SEER data quality based on November 2004 data submission.
† Registry members of the National Program of Cancer Registries whose data are not included in this report chose
whether to have their data quality information listed.
‡ Completeness of case ascertainment was estimated by methods developed by the North American Association of Central
Cancer Registries.
Sources:
Howe HL. Conclusions of the Workgroup for High-Quality Criteria for Data Use: The NAACCR Narrative. Springfield,
IL: North American Association of Central Cancer Registries; 2001.
Tucker TC, Howe HL, Weir HK. Certification of population-based cancer registries. Journal of Registry Management
1999;26(1):24-27.
§ Computerized edits test the validity and logic of data components reported for selected items.
¶ DCOs = death certificate only cases; that is, cancer cases ascertained solely on the basis of a death certificate after the
registry has completed a routine procedure known as death clearance and followback. 
# Greater Bay includes San Francisco-Oakland and San Jose-Monterey Registries.
** NDC = no death clearance; registry did not conduct death clearance and followback.
SEER = Surveillance, Epidemiology, and End Results.
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Table I.2: Confirmation Rates* and Detection Rates† for Cancer Mortality‡
by Anatomic Site and International Classification of Disease (ICD) Version—
United States
Confirmation Rate* (%) Detection Rate* (%)
Cancer site ICD–9 ICD–8A ICD–9 ICD–8A
All malignant sites 84.8 82.7 83.3 82.7
Oral cavity and pharynx NA§ NA NA NA 
Esophagus 77.0 86.1 93.7 93.2
Stomach 93.9 90.9 88.1 89.2
Colon and rectum 95.6 95.0 92.7 92.9
Liver and intrahepatic bile duct§ NA 76.7 NA 49.6
Liver§ 70.2 NA 78.3 NA
Pancreas 90.3 89.0 91.5 90.2
Larynx 69.3 73.2 72.2 80.3
Lung and bronchus§ 94.3 NA 95.4 NA
Trachea, lung, and bronchus§ NA 93.9 NA 95.0
Melanomas of the skin 88.6 90.5 89.7 87.6
Breast¶ 98.7 98.1 95.7 95.0
Cervix uteri 93.2 90.4 81.1 79.0
Corpus and uterus, NOS§ NA 71.5 NA 81.5
Corpus§ 93.3 NA 43.9 NA
Ovary§ 91.9 NA 90.7 NA
Ovary, fallopian tube, etc.§ NA 88.2 NA 88.3
Prostate 98.1 96.3 93.5 94.7
Testis 75.9 90.4 90.6 83.1
Urinary bladder 95.7 93.6 88.9 91.1
Kidney and renal pelvis§ 93.5 NA 89.6 NA
Kidney§ NA 93.0 NA 87.9
Brain and other nervous system 93.1 89.2 97.1 97.2
Thyroid 96.6 91.5 88.6 87.2
Hodgkin lymphoma 95.6 92.5 83.5 86.7
Non-Hodgkin lymphoma 92.8 88.4 87.5 83.2
Multiple myeloma 97.2 98.1 97.3 96.6
Leukemias NA NA NA NA
* Confirmation rate = Percentage of cancer listed as underlying cause of death (UCD) on the death certificate that agrees
with the original cancer diagnosis as coded in the medical record.  
† Detection rate = Percentage of original cancer diagnoses as coded in the medical record that agrees with cancer as UCD
on the death certificate.
‡ Adapted from the following sources:
Percy C, Stanek E III, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics.
American Journal of Public Health 1981;71(3):242–250.
Percy CL, Miller BA, Gloeckler Ries LA. Effect of changes in cancer classification and the accuracy of cancer death
certificates on trends in cancer mortality. Annals of the New York Academy of Sciences 1990;609:87–97.
§ Because of inconsistencies in site categories, caution should be used when comparing ICD–9 and ICD–8A confirmation and
detection rates.
¶
Includes both male and female breast cancer.  
NA = not available. 
NOS = not otherwise specified.
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Table J.1: SEER Site Groups for Primary Cancer Sites Based on International
Classification of Diseases for Oncology, Third Edition (ICD–O–3)
Oral Cavity and Pharynx 
Lip C000-C009
Tongue C019-C029
Salivary gland C079-C089
Floor of mouth C040-C049
Gum and other mouth C030-C039, C050-C059, C060-C069 excluding 9590-9989, 
Nasopharynx C110-C119 and sometimes 
Tonsil C090-C099 9050-9055, 9140*
Oropharynx C100-C109
Hypopharynx C129, C130-C139
Other oral cavity and pharynx C140, C142-C148
Digestive System
Esophagus C150-C159 excluding 9590-9989, 
Stomach C160-C169 and sometimes 
Small intestine C170-C179 9050-9055, 9140*
Colon and rectum
Colon excluding rectum 
Cecum C180 
Appendix C181 
Ascending colon C182
Hepatic flexure C183 excluding 9590-9989, 
Transverse colon C184 and sometimes 
Splenic flexure C185 9050-9055, 9140*
Descending colon C186 
Sigmoid colon C187
Large intestine, NOS C188-C189, C260 
Rectum and rectosigmoid junction 
Rectosigmoid junction C199 excluding 9590-9989, 
Rectum C209 and sometimes 
Anus, anal canal, and anorectum C210-C212, C218 9050-9055, 9140*
Liver and intrahepatic bile duct
Liver C220 
Intrahepatic bile duct C221 
Gallbladder C239 
Other biliary C240-C249 excluding 9590-9989, 
Pancreas C250-C259 and sometimes 
Retroperitoneum C480 9050-9055, 9140*
Peritoneum, omentum, and C481-C482 
mesentery
Other digestive organs C268-C269, C488
Respiratory System 
Nose, nasal cavity, and middle ear C300-C301, C310-C319 
Larynx C320-C329 excluding 9590-9989,
Lung and bronchus C340-C349 and sometimes
Pleura C384 9050-9055, 9140*
Trachea, mediastinum, and C339, C381-C383, C388, C390, 
other respiratory organs C398, C399 
Bones and Joints C400-C419     excluding 9590-9989, 
and sometimes 
9050-9055, 9140*
Site Group Primary Site Histologic Type
continued
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Soft Tissue including Heart C380, C470-C479, C490-C499 excluding 9590-9989, 
and sometimes 
9050-9055, 9140*
Skin excluding Basal and Squamous
Melanoma of the skin C440-C449 8720-8790
Other non-epithelial skin C440-C449 excluding 8000-8005, 
8010-8045, 8050-8084,
8090-8110, 8720-8790,
9590-9989, and 
sometimes 9050-9055, 
9140*
Breast C500-C509 excluding 9590-9989, 
and sometimes 
9050-9055, 9140*
Female Genital System
Cervix uteri C530-C539 
Corpus and uterus, NOS
Corpus uteri C540-C549 
Uterus, NOS C559 excluding 9590-9989, 
Ovary C569 and sometimes 
Vagina C529 9050-9055, 9140*
Vulva C510-C519 
Other female genital organs C570-C589 
Male Genital System
Prostate C619 excluding 9590-9989, 
Testis C620-C629 and sometimes 
Penis C600-C609 9050-9055, 9140*
Other male genital organs C630-C639 
Urinary System
Urinary bladder C670-C679 excluding 9590-9989, 
Kidney and renal pelvis C649, C659 and sometimes 
Ureter C669 9050-9055, 9140*
Other urinary organs C680-C689 
Eye and Orbit C690-C699 excluding 9590-9989, 
and sometimes 
9050-9055, 9140*
Brain and Other Nervous System 
Brain C710-C719 excluding 9530-9539, 
9590-9989, and 
sometimes 9050-9055, 
9140*
Cranial nerves; other nervous system C710-C719 9530-9539
C700-C709, C720-C729 excluding 9590-9989, 
and sometimes 
9050-9055, 9140*
Table J.1: SEER Site Groups for Primary Cancer Sites Based on International
Classification of Diseases for Oncology, Third Edition (ICD–O–3)(continued)
continued
Site Group Primary Site Histologic Type
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Endocrine System
Thyroid C739 excluding 9590-9989
Other endocrine including thymus C379, C740-C749, C750-C759 and sometimes 
9050-9055, 9140*
Lymphoma
Hodgkin lymphoma 
Hodgkin - nodal C024, C098-C099, C111, C142, 9650-9667
C379, C422, C770-C779
Hodgkin - extranodal All other sites
Non-Hodgkin lymphoma (NHL)
NHL - nodal C024, C098-C099, C111, C142, 9590-9596, 9670-9671,
C379, C422, C770-C779 9673, 9675, 9678-9680,
9684, 9687, 9689-9691,
9695, 9698-9702, 
9705, 9708-9709, 
9714-9719, 9727-9729,
9823, 9827
NHL - extranodal All sites except C024, C098-C099, C111, 9590-9596, 9670-9671,
C142, C379, C422, C770-C779 9673, 9675, 9678-
9680, 9684, 9687, 
9689-9691, 9695, 
9698-9702, 9705, 
9708-9709, 9714-9719,
9727-9729
All sites except C024, C098-C099, C111, 9823, 9827
C142, C379, C420-C422, C424, 
C770-C779
Myeloma 9731-9732, 9734
Leukemia
Lymphocytic leukemia 
Acute lymphocytic leukemia 9826, 9835-9837 
Chronic lymphocytic leukemia C420, C421, C424 9823
Other lymphocytic leukemia 9820, 9832-9834, 9940
Myeloid and monocytic leukemia
Acute myeloid leukemia 9840, 9861, 9866, 
9867, 9871-9874, 
9895-9897, 9910, 9920
Acute monocytic leukemia 9891
Chronic myeloid leukemia 9863, 9875, 9876, 
9945, 9946
Other myeloid/monocytic leukemia 9860, 9930
Other leukemia
Other acute leukemia 9801, 9805, 9931 
Aleukemic, subleukemic, and NOS 9733, 9742, 9800, 
9831, 9870, 9948, 
9963, 9964
C420, C421, C424 9827
Mesothelioma* 9050-9055
continued
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Site Group Primary Site Histologic Type
Kaposi sarcoma* 9140
Miscellaneous 9740-9741, 9750-9758,
9750-9758, 9760-9769,
9950, 9960-9962, 
9970, 9975, 9980, 
9982-9987, 9989
C420-C424, C760-C768, C770-C779, excluding 9590-9989, 
C809 and sometimes 
9050-9055, 9140*
Invalid Site or histology code not within valid range or site code not found 
in this table.
Table J.1: SEER Site Groups for Primary Cancer Sites Based on International
Classification of Diseases for Oncology, Third Edition (ICD–O–3)(continued)
* Mesothelioma (9050-9055) and Kaposi sarcoma (9140) can be listed separately or within site-specific groupings. 
The table contains both possibilities.
NOS = not otherwise specified.
SEER = Surveillance, Epidemiology, and End Results.
Source: http://seer.cancer.gov/iccc/seericcc.html._
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Table J.2: SEER Modification of Site Groups for Primary Cancer Sites Based on
International Classification of Childhood Cancer 
I Leukemia 
(a) Lymphoid leukemia  
Acute lymphocytic leukemia (ALL) 9821, 9828 C000-C809
Lymphoid excluding ALL 9820, 9822-9827, 9850 C000-C809 
(b) Acute non-lymphocytic leukemia 9840, 9841, 9861, 9864, 9866, 9867, C000-C809 
9871-9874, 9891, 9894, 9910 
(c) Chronic myeloid leukemia 9863, 9868 C000-C809 
(d) Other specified leukemia 9830, 9842, 9860, 9862, 9870, 9875-9890, C000-C809 
9892, 9893, 9900, 9930-9941 
(e) Unspecified leukemia 9800-9804 C000-C809 
II Lymphoma and Reticuloendothelial 
Neoplasms 
(a) Hodgkin lymphoma 9650-9667 C000-C809 
(b) Non-Hodgkin lymphoma 9591-9595, 9670-9686, 9688, 9690-9717, 9723 C000-C809 
(c) Burkitt lymphoma 9687 C000-C809 
(d) Miscellaneous lymphoreticular  9720, 9731-9764 C000-C809 
neoplasms
(e) Unspecified lymphoma 9590 C000-C809 
III Central Nervous System (CNS) 
and Miscellaneous Intracranial 
and Intraspinal Neoplasms 
(a) Ependymoma 9383, 9390-9394 C000-C809 
(b) Astrocytoma 9380 C723 
9381, 9400-9441* C700-C729, 
C751-C753, 
C692* 
(c) Primitive neuroectodermal tumors 9470-9473* C700-C729, 
C751-C753, 
C809* 
9500* C710-C719, 
C751-C753* 
9362* C000-C809* 
(d) Other gliomas 9380 C700-C722, 
C724-C729 
9382, 9384 C000-C809 
9442-9460, 9481 C000-C809 
(e) Miscellaneous intracranial and 8270-8281, 8300, 9350-9361, C000-C809* 
intraspinal neoplasms 9480, 9505, 9530-9539*
(f) Unspecified intracranial and 8000-8004 C700-C729, 
intraspinal neoplasms C751-C753
IV Sympathetic Nervous System Tumors 
(a) Neuroblastoma and  9490 C000-C809 
ganglioneuroblastoma 9500* C000-C709, 
C720-C750, 
C754-C809* 
(b) Other sympathetic nervous 8680, 8693-8710, 9501-9504, 9520-9523 C000-C809 
system tumors 
V Retinoblastoma 9510-9512 C000-C809 
Site Group Histologic Type Primary Site
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VI Renal Tumors 
(a) Wilms tumor, rhabdoid, and 8963 C649, C809 
clear cell sarcoma 8960, 8964 C000-C809 
(b) Renal carcinoma 8010-8041, 8050-8075, 8082, 8120-8122, 
8130-8141, 8143, 8155, 8190-8201, 8210, 
8211, 8221-8231, 8240, 8241, 8244-8246, 
8260-8263, 8290, 8310, 8320, 8323, 8401, 
8430, 8440, 8480-8490, 8504, 8510, 8550, 
8560-8573 C649 
8312 C000-C809 
(c) Unspecified malignant renal tumors 8000-8004 C649 
VII Hepatic Tumors
(a) Hepatoblastoma 8970 C000-C809 
(b) Hepatic carcinoma 8010-8041, 8050-8075, 8082, 8120-8122, 
8140, 8141, 8143, 8155, 8190-8201, 8210, 
8211, 8230, 8231, 8240, 8241, 8244-8246, 
8260-8263, 8310, 8320, 8323, 8401, 8430, 
8440, 8480-8490, 8504, 8510, 8550, 8560-8573 C220, C221 
8160-8180 C000-C809 
(c) Unspecified malignant hepatic tumors 8000-8004 C220, C221 
VIII Malignant Bone Tumors 
(a) Osteosarcoma 9180-9200 C000-C809 
(b) Chrondosarcoma 9220-9230 C000-C809 
9231, 9240 C400-C419 
(c) Ewing sarcoma 9260 C400-C419, 
C809 
9363, 9364 C400-C419 
9473* C400-C419* 
(d) Other specified malignant 8812, 9250, 9261-9330, 9370 C000-C809 
bone tumors 
(e) Unspecified malignant bone tumors 8000-8004, 8800, 8801, 8803, 8804 C400-C419 
IX Soft-Tissue Sarcomas 
(a) Rhabdomyosarcoma and 8900-8920, 8991 C000-C809 
embryonal sarcoma 
(b) Fibrosarcoma, neurofibrosarcoma, 8810, 8811, 8813-8833, 9540-9561 C000-C809 
and other fibromatous neoplasms 
(c) Kaposi sarcoma 9140 C000-C809 
(d) Other specified soft-tissue sarcomas  
Excludes misclassification from III(c) 8840-8896, 8982, 8990, 9040-9044, C000-C809
(Primitive neuroectodermal tumors 9120-9134, 9150-9170, 9251, 9581 
[PNET])
8963 C000-C639, 
C659-C768 
9231, 9240, 9363, 9364 C000-C399, 
C440-C809 
9260 C000-C399, 
C470-C768 
Site Group Histologic Type Primary Site
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PNET—not in brain/CNS/bone 9473* C000-C399, 
C420-C699, 
C730-C750, 
C754-C808* 
(e) Unspecified soft-tissue sarcomas 8800-8804 C000-C399, 
C440-C809 
X Germ-Cell, Trophoblastic, and 
Other Gonadal Neoplasms 
(a) Intracranial and intraspinal 9060-9102 C700-C729, 
germ-cell tumors C751-C753 
(b) Other and unspecified non-gonadal 9060-9102 C000-C559, 
germ-cell tumors C570-C619, 
C630-C699, 
C739-C750, 
C754-C809 
(c) Gonadal germ-cell tumors 9060-9102 C569, 
C620-C629 
(d) Gonadal carcinomas 8010-8041, 8050-8075, 8120-8122, C569,
8130-8141, 8143, 8155, 8190-8201, C620-C629 
8210, 8211, 8221-8241, 8244-8246, 
8260-8263, 8290, 8310, 8320, 8323, 
8430, 8440, 8480-8490, 8504, 8510, 
8550, 8560-8573 
8380, 8381, 8441-8473 C000-C809 
(e) Other and unspecified malignant 8590-8670, 9000 C000-C809 
gonadal tumors 8000-8004 C569, 
C620-C629 
XI Carcinomas and Other Malignant 
Epithelial Neoplasms 
(a) Adrenocortical carcinoma 8370-8375 C000-C809 
(b) Thyroid carcinoma 8010-8041, 8050-8075, 8082, 8120-8122, C739
8130-8141, 8155, 8190, 8200, 8201, 8211, 
8230, 8231, 8244-8246, 8260-8263, 8290, 
8310, 8320, 8323, 8430, 8440, 8480, 8481, 
8500-8573 
8330-8350 C000-C809 
(c) Nasopharyngeal carcinoma 8010-8041, 8050-8075, 8082, 8120-8122, C110-C119 
8130-8141, 8155, 8190, 8200, 8201, 8211, 
8230, 8231, 8244-8246, 8260-8263, 8290, 
8310, 8320, 8323, 8430, 8440, 8480, 8481, 
8504, 8510, 8550, 8560-8573 
(d) Malignant melanoma 8720-8780 C000-C809 
(e) Skin carcinoma 8010-8041, 8050-8075, 8082, 8090-8110, C440-C449
8140, 8143, 8147, 8190, 8200, 8240, 8246, 
8247, 8260, 8310, 8320, 8323, 8390-8420, 
8430, 8480, 8542, 8560, 8570-8573, 8940 
Site Group Histologic Type Primary Site
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(f) Other and unspecified carcinomas 8010-8082, 8120-8155, 8190-8263, C000-C109, 
8290, 8310, 8314-8323, 8430-8440, C129-C218, 
8480-8580, 8940, 8941 C239-C399, 
C480-C488, 
C500-C559, 
C570-C619, 
C630-C639, 
C659-C729, 
C750-C809 
XII Other and Unspecified 
Malignant Neoplasms 
(a) Other specified malignant tumors 8930, 8933, 8950, 8951, 8971-8981, C000-C809 
9020, 9050-9053, 9110, 9580 
(b) Other unspecified malignant  8000-8004 C000-C218, 
tumors C239-C399, 
C420-C559, 
C570-C619, 
C630-C639, 
C659-C699, 
C739-C750, 
C754-C809 
Not Classified by SEER Site or histology code not found in this table.
Site Group Histologic Type Primary Site
* ICD–O–2 histology and site definitions differ between International Agency for Research on Cancer (IARC) Technical
Report No. 29 and the SEER modification.
ICD–O–2 = International Classification of Diseases for Oncology, Second Edition.
SEER = Surveillance, Epidemiology, and End Results.
Source: http://seer.cancer.gov/iccc/seericcc.html.
Table J.2: SEER Modification of Site Groups for Primary Cancer Sites Based on
International Classification of Childhood Cancer (continued)
United States Cancer Statistics: 2002 Incidence and Mortality
J–10
Table J.3: Death Recodes for Cancer Causes of Death, International
Classification of Diseases, Tenth Edition (ICD–10)
All Malignant Cancers C00-C97
Oral Cavity and Pharynx
Lip C00
Tongue C01-C02
Salivary gland C07-C08
Floor of mouth C04
Gum and other mouth C03, C05-C06
Nasopharynx C11
Tonsil C09
Oropharynx C10
Hypopharynx C12-C13
Other oral cavity and pharynx C14
Digestive System
Esophagus C15
Stomach C16
Small intestine C17
Colon and rectum
Colon excluding rectum C18, C26.0
Rectum and rectosigmoid junction C19-C20
Anus, anal canal, and anorectum C21
Liver and intrahepatic bile duct
Liver C22.0, C22.2-C22.4, C22.7, C22.9
Intrahepatic bile duct C22.1
Gallbladder C23
Other biliary C24
Pancreas C25
Retroperitoneum C48.0
Peritoneum, omentum, and mesentery C45.1*, C48.1-C48.2
Other digestive organs C26.8-C26.9, C48.8
Respiratory System
Nose, nasal cavity, and middle ear C30-C31
Larynx C32
Lung and bronchus C34
Pleura C38.4, C45.0*
Trachea, mediastinum, and 
other despiratory organs C33, C38.1-C38.3, C38.8, C39
Bones and Joints C40-C41
Soft Tissue including Heart C47, C49, C38.0, C45.2*
Skin excluding Basal and Squamous
Melanoma of the skin C43
Other non-epithelial skin C44, C46*
Breast C50
Female Genital System
Cervix uteri C53
Corpus and uterus, NOS
Corpus uteri C54
Uterus, NOS C55
Ovary C56
Vagina C52
Vulva C51
Other female genital organs C57-C58
Cancer Causes of Death ICD–10 Codes
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Male Genital System
Prostate C61
Testis C62
Penis C60
Other male genital organs C63
Urinary System
Urinary bladder C67
Kidney and renal pelvis C64-C65
Ureter C66
Other urinary organs C68
Eye and Orbit C69
Brain and Other Nervous System C70, C71, C72
Endocrine System
Thyroid C73
Other endocrine including thymus C37, C74-C75
Lymphoma
Hodgkin lymphoma C81
Non-Hodgkin lymphoma C82-C85, C96.3
Myeloma C90.0, C90.2
Leukemia
Lymphocytic leukemia
Acute lymphocytic leukemia C91.0
Chronic lymphocytic leukemia C91.1
Other lymphocytic leukemia C91.2-C91.4, C91.7, C91.9
Myeloid and monocytic leukemia
Acute myeloid leukemia C92.0, C92.4-C92.5, C94.0, C94.2
Acute monocytic leukemia C93.0
Chronic myeloid leukemia C92.1
Other myeloid/monocytic leukemia C92.2-C92.3, C92.7, C92.9, C93.1-C93.2, C93.7, C93.9
Other leukemia
Other acute leukemia C94.4, C94.5, C95.0
Aleukemic, subleukemic, and NOS C90.1, C91.5, C94.1, C94.3, C94.7, C95.1, C95.2, C95.7, C95.9
Mesothelioma C45*
Kaposi Sarcoma C46*
Miscellaneous Malignant Cancer C26.1, C45.7*, C45.9*, C76-C80, C88, C96.0-C96.2, C96.7, C96.9, C97
Cancer Causes of Death ICD–10 Codes
* Mesothelioma (C45) and Kaposi sarcoma (C46) can be listed as separate recodes or within site-specific groupings. 
The table contains both possibilities.
NOS = not otherwise specified.
Source: http://seer.cancer.gov/codrecode/1969+_d09172004/index.html.
Table J.3: Death Recodes for Cancer Causes of Death, International
Classification of Diseases, Tenth Edition (ICD–10) (continued)
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Tumors of Neuroepithelial Tissue
Pilocytic astrocytoma 9421
Diffuse astrocytoma 9410, 9420
Anaplastic astrocytoma 9401, 9411
Unique astrocytoma variants 9424
Astrocytoma, NOS 9400
Glioblastoma 9440, 9441, 9442
Oligodendroglioma 9450, 9451, 9460
Ependymoma 9391, 9392, 9393
Mixed glioma 9382
Glioma malignant, NOS 9380
Choroid plexus 9390
Neuroepithelial 9381, 9423, 9430
Neuronal/glial, neuronal 8680, 8693, 9490, 9500, 9505, 9522, 9523
Pineal parenchymal 9362
Embryonal/primitive/medulloblastoma 8963, 9364, 9470, 9471, 9472, 9473, 9474, 9501, 
9502, 9503, 9508
Tumors of Cranial and Spinal Nerves
Nerve sheath, malignant 9540, 9560, 9561, 9571
Tumors of Meninges
Meningioma 9530, 9538, 9539
Other mesenchymal, malignant 8728, 8800, 8801, 8802, 8803, 8804, 8805, 8806, 
8810, 8815, 8830, 8850, 8851, 8857, 8890, 8900, 
8910, 8920, 8990, 9040, 9150, 9180, 9260, 9480
Lymphomas and Hemopoietic Neoplasms
Lymphoma 9590, 9591, 9596, 9650, 9651, 9652, 9653, 9654, 
9655, 9659, 9661, 9662, 9663, 9664, 9665, 9667,
9670, 9671, 9673, 9675, 9680, 9684, 9687, 9690, 
9691, 9695, 9698, 9699, 9701, 9702, 9705, 9714, 
9719, 9727, 9728, 9729, 9731, 9733, 9734, 9740, 
9741, 9750, 9755, 9756, 9757, 9758, 9827, 9861,
9930
Germ Cell Tumors and Cysts
Germ cell tumors, cysts, and heterotopias 8020, 9060, 9061, 9064, 9065, 9070, 9071, 9072, 
9080, 9081, 9082, 9083, 9084, 9085, 9100
Tumors of Sellar Region
8022, 8140, 8246, 8260, 8270, 8272, 8280, 8281, 
8290, 8300, 8323, 8333
Local Extensions from Regional Tumors
Chordoma/chondrosarcoma 9220, 9231, 9240, 9370, 9371, 9372
Unclassified Tumors
Hemangioma 9120, 9130, 9133, 9140
Neoplasm, unspecified 8000, 8001, 8002, 8003, 8004, 8005, 8010, 8013, 
8021
All other 8720, 9580, 9754
Histology ICD–O–3 Histology Code
* As determined by the Consensus Conference on Cancer Registration of Brain and Central Nervous System Tumors.
ICD–O–3 = International Classification of Diseases for Oncology, Third Edition.
NOS = not otherwise specified.
Table J.4: Brain and Other Nervous System Standard Histology Groupings*
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Tables K.1M–K.2
Table K.1M: Population Counts by U.S. Census Region and Division, State and Metropolitan Area, Race and
Ethnicity
Males, 2002
Asian/Pacific American Indian/
Area All Races White Black Islander Alaska Native Hispanic∗
United States 141,533,415 115,812,637 17,951,616 6,236,710 1,532,452 19,849,433
USCS Areas for Incidence† 131,788,741 108,253,411 16,063,722 6,017,739 1,453,869 19,467,547
Northeast 26,230,204 21,576,866 3,276,670 1,259,219 117,449 2,803,356
New England 6,854,849 6,167,741 434,341 224,574 28,193 468,977
Connecticut 1,677,993 1,449,423 170,856 50,941 6,773 171,170
Maine 630,863 616,278 5,429 5,207 3,949 5,246
Massachusetts 3,101,478 2,735,189 214,833 140,821 10,635 229,193
New Hampshire 627,555 608,495 7,097 9,931 2,032 11,563
Rhode Island 514,373 462,666 33,654 14,750 3,303 48,940
Vermont 302,587 295,690 2,472 2,924 1,501 2,865
Middle Atlantic 19,375,355 15,409,125 2,842,329 1,034,645 89,256 2,334,379
New Jersey 4,169,170 3,270,530 604,013 278,927 15,700 615,547
New York 9,241,027 6,936,933 1,618,273 624,669 61,152 1,505,569
Pennsylvania 5,965,158 5,201,662 620,043 131,049 12,404 213,263
Midwest 31,954,685 27,692,280 3,289,266 734,539 238,600 1,799,442
East North Central 22,368,297 19,021,257 2,695,808 537,826 113,406 1,423,225
Illinois 6,172,717 4,985,151 915,041 249,375 23,150 881,961
Indiana 3,025,422 2,714,436 261,595 38,813 10,578 127,728
Michigan 4,931,336 4,079,588 704,089 111,514 36,145 182,848
Detroit‡ 1,965,730 1,409,190 482,440 65,200 8,900 66,822
Ohio 5,548,639 4,795,622 652,562 83,922 16,533 118,077
Wisconsin 2,690,183 2,446,460 162,521 54,202 27,000 112,611
West North Central 9,586,388 8,671,023 593,458 196,713 125,194 376,217
Iowa 1,442,618 1,375,461 38,146 23,631 5,380 48,446
Kansas 1,342,846 1,211,087 86,851 29,498 15,410 109,251
Minnesota 2,491,001 2,266,458 108,363 84,503 31,677 85,572
Missouri 2,762,686 2,393,093 314,132 39,525 15,936 66,960
Nebraska 852,959 792,083 38,155 14,234 8,487 55,571
North Dakota 316,635 295,026 3,381 2,405 15,823 4,349
South Dakota 377,643 337,815 4,430 2,917 32,481 6,068
South 50,615,226 39,412,524 9,580,857 1,181,374 440,471 6,651,090
South Atlantic 26,208,159 19,770,064 5,620,024 671,552 146,519 2,522,189
Delaware 392,132 304,156 76,235 10,024 1,717 22,030
District of Columbia 268,549 102,493 156,471 8,452 1,133 27,278
Florida 8,166,175 6,676,575 1,283,571 167,518 38,511 1,515,686
Georgia 4,213,392 2,910,279 1,180,022 107,282 15,809 297,917
Atlanta‡ 1,502,272 895,290 525,258 75,866 5,858 162,073
Maryland 2,635,979 1,772,249 731,174 122,393 10,163 131,237
North Carolina 4,076,923 3,080,489 868,635 72,689 55,110 257,992
South Carolina 1,995,069 1,383,047 580,734 23,030 8,258 63,980
Virginia 3,580,489 2,700,741 711,808 154,157 13,783 199,495
West Virginia 879,451 840,035 31,374 6,007 2,035 6,574
East South Central 8,381,185 6,591,004 1,670,204 85,935 34,042 193,877
Alabama 2,166,602 1,580,799 553,607 19,485 12,711 48,002
Kentucky 2,002,393 1,821,881 155,885 19,275 5,352 40,231
U
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Table K.1M: Population Counts by U.S. Census Region and Division, State and Metropolitan Area, Race and
Ethnicity (continued)
Males, 2002
Asian/Pacific American Indian/
Area All Races White Black Islander Alaska Native Hispanic∗
Mississippi 1,387,465 870,736 499,036 11,314 6,379 24,413
Tennessee 2,824,725 2,317,588 461,676 35,861 9,600 81,231
West South Central 16,025,882 13,051,456 2,290,629 423,887 259,910 3,935,024
Arkansas 1,323,287 1,092,069 208,039 13,041 10,138 53,467
Louisiana 2,170,522 1,423,852 698,807 33,596 14,267 58,497
Oklahoma 1,719,261 1,391,102 143,055 30,533 154,571 103,504
Texas 10,812,812 9,144,433 1,240,728 346,717 80,934 3,719,556
West 32,733,300 27,130,967 1,804,823 3,061,578 735,932 8,595,545
Mountain 9,546,529 8,621,476 338,308 236,976 349,769 2,036,817
Arizona 2,720,205 2,409,889 102,436 62,214 145,666 761,122
Colorado 2,269,343 2,073,127 105,435 61,327 29,454 428,444
Idaho 673,177 649,254 5,180 8,115 10,628 60,840
Montana 453,738 417,582 2,754 2,832 30,570 9,715
Nevada 1,104,367 949,172 81,432 56,189 17,574 245,193
New Mexico 910,998 782,409 23,764 12,746 92,079 394,451
Utah 1,163,636 1,099,766 14,402 31,872 17,596 119,840
Wyoming 251,065 240,277 2,905 1,681 6,202 17,212
Pacific 23,186,771 18,509,491 1,466,515 2,824,602 386,163 6,558,728
Alaska 331,720 245,535 14,813 15,950 55,422 14,741
California 17,460,820 13,846,159 1,261,297 2,110,727 242,637 6,066,675
San Francisco-Oakland‡ 2,061,224 1,399,168 201,878 443,544 16,634 403,992
San Jose-Monterey‡ 1,218,570 897,539 40,094 267,126 13,811 369,879
Los Angeles‡ 4,833,162 3,680,151 474,702 616,923 61,386 2,265,682
Hawaii 622,212 161,858 21,038 436,913 2,403 44,874
Oregon 1,748,055 1,614,795 39,081 65,466 28,713 171,379
Washington 3,023,964 2,641,144 130,286 195,546 56,988 261,059
Seattle-Puget Sound‡ 2,075,186 1,750,912 113,374 175,257 35,643 129,941
∗ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
† Population estimates for all geographic areas combined that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for data
quality criteria and registry-specific data quality information. Populations covered represent approximately 93% of the U.S. population.
‡ The populations of the metropolitan areas of Detroit, Atlanta, San Francisco-Oakland, San Jose-Monterey, Los Angeles, and Seattle-Puget Sound are shown
separately because these populations have separate metropolitan area Surveillance, Epidemiology, and End Results (SEER) cancer registries. State population
totals include the populations of the SEER metropolitan areas.
Source: Census Bureau population figures, as modified by the SEER program. Available from: http://www.seer.cancer.gov/popdata [accessed 2/15/05].
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Table K.1F: Population Counts by U.S. Census Region and Division, State and Metropolitan Area, Race and
Ethnicity
Females, 2002
Asian/Pacific American Indian/
Area All Races White Black Islander Alaska Native Hispanic∗
United States 146,440,586 118,590,752 19,724,044 6,587,460 1,538,330 18,634,350
USCS Areas for Incidence† 136,275,365 110,830,337 17,634,658 6,350,807 1,459,563 18,322,220
Northeast 27,942,619 22,825,443 3,712,346 1,286,610 118,220 2,817,481
New England 7,279,597 6,550,093 466,757 234,340 28,407 473,195
Connecticut 1,780,595 1,533,680 187,956 52,456 6,503 170,720
Maine 664,034 649,310 4,193 6,300 4,231 5,011
Massachusetts 3,320,322 2,931,364 232,138 146,019 10,801 233,736
New Hampshire 646,854 628,717 5,931 10,364 1,842 10,818
Rhode Island 553,955 500,088 34,556 15,761 3,550 50,091
Vermont 313,837 306,934 1,983 3,440 1,480 2,819
Middle Atlantic 20,663,022 16,275,350 3,245,589 1,052,270 89,813 2,344,286
New Jersey 4,406,082 3,434,059 672,573 284,590 14,860 597,931
New York 9,893,266 7,315,730 1,881,813 633,506 62,217 1,544,621
Pennsylvania 6,363,674 5,525,561 691,203 134,174 12,736 201,734
Midwest 33,144,150 28,531,301 3,617,638 754,604 240,607 1,581,974
East North Central 23,266,678 19,606,388 2,995,789 551,246 113,255 1,258,547
Illinois 6,413,730 5,096,540 1,036,033 258,496 22,661 784,405
Indiana 3,131,491 2,798,805 283,834 38,972 9,880 106,178
Michigan 5,111,885 4,183,747 779,856 111,450 36,832 163,308
Detroit‡ 2,084,636 1,450,879 559,822 64,289 9,646 60,102
Ohio 5,860,062 5,032,887 723,319 87,450 16,406 109,505
Wisconsin 2,749,510 2,494,409 172,747 54,878 27,476 95,151
West North Central 9,877,472 8,924,913 621,849 203,358 127,352 323,427
Iowa 1,493,222 1,428,426 35,384 23,940 5,472 40,420
Kansas 1,368,923 1,238,090 85,445 30,152 15,236 95,271
Minnesota 2,533,790 2,312,764 102,085 86,807 32,134 72,163
Missouri 2,906,859 2,494,694 354,613 41,890 15,662 59,722
Nebraska 874,605 811,877 39,025 14,884 8,819 46,764
North Dakota 317,277 295,907 2,420 2,569 16,381 3,780
South Dakota 382,796 343,155 2,877 3,116 33,648 5,307
South 52,582,778 40,312,724 10,587,616 1,246,674 435,764 6,165,191
South Atlantic 27,355,512 20,264,297 6,228,961 721,477 140,777 2,268,565
Delaware 413,814 316,921 84,582 10,648 1,663 18,999
District of Columbia 300,638 101,278 187,878 10,291 1,191 24,062
Florida 8,525,526 6,925,234 1,378,787 186,222 35,283 1,494,480
Georgia 4,330,613 2,896,951 1,310,304 110,016 13,342 208,517
Atlanta‡ 1,535,166 865,477 589,609 75,251 4,829 111,446
Maryland 2,814,546 1,841,786 831,139 131,441 10,180 120,356
North Carolina 4,228,897 3,125,844 972,052 74,967 56,034 178,913
South Carolina 2,108,701 1,417,875 658,221 24,720 7,885 44,131
Virginia 3,707,340 2,751,968 775,149 166,969 13,254 173,198
West Virginia 925,437 886,440 30,849 6,203 1,945 5,909
East South Central 8,844,062 6,845,817 1,874,078 91,428 32,739 139,930
Alabama 2,312,294 1,644,220 634,571 20,964 12,539 36,890
Kentucky 2,087,429 1,899,857 162,513 20,180 4,879 28,075
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continued
Table K.1F: Population Counts by U.S. Census Region and Division, State and Metropolitan Area, Race and
Ethnicity (continued)
Females, 2002
Asian/Pacific American Indian/
Area All Races White Black Islander Alaska Native Hispanic∗
Mississippi 1,479,268 898,971 561,357 12,373 6,567 17,940
Tennessee 2,965,071 2,402,769 515,637 37,911 8,754 57,025
West South Central 16,383,204 13,202,610 2,484,577 433,769 262,248 3,756,696
Arkansas 1,382,981 1,126,498 232,027 14,129 10,327 42,570
Louisiana 2,305,671 1,476,717 781,890 33,033 14,031 55,430
Oklahoma 1,770,439 1,431,728 146,827 32,007 159,877 88,419
Texas 10,924,113 9,167,667 1,323,833 354,600 78,013 3,570,277
West 32,771,039 26,921,284 1,806,444 3,299,572 743,739 8,069,704
Mountain 9,486,262 8,546,605 314,071 263,120 362,466 1,893,266
Arizona 2,720,920 2,406,200 94,374 67,673 152,673 708,331
Colorado 2,231,708 2,037,856 98,164 67,255 28,433 388,281
Idaho 669,947 646,108 3,871 9,208 10,760 52,770
Montana 456,635 419,923 1,934 3,620 31,158 9,442
Nevada 1,063,088 901,006 79,640 64,993 17,449 214,069
New Mexico 941,046 806,122 22,126 14,745 98,053 400,583
Utah 1,155,153 1,092,336 11,623 33,471 17,723 103,700
Wyoming 247,765 237,054 2,339 2,155 6,217 16,090
Pacific 23,284,777 18,374,679 1,492,373 3,036,452 381,273 6,176,438
Alaska 309,763 224,164 13,608 17,318 54,673 13,601
California 17,541,166 13,723,680 1,312,873 2,266,622 237,991 5,753,393
San Francisco-Oakland‡ 2,103,187 1,382,027 222,508 482,546 16,106 371,398
San Jose-Monterey‡ 1,179,048 863,378 34,203 268,455 13,012 334,212
Los Angeles‡ 4,935,074 3,658,127 541,471 676,473 59,003 2,216,654
Hawaii 618,452 140,263 15,271 460,783 2,135 42,686
Oregon 1,772,300 1,636,635 35,146 71,571 28,948 139,475
Washington 3,043,096 2,649,937 115,475 220,158 57,526 227,283
Seattle-Puget Sound‡ 2,086,562 1,751,785 101,842 197,115 35,820 111,283
∗ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
† Population estimates for all geographic areas combined that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for data
quality criteria and registry-specific data quality information. Populations covered represent approximately 93% of the U.S. population.
‡ The populations of the metropolitan areas of Detroit, Atlanta, San Francisco-Oakland, San Jose-Monterey, Los Angeles, and Seattle-Puget Sound are shown
separately because these populations have separate metropolitan area Surveillance, Epidemiology, and End Results (SEER) cancer registries. State population
totals include the populations of the SEER metropolitan areas.
Source: Census Bureau population figures, as modified by the SEER program. Available from: http://www.seer.cancer.gov/popdata [accessed 2/15/05].
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Table K.2: Population Counts for Ages 0-19, United States, 2002
A. By Sex and Race
Asian/Pacific American Indian/
Sex All Races White Black Islander Alaska Native Hispanic∗
Incidence†
Male 38,673,980 30,396,679 5,982,489 1,757,380 537,432 7,322,013
Female 36,792,474 28,799,481 5,789,225 1,683,119 520,649 6,936,310
Mortality‡
Male 41,500,140 32,424,998 6,685,362 1,821,583 568,197 7,449,792
Female 39,477,251 30,709,298 6,472,958 1,744,612 550,383 7,053,924
B. By Age (years)
0-14 0-19 <1 1-4 5-9 10-14 15-19
Incidence†
All Races, Male and Female 56,528,975 75,466,454 3,726,194 14,512,390 18,621,024 19,669,367 18,937,479
Mortality‡
All Races, Male and Female 60,629,725 80,977,391 4,000,012 15,575,524 19,960,444 21,093,745 20,347,666
∗ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
† Population estimates for all geographic areas combined that meet the data quality criteria for all invasive cancer sites combined. See Appendix I for
data quality criteria and registry-specific data quality information. Populations covered represent approximately 93% of the U.S. population.
‡ Population estimates for entire United States.
Source: Census Bureau population figures, as modified by the SEER program. Available from: http://www.seer.cancer.gov/popdata [accessed 2/15/05].
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Appendix L

Appendix L
L–1
Criteria for Reporting Age-Adjusted Cancer
Incidence Rates for U.S. Census Regions 
and Divisions 
The annual age-adjusted cancer incidence rates for some
U.S. Census regions and divisions are not available
because the data from the cancer registries of some states
in those regions or divisions do not meet the eligibility
criteria for inclusion in this report. In contrast, the annual
age-adjusted cancer death rates are available for all states
in every Census region or division. However, the age-
adjusted incidence rate for Census regions or divisions in
which the data of less than 100% of the cancer registries
meet eligibility criteria can be estimated by assuming 
the following: the incidence-to-mortality ratio for states
without eligible cancer registry data in that Census region
or division equals the incidence-to-mortality ratio for
states with eligible cancer registry data in that Census
region or division.  
Let
M1 = age-adjusted death rate in states with eligible
cancer registries
M0 = age-adjusted death rate in states without eligible
cancer registries
I1 = age-adjusted incidence rate in states with eligible
cancer registries
I0 = age-adjusted incidence rate in states without
eligible cancer registries (incidence data are not
available)
P1 = proportion of the population in the Census region
or division that resides in states with eligible
cancer registries
R =
Îtotal = age-adjusted incidence rate for the entire Census
region or division where “eligible” refers to the
state and metropolitan area cancer registries that
meet this report’s data quality criteria for all inva-
sive cancer sites combined.  
Since we are assuming that                 
,
the estimate of the age-adjusted incidence rate for states
without eligible cancer registries is                              
Thus, an estimate of the age-adjusted incidence rate for
100% of the Census region or division is computed as
the following weighted average:
As an example, consider invasive female breast cancer 
in a hypothetical Census region with seven states.
Incidence data for five states that cover 86.3% of the
population (P1 = 0.863) are eligible for inclusion in the
calculation of the regional incidence rate; data for two
states are not eligible. The female breast cancer death
rate for the five eligible states is 
M1 =          ,      
and the rate for the two ineligible states is 
M0 =          .          
The age-adjusted incidence rate for states with eligible
cancer registries is 
I1 =           .
The age-adjusted incidence rate for female invasive
breast cancer in the entire Census region (i.e., corrected
for the data not available from the ineligible registries) is 
I1
M1
I0
M0
=
M0
M1
I0 = I1 (      ) = I1R.
Îtotal = P1I1 + (1 – P1)I0 = P1I1 + (1 – P1)I1R
= I1 [P1 + (1 – P1)R].
Îtotal =           * [0.863 + 0.137 (        )] =              .
145.1
105
145.39
105
27.7
27.3
27.3
105
27.7
105
145.1
105
M0
M1
The underlying assumptions for this method are that 
the age-adjusted death rates for states with and without
eligible cancer registries are accurate and that the
incidence-to-mortality ratio for states without eligible
cancer registries in that Census region or division equals
the incidence-to-mortality ratio for states with eligible
cancer registries in that Census region or division.
For each Census region or division in which less than
100% of the registries provided data eligible for this
report, we used the above-described method to estimate
the age-adjusted incidence rates (Îtotal ) for the six major
cancer sex-site groups: breast (female only), prostate, male
and female colorectal, and male and female lung and
bronchus. If the estimate of the age-adjusted incidence
rate for each of the six cancer sites for that Census
region or division falls within the confidence interval of
the observed age-adjusted incidence rate for states with
eligible cancer registries, then the observed age-adjusted
incidence rates for all cancer sites are published. If one
or more of the six estimates of age-adjusted incidence
rates falls outside the confidence interval, then the
observed age-adjusted cancer incidence rates are not
reported for that U.S. Census region or division.  
We emphasize, however, that all cancer incidence rates 
in this report (1) are based exclusively on data obtained
from states with eligible cancer registries and (2) are 
not the estimates of the age-adjusted incidence rates
calculated using the methods described in this appendix.  
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List of Abbreviations
ALL acute lymphatic leukemia
CDC Centers for Disease Control and Prevention
CI confidence interval
CNS central nervous system
CTR Certified Tumor Registrar
IARC International Agency for Research on Cancer
IBD intrahepatic bile duct
ICCC International Classification of Childhood Cancer
ICD–9 International Classification of Diseases, Ninth Edition
ICD–O International Classification of Diseases for Oncology
ICD–10 International Classification of Diseases, Tenth Edition
IHS Indian Health Service
KS Kaposi sarcoma
NAACCR North American Association of Central Cancer Registries
NCHS National Center for Health Statistics
NCI National Cancer Institute
NHL non-Hodgkin lymphoma
NIH National Institutes of Health
NOS not otherwise specified
NPCR National Program of Cancer Registries
NVSS National Vital Statistics System
ONS other nervous system
SEER Surveillance, Epidemiology, and End Results
USCS United States Cancer Statistics

